0001558370-24-005326.txt : 20240419 0001558370-24-005326.hdr.sgml : 20240419 20240418215530 ACCESSION NUMBER: 0001558370-24-005326 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 103 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XCel Brands, Inc. CENTRAL INDEX KEY: 0001083220 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 760307819 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37527 FILM NUMBER: 24855486 BUSINESS ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (347) 727-2474 MAIL ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: NETFABRIC HOLDINGS, INC DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: HOUSTON OPERATING CO DATE OF NAME CHANGE: 19990402 10-K 1 xelb-20231231x10k.htm 10-K
1.070.201971163719624669P18YP7YP3Y00010832202023FYfalseP5YP7YP5YP7YP3YP6YP1Y7M27DP8Y6M16DP7M27D0.5000019624860197950530.5P4Y6M0001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMemberxelb:BusinessVentureAgreementMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2023-11-012023-11-300001083220xelb:HalstonBrandMembersrt:MinimumMember2023-05-152023-05-150001083220xelb:HalstonBrandMembersrt:MaximumMember2023-05-152023-05-150001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-312022-05-3100010832202023-10-172023-10-170001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMemberxelb:BusinessVentureAgreementMember2024-04-122024-04-120001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-122024-04-120001083220xelb:OfficeSpaceLeaseMember2023-01-012023-12-310001083220xelb:UnconsolidatedAffiliateMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-12-310001083220xelb:HalstonHeritageMember2022-01-012022-12-3100010832202022-05-272022-05-270001083220xelb:XcelTermLoanMember2021-12-302021-12-300001083220xelb:HalstonBrandMember2023-01-012023-12-310001083220xelb:IsaacMizrahisMember2020-02-242020-02-240001083220xelb:LongabergerQurateAgreementMember2023-01-012023-12-310001083220xelb:LogoQurateAgreementMember2023-01-012023-12-310001083220xelb:CWonderQurateAgreementMember2023-01-012023-12-310001083220xelb:HalstonHeritageMember2019-02-112019-02-110001083220xelb:LoriGoldsteinBrandMember2021-04-012021-04-010001083220us-gaap:SubsequentEventMember2024-02-162024-02-160001083220xelb:LoriGoldsteinBrandMember2023-01-012023-12-310001083220xelb:LoriGoldsteinBrandMember2022-01-012022-12-310001083220xelb:HalstonBrandMember2023-05-152023-05-150001083220xelb:HalstonBrandMember2023-05-150001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2023-01-012023-12-310001083220xelb:ConsultantsMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001083220xelb:ConsultantsMember2023-01-012023-12-310001083220xelb:ConsultantsMemberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001083220xelb:ConsultantsMember2022-01-012022-12-310001083220us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:CommonStockMember2023-01-012023-12-310001083220srt:DirectorMemberus-gaap:CommonStockMember2023-01-012023-12-310001083220srt:DirectorMemberus-gaap:CommonStockMember2022-01-012022-12-310001083220xelb:ConsultantsMemberus-gaap:CommonStockMember2023-01-012023-12-310001083220xelb:ConsultantsMemberus-gaap:CommonStockMember2022-01-012022-12-310001083220us-gaap:CommonStockMember2022-01-012022-12-310001083220us-gaap:RetainedEarningsMember2023-12-310001083220us-gaap:NoncontrollingInterestMember2023-12-310001083220us-gaap:AdditionalPaidInCapitalMember2023-12-310001083220us-gaap:RetainedEarningsMember2022-12-310001083220us-gaap:NoncontrollingInterestMember2022-12-310001083220us-gaap:AdditionalPaidInCapitalMember2022-12-310001083220us-gaap:RetainedEarningsMember2021-12-310001083220us-gaap:NoncontrollingInterestMember2021-12-310001083220us-gaap:AdditionalPaidInCapitalMember2021-12-310001083220us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001083220us-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-12-310001083220us-gaap:RestrictedStockMember2022-05-012022-05-310001083220us-gaap:RestrictedStockMember2022-04-012022-04-300001083220us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:CommonStockMember2022-01-012022-12-310001083220srt:ExecutiveOfficerMemberus-gaap:CommonStockMember2022-01-012022-12-310001083220us-gaap:CommonStockMember2023-12-310001083220us-gaap:CommonStockMember2022-12-310001083220us-gaap:CommonStockMember2021-12-310001083220us-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2024-03-140001083220xelb:NonManagementDirectorsMemberus-gaap:EmployeeStockOptionMember2023-01-012023-12-310001083220us-gaap:PerformanceSharesMember2023-01-012023-12-310001083220us-gaap:PerformanceSharesMemberxelb:TargetPrice5Member2023-12-310001083220us-gaap:PerformanceSharesMemberxelb:TargetPrice4Member2023-12-310001083220us-gaap:PerformanceSharesMemberxelb:TargetPrice3Member2023-12-310001083220us-gaap:PerformanceSharesMemberxelb:TargetPrice2Member2023-12-310001083220us-gaap:PerformanceSharesMemberxelb:TargetPrice1Member2023-12-310001083220us-gaap:PerformanceSharesMember2023-12-310001083220xelb:NonManagementDirectorsMemberus-gaap:EmployeeStockOptionMember2023-04-012023-04-300001083220xelb:ConsultantMemberus-gaap:EmployeeStockOptionMember2022-04-262022-04-260001083220xelb:EmployeeMemberus-gaap:EmployeeStockOptionMember2022-04-202022-04-200001083220srt:ManagementMemberus-gaap:EmployeeStockOptionMember2022-04-202022-04-200001083220us-gaap:EmployeeStockOptionMember2023-12-310001083220srt:MinimumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-12-310001083220srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-12-310001083220srt:MinimumMemberus-gaap:EmployeeStockOptionMember2022-01-012022-12-310001083220srt:MaximumMemberus-gaap:EmployeeStockOptionMember2022-01-012022-12-310001083220us-gaap:WarrantMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-01-012023-12-310001083220us-gaap:WarrantMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-012023-12-310001083220us-gaap:WarrantMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-01-012023-12-310001083220us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-01-012023-12-310001083220us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-012023-12-310001083220us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-01-012023-12-310001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-01-012023-12-310001083220xelb:IsaacMizrahisMemberus-gaap:RestrictedStockMember2022-05-312022-05-310001083220xelb:NonManagementDirectorsMember2023-08-232023-08-230001083220xelb:EmployeeMember2023-07-202023-07-200001083220xelb:ConsultantMember2023-05-152023-05-150001083220xelb:ConsultantMember2023-04-172023-04-170001083220xelb:ConsultantMember2023-01-012023-01-010001083220xelb:IsaacMizrahisMemberxelb:ConsultantMemberus-gaap:RestrictedStockMember2022-05-312022-05-310001083220xelb:EmployeeMember2022-05-312022-05-310001083220xelb:SeniorManagementMemberus-gaap:RestrictedStockMember2022-04-202022-04-200001083220xelb:NonManagementDirectorsMemberus-gaap:RestrictedStockMember2022-04-202022-04-200001083220xelb:ConsultantMemberus-gaap:RestrictedStockMember2022-04-202022-04-200001083220us-gaap:CommonStockMember2023-01-012023-12-310001083220xelb:NonManagementDirectorsMemberus-gaap:CommonStockMemberxelb:ShareBasedPaymentArrangementTrancheSixMember2023-08-232023-08-230001083220xelb:NonManagementDirectorsMemberus-gaap:CommonStockMemberxelb:ShareBasedPaymentArrangementTrancheFourMember2023-08-232023-08-230001083220xelb:NonManagementDirectorsMemberus-gaap:EmployeeStockOptionMember2023-08-232023-08-230001083220xelb:NonManagementDirectorsMemberus-gaap:CommonStockMemberxelb:ShareBasedPaymentArrangementTrancheSixMember2022-04-202022-04-200001083220xelb:NonManagementDirectorsMemberus-gaap:CommonStockMemberxelb:ShareBasedPaymentArrangementTrancheFiveMember2022-04-202022-04-200001083220xelb:NonManagementDirectorsMemberus-gaap:RestrictedStockMember2021-04-202021-04-200001083220us-gaap:ScenarioPlanMember2023-01-012023-12-310001083220xelb:IMTopcoLLCMemberxelb:YearEndingDecember312025Memberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberxelb:TwelveMonthPeriodEndingMarch312025Memberus-gaap:SubsequentEventMember2024-04-120001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2022-12-160001083220srt:MaximumMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2022-05-310001083220xelb:IMTopcoLLCMember2023-11-012023-11-300001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2023-01-012023-12-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-12-310001083220xelb:HalstonBrandMemberus-gaap:LicenseMember2023-01-012023-12-310001083220us-gaap:ProductMember2023-01-012023-12-310001083220us-gaap:LicenseMember2023-01-012023-12-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001083220us-gaap:ProductMember2022-01-012022-12-310001083220us-gaap:LicenseMember2022-01-012022-12-310001083220xelb:IsaacMizrahisMember2022-05-312022-05-310001083220xelb:NewLoanAndSecurityAgreementMember2022-05-312022-05-310001083220us-gaap:RetainedEarningsMember2023-01-012023-12-310001083220us-gaap:NoncontrollingInterestMember2023-01-012023-12-310001083220us-gaap:RetainedEarningsMember2022-01-012022-12-310001083220us-gaap:NoncontrollingInterestMember2022-01-012022-12-310001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-272022-05-270001083220xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-312022-05-310001083220us-gaap:TrademarksMember2022-01-012022-12-310001083220us-gaap:SubsequentEventMemberxelb:PublicOfferingAndPrivatePlacementMember2024-03-152024-03-1500010832202024-03-012024-03-310001083220us-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2024-03-142024-03-140001083220us-gaap:SubsequentEventMemberxelb:PublicOfferingMember2024-03-192024-03-190001083220xelb:OrmeLiveMemberus-gaap:RelatedPartyMember2023-12-042023-12-040001083220xelb:OrmeLiveMember2023-12-012023-12-310001083220xelb:IMTopcoLLCMember2022-05-272022-05-270001083220xelb:NewLoanAndSecurityAgreementMember2021-12-302021-12-300001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2022-05-310001083220xelb:IndefiniteLivedMember2023-12-3100010832202017-12-310001083220srt:RetailSiteMember2022-01-012022-12-310001083220us-gaap:SubsequentEventMember2024-01-262024-01-2600010832202022-01-012023-12-310001083220xelb:IsaacMizrahisMember2023-01-012023-12-310001083220xelb:IsaacMizrahisMember2022-01-012022-12-310001083220xelb:IsaacMizrahisMember2021-01-012021-12-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-11-012023-11-300001083220xelb:HilcoGlobalMemberxelb:LongabergerLicensingLLCMember2023-12-310001083220xelb:OrmeLiveMember2023-12-310001083220xelb:OrmeLiveMembersrt:DirectorMemberus-gaap:RelatedPartyMember2023-12-040001083220xelb:OrmeLiveMemberus-gaap:RelatedPartyMember2023-12-040001083220xelb:IMTopcoLLCMember2022-05-310001083220xelb:IMTopcoLLCMember2022-05-270001083220xelb:UnconsolidatedAffiliateMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-12-310001083220us-gaap:SubsequentEventMember2024-01-120001083220srt:MinimumMemberxelb:OfficeSpaceLeaseMember2023-01-012023-12-310001083220srt:MaximumMemberxelb:OfficeSpaceLeaseMember2023-01-012023-12-310001083220xelb:MainHeadquartersLeaseMember2023-01-012023-12-310001083220us-gaap:SubsequentEventMember2024-01-122024-01-120001083220xelb:XcelTermLoanMember2023-01-012023-12-310001083220xelb:XcelTermLoanMember2022-01-012022-12-3100010832202022-05-312022-05-310001083220xelb:ImTopcoMember2023-01-012023-12-310001083220xelb:ImTopcoMember2022-01-012022-12-310001083220xelb:IMTopcoLLCMember2023-01-012023-12-310001083220xelb:IMTopcoLLCMember2022-01-012022-12-310001083220srt:RetailSiteMember2023-01-012023-12-310001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-01-012022-12-310001083220srt:MinimumMember2023-12-310001083220srt:MaximumMember2023-12-310001083220us-gaap:TrademarksMember2023-12-310001083220us-gaap:IntellectualPropertyMember2023-12-310001083220us-gaap:TrademarksMember2022-12-310001083220us-gaap:IntellectualPropertyMember2022-12-3100010832202022-05-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMember2023-12-310001083220xelb:IMTopcoLLCMember2023-12-310001083220xelb:IMTopcoLLCMember2022-05-310001083220xelb:IMTopcoLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-270001083220us-gaap:EmployeeStockOptionMember2022-12-310001083220xelb:SeniorManagementMember2022-04-200001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-270001083220us-gaap:SwapMember2023-10-190001083220xelb:IsraelDiscountBankOfNewYorkMemberus-gaap:SwapMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-190001083220xelb:HalstonBrandMember2023-12-310001083220xelb:NewLoanAndSecurityAgreementMember2023-10-192023-10-190001083220xelb:NewLoanAndSecurityAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-190001083220xelb:NewLoanAndSecurityAgreementMemberxelb:LiborLondonInterbankOfferedRateMember2021-12-300001083220xelb:XcelTermLoanMember2023-12-310001083220xelb:XcelTermLoanMember2022-12-310001083220xelb:NewLoanAndSecurityAgreementMember2021-12-300001083220xelb:NewLoanAndSecurityAgreementMember2023-12-3100010832202023-10-310001083220xelb:NewLoanAndSecurityAgreementMember2023-10-190001083220xelb:IsaacMizrahisMemberxelb:LaughClubAnnualFeeMemberus-gaap:RelatedPartyMember2022-02-242022-02-240001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-12-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-12-310001083220xelb:HalstonBrandMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-12-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001083220us-gaap:SubsequentEventMemberxelb:PublicOfferingMember2024-03-150001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-150001083220us-gaap:RestrictedStockMember2022-12-310001083220srt:ExecutiveVicePresidentMemberus-gaap:SubsequentEventMemberxelb:PublicOfferingMember2024-03-150001083220srt:DirectorMemberus-gaap:SubsequentEventMemberxelb:PublicOfferingMember2024-03-150001083220srt:ChiefExecutiveOfficerMemberus-gaap:SubsequentEventMemberxelb:PublicOfferingMember2024-03-150001083220us-gaap:SubsequentEventMemberxelb:PublicOfferingAndPrivatePlacementMember2024-03-150001083220xelb:AgreementsMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:ExecutiveVicePresidentMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:DirectorMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:ChiefExecutiveOfficerMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2024-03-140001083220us-gaap:RestrictedStockMember2023-12-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2021Member2023-12-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2011Member2023-12-310001083220xelb:EquityIncentivePlan2021Member2023-12-310001083220xelb:EquityIncentivePlan2021Member2022-12-310001083220us-gaap:WarrantMember2023-12-310001083220us-gaap:WarrantMember2022-12-310001083220us-gaap:WarrantMemberus-gaap:SubsequentEventMember2024-03-190001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-1500010832202021-12-310001083220xelb:LoriGoldsteinBrandMember2023-12-310001083220xelb:LoriGoldsteinBrandMember2022-12-310001083220xelb:OfficeSpaceLeaseMember2023-12-310001083220us-gaap:WarrantMember2023-01-012023-12-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001083220us-gaap:WarrantMember2022-01-012022-12-310001083220us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001083220xelb:EmployeeMember2023-01-012023-12-310001083220xelb:DirectorAndConsultantsMember2023-01-012023-12-310001083220us-gaap:WarrantMember2023-01-012023-12-310001083220us-gaap:RestrictedStockMember2023-01-012023-12-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001083220xelb:NonManagementDirectorsMember2022-01-012022-12-310001083220xelb:EmployeeMember2022-01-012022-12-310001083220us-gaap:WarrantMember2022-01-012022-12-310001083220us-gaap:RestrictedStockMember2022-01-012022-12-310001083220us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001083220us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001083220us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-3100010832202022-01-012022-12-310001083220us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001083220srt:ExecutiveOfficerMemberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001083220us-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001083220srt:ExecutiveOfficerMember2022-01-012022-12-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-12-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-12-3100010832202023-12-3100010832202022-12-3100010832202023-10-012023-12-3100010832202023-06-3000010832202024-04-0300010832202023-01-012023-12-31xbrli:sharesiso4217:USDutr:sqftiso4217:USDxbrli:sharesxbrli:purexelb:itemxelb:Y

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2023

OR

  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-37527

XCEL BRANDS, INC.

(Exact name of Registrant as specified in its charter)

Delaware

    

76-0307819

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

550 Seventh Avenue, 11th Floor, New York, NY 10018

(Address of Principal Executive Offices)

(347) 727-2474

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, $0.001 par value per share

XELB

NASDAQ Capital Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     Yes         No     

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.     Yes         No     

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes         No     

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes         No     

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer    

    

Accelerated filer    

Non-accelerated filer    

Smaller reporting company    

Emerging growth company    

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.     

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.      

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).     

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes         No     

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter was $17,934,000 based upon the closing price of such common stock on June 30, 2023.

The number of shares of the issuer’s common stock issued and outstanding as of April 3, 2024 was 23,492,117 shares.

Documents Incorporated By Reference: None

TABLE OF CONTENTS

    

Page

PART I

Item 1

Business

4

Item 1A

Risk Factors

13

Item 1B

Unresolved Staff Comments

33

Item 1C

Cybersecurity

33

Item 2

Properties

33

Item 3

Legal Proceedings

34

Item 4

Mine Safety Disclosures

34

PART II

Item 5

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

34

Item 6

[Reserved]

36

Item 7

Management’s Discussion and Analysis of Financial Condition and Results of Operations

36

Item 7A

Quantitative and Qualitative Disclosures About Market Risk

50

Item 8

Financial Statements and Supplementary Data

51

Item 9

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

90

Item 9A

Controls and Procedures

90

Item 9B

Other Information

91

Item 9C

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

91

PART III

Item 10

Directors, Executive Officers and Corporate Governance

91

Item 11

Executive Compensation

99

Item 12

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

102

Item 13

Certain Relationships and Related Transactions, and Director Independence

104

Item 14

Principal Accountant Fees and Services

106

PART IV

Item 15

Exhibit and Financial Statement Schedules

107

Signatures

110

2

PART I

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. All statements other than statements of historical fact contained in this Annual Report, including statements regarding future events, our future financial performance, business strategy, and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “ongoing,” “could,” “estimates,” “expects,” “intends,” “may,” “appears,” “suggests,” “future,” “likely,” “goal,” “plans,” “potential,” “projects,” “predicts,” “seeks,” “should,” “would,” “guidance,” “confident,” or “will” or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans, and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates, and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors, including, without limitation, the risks outlined under “Risk Factors” or elsewhere in this Annual Report, as well as adverse effects on us, our licensees, and customers due to natural disasters, pandemic disease, and other unexpected events, which may cause our or our industry’s actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements. You should not place undue reliance on any forward-looking statements. Except as expressly required by the federal securities laws, we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events, changed circumstances, or any other reason.

The "LOGO by Lori Goldstein," "Halston," "Halston Heritage," "H by Halston®," "H Halston," "Roy Frowick," "Judith Ripka LTD," "Judith Ripka Collection," "Judith Ripka Legacy," "Judith Ripka®,” "Judith Ripka Sterling," "C. Wonder," "C. Wonder Limited," and “TowerHill by Christie Brinkley” brands and all related logos and other trademarks or service marks of the Company appearing in this Annual Report are the property of the Company. Brands and all related logos and other trademarks or service marks of other entities (for example, QVC, HSN, JTV, etc.) are the property of those respective entities.

3

Item 1.   Business

Overview

Xcel Brands, Inc. (the “Company,” “Xcel,” “We,” “Us,” or “Our”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce. Currently, our brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands, including:

the Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand, which are wholly owned by the Company;
the Longaberger Brand, which we manage through our 50% ownership interest in Longaberger Licensing, LLC, and the CB Brand, which is a co-owned brand between Xcel and Christie Brinkley; and
the Isaac Mizrahi Brand, which we wholly owned and managed through May 31, 2022. On May 31, 2022, we sold a majority interest in the brand to a third party, but retained a 30% noncontrolling interest in the brand and continue to contribute to the operations of the brand through a service agreement.

We also own a 30% interest in ORME Live Inc. (“ORME”), a short-form video and social commerce marketplace that launched in the first quarter of 2024.

Xcel continues to pioneer a true omni-channel and social commerce sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. Our brands have generated over $5 billion in retail sales via live streaming in interactive television and digital channels alone, and our brands collectively reach over 5 million social media followers through Facebook, Instagram, and TikTok. All of the followers may not be unique followers, as many followers may follow multiple brands and follow our brands on multiple platforms.

Our objective is to build a diversified portfolio of lifestyle consumer products brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

distribution and/or licensing our brands for sale through interactive television (e.g., QVC, HSN, The Shopping Channel, JTV, etc.);
licensing of our brands to retailers that sell to the end consumer;
direct-to-consumer distribution of our brands through e-commerce and live streaming;
licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels; and
acquiring additional consumer brands and integrating them into our operating platform, and leveraging our operating infrastructure and distribution relationships.

4

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

our management team, including our officers’ and directors’ experience in, and relationships within the industry;
our deep knowledge, expertise, and proprietary technology in live streaming and social commerce;
our design, sales, marketing, and technology platform that enables us to design trend-right product; and
our significant media and digital presence.

Recent Developments

Prior to 2023, the Company engaged in certain wholesale and direct-to-consumer sales of products under its brands. In 2023, we signed master license agreements for our Halston Brand and Judith Ripka Brand, and license agreements for the supply of products under certain on our brands to HSN, that enabled us to outsource a majority of our wholesale and direct-to-consumer operations and revert to a working capital light business model. In addition to licensing out the brands described above, we outsourced the operations of Longaberger through a license agreement with a third party to operate and manage the Longaberger e-commerce website in the fourth quarter of 2023, and have recently launched Longaberger on ORME in early 2024.

Company History and Corporate Information

The Company was incorporated on August 31, 1989 in the State of Delaware under the name Houston Operating Company. On April 19, 2005, we changed our name to NetFabric Holdings, Inc. On September 29, 2011, Xcel Brands, Inc., a privately-held Delaware corporation (which we refer to as Old Xcel), Netfabric Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Company, and certain stockholders of the Company entered into an agreement of merger and plan of reorganization pursuant to which Netfabric Acquisition Corp. was merged with and into Old Xcel, with Old Xcel surviving as a wholly owned subsidiary of the Company. On September 29, 2011, we changed our name to Xcel Brands, Inc.

Our principal office is currently located at 550 Seventh Avenue, 11th Floor, New York, NY 10018.

Our telephone number is (347) 727-2474.

Our corporate website is www.xcelbrands.com. Additionally, we maintain websites for our respective brands at www.lorigoldstein.com, www.halston.com, www.judithripka.com, www.cwonder.com, www.longaberger.com, and www.isaacmizrahi.com. None of the content on our websites is incorporated by reference into this Annual Report on Form 10-K.

Our Brand Portfolio

Currently, our brand portfolio consists of the Lori Goldstein, Halston, Judith Ripka, C Wonder, Longaberger, CB, and Isaac Mizrahi Brands, and other proprietary brands, including the various labels under these brands.

Lori Goldstein

Lori Goldstein helped the fashion industry recognize the value and influence of a visionary stylist by telling powerful, transformative, and authentic stories through the static image. After 35 years behind the camera, Lori ventured in front of it in 2009 when she launched LOGO by Lori Goldstein, an exclusive collection for QVC. LOGO was born from Lori's lifelong passion for layering clothes and her "anything goes with everything" approach to fashion, and is a sophisticated lifestyle brand that embraces Lori's aesthetic and speaks to everyday women. LOGO draws inspiration from the beauty of women of all ages and sizes and gives them the tools and fashion pieces to be their most fabulous selves. We acquired the

5

Lori Goldstein brands, including LOGO by Lori Goldstein, in April 2021, and the brand is currently available through the QVC channel.

Halston

The Halston brand was founded by Roy Halston Frowick in the 1960s, and quickly became one of the most important American fashion brands in the world, becoming synonymous with glamour, sophistication, and femininity. Halston’s groundbreaking designs and visionary style still influence designers around the world today. We acquired the H Halston brands in December 2014, and since our acquisition of the Halston Heritage brands in February 2019, we own all Halston labels under our brands. The brand is available across various distribution channels – including premium and better department stores, e-commerce, interactive television, and national specialty retailers – through our long-term master license agreement with G-III Apparel Group.

Judith Ripka

Judith Ripka is a luxury jewelry brand founded by Judith Ripka in 1977. This brand has become known worldwide for its distinctive designs featuring intricate metalwork, vibrant colors, and distinctive use of texture. The Judith Ripka Fine Jewelry collection consists of pieces in 18 karat gold and sterling silver with precious colored jewels and diamonds, and is currently available in fine jewelry stores, luxury retailers, and via e-commerce. We acquired the Ripka brand in April 2014. In 2017 and 2018, we launched our Judith Ripka Fine Jewelry e-commerce operations and wholesale operations; these businesses were subsequently licensed to JTV in the first quarter of 2023. In 2021, we opened a retail store for Judith Ripka Fine Jewelry in Westchester, New York, which was subsequently closed in 2022.

C Wonder

The C Wonder brand was founded by J. Christopher Burch in 2011. This brand is built upon a foundation of bold, vibrant colors and exceptional, eye-catching prints that celebrate the art of everyday dressing. C Wonder offers women’s clothing, footwear, jewelry and accessories, and delightful surprises at every turn. We acquired the C Wonder Brand in July 2015. The brand is currently available through HSN.

Longaberger

Longaberger is an iconic American heritage home and collectibles brand that began making baskets in 1896 and launched a direct sales company in 1973 by the Longaberger family. The brand is best known for its distinctive handwoven baskets. We acquired a 50% ownership interest in this brand through a business venture with Hilco Global in November 2019, and are actively managing this brand to build on its history and bring it into the future as a digital first live-streaming and social commerce business. We launched our Longaberger e-commerce and live-streaming operations in February 2020. In the fourth quarter of 2023, we outsourced the operations and management of the brand’s e-commerce business to a third party.

TowerHill by Christie Brinkley

TowerHill by Christie Brinkley is a new brand announced December 2023 as a co-branded collaboration between Xcel Brands, Inc. and Christie Lee Brinkley, an iconic American supermodel with over one million followers on social media. The brand is scheduled to launch in May 2024 on HSN, with plans to license and launch products outside of HSN starting in 2025.

Isaac Mizrahi

Isaac Mizrahi is an iconic American brand that stands for timeless, cosmopolitan style. Isaac Mizrahi, the designer, launched his eponymous label in 1987 to critical acclaim, including four Council of Fashion Designers of America (CFDA) awards. Since then, this brand has become known and beloved around the world for its colorful and stylish designs. As a true lifestyle brand, under Xcel’s ownership it has expanded into over 150 different product categories including sportswear, footwear, handbags, watches, eyewear, tech accessories, home, and other merchandise. The brand is available across various distribution channels to reach customers wherever they shop: better department stores, such as Saks and

6

Hudson’s Bay; interactive television, including QVC and The Shopping Channel; and national specialty retailers. The brand is also sold in various global locations, including Canada, Italy, the United Kingdom, and Japan. We acquired the Isaac Mizrahi brand in September 2011, and in May 2022, we sold a majority interest in the brand to a third party, retaining a 30% noncontrolling interest in the brand.

Growth Strategy

We plan to continue to grow our brands and business through three primary strategies:

organic growth in our existing brands;
developing new brands that are well positioned in social commerce; and
the acquisition of brands and businesses that fit our long-term strategy.

With respect to organic growth in our existing brands, we have recently entered into master license agreements for our Halston Brand and Judith Ripka Brand. The Halston master license agreement is with G-III Apparel Group (“G-III”), which is a publicly traded company and one of the largest designers and suppliers of wholesale apparel and accessories in the world, with annual revenues of over $3 billion. While the license provides for guaranteed minimum royalties to us during the term (which extends for 25 years, including an initial term of five years plus renewal options), G-III is expected to launch the brand through its existing distribution channels in Fall 2024, and we expect that the business and corresponding royalty revenues to Xcel will ramp up beginning with the launch. Additionally, we entered into an interactive television license and an e-commerce license in 2023 with America’s Collectible Network, Inc., d/b/a JTV, for our Judith Ripka Brand, which officially launched on JTV’s television channel in October 2023 and which we expect to continue to ramp up in 2024 and beyond, as JTV has expressed plans to make Judith Ripka one of the core brands on its network. Finally, the C Wonder Brand launched on HSN in mid-2023, and performed extremely well in its launch year. HSN has advised us that it has planned increases in the business in 2024, which we expect will result in increased revenues from the brand in 2024 and beyond. We are also working on licensing other categories under the C Wonder Brand for distribution both on HSN and outside of the network.

TowerHill by Christie Brinkley is a brand that we are scheduled to launch in May 2024 on HSN, and with plans to license and launch products outside of HSN starting in 2025. While this is a new brand for Xcel, it is an example of a brand that we developed with low up-front costs and that we were able to leverage our unique experience, relationships, and social commerce knowledge to launch. We are excited about launching this brand with Christie Brinkley, and expect to launch at least one other similarly-developed brand later in 2024.

We have a proven track record of acquiring brands and/or businesses that are strategically important to and synergistic with our business, and are consistently reviewing potential acquisition targets. Potential acquisitions may include established or newer brands that do or would perform well in live streaming or social commerce, direct-to-consumer brands or platforms with significant consumer following, or established media companies which could benefit from our expertise in direct-response television, live streaming, and social commerce. While our strategy is not dependent on such acquisitions, we carefully consider potential acquisitions as a means to leverage our infrastructure and expertise and accelerate our growth.

Finally, in December 2023, Xcel acquired a 30% interest in ORME, which is a brand new short-form video social commerce marketplace that launched in the first quarter of 2024. While we will not consolidate ORME’s financial results of operations with our own (given our minority noncontrolling position in the company) and do not anticipate receiving regular dividends or other distributions from ORME in the near future, we believe that ORME has significant growth potential and would add significant value to Xcel, both through our equity interest in ORME as well as our ability to leverage ORME in order to grow additional direct-to-consumer brands that would perform well in social commerce pursuant to our aforementioned brand development and acquisition strategies. ORME licenses the technology utilized by its marketplace from KonnectBio Inc., of which Robert D’Loren, our Chairman of the Board, Chief Executive Officer, and President, owns an approximate 20% noncontrolling interest.

7

Licensing

Our working-capital-light “licensing plus” business model allows us to focus on our core competencies of design, marketing, and brand management without the investment requirements in inventory associated with traditional consumer product companies.

Qurate Agreements

Qurate Retail Group (“Qurate”) is an important strategic partner in our interactive television business, and is the largest licensee for the Lori Goldstein, C Wonder, and Isaac Mizrahi brands. Qurate’s business model is to promote and sell products through its interactive television programs featured on QVC and HSN and related e-commerce and mobile platforms. We employ and manage on-air spokespersons under each of these brands in order to promote products under our brands on QVC and HSN. Qurate’s programming currently reaches over 200 million homes worldwide. Our agreements with Qurate allow our on-air spokespersons to promote our non-Qurate product lines and certain strategic partnerships through QVC’s and HSN’s programs, subject to certain parameters including, in certain cases, the payment of a portion of our non-Qurate revenues to Qurate. We believe that our ability to continue to leverage Qurate’s media platform, reach, and attractive customer base to cross-promote products in and drive traffic to our other channels of distribution provides us a unique advantage.

Through our wholly owned subsidiaries, we have entered into direct-to-retail license agreements with Qurate, collectively referred to as the Qurate Agreements (individually, each a “Qurate Agreement”), pursuant to which we design, and Qurate sources and sells, various products under our LOGO by Lori Goldstein brand, the Longaberger brand, and the C Wonder brand. We were also previously party to similar agreements with Qurate related to the IsaacMizrahiLIVE brand and the Judith Ripka brand. Qurate owns the rights to all designs produced under these agreements, and the agreements include the sale of products across various categories through Qurate’s television media and related internet sites.

Pursuant to these agreements, we have granted to Qurate and its affiliates the exclusive, worldwide right to promote our branded products, and the right to use and publish the related trademarks, service marks, copyrights, designs, logos, and other intellectual property rights owned, used, licensed and/or developed by us, for varying terms as set forth below. In connection with the Qurate Agreements and during the same periods, Qurate and its subsidiaries have the exclusive, worldwide right to use the names, likenesses, images, voices, and performances of our spokespersons to promote the respective products.

Xcel Commenced

Qurate

Agreement

    

Current Term Expiry

    

Automatic Renewal

    

Brand with Qurate

    

Product Launch

LOGO Qurate Agreement (QVC)

November 1, 2024

one-year period

April 2021

2009

Longaberger Qurate Agreement (QVC)

October 31, 2025

 

two-year period

 

November 2019

 

2019

C Wonder Qurate Agreement (HSN)

December 31, 2024

two-year period

March 2023

2023

On May 31, 2022, in connection with our sale of a majority interest in the Isaac Mizrahi brand to a third party, the agreement with Qurate related to the IsaacMizrahiLIVE brand was assigned to IM Topco, LLC.
On August 30, 2022, Qurate and Xcel amended the licensing agreement for the Judith Ripka brand to terminate the license period effective December 31, 2021. Effective January 1, 2022, the agreement entered a sell-off period, under which Qurate was allowed to continue to license the Ripka brand on a non-exclusive basis for as long as necessary to sell off any of its remaining inventory. The sell-off period ended in 2023.

Under the Qurate Agreements, Qurate is obligated to make payments to us on a quarterly basis, based upon the net retail sales of the specified branded products. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes.

The Qurate Agreements generally prohibit us from selling products under the specified respective brands to a direct competitor of Qurate without Qurate’s consent. Under certain of the Qurate Agreements, we may, with the permission of

8

Qurate, sell the respective branded products via certain specified sales channels in exchange for making reverse royalty payments to Qurate based on the net retail sales of such products through such channels. However, we are generally restricted from selling products under the specified respective brands or trademarks to certain mass merchants.

Also, under certain of the Qurate Agreements, we may be required for a period of time to pay a royalty participation fee to Qurate on revenue earned from the sale, license, consignment, or any other form of distribution of any products, bearing, marketed in connection with, or otherwise associated with the specified trademarks and brands.

For the years ended December 31, 2023 and 2022, net licensing revenue from Qurate collectively accounted for approximately 34% and 44%, respectively, of the total net revenue of the Company.

Halston Master License

On May 15, 2023, the Company, through our wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III (as licensee) for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company (including certain guaranteed minimum royalties), includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.44 million of deferred revenue contract liabilities on its consolidated balance sheet as of December 31, 2023 related to this contract, of which $0.89 million was classified as a current liability and $3.55 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue through December 31, 2028.

For the year ended December 31, 2023, net licensing revenue from the Halston Master License accounted for approximately 9% of the total net revenue of the Company.

Other Licensing Agreements

We have entered into numerous other licensing agreements for sales and distribution through e-commerce and traditional brick-and-mortar retailers. Authorized distribution channels include department stores, mass merchant retailers, clubs, and national specialty retailers. Under our other licenses, a supplier is granted rights, typically on an exclusive basis, to a single or small group of related product categories for sale to multiple accounts within an approved channel of distribution and territory. Our other license agreements typically provide the licensee with the exclusive rights for a certain product category in a specified territory and/or distribution channel under a specific brand or brands. Our other license agreements cover various categories, including but not limited to women’s apparel, footwear, and accessories; bath and body; jewelry; home products; men’s apparel and accessories; children’s and infant apparel, footwear, and accessories; and electronics cases and accessories. The terms of the agreements generally range from three to six years with renewal options.

We are in discussions with other potential licensees and strategic partners to license and/or co-brand our brand portfolio for additional categories. In certain cases, we have engaged licensing agents to assist in the procurement of such licenses for which we or our licensees pay such agents’ fees based upon a percentage of the net sales of licensed products by such licensees, or a percentage of the royalty payments that we receive from such licensees. While many of the new and proposed licensing agreements will likely require us to provide seasonal design services, most of our new and prospective licensing partners have their own design staff, and we therefore expect low incremental overhead costs related to expanding

9

our licensing business. We will endeavor, where possible, to require licensees to provide guaranteed minimum royalties under their license agreements.

Our licensees currently sell our branded licensed products through brick-and-mortar retailers, e-commerce, and in certain cases supply products to interactive television companies for sale through their television programs and/or through their internet websites. We generally recognize revenues from our other licenses based on a percentage of the sales of products under our brands, but excluding (i) sales of products to interactive television networks, where we receive a retail royalty directly from the interactive television licensee, and (ii) sales of products through e-commerce sites operated by us. Additionally, based upon guaranteed minimum royalty provisions required under many of the license agreements, we are able to recognize revenue related to certain other licenses based on the greater of the sales-based royalty or the guaranteed minimum royalty.

Collaborations

In certain cases, the Company collaborates with and provides promotional services to other brands or companies, which arrangements may include the use of our brands for the promotion of such company or brands through the internet, television, or other digital content, print media, or other marketing campaigns featuring in-person appearances by our celebrity spokespersons, the development of limited collections of products (which may include co-branded products) for such company, or other services as determined on a case-by-case basis. These have included promotions with Sesame Street, Crayola, Hewlett Packard, Revlon, Johnson & Johnson, and Kleenex.

We also provide certain technology services to our retail partners and certain of our licensees under our proprietary integrated technology platform.

Marketing

Marketing is a critical element to maximize brand value to our licensees and our Company. We employ live streaming, social media, and other marketing and public relations support for our brands.

Given our true omni-channel retail sales strategy focusing on the sale of branded products through various distribution channels (including live-streaming, e-commerce, interactive television, and traditional brick-and-mortar sales channels), our marketing efforts currently focus on leveraging micro and mega-influencers, entertainment tie-ins, PR and editorial, social media campaigns, personal appearances, and digital content in order to drive retail sales of product and consumer awareness across our various sales distribution channels. We seek to create the intersection where shopping, entertainment, and social media meet. As such, our marketing is currently conducted primarily through live-streaming and social media, videos, images, and other digital content that are all updated regularly and are amplified by micro and mega-influencers and entertainment tie-ins. Our efforts also include promoting namesakes of our brands and our personalities through various media including live-streaming, television, design for performances, and other events. We also work with our retail partners to leverage their marketing resources, including e-commerce platforms and related digital marketing campaigns, social media platforms, direct mail pieces, and public relations efforts.

We also market the Lori Goldstein brand through www.lorigoldstein.com, the Halston Brand through www.halston.com, the Judith Ripka brand through www.judithripka.com, the C Wonder brand through www.cwonder.com, and the Longaberger brand through www.longaberger.com. Through our websites, we are able to present the products under our brands to customers with branding that reflects each brand’s heritage and unique point of view.

10

Competition

Each of our current brands has and any future acquired brand will likely have many competitors within each of its specific distribution channels that span a broad variety of product categories, including the apparel, footwear, accessories, jewelry, home furnishings and décor, food products, and sporting goods industries. These competitors have the ability to compete with the Company and our licensees in terms of fashion, quality, price, products, and/or marketing, and ultimately retail floor space and consumer spending.

Because many of our competitors have significantly greater cash, revenues, and resources than we do, we must work to differentiate ourselves from our direct and indirect competitors to successfully compete for market share with the brands we own and for future acquisitions. We believe that the following factors help differentiate our Company in an increasingly crowded competitive landscape:

our management team, including our officers’ and directors’ historical track records and relationships within the industry;
our brand management platform, which has a strong focus on design, product, marketing, and technology; and
our operating strategies of licensing brands with significant media presence and driving sales through our true omni-channel retail sales strategy across interactive television, live streaming, and e-commerce distribution channels.

We expect our existing and future licenses to relate to products in the apparel, footwear, accessories, jewelry, home goods, and other consumer products industries, in which our licensees face intense competition, including from our other brands and licensees. In general, competitive factors include quality, price, style, name recognition, and service. In addition, various fashion trends and the limited availability of shelf space could affect competition for our licensees’ products. Many of our licensees’ competitors have greater financial, distribution, marketing, and other resources than our licensees and have achieved significant name recognition for their brand names. Our licensees may be unable to successfully compete in the markets for their products, and we may not be able to continue to compete successfully with respect to our licensing arrangements.

Trademarks

The Company, through its wholly owned subsidiaries, owns and exploits the Lori Goldstein brands, which include the trademarks and brands LOGO by Lori Goldstein, LOGO, LOGO Links, LOGO Lounge, LOGO Layers, and LOGO Luna; the Halston brands, which include the trademarks and brands Halston, Halston Heritage, Roy Frowick, H by Halston, and H Halston; the Ripka brands, which include the trademarks and brands Judith Ripka LTD, Judith Ripka Collection, Judith Ripka Legacy, Judith Ripka, and Judith Ripka Sterling; and the C Wonder brands, which include the trademarks and brands C Wonder and C Wonder Limited. We manage and have a 50% ownership interest in the brands and trademarks of the Longaberger brand through our business venture with Hilco Global. We also have a 30% ownership interest in IM Topco, which owns the Mizrahi brands, including the trademarks and brands Isaac Mizrahi, Isaac Mizrahi New York, IMNYC Isaac Mizrahi, and IsaacMizrahiLIVE.

Where laws limit our ability to record in our name trademarks that we have purchased, we have obtained by way of license all necessary rights to operate our business. Certain of these trademarks and associated marks are registered or pending registration with the U.S. Patent and Trademark Office in block letter and/or logo formats, as well as in combination with a variety of ancillary designs for use in connection with a variety of product categories, such as apparel, footwear and various other goods and services including, in some cases, home furnishings and decor. The Company intends to renew and maintain registrations as appropriate prior to expiration and it makes efforts to diligently prosecute all pending applications consistent with the Company’s business goals. In addition, the Company registers its trademarks in certain other countries and regions around the world as it deems appropriate.

The Company and its licensees do not presently earn a material amount of revenue from either the licensing of our trademarks internationally or the sale of products under our trademarks internationally. However, the Company has

11

registered its trademarks in certain territories where it expects that it may do business in the foreseeable future. If the Company or a licensee intends to make use of the trademarks in international territories, the Company will seek to register its trademarks in such international territories as it deems appropriate based upon factors including the revenue potential, prospective market, and trademark laws in such territory or territories.

Generally, the Company is primarily responsible for monitoring and protecting its trademarks around the world. The Company seeks to require its licensing partners to advise the Company of any violations of its trademark rights of which its licensing partners become aware and relies primarily upon a combination of federal, state, and local laws, as well as contractual restrictions to protect its intellectual property rights both domestically and internationally.

Human Capital

Our employees’ knowledge, social, and personality attributes enable our company to achieve its goals, develop our business, and remain innovative. As of December 31, 2023, we had 34 full-time employees and 2 part-time employees. We value our employees and are committed to providing a healthy and safe work environment. For certain key employees, including our executives, brand ambassadors, and spokespersons, we typically enter into multi-year employment agreements. Overall, we believe that our relationship with our employees is good. None of our employees are represented by a labor union.

Government Regulation

We are subject to federal, state, and local laws and regulations affecting our business, including those promulgated under the Occupational Safety and Health Act, the Consumer Product Safety Act, the Flammable Fabrics Act, the Textile Fiber Product Identification Act, the rules and regulations of the Consumer Product Safety Commission, and various environmental laws and regulations. We believe that we are in compliance in all material respects with all applicable governmental regulations.

12

Item 1A.   Risk Factors

In addition to the other information contained herein or incorporated herein by reference, the risks and uncertainties and other factors described below could have a material adverse effect on our business, financial condition, results of operations and share price and could also cause our future business, financial condition and results of operations to differ materially from the results contemplated by any forward-looking statement we may make herein, in any other document we file with the Securities and Exchange Commission (“SEC”), or in any press release or other written or oral statement we may make. Please also see “Forward-Looking Statements” on page 3 for additional information regarding Forward-Looking Statements.

Summary of Risk Factors

Our business is subject to a number of risks, which include, but are not limited to, risks related to:

our limited amount of cash;
our concentration of revenue with a limited number of licensees;
restrictions related to certain key licensing agreements;
conducting operations through joint ventures and our dependence on the joint ventures;
our dependency upon our spokespersons;
the operational performance and/or strategic initiatives of our licensees and retail partners;
continued market acceptance of our brands and products;
the use of social media and influencers to market brands and products;
changing consumer preferences and shifting industry trends;
execution of our growth strategy, including the acquisition of new brands;
our dependency on our Chief Executive Officer and other key executives;
intense competition in the apparel, fashion, and jewelry industries, and within our licensees’ markets; and
protection of our trademarks and other intellectual property rights.

An investment in our securities is subject to a number of risks, which include, but are not limited to, risks related to:

management’s significant control over matters requiring shareholder approval;
potential difficulty in liquidating an investment in shares of our common stock;
the potential impact of SEC “penny stock” rules on trading of our shares of our common stock;
declines of and volatility in the market price of our common stock;
the potential issuance of a substantial number of shares of common stock upon exercise of warrants and options;

13

the potential impact of Rule 144 restrictions on our shares of common stock as a former shell company;
our intent to not pay any cash dividends for the foreseeable future; and
provisions of our corporate charter documents which could delay or prevent change of control.

We are also subject to general risks, which include, but are not limited to, risks related to:

a pandemic or outbreak of disease or similar public health threat, or fear of such an event;
supply chain disruptions;
the Ukrainian-Russian conflict;
a decline in general economic conditions or consumer spending levels;
inflation and/or a potential recession;
extreme or unseasonable weather conditions;
potential impairment of our trademarks and other intangible assets under accounting guidelines;
changes in our effective tax rates or adverse outcomes resulting from examination of our tax returns;
maintenance and security of our information technology systems;
changes in laws and regulations;
maintaining an effective system of internal control; and
limitations on liabilities of our directors and executive officers.

Risks Related to Our Business

We have a limited amount of cash to grow our operations. If we cannot obtain additional sources of cash, our growth prospects and future profitability may be materially adversely affected, and we may not be able to implement our business plan. Such additional financing may not be available on satisfactory terms or it may not be available when needed, or at all.

As of December 31, 2023, we had cash and cash equivalents of approximately $3.0 million, and during the year ended December 31, 2023, we used $6.5 million of cash in operating activities. On March 19, 2024, we closed on a public offering and private placement of our common stock, which resulted in aggregate net proceeds to us of approximately $2.0 million. Although we believe that our current levels of cash and our anticipated cash flow from operations will be sufficient to sustain our operations at our current expense levels for at least twelve months subsequent to the date of the filing of this Annual Report on Form 10-K, we may require significant additional cash to satisfy our working capital requirements, expand our operations, or acquire and develop additional brands. Our inability to finance our growth, either internally through our operations or externally, may limit our growth potential and our ability to execute our business strategy successfully. If we issue additional securities to raise capital to finance operations and/or pay down or restructure our debt, our existing stockholders may experience dilution. In addition, the new securities may have rights senior to those of our common stock.

14

A substantial portion of our revenue is concentrated with a limited number of licensees such that the loss of any of such licensees could decrease our revenue and impair our cash flows.

A substantial portion of our revenue has been paid by Qurate, through the respective agreements with Qurate through QVC and HSN. During the years ended December 31, 2023 and 2022, Qurate accounted for approximately 34% and 44%, respectively, of our total net revenue. Because we are dependent on these agreements with Qurate for a significant portion of our revenues, if Qurate were to have financial difficulties, or if Qurate decides not to renew or extend its existing agreements with us, our revenue and cash flows could be reduced substantially. Our cash flow would also be significantly impacted if there were significant delays in our collection of receivables from Qurate. Additionally, we have limited control over the programming that Qurate devotes to our brands or its promotional sales with our brands (such as “Today’s Special Value” sales). If Qurate reduces or modifies its programming or promotional sales related to our brands, our revenues and cash flows could be reduced substantially. In order to increase sales of a brand through Qurate, we generally require additional television programming time dedicated to the brand by Qurate. Qurate is not required to devote any minimum amount of programming time for any of our brands.

Our Qurate revenues have declined since 2021, and there can be no guarantee that our Qurate revenues will grow in the future or that they will not decline further. Additionally, there can be no assurance that our other licensees will be able to generate sales of products under our brands or grow their existing sales of products under our brands, and if they do generate sales, there is no guarantee that they will not cause a decline in sales of products being sold through Qurate.

Our agreements with Qurate restrict us from selling products under our brands with certain retailers, or branded products we sell on Qurate to any other retailer except certain interactive television channels in other territories approved by Qurate, and provides Qurate with a right to terminate the respective agreement if we breach these provisions.

Although most of our licenses and our Qurate Agreements prohibit the sale of products under our brands to retailers who are restricted by Qurate, and our license agreements with other interactive television companies prohibit such licensees from selling products to retailers restricted by Qurate under the brands we sell on Qurate outside of certain approved territories, one or more of our licensees could sell to a restricted retailer or territory, putting us in breach of our agreements with Qurate and exposing us to potential termination by Qurate. A breach of any of these agreements could also result in Qurate seeking monetary damages, seeking an injunction against us and our other licensees, reducing the programming time allocated to our brands, and/or terminating the respective agreement, which could have a material adverse effect on our net income and cash flows.

We conduct certain of our operations through joint ventures. Joint ventures could fail to meet our expectations or cease to deliver anticipated benefits. There could also be disagreements with our joint venture partners that could adversely affect our interest a joint venture.

We hold a 30% interest in each of IM Topco, LLC and ORME. We may enter into additional joint ventures in the future. Our operating results are, in part, dependent upon the performance of IM Topco, LLC and ORME, and, in the future, could also be dependent in part upon the performance of future joint ventures. Joint ventures involve numerous risks, and could fail to meet our initial or ongoing expectations. While we provide certain services to IM Topco, LLC and may provide services to future joint ventures, we do not control the day-to-day operations of IM Topco, LLC or ORME, and may not control the day-to-day operations of future joint ventures. The anticipated synergies or other benefits of a joint venture may fail to materialize due to changing business conditions or changes in our business priorities or those of our joint venture partners. Our joint venture partners, as well as any future partners, may have interests that are different from our interests that may result in conflicting views as to the conduct of the business or future direction of the joint venture. In the event that we have a disagreement with a joint venture partner with respect to a particular issue to come before the joint venture, or as to the management or conduct of the business of the joint venture, we may not be able to resolve such disagreement in our favor. Any such disagreement could have a material adverse effect on our interest in the joint venture, the business of the joint venture, or the portion of our growth strategy related to the joint venture.

15

We are dependent on our joint ventures to provide timely and accurate information about their sales and operations, which we rely upon to effectively manage their brands.

IM Topco, LLC and ORME are, and we expect any future joint ventures will be, contractually obligated to provide timely and accurate information regarding their sales and operations. We rely on this information to prepare our consolidated financial statements. Any delay in reporting reduces our visibility into the results of operations for IM Topco, LLC and any future joint ventures, and our inability to collect timely and accurate information may affect our ability to timely complete our financial statements and timely file reports and other information with the SEC and may adversely affect our business and results of operations.

We are dependent upon the promotional services of Lori Goldstein and our other spokespersons as they relate to our respective brands.

If we lose the services of Lori Goldstein, we may not be able to fully comply with the terms of our agreement with Qurate, and it may result in significant reductions in the value of the LOGO by Lori Goldstein brand and our prospects, revenues, and cash flows. Lori Goldstein is a key individual in our continued promotion of the LOGO by Lori Goldstein brand and the principal salesperson of the LOGO by Lori Goldstein brand on Qurate. Failure of Lori Goldstein to provide services to Qurate could result in a termination of related agreements with Qurate, which could trigger an event of default under our credit facility. Although we have entered into an employment agreement with Ms. Goldstein, there is no guarantee that we will not lose her services. To the extent that any of Ms. Goldstein’s services become unavailable to us, we will likely need to find a replacement for Ms. Goldstein to promote the LOGO by Lori Goldstein brand. Competition for skilled designers and high-profile brand promoters is intense, and compensation levels may be high, and there is no guarantee that we would be able to identify and attract a qualified replacement, or if Ms. Goldstein’s services are not available to us, that we would be able to promote the LOGO by Lori Goldstein brand as well as we are able to with Ms. Goldstein. This could significantly affect the value of the LOGO by Lori Goldstein brand and our ability to market the brand, and could impede our ability to fully implement our business plan and future growth strategy, which would harm our business and prospects. Additionally, while we acquired all trademarks, image, and likeness of Lori Goldstein, pursuant to the acquisition of the LOGO by Lori Goldstein assets and her employment agreement, Ms. Goldstein has retained certain rights to participate in outside business activities, including hosting and appearing in television shows, movies and theater productions, and writing and publishing books and other publications. Ms. Goldstein’s participation in these personal business ventures could limit her availability to us and affect her ability to perform under this employment agreement. Finally, there is no guarantee that Ms. Goldstein will not take an action that consumers view as negative, which may harm the LOGO by Lori Goldstein brand as well as our business and prospects.

We will also be dependent upon the services of our other spokespersons and our joint venture partner’s spokesperson to promote our other brands and the brands of our joint venture. The loss of a spokesperson or a joint ventures’ spokesperson could significantly affect the value of the related brand or our related joint venture interest and our or our related joint venture’s ability to market the brand which would harm our business and prospects.

The company has withheld and rescheduled payment of the $963,642 earnout payment for 2023 due to a spokesperson due to alleged uncured breaches of the spokesperson’s obligations under an employment agreement.

 

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the company, advised the company that the Company was in material breach of the March 31, 2021 asset purchase agreement for failure to pay the earn-out achieved for 2023 in the amount of $963,642 (the “2023 Earn-out”) under the terms of the agreement, and is instead intending on paying such amount quarterly in 2024. The Company does not dispute the amount of the 2023 Earn-out and advised Ms. Goldstein that due to Ms. Goldstein’s failure to make all of the QVC appearances as required by her employment agreement, the Company was not willing to pay the 2023 Earn-out in a lump sum but would make the payment in four quarterly installments. Failure to amicably resolve this dispute could adversely affect the Company’s cash flow and the availability of Ms. Goldstein’s services. To the extent that any of Ms. Goldstein’s services become unavailable to us, we will likely need to utilize our existing back-up guest hosts in lieu of Ms. Goldstein and/or find a replacement for Ms. Goldstein to promote the LOGO by Lori Goldstein brand. Competition for skilled designers and high-profile brand promoters is intense, and compensation levels may be high, and there is no guarantee that we would be able to identify and attract a qualified replacement, or if Ms. Goldstein’s services are not available to us, that we would be able to promote

16

the LOGO by Lori Goldstein brand on QVC and otherwise. This could significantly affect the value of the LOGO by Lori Goldstein brand and our ability to market the brand, and could impede our ability to fully implement our business plan and future growth strategy for the Lori Goldstein brands, which would harm our business and prospects and adversely impact our results of operations, financial conditions, and cash flows.

The failure of our licensees to adequately produce, market, source, and sell quality products bearing our brand names in their license categories or to pay their obligations under their license agreements could result in a decline in our results of operations.

Our revenues are dependent on payments made to us under our licensing agreements. Although the licensing agreements for our brands typically require the advance payment to us of a portion of the licensing fees and in many cases provide for guaranteed minimum royalty payments to us, the failure of our licensees to satisfy their obligations under these agreements or their inability to operate successfully or at all, could result in their breach and/or the early termination of such agreements, the non-renewal of such agreements, or our decision to amend such agreements to reduce the guaranteed minimums or sales royalties due thereunder, thereby eliminating some or all of that stream of revenue. Moreover, during the terms of the license agreements, we are substantially dependent upon the efforts and abilities of our licensees to maintain the quality and marketability of the products bearing our trademarks, as their failure to do so could materially tarnish our brands, thereby harming our future growth and prospects. In addition, the failure of our licensees to meet their production, manufacturing, sourcing, and distribution requirements or actively market the branded licensed products could cause a decline in their sales and potentially decrease the amount of royalty payments (over and above the guaranteed minimums) due to us. A weak economy or softness in the apparel and retail sectors could exacerbate this risk. This, in turn, could decrease our potential revenues. The concurrent failure by several of our material licensees to meet their financial obligations to us could adversely affect our business, results of operations, and cash flows.

If our retail customers change their buying patterns, request additional allowances, develop their own private label brands or enter into agreements with national brand manufacturers to sell their products on an exclusive basis, our sales to these customers could be materially adversely affected.

Our retail customers’ buying patterns, as well as the need to provide additional allowances to customers, could have a material adverse effect on our business, results of operations and financial condition. Customers’ strategic initiatives, including developing their own private labels brands, selling national brands on an exclusive basis, reducing the number of vendors they purchase from, or reducing the floor space dedicated to our brands could also impact our sales to these customers. There is a trend among major retailers to concentrate purchasing among a narrowing group of vendors. To the extent that any key customer reduces the number of its vendors or allocates less floor space for our products and, as a result, reduces or eliminates purchases from us, there could be a material adverse effect on us.

Our business is dependent on continued market acceptance of our brands, our joint venture brands, and any future brands we may acquire directly or through a joint venture, and the products of our licensees.

Although certain of our licensees guarantee minimum net sales and minimum royalties to us, some of our licensees are not yet selling licensed products or currently have limited distribution of licensed products, and a failure of our brands or of our joint venture brands or of products bearing our brands or our joint venture brands to achieve or maintain broad market acceptance could cause a reduction of our licensing revenues, diminish the value of and generally affect the operating results of our joint ventures, and could further cause existing licensees not to renew their agreements. Such failure could also cause the devaluation of our trademarks, which are our primary assets and the primary assets of our joint ventures, making it more difficult for us or our joint ventures to renew our current licenses upon their expiration or enter into new or additional licenses for such trademarks. In addition, if such devaluation of our trademarks were to occur, a material impairment in the carrying value of one or more of our trademarks, which had an aggregate carrying value of $41.5 million as of December 31, 2023, could also occur and be charged as an expense to our operating results. Continued market acceptance of our brands, our joint ventures’ brands, and our licensees’ products, as well as market acceptance of any future products bearing any future brands we may acquire, is subject to a high degree of uncertainty and constantly changing consumer tastes, preferences, and purchasing patterns. Creating and maintaining market acceptance of our licensees’ products and creating market acceptance of new products and categories of products bearing our marks may require substantial marketing efforts, which may, from time to time, also include our expenditure of significant additional

17

funds to keep pace with changing consumer demands, which funds may or may not be available on a timely basis, on acceptable terms or at all. Additional marketing efforts and expenditures may not, however, result in either increased market acceptance of, or additional licenses for, our trademarks or increased market acceptance, or sales, of our licensees’ products. Furthermore, we do not actually design or manufacture all of the products bearing our marks, and therefore, have less control over such products’ quality and design than a traditional product manufacturer might have. The failure of our licensees and joint ventures to maintain the quality of their products could harm the reputation and marketability of our brands and our joint ventures’ brands, which would adversely impact our business and the business of our joint ventures.

Negative claims or publicity regarding Xcel, IM Topco, LLC, any future joint ventures, our or their brands, or products could adversely affect our reputation and sales regardless of whether such claims are accurate. Social media, which accelerates the dissemination of information, can increase the challenges of responding to negative claims. In the past, many apparel companies have experienced periods of rapid growth in sales and earnings followed by periods of declining sales and losses. Our businesses may be similarly affected in the future.

Use of social media and influencers may materially and adversely affect our reputation or subject us to fines or other penalties.

We use and our joint ventures may use third-party social media platforms as, among other things, marketing tools. We also maintain, and our joint ventures may maintain, relationships with many social media influencers and engage in sponsorship initiatives. As existing e-commerce and social media platforms continue to rapidly evolve and new platforms develop, we and our joint ventures must continue to maintain a presence on these platforms and establish presences on new or emerging popular social media platforms. If we or our joint ventures are unable to cost-effectively use social media platforms as marketing tools or if the social media platforms we or our joint ventures use change their policies or algorithms, we or our joint ventures may not be able to fully optimize such platforms, and our and their ability to maintain and acquire customers and our financial condition may suffer.

Furthermore, as laws and regulations and public opinion rapidly evolve to govern the use of these platforms and devices, the failure by us, our employees, our network of social media influencers, our sponsors or third parties acting at our direction to abide by applicable laws and regulations in the use of these platforms and devices or otherwise could subject us to regulatory investigations, class action lawsuits, liability, fines or other penalties and have a material adverse effect on our business, financial condition and operating results.

In addition, an increase in the use of social media for product promotion and marketing may cause an increase in the burden on us and our joint ventures to monitor compliance of such materials, and increase the risk that such materials could contain problematic product or marketing claims in violation of applicable regulations. For example, in some cases, the Federal Trade Commission has sought enforcement action where an endorsement has failed to clearly and conspicuously disclose a financial relationship or material connection between an influencer and an advertiser.

We do not prescribe what our influencers post, and if we were held responsible for the content of their posts or their actions, we could be fined or forced to alter our practices, which could have an adverse impact on our business.

Negative commentary regarding us, our joint ventures or our or their products or influencers and other third parties who are affiliated with us or our joint ventures may also be posted on social media platforms and may be adverse to our or our joint ventures’ reputation or business. Influencers with whom we or our joint ventures maintain relationships could engage in behavior or use their platforms to communicate directly with our customers in a manner that reflects poorly on our or our joint ventures’ brand and may be attributed to us or our joint ventures or otherwise adversely affect us or our joint ventures. It is not possible to prevent such behavior, and the precautions we and our joint ventures take to detect this activity may not be effective in all cases. Our and our joint ventures’ target consumers often value readily available information and often act on such information without further investigation and without regard to its accuracy. The harm may be immediate, without affording us and our joint ventures an opportunity for redress or correction.

18

If we are unable to anticipate and respond to changing customer preferences and shifts in fashion and industry trends in a timely manner, our business, financial condition, and operating results could be harmed.

Our success largely depends on our ability to consistently gauge tastes and trends and provide a diverse and balanced assortment of merchandise that satisfies customer demands in a timely manner. Our ability to accurately forecast demand for our products could be affected by many factors, including an increase or decrease in demand for our products or for products of our competitors, our failure to accurately forecast acceptance of new products, product introductions by competitors, unanticipated changes in general market conditions, and weakening of economic conditions or consumer confidence in future economic conditions. We typically enter into agreements to manufacture and purchase our merchandise in advance of the applicable selling season and our failure to anticipate, identify or react appropriately, or in a timely manner to changes in customer preferences, tastes and trends or economic conditions could lead to, among other things, missed opportunities, excess inventory or inventory shortages, markdowns and write-offs, all of which could negatively impact our profitability and have a material adverse effect on our business, financial condition, and operating results. Failure to respond to changing customer preferences and fashion trends could also negatively impact the image of our brands with our customers and result in diminished brand loyalty.

If major department, mass merchant, and specialty store chains consolidate, continue to close stores, or cease to do business, our business could be negatively affected.

Certain of our licensees sell our branded products through major department, mass merchant, and specialty store chains. Continued consolidation in the retail industry, as well as store closures or retailers ceasing to do business, could negatively impact our business. Consolidation could also reduce the number of our customers and potential customers who can access our branded products. A store group could decide to close stores, decrease the amount of our branded product purchased from our licensees, modify the amount of floor space allocated to apparel in general or to our brands specifically, or focus on promoting private label products or national brand products for which it has exclusive rights rather than promoting our brands. Customers are also concentrating purchases among a narrowing group of vendors. These types of decisions could adversely affect our business.

We expect to achieve growth based upon our plans to expand our business under our existing brands and brands we may develop independently or through collaborations or acquire. If we fail to manage our expected future growth, our business and operating results could be materially harmed.

We expect to achieve growth in our existing brands and brands we may develop independently or through collaborations or acquire through expansion of our licensing activities and social media e-commerce platforms, including ORME. We continue to seek new opportunities and international expansion through interactive television and licensing arrangements, as well as joint ventures and collaborations. The success of our company, however, will remain largely dependent on our ability to build and maintain broad market acceptance of our brands, to contract with and retain key licensees and on our licensees’ ability to accurately predict upcoming fashion and design trends within customer bases and fulfill the product requirements of retail channels within the global marketplace.

Our ability to compete effectively and to manage future growth, if any, will depend on the sufficiency and adequacy of our current resources and infrastructure and our ability to continue to identify, attract and retain personnel to manage our brands and integrate any brands we may acquire into our operations. There can be no assurance that our personnel, systems, procedures and controls will be adequate to support our operations and properly oversee our brands. The failure to support our operations effectively and properly oversee our brands could cause harm to our brands and have a material adverse effect on the value of such brands and on our reputation, business, financial condition and results of operations. In addition, we may be unable to leverage our core competencies in managing apparel and jewelry brands to managing brands in new product categories.

Also, there can be no assurance that we will be able to achieve and sustain meaningful growth. Our growth may be limited by a number of factors including increased competition among branded products at brick-and-mortar, internet and interactive retailers, decreased airtime on QVC, HSN, and JTV, competition for retail licenses and brand acquisitions, joint ventures and collaborations, and insufficient capitalization for future transactions.

19

We are dependent upon our Chief Executive Officer and other key executives. If we lose the services of these individuals, we may not be able to fully implement our business plan and future growth strategy, which would harm our business and prospects.

Our success is largely dependent upon the efforts of Robert W. D’Loren, our Chief Executive Officer and Chairman of our board of directors. Our continued success is largely dependent upon his continued efforts and those of our other key executives. Although we entered into an employment agreement with Mr. D’Loren, as well as employment agreements with other executives and key employees, such persons can terminate their employment with us at their option, and there is no guarantee that we will not lose the services of our executive officers or key employees. To the extent that any of their services become unavailable to us, we will be required to hire other qualified executives, and we may not be successful in finding or hiring adequate replacements. This could impede our ability to fully implement our business plan and future growth strategy, which would harm our business and prospects.

If we are unable to identify and successfully acquire additional trademarks or enter into joint ventures or collaborations for brands, our growth may be limited and, even if additional trademarks are acquired or joint ventures and collaborations are formed, we may not realize anticipated benefits due to integration or licensing difficulties.

While we are focused on growing our existing brands, we intend to selectively seek to acquire additional intellectual property, either directly or through the formation of joint ventures or collaborations. However, as our competitors continue to pursue a brand management model, acquisitions, joint ventures, and collaborations may become more expensive and suitable candidates could become more difficult to find. In addition, even if we successfully acquire additional intellectual property or the rights to use additional intellectual property, we may not be able to achieve or maintain profitability levels that justify our investment in, or realize planned benefits with respect to, those additional brands.

Although we will seek to temper our acquisition, joint venture, and collaboration risks by following guidelines relating to purchase price and valuation, projected returns, existing strength of the brand, its diversification benefits to us, its potential licensing scale and creditworthiness of licensee base, acquisitions, joint ventures, and collaborations, whether they be of additional intellectual property assets or of the companies that own them, entail numerous risks, any of which could detrimentally affect our reputation, our results of operations, and/or the value of our common stock. These risks include, among others:

unanticipated costs associated with the target acquisition, joint venture, or collaboration, or its integration with our company;
our ability to identify or consummate additional quality business opportunities, including potential licenses and new product lines and markets;
negative effects on reported results of operations from acquisition related charges and costs, and amortization of acquired intangibles;
diversion of management’s attention from other business concerns;
the challenges of maintaining focus on, and continuing to execute, core strategies and business plans as our brand and license portfolio grows and becomes more diversified;
adverse effects on existing licensing and other relationships;
potential difficulties associated with the retention of key employees, and difficulties, delays and unanticipated costs associated with the assimilation of personnel, operations, systems and cultures, which may be retained by us in connection with or as a result of our acquisitions;

20

risks of entering new domestic and international markets (whether it be with respect to new licensed product categories or new licensed product distribution channels) or markets in which we have limited prior experience; and
increased concentration in our revenues with one or more customers in the event that the brand has distribution channels in which we currently distribute products under one or more of our brands.

When we acquire intellectual property assets or the companies that own them, or enter into joint ventures or collaborations, our due diligence reviews are subject to inherent uncertainties and may not reveal all potential risks. We may therefore fail to discover or inaccurately assess undisclosed or contingent liabilities, including liabilities for which we may have responsibility as a successor to the seller or the target company. As a successor, we may be responsible for any past or continuing violations of law by the seller or the target company. Although we will generally attempt to seek contractual protections through representations, warranties and indemnities, we cannot be sure that we will obtain such provisions or that such provisions will fully protect us from all unknown, contingent or other liabilities or costs. Finally, claims against us relating to any acquisition may necessitate our seeking claims against the seller for which the seller may not, or may not be able to, indemnify us or that may exceed the scope, duration or amount of the seller’s indemnification obligations.

Acquiring additional intellectual property could also have a significant effect on our financial position and could cause substantial fluctuations in our quarterly and yearly operating results. Acquisitions and joint ventures could result in the recording of significant goodwill and intangible assets on our financial statements, the amortization or impairment of which would reduce our reported earnings in subsequent years. No assurance can be given with respect to the timing, likelihood or financial or business effect of any possible transaction. Moreover, our ability to grow through the acquisition of additional intellectual property, joint ventures and collaborations will also depend on the availability of capital to complete the necessary acquisition arrangements. In the event that we are unable to obtain debt financing on acceptable terms for a particular transaction, we may elect to pursue the transaction through the issuance by us of shares of our common stock (and, in certain cases, convertible securities) as equity consideration, which could dilute our common stock and reduce our earnings per share, and any such dilution could reduce the market price of our common stock unless and until we were able to achieve revenue growth or cost savings and other business economies sufficient to offset the effect of such an issuance. Acquisitions of additional brands may also involve challenges related to integration into our existing operations, merging diverse cultures, and retaining key employees. Any failure to integrate additional brands successfully in the future may adversely impact our reputation and business.

As a result, there is no guarantee that our stockholders will achieve greater returns as a result of any future acquisitions we complete.

Intense competition in the apparel, fashion, and jewelry industries could reduce our sales and profitability.

As a fashion company, we face intense competition from other domestic and foreign apparel, footwear, accessories, and jewelry manufacturers and retailers. Competition has and may continue to result in pricing pressures, reduced profit margins, lost market share, or failure to grow our market share, any of which could substantially harm our business and results of operations. Competition is based on many factors including, without limitation, the following:

establishing and maintaining favorable brand recognition;
developing products that appeal to consumers;
pricing products appropriately;
determining and maintaining product quality;
obtaining access to sufficient floor space in retail locations;
providing appropriate services and support to retailers;

21

maintaining and growing market share;
developing and maintaining a competitive e-commerce site;
hiring and retaining key employees; and
protecting intellectual property.

Competition in the apparel, fashion and jewelry industries is intense and is dominated by a number of very large brands, many of which have longer operating histories, larger customer bases, more established relationships with a broader set of potential licensees, greater brand recognition, and greater financial, research and development, marketing, distribution, and other resources than we do. These capabilities of our competitors may allow them to better withstand downturns in the economy or apparel, fashion and jewelry industries. Any increased competition, or our failure to adequately address any of these competitive factors which we have seen from time to time, could result in reduced sales, which could adversely affect our business, financial condition, and operating results.

Competition, along with such other factors as consolidation within the retail industry and changes in consumer spending patterns, could also result in significant pricing pressure and cause the sales environment to be more promotional, as it has been in recent years, impacting our financial results. If promotional pressure remains intense, either through actions of our competitors or through customer expectations, this may cause a further reduction in our sales and gross margins and could have a material adverse effect on our business, financial condition, and operating results.

Because of the intense competition within our existing and potential wholesale licensees’ markets and the strength of some of their competitors, we and our licensees may not be able to continue to compete successfully.

We expect our existing and future licenses to relate to products in the apparel, footwear, accessories, jewelry, home goods, and other consumer industries, in which our licensees face intense competition, including from our other brands and licensees. In general, competitive factors include quality, price, style, name recognition, and service. In addition, various fashion trends and the limited availability of shelf space could affect competition for our licensees’ products. Many of our licensees’ competitors have greater financial, distribution, marketing, and other resources than our licensees and have achieved significant name recognition for their brand names. Our licensees may be unable to successfully compete in the markets for their products, and we may not be able to continue to compete successfully with respect to our contractual arrangements.

If our competition for licenses increases, or any of our current licensees elect not to renew their licenses or renew on terms less favorable than today, our growth plans could be slowed and our business, financial condition and results of operations would be adversely affected.

To the extent we seek to acquire additional brands, we will face competition to retain licenses and to complete such acquisitions. The ownership, licensing, and management of brands is becoming a more widely utilized method of managing consumer brands as production continues to become commoditized and manufacturing capacity increases worldwide. We face competition from numerous direct competitors, both publicly and privately-held, including traditional apparel and consumer brand companies, other brand management companies and private equity groups. Companies that traditionally focused on wholesale manufacturing and sourcing models are now exploring licensing as a way of growing their businesses through strategic licensing partners and direct-to-retail contractual arrangements. Furthermore, our current or potential licensees may decide to develop or purchase brands rather than renew or enter into contractual agreements with us. In addition, this increased competition could result in lower sales of products offered by our licensees under our brands. If our competition for licenses increases, it may take us longer to procure additional licenses, which could slow our growth rate.

22

Difficulties with foreign sourcing may adversely affect our business.

Our licensees work with several manufacturers overseas, primarily located overseas, including in China and Thailand. A manufacturing contractor’s failure to ship products to our licensees in a timely manner or to meet the required quality standards could cause the licensee to miss the delivery date requirements of its customers for those items or not have seasonal product available for a selling season. The failure to make timely deliveries may cause their customers to cancel orders, refuse to accept deliveries or demand reduced prices, any of which could reduce our licensing royalties, which could have a material adverse effect on us. As a result of the magnitude of our licensees’ foreign sourcing, our business is subject to the following risks:

political and economic instability in countries or regions, especially Asia, including heightened terrorism and other security concerns, which could subject imported or exported goods to additional or more frequent inspections, leading to delays win deliveries or impoundment of goods;
imposition of regulations, quotas and other trade restrictions relating to imports, including quotas imposed by bilateral textile agreements between the U.S. and foreign countries;
currency exchange rates;
imposition of increased duties, taxes and other charges on imports;
pandemics and disease outbreaks such as COVID-19;
labor union strikes at ports through which our products enter the U.S.;
labor shortages in countries where contractors and suppliers are located;
restrictions on the transfer of funds to or from foreign countries;
disease epidemics and health-related concerns, which could result in closed factories, reduced workforces, scarcity of raw materials and scrutiny or embargoing of goods produced in infected areas;
the migration and development of manufacturing contractors, which could affect where our brands are or are planned to be produced;
increases in the costs of fuel, travel and transportation; and
violations by foreign contractors of labor and wage standards and resulting adverse publicity.

If these risks limit or prevent our licensees from manufacturing products in any significant international market, prevent us from acquiring products from foreign suppliers, the production and sale of our brands be seriously disrupted until alternative suppliers are found or alternative markets are developed, which could negatively impact our business.

Our failure to protect our proprietary rights could compromise our competitive position and decrease the value of our brands.

We own, through our wholly owned subsidiaries, various U.S. federal trademark registrations and foreign trademark registrations for our brands, together with pending applications for registration, which are vital to the success and further growth of our business and which we believe have significant value. We rely primarily upon a combination of trademarks, copyrights, and contractual restrictions to protect and enforce our intellectual property rights domestically and internationally. We believe that such measures afford only limited protection and, accordingly, there can be no assurance that the actions taken by us to establish, protect, and enforce our trademarks and other proprietary rights will prevent

23

infringement of our intellectual property rights by others, or prevent the loss of licensing revenue or other damages caused therefrom.

For instance, despite our efforts to protect and enforce our intellectual property rights, unauthorized parties may attempt to copy aspects of our intellectual property, which could harm the reputation of our brands, decrease their value, and/or cause a decline in our licensees’ sales and thus our revenues. Further, we and our licensees may not be able to detect infringement of our intellectual property rights quickly or at all, and at times, we or our licensees may not be successful in combating counterfeit, infringing, or knockoff products, thereby damaging our competitive position. In addition, we depend upon the laws of the countries where our licensees’ products are sold to protect our intellectual property. Intellectual property rights may be unavailable or limited in some countries because standards of registration and ownership vary internationally. Consequently, in certain foreign jurisdictions, we have elected or may elect not to apply for trademark registrations.

While we generally apply for trademarks in most countries where we license or intend to license our trademarks, we may not accurately predict all of the countries where trademark protection will ultimately be desirable. If we fail to timely file a trademark application in any such country, we may be precluded from obtaining a trademark registration in such country at a later date. Failure to adequately pursue and enforce our trademark rights could damage our brands, enable others to compete with our brands and impair our ability to compete effectively.

In addition, in the future, we may be required to assert infringement claims against third parties or more third parties may assert infringement claims against us. Any resulting litigation or proceeding could result in significant expense to us and divert the efforts of our management personnel, whether or not such litigation or proceeding is determined in our favor. To the extent that any of our trademarks were ever deemed to violate the proprietary rights of others in any litigation or proceeding or as a result of any claim, we may be prevented from using them, which could cause a termination of our contractual arrangements, and thus our revenue stream, with respect to those trademarks. Litigation could also result in a judgment or monetary damages being levied against us.

Risks Related to an Investment in Our Securities

Management exercises significant control over matters requiring shareholder approval, which may result in the delay or prevention of a change in our control.

Pursuant to voting agreements, certain shareholders agreed to appoint a person designated by our board of directors as their collective irrevocable proxy and attorney-in-fact with respect to the shares of the common stock received by them. The proxy holder will vote in favor of matters recommended or approved by the board of directors. The board of directors has designated Robert W. D’Loren as proxy. Also, pursuant to separate voting agreements, certain other stockholders have agreed to appoint Mr. D’Loren as their respective irrevocable proxy and attorney-in-fact with respect to the shares of the common stock issued to them by us. The proxy holder shall vote in favor of matters recommended or approved by the board of directors.

The combined voting power of the common stock ownership of our directors and executive officers is approximately 45% of our voting securities as of March 31, 2024. As a result, our management through such stock ownership will exercise significant influence over all matters requiring shareholder approval, including the election of our directors and approval of significant corporate transactions. This concentration of ownership in management may also have the effect of delaying or preventing a change in control of us that may be otherwise viewed as beneficial by stockholders other than management. There is also a risk that our existing management and a limited number of stockholders may have interests which are different from certain stockholders and that they will pursue an agenda which is beneficial to themselves at the expense of other stockholders.

24

Our failure to meet the continued listing requirements of the Nasdaq Capital Market could result in a delisting of our common stock, which could negatively impact the market price and liquidity of our common stock and our ability to access the capital markets.

On April 16, 2024, we received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying us that the minimum bid price per share for our common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, the Company did not meet the minimum bid price requirement set forth in the Nasdaq Listing Rules.

The letter also states that pursuant to Nasdaq Listing Rules 5810(c)(3)(A), we will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until October 14, 2024.

We can regain compliance if, at any time during the Tolling Period or such 180-day period, the closing bid price of our common stock is at least $1.00 for a minimum period of 10 consecutive business days. If by October 14, 2024, we do not regain compliance with the Nasdaq Listing Rules, we may be eligible for additional time to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii). We would also need to provide written notice to Nasdaq of our intention to cure the minimum bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary. As part of its review process, the Nasdaq staff will make a determination of whether it believes we will be able to cure this deficiency. Should the Nasdaq staff conclude that we will not be able to cure the deficiency, or should we determine not to submit a transfer application or make the required representation, Nasdaq will provide notice that our shares of common stock will be subject to delisting.

If we do not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that our shares of common stock will be subject to delisting from the Nasdaq Capital Market. At such time, we may appeal the delisting determination to a hearings panel.

We intend to monitor our common stock closing bid price between now and October 14, 2024 and will consider available options to resolve the Company’s noncompliance with the minimum bid price requirement, as may be necessary. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq listing criteria.

Our common stock may be subject to the penny stock rules adopted by the SEC that require brokers to provide extensive disclosure to their customers prior to executing trades in penny stocks. These disclosure requirements may cause a reduction in the trading activity of our common stock, which could make it more difficult for our stockholders to sell their securities.

Rule 3a51-1 of the Exchange Act establishes the definition of a “penny stock,” for purposes relevant to us, as any equity security that has a minimum bid price of less than $5.00 per share, subject to a limited number of exceptions, including for having securities registered on certain national securities exchanges. If our common stock were delisted from the NASDAQ, market liquidity for our common stock could be severely and adversely affected.

For any transaction involving a penny stock, unless exempt, the penny stock rules require that a broker or dealer approve a person’s account for transactions in penny stocks and the broker or dealer receive from the investor a written agreement to the transaction setting forth the identity and quantity of the penny stock to be purchased. In order to approve a person’s account for transactions in penny stocks, the broker or dealer must obtain financial information and investment experience and objectives of the person and make a reasonable determination that the transactions in penny stocks are suitable for that person and that that person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prepared by the SEC relating to the penny stock market, which, in highlight form, sets forth:

the basis on which the broker or dealer made the suitability determination; and
that the broker or dealer received a signed, written agreement from the investor prior to the transaction.

25

Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and commission payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

Because of these regulations, broker-dealers may not wish to engage in the above-referenced necessary paperwork and disclosures and/or may encounter difficulties in their attempt to sell shares of our common stock, which may affect the ability of selling stockholders or other holders to sell their shares in any secondary market and have the effect of reducing the level of trading activity in any secondary market. These additional sales practice and disclosure requirements could impede the sale of our common stock even if and when our common stock becomes listed on the NASDAQ Capital Market. In addition, the liquidity for our common stock may decrease, with a corresponding decrease in the price of our common stock.

No assurance can be given that our stock will not be subject to these “penny stock” rules in the future.

Investors should be aware that, according to Commission Release No. 34-29093, the market for “penny stocks” has suffered in recent years from patterns of fraud and abuse. Such patterns include: (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. The occurrence of these patterns or practices could increase the future volatility of our share price.

Our common stock has historically been thinly traded, and you may be unable to sell at or near ask prices or at all if you need to sell or liquidate a substantial number of shares at one time.

Although our common stock is listed on the NASDAQ Capital Market, our common stock has historically been traded at relatively low volumes. As a result, the number of persons interested in purchasing our common stock at or near bid prices at any given time may be relatively small. This situation is attributable to a number of factors, including that we are currently a small company which is still relatively unknown to securities analysts, stock brokers, institutional investors and others in the investment community that generate or influence sales volume, and that even if we came to the attention of such persons, they tend to be risk-averse and reluctant to follow an unproven company such as ours or purchase or recommend the purchase of our shares until such time as we become more seasoned and viable. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot provide any assurance that a broader or more active public trading market for our common stock will develop or be sustained, or that trading levels will be sustained.

The market price of our common stock has declined over the past several years and may be volatile, which could reduce the market price of our common stock.

Currently the publicly traded shares of our common stock are not widely held, and do not have significant trading volume, and, therefore, may experience significant price and volume fluctuations. Although our common stock is quoted on the NASDAQ Capital Market, this does not assure that a meaningful, consistent trading market will develop or that the volatility will decline. This market volatility could reduce the market price of the common stock, regardless of our operating performance. In addition, the trading price of the common stock has been volatile over the past several years and could change significantly over short periods of time in response to actual or anticipated variations in our quarterly operating results, announcements by us, our licensees or our respective competitors, factors affecting our licensees’ markets generally and/or changes in national or regional economic conditions, making it more difficult for shares of the common stock to be sold at a favorable price or at all. The market price of the common stock could also be reduced by general market price declines or market volatility in the future or future declines or volatility in the prices of stocks for companies in the trademark licensing business or companies in the industries in which our licensees compete.

26

We may issue a substantial number of shares of common stock upon exercise of outstanding warrants and options.

As of December 31, 2023, we had outstanding warrants and options to purchase 6,264,605 shares of our common stock with a weighted average exercise price of $1.96. The holders of warrants and options will likely exercise such securities at a time when the market price of our common stock exceeds the exercise price. Therefore, exercises of warrants and options will result in a decrease in the net tangible book value per share of our common stock and such decrease could be material.

The issuance of shares upon exercise of outstanding warrants and options will dilute our then-existing stockholders’ percentage ownership of our company, and such dilution could be substantial. In addition, our growth strategy includes the acquisition of additional brands, and we may issue shares of our common stock as consideration for acquisitions. Sales or the potential for sale of a substantial number of such shares could adversely affect the market price of our common stock, particularly if our common stock remains thinly traded at such time.

As of December 31, 2023, we had an aggregate of 3,103,941 shares of common stock available for grants under our 2021 Equity Incentive Plan (the "2021 Plan") to our directors, executive officers, employees, and consultants. Issuances of common stock pursuant to the exercise of stock options or other stock grants or awards which may be granted under our 2021 Plan will dilute your interest in us.

Holders of our common stock may be subject to restrictions on the use of Rule 144 by shell companies or former shell companies.

Historically, the SEC has taken the position that Rule 144 under the Securities Act of 1933, as amended, or the Securities Act, is not available for the resale of securities initially issued by companies that are, or previously were, shell companies (we were considered a shell company on and prior to September 29, 2011), to their promoters or affiliates despite technical compliance with the requirements of Rule 144. The SEC prohibits the use of Rule 144 for resale of securities issued by shell companies (other than business transaction related shell companies) or issuers that have been at any time previously a shell company. The SEC has provided an important exception to this prohibition, however, if the following conditions are met: the issuer of the securities that was formerly a shell company has ceased to be a shell company; the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. As such, due to the fact that we had been a shell company prior to September 2011, holders of “restricted securities” within the meaning of Rule 144, when reselling their shares pursuant to Rule 144, shall be subject to the conditions set forth herein.

We do not anticipate paying cash dividends on our common stock.

You should not rely on an investment in our common stock to provide dividend income, as we have not paid dividends on our common stock, and we do not plan to pay any dividends in the foreseeable future. Instead, we plan to retain any earnings to maintain and expand our existing licensing operations, further develop our trademarks, and finance the acquisition of additional trademarks. Accordingly, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any return on their investment. In addition, our credit facility limits the amount of cash dividends we may pay while amounts under the credit facility are outstanding.

Provisions of our corporate charter documents could delay or prevent change of control.

Our certificate of incorporation authorizes our board of directors to issue up to 1,000,000 shares of preferred stock without stockholder approval, in one or more series, and to fix the dividend rights, terms, conversion rights, voting rights, redemption rights and terms, liquidation preferences, and any other rights, preferences, privileges, and restrictions applicable to each new series of preferred stock. The designation of preferred stock in the future could make it difficult for third parties to gain control of our company, prevent or substantially delay a change in control, discourage bids for the common stock at a premium, or otherwise adversely affect the market price of the common stock.

27

General Risks

A pandemic outbreak of disease or similar public health threat, or fear of such an event, could have a material adverse impact on the Company's business, operating results and financial condition.

A pandemic or outbreak of disease or similar public health threat, such as the COVID-19 pandemic, or fear of such an event, could have a material adverse impact on our business, operating results, and financial condition. The COVID-19 pandemic caused a disruption to our business, beginning in March 2020.

The impacts of the ongoing COVID-19 pandemic (including actions taken by national, state, and local governments in response to COVID-19) negatively impacted the U.S. and global economy, disrupted consumer spending and global supply chains, and created significant volatility and disruption of financial markets. The initial onset of the pandemic in 2020 resulted in a sudden decrease in sales for many of the Company’s products, from which we have yet to fully recover. The global pandemic affected the financial health of certain of our customers, and the bankruptcy of certain other customers; as a result, we may be required to make additional adjustments for doubtful accounts which would increase our operating expenses in future periods and negatively impact our operating results.

Supply chain disruptions have adversely affected, and could continue to adversely affect, our licensees’ ability to import our products in a timely manner.

The effects of the COVID-19 pandemic on the shipping industry negatively impacted our and our licensees’ ability to import our branded products in a manner that allows for timely delivery to customers. Congestion at ports of loading and ports of entry caused significant delays in deliveries and changes to the itineraries of steamship carriers. Use of alternate routes or delivery methods would require additional trucking for our licensees and their customers. Truck driver shortages, shortages of truck equipment and the inability of ports to provide reliable pick up times, also negatively impacted our and our licensees’ ability to timely receive goods in the past. If our licensees are unable to mitigate supply chain disruptions, their ability to meet customer expectations, manage inventory and complete sales could be materially adversely affected.

Contractual shipping rates have increased as a result of increased demand for container space and the logistical delays experienced by the shipping industry. Costs have increased as a result of higher contractual shipping rates and the need to purchase additional container space on the secondary market at higher spot rates. Terminals are also now imposing additional fees on importers not picking up containers on time, even when equipment and labor shortages negatively affect the ability of importers to pick up in a timely manner.

If our licensees are unable to secure container space on a vessel for our branded product due to limited availability, they may experience delays in shipping product from overseas suppliers and ultimately to their customers. Furthermore, even if they are able to secure space, ports around the world are experiencing congestion from time to time, slowing transit times of product through ports of entry which negatively affects their ability to timely receive and deliver product to their retail partners and customers.

If our licensees are unable to mitigate these supply chain disruptions, their ability to meet customer expectations, manage inventory and complete sales could be materially adversely affected, which could adversely affect our results of operations.

The Ukrainian-Russian conflict could have a material adverse impact on our business.

The Ukrainian-Russian conflict, the responses thereto, such as sanctions imposed by the United States and other western democracies, and any expansion thereof is likely to have unpredictable and wide-ranging effects on the domestic and global economy and financial markets, which could have an adverse effect on our business and results of operations. Already the conflict has caused market volatility, a sharp increase in certain commodity prices, such as wheat and oil, and an increasing number and frequency of cybersecurity threats. So far, we have not experienced any direct impact from the conflict and, as our business is conducted exclusively in the United States, we are probably less vulnerable than companies with international operations. Nevertheless, we will continue to monitor the situation carefully and, if necessary, take action to protect our business, operations, and financial condition.

28

A decline in general economic conditions resulting in a decrease in consumer spending levels and an inability to access capital may adversely affect our business.

The success of our operations depends on consumer spending. Consumer spending is impacted by a number of factors which are beyond our control, including actual and perceived economic conditions affecting disposable consumer income (such as unemployment, wages, energy costs and consumer debt levels), customer traffic within shopping and selling environments, business conditions, interest rates and availability of credit and tax rates in the general economy and in the international, regional and local markets in which our products are sold and the impact of natural disasters and pandemics and disease outbreaks such as the COVID-19 pandemic. Global economic conditions historically included significant recessionary pressures and declines in employment levels, disposable income and actual and/or perceived wealth and further declines in consumer confidence and economic growth. A depressed economic environment is often characterized by a decline in consumer discretionary spending and has disproportionately affected retailers and sellers of consumer goods, particularly those whose goods are viewed as discretionary or luxury purchases, including fashion apparel and accessories such as ours. Such factors as well as another shift towards recessionary conditions have in the past, and could in the future, devalue our brands, which could result in an impairment in its carrying value, which could be material, create downward pricing pressure on the products carrying our brands, and adversely impact our sales volumes and overall profitability. Further, economic and political volatility and declines in the value of foreign currencies could negatively impact the global economy as a whole and have a material adverse effect on the profitability and liquidity of our operations, as well as hinder our ability to grow through expansion in the international markets. In addition, domestic and international political situations also affect consumer confidence, including the threat, outbreak or escalation of terrorism, military conflicts or other hostilities around the world. Furthermore, changes in the credit and capital markets, including market disruptions, limited liquidity, and interest rate fluctuations, may increase the cost of financing or restrict our access to potential sources of capital for future acquisitions.

The risks associated with our business are more acute during periods of economic slowdown or recession. Accordingly, any prolonged economic slowdown or a lengthy or severe recession with respect to either the U.S. or the global economy is likely to have a material adverse effect on our results of operations, financial condition, and business prospects.

Inflation and/or a potential recession could adversely impact our business and results of operations.

Many of the components of our cost of goods sold are subject to price increases that are attributable to factors beyond our control, including but not limited to, global economic conditions, trade barriers or restrictions, supply chain disruptions, changes in crop size, product scarcity, demand dynamics, currency rates, water supply, weather conditions, import and export requirements, and other factors. The cost of raw materials, labor, manufacturing, energy, fuel, shipping and logistics, and other inputs related to the production and distribution of our products have increased and may continue to increase unexpectedly.

In addition, poor economic and market conditions, including a potential recession, may negatively impact market sentiment, decreasing the demand for apparel, footwear, accessories, fine jewelry, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of the inflation as well as a potential recession, our business, financial condition, and results of operations could be adversely affected.

Extreme or unseasonable weather conditions could adversely affect our business.

Extreme weather events and changes in weather patterns can influence customer trends and shopping habits. Extended periods of unseasonably warm temperatures during the fall and winter seasons, or cool weather during the summer season, may diminish demand for our seasonal merchandise. Heavy snowfall, hurricanes or other severe weather events in the areas in which our retail stores and the retail stores of our wholesale customers are located may decrease customer traffic in those stores and reduce our sales and profitability. If severe weather events were to force closure of or disrupt operations at the distribution centers we use for our merchandise, we could incur higher costs and experience longer lead times to distribute our products to our retail stores, wholesale customers or digital channel customers. If prolonged, such extreme or unseasonable weather conditions could adversely affect our business, financial condition, and results of operations.

29

Our trademarks and other intangible assets are subject to impairment charges under accounting guidelines.

Our intangible assets including our trademarks had a net carrying value of $41.5 million as of December 31, 2023 and represent a substantial portion of our assets. Under accounting principles generally accepted in the United States of America (“GAAP”), finite-lived intangible assets are amortized over their estimated useful lives, and reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. Non-renewal of license agreements or other factors affecting our market segments or brands could result in significantly reduced revenue for a brand, which could result in a devaluation of the affected trademark. If such devaluations of our trademarks were to occur, a material impairment in the carrying value of one or more of our trademarks could also occur and be charged as a non-cash expense to our operating results, which could be material. Any write-down of intangible assets resulting from future periodic evaluations would, as applicable, either decrease our net income or increase our net loss and those decreases or increases could be material.

Changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our results.

Our future effective tax rates could be adversely affected by changes in the valuation of our deferred tax assets and liabilities, or by changes in tax laws or by a change in allocation of state and local jurisdictions, or interpretations thereof. The Company currently files U.S. federal tax returns and various state tax returns. Tax years that remain open for assessment for federal and state purposes include the years ended December 31, 2020 through December 31, 2023. We regularly assess the likelihood of recovering the amount of deferred tax assets recorded on the balance sheet and the likelihood of adverse outcomes resulting from examinations by various taxing authorities in order to determine the adequacy of our provision for income taxes. Although under the 2017 Tax Cuts and Jobs Act Federal tax rates are lower, certain expenses will be either reduced or eliminated, causing the Company to have increased taxable income, which may have an adverse effect on our future income tax obligations. We cannot guarantee that the outcomes of these evaluations and continuous examinations will not harm our reported operating results and financial condition.

We must successfully maintain and/or upgrade our information technology systems.

We rely on various information technology systems to manage our operations, which subject us to inherent costs and risks associated with maintaining, upgrading, replacing, and changing these systems, including impairment of our information technology, potential disruption of our internal control systems, substantial capital expenditures, demands on management time, cyber security breaches and other risks of delays or difficulties in upgrading, transitioning to new systems, or of integrating new systems into our current systems.

System security risk issues as well as other major system failures could disrupt our internal operations or information technology services, and any such disruption could negatively impact our revenues, increase our expenses, and harm our reputation.

 

Consumers are increasingly concerned over the security of personal information transmitted over the internet, consumer identity theft, and user privacy, and any compromise of customer information could subject us to customer or government litigation and harm our reputation, which could adversely affect our business and growth. Moreover, we could incur significant expenses or disruptions of our operations in connection with system failures or breaches. In addition, sophisticated hardware and operating system software and applications that we procure from third parties may contain defects in design or manufacture, including “bugs” and other problems that could unexpectedly interfere with the operation of our systems. The costs to us to eliminate or alleviate security problems, viruses, and bugs, or any problems associated with our newly transitioned systems or outsourced services could be significant, and the efforts to address these problems could result in interruptions, delays or cessation of service that may impede our sales, distribution or other critical functions. In addition to taking the necessary precautions ourselves, we require that third-party service providers implement reasonable security measures to protect our customers’ identity and privacy as well as credit card information. We do not, however, control these third-party service providers and cannot guarantee that no electronic or physical computer break-ins and security breaches will occur in the future. We could also incur significant costs in complying with the multitude of state, federal, and foreign laws regarding the use and unauthorized disclosure of personal information, to the extent they are applicable. In the case of a disaster affecting our information technology systems, we may experience

30

delays in recovery of data, inability to perform vital corporate functions, tardiness in required reporting and compliance, failures to adequately support our operations, and other breakdowns in normal communication and operating procedures that could materially and adversely affect our financial condition and results of operations.

 

We rely significantly on information technology systems and any failure, inadequacy, interruption, or security lapse of that technology, including any cybersecurity incidents, could harm our ability to operate our business effectively and have a material adverse effect on our business, reputation, financial condition, and results of operations.

 

We rely significantly on our information technology systems to effectively manage and maintain our operations, and internal reports. Any failure, inadequacy, or interruption of that infrastructure or security lapse (whether intentional or inadvertent) of that technology, including cybersecurity incidents or attacks, could harm our ability to operate our business effectively. Our investment in ORME also leverages certain artificial intelligence (AI) technologies, which ORME’s technology partner licenses from several third parties including but not limited to Amazon and ChatGPT, and which technologies are nascent and rapidly evolving.

 

In addition, our technology systems, including our cloud technologies, continue to increase in multitude and complexity, making them potentially vulnerable to breakdown, cyberattack, and other disruptions. Potential problems and interruptions associated with the implementation of new or upgraded technology systems or with maintenance or adequate support of existing systems could disrupt or reduce the efficiency of our operations and expose us to greater risk of security breaches. Cybersecurity incidents resulting in the failure of our enterprise resource planning system, production management, or other systems to operate effectively or to integrate with other systems, or a breach in security or other unauthorized access or unavailability of these systems or those of any third parties on whom we depend, have occurred in the past and may affect our ability in the future to manage and maintain our operations, internal reports, and result in reduced efficiency of our operations.

 

As part of our business, we collect, store, and transmit large amounts of confidential information, proprietary data, intellectual property, and personal data. The information and data processed and stored in our technology systems, and those of our licensees, joint ventures, and other third parties on whom we depend to operate our business, may be vulnerable to loss, damage, denial-of-service, unauthorized access, or misappropriation. Data security incidents may be the result of unauthorized or unintended activity (or lack of activity) by our employees, contractors, or others with authorized access to our network or malware, hacking, business email compromise, phishing, ransomware, or other cyberattacks directed by third parties. While we have implemented measures to protect our information and data stored in our technology systems and those of the third parties that we rely on, our efforts may not be successful. In addition, employee error, malfeasance, or other errors in the storage, use, or transmission of any such information could result in a disclosure to third parties outside of our network. As a result, we could incur significant expenses addressing problems created by any such inadvertent disclosure or any security breaches of our network.

 

We have experienced and may continue to experience cybersecurity incidents, including an unsuccessful ransomware attack in February 2024, although to our knowledge we have not experienced any material incident or interruption to date. If such a significant event were to occur, it could result in a material disruption of our business and commercial operations, including due to a loss, corruption, or unauthorized disclosure of our trade secrets, personal data, or other proprietary or sensitive information. Further, these cybersecurity incidents can lead to the public disclosure of personal information (including sensitive personal information) of our employees, customers, and others and result in demands for ransom or other forms of blackmail. Such attacks, including phishing attacks and attempts to misappropriate or compromise confidential or proprietary information or sabotage enterprise information technology systems, are of ever-increasing levels of sophistication and are made by groups and individuals with a wide range of motives (including industrial espionage) and expertise, including by organized criminal groups, “hacktivists,” nation states, and others. Moreover, the costs to us to investigate and mitigate cybersecurity incidents could be significant. Any security breach that results in the unauthorized access, use, or disclosure of personal data may require us to notify individuals, governmental authorities, credit reporting agencies, or other parties pursuant to privacy and security laws and regulations or other obligations. Such a security compromise could harm our reputation, erode confidence in our information security measures, and lead to regulatory scrutiny. To the extent that any disruption or security breach resulted in a loss of, or damage to, our data or systems, or inappropriate disclosure of confidential, proprietary, or personal information, we could be exposed to a risk of

31

loss, enforcement measures, penalties, fines, indemnification claims, litigation and potential civil or criminal liability, which could materially adversely affect our business, financial condition and results of operations.

 

Not all our contracts contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.

 

Further, the SEC has adopted new rules that require us to provide greater disclosures around proactive security protections that we employ and reactive issues (e.g., security incidents). Any such disclosures, including those under state data breach notification laws, can be costly, and the disclosures we make to comply with, or the failure to comply with, such requirements could lead to adverse consequences.

Changes in laws could make conducting our business more expensive or otherwise change the way we do business.

We are subject to numerous domestic and international regulations, including labor and employment, customs, truth-in-advertising, consumer protection, data protection, and zoning and occupancy laws and ordinances that regulate retailers generally or govern the importation, promotion and sale of merchandise and the operation of stores and warehouse facilities. If these regulations were to change or were violated by our management, employees, vendors, independent manufacturers or partners, the costs of certain goods could increase, or we could experience delays in shipments of our products, be subject to fines or penalties, or suffer reputational harm, which could reduce demand for our merchandise and hurt our business and results of operations.

In addition to increased regulatory compliance requirements, changes in laws could make ordinary conduct of business more expensive or require us to change the way we do business. Laws related to employee benefits and treatment of employees, including laws related to limitations on employee hours, supervisory status, leaves of absence, mandated health benefits, overtime pay, unemployment tax rates and citizenship requirements, could negatively impact us, by increasing compensation and benefits costs, which would in turn reduce our profitability.

Moreover, changes in product safety or other consumer protection laws could lead to increased costs to us for certain merchandise, or additional labor costs associated with readying merchandise for sale. It is often difficult for us to plan and prepare for potential changes to applicable laws and future actions or payments related to such changes could be material to us.

If we fail to maintain an effective system of internal control, we may not be able to report our financial results accurately or in a timely fashion, and we may not be able to prevent fraud. In such case, our stockholders could lose confidence in our financial reporting, which would harm our business and could negatively impact the price of our stock.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we are required to include in our Annual Report on Form 10-K our assessment of the effectiveness of our internal control over financial reporting. We have dedicated a significant amount of time and resources to comply with this legislation for the years ended December 31, 2023 and 2022, and will continue to do so for future fiscal periods. However, our management has concluded that our internal control over financial reporting was not effective as of December 31, 2023 due to the material weakness. We cannot be certain that our internal controls will become effective or that future material changes to our internal control over financial reporting will be effective. If we cannot adequately obtain and maintain the effectiveness of our internal control over financial reporting, we may be subject to sanctions or investigation by regulatory authorities, such as the SEC. Any such action could adversely affect our financial results and the market price of our common stock. Moreover, if we discover a material weakness, the disclosure of that fact, even if quickly remedied, could reduce the market’s confidence in our financial statements and harm our stock price.

Our independent registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting until we are no longer a “smaller reporting company.” At such time that an attestation is required,

32

our independent registered public accounting firm may issue a report that is adverse or qualified in the event that they are not satisfied with the level at which our controls are documented, designed or operating. Our remediation efforts may not enable us to avoid a material weakness or significant deficiency in the future.

There are limitations on the liabilities of our directors and executive officers. Under certain circumstances, we are obligated to indemnify our directors and executive officers against liability and expenses incurred by them in their service to us.

Pursuant to our amended and restated certificate of incorporation and under Delaware law, our directors are not liable to us or our stockholders for monetary damages for breach of fiduciary duty, except for liability for breach of a director’s duty of loyalty, acts or omissions by a director not in good faith or which involve intentional misconduct or a knowing violation of law, dividend payments or stock repurchases that are unlawful under Delaware law or any transaction in which a director has derived an improper personal benefit. In addition, we have entered into indemnification agreements with each of our directors and executive officers. These agreements, among other things, require us to indemnify each director and executive officer for certain expenses, including attorneys’ fees, judgments, fines and settlement amounts, incurred by any such person in any action or proceeding, including any action by us or in our right, arising out of the person’s services as one of our directors or executive officers. The costs associated with providing indemnification under these agreements could be harmful to our business and have an adverse effect on results of operations.

Item 1B. Unresolved Staff Comments

Not applicable.

Item 1C.Cybersecurity  

In the ordinary course of business, we receive, process, use, and store digitally large amounts of data, including customer data as well as confidential, sensitive, proprietary, and personal information. Maintaining the integrity and availability of our information technology systems and this information, as well as appropriate limitations on access and confidentiality of such information, is important to us and our business operations. To this end, we have implemented a program designed to assess, identify, and manage risks from potential unauthorized occurrences on or through our information technology systems that may result in adverse effects on the confidentiality, integrity, and availability of these systems and the data residing in them.

The program is managed by our executive management team, and includes mechanisms, controls, technologies, systems, policies, and other processes designed to prevent or mitigate data loss, theft, misuse, or other security incidents or vulnerabilities affecting the systems and data residing in them. We consult with and rely upon outside advisors and experts to assist us with assessing, identifying, and managing cybersecurity risks.

We consider cybersecurity, along with other significant risks that we face, within our overall enterprise risk management framework. Our Board of Directors has oversight for the most significant risks facing us and for our processes to identify, prioritize, assess, manage, and mitigate those risks. The Board of Directors receives periodic updates on cybersecurity and information technology matters and related risk exposures from management.

Item 2.      Properties

We currently lease and maintain our corporate offices and operations facility located at 550 Seventh Avenue, 11th floor, New York, New York. We entered into a lease agreement effective February 29, 2024 for such offices of approximately 12,000 square feet of office space. This lease commenced in April 2024 and shall expire seven years from the commencement date, in 2031.

We also currently lease approximately 29,600 square feet of office space at 1333 Broadway, 10th floor, New York, New York; this location represented our former corporate offices and operations facility and shall expire on October 30, 2027. We have subleased this office space to a third-party subtenant through October 30, 2027.

33

Item 3.      Legal Proceedings

In the ordinary course of business, from time to time we become involved in legal claims and litigation. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against us is unlikely to have, individually or in the aggregate, a materially adverse effect on our business, financial position, results of operations, or cash flows.

Item 4.       Mine Safety Disclosures

None.

PART II

Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock is listed on the NASDAQ Capital Market, under the trading symbol “XELB.”

Holders

As of December 31, 2023, the number of our stockholders of record was 556 (excluding beneficial owners and any shares held in street name or by nominees).

Dividends

We have never declared or paid any cash dividends on our common stock. We expect to retain future earnings to finance our operations and expansion. The payment of cash dividends in the future will be at the discretion of our board of directors and will depend upon our earnings levels, capital requirements, any restrictive loan covenants, and other factors the board of directors considers relevant.

Securities authorized for issuance under equity compensation plans

2021 Equity Incentive Plan

Our 2021 Equity Incentive Plan, which we refer to as the 2021 Plan, is designed and utilized to enable the Company to offer its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. The following is a description of the 2021 Plan.

The 2021 Plan provides for the grant of stock options, restricted stock, restricted stock units, performance awards, or cash awards (any grant under the 2021 Plan, an “Award”). The stock options may be incentive stock options or non-qualified stock options.
A total of 4,000,000 shares of common stock are eligible for issuance under the 2021 Plan.
The 2021 Plan may be administered by the Board of Directors (the “Board”) or a committee consisting of two or more members of the Board of Directors appointed by the Board (for purposes of this description, any such committee, a “Committee”).
Officers and other employees of our Company or any parent or subsidiary of our Company who are at the time of the grant of an Award employed by us or any parent or subsidiary of our Company are eligible to be granted

34

options or other Awards under the 2021 Plan. In addition, non-qualified stock options and other Awards may be granted under the 2021 Plan to any person, including, but not limited to, directors, independent agents, consultants, and attorneys who the Board or the Committee, as the case may be, believes has contributed or will contribute to our success.
With respect to incentive stock options granted to an eligible employee owning stock possessing more than 10% of the total combined voting power of all classes of our stock or the stock of a parent or subsidiary of our Company immediately before the grant (each, a “10% Stockholder”), such incentive stock option shall not be exercisable more than 5 years from the date of grant.
The exercise price of a stock option will not be less than the fair market value of the shares underlying the option on the date the option is granted, provided, however, that the exercise price of a stock option granted to a 10% Stockholder may not be less than 110% of such fair market value.
Restricted stock awards give the recipient the right to receive a specified number of shares of common stock, subject to such terms, conditions and restrictions as the Board or the Committee, as the case may be, deems appropriate. Restrictions may include limitations on the right to transfer the stock until the expiration of a specified period of time and forfeiture of the stock upon the occurrence of certain events such as the termination of employment prior to expiration of a specified period of time.
Restricted stock unit awards will be settled in cash or shares of common stock, in an amount based on the fair market value of our common stock on the settlement date. The RSUs will be subject to forfeiture and restrictions on transferability as set forth in the 2021 Plan and the applicable award agreement and as may be otherwise determined by the Board or the Committee. There were no RSUs outstanding as of December 31, 2023.
Certain Awards made under the Plan may be granted so that they qualify as “performance-based compensation” (as this term is used in Internal Revenue Code Section 162(m) and the regulations thereunder) and are exempt from the deduction limitation imposed by Code Section 162(m) (these Awards are referred to as “Performance-Based Awards”). Under Internal Revenue Code Section 162(m), our tax deduction may be limited to the extent total compensation paid to the chief executive officer, or any of the four most highly compensated executive officers (other than the chief executive officer) exceeds $1 million in any one tax year. In accordance with the 2017 Tax Cuts and Jobs Act, the tax deductibility for each of these executives will be limited to $1,000,000 of compensation annually, including any performance-based compensation. Among other criteria, Awards only qualify as performance-based awards if at the time of grant the compensation committee is comprised solely of two or more “outside directors” (as this term is used in Internal Revenue Code Section 162(m) and the regulations thereunder). In addition, we must obtain stockholder approval of material terms of performance goals for such “performance-based compensation.”
All stock options and certain stock awards, performance awards, and stock units granted under the Plan, and the compensation attributable to such Awards, are intended to (i) qualify as performance-based awards or (ii) be otherwise exempt from the deduction limitation imposed by Internal Revenue Code Section 162(m).
Cash awards may be issued under the 2021 Plan either alone or in addition to or in tandem with other Awards granted under the 2021 Plan or other payments made to a participant not under the 2021 Plan. The Board or Committee shall determine the eligible persons to whom, and the time or times at which, cash awards will be made, the amount that is subject to the cash award, the circumstances and conditions under which such amount shall be paid, in whole or in part, the time of payment, and all other terms and conditions of the Awards. Each cash award shall be confirmed by, and shall be subject to the terms of, an agreement executed
No Awards may be granted on or after the tenth anniversary of the effective date of the 2021 Plan.

35

2011 Equity Incentive Plan

The key terms and provisions of our Amended and Restated 2011 Equity Incentive Plan, which we refer to as the 2011 Plan, were substantially similar to the 2021 Plan described above, with the major difference being the number of shares of common stock reserved for issuance under the 2011 Plan. Stock-based awards (including options, warrants, and restricted stock) previously granted under the 2011 Plan remain outstanding, and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Issuances

From time to time, the Company issues stock-based compensation to its officers, directors, employees, and consultants through its equity compensation plans. The maximum term of options granted is generally five years and generally options vest over a period of six months to two years. However, the Board may approve other vesting schedules. Options may be exercised in whole or in part. The exercise price of stock options granted is generally the fair market value of the Company’s common stock on the date of grant.

The fair value of each stock option award is estimated using the Black-Scholes option pricing model based on certain assumptions. The assumption for expected term is based on evaluations of expected future employee exercise behavior. Because of a lack of historical information related to exercise activity, we use the simplified method to determine the expected term. The risk-free interest rate is based on the U.S. Treasury rates at the date of grant with maturity dates approximately equal to the expected term at the grant date. The historical volatility of our common stock is used as the basis for the volatility assumption. The Company has never paid cash dividends, and does not currently intend to pay cash dividends, and thus assumes a 0% dividend yield.

The following table sets forth information as of December 31, 2023 regarding compensation plans under which our equity securities are authorized for issuance:  

Number of Securities

Number of Securities

Remaining Available for

to be Issued Upon

Weighted Average

Future Issuance Under

Exercise of

Exercise Price of

Equity Compensation Plans

Outstanding Options,

Outstanding Options,

(Excluding Securities

Warrants and Rights

Warrants and Rights

Reflected in Column (a))

Plan Category

    

(a)

    

(b)

    

(c)

Equity compensation Plans (1)

5,264,605

$

2.05

3,103,941

(1)   Pursuant to our 2011 and 2021 Equity Incentive Plans.

Recent Sales of Unregistered Securities

There were no sales of unregistered or registered securities during the years ended December 31, 2023 and 2022.

Purchases of equity securities by the issuer and affiliated purchasers

We did not repurchase any shares of common stock during the fourth fiscal quarter ended December 31, 2023.

Item 6.[Reserved]

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read together with our consolidated financial statements and the notes thereto, included in Item 8 of this Annual Report on Form 10-K. This discussion summarizes the significant factors affecting our consolidated operating results, financial condition and liquidity and cash flows for the years ended December 31, 2023 and 2022. Except for historical information, the matters discussed in this Management’s Discussion

36

and Analysis of Financial Condition and Results of Operations are forward-looking statements that involve risks and uncertainties and are based upon judgments concerning factors that are beyond our control.

Overview

Xcel Brands is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce. Currently, Xcel’s brand portfolio consists of the LOGO by Lori Goldstein Brand, the Halston Brand, the Ripka Brand, the C Wonder Brand, the Longaberger Brand, the CB Brand, the Isaac Mizrahi Brand, and other proprietary brands, including:

the Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand, which are wholly owned by the Company;
the Longaberger Brand, which we manage through our 50% ownership interest in Longaberger Licensing, LLC, and the CB Brand, which is a co-owned brand between Xcel and Christie Brinkley; and
the Isaac Mizrahi Brand, which we wholly owned and managed through May 31, 2022. On May 31, 2022, we sold a majority interest in the brand to a third party, but retained a 30% noncontrolling interest in the brand and continue to contribute to the operations of the brand through a service agreement.

We also own a 30% interest in ORME Live Inc. (“ORME”), a short-form video and social commerce marketplace that launched in the first quarter of 2024.

Xcel continues to pioneer a true omni-channel and social commerce sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. Our brands have generated over $5 billion in retail sales via live streaming in interactive television and digital channels alone, and our brands collectively reach over 5 million social media followers through Facebook, Instagram, and TikTok. All of the followers may not be unique followers, as many followers may follow multiple brands and follow our brands on multiple platforms.

Our objective is to build a diversified portfolio of lifestyle consumer products brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

distribution and/or licensing our brands for sale through interactive television (e.g., QVC, HSN, The Shopping Channel, JTV, etc.);
licensing of our brands to retailers that sell to the end consumer;
direct-to-consumer distribution of our brands through e-commerce and live streaming;
licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels; and
acquiring additional consumer brands and integrating them into our operating platform, and leveraging our operating infrastructure and distribution relationships.

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

our management team, including our officers’ and directors’ experience in, and relationships within the industry;

37

our deep knowledge, expertise, and proprietary technology in live streaming and social commerce;
our design, sales, marketing, and technology platform that enables us to design trend-right product; and
our significant media and digital presence.

Business Model and Operations Restructuring

In the first quarter of 2023, we began to restructure and transition our business operations from a more capital-intensive wholesale/licensing hybrid model to a capital-light “licensing plus” model, by entering into new licensing agreements with best-in-class business partners. We entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a JTV (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions were executed. In conjunction with the launch of the C Wonder Brand on HSN, we licensed the wholesale production operations related to that brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes other new celebrity brands that we plan to launch in 2024 and beyond.

In the second quarter of 2023, we entered into a new master license agreement with G-III Apparel Group, an industry-leading wholesale apparel company, for the Halston Brand, covering men’s, women’s, and children’s apparel and accessories, and other product categories, for distribution through department stores, e-commerce, and other retailers. This master license for the Halston Brand provides for an upfront cash payment and royalties to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term.

The transition of these operating businesses was substantially completed by the end of the second quarter of 2023.

In the third quarter of 2023, we entered into various settlements and incurred approximately $1 million of expenses to restructure certain contractual arrangements related to our former wholesale operations.

In the fourth quarter of 2023, we entered into a new term loan agreement, which provided us with approximately $5 million of additional liquidity. Additionally, Longaberger Licensing, LLC outsourced the operations of the Longaberger Brand through a license agreement with a third party to operate and manage the Longaberger e-commerce website  ’s e-commerce business to a third party.

Overall, we believe that this evolution of our operating model will provide significant cost savings and allow us to reduce and better manage our exposure to operating risks. As of December 31, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Critical Accounting Policies and Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that are the most important to the portrayal of our financial condition and results of operations, and that require our most difficult, subjective, and complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. Critical accounting estimates are those that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results of operations. While our significant accounting policies and estimates are described in more detail in the notes to our consolidated financial statements, our most critical accounting policies and estimates, discussed below, pertain to revenue recognition, trademarks and other intangible assets, income taxes, and equity method investments. These include but are not limited to the estimation of the useful lives of our trademarks, the estimation of the future cash flows related to our trademarks, and the estimation of our incremental borrowing rate (for purposes of accounting for leases). In applying such policies, we must use some amounts that are based upon our informed judgments and best estimates.

38

Estimates, by their nature, are based upon judgments and available information. The estimates that we make are based upon historical factors, current circumstances, and the experience and judgment of management. We evaluate our assumptions and estimates on an ongoing basis.

Revenue Recognition

Licensing

In connection with our “licensing plus” business model, we follow Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606-10-55-65, by which we recognize licensing revenue at the later of when (1) the subsequent sale or usage occurs or (2) the performance obligation to which some or all of the sales- or usage-based royalty has been allocated is satisfied (in whole or in part). More specifically, we separately identify:

(i)   Contracts for which, based on experience, royalties are expected to exceed any applicable minimum guaranteed payments, and to which an output-based measure of progress based on the “right to invoice” practical expedient is applied because the royalties due for each period correlate directly with the value to the customer of our performance in each period (this approach is identified as “View A” by the FASB Revenue Recognition Transition Resource Group, “TRG”); and

(ii)   Contracts for which revenue is recognized based on minimum guaranteed payments using an appropriate measure of progress, in which minimum guaranteed payments are straight-lined over the term of the contract and recognized ratably based on the passage of time, and to which the royalty recognition constraint to the sales-based royalties in excess of minimum guaranteed is applied and such sales-based royalties are recognized to the distinct period only when the minimum guaranteed is exceeded on a cumulative basis (this approach is identified as “View C” by the TRG).

Wholesale Sales

Prior to the restructuring of our business model and operations in 2023, we generated a portion of our revenue through sale of branded jewelry and apparel to both domestic and international customers who, in turn, sold the products to their consumers. We recognized revenue from such transactions within net sales in the accompanying consolidated statements of operations when performance obligations identified under the terms of contracts with our customers were satisfied, which occurred upon the transfer of control of the merchandise in accordance with the contractual terms and conditions of the sale. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Direct-to-Consumer Sales

Our revenue associated with our e-commerce jewelry operations and the Longaberger brand (prior to the restructuring of our business model and operations in 2023) was recognized within net sales in the accompanying consolidated statements of operations at the point in time when product is shipped to the customer. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Trademarks and Other Intangible Assets

Our finite-lived intangible assets (primarily trademarks, along with other intangible assets) are amortized over their estimated useful lives, which are estimated based principally on our expected use and strategic plans for each asset, our own historical experience with similar assets, and our expectations related to demand, competition, and other economic factors.

Our finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To test our finite-lived intangible assets for impairment, we group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows

39

do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flows analysis or appraisals.

There were no impairment charges recorded for our intangible assets for the years ended December 31, 2023 and 2022.

Income Taxes

Income tax expense is the tax payable for the period and the change during the period in deferred tax assets and liabilities. Deferred income taxes are determined based on the temporary difference between the financial reporting and tax bases of assets and liabilities using enacted rates in effect during the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. We consider forecasted earnings, future taxable income, and prudent and feasible tax planning strategies in determined the need for these valuation allowances.

With respect to any uncertainties in income taxes recognized in our financial statements, tax positions are initially recognized in the financial statements when it is more likely than not that the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax benefit that has a probability of fifty percent or greater of being realized upon ultimate settlement with the tax authority, assuming full knowledge of the position and all relevant facts. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2020 through December 31, 2023.

Equity Method Investments

We account for our investments in entities over which we have the ability to exercise significant influence, but do not control, under the equity method of accounting, and we recognize our proportionate share of income or losses from the entity within other operating costs and expenses (income) in the consolidated statement of operations.

We initially measure our investment in an equity method investee at cost. In cases where we retain a noncontrolling interest in an investee which we had previously consolidated, we initially measure such retained interest at fair value. In estimating fair value in such cases, we seek to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

Subsequent recognition of an investor’s proportionate share of income or losses of an equity method investee is generally determined based on the investor’s proportional ownership interest. However, in cases where contractual agreements specify allocation ratios for profits and losses, specified costs and expenses, and/or distributions of cash from operations, that differ from our ownership interest, we use such specified allocation ratios for purposes of determining our share of income or losses from the investee if the agreement is considered substantive.

Recently Adopted Accounting Pronouncements

We adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which generally results in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on our results of operations, cash flows, or financial condition.

40

Summary of Operating Results

The consolidated financial statements and related notes included elsewhere in this Form 10-K are as of or for the years ended December 31, 2023 (the “Current Year”), and December 31, 2022 (the “Prior Year”).

Revenues

Current Year net revenue decreased $8.0 million to $17.8 million from $25.8 million for the Prior Year.

Net licensing revenue decreased by approximately $5.5 million in the Current Year to approximately $9.2 million, compared with approximately $14.7 million in the Prior Year. This decrease in licensing revenue was primarily attributable to the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand through the sale of a 70% interest in IM Topco, LLC to WHP, partially offset by increased licensing revenue generated by the C Wonder brand through interactive television.

Net sales decreased by approximately $2.5 million in the Current Year to approximately $8.6 million, compared with approximately $11.1 million in the Prior Year. This decrease in net sales was primarily attributable to the exit from our wholesale apparel and fine jewelry sales operations in the Current Year as part of the restructuring and transformation of our business operating model.

Cost of Goods Sold and Gross Profit

Current Year cost of goods sold was $6.9 million, compared with $8.0 million for the Prior Year.

Gross profit margin from net product sales (net sales less cost of goods sold, divided by net sales) decreased from approximately 28% in the Prior Year to approximately 20% in the Current Year. This decrease in gross profit margin percentage was the result of selling our remaining jewelry inventory at an agreed-upon price which was less than historical margins and the sale of our remaining apparel inventory at discounted prices.

Gross profit (net revenue less cost of goods sold) decreased approximately $7.0 million to $10.8 million from $17.8 million in the Prior Year, primarily driven by the aforementioned decrease in net licensing revenue.

Direct Operating Costs and Expenses

Direct operating costs and expenses decreased approximately $9.8 million from $33.1 million in the Prior Year to $23.3 million in the Current Year. This decrease was primarily attributable to lower salaries, benefits and employment costs, driven by the combination of (i) the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand and the transfer of the employees associated with the Isaac Mizrahi brand to the IM Topco, LLC business venture, and (ii) reductions in staffing levels and other costs during 2023 related to the restructuring and transformation of our business operating model. These decreases were partially offset by $0.8 million in costs related to the restructuring of certain contractual arrangements in connection with the shift and evolution in the Company’s business operations, and also by a $0.1 million impairment charge related to certain capitalized software assets.

Other Operating Costs and Expenses (Income)

Depreciation and amortization expense was approximately $7.0 million and $7.3 million in the Current Year and Prior Year, respectively.

In the Prior Year, we recognized a gain on the sale of a majority interest in the Isaac Mizrahi brand of approximately $20.6 million, which was comprised of $46.2 million of cash proceeds plus the recognition of the fair value of our retained interest in the brand of $19.8 million, less $0.9 million of fees and expenses directly related to the transaction and the derecognition of the brand trademarks previously recorded on our balance sheet of $44.5 million.

41

We account for our interest in the ongoing operations of IM Topco, LLC using the equity method of accounting. We recognized an equity method loss related to our investment of $2.1 million and $1.2 million for the Current Year and Prior Year, respectively, based on the distribution provisions set forth in the related business venture agreement.

Also during the Current Year, we recognized a gain of $0.36 million related to the sale of a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016, and recognized a gain of $0.44 million related to a lease termination settlement with the landlord of our former retail store location.

In the Prior Year, we recognized a $0.9 million gain on the reduction of contingent obligations. In connection with our 2019 purchase of the Halston Heritage trademarks, we agreed to pay the seller additional consideration if certain royalty targets were met from 2019 through December 31, 2022. This potential earn-out was initially recorded as a liability of $0.9 million, based on the difference at the date of acquisition between the fair value of the acquired assets of the Halston Heritage trademarks and the total consideration paid. The final royalty target year ended on December 31, 2022, and the seller ultimately did not earn any additional consideration based on the formula set forth in the related asset purchase agreement.

Interest and Finance Expense

Interest and finance expense for the Current Year was $0.4 million, compared with $3.5 million for the Prior Year.

In the Prior Year, we incurred $1.2 million of interest expense related to term loan debt, reflecting an effective interest rate of approximately 9.8% on an average principal balance of $28.7 million from January 1, 2022 through May 31, 2022. We repaid all of such term loan debt on May 31, 2022 and recognized a loss on early extinguishment of debt of $2.3 million in the Prior Year.

In contrast, during the Current Year we did not have any outstanding debt for most of the year. In October 2023, we entered into a new term loan agreement for a borrowing of $5.0 million at a floating interest rate, incurring total interest expense of only $0.4 million during the Current Year.

Income Tax Provision (Benefit)

The effective income tax rate for the Current Year was approximately -6%, resulting in a $1.2 million income tax provision. During the Current Year, the federal statutory rate differed from the effective tax rate primarily due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

The effective income tax rate for the Prior Year was approximately 10%, resulting in a $0.4 million income tax benefit. During the Prior Year, the effective tax rate was primarily attributable to the impacts of stock-based compensation, which decreased the effective rate by approximately 6%, and federal tax true-ups, which decreased the effective tax rate by approximately 5%. The effective tax rate was also impacted by recurring permanent differences; the largest such recurring permanent differences were state and local tax provisions, which increased the effective rate in 2022 by approximately 6%, and disallowed excess compensation, which decreased the effective rate in 2022 by approximately 5%.

Net Loss

We had a net loss of approximately $21.1 million for the Current Year, compared with a net loss of approximately $4.0 million for the Prior Year, as a result of the factors discussed above.

42

Non-GAAP Net Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of $12.2 million or $(0.62) per share (“non-GAAP diluted EPS”) based on 19,711,637 weighted average shares outstanding for the Current Year, compared with a non-GAAP net loss of $15.0 million or $(0.77) per share based on 19,624,669 weighted average shares outstanding for the Prior Year. Non-GAAP net income is a non-GAAP unaudited term, which we define as net income (loss) attributable to Xcel Brands, Inc. stockholders, exclusive of asset impairments, amortization of trademarks, our proportional share of trademark amortization of equity method investees, stock-based compensation and cost of licensee warrants, loss on extinguishment of debt, certain adjustments to the provision for doubtful accounts related to the bankruptcy of and economic impact on certain retail customers, gains on sales of assets and investments, gain on lease termination, gain on reduction of contingent obligation, and income taxes. Non-GAAP net income and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy.

We had Adjusted EBITDA of approximately $(5.7) million for the Current Year, compared with Adjusted EBITDA of approximately $(12.5) million for the Prior Year. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to Xcel Brands, Inc. stockholders before asset impairments, depreciation and amortization, our proportional share of trademark amortization of equity method investees, interest and finance expenses (including loss on extinguishment of debt, if any), income taxes, other state and local franchise taxes, stock-based compensation and cost of licensee warrants, certain adjustments to the provision for doubtful accounts related to the bankruptcy of and economic impact on certain retail customers, gains on sales of assets and investments, gain on lease termination, gain on reduction of contingent obligation, and costs associated with restructuring of operations. Costs associated with restructuring of operations include the current year operating losses generated by certain of our businesses that have been restructured or discontinued (i.e., wholesale apparel and fine jewelry), as well as non-cash charges associated with the restructuring of certain contractual arrangements.

Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company’s results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results.

Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do.

In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

43

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net loss:  

 

Year Ended December 31, 

($ in thousands)

 

2023

    

2022

Net loss attributable to Xcel Brands, Inc. stockholders

$

(21,052)

$

(4,018)

Asset impairments

100

274

Amortization of trademarks

 

6,085

 

6,079

Proportional share of trademark amortization of equity method investee

2,060

1,202

Stock-based compensation and cost of licensee warrants

 

242

 

620

Loss on early extinguishment of debt

2,324

Certain adjustments to provision for doubtful accounts

413

Gains on sales of assets and investments

(359)

(20,586)

Gain on lease termination

(445)

Gain on reduction of contingent obligation

(900)

Income tax provision (benefit)

 

1,212

 

(431)

Non-GAAP net loss

$

(12,157)

$

(15,023)

The following table is a reconciliation of diluted loss per share to non-GAAP diluted EPS:

Year Ended December 31, 

    

2023

    

2022

Diluted net loss attributable to Xcel Brands, Inc. stockholders

$

(1.07)

$

(0.20)

Asset impairments

0.01

0.01

Amortization of trademarks

 

0.31

 

0.31

Proportional share of trademark amortization of equity method investee

0.10

0.06

Stock-based compensation and cost of licensee warrants

 

0.01

 

0.03

Loss on early extinguishment of debt

0.12

Certain adjustments to provision for doubtful accounts

0.02

Gains on sales of assets and investments

(0.02)

(1.05)

Gain on lease termination

(0.02)

Gain on reduction of contingent obligation

(0.05)

Income tax provision (benefit)

 

0.06

 

(0.02)

Non-GAAP diluted EPS

$

(0.62)

$

(0.77)

Diluted weighted average shares outstanding

 

19,711,637

 

19,624,669

44

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

Year Ended December 31, 

($ in thousands)

    

2023

    

2022

Net loss attributable to Xcel Brands, Inc. stockholders

$

(21,052)

$

(4,018)

Asset impairments

 

100

 

274

Depreciation and amortization

 

6,954

 

7,263

Proportional share of trademark amortization of equity method investee

2,060

1,202

Interest and finance expense

 

381

 

3,527

Income tax provision (benefit)

 

1,212

 

(431)

State and local franchise taxes

 

76

 

102

Stock-based compensation and cost of licensee warrants

 

242

 

620

Certain adjustments to provision for doubtful accounts

413

Gains on sales of assets and investments

(359)

(20,586)

Gain on lease termination

(445)

Gain on reduction of contingent obligation

 

 

(900)

Costs associated with restructuring of operations

5,106

Adjusted EBITDA

$

(5,725)

$

(12,534)

Liquidity and Capital Resources

General

As of December 31, 2023 and 2022, our cash and cash equivalents were $3.0 million and $4.6 million, respectively.

Our principal capital requirements have been to fund working capital needs, acquire new brands, and to a lesser extent, capital expenditures. Notwithstanding certain investments made in 2020 and 2021, our current “licensing plus” operating model is a working capital light business model, and generally does not require material capital expenditures. As of December 31, 2023, we have no significant commitments for future capital expenditures. Material cash requirements from known contractual and other obligations are discussed under “Obligations and Commitments” below.

Working Capital

Our working capital (current assets less current liabilities, excluding the current portion of lease obligations and any contingent liabilities payable in common stock) was $2.1 million and $8.8 million as of December 31, 2023 and 2022, respectively. Commentary on components of our cash flows for the Current Year compared with the Prior Year is set forth below.

Liquidity and Management’s Plans

We incurred net losses of approximately $21.1 million and $5.4 million during the years ended December 31, 2023 and 2022, respectively (which included non-cash expenses of approximately $9.0 million and $8.2 million, respectively), and had an accumulated deficit of approximately $53.8 million and $32.8 million as of December 31, 2023 and 2022, respectively. Net cash used in operating activities was $6.5 million in 2023 and $14.2 million in 2022. These factors raise uncertainties about the Company’s ability to continue as a going concern.

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar

45

transactions were executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to develop and launch in 2024 and beyond. In the second quarter of 2023, the Company entered into a new master license agreement for the Halston Brand, covering men’s, women’s, and children’s apparel, fashion accessories, and other product categories, with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers.

These restructuring initiatives were substantially completed as of June 30, 2023.  

Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Further, in October 2023, the Company entered into a new term loan agreement in the amount of $5 million. Subsequent to year end, in January 2024, the Company entered into a sublease of its offices at 1333 Broadway in New York, NY, and in March 2024, the Company issued new shares of common stock for net proceeds of approximately $2 million.

Based on these recent events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Annual Report on Form 10-K; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of December 31, 2023, have been alleviated.

Operating Activities

Net cash used in operating activities was approximately $6.5 million and $14.2 million in the Current Year and Prior Year, respectively.

The Current Year’s cash used in operating activities was primarily attributable to the combination of the net loss of $(22.2) million, partially offset by non-cash items of approximately $10.5 million and a net change in operating assets and liabilities of approximately $5.2 million. Non-cash items were primarily comprised of, but not limited to, $7.0 million of depreciation and amortization, the $2.1 million undistributed proportional share of net loss of equity method investee, $1.1 million of deferred taxes, and $0.8 million of bad debt expense, partially offset by a $(0.4) million gain on the sale of a financial asset and a $(0.4) million gain on the settlement of a lease liability. The net change in operating assets and liabilities was primarily comprised of (i) an increase in deferred revenue of approximately $4.4 million, which was mainly attributable to the upfront payment received for the Halston Master License agreement entered into during the Current Year, (ii) a decrease in inventory of approximately $2.4 million, driven by the sale of all of our C Wonder apparel inventory to HSN and the sale of all of our Judith Ripka fine jewelry inventory to JTV, as part of the restructuring and transformation of our business operating model. Partially offsetting these net changes in operating assets and liabilities were decreases in various operating liabilities of approximately $(2.9) million.

The Prior Year’s cash used in operating activities was primarily attributable to the combination of the net loss of $(5.4) million plus non-cash items of approximately $(10.2) million, partially offset by a net change in operating assets and liabilities of approximately $1.4 million. Non-cash items were primarily comprised of, but not limited to, the net gain on sale of assets of $(20.6) million, $7.3 million of depreciation and amortization, a $2.3 million loss on extinguishment of debt, and the $1.2 million undistributed proportional share of net income of equity method investee. The net change in operating assets and liabilities notably included a decrease in accounts receivable of $2.1 million, a decrease in inventory of $0.5 million, a decrease in prepaid expenses and other assets of $0.6 million, and decreases in various operating liabilities of $(1.4) million. The decrease in accounts receivable was primarily related to the Prior Year sale of a majority interest in the Isaac Mizrahi brand, resulting in lower licensing revenues and thus lower receivable balances. The decreases in inventory and other operating assets and liabilities were primarily reflective of the declines in our wholesale business due to retailers pausing or canceling orders during the Prior Year.

46

Investing Activities

Net cash provided by investing activities for the Current Year was approximately $0.2 million, primarily driven by $0.5 million of proceeds received from the sale of a limited partner ownership interest in an unconsolidated affiliate, partially offset by approximately $0.2 million capital contributions made to a new equity method investee.

Net cash provided by investing activities for the Prior Year was approximately $44.5 million, and was attributable to $45.4 million of net proceeds from the sale of a majority interest in the Isaac Mizrahi brand to WHP, partially offset by $0.6 million of capital contributions to our equity method investee IM Topco and approximately $0.3 million of capital expenditures.  

Financing Activities

Net cash provided by financing activities for the Current Year was approximately $4.7 million, which primarily consisted of $5.0 million of proceeds from borrowings incurred under new term loan debt, partially offset by the payment of $0.3 million of debt issuance costs.  

Net cash used in financing activities for the Prior Year was approximately $31.0 million, which mainly consisted of $29.0 million of repayments of our term loan debt, and, to a lesser extent, $1.5 million of prepayment and other fees associated with the early extinguishment of debt, as well as $0.4 million of shares repurchased related to withholding taxes on vested restricted stock.  

Equity Transactions – Public Offering and Private Placement

On March 19, 2024, the Company closed on a public offering of 3,284,421 shares of common stock at an offering price of $0.65 per share and a private placement of 294,642 shares of common stock at an offering price of $0.98 per share. In connection with the public offering, Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares of common stock, respectively. Robert W. D’Loren, an affiliate of Mark DiSanto, and Seth Burroughs also purchased 132,589, 132,589, and 29,464 shares of common stock, respectively, in the private placement.  The aggregate net proceeds from the equity transactions were approximately $2.0 million.

Obligations and Commitments

Term Loan Debt

On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned subsidiary of Xcel Brands, Inc., entered into a term loan agreement (the “Loan Agreement”) with Israel Discount Bank of New York (“IDB”). Pursuant to the Loan Agreement, IDB made a term loan in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the Loan Agreement of approximately $0.1 million (including a commitment fee paid to IDB in the amount of $50,000 and legal fees paid to counsel of IDB in the amount of $82,000), and may be used for working capital purposes.

In connection with the Loan Agreement, the Borrower and H Licensing, LLC (“H Licensing”), another wholly owned subsidiary of Xcel, entered into a security agreement in favor of IDB, and Xcel entered into a membership interest pledge agreement in favor of IDB. Pursuant to the security agreement, the Borrower and H Licensing granted IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the Loan Agreement.  Pursuant to the membership interest pledge agreement, Xcel granted IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the Loan Agreement.

47

The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.

Interest on the term loan accrues at Term SOFR (defined in the Loan Agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month.

The Loan Agreement contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, and minimum cash balance levels, all as specified and defined in the Loan Agreement.

In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the term loan principal amount.

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, we agreed to pay the seller additional cash consideration of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out of was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and thus $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability. The $0.2 million of additional consideration was paid to the seller during 2023.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately 1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. Accordingly, as of December 31, 2023, $1.0 million of the remaining balance was recorded as a current liability and approximately $5.4 million was recorded as a long-term liability.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi brand, we agreed with WHP (the buyer) that, in the event that IM Topco, LLC receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from us up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by us in either cash or equity interests in IM Topco, LLC held by us.

In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. No amount has been recorded in the Company’s consolidated balance sheets related to this contingent obligation.

Subsequently, in April 2024, the Company, WHP, and IM Topco, LLC entered into an amendment of this agreement, such that the purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025. Additionally, the parties agreed that if IM Topco, LLC royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco, LLC to WHP, such that Xcel’s ownership interest in IM Topco,

48

LLC would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco, LLC would increase from 70% to 82.5%

Contingent Obligation – Halston Heritage Earn-Out

In connection with the February 11, 2019 purchase of the Halston Heritage trademarks, we agreed to pay the seller additional consideration of up to an aggregate of $6.0 million, based on royalties earned from 2019 through December 31, 2022. The final royalty target year ended on December 31, 2022, and the seller ultimately did not earn any additional consideration based on the formula set forth in the related asset purchase agreement. As such, during the year ended December 31, 2022, we recorded a $0.9 million gain on the reduction of contingent obligations in the accompanying consolidated statement of operations. As of December 31, 2022, there were no amounts remaining under the Halston Heritage Earn-Out.

Real Estate Leases

As described in Item 2 of this Annual Report on Form 10-K, as of December 31, 2023 we had a lease for approximately 29,600 square feet of office space at 1333 Broadway, 10th floor, New York, New York. Future payments under this lease are expected to be approximately $1.6 million for each of the years ending December 31, 2024 – 2026, and $1.3 million for the year ending December 31, 2027.

Subsequent to December 31, 2023, we entered into a new lease of office space at 550 Seventh Avenue, 11th floor, New York, New York, and a sublease of our office space at 1333 Broadway. These leasing transactions are further described in Item 8, Note 12 of this Annual Report on Form 10-K.

Employment Contracts

We have entered into contracts with certain executives and key employees. The future minimum payments under these contracts is expected to be approximately $17.7 million, of which, approximately $4.3 million is expected to be paid in 2024, approximately $2.1 million is expected to be paid for each of the years ending December 31, 2025 – 2030, and approximately $0.5 million is expected to be paid in 2031.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations or liquidity.

49

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Lori Goldstein brand, Halston brand, C Wonder brand, and TowerHill by Christie Brinkley brand have a core business in fashion apparel and accessories. The Ripka brand is a fine jewelry business, and the Longaberger brand focuses on home good products, which we believe helps diversify our industry focus while at the same time complements our business operations and relationships.

While the 2022 sale of a majority interest in the Isaac Mizrahi brand has resulted in a decrease in our revenues, as that brand represented a significant portion of our historical revenues, we are taking actions to replace those revenues in the long-term with new strategic business initiatives, as we concentrate our resources on growing our brands, launching new brands, and entering into new business partnerships. We continue to seek new opportunities, including expansion through interactive television, live streaming, and additional domestic and international licensing arrangements, and acquiring and collaborating with additional brands, launching the C Wonder by Christian Siriano business on HSN, and the planned May 2024 launch of the TowerHill by Christie Brinkley brand.

During 2023, we restructured our business operations by shifting our business from a wholesale/licensing hybrid model into a “licensing plus” business model. These efforts included entering into new structured contractual arrangements with best-in-class business partners in order to more efficiently operate our wholesale and e-commerce businesses and reduce and better manage our exposure to operating risks. These restructuring initiatives, on a go-forward basis, are expected to provide us with approximately $15 million of cost savings on an annualized basis compared to our previous operating model.

However, we continue to face a number of headwinds in the current macroeconomic environment. Poor economic and market conditions, including inflation, rising consumer debt levels, and a potential recession, may negatively impact market sentiment, decreasing the demand for apparel, footwear, accessories, fine jewelry, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of inflation and/or a potential recession, our business, financial condition, and results of operations could be adversely affected.

Our long-term success, however, will still remain largely dependent on our ability to build and maintain our brands’ awareness and continue to attract wholesale and direct-to-consumer customers, and contract with and retain key licensees and business partners, as well as our and our licensees’ ability to accurately predict upcoming fashion and design trends within their respective customer bases and fulfill the product requirements of the particular retail channels within the global marketplace. Unanticipated changes in consumer fashion preferences and purchasing patterns, slowdowns in the U.S. economy, changes in the prices of supplies, consolidation of retail establishments, and other factors noted in the section captioned “Risk Factors” could adversely affect our licensees’ ability to meet and/or exceed their contractual commitments to us and thereby adversely affect our future operating results.

Item 7A.Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

50

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors of

Xcel Brands, Inc. and Subsidiaries

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Xcel Brands, Inc. and Subsidiaries (collectively, the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of operations, stockholders’ equity and cash flows for each of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Liquidity and Management’s Plans

Critical Audit Matter Description

As described further in Note 1 to the financial statements, the Company has incurred recurring losses from operations, has used net cash in operating activities, and has an accumulated deficit. The ability of the Company to continue as a going concern is dependent on executing its business plans and meeting its obligations as they come due within the next twelve months from the filing date of this Annual Report on Form 10-K. Accordingly, the Company has determined that these factors raise uncertainty as to the Company’s ability to continue as a going concern. However, management has

52

implemented plans which are expected to mitigate these conditions or events, and therefore, has concluded that such conditions or events have been alleviated.

How the Critical Audit Matter was Addressed in the Audit

We determined the Company’s ability to continue as a going concern is a critical audit matter due to the estimation and uncertainty regarding the Company’s available capital and the risk of bias in management’s judgments and assumptions in their determination. Our audit procedures related to considering whether the results of our audit procedures, when considered in the aggregate, indicate that there could be uncertainty about the Company’s ability to continue as a going concern for a reasonable period of time, obtaining information about management’s plans that are intended to mitigate the effect of such conditions or events, and assessing the likelihood that such plans can be effectively implemented, included the following, among others:

We reviewed the Company’s assessment and conclusions regarding their ability to generate cashflows for at least twelve months from the filing date of this Annual Report on Form 10-K.
We inquired of Company management and reviewed Company records to assess whether there are additional factors that contribute to the uncertainties disclosed.
We assessed whether the Company’s determination that there are factors that raise such uncertainties about its ability to continue as a going concern, were adequately disclosed in the financial statements.
We reviewed and evaluated management's plans for alleviating such conditions and uncertainties and considered whether it is likely that these conditions and uncertainties would be mitigated for a reasonable period and that such plans can be effectively implemented.  
We performed testing procedures such as reviewing; prospective financial information for the twelve-month period beginning with the filing date of this Annual Report on Form 10-K, actual operating performance for periods after December 31, 2023, other events and transactions occurring after December 31, 2023,  implemented reductions in operating expenses, plans for further reductions to support expected cashflows, and implemented changes in the business.
We performed sensitivity analysis of management's forecasts and key assumptions used in developing their prospective financial information.

Finite-Lived Trademarks and Other Intangible Assets

Critical Audit Matter Description

As described further in Note 4 to the financial statements, the carrying amount of finite-lived trademarks and other intangible assets was $41.5 million as of December 31, 2023. Under the applicable accounting guidance, these assets shall be tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. Management has concluded that these assets are not impaired as of December 31, 2023.

How the Critical Audit Matter was Addressed in the Audit

We determined the Company’s ability to assess if their finite-lived trademarks and other intangible assets are impaired is a critical audit matter due to the estimation and uncertainty regarding the Company’s ability to generate sufficient undiscounted cash flows, to be in excess of the carrying amounts of these assets.

The Company evaluates its finite-lived trademarks and other intangible assets for impairment when events are triggered by economic conditions.  These events require the Company to compare the carrying values to the undiscounted cash flows from the operation and eventual disposition of these assets over their estimated useful lives (“undiscounted cash flows”).    

53

If the carrying value of any of these assets is considered to be impaired, as described above, the amount of the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds its fair value.                                    

Auditing the Company’s finite-lived trademarks and other intangible assets for impairment is complex and subjective due to the significant estimation required to determine the forecasted undiscounted cash flows used in the Company’s evaluation. Specifically, the forecasted undiscounted cash flows are sensitive to significant assumptions such as revenue growth rates, including the terminal growth rates, margins, and expenses over the estimated useful lives of these assets, all of which are affected by expected future market or economic conditions, and other factors.

The primary procedures we performed to address this critical audit matter included the following, among others:

We evaluated management’s assessment of events and changes in circumstances, which required a more detailed evaluation of undiscounted cash flows.
We obtained management’s forecasts of undiscounted cash flows, and assumptions utilized in developing such forecasts.
We evaluated management’s forecasts and key assumptions utilized to arrive at undiscounted cash flows.
We performed sensitivity analysis of management’s forecasts and key assumptions used to arrive at undiscounted cash flows.
We compared undiscounted cash flows to the carrying amounts of the respective assets and determined in all cases that undiscounted cash flows exceeded the carrying amounts.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2021.

New York, NY

April 18, 2024

54

Xcel Brands, Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share and per share data)

    

December 31, 2023

    

December 31, 2022

Assets

 

  

 

  

Current Assets:

 

  

 

  

Cash and cash equivalents

$

2,998

$

4,608

Accounts receivable, net

 

3,454

 

5,110

Inventory

 

453

 

2,845

Prepaid expenses and other current assets

 

398

 

1,457

Total current assets

 

7,303

 

14,020

Non-current Assets:

Property and equipment, net

 

634

 

1,418

Operating lease right-of-use assets

4,453

5,420

Trademarks and other intangibles, net

 

41,520

 

47,665

Equity method investment in IM Topco, LLC

17,585

19,195

Deferred tax assets, net

1,107

Other assets

 

165

 

110

Total non-current assets

 

64,357

 

74,915

Total Assets

$

71,660

$

88,935

Liabilities and Stockholders' Equity

 

  

 

  

Current Liabilities:

 

  

 

  

Accounts payable, accrued expenses and other current liabilities

$

2,127

$

3,870

Deferred revenue

 

889

 

88

Accrued income taxes payable

372

568

Accrued payroll

 

109

 

416

Current portion of operating lease obligations

1,258

1,376

Current portion of long-term debt

 

750

 

Current portion of contingent obligation

 

964

 

243

Total current liabilities

 

6,469

 

6,561

Long-Term Liabilities:

 

  

 

  

Long-term portion of operating lease obligations

4,021

5,839

Deferred revenue

3,556

Long-term debt, net, less current portion

 

3,971

 

Long-term portion of contingent obligation

5,432

6,396

Other long-term liabilities

 

40

 

Total long-term liabilities

 

17,020

 

12,235

Total Liabilities

 

23,489

 

18,796

Commitments and Contingencies

 

  

 

  

Stockholders' Equity:

 

  

 

  

Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding

 

 

Common stock, $.001 par value, 50,000,000 shares authorized, and 19,795,053 and 19,624,860 shares issued and outstanding at December 31, 2023 and 2022, respectively

 

20

 

20

Paid-in capital

 

103,861

 

103,592

Accumulated deficit

 

(53,849)

 

(32,797)

Total Xcel Brands, Inc. stockholders' equity

 

50,032

 

70,815

Noncontrolling interest

(1,861)

(676)

Total Stockholders' Equity

 

48,171

 

70,139

Total Liabilities and Stockholders' Equity

$

71,660

$

88,935

See accompanying Notes to Consolidated Financial Statements.

55

Xcel Brands, Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except share and per share data)

For the Year Ended

December 31, 

2023

    

2022

Revenue

  

 

  

Net licensing revenue

$

9,156

$

14,737

Net sales

 

8,599

 

11,044

Net revenue

 

17,755

 

25,781

Cost of goods sold

 

6,918

 

7,980

Gross profit

 

10,837

 

17,801

Direct operating costs and expenses

 

  

 

  

Salaries, benefits and employment taxes

 

9,910

 

16,802

Other selling, general and administrative expenses

 

13,361

 

16,280

Total direct operating costs and expenses

 

23,271

 

33,082

Other operating costs and expenses (income)

Depreciation and amortization

6,954

7,263

Gain on sale of majority interest in Isaac Mizrahi brand

(20,586)

Loss from equity method investment

2,060

1,202

Gain on sale of limited partner ownership interest

(359)

Gain on settlement of lease liability

(445)

Gain on reduction of contingent obligation

(900)

Operating loss

 

(20,644)

 

(2,260)

Interest and finance expense

 

  

 

  

Interest expense

 

113

 

1,187

Other interest and finance charges, net

 

268

 

16

Loss on early extinguishment of debt

2,324

Total interest and finance expense

 

381

 

3,527

Loss before income taxes

 

(21,025)

 

(5,787)

Income tax provision (benefit)

 

1,212

 

(431)

Net loss

(22,237)

(5,356)

Net loss attributable to noncontrolling interest

(1,185)

(1,338)

Net loss attributable to Xcel Brands, Inc. stockholders

$

(21,052)

$

(4,018)

Loss per common share attributable to Xcel Brands, Inc. stockholders:

 

  

 

  

Basic and diluted net loss per share

$

(1.07)

$

(0.20)

Weighted average number of common shares outstanding:

 

  

 

  

Basic and diluted weighted average common shares outstanding

 

19,711,637

 

19,624,669

See accompanying Notes to Consolidated Financial Statements.

56

Xcel Brands, Inc. and Subsidiaries

Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

Xcel Brands, Inc. Stockholders

Common Stock

Paid-in

Accumulated

Noncontrolling

    

Shares

    

Amount

    

Capital

    

Deficit

    

Interest

    

Total

Balance as of January 1, 2022

 

19,571,119

 

20

103,039

(28,779)

662

 

74,942

Compensation expense related to stock options and restricted stock

 

 

 

534

 

 

534

Shares issued to executive in connection with stock grants for bonus payments

178,727

281

281

Shares repurchased from executive in exchange for withholding taxes

(53,882)

(85)

(85)

Shares issued to directors in connection with restricted stock grants

50,000

Shares issued to consultants in connection with stock grants

20,064

33

33

Shares issued to consultant in connection with sale transaction (see Note 3 and Note 7)

65,275

97

97

Shares issued to key employee in connection with stock grant

33,557

 

50

 

 

50

Shares repurchased from key employee in exchange for withholding taxes related to vesting of restricted shares

 

(240,000)

 

 

(357)

 

 

(357)

Net loss for the year ended December 31, 2022

 

 

 

 

(4,018)

 

(1,338)

(5,356)

Balance as of December 31, 2022

 

19,624,860

 

20

 

103,592

 

(32,797)

 

(676)

 

70,139

Compensation expense related to stock options and restricted stock

 

 

 

161

 

 

 

161

Contra-revenue related to warrants granted to licensee

26

26

Shares issued to directors in connection with restricted stock grants

40,000

Forfeitures of restricted stock grants

(5,000)

Shares issued to consultant in connection with stock grants

66,668

45

 

 

45

Shares issued to employee in connection with stock grant

7,300

10

 

10

Shares issued on exercises of stock options, net of shares surrendered for cashless exercises

61,225

27

27

Net loss for the year ended December 31, 2023

 

 

 

 

(21,052)

 

(1,185)

 

(22,237)

Balance as of December 31, 2023

 

19,795,053

$

20

$

103,861

$

(53,849)

$

(1,861)

$

48,171

See accompanying Notes to Consolidated Financial Statements.

57

Xcel Brands, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

For the Year Ended December 31, 

    

2023

    

2022

Cash flows from operating activities

 

  

 

  

Net loss

$

(22,237)

$

(5,356)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

Depreciation and amortization expense

 

6,954

 

7,263

Asset impairment charges

 

100

 

274

Amortization of deferred finance costs included in interest expense

 

22

 

156

Stock-based compensation and cost of licensee warrants

 

242

 

620

Provision for credit losses

787

413

Undistributed proportional share of net loss of equity method investee

2,060

1,202

Loss on early extinguishment of debt

2,324

Deferred income tax provision (benefit)

 

1,107

 

(965)

Gain on sale of majority interest in Isaac Mizrahi brand

(20,586)

Gain on sale of limited partner ownership interest

(359)

Gain on settlement of lease liability

(445)

Gain on reduction of contingent obligation

(900)

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

869

 

2,117

Inventory

 

2,391

 

530

Prepaid expenses and other current and non-current assets

 

1,034

 

566

Deferred revenue

4,356

54

Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities

 

(2,936)

 

(1,426)

Lease-related assets and liabilities

(525)

(244)

Other liabilities

 

35

 

(224)

Net cash used in operating activities

 

(6,545)

 

(14,182)

Cash flows from investing activities

 

  

 

  

Net proceeds from sale of majority interest in Isaac Mizrahi brand

45,386

Capital contribution to equity method investees

(150)

(600)

Net proceeds from sale of assets

459

Purchase of property and equipment

 

(100)

 

(265)

Net cash provided by investing activities

 

209

 

44,521

Cash flows from financing activities

 

  

 

  

Proceeds from exercise of stock options

27

Shares repurchased including vested restricted stock in exchange for withholding taxes

 

(442)

Proceeds from long-term debt

5,000

Payment of deferred finance costs

 

(301)

 

Payment of long-term debt

 

 

(29,000)

Payment of prepayment, breakage and other fees associated with early extinguishment of long-term debt

(1,511)

Net cash provided by (used in) financing activities

 

4,726

 

(30,953)

Net decrease in cash and cash equivalents

 

(1,610)

 

(614)

Cash and cash equivalents at beginning of year

4,608

5,222

Cash and cash equivalents at end of year

$

2,998

$

4,608

Supplemental disclosure of non-cash activities:

Liability for equity-based bonuses and other equity-based payments

$

$

(283)

Supplemental disclosure of cash flow information:

 

  

 

  

Cash paid during the period for interest

$

56

$

1,032

Cash paid during the period for income taxes

$

99

$

See accompanying Notes to Consolidated Financial Statements.

58

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

1.   Nature of Operations, Background, and Basis of Presentation

Xcel Brands, Inc. (“Xcel” and, together with its subsidiaries, the “Company”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the “Halston Brand”), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the “C Wonder Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the “Isaac Mizrahi Brand”), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party (see Note 3 for additional details).
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a 30% ownership interest in IM Topco, LLC and continues to participate in the operations of the business; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting (see Note 3 for additional details).
The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch in 2024.

The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024.

The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop.

Prior to 2023, and for a portion of 2023, the Company also engaged in certain wholesale and direct-to-consumer sales of products under its brands. The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Consolidated Statements of Operations, separately from the Company’s licensing revenues.

Liquidity and Management’s Plans  

The Company incurred a net loss attributable to Company stockholders of approximately $21.1 million and $4.0 million during the years ended December 31, 2023 and 2022, respectively (which included non-cash expenses of approximately $9.0 million and $8.2 million, respectively), and had an accumulated deficit of approximately $53.8 million and $32.8 million as of December 31, 2023 and 2022, respectively. Net cash used in operating activities was $6.5 million in 2023 and $14.2 million in 2022. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations) of approximately $2.1 million and $8.8 million as of December 31, 2023 and 2022, respectively. The Company’s cash and cash equivalents were approximately $3.0 million and $4.6 million as of December

59

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

31, 2023 and 2022, respectively. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.  

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions were executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to develop and launch in 2024 and beyond. In the second quarter of 2023, the Company entered into a new master license agreement for the Halston Brand, covering men’s, women’s, and children’s apparel, fashion accessories, and other product categories, with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 5 for details).

These restructuring initiatives were substantially completed as of June 30, 2023.  

Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Further, in October 2023, the Company entered into a new term loan agreement in the amount of $5 million (see Note 6 for details). Subsequent to year end, in January 2024, the Company entered into a sublease of its offices at 1333 Broadway in New York, NY (see Note 12 for details), and in March 2024, the Company issued new shares of common stock for net proceeds of approximately $2 million (see Note 12 for details).

Based on these recent events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Annual Report on Form 10-K; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of December 31, 2023, have been alleviated.

2.   Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of Xcel, its wholly owned subsidiaries, and entities in which Xcel has a controlling financial interest as of and for the years ended December 31, 2023 (the "Current Year") and 2022 (the "Prior Year"). The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). All significant intercompany accounts and transactions have been eliminated in consolidation, and net earnings have been adjusted by the portion of operating results of consolidated entities attributable to noncontrolling interests.

60

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Investments in Unconsolidated Affiliates

The Company holds a noncontrolling equity interest in IM Topco, LLC, which was entered into during the Prior Year, and a noncontrolling equity interest in ORME Live, Inc., which was entered into during the Current Year. These investments are accounted for in accordance with ASC Topic 323, “Investments – Equity Method and Joint Ventures,” as the Company has the ability to exercise significant influence over their operating and financial policies of these affiliates, but does not control the affiliates.

The Company recognizes its share of the ongoing operating results of these affiliates within other operating costs and expenses (income) in the accompanying consolidated statements of operations. The Company’s investments in unconsolidated affiliates are reviewed for impairment whenever there are indicators that their carrying value may not be recoverable; if a decrease in value of the investment has occurred and such decrease is determined to be other than temporary in nature, the Company shall record an impairment charge to reduce the carrying amount of the investment to its fair value.

See Note 3 for additional information related to the Company’s investments in unconsolidated affiliates.  

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.

The Company deems the following items to require significant estimates from management:

Allowances for credit losses;
Useful lives of trademarks;
Assumptions used in the valuation of intangible assets, including cash flow estimates for initial determinations of fair value and/or impairment analysis; and
Stock-based compensation.

Cash and Cash Equivalents

All highly liquid investments with original maturities of three months or less are considered to be cash equivalents.

Accounts Receivable

Accounts receivable are reported net of an allowance for credit losses. As of December 31, 2023 and 2022, the Company had $3.5 million and $5.1 million, respectively, of accounts receivable, net of allowances of $0.8 million and $0, respectively.

61

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.

A rollforward of the allowance for credit losses for the Current Year is as follows:

($ in thousands)

    

Balance at December 31, 2022

$

Credit loss expense

 

787

Write-offs

 

Recoveries

 

Balance at December 31, 2023

$

787

The Company recognized credit loss expense of $0.4 million in the Prior Year, which was related to the bankruptcy of several retail customers due to the 2020 – 2023 coronavirus disease pandemic. The Company wrote-off approximately $1.5 million of such customers’ outstanding receivable balances in the Prior Year.

Additionally, on October 17, 2023, the Company and one of the licensees managed under the Halston Master License (see Note 5) entered into an amendment of their respective licensing agreement. Under this amendment, the payment terms of the $0.76 million outstanding balance due to the Company were changed such that this receivable (and collection thereof) became contractually contingent upon the licensee’s future performance. The licensee is also required to pay interest to the Company on a monthly basis until the outstanding balance is paid in full. The Company recorded a non-cash charge of $0.76 million within other selling, general and administrative expenses in the Current Year related to the restructuring of this licensing arrangement, in order to write-down the previously-recorded receivable to zero, which is not included in the credit loss expense and allowance for credit losses amounts set forth above.

There is no earned revenue that has been accrued but not billed as of December 31, 2023 and 2022.

As of December 31, 2023 and 2022, approximately $0.04 million and $1.7 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the Prior Year, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During both the Current Year and Prior Year, the Company paid less than $0.1 million in fees to the agent under the aforementioned services agreement.

Inventory

All of the Company’s inventory consists of finished goods. As of December 31, 2022, inventory was composed of jewelry, wholesale apparel, and home goods. During the Current Year, as a result of the restructuring of its business operating model, the Company sold all of its wholesale apparel inventory and substantially all of its remaining fine jewelry inventory to its new business partners and licensees. Thus, as of December 31, 2023, inventory was primarily composed of home goods and related items for the Longaberger Brand.

Inventory is recorded at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of its inventories in order to identify obsolete, slow-moving, or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventories, the Company

62

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

will record a write-down to net realizable value in the period that the decline in value is first recognized. Write-downs for inventory shrinkage, representing the risk of physical loss of inventory, are estimated based on historical experience and are adjusted based upon physical inventory counts.

Property and Equipment

Furniture, equipment, and software are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over their estimated useful lives, generally three (3) to seven (7) years. Depreciation expense for the years ended December 31, 2023 and 2022 was approximately $0.8 million and $1.1 million, respectively.

Leasehold improvements are amortized over the shorter of their estimated useful lives or the terms of the leases. Betterments and improvements are capitalized, while repairs and maintenance are expensed as incurred.

Costs to develop or acquire software for internal use incurred during the preliminary project stage and the post implementation stage are expensed, while internal and external costs to acquire or develop software for internal use incurred during the application development stage – including design, configuration, coding, testing, and installation – are generally capitalized.

The Company’s long-lived property and equipment assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on a discounted cash flows analysis or appraisals. The inputs utilized in the impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurement.”

The Company recognized impairment charges of $0.3 million in the Prior Year related to store fixtures purchased for an apparel program with one of the Company’s retail partners.

Trademarks and Other Intangible Assets

The Company’s finite-lived intangible assets are amortized over their estimated useful lives of three (3) to eighteen (18) years. The Company re-evaluates the remaining useful life of its finite-lived intangible assets on an annual basis, based on consideration of current events and circumstances, the expected use of the asset, and the effects of demand, competition, and other economic factors. No changes were made to the estimated useful lives of intangible assets in the Current Year or Prior Year.

The Company’s finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value, based on a discounted cash flows analysis or appraisals. The inputs utilized in the finite-lived intangible assets impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in ASC Topic 820. No impairment charges were recorded related to intangible assets for the Current Year or Prior Year.

See Note 4 for additional information related to the Company’s trademarks and other intangible assets.

63

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Deferred Finance Costs

The Company incurred costs (primarily professional fees and lender underwriting fees) in connection with borrowings under term loans. These costs have been deferred on the consolidated balance sheet as a reduction to the carrying value of the associated borrowings, and are being amortized as interest expense over the term of the related borrowings using the effective interest method.

Contingent Obligations

When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired is greater than the consideration paid, any contingent obligations are recognized and recorded as the positive difference between the fair value of the assets acquired and the consideration paid for the acquired assets.

When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired are equal to the consideration paid, any contingent obligations are recognized based upon the Company’s best estimate of the amount that will be paid to settle the liability.

Under the applicable accounting guidance, the Company is required to carry such contingent liability balances on its consolidated balance sheet until the measurement period of the earn-out expires and all related contingencies have been resolved.

The Company recorded contingent obligations in connection with the purchase of the Halston Heritage trademarks in 2019 and the purchase of the LOGO by Lori Goldstein trademarks in 2021, but no amount has been recorded for the contingent obligation related to the sale of a majority interest in the Isaac Mizrahi Brand in 2022.

See Note 9 for additional information related to the Company’s contingent obligations.

Revenue Recognition

The Company applies the guidance in ASC Topic 606, “Revenue from Contracts with Customers” to recognize revenue.

Licensing

The Company recognizes revenue continuously over time as it satisfies its continuous obligation of granting access to its licensed intellectual properties, which are deemed symbolic intellectual properties under the applicable revenue accounting guidance. Payments are typically due after sales have occurred and have been reported by the licensees or, where applicable, in accordance with minimum guaranteed payment provisions. The timing of performance obligations is typically consistent with the timing of payments, though there may be differences if contracts provide for advances or significant escalations of contractually guaranteed minimum payments. With the exception of the Halston Master License agreement described in Note 5, there were no such differences that would have a material impact on the Company’s consolidated balance sheets at December 31, 2023 and 2022. In accordance with ASC 606-10-55-65, the Company recognizes net licensing revenue at the later of when (1) the subsequent sale or usage occurs or (2) the performance obligation to which some or all of the sales- or usage-based royalty has been allocated is satisfied (in whole or in part). More specifically, the Company separately identifies:

(i)Contracts for which, based on experience, royalties are expected to exceed any applicable minimum guaranteed payments, and to which an output-based measure of progress based on the “right to invoice” practical expedient is applied because the royalties due for each period correlate directly with the value to the customer of the Company’s performance in each period (this approach is identified as “View A” by the FASB Revenue Recognition Transition Resource Group, “TRG”); and

64

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

(ii)Contracts for which revenue is recognized based on minimum guaranteed payments using an appropriate measure of progress, in which minimum guaranteed payments are straight-lined over the term of the contract and recognized ratably based on the passage of time, and to which the royalty recognition constraint to the sales-based royalties in excess of minimum guaranteed is applied and such sales-based royalties are recognized to the distinct period only when the minimum guaranteed is exceeded on a cumulative basis (this approach is identified as “View C” by the TRG).

The Company’s unconditional right to receive consideration based on the terms and conditions of licensing contracts is presented as accounts receivable on the accompanying consolidated balance sheets. The Company does not typically perform by transferring goods or services to customers before the customer pays consideration or before payment is due, thus the amounts of contract assets as defined by ASC 606-10-45-3 related to licensing contracts were not material as of December 31, 2023 and 2022. The Company typically does not receive consideration in advance of performance and, consequently, amounts of contract liabilities as defined by ASC 606-10-45-2 related to licensing contracts were not material as of December 31, 2022; however, as of December 31, 2023, the Company has recognized approximately $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet related to the Halston Master License agreement (see Note 5).

The Company does not disclose the amount attributable to unsatisfied or partially satisfied performance obligations for variable revenue contracts (identified under “View A” above) in accordance with the optional exemption allowed under ASC 606. The Company did not have any revenue recognized in the reporting period from performance obligations satisfied, or partially satisfied, in previous periods. Remaining minimum guaranteed payments for active contracts as of December 31, 2023 are expected to be recognized ratably in accordance with View C over the remaining term of each contract based on the passage of time and through December 2028, subject to renewal or extension upon termination.

Wholesale Sales

Prior to the restructuring of the Company’s business model and operations in the Current Year, the Company generated a portion of its revenue through the design, sourcing, and sale of branded jewelry and apparel to both domestic and international customers who, in turn, sold the products to the consumer. The Company recognized such revenue within net sales in the accompanying consolidated statements of operations when performance obligations identified under the terms of contracts with its customers were satisfied, which occurred upon the transfer of control of the merchandise in accordance with the contractual terms and conditions of the sale. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Direct-to-Consumer Sales

The Company’s revenue associated with its e-commerce jewelry operations and the Longaberger Brand (prior to the restructuring of the Company’s business model and operations in the Current Year) was recognized within net sales in the accompanying consolidated statements of operations at the point in time when product is shipped to the customer. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Advertising Costs

All costs associated with production for the Company’s advertising, marketing, and promotion are expensed during the periods when the activities take place. All other advertising costs, such as print and online media, are expensed when the advertisement occurs. The Company incurred approximately $1.0 million and $2.6 million in advertising and marketing costs for the Current Year and Prior Year, respectively, which are included within other selling, general and administrative expenses in the accompanying consolidated statements of operations.  

65

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Leases

The Company determines if an arrangement is a lease (as defined in ASC Topic 842, “Leases”) at the inception of the arrangement. The Company generally recognizes a right-of-use (“ROU”) asset, representing its right to use the underlying leased asset for the lease term, and a liability for its obligation to make future lease payments (the lease liability) at commencement date (the date on which the lessor makes the underlying asset available for use) based on the present value of lease payments over the lease term. The Company does not recognize ROU assets and lease liabilities for lease terms of 12 months or less, but recognizes such lease payments in operations on a straight-line basis over the lease terms.

As the Company’s leases typically do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

For real estate leases of office space, the Company accounts for the lease and non-lease components as a single lease component. Variable lease payments that do not depend on an index or rate (such as real estate taxes and building insurance and lessee’s shares thereof), if any, are excluded from lease payments at lease commencement date for initial measurement. Subsequent to initial measurement, these variable payments are recognized when the event determining the amount of variable consideration to be paid occurs.

Lease expense for operating lease payments is generally recognized on a straight-line basis over the lease term. The Company recognizes income from subleases (in which the Company is the sublessor) on a straight-line basis over the term of the sublease, as a reduction to lease expense.

See Note 9 for additional information related to the Company’s leases.

Stock-Based Compensation

The Company accounts for stock-based compensation by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.

The fair value of stock options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected life of the awards and the expected stock price volatility over the terms of the awards. The expected life is based on the estimated average life of options and warrants using the simplified method; the Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The risk-free rate is based on the U.S. Treasury rate for the expected term at the time of grant, volatility is based on the historical volatility of the Company’s common stock, and the expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant, based on the quoted market price of the Company’s common shares on the NASDAQ Capital Market.

Non-employee awards are measured at the grant date fair value of the equity instruments to be issued, and the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant.

The Company accounts for forfeitures as a reduction of compensation cost in the period when such forfeitures occur.

For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant

66

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

See Note 7 for additional information related to stock-based compensation.

Income Taxes

Current income taxes are based on the respective period’s taxable income for federal and state income tax reporting purposes. Deferred tax assets and liabilities are determined based on the differences between the financial statement and income tax bases of assets and liabilities, using enacted tax rates and laws that will be in effect for the year in which the differences are expected to reverse.

A valuation allowance is recognized when necessary to reduce deferred tax assets to the amount expected to be realized. In determining the need for a valuation allowance, management reviews both positive and negative evidence, including current and historical results of operations, future income projections, and the overall prospects of the Company’s business. A valuation allowance is established if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company applies the FASB guidance on accounting for uncertainty in income taxes, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and also addresses derecognition, classification, interest, and penalties related to uncertain tax positions. The Company has no unrecognized tax benefits as of December 31, 2023 and 2022. Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2020 through December 31, 2023.

The income tax effects of changes in tax laws are recognized in the period when enacted.

See Note 10 for additional information related to income taxes.

Fair Value

ASC Topic 820, “Fair Value Measurement,” defines fair value and establishes a framework for measuring fair value under U.S. GAAP. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of the Company’s assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of term loan debt approximates fair value due to the floating interest rate structure of the term loan agreement.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company limits its credit risk with respect to cash and cash equivalents by maintaining such balances with high quality financial institutions. At times, the Company’s cash and cash equivalents may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are not considered

67

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

significant due to the collection history and due to the nature of the Company’s royalty revenues. Generally, the Company does not require collateral or other security to support accounts receivable.

Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted earnings (loss) per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants using the treasury stock method. The difference between basic and diluted weighted-average common shares results from the assumption that all dilutive stock options and warrants outstanding were exercised into common stock if the effect is not anti-dilutive. See Note 8 for additional information related to earnings (loss) per share.

Recently Adopted Accounting Pronouncements

The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively, and is effective for fiscal years beginning after December 15, 2024. The Company does not anticipate that the adoption of this ASU will have a significant impact on its consolidated financial statements.

3. Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities

Sale of Majority Interest in Isaac Mizrahi Brand

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.

The purchase price paid by WHP to the Company at the closing of the transaction in exchange for the 70% membership interest in IM Topco consisted of $46.2 million in cash. The Company incurred approximately $0.9 million of expenses directly related to this transaction, including legal fees and agent fees, of which $0.1 million of the agent fees were paid through the issuance of 65,275 shares of the Company’s common stock, which were recognized as a reduction to the gain from the transaction. The Company recognized a net pre-tax gain from the transaction of $20.6 million, which is classified

68

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

as a component of other operating costs and expenses (income) in the consolidated statement of operations for the Prior Year.

Pursuant to the May 27, 2022 purchase agreement, the Company was also entitled to receive an “earn-out” payment in the amount of $2.0 million if, during the period from January 1, 2023 through December 31, 2023, (i) IM Topco received Net Royalty Revenue (as defined in the purchase agreement) in an amount equal to or greater than $17.5 million and (ii) IM Topco generated EBITDA (as defined in the purchase agreement) in an amount equal to or greater than $11.8 million. These conditions were not met during 2023, and ultimately the Company did not receive any additional “earn-out” payment.

Additionally, the purchase agreement provided that, in the event IM Topco receives less than $13.347 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on the third anniversary of the closing, WHP would be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP for such period, as an adjustment to the purchase price, payable in either cash or equity interests in IM Topco held by the Company. This provision was subsequently amended in November 2023, as described further below, and was subsequently further amended in April 2024 (see Note 12 for additional information).

In connection with the May 27, 2022 membership purchase agreement, the Company and WHP also entered into an Amended and Restated Limited Liability Company Agreement of IM Topco (the “Business Venture Agreement”) governing the operation of IM Topco as a partnership between the Company and WHP following the closing. Pursuant to the Business Venture Agreement, IM Topco is managed by a single Manager appointed by the vote of a majority-in-interest of IM Topco’s members, and WHP serves as the sole Manager of IM Topco. The Business Venture Agreement contains customary provisions for the governance of a partnership, including with respect to decision making, access to information, restrictions on transfer of interests, and covenants.

Pursuant to the Business Venture Agreement, IM Topco’s Net Cash Flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective ownership interests.

The distribution provisions in the Business Venture Agreement were subsequently amended in April 2024 (see Note 12 for additional information).

The Company also entered into a number of other related agreements on May 31, 2022 in connection with the transaction, including a services agreement with IM Topco and a license agreement with IM Topco (see Note 11 for details), while the Company’s employment agreement with Mr. Mizrahi and the Company’s services agreement with Laugh Club (see Note 11) were transferred to IM Topco. Further, the Company’s licensing agreement with Qurate Retail Group related to the Isaac Mizrahi Brand (see Note 5) was assigned to IM Topco as of May 31, 2022.

Management assessed and evaluated the ownership structure and other terms of the May 27, 2022 membership purchase agreement and Business Venture Agreement, as well as considered the Company’s continuing involvement with the Isaac Mizrahi Brand through the aforementioned services agreement and license agreement with IM Topco, and concluded that (i) IM Topco is not a Variable Interest Entity under ASC Topic 810, and (ii) the Company has significant influence over, but does not control, IM Topco. As such, on May 31, 2022, the Company de-recognized the carrying amount of the Isaac Mizrahi Brand trademarks of $44.5 million and recognized the fair value of its retained interest in IM Topco of

69

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

approximately $19.8 million as an equity method investment. The fair value of the Company’s retained interest was determined by applying the Company’s ownership percentage to the implied enterprise value of IM Topco, which was calculated based on the price paid by WHP for the 70% controlling interest, as the May 31, 2022 sale transaction was considered an arms-length transaction between knowledgeable market participants and the most relevant and reasonable indication of value to utilize. The inputs and assumptions for this nonrecurring fair value measurement are classified as Level 3 within the fair value hierarchy defined in ASC Topic 820.

Investment in IM Topco, LLC

The Company accounts for its interest in the ongoing operations of IM Topco as a component of other operating costs and expenses (income) under the equity method of accounting. Based on the aforementioned distribution provisions set forth in the Business Venture Agreement, the Company recognized an equity method loss of approximately $2.1 and $1.2 million related to its investment for the years ended December 31, 2023 and 2002, respectively. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for all of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal to Xcel’s share of amortization expense.

Summarized financial information for IM Topco is as follows:

    

For the year ended

December 31,

($ in thousands)

2023

2022(1)

Revenues

$

12,119

$

7,791

Gross profit

12,119

7,791

(Loss) income from continuing operations

(1,961)

316

Net (loss) income

(1,961)

316

(1)Represents financial information for the period commencing May 31, 2022 (the date of the sale of a majority interest in IM Topco) through December 31, 2022.

During the Prior Year (subsequent to the May 27, 2022 transaction), the Company made a capital contribution to IM Topco of $0.6 million in cash, which did not change the Company’s noncontrolling ownership interest of 30%.

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which the parties agreed to waive the purchase price adjustment provision until the measurement period ending March 31, 2024. In exchange, Xcel agreed to make additional royalty payments to IM Topco totaling $0.45 million over the next 11 months. As a result of this amendment, the Company recognized a $0.45 million increase to the carrying value basis of its equity method investment and a corresponding increase in current liabilities.

The provisions of the membership purchase agreement were subsequently further amended in April 2024 (see Note 12 for additional information).

Investment in Orme Live, Inc.

In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s consolidated balance sheet. The Company accounts for its interest in the operations of ORME as a component of other operating costs and expenses (income) under the equity method of accounting; the Company’s proportional share of the operating results of ORME were not material in the Current Year.

70

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Sale of Investment in Unconsolidated Affiliate

The Company previously held a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016. This investment did not have a readily determinable fair value and in accordance with ASC 820-10-35-59, the investment was valued at cost, less impairment, plus or minus observable price changes of an identical or similar investment of the same issuer. This investment was included within other assets on the Company’s consolidated balance sheet at December 31, 2022, at a carrying value of $0.1 million. During the Current Year, the Company sold its ownership interest in this entity, and recognized a gain of $0.36 million related to the sale within other operating costs and expenses (income) on the consolidated statement of operations.

Longaberger Licensing, LLC Variable Interest Entity

Since 2019, Xcel has been party to a limited liability company agreement (the “LLC Agreement”) with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC Agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

4.   Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

December 31, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

27,431

 

41,449

Copyrights and other intellectual property

 

8 years

 

429

 

358

 

71

Total

$

69,309

$

27,789

$

41,520

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

During the Prior Year, the Company sold its $44.5 million of indefinite-lived trademarks related to the Isaac Mizrahi Brand (see Note 3 for details).

Amortization expense for intangible assets was approximately $6.1 million for both the Current Year and Prior Year.

71

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Estimated future amortization expense related to finite-lived intangible assets over the remaining useful lives is as follows:

($ in thousands)

Amortization

Year Ending December 31, 

    

Expense

2024

$

6,115

2025

 

4,177

2026

 

3,506

2027

 

3,504

2028

 

3,504

Thereafter (through 2036)

 

20,714

Total

$

41,520

5.   Significant Contracts

Qurate Agreements

Through its wholly owned subsidiaries, the Company has entered into direct-to-retail license agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements (individually, each a “Qurate Agreement”), pursuant to which the Company designs, and Qurate sources and sells, various products under the LOGO by Lori Goldstein brand, the Longaberger brand, and the C Wonder brand. The Company was also previously party to similar agreements with Qurate related to the IsaacMizrahiLIVE brand and the Judith Ripka brand. Qurate owns the rights to all designs produced under these agreements, and the agreements include the sale of products across various categories through Qurate’s television media (including QVC and HSN) and related internet sites.

Pursuant to these agreements, the Company has granted to Qurate and its affiliates the exclusive, worldwide right to promote the Company’s branded products, and the right to use and publish the related trademarks, service marks, copyrights, designs, logos, and other intellectual property rights owned, used, licensed and/or developed by the Company, for varying terms as set forth below. In connection with the Qurate Agreements and during the same periods, Qurate and its subsidiaries have the exclusive, worldwide right to use the names, likenesses, images, voices, and performances of the Company’s spokespersons to promote the respective products.

Xcel Commenced

Qurate

Agreement

    

Current Term Expiry

    

Automatic Renewal

    

Brand with Qurate

    

Product Launch

LOGO Qurate Agreement (QVC)

November 1, 2024

one-year period

April 2021

2009

Longaberger Qurate Agreement (QVC)

October 31, 2025

 

two-year period

 

November 2019

 

2019

C Wonder Qurate Agreement (HSN)

December 31, 2024

two-year period

March 2023

2023

On May 31, 2022, in connection with the sale of a majority interest in the Isaac Mizrahi brand to a third party, the Qurate Agreement related to the IsaacMizrahiLIVE brand was assigned to IM Topco, LLC. See Note 3 for additional details.
On August 30, 2022, Qurate and Xcel amended the licensing agreement for the Judith Ripka brand to terminate the license period effective December 31, 2021. Effective January 1, 2022, the agreement entered a sell-off period, under which Qurate was allowed to continue to license the Ripka brand on a non-exclusive basis for as long as necessary to sell off any of its remaining inventory. The sell-off period ended in 2023.

Under the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based upon the net retail sales of the specified branded products. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes.

72

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

The Qurate Agreements generally prohibit the Company from selling products under the specified respective brands to a direct competitor of Qurate without Qurate’s consent. Under certain of the Qurate Agreements, the Company may, with the permission of Qurate, sell the respective branded products via certain specified sales channels in exchange for making reverse royalty payments to Qurate based on the net retail sales of such products through such channels. However, the Company is generally restricted from selling products under the specified respective brands or trademarks to certain mass merchants.

Also, under certain of the Qurate Agreements, the Company may be required for a period of time to pay a royalty participation fee to Qurate on revenue earned from the sale, license, consignment, or any other form of distribution of any products, bearing, marketed in connection with, or otherwise associated with the specified trademarks and brands.

Net licensing revenue from Qurate totaled $6.0 million and $11.4 million for the Current Year and Prior Year, respectively, representing approximately 34% and 44% of the Company’s total net revenue, respectively. As of December 31, 2023 and 2022, the Company had receivables from Qurate of $1.5 million and $0.9 million, representing approximately 43% and 17% of the Company’s accounts receivable, respectively. The December 31, 2023 and 2022 Qurate receivables did not include any earned revenue accrued but not yet billed as of the respective balance sheet dates.

Halston Master License

On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet as of December 31, 2023 related to this contract, of which $0.9 million was classified as a current liability and approximately $3.5 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 5.0 years. Net licensing revenue recognized from the Halston Master License was $1.6 million for the Current Year, representing approximately 9% of the Company’s total net revenue for the Current Year.

Additionally, in connection with the Halston Master License, the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the Current Year was approximately $0.03 million. As of December 31, 2023, no portion of this warrant had vested.

73

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

6.   Debt

The Company’s net carrying amount of debt was comprised of the following:

December 31, 

($ in thousands)

2023

    

2022

Term loan debt

$

5,000

$

Unamortized deferred finance costs related to term loan debt

 

(279)

 

Total

 

4,721

 

Current portion of debt

 

750

 

Long-term debt

$

3,971

$

For the Current Year and Prior Year, the Company incurred interest expense of approximately $0.4 million and $1.2 million, respectively, related to term loan debt. The effective interest rate related to term loan debt was approximately 11.6% and 9.8% for the Current Year and Prior Year, respectively.

Previous Term Loan Debt (through May 31, 2022)

On December 30, 2021, Xcel, as Borrower, and its wholly-owned subsidiaries entered into a loan and security agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”), as lead arranger and as administrative agent and collateral agent, and the financial institutions party thereto as lenders. Pursuant to this loan agreement, the lenders made a term loan in the aggregate amount of $29.0 million. This term loan bore interest at “LIBOR” plus 7.5% per annum, with “LIBOR” defined as the greater of (a) the rate of interest per annum for deposits in dollars for an interest period equal to three months as published by Bloomberg or a comparable or successor quoting service at approximately 11:00 a.m. (London time) two business days prior to the last business day of each calendar month and (b) 1.0% per annum.

Upon entering into the December 2021 loan agreement, Xcel paid a 1.75% closing fee to FEAC for the benefit of the lenders; the Company also paid approximately $0.5 million of various legal and other fees in connection with the execution of the loan agreement. These fees and costs totaling approximately $0.97 million were deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, to be subsequently amortized to interest expense over the term of the debt using the effective interest method.

The December 2021 term loan was to mature on April 14, 2025. Principal on this debt was payable in quarterly installments of $625,000 on each of March 31, June 30, September 30 and December 31 of each year, commencing on March 31, 2022 and ending on March 31, 2025, with a final payment of $20,875,000 on the maturity date of April 14, 2025.

The December 2021 term loan agreement also contained customary covenants, including reporting requirements, trademark preservation, and certain financial covenants; the Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the consolidated financial statements.

Extinguishment of Previous Term Loan Debt

On May 31, 2022, the Company used $30.1 million of the proceeds received from the transaction related to the Isaac Mizrahi Brand (see Note 3) to repay all amounts outstanding under the December 30, 2021 term loan agreement with FEAC, consisting of $28.4 million in principal amount, a $1.4 million prepayment fee, and approximately $0.3 million in interest and related expenses. As a result, the Company recognized a loss on early extinguishment of debt of approximately $2.3 million during the Prior Year, consisting of approximately $1.4 million of debt prepayment premium, the immediate write-off of approximately $0.8 million of unamortized deferred finance costs, and approximately $0.1 million of other costs.

74

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

New Term Loan Debt

On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.30 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.

In connection with October 2023 loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.

The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.

As of December 31, 2023, the aggregate remaining principal payments under the October 2023 term loan were as follows:

    

Amount of

($ in thousands)

Principal

Year Ending December 31, 

Payment

2024

$

750

2025

 

1,000

2026

1,000

2027

1,000

2028

 

1,250

Total

$

5,000

Interest on the October 2023 term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month.

The October 2023 term loan agreement contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount.

75

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

7.   Stockholders’ Equity

The Company has authority to issue up to 51,000,000 shares, consisting of 50,000,000 shares of common stock and 1,000,000 shares of preferred stock.

Equity Incentive Plans

The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 4,000,000 shares of common stock are eligible for issuance under the 2021 Plan. The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-Based Compensation

Total expense recognized for all forms of stock-based compensation was approximately $0.22 million and $0.72 million in the Current Year and Prior Year, respectively.

Of the Current Year expense amount, approximately $0.02 related to employees and approximately $0.20 related to directors and consultants; all of this expense was recorded as a direct operating cost in the accompanying statement of operations.

Of the Prior Year expense amount, approximately $0.41 million related to employees and approximately $0.31 million related to directors and consultants; approximately $0.62 million was recorded as a direct operating cost and approximately $0.10 million was recorded within other operating costs and expenses (income).

Stock Options

Options granted under the Company’s equity incentive plans expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s stock option activity for the Current Year is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

200,000

 

1.51

 

  

 

  

Exercised

 

(87,750)

 

0.80

 

  

 

  

Expired/Forfeited

 

(578,020)

 

2.96

 

  

 

  

Outstanding at December 31, 2023, and expected to vest

 

5,148,540

$

2.03

 

4.26

$

Exercisable at December 31, 2023

 

1,398,540

$

2.88

 

1.66

$

76

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Current Year stock option grants were as follows:

In April 2023, the Company granted options to purchase an aggregate of 100,000 shares of common stock to a key individual. The exercise price of the options is $1.50 per share, and the vesting of such options is dependent upon the achievement of certain revenue targets. None of these options were vested as of December 31, 2023.

On August 23, 2023 the Company granted options to purchase an aggregate of 100,000 shares of common stock to non-management directors. The exercise price of the options is $1.51 per share, and 50% of the options vest on each of April 1, 2024 and April 1, 2025.

Prior Year stock option grants were as follows:

On April 20, 2022, the Company granted options to purchase an aggregate of 380,850 shares of common stock to various employees. The exercise price of the options is $1.62 per share, and all options vested immediately on the date of grant.

On April 20, 2022 the Company granted options to purchase an aggregate of 125,000 shares of common stock to non-management directors. The exercise price of the options is $1.62 per share. Half of the options vested on April 20, 2023, and the remaining half of the options will vest on April 20, 2024.

On April 26, 2022, the Company granted options to purchase an aggregate of 100,000 shares of common stock to a consultant. The exercise price of the options is $1.58 per share, and all options vested immediately on the date of grant.

The fair values of the options granted were estimated at the respective dates of grant using the Black-Scholes option pricing model with the following range of assumptions:

Year Ended December 31, 

 

    

2023

    

2022

 

Expected Volatility

 

8990

%  

5793

%

Expected Dividend Yield

 

%  

%

Expected Life (Term, in years)

 

2.7510

 

0.673.25

Risk-Free Interest Rate

 

4.04.7

%  

1.62.8

%

Compensation expense related to stock options for the Current Year and Prior Year was approximately $0.1 million and $0.5 million, respectively. Total unrecognized compensation expense related to unvested stock options (excluding stock options with performance-based vesting) at December 31, 2023 amounts to approximately $0.1 million and is expected to be recognized over a weighted average period of 1.05 years.

Of the total stock options outstanding at December 31, 2023, the vesting of 3,500,000 options is contingent upon the Company’s common stock achieving certain target prices as follows:

Target Prices

    

Number of Options Vesting

$3.00

1,000,000

$5.00

850,000

$7.00

700,000

$9.00

550,000

$11.00

400,000

As of December 31, 2023, none of these 3,500,000 performance-based stock options have vested, and no compensation expense has been recorded related to such options.

77

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

The following table summarizes the Company’s stock option activity for non-vested options for the Current Year:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

200,000

 

0.68

Vested

 

(135,000)

0.68

Forfeited or Canceled

 

(12,500)

 

0.89

Balance at December 31, 2023

 

3,750,000

$

0.05

Stock Awards

A summary of the Company’s restricted stock activity for the Current Year is as follows:

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

113,968

 

1.01

Vested

 

(108,968)

 

1.08

Expired/Forfeited

 

(5,000)

 

1.62

Outstanding at December 31, 2023

 

333,333

$

3.69

Current Year stock award grants were as follows:

On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On April 17, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On May 15, 2023, the Company issued 50,000 shares of common stock to a consultant, which vested immediately.

On July 20, 2023, the Company issued 7,300 shares of common stock to an employee, which vested immediately.

On August 23, 2023, the Company issued an aggregate of 40,000 shares of common stock to non-management directors, of which 50% shall vest on April 1, 2024, and 50% shall vest on April 1, 2025.

Prior Year stock award grants were as follows:

On April 20, 2022, the Company issued an aggregate of 50,000 shares of common stock to non-management directors, which vest evenly over two years. Half of these shares vested on April 20, 2023, and the remaining half shall vest on April 20, 2024.

On April 20, 2022, the Company issued 20,064 shares of common stock to a consultant, which vested immediately.

On May 31, 2022, the Company issued 65,275 shares of common stock to a consultant in connection with the transaction related to the Isaac Mizrahi Brand (see Note 3); these shares vested immediately.

On May 31, 2022, the Company issued 33,557 shares of common stock to Isaac Mizrahi, which vested immediately (see Note 11 for additional details).

78

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Additionally, on April 20, 2022, the Company issued 178,727 shares of common stock to a member of senior management as payment for a performance bonus earned in 2021. These shares vested immediately. The Company had previously recognized compensation expense of approximately $0.28 million in the 2021 to accrue for this performance bonus.

Notwithstanding the foregoing, each grantee may extend the first anniversary of all or a portion of the restricted stock by six months and, thereafter one or more times may further extend such date with respect to all or a portion of the restricted stock until the next following date exactly six months thereafter, by providing written notice of such election to extend such date with respect to all or a portion of the restricted stock prior to such date.

Total compensation expense related to stock awards for the Current Year and Prior Year (inclusive of the amounts detailed above) was approximately $0.1 million and $0.3 million, respectively. Total unrecognized compensation expense related to unvested restricted stock grants at December 31, 2023 amounts to $0.1 million and is expected to be recognized over a weighted average period of 1.06 years.

The following table provides information with respect to restricted stock purchased and retired by the Company during the Current Year and Prior Year:

Number of

Shares

Purchased as

Part of

Total Number

Actual

Publicly

Fair value of

of Shares

Price Paid

Announced

Re-Purchased

Date

    

Purchased

    

per Share

    

Plan

    

Shares

None

 

 

 

 

Total 2023

 

$

 

$

April 20, 2022 (i)

53,882

 

1.57

 

 

84,000

May 31, 2022 (i)

 

240,000

 

1.49

 

 

358,000

Total 2022

 

293,882

$

1.50

 

$

442,000

(i)The shares were exchanged from employees and directors in connection with the income tax withholding obligations on behalf of such employees and directors from the vesting of restricted stock or the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.

Restricted Stock Units

There were no restricted stock units outstanding as of December 31, 2023 and 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

At December 31, 2023, there were 3,103,941 shares of common stock available for award grants under the 2021 Plan.

Shares Reserved for Issuance

At December 31, 2023, there were 8,368,546 shares of common stock reserved for issuance, including 4,771,255 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,103,941 shares available for issuance under the 2021 Plan.

79

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Warrants

Warrants granted by the Company expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s warrant activity for the Current Year is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

1,000,000

 

1.50

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at December 31, 2023

 

1,116,065

$

1.67

 

8.46

$

Exercisable at December 31, 2023

 

116,065

$

3.15

 

0.57

$

See Note 5 for information regarding the warrant to purchase 1,000,000 shares of common stock granted during the Current Year in connection with the Halston Master License; the Company recognized contra-revenue of approximately $0.03 million in the Current Year with respect to this warrant. There was no compensation expense related to other warrants recognized in the Current Year or Prior Year.

Dividends

The Company has not paid any dividends to date.

8. Earnings (Loss) Per Share

The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the years ended December 31, 2023 and 2022:

Year Ended

December 31, 

    

2023

    

2022

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(21,052)

$

(4,018)

Denominator:

Basic weighted average number of shares outstanding

19,711,637

 

19,624,669

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

19,711,637

 

19,624,669

Basic net loss per share

$

(1.07)

$

(0.20)

Diluted net per share

$

(1.07)

$

(0.20)

80

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

As a result of the net loss presented for the Current Year and Prior Year, the Company calculated diluted loss per share using basic weighted-average shares outstanding for both years, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of basic and diluted loss per share excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

Year Ended December 31, 

2023

    

2022

Stock options

5,148,540

5,614,310

Warrants

1,116,065

116,065

Total

 

6,264,605

 

5,730,375

9.   Commitments and Contingencies

Leases

The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.

The Company's real estate leases have remaining lease terms between approximately 5 to 7 years. As of December 31, 2023, the weighted average remaining lease term was 3.83 years and the weighted average discount rate was 6.25%.

As of December 31, 2023, the Company leased approximately 29,600 square feet of office space at 1333 Broadway, 10th floor, New York, New York for its corporate offices and operations facility. This lease commenced on March 1, 2016 and expires on October 30, 2027. This lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property.

The Company previously leased approximately 1,300 square feet of retail space for its former retail store location in Westchester, New York, which was closed in the Prior Year. In the Current Year, the Company successfully negotiated a settlement with the lessor resulting in the termination of this lease, and recognized a gain related to the settlement of $0.4 million within other operating costs and expenses (income) in the consolidated statement of operations. The Company had recorded an impairment charge of $0.7 million to fully impair the right-of-use asset for this lease in the Prior Year.

The Company also previously leased certain office space in New York, New York, which was subleased to a third-party subtenant through February 27, 2022, and the Company's lease of this office space expired by its terms on February 28, 2022.

For the years ended December 31, 2023 and 2022, total lease expense included in selling, general and administrative expenses on the Company's consolidated statements of operations was approximately $1.6 million for both periods. The Company’s total lease costs for the years ended December 31, 2023 and 2022 were comprised of the following:

($ in thousands)

    

2023

    

2022

Operating lease cost

$

1,337

$

1,474

Short-term lease cost

 

62

 

55

Variable lease cost

 

233

 

217

Sublease income

 

 

(104)

Total lease cost

$

1,632

$

1,642

81

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Cash paid for amounts included in the measurement of operating lease liabilities was $1.6 million and $1.7 million in the Current Year and Prior Year, respectively. Cash received from subleasing in the Prior Year was $0.1 million.

As of December 31, 2023, the maturities of lease liabilities were as follows:

Amount

Year

    

(in thousands)

2024

$

1,552

2025

1,552

2026

 

1,552

2027

 

1,294

Total lease payments

5,950

Less: Discount

671

Present value of lease liabilities

5,279

Current portion of lease liabilities

1,258

Non-current portion of lease liabilities

$

4,021

Employment Agreements

The Company has employment contracts with certain executives and key employees. The future minimum payments under these contracts are as follows:

Employment

($ in thousands)

Contract

Year Ended December 31, 

    

Payments

2024

$

4,292

2025

 

2,150

2026

2,150

2027

2,150

2028

2,150

Thereafter

 

4,837

Total future minimum employment contract payments

$

17,729

In addition to the employment contract payments stated above, the Company’s employment contracts with certain executives and key employees contain performance-based bonus provisions. These provisions include bonuses based on the Company achieving revenues in excess of established targets and/or on operating results.

Certain of the employment agreements contain severance and/or change in control provisions. Aggregate potential severance compensation amounted to approximately $2.9 million as of December 31, 2023.

Contingent Obligation – Halston Heritage Earn-Out

In connection with the February 11, 2019 purchase of the Halston Heritage trademarks, the Company agreed to pay the seller additional consideration (the “Halston Heritage Earn-Out”) of up to an aggregate of $6.0 million, based on royalties earned from 2019 through December 31, 2022. The final royalty target year for the Halston Heritage Earn-Out ended on December 31, 2022, and the seller ultimately did not earn any additional consideration based on the formula set forth in the related asset purchase agreement. As such, during the Prior Year, the Company recorded a $0.9 million gain on the reduction of contingent obligations in the accompanying consolidated statement of operations. As of December 31, 2022, there were no amounts remaining under the Halston Heritage Earn-Out.

82

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and thus $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability. The $0.2 million of additional consideration was paid to the seller during the Current Year.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. Accordingly, as of December 31, 2023, $1.0 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 3), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024.

No amount has been recorded in the accompanying consolidated balance sheets related to this contingent obligation.

The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details).

Legal Proceedings

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation pending against the Company as of December 31, 2023 is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

See Note 12 for information related to certain legal matters which arose subsequent to December 31, 2023.

83

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

10.   Income Taxes

The income tax provision (benefit) for income taxes in the consolidated statements of operations consists of the following:

Years Ended December 31, 

($ in thousands)

    

2023

    

2022

Current:

 

  

 

  

Federal

$

22

$

300

State and local

 

83

 

234

Total current

 

105

 

534

Deferred:

 

  

 

  

Federal

 

727

 

(509)

State and local

 

380

 

(456)

Total deferred

 

1,107

 

(965)

Total provision (benefit)

$

1,212

$

(431)

The reconciliation of the federal statutory income tax rate to the Company’s effective tax rate reflected in the income tax provision (benefit) shown in the consolidated statements of operations is as follows:

Years Ended December 31, 

    

2023

    

2022

 

U.S. statutory federal rate

 

21.00

%  

21.00

%

State and local rate, net of federal tax benefit

 

6.36

 

6.10

Stock compensation

 

(0.14)

 

(6.14)

Excess compensation deduction

 

(0.27)

 

(5.32)

Federal true-ups

 

0.18

 

(5.09)

Life insurance

 

(0.12)

 

(0.52)

Change in valuation allowance

 

(33.16)

 

Income tax (provision) benefit

 

(6.15)

%  

10.03

%

84

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

The significant components of net deferred tax assets (liabilities) of the Company consist of the following:

December 31, 

($ in thousands)

    

2023

    

2022

Deferred tax assets

 

  

 

  

Stock-based compensation

$

712

$

712

Federal, state and local net operating loss carryforwards

 

8,127

 

3,175

Accrued compensation and other accrued expenses

 

451

 

748

Allowance for doubtful accounts

 

231

 

Basis difference arising from discounted note payable

 

11

 

11

Charitable contribution carryover

 

1

 

Property and equipment

 

169

 

497

Interest expense

 

31

 

Total deferred tax assets

9,733

5,143

Valuation allowance

(6,537)

Total deferred tax assets, net of valuation allowance

3,196

5,143

Deferred tax liabilities

Basis difference arising from intangible assets of acquisition

 

(3,196)

 

(4,036)

Total deferred tax liabilities

 

(3,196)

 

(4,036)

Net deferred tax assets

$

$

1,107

As of December 31, 2023 and 2022, the Company had approximately $28.6 million and $10.9 million, respectively, of federal net operating loss carryforwards ("NOLs") available to offset future taxable income. The NOL as of December 31, 2017 of $0.3 million has an expiration period through 2037. The NOL generated during tax years beginning after December 31, 2017 of $28.3 million has an indefinite life and does not expire.

As of December 31, 2023 and 2022, management does not believe the Company has any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its consolidated financial statements. The Company will continue to evaluate its uncertain tax positions in future periods to determine if measurement and recognition in its consolidated financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.

During the Current Year, the Company recognized a valuation allowance in order to reduce deferred tax assets to the amount expected to be realized. The change in the valuation allowance from December 31, 2022 to December 31, 2023 was approximately $6.5 million.

85

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

11.   Related Party Transactions

IM Topco, LLC

As described in Note 3, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

Services Agreement

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year.

In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.

For the year ended December 31, 2023, the Company recognized service fee income related to this agreement of $150,000.

License Agreement

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.

Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the year ended December 31, 2023, the estimated amount of such shortfall was approximately $325,000, which the Company recognized as royalty expense in the consolidated statements of operations.

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which the parties agreed to waive the purchase price adjustment provision until the measurement period ending March 31, 2024 (see Note 3 for details). In exchange, Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities.

86

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

Isaac Mizrahi

Isaac Mizrahi is a principal stockholder and former employee of the Company.

Employment Agreement

On February 24, 2020, the Company entered into an employment agreement with Mr. Mizrahi for him to continue to serve as Chief Design Officer of the Isaac Mizrahi Brand. This employment agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (see Note 3 for details).

The employment agreement provided Mr. Mizrahi with a base salary of $1.8 million, $2.0 million, and $2.1 million per annum for 2020, 2021, and 2022, respectively. Mr. Mizrahi was also eligible to receive an annual cash bonus (the “Bonus”) up to an amount equal to $2.5 million less base salary for 2020 and $3.0 million less base salary for 2021 and 2022. The Bonus consisted of the DRT Revenue, Bonus, the Brick-and-Mortar Bonus, the Endorsement Bonus and the Monday Bonus, if any, as determined in accordance with the below:

“DRT Bonus” means for any calendar year an amount equal to 10% of the aggregate net revenue related to sales of Isaac Mizrahi Brand products through direct response television. The DRT Revenue Bonus shall be reduced by the amount of the Monday Bonus.
“Brick-and-Mortar Bonus” means for any calendar year an amount equal to 10% of the net revenues from sales of products under the Isaac Mizrahi Brand, excluding DRT revenue and endorsement revenues.
“Endorsement Bonus” means for any calendar year an amount equal to 40% of revenues derived from projects undertaken by the Company with one or more third parties solely for Mr. Mizrahi to endorse the third party’s products through the use of Mr. Mizrahi’s name, likeness, and/or image, and neither the Company nor Mr. Mizrahi provides licensing or design.
“Monday Bonus” means $10,000 for each appearance by Mr. Mizrahi on Qurate’s QVC channel on Mondays (subject to certain expectations) up to a maximum of 40 such appearances in a calendar year.

In addition, on May 31, 2022, all 522,500 unvested shares of restricted stock of the Company held by Mr. Mizrahi (for which all stock-based compensation expense had been previously recognized in prior periods) were immediately vested, with 240,000 of such shares being surrendered for cancellation in satisfaction of withholding tax obligations. Also on May 31, 2022, the Company issued 33,557 additional shares of common stock of the Company (valued at $50,000) to Mr. Mizrahi, which vested immediately, and made a $100,000 cash payment to Mr. Mizrahi

Laugh Club Services Agreement

On February 24, 2020 the Company entered into a services agreement with Laugh Club, an entity wholly-owned by Mr. Mizrahi, pursuant to which Laugh Club provided services to Mr. Mizrahi necessary for Mr. Mizrahi to perform his services pursuant to the employment agreement. The Company paid Laugh Club an annual fee of $0.72 million for such services. This services agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (see Note 3 for details).

87

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

ORME

On December 4, 2023, the Company acquired a 30% equity ownership interest in ORME, a short-form video and social commerce marketplace that is planned to launch in 2024, for a purchase price of $150,000. ORME licenses the technology utilized by its marketplace from KonnectBio Inc., in which Robert W. D’Loren, the Company’s Chairman of the Board, Chief Executive Officer, and President, owns an approximate 20% noncontrolling interest.

12.Subsequent Events

Leasing Transactions

Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and shall expire seven years from the commencement date in 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year.

On January 26, 2024, the Company, as lessor, entered into a lease agreement for the sublease of its former corporate offices and operations facility located at 1333 Broadway, 10th floor, New York, New York to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of this sublease is approximately $0.8 million per year. As a result of entering into this sublease, the Company recognized an impairment charge of approximately $2.1 million related to the right-of-use asset. The loss recognition will coincide with the departure date. February 29, 2024 has been determined to be the date of a fundamental change to the use of the 1333 Broadway premises.

Public Offering and Private Placement

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,421 shares of the Company’s common stock at a price to the public of $0.65 per share. In connection with the Offering, Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares of common stock, respectively.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1,735,000.

 

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 178,953 shares of common stock (the “Representative’s Warrants”) as compensation. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

On March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $265,000. The purchase of the Private Placement Shares closed concurrently with the Offering.

88

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2023 and 2022

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,063 shares and the total net proceeds received was approximately $2,000,000.

IM Topco

On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 membership purchase agreement and the Business Venture Agreement. Under these amendments, the parties agreed to the following:

The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025.
If IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco under the second amendment (which totaled $375,000 as of December 31, 2023).
On and after January 1, 2026, WHP shall receive 50% of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to $1.0 million.  

Legal Matters

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the March 31, 2021 asset purchase agreement for failure to pay $963,642 earned in 2023 in accordance with the provisions of the Lori Goldstein Earn-Out (as described in Note 9) under the terms of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to Ms. Goldstein’s failure to make all of the QVC appearances as required by her employment agreement, the Company was not willing to pay the amount due in a lump sum, but instead would make the payment in four quarterly installments. Failure to amicably resolve this dispute could adversely affect the Company’s cash flows and the availability of Ms. Goldstein’s services.

89

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

There were no disagreements with our auditors which would require disclosure under Item 304(b) of Regulation S-K.

Item 9A.Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in its Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Such controls and procedures, by their nature, can provide only reasonable assurance regarding management’s control objectives.

Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a 15(f) and 15d 15(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of December 31, 2023. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of December 31, 2023, due to the material weakness described below.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, the chief executive officer and principal financial officer and effected by our board of directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the design and effectiveness of our internal control over financial reporting based on the criteria set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on our evaluation under the framework described above, our management has concluded that our internal control over financial reporting was not effective as of December 31, 2023 due to the material weakness set forth below. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

The basis for the conclusion that such internal control was ineffective included the following considerations:

The Company was unable to file its Annual Report on Form 10-K within the time specified in SEC rules and forms, due to a failure to obtain audited financial statements of the Company’s investment in an equity method investee. Additional procedures were required for the Company’s audit, which impacted on the resources required to timely file the Company’s Form 10-K.

During the middle of February 2024, our equity method investee engaged an independent audit accounting firm (separate from Marcum, LLP) to conduct its audit. We agreed to pay for all fees of the audit, and on February 23, 2024, paid a retainer to the audit firm, in accordance with the engagement. The audit firm was the same firm which conducted the audit for the year ended December 31, 2022 for the same equity method investee and delivered timely such audited financial statements for such prior audit. However, the audit firm for the equity method investee has not completed the 2023 audit on a timely basis. It was determined their progress was significantly deficient, and there would not be sufficient time to engage a new audit firm to receive timely, audited financial statements of the equity method investee. The determination was made to terminate this firm’s 2023 engagement and have a new firm engaged to provide the 2023 audited financial statements.

90

Going forward, the Company will arrange for the appointment of a different auditor by the equity method investee and take a more active role in communicating with the auditor of the equity method investee, including assessing progress and timing.

This annual report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. We were not required to have, nor have we, engaged the Company’s independent registered public accounting firm to perform an audit of internal control over financial reporting pursuant to the rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.

Changes in Internal Control over Financial Reporting

There was no change in the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during our most recent completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Item 9B.   Other Information

None.

Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

PART III

Item 10.   Directors, Executive Officers and Corporate Governance

The following table sets forth the names, ages, and positions of our executive officers and directors as of the date hereof. Executive officers are appointed by our board of directors. Each executive officer holds office until resignation, is removed by the Board, or a successor is elected and qualified. Each director holds office until a successor is elected and qualified or earlier resignation or removal.  

NAME

    

AGE

    

POSITION

Robert W. D’Loren

 

66

 

Chairman of the Board of Directors and Chief Executive Officer and President

James F. Haran

 

63

 

Chief Financial Officer and Assistant Secretary, and Principal Financial and Accounting Officer

Seth Burroughs

 

44

 

Executive Vice President of Business Development and Treasury and Secretary

Mark DiSanto

 

62

 

Director

James Fielding

 

59

 

Director

Howard Liebman

 

81

 

Director

Deborah Weinswig

 

53

 

Director

Below are the biographies of each of our officers and directors as of December 31, 2023.

Robert W. D’Loren has been the Chairman of our Board and our Chief Executive Officer and President since September 2011. Mr. D’Loren has been an entrepreneur, innovator, and pioneer of the consumer branded products industry for over 35 years. Mr. D’Loren has spearheaded the Company’s omni-channel platform, connecting the channels of digital, brick-and-mortar, social media, and direct-response television to create a single customer view and brand experience for Xcel’s brands. He served as Chairman and CEO of IPX Capital, LLC and its subsidiaries, a consumer products investment company, from 2009 to 2011. He continues to serve as IPX Capital LLC’s Chairman.

Prior to founding the Company, from June 2006 to July 2008, Mr. D’Loren was a director, President and CEO of NexCen Brands, Inc., a global brand acquisition and management company with holdings that included The Athlete’s Foot,

91

Waverly Home, Bill Blass, MaggieMoo’s, Marble Slab Creamery, Pretzel Time, Pretzelmaker, Great American Cookies, and The Shoe Box.

From 2002 to 2006, Mr. D’Loren’s work among consumer brands continued as President and CEO of UCC Capital Corporation, an intellectual property investment company where he invested in the consumer branded products, media, and entertainment sectors. From 1997 to 2002, Mr. D’Loren founded and acted as President and Chief Operating Officer of CAK Universal Credit Corporation, an intellectual property finance company. Mr. D’Loren’s total career debt and equity investments in over 30 entertainment and consumer branded products companies have exceeded $1.0 billion. In 1985, he founded and served as President and CEO of the D’Loren Organization, an investment and restructuring firm responsible for over $2 billion of transactions. Mr. D’Loren has also served as an asset manager for Fosterlane Management, as well as a manager with Deloitte.

Mr. D’Loren has served on the Board of Directors for Iconix Brand Group, Longaberger Company, Business Loan Center, and as a board advisor to The Athletes Foot and Bill Blass, Ltd. He also serves on the board of directors for the Achilles Track Club International. Mr. D’Loren is a Certified Public Accountant and holds an M.S. degree from Columbia University and a B.S. degree from New York University.

James F. Haran has been our Chief Financial Officer since September 2011. Mr. Haran served as CFO of IPX Capital, LLC and its related subsidiaries, from June 2008 to September 2011. Mr. Haran was the Executive Vice President, Capital Markets for NexCen Brands, Inc. from 2006 to May 2008 and Chief Financial Officer and Chief Credit Officer for UCC Capital Corporation, and its predecessor company, CAK Universal Credit Corp., from 1998 to 2006. Prior to joining UCC, Mr. Haran was a partner at Sidney Yoskowitz and Company P.C., a registered diversified certified public accounting firm. During his tenure, which began in 1987, his focus was on real estate and financial services companies. Mr. Haran is a Certified Public Accountant and holds a B.S. degree from State University of New York at Plattsburgh.

Seth Burroughs has been our Executive Vice President of Business Development and Treasury since September 2011. From June 2006 to October 2010, Mr. Burroughs served as Vice President of NexCen Brands, Inc. Prior to his role at NexCen, from 2003 to 2006, Mr. Burroughs served as Director of M&A Advisory and Investor Relations at UCC Capital Corporation, an intellectual property investment company, where he worked on $500 million in acquisitions and $300 million in specialty financing as an advisor to consumer branded products companies in the franchising and apparel industries. From 2001 to 2003, Mr. Burroughs worked as a Senior Financial Analyst at The Pullman Group where he was involved with structuring the first securitizations of music royalties, including the Bowie Bonds, and as a Financial Analyst at Merrill Lynch’s private client group. Mr. Burroughs received a B.S. degree in economics from The Wharton School of Business at the University of Pennsylvania.

Mark DiSanto has served as a member of our Board since October 2011. Since 1988, Mr. DiSanto has served as the Chief Executive Officer of Triple Crown Corporation, a regional real estate development and investment company with commercial and residential development projects exceeding 1.5 million square feet. Mr. DiSanto received a degree in business administration from Villanova University’s College of Commerce and Finance, a J.D. degree from the University of Toledo College of Law, and an M.S. degree in real estate development from Columbia University.

James Fielding was appointed as a member of our Board in July 2018. He is a 25-year veteran in the consumer retail space, and previously served as the Global Head of Consumer Products for Dreamworks Animation and Awesomeness TV. Prior to that, Mr. Fielding served as the CEO of Claire’s Stores Inc., where he oversaw strategic growth and international development for the retail chain’s 3,000-plus stores worldwide. From May 2008 to 2012 Mr. Fielding served as the President of Disney Stores Worldwide.

Howard Liebman has served as a member of our Board since October 2011. He was President, Chief Operating Officer and a director of Hobart West Group, a provider of national court reporting and litigation support services, from 2007 until the sale of the business in 2008. Mr. Liebman served as a consultant to Hobart from 2006 to 2007. Mr. Liebman was President, Chief Financial Officer, and a director of Shorewood Packaging Corporation, a multinational manufacturer of high-end value-added paper and paperboard packaging for the entertainment, tobacco, cosmetics and other consumer products markets. Mr. Liebman joined Shorewood in 1994 as Executive Vice President and Chief Financial Officer, and served as its President from 1999 until Shorewood was acquired by International Paper in 2000. Mr. Liebman continued

92

as Executive Vice President of Shorewood until his retirement in 2005. Mr. Liebman is a Certified Public Accountant and was an audit partner with Deloitte and Touche, LLP (and its predecessors) from 1974 to 1994.

Deborah Weinswig was appointed as a member of our Board in January 2018. She is a Managing Director of Funding Global Retail & Technology (“FGRT”), the think tank for the Hong Kong-based Fung Group, since April 2014 where she is responsible for building the team’s research capabilities and providing insights into the disruptive technologies that are reshaping today’s global retail landscape. Prior to leading FGRT, Weinswig served as Chief Customer Officer for Profitect Inc., a predictive analytics and big data software provider. From March 2002 to October 2013, Ms. Weinswig was employed by Citigroup, Inc., most recently where she was Managing Director and Head of the Global Staples & Consumer Discretionary team at Citi Research. Ms. Weinswig also serves as an e-commerce expert for the International Council of Shopping Centers’ Research Task Force and was a founding member of the Oracle Retail Industry Strategy Council. Lastly, she is a member of the Board of Directors of Kiabi (affiliated with the Auchan Group). Ms. Weinswig is a Certified Public Accountant and holds an MBA from the University of Chicago.

Directors’ Qualifications

In furtherance of our corporate governance principles, each of our directors brings unique qualities and qualifications to our Board. We believe that all of our directors have a reputation for honesty, integrity, and adherence to high ethical standards. They each have demonstrated business acumen, leadership, and an ability to exercise sound judgment, as well as a commitment to serve the Company and our Board. The following descriptions demonstrate the qualifications of each director:

Robert W. D’Loren has extensive experience in and knowledge of the licensing and commercial business industries and financial markets. This knowledge and experience, including his experience as director, president, and chief executive officer of a global brand management company, provide us with valuable insight to formulate and create our acquisition strategy and how to manage and license acquired brands.

Mark DiSanto has considerable experience in building and running businesses and brings his strong business acumen to the Board.

James Fielding brings extensive senior level experience in the consumer retail space, as well as strong relationships in the media and retail industries.

Howard Liebman brings comprehensive knowledge of accounting, the capital markets, mergers and acquisitions, financial reporting, and financial strategies from his extensive public accounting experience and prior service as Chief Financial Officer of a public company.

Deborah Weinswig brings thought leadership in the retail and licensing industries, particularly in the areas of sourcing and logistics.

Key Employees

Lori Goldstein is Chief Creative Officer and Spokeswoman for the Lori Goldstein Brands. As Chief Creative Officer, she is responsible for providing design input and guidance to Xcel Brands for all brands under her name. Ms. Goldstein’s work has covered a vast range, from her collaborations with photographers Annie Leibovitz at Vanity Fair to Steven Meisel at Vogue Italia, to her styling for designers Donatella Versace and Vera Wang. Ms. Goldstein stepped in front of the camera in 2009 when she launched LOGO by Lori Goldstein, her exclusive collection for QVC. She is the author of “Style Is Instinct,” which was published in 2013. In 2014, Ms. Goldstein’s brand was awarded “Apparel Product Concept of the Year” and she was named QVC Ambassador.

93

Employment Agreements with Executives

Robert W. D’Loren

On February 28, 2019, and effective as of January 1, 2019, the Company entered into a three-year employment agreement with Robert W. D’Loren for him to continue to serve as Chief Executive Officer of the Company, referred to as the D’Loren Employment Agreement. Following the initial three-year term, the agreement automatically renewed for successive one-year terms in 2022, 2023, and 2024, and will be automatically renewed for one-year terms thereafter unless either party gives written notice of intent to terminate at least 90 days prior to the termination of the then current term. Pursuant to the D’Loren Employment Agreement, Mr. D’Loren’s annual base salary is $0.89 million. The Company’s board of directors or the compensation committee may approve increases (but not decreases) from time to time. Following the initial three-year term, Mr. D’Loren’s base salary will be reviewed at least annually. Mr. D’Loren receives an allowance for an automobile appropriate for his level of position and the Company pays (in addition to monthly lease or other payments) all of the related expenses for gasoline, insurance, maintenance, repairs, or any other costs with Mr. D’Loren’s automobile.

Bonus

Mr. D’Loren will be eligible to receive an annual cash bonus in an amount equal to (i) 2.5% of all income generated from the sales of the Company’s products and by the trademarks and other intellectual property owned, operated or managed by us (“IP Income”), in excess of $8.0 million earned and received by us in such fiscal year: provided that any IP income generated through net sales shall be multiplied by (x) 7% in the case of net sales from wholesale sales, and private label sales and (y) 3% in the case of net sales from e-commerce sales through the Company’s web sites and (ii) 5% of the Company’s adjusted EBITDA (as defined in the D’Loren Employment Agreement) for such fiscal year. Mr. D’Loren shall have the right to elect to receive the cash bonus through the issuance of shares of the Company’s common stock.

Pursuant to the D’Loren Agreement, Mr. D’Loren was granted an option to purchase up to 2,578,947 shares of the Company’s common stock at an exercise price of $1.72 per share. The option is exercisable until February 28, 2029 and shall vest, subject to Mr. D’Loren remaining employed by the Company and based upon the Company’s common stock achieving the following target prices:

Target Prices

    

Number of Option Shares Vesting

$3.00

736,842

$5.00

626,316

$7.00

515,789

$9.00

405,263

$11.00

294,737

Severance

If Mr. D’Loren’s employment is terminated by the Company without cause, or if Mr. D’Loren resigns with good reason, or if the Company fails to renew the term, then Mr. D’Loren will be entitled to receive his unpaid base salary and cash bonuses through the termination date and a lump sum payment equal to the base salary in effect on the termination date for the longer of two years from the termination date or the remainder of the then-current term. Additionally, Mr. D’Loren would be entitled to two hundred times the average annual cash bonuses paid in the preceding 12 months. Mr. D’Loren would also be entitled to continue to participate in the Company’s group medical plan or receive reimbursement for premiums paid for other medical insurance in an amount not to exceed the cost to participate in the Company’s plan, subject to certain conditions, for a period of 36 months from the termination date.

Change of Control

In the event Mr. D’Loren’s employment is terminated within 12 months following a change of control by the Company without cause or by Mr. D’Loren with good reason, he would be entitled to a lump sum payment equal to two times (i) his base salary in effect on the termination date for the longer of two years from the termination date or the remainder of the then-current term and (ii) two times the average annual cash bonuses paid in the preceding 12 months, minus $100.

94

“Change of control,” as defined in Mr. D’Loren’s employment agreement, means a merger or consolidation to which we are a party, a sale, lease or other transfer, exclusive license or other disposition of all or substantially all of our assets, a sale or transfer by our stockholders of voting control, in a single transaction or a series of transactions or, if during any twelve consecutive month period, the individuals who at the beginning of such period, constitute the board of directors of the Company (the “Incumbent Directors”) cease (other than due to death) to constitute a majority of the members of the board at the end of such period; provided that directors elected by or on the recommendation of a majority of the directors who so qualify as Incumbent Directors shall be deemed to be Incumbent Directors. Upon a change of control, notwithstanding the vesting and exercisability schedule in any stock option or other grant agreement between Mr. D’Loren and the Company, all unvested stock options, shares of restricted stock and other equity awards granted by the Company to Mr. D’Loren pursuant to any such agreement shall immediately vest, and all such stock options shall become exercisable and remain exercisable for the lesser of 180 days after the date the change of control occurs or the remaining term of the applicable option.

Non-Competition and Non-Solicitation

During the term of his employment by the Company and for a one-year period after the termination of such employment (unless Mr. D’Loren’s employment was terminated without cause or was terminated by him for good reason, in which case only for his term of employment and a six-month period after the termination of such employment), Mr. D’Loren may not permit his name to be used by or participate in any business or enterprise (other than the mere passive ownership of not more than 5% of the outstanding stock of any class of a publicly held corporation whose stock is traded on a national securities exchange or in the over-the-counter market) that engages or proposes to engage in our business in the United States, its territories and possessions and any foreign country in which we do business as of the date of termination of his employment. Also, during his employment and for a one-year period after the termination of such employment, Mr. D’Loren may not, directly or indirectly, solicit, induce or attempt to induce any customer, supplier, licensee, or other business relation of the Company or any of its subsidiaries to cease doing business with the Company or any of its subsidiaries; or solicit, induce or attempt to induce any person who is, or was during the then-most recent 12-month period, a corporate officer, general manager, or other employee of the Company or any of its subsidiaries, to terminate such employee’s employment with the Company or any of its subsidiaries; or hire any such person unless such person’s employment was terminated by the Company or any of its subsidiaries; or in any way interfere with the relationship between any such customer, supplier, licensee, employee, or business relation and the Company or any of its subsidiaries.

James Haran

On February 28, 2019, and effective as of January 1, 2019, the Company entered into a two-year employment agreement with James Haran for him to continue to serve as the Company’s Chief Financial Officer, referred to as the Haran Employment Agreement. Following the initial two-year term, the agreement automatically renewed for successive one-year terms in 2021, 2022, 2023, and 2024, and will be automatically renewed for one-year terms thereafter unless either party gives written notice of intent to terminate at least 30 days prior to the expiration of the then current term. Pursuant to the Haran Employment Agreement, Mr. Haran’s annual base salary is $0.37 million per annum. The board of directors or the compensation committee may approve increases (but not decreases) from time to time. Following the initial two-year term, the base salary shall be reviewed at least annually. In addition, Mr. Haran receives a car allowance of $1,500 per month.

Bonus

Mr. Haran will be eligible to receive a performance cash bonus in an amount equal to (i) 0.23% of all IP Income in excess of $12.0 million earned and received by us in such fiscal year; provided that any IP income generated through net sales shall be multiplied by (x) 7% in the case of net sales from wholesale sales, and private label sales and (y) 3% in the case of net sales from e-commerce sales through the Company’s web sites plus (ii) 0.375% of the Company’s adjusted EBITDA (as defined in the Haran Employment Agreement) for such fiscal year. Notwithstanding the foregoing, for (i) 2019, $0.04 million of Mr. Haran’s bonus was guaranteed, of which $0.01 million was paid to Mr. Haran upon execution of the Haran Employment Agreement and $0.03 million was paid prior to June 30, 2019, and (ii) for 2020, $0.03 million of Mr. Haran’s bonus was guaranteed and paid prior to June 30, 2020, in each case.

95

Pursuant to the Haran Employment Agreement, Mr. Haran was granted an option to purchase up to 552,632 shares of the Company’s common stock at an exercise price of $1.72 per share. The option is exercisable until February 28, 2029 and shall vest, subject to Mr. Haran remaining employed with the Company and based upon the Company’s common stock achieving target prices as follows:

Target Prices

    

Number of Option Shares Vesting

$3.00

 

157,895

$5.00

 

134,211

$7.00

 

110,526

$9.00

 

86,842

$11.00

 

63,158

Severance

If Mr. Haran’s employment is terminated by the Company without cause, or if Mr. Haran resigns with good reason, or if the Company fails to renew the term, then Mr. Haran will be entitled to receive his unpaid base salary and cash bonuses through the termination date and a lump sum payment equal to his base salary in effect on the termination date for 12 months. Mr. Haran would also be entitled to continue to participate in our group medical plan, subject to certain conditions, for a period of 12 months from the termination date.

Change of Control

In the event Mr. Haran’s employment is terminated within 12 months following a change of control by the Company without cause or by Mr. Haran with good reason, Mr. Haran would be entitled to a lump sum payment equal to his base salary in effect on the termination date for 12 months following such termination. “Change of control,” as defined in Mr. Haran’s employment agreement, means a merger or consolidation to which we are a party, a sale, lease or other transfer, exclusive license or other disposition of all or substantially all of our assets, or a sale or transfer by our stockholders of voting control, in a single transaction or a series of transactions. Upon a change of control, notwithstanding the vesting and exercisability schedule in any stock option or other grant agreement between Mr. Haran and us, all unvested stock options, shares of restricted stock and other equity awards granted by us to Mr. Haran pursuant to any such agreement shall immediately vest, and all such stock options shall become exercisable and remain exercisable for the lesser of 180 days after the date the change of control occurs or the remaining term of the applicable option.

Non-Competition and Non-Solicitation

During the term of his employment by the Company and for a one-year period after the termination of such employment, Mr. Haran may not permit his name to be used by or participate in any business or enterprise (other than the mere passive ownership of not more than 5% of the outstanding stock of any class of a publicly held corporation whose stock is traded on a national securities exchange or in the over-the-counter market) that engages or proposes to engage in our business in the United States, its territories and possessions and any foreign country in which we do business as of the date of termination of such employment. Also, during his employment and for a one-year period after the termination of his employment, Mr. Haran may not, directly or indirectly, solicit, induce or attempt to induce any customer, supplier, licensee, or other business relation of the Company or any of its subsidiaries to cease doing business with the Company or any of its subsidiaries; or solicit, induce or attempt to induce any person who is, or was during the then-most recent 12-month period, a corporate officer, general manager or other employee of the Company or any of its subsidiaries, to terminate such employee’s employment with the Company or any of its subsidiaries; or hire any such person unless such person’s employment was terminated by the Company or any of its subsidiaries; or in any way interfere with the relationship between any such customer, supplier, licensee, employee or business relation and the Company or any of its subsidiaries.

96

Seth Burroughs

On February 28, 2019, and effective as of January 1, 2019, the Company entered into a two-year employment agreement with Seth Burroughs for him to continue to serve as the Company’s Executive Vice President – Business Development and Treasury, referred to as the Burroughs Employment Agreement. Following the initial two-year term, the agreement automatically renewed for successive one-year terms in 2021, 2022, 2023, and 2024, and will be automatically renewed for one-year terms thereafter unless either party gives written notice of intent to terminate at least 30 days prior to the expiration of the then current term. Pursuant to the Burroughs Employment Agreement, Mr. Burroughs’ annual base salary is $0.34 million per annum. The board of directors or the compensation committee may approve increases (but not decreases) from time to time. Following the initial two-year term, the base salary shall be reviewed at least annually.

Bonus

Mr. Burroughs will be eligible to receive a performance cash bonus in an amount equal to (i) 0.23% of all IP Income in excess of $12.0 million earned and received by us in such fiscal year; provided that any IP income generated through net sales shall be multiplied by (x) 7% in the case of net sales from wholesale sales, and private label sales and (y) 3% in the case of net sales from e-commerce sales through the Company’s web sites plus (ii) 0.375% of the Company’s adjusted EBITDA (as defined in the Haran Employment Agreement) for such fiscal year.

Pursuant to the Burroughs Employment Agreement, Mr. Burroughs was granted an option to purchase up to 368,421 shares of the Company’s common stock at an exercise price of $1.72 per share. The option is exercisable until February 28, 2029 and shall vest, subject to Mr. Burroughs remaining employed with the Company and based upon the Company’s common stock achieving target prices as follows:

Target Prices

    

Number of Option Shares Vesting

$3.00

 

105,263

$5.00

 

89,474

$7.00

 

73,684

$9.00

 

57,895

$11.00

 

42,105

Severance

If Mr. Burrough’s employment is terminated by the Company without cause, or if Mr. Burroughs resigns with good reason, or if the Company fails to renew the term, then Mr. Burroughs will be entitled to receive his unpaid base salary and cash bonuses through the termination date and a lump sum payment equal to his base salary in effect on the termination date for 12 months. Mr. Burroughs would also be entitled to continue to participate in our group medical plan, subject to certain conditions, for a period of 12 months from the termination date.

Change of Control

In the event Mr. Burroughs’ employment is terminated within 12 months following a change of control by the Company without cause or by Mr. Burroughs with good reason, Mr. Burroughs would be entitled to a lump sum payment equal to his base salary in effect on the termination date for 12 months following such termination. “Change of control,” as defined in Mr. Burroughs’ employment agreement, means a merger or consolidation to which we are a party, a sale, lease or other transfer, exclusive license or other disposition of all or substantially all of our assets, or a sale or transfer by our stockholders of voting control, in a single transaction or a series of transactions. Upon a change of control, notwithstanding the vesting and exercisability schedule in any stock option or other grant agreement between Mr. Burroughs and us, all unvested stock options, shares of restricted stock and other equity awards granted by us to Mr. Burroughs pursuant to any such agreement shall immediately vest, and all such stock options shall become exercisable and remain exercisable for the lesser of 180 days after the date the change of control occurs or the remaining term of the applicable option.

97

Non-Competition and Non-Solicitation

During the term of his employment by the Company and for a one-year period after the termination of such employment, Mr. Burroughs may not permit his name to be used by or participate in any business or enterprise (other than the mere passive ownership of not more than 5% of the outstanding stock of any class of a publicly held corporation whose stock is traded on a national securities exchange or in the over-the-counter market) that engages or proposes to engage in our business in the United States, its territories and possessions and any foreign country in which we do business as of the date of termination of such employment. Also, during his employment and for a one-year period after the termination of his employment, Mr. Burroughs may not, directly or indirectly, solicit, induce or attempt to induce any customer, supplier, licensee, or other business relation of the Company or any of its subsidiaries to cease doing business with the Company or any of its subsidiaries; or solicit, induce or attempt to induce any person who is, or was during the then-most recent 12-month period, a corporate officer, general manager or other employee of the Company or any of its subsidiaries, to terminate such employee’s employment with the Company or any of its subsidiaries; or hire any such person unless such person’s employment was terminated by the Company or any of its subsidiaries; or in any way interfere with the relationship between any such customer, supplier, licensee, employee or business relation and the Company or any of its subsidiaries.

Family Relationships

There are no family relationships among our directors or officers.

Independence of the Board of Directors

The board has determined that Messrs. Howard Liebman, Mark DiSanto, James Fielding, and Ms. Deborah Weinswig meet the director independence requirements under the applicable listing rule of the NASDAQ Stock Market LLC (“NASDAQ”). Each current member of the Audit Committee, Compensation Committee, and Nominating Committee is independent and meets the applicable rules and regulations regarding independence for such committee, including those set forth in the applicable NASDAQ rules, and each member is free of any relationship that would interfere with his individual exercise of independent judgment.

Section 16(a) Beneficial Ownership Reporting Compliance

To our knowledge, based solely on a review of Forms 3 and 4 and any amendments thereto furnished to our Company pursuant to Rule 16a-3(e) under the Securities Exchange Act of 1934, or representations that no Forms 5 were required, all Section 16(a) filing requirements applicable to our officers, directors, and beneficial owners of more than 10% of our equity securities were timely filed, except that Deborah Weinswig filed a late Form 4 for one transaction.

Code of Ethics

On September 29, 2011, we adopted a code of ethics that applies to our officers, employees, and directors, including our Chief Executive Officer, Chief Financial Officer, and senior executives. Our Code of Ethics can be accessed on our website, www.xcelbrands.com.

Insider Trading Policy

We have adopted an insider trading policy (the “Trading Policy”) that is designed to promote compliance with federal securities laws, rules, and regulations, as well as the rules and regulations of the NASDAQ Stock Market. The Trading Policy provides Xcel’s standards on trading and causing the trading of our securities or securities of other publicly traded companies while in possession of confidential information. It prohibits trading in certain circumstances and applies to all of our directors, officers, and employees, as well as independent contractors or consultants who have access to material nonpublic information of Xcel. Additionally, our Trading Policy imposes special additional trading restrictions applicable to all of our directors and executive officers. The Trading Policy is annexed to this Annual Report as an exhibit and the full text of the Trading Policy is available on our website at www.xcelbrands.com.

98

Audit Committee and Audit Committee Financial Expert

Our board of directors has appointed an Audit Committee which consists of Mr. Liebman, Mr. DiSanto, and Ms. Weinswig. Each of such persons has been determined to be an “independent director” under the applicable NASDAQ and SEC rules, which is the independence standard that was adopted by our board of directors. The board of directors has determined that Mr. Liebman meets the requirements to serve as the Audit Committee Financial Expert by our board of directors. The Audit Committee operates under a written charter adopted by our board of directors. The Audit Committee assists the board of directors by providing oversight of our accounting and financial reporting processes, appoints the independent registered public accounting firm, reviews with the registered independent registered public accounting firm the scope and results of the audit engagement, approves professional services provided by the independent registered public accounting firm, reviews the independence of the independent registered public accounting firm, considers the range of audit and non-audit fees and reviews the adequacy of internal accounting controls.

Compensation Committee

Our board of directors has appointed a Compensation Committee consisting of Messrs. DiSanto and Fielding. Each of such persons has been determined to be an “independent director” under the applicable NASDAQ rules. Our board of directors has adopted a written Compensation Committee Charter that sets forth the committee’s responsibilities. The committee is responsible for determining all forms of compensation for our executive officers, and establishing and maintaining executive compensation practices designed to enhance long-term stockholder value.

Nominating Committee

Our board of directors has appointed a Nominating Committee consisting of Messrs. DiSanto and Liebman. Each of such persons has been determined to be an “independent director” under the applicable NASDAQ rules. Our board of directors has adopted a written Nominating Committee Charter that sets forth the committee’s responsibilities.

Item 11.   Executive Compensation

The following table sets forth information regarding all cash and non-cash compensation earned, during the years ended December 31, 2023 and 2022, by our principal executive officer and our two other most highly compensated executive officers, which we refer to collectively as the named executive officers, for services in all capacities to the Company:

Summary Compensation Table

    

    

    

    

    

Salary

    

Bonus

    

Stock Awards

    

All Other

    

    

Name

Title

Year

 (1)

 (2)

 (3)

 Compensation

Total

Robert W. D’Loren

 

CEO and Chairman

 

2023

$

888,500

$

187,731

$

$

1,890

$

1,078,121

 

 

2022

$

888,500

$

863,534

$

280,601

$

10,698

$

2,043,333

James F. Haran

 

CFO

 

2023

$

366,000

$

7,896

$

$

961

$

374,857

 

 

2022

$

366,000

$

139,672

$

$

3,332

$

509,004

Seth Burroughs

 

EVP - Business

 

2023

$

340,600

$

7,896

$

$

35

$

348,531

Development

2022

$

340,600

$

154,672

$

$

$

495,272

 

and Treasury

 

(1)Robert W. D’Loren’s salary amount for 2022 includes a voluntary temporary deferral of salary of $178,265, which was paid to Mr. D’Loren in 2023.
(2)Bonuses in 2023 include amounts paid in accordance with the executives’ respective employment agreements (see “Employment Agreements with Executives” in Item 10). Bonuses in 2022 include (i) amounts paid in accordance with the executives’ respective employment agreements and (ii) amounts awarded by the board of directors as transaction bonuses related to the May 2022 sale of a majority interest in the Isaac Mizrahi brand.

99

(3)The amount shown represents the grant date fair value of fully-vested common stock awards issued as payment for a performance bonus earned in 2021.

Outstanding Equity Awards as of December 31, 2023

Options and Warrant Awards

Stock Awards

Number of

Number of

Securities 

 

Securities 

 

 

 

Market 

Underlying 

 

Underlying 

 

 

Number of 

Value of

Unexercised 

 

Unexercised 

 

Option or

Shares of

Shares of

Options &

 

Options &

Warrant 

 Stock that

  Stock that 

 Warrants,

 

 Warrants,

Exercise

Expiration 

 Have Not

Have Not 

Name

    

Title

    

 Exercisable

    

 Unexercisable

    

 Price

    

Date

    

 Vested

    

Vested

Robert W. D’Loren

CEO, Chairman

2,578,947

(1)

$

1.72

2/28/2029

$

 

James F. Haran

 

CFO

552,632

(1)

$

1.72

2/28/2029

$

 

Seth Burroughs

 

EVP - Bus. Development

368,421

(1)

$

1.72

2/28/2029

 

$

 

& Treasury

(1)These options shall become exercisable based upon the Company’s common stock achieving specified target prices as outlined in the executive’s employment agreement, and expire on February 28, 2029. See “Employment Agreements with Executives” in Item 10.

Clawback Policy

 

The Board has adopted a clawback policy which allows us to recover performance-based compensation, whether cash or equity, from a current or former executive officer in the event of an Accounting Restatement. The clawback policy defines an Accounting Restatement as an accounting restatement of our financial statements due to our material noncompliance with any financial reporting requirement under the securities laws. Under such policy, we may recoup incentive-based compensation previously received by an executive officer that exceeds the amount of incentive-based compensation that otherwise would have been received had it been determined based on the restated amounts in the Accounting Restatement.

 

The Board has the sole discretion to determine the form and timing of the recovery, which may include repayment, forfeiture, and/or an adjustment to future performance-based compensation payouts or awards. The remedies under the clawback policy are in addition to, and not in lieu of, any legal and equitable claims available to the Company. The clawback policy is annexed to this Annual Report as an exhibit.

Director Compensation

We pay our non-employee directors $3,000 for each board of directors and committee meeting attended, up to a maximum of $12,000 per year for board of directors’ meetings and up to a maximum of $12,000 per year for committee meetings, except that the chairman of each committee receives $4,000 for each such committee meeting attended, up to a maximum of $16,000 per year. The following table sets forth information with respect to each non-employee director’s compensation for the year ended December 31, 2023. The dollar amounts shown for Stock Awards represent the grant date fair value of the restricted stock awards or stock options granted during the fiscal year calculated in accordance with ASC Topic 718.

Fees Earned

 

or Paid 

 

Stock

Option

Name

    

in Cash

    

Awards

    

Awards

    

Total

Mark DiSanto (1) (2)

$

24,000

$

15,100

$

21,544

$

60,644

Howard Liebman (1) (2)

$

28,000

$

15,100

$

21,544

$

64,644

Deborah Weinswig (1) (2)

$

21,000

$

15,100

$

21,544

$

57,644

James Fielding (1) (2)

$

12,000

$

15,100

$

21,544

$

48,644

(1)On August 23, 2023, each non-employee directory was granted 10,000 shares of restricted stock pursuant to the terms and conditions of the 2021 Equity Incentive Plan. Such shares of restricted stock will vest evenly over approximately

100

19 months, whereby 50% shall vest on April 1, 2024 and 50% shall vest on April 1, 2025. Notwithstanding the foregoing, each grantee may extent the vesting date of all or a portion of the restricted shares by six months and, thereafter one or more times may further extend such date with respect to all or a portion of the restricted shares until the next following October 1 or April 1, as the case may be. The grant date fair value of the shares was $1.51 per share.
(2)On August 23, 2023, each non-employee director was granted options to purchase 25,000 shares of stock pursuant to the terms and conditions of the 2021 Equity Incentive Plan. Such options will vest evenly over approximately 19 months, whereby 50% shall vest on April 1, 2024 and 50% shall vest on April 1, 2025. The exercise price of the options is $1.51 per share.

2021 Equity Incentive Plan

Our 2021 Equity Incentive Plan, which we refer to as the 2021 Plan, is designed and utilized to enable the Company to offer its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company.

The 2021 Plan provides for the grant of stock options, restricted stock, restricted stock units, performance awards, or cash awards. The stock options may be incentive stock options or non-qualified stock options. A total of 4,000,000 shares of common stock are eligible for issuance under the 2021 Plan. The 2021 Plan may be administered by the board of directors or a committee consisting of two or more members of the board of directors appointed by the board of directors.

Officers and other employees of Xcel or any parent or subsidiary of Xcel who are at the time of the grant of an award employed by us or any parent or subsidiary of Xcel are eligible to be granted options or other awards under the 2021 Plan. In addition, non-qualified stock options and other awards may be granted under the 2021 Plan to any person, including, but not limited to, directors, independent agents, consultants, and attorneys who the board of directors or the committee, as the case may be, believes has contributed or will contribute to our success.

Cash awards may be issued under the 2021 Plan either alone or in addition to or in tandem with other awards granted under the 2021 Plan or other payments made to a participant not under the 2021 Plan. The board or committee, as the case may be, shall determine the eligible persons to whom, and the time or times at which, cash awards will be made, the amount that is subject to the cash award, the circumstances and conditions under which such amount shall be paid, in whole or in part, the time of payment, and all other terms and conditions of the awards.

With respect to incentive stock options granted to an eligible employee owning stock possessing more than 10% of the total combined voting power of all classes of our stock or the stock of a parent or subsidiary of our Company immediately before the grant, such incentive stock option shall not be exercisable more than 5 years from the date of grant. The exercise price of an incentive stock option will not be less than the fair market value of the shares underlying the option on the date the option is granted, provided, however, that the exercise price of an incentive stock option granted to a 10% stockholder may not be less than 110% of such fair market value. The exercise price of a non-qualified stock option may not be less than fair market value of the shares of common stock underlying the option on the date the option is granted.

Restricted stock awards give the recipient the right to receive a specified number of shares of common stock, subject to such terms, conditions and restrictions as the board or the committee, as the case may be, deems appropriate. Restrictions may include limitations on the right to transfer the stock until the expiration of a specified period of time and forfeiture of the stock upon the occurrence of certain events such as the termination of employment prior to expiration of a specified period of time. Restricted stock unit (“RSU”) awards will be settled in cash or shares of common stock, in an amount based on the fair market value of our common stock on the settlement date. The RSUs will be subject to forfeiture and restrictions on transferability as set forth in the 2021 Plan and the applicable award agreement and as may be otherwise determined by the board or the committee. There were no RSUs outstanding as of December 31, 2022.

101

Certain awards made under the 2021 Plan may be granted so that they qualify as “performance-based compensation” (as this term is used in Internal Revenue Code Section 162(m) and the regulations thereunder) and are exempt from the deduction limitation imposed by Code Section 162(m). Under Internal Revenue Code Section 162(m), our tax deduction may be limited to the extent total compensation paid to the chief executive officer, or any of the four most highly compensated executive officers (other than the chief executive officer) exceeds $1 million in any one tax year. Among other criteria, awards only qualify as performance-based awards if at the time of grant the compensation committee is comprised solely of two or more “outside directors” (as this term is used in Internal Revenue Code Section 162(m) and the regulations thereunder). In addition, we must obtain stockholder approval of material terms of performance goals for such performance-based compensation.

All stock options and certain stock awards, performance awards, and stock units granted under the 2021 Plan, and the compensation attributable to such awards, are intended to (i) qualify as performance-based awards or (ii) be otherwise exempt from the deduction limitation imposed by Internal Revenue Code Section 162(m). No awards may be granted on or after the fifth anniversary of the effective date of the 2021 Plan.

The 2021 Equity Incentive Plan became effective April 19, 2022. Prior to the effectiveness of the 2021 Plan, the Company made awards under our Amended and Restated 2011 Equity Incentive Plan (the “2011 Plan”), the key terms and provisions of which were substantially similar to the 2021 Plan described above, with the major difference being the number of shares of common stock eligible for issuance. Stock-based awards (including options, warrants, and restricted stock) previously granted under our 2011 Plan remain outstanding, and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table lists, as of April 3, 2024, the number of shares of common stock beneficially owned by (i) each person or entity known to the Company to be the beneficial owner of more than 5% of the outstanding common stock; (ii) each named executive officer and director of the Company, and (iii) all officers and directors as a group. Information relating to beneficial ownership of common stock by our principal stockholders and management is based upon information furnished by each person using “beneficial ownership” concepts under the rules of the Securities and Exchange Commission. Under these rules, a person is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or direct the voting of the security, or investment power, which includes the power to dispose of or direct the disposition of the security. The person is also deemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership within 60 days. Under the Securities and Exchange Commission rules, more than one person may be deemed to be a beneficial owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which he or she may not have any pecuniary beneficial interest. Except as noted below, each person has sole voting and investment power. Unless otherwise indicated, the address for such person is c/o Xcel Brands, Inc., 550 Seventh Avenue, 11th Floor, New York, New York 10018.

102

The percentages below are calculated based on 23,492,117 shares of common stock issued and outstanding as of April 3, 2023:

Number of 

 

Shares 

 

of Common 

Stock 

Percent 

Beneficially 

Beneficially 

Name and Address

    

Owned

    

Owned

Named executive officers and directors:

Robert W. D’Loren (1)

 

7,793,399

 

33.17

%

James F. Haran (2)

 

204,018

 

*

Seth Burroughs (3)

 

372,513

 

1.59

Howard Liebman (4)

 

196,165

 

*

Mark DiSanto (5)

 

1,841,915

 

7.81

Deborah Weinswig (6)

 

148,000

 

*

James Fielding (7)

 

140,000

 

*

All directors and executive officers as a group (7 persons) (8)

 

10,696,010

 

44.84

5% Shareholders:

Isaac Mizrahi (9)

 

2,366,882

 

10.03

*  Less than 1%.

(1)Consists of (i) 2,017,829 shares held by Mr. D’Loren, (ii) 607,317 shares owned by Irrevocable Trust of Rose Dempsey (or the Irrevocable Trust) of which Mr. D’Loren and Mr. DiSanto are the trustees and as to which Mr. D’Loren has sole voting and dispositive power, (iii) 1,988,390 shares of common stock held in the name of Isaac Mizrahi, (iv) 1,056,667 shares of common stock held in the name of Hilco Trading, LLC, and (v) 2,123,196 shares of common stock as to which holders thereof granted to Mr. D’Loren irrevocable proxy and attorney-in-fact with respect to the shares. Certain holders or grantees have entered into certain agreements, pursuant to which appoint a person designated by our board of directors as their irrevocable proxy and attorney-in-fact with respect to the shares set forth in clauses (iii), (iv), and (v). Mr. D’Loren does not have any pecuniary interest in these shares described in clauses (iii), (iv), and (v) and disclaims beneficial ownership thereof. Does not include 326,671 shares held by the D’Loren Family Trust (or the Family Trust) of which Mark DiSanto is a trustee and has sole voting and dispositive power. Does not include 2,578,947 options that are not yet exercisable.
(2)Consists of (i) 204,018 shares of common stock. Does not include 552,632 options that are not yet exercisable.
(3)Consists of (i) 372,513 shares of common stock. Does not include 368,421 options that are not yet exercisable.
(4)Consists of (i) 36,165 shares of common stock, (ii) 70,000 restricted shares, and (iii) immediately exercisable options to purchase 90,000 shares.
(5)Consists of (i) 26,500 shares of common stock, (ii) 326,671 shares held by the D’Loren Family Trust, of which Mark DiSanto is trustee and has sole voting and dispositive power over the shares held by the D’Loren Family Trust, (iii) 1,296,352 shares held by Mark X. DiSanto Investment Trust, of which Mark DiSanto is trustee and has sole voting and dispositive power over the shares held by the Trust, (iv) 20,000 restricted shares, (v) 90,000 shares issuable upon exercise of warrants and options that have vested, and (vi) 82,392 shares held by other trusts, of which Mark DiSanto is trustee and has sole voting and dispositive power over the shares held by the trusts.
(6)Consists of (i) 58,000 restricted shares and (ii) immediately exercisable options to purchase 90,000 shares.
(7)Consists of (i) 30,000 shares of common stock, (ii) 20,000 restricted shares, and (iii) immediately exercisable options to purchase 90,000 shares.

103

(8)Includes (i) 4,392,440 shares of common stock, (ii) 168,000 restricted shares, (iii) 360,000 shares issuable upon exercise of options that are currently exercisable, and (iv) 5,775,570 other shares of common stock as to which holders thereof granted to Mr. D’Loren irrevocable proxy and attorney-in-fact with respect to the shares.
(9)Consists of (i) 2,266,882 shares of common stock and (ii) immediately exercisable options to purchase 100,000 shares.

Item 13.   Certain Relationships and Related Transactions, and Director Independence

IM Topco, LLC

The Company holds a noncontrolling interest in IM Topco, LLC (“IM Topco”), which is accounted for under the equity method of accounting.

Services Agreement

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year.

In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.

For the year ended December 31, 2023, the Company recognized service fee income related to this agreement of $150,000.

License Agreement

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.

Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the year ended December 31, 2023, the estimated amount of such shortfall was approximately $325,000, which the Company recognized as royalty expense in the consolidated statements of operations.

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which the parties agreed to waive the purchase price adjustment provision until the measurement period ending March 31, 2024 (see Note 3 for details). In exchange, Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities.

104

Isaac Mizrahi

Isaac Mizrahi is a principal stockholder and former employee of the Company.

Employment Agreement

On February 24, 2020, the Company entered into an employment agreement with Mr. Mizrahi for him to continue to serve as Chief Design Officer of the Isaac Mizrahi Brand. This employment agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (WHP).

The employment agreement provided Mr. Mizrahi with a base salary of $1.8 million, $2.0 million, and $2.1 million per annum for 2020, 2021, and 2022, respectively. Mr. Mizrahi was also eligible to receive an annual cash bonus (the “Bonus”) up to an amount equal to $2.5 million less base salary for 2020 and $3.0 million less base salary for 2021 and 2022. The Bonus consisted of the DRT Revenue, Bonus, the Brick-and-Mortar Bonus, the Endorsement Bonus and the Monday Bonus, if any, as determined in accordance with the below:

“DRT Bonus” means for any calendar year an amount equal to 10% of the aggregate net revenue related to sales of Isaac Mizrahi Brand products through direct response television. The DRT Revenue Bonus shall be reduced by the amount of the Monday Bonus.
“Brick-and-Mortar Bonus” means for any calendar year an amount equal to 10% of the net revenues from sales of products under the Isaac Mizrahi Brand, excluding DRT revenue and endorsement revenues.
“Endorsement Bonus” means for any calendar year an amount equal to 40% of revenues derived from projects undertaken by the Company with one or more third parties solely for Mr. Mizrahi to endorse the third party’s products through the use of Mr. Mizrahi’s name, likeness, and/or image, and neither the Company nor Mr. Mizrahi provides licensing or design.
“Monday Bonus” means $10,000 for each appearance by Mr. Mizrahi on Qurate’s QVC channel on Mondays (subject to certain expectations) up to a maximum of 40 such appearances in a calendar year.

In addition, on May 31, 2022, all 522,500 unvested shares of restricted stock of the Company held by Mr. Mizrahi (for which all stock-based compensation expense had been previously recognized in prior periods) were immediately vested, with 240,000 of such shares being surrendered for cancellation in satisfaction of withholding tax obligations. Also on May 31, 2022, the Company issued 33,557 additional shares of common stock of the Company (valued at $50,000) to Mr. Mizrahi, which vested immediately, and made a $100,000 cash payment to Mr. Mizrahi

Laugh Club Services Agreement

On February 24, 2020 the Company entered into a services agreement with Laugh Club, an entity wholly-owned by Mr. Mizrahi, pursuant to which Laugh Club provided services to Mr. Mizrahi necessary for Mr. Mizrahi to perform his services pursuant to the employment agreement. The Company paid Laugh Club an annual fee of $0.72 million for such services. This services agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (WHP).

ORME

On December 4, 2023, the Company acquired a 30% equity ownership interest in Orme Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024, for a purchase price of $150,000. ORME licenses the technology utilized by its marketplace from KonnectBio Inc., in which Robert W. D’Loren, the Company’s Chairman of the Board, Chief Executive Officer, and President, owns an approximate 20% noncontrolling interest.

105

Equity Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,421 shares of the Company’s common stock at a price to the public of $0.65 per share. In connection with the Offering, Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares of common stock, respectively.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, are expected to be approximately $1,735,000.

 

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 178,953 shares of common stock (the “Representative’s Warrants”) as compensation. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

On March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $265,000. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,063 shares and the total net proceeds received was approximately $2,000,000.

Item 14.   Principal Accountant Fees and Services

Audit Fees

The aggregate fees billed or to be billed for professional services rendered by our Independent Registered Public Accounting Firm, Marcum LLP, for the audit of our annual consolidated financial statements, review of our consolidated financial statements included in our quarterly reports, and other fees that are normally provided by the accounting firm in connection with statutory and regulatory filings or engagements for the years ended December 31, 2023 and 2022 were approximately $453,000 and $353,000, respectively.

Audit-Related Fees

There were no fees billed by our Independent Registered Public Accounting Firm for audit-related services for the fiscal years ended December 31, 2023 and 2022.

Tax Fees

There were no fees billed for professional services rendered by our Independent Registered Public Accounting Firm for tax compliance, tax advice, and tax planning for the fiscal years ended December 31, 2023 and 2022.

All Other Fees

There were no fees billed for non-audit services by our Independent Registered Public Accounting Firm for the fiscal years ended December 31, 2023 and 2022.

106

Audit Committee Determination

The Audit Committee considered and determined that the services performed are compatible with maintaining the independence of the independent registered public accounting firm.

Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditor

The Audit Committee is responsible for pre-approving all audit and permitted non-audit services to be performed for us by our Independent Registered Public Accounting Firm as outlined in its Audit Committee charter. Prior to engagement of the Independent Registered Public Accounting Firm for each year’s audit, management or the Independent Registered Public Accounting Firm submits to the Audit Committee for approval an aggregate request of services expected to be rendered during the year, which the Audit Committee pre-approves. During the year, circumstances may arise when it may become necessary to engage the Independent Registered Public Accounting Firm for additional services not contemplated in the original pre-approval. In those circumstances, the Audit Committee requires specific pre-approval before engaging the Independent Registered Public Accounting Firm. The engagements of our Independent Registered Public Accounting Firm were approved by the Company’s Audit Committee.

PART IV

Item 15.Exhibit and Financial Statement Schedules

INDEX TO EXHIBITS

Exhibit
Number

    

Description

3.1

Amended and Restated Certificate of Incorporation of Xcel Brands, Inc. (7)

3.2

Third Restated and Amended Bylaws of Xcel Brands, Inc. (8)

4.1

Third Amended and Restated Equity Incentive Plan and Forms of Award Agreements (9)

4.2

2021 Equity Incentive Plan (11)

4.3

Description of Registrant’s Securities (10)

4.4

Warrant issued to G-III Apparel Group (15)

4.5

Form of Representative’s Warrant issued on March 19, 2024 (14)

9.1

Amended and Restated Voting Agreement between Xcel Brands, Inc. and IM Ready-Made, LLC, dated as of December 24, 2013 (2)

9.2

Voting Agreement between Xcel Brands, Inc. and Judith Ripka Berk, dated as of April 3, 2014 (4)

9.3

Voting Agreement dated as of December 22, 2014 by and between Xcel Brands, Inc. and H Company IP, LLC (5)

9.4

Form of Voting Agreement dated as of February 11, 2019 (1)

10.1

Employment Agreement between the Company and Robert D’Loren dated February 27, 2019 (10)

10.2

Employment Agreement between the Company and James Haran dated February 27, 2019 (10)

10.3

Employment Agreement between the Company and Seth Burroughs dated February 27, 2019 (12)

107

10.4

Amended and Restated Fifth Amendment, entered into as of March 14, 2014 and effective as of December 24, 2013, to the Asset Purchase Agreement filed as Exhibit 10.1 (3)

10.5

Sublease Agreement, dated as of July 8, 2015, by and between Xcel Brands, Inc. and GBG USA Inc. (6)

10.6

Membership Interest Purchase Agreement (13)

10.7

Second Amendment to Membership Interest Purchase Agreement (15)

10.8

Third Amendment to Membership Interest Purchase Agreement (15)

10.9

Term Loan Agreement between H Halston IP, LLC, as borrower, and Israel Discount Bank, as lender, dated October 19, 2023 (15)

10.10

Subscription Agreement, dated as of March 15, 2024, by and between Robert W. D’Loren and Xcel Brands, Inc. (14)

10.11

Subscription Agreement, dated as of March 15, 2024, by and between Seth Burroughs and Xcel Brands, Inc. (14)

10.12

Subscription Agreement, dated as of March 15, 2024, by and between Mark X. DiSanto Investment Trust and Xcel Brands, Inc. (14)

21.1

Subsidiaries of the Registrant (15)

23.1

Independent Registered Public Accounting Firm’s Consent (16)

31(i).1

Rule 13a-14(a)/15d-14(a) Certification (CEO) (15)

31(i).2

Rule 13a-14(a)/15d-14(a) Certification (CFO) (15)

32(i).1

Section 1350 Certification (CEO) (15)

32(i).2

Section 1350 Certification (CFO) (15)

97.1

Clawback Policy (15)

99.1

IM Topco, LLC Financial Statements as of December 31, 2023 and 2022, and for the Year Ended December 31, 2023 and Period from May 11, 2022 (inception) through December 31, 2022 and Independent Auditor’s Report (16)

101.INS

Inline XBRL Instance Document (15)

101.SCH

Inline XBRL Taxonomy Schema (15)

101.CAL

Inline XBRL Taxonomy Calculation Linkbase (15)

101.DEF

Inline XBRL Taxonomy Definition Linkbase (15)

101.LAB

Inline XBRL Taxonomy Label Linkbase (15)

101.PRE

Inline XBRL Taxonomy Presentation Linkbase (15)

108

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) (15)

(1)This Exhibit is incorporated by reference to the appropriate exhibit to the Current Report on Form 8-K, which was filed with the SEC on February 15, 2019.
(2)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on December 24, 2013.
(3)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on March 20, 2014.
(4)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on April 9, 2014.
(5)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on December 24, 2014.
(6)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on July 14, 2015.
(7)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on October 24, 2017.
(8)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on December 8, 2017.
(9)This Exhibit is incorporated by reference to the appropriate Exhibit to the Definitive Proxy Statement on Form DEF 14-A, which was filed with the SEC on August 15, 2016.
(10)This Exhibit is incorporated by reference to the appropriate Exhibit to the Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on April 23, 2021.
(11)This Exhibit is incorporated by reference to the appropriate Exhibit to the revised Definitive Proxy Statement on Form DEF 14-A, which was filed with the SEC on October 20, 2021.
(12)This Exhibit is incorporated by reference to the appropriate Exhibit to the Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on April 15, 2022.
(13)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on June 3, 2022.
(14)This Exhibit is incorporated by reference to the appropriate Exhibit to the Current Report on Form 8-K, which was filed with the SEC on March 19, 2024.
(15)Filed herewith.
(16)To be filed by amendment.

109

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 18, 2024

    

/s/ Robert W. D’Loren

 

Robert W. D’Loren, Chairman, President,

 

Chief Executive Officer and Director

 

(Principal Executive Officer)

Pursuant to the requirements of the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name

    

Title

    

 

/s/ Robert W. D’Loren

 

Chief Executive Officer and Chairman

 

April 18, 2024

Robert W. D’Loren

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ James F. Haran

 

Chief Financial Officer

 

April 18, 2024

James F. Haran

 

(Principal Financial Officer and

Principal Accounting Officer)

 

 

 

 

 

 

 

/s/ Mark DiSanto

 

Director

 

April 18, 2024

Mark DiSanto

 

 

 

 

 

 

 

 

 

 

Director

 

James Fielding

 

 

 

 

 

 

 

 

 

/s/ Howard Liebman

 

Director

 

April 18, 2024

Howard Liebman

 

 

 

 

 

 

 

 

 

/s/ Deborah Weinswig 

 

Director

 

April 18, 2024

Deborah Weinswig

 

 

 

 

110

EX-4.4 2 xelb-20231231xex4d4.htm EX-4.4

Exhibit 4.4

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT WHICH SHALL BE ACCEPTABLE TO THE COMPANY.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

XCEL BRANDS, Inc.

Warrant No.:  XC-1

Warrant Shares: 1,000,000

Initial Exercise Date: May 15, 2023

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [   ] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after vesting and on or prior to the close of business on May 15 2033 (the “Termination Date”) but not thereafter, to subscribe for and purchase from XCel Brands, Inc., a Delaware corporation (the “Company”), up to One Million (1,000,000) shares (the “Warrant Shares”) of Common Stock.  The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).  This Warrant has been issued pursuant to that certain licenses agreement effective as of May 15, 2023, by and among the H Halston, LLC and H Heritage Licensing, LLC, subsidiaries of the Company, as licensor, and G-III Leather Fashions, Inc. and G-III Apparel Group, LLC (the “License Agreement”).

Section 1.Definitions.  The term “Business Day” shall mean a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business.  The term “Trading Day” shall mean a day on which the Common Stock is traded on any of the following markets or exchanges: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the American Stock Exchange, the New York Stock Exchange or the OTC Bulletin Board.
Section 2.Exercise.
a)Exercise of Warrant.  Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after vesting as to the number of Warrant Shares as to which this Warrant shall vest and on or before the Termination Date by delivery to the Company (or such other office or agency of the

135944.00120/134653214v.1


Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto; and, within one (1) Trading Day of the date said Notice of Exercise is delivered to the Company, the Company shall have received the original Warrant and, except as, provided for in section 2(c) below, payment of the aggregate Exercise Price of the Warrant Shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank.  In the case of the purchase of less than all of the Warrant Shares represented by this Warrant, the Company shall, upon receipt of this Warrant, cause this Warrant to be cancelled and shall execute and deliver a new Warrant of like tenor for the remaining Warrant Shares.
b)Exercise Price.  The exercise price per share of the Common Stock under this Warrant shall be $1.50, subject to adjustment hereunder (the “Exercise Price”).
c)Vesting.  This Warrant shall vest as to all or a portion of the Warrant Shares as set forth under the caption “Warrants” on the Schedule A to the License Agreement.  To the extent this Warrant has not vested as to all or a portion of the Warrant Shares as prior to the Termination Date, this Warrant shall expire unexercised as to the Warrant Shares not so vested.
d)Mechanics of Exercise.
i.Delivery of Certificates Upon Exercise.  Certificates for shares purchased hereunder shall be transmitted within five (5) Trading Days from the delivery to the Company of the Notice of Exercise Form, surrender of this Warrant and payment of the aggregate Exercise Price as set forth above (the “Warrant Share Delivery Date”).  This Warrant shall be deemed to have been exercised on the date the Exercise Price is received by the Company.  The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised by payment to the Company of the Exercise Price and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(iv) prior to the issuance of such shares, have been paid.
ii.Delivery of New Warrants Upon Exercise.  If this Warrant shall have been exercised in part, the Company shall, upon surrender of this Warrant certificate, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to Holder a new Warrant evidencing the rights of Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.
iii.No Fractional Shares or Scrip.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.  As to any fraction of a share which Holder would otherwise be

2

 


entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.
iv.Charges, Taxes and Expenses.  Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
v.Closing of Books.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.
Section 3.Certain Adjustments.
a)Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding whether, directly or indirectly, including, without limitation, by merger, consolidation, recapitalization or otherwise: (i) pays a stock dividend or otherwise makes a distribution or distributions to all holders of Common Stock payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.
b)Extraordinary Cash Dividend:  If the Company, at any time while this Warrant is outstanding pays an Extraordinary Cash Dividend (defined below), then in each case, the Exercise Price shall be adjusted by reducing the Exercise Price in effect

3

 


immediately prior to the payment of such Extraordinary Cash Dividend by the per share amount of such Extraordinary Cash Dividend.  Any adjustment made pursuant to this Section 3(b) shall become effective immediately after the payment date of such Extraordinary Cash Dividend.  “Extraordinary Dividend” means a non-recurring cash dividend or cash distribution, in either case, paid to holders of Common Stock generally, and does not include any cash dividend or cash distribution which the Board establishes as a regularly scheduled cash dividend or chase distribution.
c)Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.
d)Notice to Holder.  
i.Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.
ii.Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, of any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for

4

 


securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice.  The Holder is entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice.
Section 4.Transfer of Warrant.
a)Transferability.  Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.  The Warrant, if properly assigned, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.  
b)New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.
c)Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
d)Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the

5

 


case may be, make representations set forth in Section 1 of the Subscription Agreement to the extent such representations and warranties relate to the undersigned and/or the purchase of Warrant Shares.
Section 5.Holder Representations and Warranties.  By its acceptance of this Warrant, the Holder hereby represents to, and covenants with, the Company as follows:
a)The Holder or its representatives are sophisticated investors familiar with the type of risks inherent in the acquisition of securities such as the Warrant and the Warrant Shares and that, by reason of its or its representatives knowledge and experience in financial and business matters in general, and investments of this type in particular, it or its representatives are capable of evaluating the merits and risks of an investment in the Warrant and the Warrant Shares;  
b)The Holder understands that the Company has determined that the exemption from the registration provisions of the Securities Act of 1933, as amended (the “Act”), for transactions not involving a public offering is applicable to the offer and sale of the Warrant (and, upon exercise of the Warrant, the Warrant Shares), based, in part, upon the representations, warranties and agreements made by the undersigned herein.
c)The Holder understands that: (A) neither the Warrants nor the Warrant Shares have been registered under the Act or the securities laws of any state, based upon an exemption from such registration requirements for non-public offerings pursuant to Regulation D under the Act; (B) the Warrant and the Warrant Shares are and will be “restricted securities”, as said term is defined in Rule 144 of the Rules and Regulations promulgated under the Act; (C) neither the Warrant nor the Warrant Shares may be sold or otherwise transferred unless they have been first registered under the Act and all applicable state securities laws, or unless exemptions from such registration provisions are available with respect to said resale or transfer; (D) except as set forth in the APA, the Company is under no obligation to register the Warrant or the Warrant Shares under the Act or any state securities laws, or to take any action to make any exemption from any such registration provisions available; (E) the certificates for the Warrant and the Warrant Shares will bear a legend to the effect that the transfer of the securities represented thereby is subject to the provisions hereof; and (F) stop transfer instructions will be placed with the transfer agent for the Warrant Shares.
d)The Holder will not sell or otherwise transfer any of the Shares or any interest therein, unless and until: (A) said Warrant and/or Warrant Shares shall have first been registered under the Act and all applicable state securities laws; or (B) the undersigned shall have first delivered to the Company a written opinion of coun­sel (which counsel and opinion (in form and substance) shall be satisfactory to the Company), to the effect that the proposed sale or transfer is exempt from the registration provisions of the Act and all applicable state securities laws.
e)The Holder is an “accredited investor,” as such term is defined in Regulation D of the Rules and Regulations promulgated under the Act.

6

 


f)The Holder is acquiring the Warrant and the Warrant Shares for its own account and for the purpose of investment and not with a view to, or for resale in connection with, any distribution within the meaning of the Act in violation of the Act.
g)The Holder has been given access to and an opportunity to examine such documents, materials and information concerning the Company as the Holder deems necessary or advisable in order to reach an informed decision as to an investment in the Warrants and Warrant Shares.
Section 6.Miscellaneous.
a)Registration Rights.  The Holder shall be entitled to the benefit of the registration rights set forth in Schedule A to the License Agreement under the caption “Warrants” with respect to the Warrant Shares.
b)No Rights as Stockholder Until Exercise.  This Warrant does not entitle the Holder to any voting rights or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(a).  
c)Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.
d)Saturdays, Sundays, Holidays, etc.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.
e)Authorized Shares.  The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock the number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant.  The Company will take all such commercially reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the trading market upon which the Common Stock may be listed.  The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in

7

 


respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).  

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

f)Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Subscription Agreement.
g)Restrictions.  The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws.
h)Nonwaiver and Expenses.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice Holder’s rights, powers or remedies, notwithstanding the fact that all rights hereunder terminate on the Termination Date.  If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
i)Notices.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Subscription Agreement.
j)Limitation of Liability.  No provision hereof, in the absence of any affirmative action by Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of Holder, shall give rise to any liability of Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.
k)Successors and Assigns.  Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder.  The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.
l)Amendment.  This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and Holders holding Warrants at least equal to a majority of the Warrant Shares issuable upon exercise of all then outstanding Warrants.

8

 


m)Severability.  Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.
n)Headings.  The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

(Signature Pages Follow)

9

 


IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of February 29, 2024.

XCEL BRANDs, Inc.

By: _/s/ James Haran_____________

Name: James Haran

Title: Chief Financial Officer

10

 


NOTICE OF EXERCISE1

To:XCEL BRANDs, Inc.

(1)The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

Payment shall take the form of lawful money of the United States.

(2) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

The Warrant Shares shall be delivered by physical delivery of a certificate to:

_______________________________

_______________________________

_______________________________

(3)  Accredited Investor.  The undersigned represents that the representations set forth in Section 5 of the Warrant (as such representations and warranties relate to the undersigned and/or its purchase of Warrant Shares) are true and correct as of the date of this Notice of Exercise.

[SIGNATURE OF HOLDER]

Name of Investing Entity: ________________________________________________________________________

Signature of Authorized Signatory of Investing Entity: _________________________________________________

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: ________________________________________________________________________________________

1 To be adjusted appropriately to the extent that the holder elects cashless exercise.

 

135944.00120/134653214v.1


ASSIGNMENT FORM

(To assign the foregoing warrant, execute
this form and supply required information.
Do not use this form to exercise the warrant.)

FOR VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

_______________________________________________ whose address is

_______________________________________________________________.

_______________________________________________________________

Dated:  ______________, _______

Holder’s Signature:_____________________________

Holder’s Address:_____________________________

_____________________________

Signature Guaranteed:  ___________________________________________

NOTE:  The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company.  Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

135944.00120/134653214v.1


EX-10.7 3 xelb-20231231xex10d7.htm EX-10.7

Exhibit 10.7

Second Amendment to Membership Interest Purchase Agreement

This Second Amendment to Membership Interest Purchase Agreement (this "Second Amendment") is made and entered into as of this 19th day of November, 2023, by and among IMWHP, LLC, a Delaware limited liability company ("Buyer'), XCEL BRANDS, INC., a Delaware corporation ("Xcel"), IM BRANDS LLC, a Delaware limited liability company ("IMB" and, together with Xcel "Seller") and IM TOPCO LLC, a Delaware limited liability company (the "Company"). Buyer, Seller and the Company are sometimes referred to .herein individually as a “Party and collectively as the "Parties".

WHEREAS, the Parties are parties to that certain Membership Interest Purchase Agreement dated as of May 27, 2023, as amended by that certain First Amendment to Membership Interest Purchase Agreement dated as of March 2, 2023 (together, the "Agreement");

WHEREAS, the Parties now desire to amend the Agreement, on and subject to the terms and conditions herein;

NOW, THEREFORE for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.Capitalized Terms. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Agreement.

2.Amendment to Section 2.S(a).

A.Section 2.S(a) of the Agreement is hereby deleted in its entirety and replaced with the following language:

"2(a). Subject to the provisions of this Section 2.5, Buyer shall be entitled to receive the Adjustment Amount from Seller if during any four (4) consecutive calendar quarters within the Adjustment Period, other than the Excluded Calendar Quarters the aggregate Royalties collected in respect of the Business, whether by Seller in respect of any pre-Closing periods or by the Company in respect any post-Closing periods, are less than $13,347,000 (the 'Adjustment Event"); provided, however, that the failure to have collected aggregate Royalties equal to or greater than $13,347,000 during any such four (4) consecutive calendar quarter period shall not constitute an Adjustment Event to the extent such failure is

caused by a (i) Force Majeure Event or (ii) a willful and material breach by Buyer of the provisions of Section 2.S(d) that directly reduces the collected Royalties.

For purposes of the foregoing, the term "Excluded Calendar Quarters" means (i) the four (4) consecutive calendar quarters ending September 30, 2023; and (ii) the four (4) consecutive calendar quarters ending December 31, 2023.'

B.Additional Revenue Payments. In consideration of the amendment to Section 2.S(a) of the Agreement set forth above:


(1)Seller shall make the following payments to Buyer constituting incremental royalties:

A.Seventy Five Thousand Dollars ($75 000) on or before December 31, 2023;

B.One Hundred Thousand Dollars ($100,000) on or before April 10, 2024;

C.Thirty Seven Thousand Five Hundred ($37,500) on or before June 30, 2024;

D.One Hundred Thousand Dollars ($100,000) on or before July 10, 2024;

E.Thirty Seven Thousand Five Hundred ($37 500) on or before September 30, 2024;and

F.One Hundred Thousand Dollars ($100,000) on or before October 10 2024; and

(2)simultaneously with entry into this Second Amendment, Seller and the Company shall enter into that certain First Amendment to Design, Interactive, Television and Talent Services Agreement, in the form set fo11h at Exhibit A hereto.

3.Entire Agreement. This Second Amendment shall form part of the Agreement. Except to the extent expressly amended herein, the terms and conditions of the Agreement shall remain in full force and effect.

{Execution Page(s) Follow(s)}


IN WITNESS WHEREOF, by their signatures below, the Parties enter into this Second Amendment as of the date first set forth above.

IMWHP, LLC

By: /s/ Yehuda Shmidman

Name: Yehuda Shmidman

Title: Chairman and CEO

XCEL BRANDS, INC.

By: /s/ Seth Burroughs

Name: Seth Burroughs

Title: Executive Vice President

IM BRANDS, LLC

By: /s/ Seth Burroughs

Name: Seth Burroughs

Title: Executive Vice President

By: /s/ Yehuda Shmidman

Name: Yehuda Shmidman

Title: Chairman and CEO


Exhibit A


First Amendment to Design. Interactive Television and Talent Services Agreement

This First Amendment to Design Interactive Television and Talent Services Agreement (this ''First Amendment") is made and entered into as of this_ day of November, 2023, by and among XCEL BRANDS, INC., a Delaware corporation(' Xcel" or "Consultant"), IM BRANDS, LLC, a Delaware limited liability company ("IM") and IM TOPCO, LLC, a Delaware limited liability company (the "Company").

WHEREAS, Xcel, IM and the Company (collectively the '"Parties") are parties to that certain Design, Interactive Television and Talent Services Agreement dated as of May 31, 2022 (the "Agreement");

WHEREAS, the Parties now desire to amend the Agreement, on and subject to the terms and conditions herein;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.Capitalized Terms. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Agreement.

Graphic
2.Service Fees. Notwithstanding anything to the contrary in the Agreement, the Consultant shall not have been and/or be entitled to any Service Fees as it relates to the period of time from July 1, 2023 through and including December 31, 2023. Within three (3) days following entry into this First Amendment, Consultant shall refund to Company the amount of One Hundred Fifty Thousand U.S. Dollars ($150,000).

3.​ ​Entire Agreement. This First Amendment shall form part of the Agreement. Except to the extent expressly amended herein, the terms and conditions of the Agreement shall remain in full force and effect.

{Execution Page(s) Follow(s)}


IN WITNESS WHEREOF, by their signatures below the Parties enter into this First Amendment as of the date first set forth above.

XCEL BRANDS, INC.IM BRANDS, LLC

By: /s/ Seth BurroughsBy: /s/ Seth Burroughs

Name:Seth BurroughsName: Seth Burroughs

Title: Executive Vice PresidentTitle: Executive Vice President

IM TOPCO, LLC

By: /s/ Yehuda Shmidman

Name: Yehuda Shmidman

Title: Chairman and CEO


EX-10.8 4 xelb-20231231xex10d8.htm EX-10.8

Exhibit 10.8

4/12/24

Third Amendment to Membership Interest Purchase Agreement

This Third Amendment to Membership Interest Purchase Agreement (this “Third Amendment”) is made and entered into as of this __ day of April, 2024, by and among IMWHP, LLC, a Delaware limited liability company (“Buyer”), XCEL BRANDS, INC., a Delaware corporation (“Xcel”), IM BRANDS, LLC, a Delaware limited liability company (“IMB” and, together with Xcel, “Seller”), and IM TOPCO, LLC, a Delaware limited liability company (the “Company”).  Buyer, Seller and the Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

WHEREAS, the Parties are parties to that certain Membership Interest Purchase Agreement dated as of May 27, 2023, as amended by (i) that certain First Amendment to Membership Interest Purchase Agreement dated as of March 2, 2023, and (ii) that certain Second Amendment to Membership Interest Purchase Agreement dated as of November 19, 2023 (together, the “Agreement”);

WHEREAS, the Parties now desire to amend the Agreement, on and subject to the terms and conditions herein;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.Capitalized Terms.  Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Agreement.

2.Amendment to Section 2.5.

A.Section 2.5(a) of the Agreement is hereby deleted in its entirety and replaced with the following language:

“(a)  

Subject to the provisions of this Section 2.5, Buyer shall be entitled to receive the Adjustment Amount from Seller if, during any four (4) consecutive calendar quarters within the Adjustment Period, other than the Excluded Calendar Quarters, the aggregate Royalties collected in respect of the Business, whether by Seller in respect of any pre-Closing periods or by the Company in respect any post-Closing periods, are less than $13,347,000 (the “Adjustment Event”); provided, however, that the failure to have collected aggregate Royalties equal to or greater than $13,347,000 during any such four (4) consecutive calendar quarter period shall not constitute an Adjustment Event to the extent such failure is caused by a (i) Force Majeure Event or (ii) a willful and material breach by Buyer of the provisions of Section 2.5(d) that directly reduces the collected Royalties.  For purposes of the foregoing, the term “Excluded Calendar Quarters” means (i) the four (4) consecutive calendar quarters ending September 30, 2023; (ii) the four (4) consecutive calendar quarters ending December 31, 2023; and (iii) the four (4) consecutive calendar quarters ending March 31, 2024.”


B.Section 2.5 of the Agreement is hereby amended by adding a new Section 2.5(g) with the following language:

“(g)

In addition to any Adjustment Amount to which Buyer may be entitled pursuant to the terms of this Section 2.5, Buyer shall be entitled to receive from Seller Equity Securities of the Company equal to 10.0% of the total outstanding Equity Securities of the Company (the “Equity Transfer Amount”) if any of the following occur:  (i) during the twelve-month period ending March 31, 2025, the aggregate Royalties collected in respect of the Business are less than $13,500,000; (ii) during the twelve-month period ending December 31, 2025, the aggregate Royalties collected in respect of the Business are less than $18,000,000; or (iii) Seller fails to make any payment to Buyer as required pursuant to Section 2(B) of that certain Second Amendment to Membership Interest Purchase Agreement dated as of November 19, 2023 (each of (i), (ii) or (iii), separately and independently, an “Equity Transfer Event”).  Buyer shall promptly notify Seller if an Equity Transfer Event has occurred, and Seller shall cause the Equity Transfer Amount to be transferred to Buyer within ten (10) Business Days after Buyer has notified Seller that an Equity Transfer Event has occurred pursuant to an agreement containing such representations, warranties and covenants made by Seller as customarily are made in transactions of a similar nature.

3.Amendment to Design, Interactive Television, and Talent Services Agreement.  Simultaneously with entry into this Third Amendment, Seller and the Company shall enter into that certain Second Amendment to Design, Interactive, Television and Talent Services Agreement, in the form set forth at Exhibit A hereto.

4.Amendment to LLC Agreement.  Simultaneously with entry into this Third Amendment, Buyer and Seller shall enter into that certain First Amendment to Amended and Restated Limited Liability Company Agreement of the Company, dated as of May 31, 2022, in the form set forth at Exhibit B hereto.

5.Entire Agreement.  This Third Amendment shall form part of the Agreement.  Except to the extent expressly amended herein, the terms and conditions of the Agreement shall remain in full force and effect.  None of the terms in this Third Amendment shall limit any other remedies available to Buyer under the Agreement.

{Execution Page(s) Follow(s)}


IN WITNESS WHEREOF, by their signatures below, the Parties enter into this Third Amendment as of the date first set forth above.

IMWHP, LLC

By: /s/ Yehuda Shmidman

Name: Yehuda Shmidman

Title: Chairman and CEO

XCEL BRANDS, INC.

By: /s/ Seth Burroughs

Name: Seth Burroughs

Title: Executive Vice President

IM BRANDS, LLC

By: /s/ Seth Burroughs

Name: Seth Burroughs

Title: Executive Vice President

By: /s/ Yehuda Shmidman

Name: Yehuda Shmidman

Title: Chairman and CEO


Exhibit A

See attached.


Second Amendment to Design, Interactive Television and Talent Services Agreement

This Second Amendment to Design, Interactive Television and Talent Services Agreement (this “Second Amendment”) is made and entered into as of this __ day of April, 2024, by and among XCEL BRANDS, INC., a Delaware corporation (“Xcel” or “Consultant”), IM BRANDS, LLC, a Delaware limited liability company (“IM”), and IM TOPCO, LLC, a Delaware limited liability company (the “Company”).  

WHEREAS, Xcel, IM and the Company (collectively, the “Parties”) are parties to that certain Design, Interactive Television and Talent Services Agreement dated as of May 31, 2022, as amended by that certain First Amendment to Design, Interactive Television and Talent Services Agreement dated as of November 19, 2023 (the “Agreement”);

WHEREAS, the Parties now desire to amend the Agreement, on and subject to the terms and conditions herein;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.Capitalized Terms.  Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Agreement.

2.Amendment. The first sentence of Section 2.1(a) of the Agreement is hereby deleted in its entirety and replaced with the following language:

“In consideration of the Services, Company shall pay to Consultant one hundred fifty thousand dollars ($150,000) (the “Service Fee”) for each fiscal year (each a “Fiscal Year”) that is the subject of an annual budget (as contemplated by the Amended and Restated Limited Liability Company Agreement of Company, dated as of May 31, 2022 (the “Operating Agreement”)) beginning with the Fiscal Year ending December 31, 2024; provided, however, that prior to payment of the Service Fee, Consultant shall directly incur, and Company shall not be obligated to pay the Service Fee to Consultant until Consultant has in fact incurred, the initial fifty-two thousand dollars ($52,000) in out-of-pocket costs and expenses included in the Annual Budget for that Fiscal Year (the “Qualifying Expense Threshold”).”

3.Entire Agreement.  This Second Amendment shall form part of the Agreement.  Except to the extent expressly amended herein, the terms and conditions of the Agreement shall remain in full force and effect.

{Execution Page(s) Follow(s)}


IN WITNESS WHEREOF, by their signatures below, the Parties enter into this Second Amendment as of the date first set forth above.

XCEL BRANDS, INC.IM BRANDS, LLC

By: /s/ Seth BurroughsBy: /s/ Seth Burroughs

Name:Seth BurroughsName: Seth Burroughs

Title: Executive Vice PresidentTitle: Executive Vice President

IM TOPCO, LLC

By: /s/ Yehuda Shmidman

Name: Yehuda Shmidman

Title: Chairman and CEO


Exhibit B

See attached.


First Amendment

to

Amended and Restated Limited Liability Company Agreement

of

IM TopCo, LLC

This First Amendment to Amended and Restated Limited Liability Company Agreement of IM TopCo, LLC (this “First Amendment”) is made and entered into as of this __ day of April, 2024, by and between XCEL BRANDS, INC., a Delaware corporation (the “Xcel Member”), and IMWHP, LLC, a Delaware limited liability company (the “WHP Member”).  

WHEREAS, the Xcel Member and the WHP Member (collectively, the “Parties”) are parties to that certain Amended and Restated Limited Liability Company Agreement of IM TopCo, LLC, dated as of May 31, 2022 (the “Agreement”);

WHEREAS, the Parties now desire to amend the Agreement, on and subject to the terms and conditions herein;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

4.Capitalized Terms.  Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Agreement.

5.Distributions.  Notwithstanding anything to the contrary in the Agreement, on and after January 1, 2026, the WHP Member shall receive from the Company fifty percent (50%) of all amounts to be distributed to the Xcel Member pursuant to Section 4.4(a)(ii) of the Agreement until the WHP Member has received an aggregate amount pursuant to the terms of this First Amendment equal to $1,000,000.

6.Entire Agreement.  This First Amendment shall form part of the Agreement.  Except to the extent expressly amended herein, the terms and conditions of the Agreement shall remain in full force and effect.

{Execution Page(s) Follow(s)}


IN WITNESS WHEREOF, by their signatures below, the Parties enter into this First Amendment as of the date first set forth above.

IMWHP, LLC

By: /s/ Yehuda Shmidman

Name: Yehuda Shmidman

Title: Chairman and CEO

XCEL BRANDS, INC.

By: /s/ Seth Burroughs

Name: Seth Burroughs

Title: Executive Vice President


EX-10.9 5 xelb-20231231xex10d9.htm EX-10.9

Execution version

Graphic

Term Loan Agreement

(SOFR)

THIS TERM LOAN AGREEMENT (including all riders, annexes, exhibits and schedules hereto, this “Agreement”) is entered into as of October 19, 2023 (the “Closing Date”), by and between H HALSTON IP, LLC, a Delaware limited liability company (“Borrower”), and ISRAEL DISCOUNT BANK OF NEW YORK (“Bank”).

For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

ARTICLE 1
DEFINITIONS
1.1CERTAIN DEFINITIONS.  The following terms will have the following meanings:

Affiliate” means, as applied to any Person, any other Person who controls, is controlled by, or is under common control with, such Person.  For purposes of this definition, “control” means the possession, directly or indirectly through one or more intermediaries, of the power to vote for the election of directors or managers or the power to direct the management and policies of a Person, whether through the ownership of Equity Interests, by contract, or otherwise.

Assignment Agreement” means the Assignment Agreement, in form and substance reasonably satisfactory to Bank, between Holdco and Borrower, pursuant to which Holdco shall have assigned to Borrower all of its right, title and interest in the Trademarks.

Available Tenor” means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if such Benchmark is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the length of an interest period pursuant to this Agreement or (y) otherwise, any payment period for interest calculated with reference to such Benchmark (or component thereof) that is or may be used for determining any frequency of making payments of interest calculated with reference to such Benchmark, in each case, as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of “Interest Period” pursuant to Section 2.5.

Bank” has the meaning set forth in the preamble to this Agreement.

Bank Expenses” has the meaning set forth in Section 8.3.

Bank Product Obligations” means, collectively, all obligations and other liabilities of Borrower to Bank arising with respect to Bank Products, including, without limitation, Hedging Obligations.


Bank Products” means any of the following services provided to Borrower by Bank: (a) any treasury or other cash management services, including deposit accounts, automated clearing house (ACH) origination and other funds transfer, depository (including cash vault and check deposit), zero balance accounts and sweeps, return items processing, controlled disbursement accounts, positive pay, lockboxes and lockbox accounts, account reconciliation and information reporting, payables outsourcing, payroll processing, trade finance services, investment accounts and securities accounts, (b) card services, including credit cards (including purchasing cards and commercial cards), prepaid cards, including payroll, stored value and gift cards, merchant services processing, and debit card services, and (c) Hedging Transactions.

Benchmark” means, initially, the Term SOFR Reference Rate; provided that if a Benchmark Transition Event has occurred with respect to the Term SOFR Reference Rate or the then-current Benchmark, then “Benchmark” means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to Section 2.5(a).

Benchmark Replacement” means with respect to any Benchmark Transition Event, any alternative set forth below and in such order of priority as Bank shall determine in its sole and absolute discretion:

(a)Daily Simple SOFR; or
(b)the sum of: (i) the alternate benchmark rate that has been selected by Bank and Borrower giving due consideration to (A) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (B) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark used by banks in the New York lending market for bilateral credit facilities, which is administratively feasible for Bank to establish and provide to its customers and which is generally adopted by Bank in its business; and (ii) an adjustment (which may be a positive or negative value or zero) that has been selected by Bank and Borrower, giving due consideration to any evolving or then-prevailing market convention, including any applicable recommendations made by the Relevant Governmental Body, for U.S. dollar-denominated bilateral facilities at such time;

provided, that in the event the Term Loan is hedged pursuant to one or more swap agreements (the “Hedged Exposure”), then the Benchmark Replacement for such Hedged Exposure shall have the meaning in effect from time to time ascribed to the “Floating Rate Option” under the relevant Confirmation(s) (as each such terms are defined in the related swap agreement).

Benchmark Transition Event” means, with respect to the then-current Benchmark, the occurrence of a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof), by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component thereof), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component thereof) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component thereof), announcing or stating that (a) such administrator has ceased or will cease on a specified date to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof); or (b) all Available Tenors

2


of such Benchmark (or such component thereof) are not, or as of a specified future date will not be, representative of the underlying market and economic reality that such Benchmark (or such component thereof) is intended to measure and that representativeness will not be restored.

Beneficial Ownership Certification” means a certification regarding beneficial ownership as required by the Beneficial Ownership Regulation.

Beneficial Ownership Regulation” means 31 C.F.R. § 1010.230.

Borrower” has the meaning set forth in the preamble to this Agreement.

Business Day” means any day that is not a Saturday, Sunday, or other day on which banks are authorized or required to close in New York, New York under the rules and regulations of the Federal Reserve System.

Change in Control” means the occurrence of any transaction by which the holders of the Equity Interests of Borrower as of the Closing Date shall cease to own, free and clear of all Liens or other encumbrances, at least a majority of the outstanding voting equity interests of Borrower on a fully diluted basis.

Closing Date” has the meaning set forth in the preamble to this Agreement.

Code” means the New York Uniform Commercial Code, as in effect from time to time, provided that, if perfection or the effect of perfection or non-perfection or the priority of any security interest in any Collateral is governed by the Uniform Commercial Code as in effect in a jurisdiction other than the State of New York, “Code” shall mean the Uniform Commercial Code as in effect from time to time in such other jurisdiction for purposes of the provisions hereof relating to such perfection, effect of perfection or non-perfection or priority.  To the extent that defined terms set forth in this Agreement have different meanings under different Articles under the Uniform Commercial Code, the meaning assigned to such defined term under Article 9 of the Uniform Commercial Code will control.

Collateral” means all real and personal property in which Bank has been granted a security interest or Lien pursuant to the Security Agreement or any other Loan Document, together with any products and proceeds of the foregoing, including, without limitation, the “Collateral” as defined in the Security Agreement.

Compliance Certificate” means a certificate substantially in the form of Exhibit 5.1(c) hereto, with appropriate insertions, to be submitted to Bank by Borrower pursuant to this Agreement and by a Responsible Officer of Borrower.

Conforming Changes” means, with respect to either the use or administration of Term SOFR or the use, administration, adoption or implementation of any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “Business Day,” the definition of “U.S. Government Securities Business Day,” the definition of “Interest Period” or any similar or analogous definition (or the addition of a concept of “interest period”), timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of Section 2.3(b) and other technical, administrative or operational matters) that Bank decides may be appropriate to reflect

3


the adoption and implementation of any such rate or to permit the use and administration thereof by Bank in a manner substantially consistent with market practice (or, if Bank decides that adoption of any portion of such market practice is not administratively feasible or if Bank determines that no market practice for the administration of any such rate exists, in such other manner of administration as Bank decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).

Daily Simple SOFR” means, for any day, SOFR, with the conventions for this rate (which will include a lookback) being established by Bank in accordance with the conventions for this rate selected or recommended by the Relevant Governmental Body for determining “Daily Simple SOFR” for bilateral business loans; provided that if Bank decides that any such convention is not administratively feasible for Bank, then Bank may establish another convention in its reasonable discretion.

Debtor Relief Laws” means the Bankruptcy Code of the United States of America, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief laws of the United States or other applicable jurisdictions from time to time in effect.

Default” means an event, condition or default that, with the giving of notice, the passage of time, or both, would be an Event of Default.

Default Rate” means a rate equal to five percent (5%) per annum.

Dollar(s)” and the sign “$” shall mean lawful money of the United States.

EBITDA” means earnings before interest, taxes, depreciation and amortization.  

Equity Interests” means shares of capital stock, partnership interests, membership interests in a limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any of the foregoing.

Event of Default” has the meaning set forth in Section 7.1.

Excluded Taxes” means any of the following taxes imposed on or with respect to Bank or required to be withheld or deducted from a payment to Bank: (a) taxes imposed on or measured by net income (however denominated) and taxes in lieu thereof, in each case, (i) imposed as a result of Bank being organized under the laws of, or having its principal office or, its applicable lending office located in, the jurisdiction imposing such tax (or any political subdivision thereof) or (ii) that are imposed as a result of a present or former connection between Bank and the jurisdiction imposing such tax (other than connections arising from Bank having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced the Loan Documents, or sold or assigned an interest in the Term Loan or the Loan Documents), (b) withholding taxes imposed on amounts payable to or for the account of Bank with respect to an applicable interest in the Term Loan pursuant to a law in effect on the date on which (i) Bank acquires such interest in the Term Loan or (ii) Bank changes its lending office, (c) taxes attributable to Bank’s failure to comply with any documentation requirement necessary to reduce or avoid taxes, which documentation the Bank is reasonably able to provide, and (d) any taxes imposed under the United States Foreign Account Tax Compliance Act.

4


Existing Liens” shall mean, collectively, the Liens described in Section 6 of the Information Certificate.

Expiration Date” has the meaning set forth in Section 2.4(c).

FCPA” has the meaning set forth in Section 3.11(b).

Fixed Charge Coverage Ratio” means, with respect to any fiscal period of Borrower, the ratio of (a) the sum of (i) Net Income for such period, plus (ii) depreciation expenses for such period, plus (iii) amortization expenses for such period, plus (iv) interest expense for such period, plus (v) tax expense for such period, minus (vi) dividends and distributions made during such period, minus (vii) taxes paid in cash during such period, to (b) the sum of (i) the aggregate amount of all principal payments on the Term Loan scheduled to be made during such period, plus (ii) interest paid in cash during such period on account of the Term Loan.

GAAP” means United States generally accepted accounting principles, consistently applied.

Guaranteed Minimum Royalties” has the meaning set forth in the License Agreement.

Guarantee” means any Guaranty Agreement in favor of Bank executed and delivered by one or more Guarantors.

Guaranteed Minimum Royalty Ratio” means, with respect to any fiscal period of Borrower, the ratio of (a) the sum of Guaranteed Minimum Royalties for such period, to (b) the sum of (i) the aggregate amount of all principal payments on the Term Loan scheduled to be made during such period, plus (ii) interest paid in cash during such period on account of the Term Loan.

Guarantor” means any Person that has guaranteed all or any part of the Obligations, including pursuant to the Guarantee.

Hedging Obligations” of any Person shall mean any and all obligations of such Person, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired under (i) any and all Hedging Transactions, (ii) any and all cancellations, buy backs, reversals, terminations or assignments of any Hedging Transactions and (iii) any and all renewals, extensions and modifications of any Hedging Transactions and any and all substitutions for any Hedging Transaction.

Hedging Transaction” of any Person shall mean (a) any transaction (including an agreement with respect to any such transaction) now existing or hereafter entered into by such Person that is a rate swap transaction, swap option, basis swap, forward rate transaction, commodity swap, commodity option, equity or equity index swap or option, bond option, interest rate option, foreign exchange transaction, cap transaction, floor transaction, collar transaction, currency swap transaction, cross-currency rate swap transaction, currency option, spot transaction, credit protection transaction, credit swap, credit default swap, credit default option, total return swap, credit spread transaction, repurchase transaction, reverse repurchase transaction, buy/sell-back transaction, securities lending transaction, or any other similar transaction (including any option with respect to any of these transactions) or any combination thereof, whether or not any such transaction is governed by or subject to any master agreement, and (b) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any

5


International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a “Master Agreement”), including any such obligations or liabilities under any Master Agreement.

Holdco” means H Licensing, LLC, a Delaware limited liability company.

Indebtedness” means the following, whether secured or unsecured, matured or unmatured, liquidated or unliquidated, joint or several: (i) all obligations for borrowed money; (ii) all obligations in respect of surety bonds and letters of credit; (iii) all obligations evidenced by notes, bonds, debentures or other similar instruments, (iv) all capital lease obligations; (v) all obligations or liabilities of others secured by a Lien on any asset of Borrower, whether or not such obligation or liability is assumed; (vi) all obligations to pay the deferred purchase price of assets (other than trade payables incurred in the ordinary course of business and repayable in accordance with customary trade practices); and (vii) all guaranties of the obligations of another Person.

Indemnified Parties” and “Indemnified Party” have the meanings assigned to such terms in Section 8.6.

Information Certificate” means any Information Certificate executed and delivered to Bank by Borrower in connection with this Agreement or the Security Agreement, the form of which is attached to the Security Agreement, as such certificate may be amended, restated, supplemented or otherwise modified from time to time.

Insolvency Proceeding” means any proceeding commenced by or against any Person under any Debtor Relief Law.

Intellectual Property” means any and all intellectual property, including copyrights, copyright licenses, patents, patent licenses, trademarks (including the Trademarks), trademark licenses, technology, know-how and processes, all rights therein, and all rights to sue at law or in equity for any past, present, or future infringement, violation, misuse, misappropriation or other impairment thereof, whether arising under US, multinational or foreign laws or otherwise, including the right to receive injunctive relief and all proceeds and damages therefrom.

Interest” means the annual rate of interest payable on the Term Loan in accordance with Section 2.2(a).

Interest Period” means, initially, the period commencing on the date the Term Loan is borrowed and ending on the last day of the calendar month in which the Term Loan is borrowed and, thereafter, the period commencing on the first day of each calendar month and ending on the last day of such calendar month; provided that (i) if any Interest Period would end on a day other than a Business Day, such Interest Period shall end on the next preceding Business Day, (ii) no Interest Period shall extend beyond the Maturity Date and (iii) no tenor that has been removed from this definition pursuant to Section 2.5 shall be available.

Late Charge” has the meaning given to such term in Section 2.2(e).

License Agreement” means the 2023 Halston-GIII License Agreement, dated May 15, 2023, between Borrower and Licensee, as amended to and in effect on the date hereof.

6


Licensee” means, individually and collectively, G-III Leather Fashions, Inc. and G-III Apparel Canada, ULC.

Lien” means, with respect to any property, any security interest, mortgage, pledge, lien, claim, charge or other encumbrance in, of, or on such property or its income, including, without limitation, the interest of a vendor or lessor under a conditional sale agreement, capital lease or other title retention agreement, or any agreement to provide any of the above, and the filing of any financing statement or similar instrument under the Code or comparable law of any jurisdiction.

Loan Account” has the meaning set forth in Section 2.1(b).

Loan Documents” means this Agreement, the Note, the Security Agreement, the Payment Direction Notice, the Pledge Agreement, the Negative Pledge Agreement, each Guarantee (if any), each Information Certificate, each rider, each schedule, each exhibit, and each contract, instrument, agreement and other document that (a) are required by this Agreement, (b) are at any time entered into or delivered to Bank in connection with this Agreement or the Term Loan or (c) otherwise creates, evidences or secures any of the Obligations.

Margin means four hundred twenty-five basis points (4.25%).

Material Adverse Change” means (a) any event or condition that Bank in good faith believes impairs, or is likely to impair, the prospect of payment or performance by Borrower of any of the Obligations, or any Guarantor (if any) of its obligations, (b) a material adverse change in the business, operations, results of operations, assets, liabilities or condition (financial or otherwise) of Borrower or any Guarantor (if any), (c) a material impairment of Bank’s ability to enforce the Obligations, or (d) a material impairment of the enforceability or priority of Bank’s Liens with respect to any of the Collateral; provided that the existence of Permitted Liens shall not be a material impairment under this clause (d).

Maturity Date” means October 19, 2028.

Negative Pledge Agreement” means the Negative Pledge Agreement, dated as of the date hereof, made by Borrower in favor of Bank, with respect to Borrower’s Intellectual Property.

Net Income” means the net income of Borrower, determined in accordance with GAAP; provided, that revenue derived from the $5,000,000 upfront payment by Licensee pursuant to the License Agreement shall be excluded from the calculation of Net Income.

Note” means that certain Term Loan Promissory Note issued by Borrower in favor of Bank dated the date of this Agreement.

Notice Threshold Amount” means $250,000.00.

Obligations” means (a) all loans (including the Term Loan), debts, principal, interest (including any interest that accrues after the beginning of an Insolvency Proceeding, regardless of whether allowed or allowable in whole or in part as a claim in any such Insolvency Proceeding), and any other reimbursement or indemnification obligations with respect to letters of credit issued by Bank for the account of Borrower (irrespective of whether contingent), premiums, liabilities (including all amounts charged to the Loan Account), obligations (including indemnification obligations), fees, Bank Expenses (including any fees or

7


expenses that accrue after the commencement of an Insolvency Proceeding, regardless of whether allowed or allowable in whole or in part as a claim in any such Insolvency Proceeding), guaranties, and all covenants and duties of any other kind and description owing by Borrower under or evidenced by this Agreement or any of the other Loan Documents, and irrespective of whether for the payment of money, whether direct or indirect, absolute or contingent, liquidated or unliquidated, determined or undetermined, voluntary or involuntary, due, not due or to become due, sole, joint, several or joint and several, incurred in the past or now existing or hereafter arising, under any Loan Document, and including all interest not paid when due, and all other expenses or other amounts that Borrower is required to pay or reimburse by the Loan Documents or by law or otherwise in connection with the Loan Documents; and (b) all Bank Product Obligations, together with all renewals, extensions, modifications or refinancings of any of the foregoing.  Any reference in this Agreement or in the Loan Documents to the Obligations will include all or any portion of the Obligations and any extensions, modifications, renewals, or alterations of the Obligations, both prior and subsequent to any Insolvency Proceeding.

OFAC” has the meaning set forth in Section 3.11(a).

Parent” means Xcel Brands, Inc., a Delaware corporation.

Patriot Act” means Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act (USA Patriot Act of 2001).

Payment Direction Notice” means the Payment Direction Notice, dated as of the date hereof, from Borrower and Bank to Licensee.

Permitted Indebtedness” means Indebtedness which is subordinated to Obligations upon terms satisfactory to Bank in its sole discretion as long as no Default or Event Default has then occurred and is continuing or would result from the incurrence of such Indebtedness.

Permitted Investments” means investments in deposit accounts maintained with Bank or otherwise permitted hereunder in the ordinary course of business.

Permitted Lien” means (a) Liens for unpaid taxes, assessments, or other governmental charges or levies that are not yet delinquent; (b) the interests of lessors under operating leases and non-exclusive licensors under license agreements; (c) purchase-money Liens or the interests of lessors under capital leases to the extent that such Liens or interests secure Permitted Indebtedness consisting of purchase-money Indebtedness and so long as (i) such Lien attaches only to the asset purchased or acquired and the cash proceeds, (ii) such Lien only secures the purchase-money Indebtedness that was incurred to acquire the asset purchased or acquired; (d) Existing Liens; and (e) other Liens which are subordinated to the Liens of Bank upon terms satisfactory to Bank in its sole discretion as long as no Default or Event Default has then occurred and is continuing or would result from the subordination of such Liens.

Person” means natural persons, corporations, limited liability companies, limited partnerships, general partnerships, limited liability partnerships, joint ventures, trusts, land trusts, business trusts, or other organizations, irrespective of whether they are legal entities, and governments and agencies and their political subdivisions.

8


Pledge Agreement” means the Membership Interest Pledge Agreement, dated as of the date hereof, made by Parent and Holdco in favor of Bank with respect to the Equity Interests of Borrower and Holdco.

Prime Rate” means at any time, the rate of interest most recently announced by Bank at its principal office as its “prime rate,” whether or not such announced rate is the lowest rate available from Bank.  Each change in the rate of interest based on the Prime Rate will become effective on the date each Prime Rate change is announced by Bank.

Relevant Governmental Body” means the Federal Reserve Board or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board or the Federal Reserve Bank of New York, or any successor thereto.

Responsible Officer” means, any of the president, the chief executive officer, the chief operating officer, the chief financial officer, the treasurer or a vice president of Borrower or such other representative of Borrower as may be designated in writing by any one of the foregoing and acceptable to Bank in its sole discretion.

Sanctions” has the meaning set forth in Section 3.11(a).

Security Agreement” means, collectively, that certain Security Agreement, dated as of the date hereof, made by Borrower in favor of Bank, and any other security agreements executed from time to time by Borrower in favor of Bank.

SOFR” means a rate equal to the secured overnight financing rate as administered by the SOFR Administrator.

SOFR Administrator” means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).

Subsidiary” of a Person means a corporation, partnership, limited liability company or other entity in which that Person directly or indirectly owns or controls the Equity Interests having ordinary voting power to elect a majority of the board of directors (or appoint other comparable managers) of such corporation, partnership, limited liability company or other entity.  Unless the context otherwise requires, each reference to Subsidiaries herein shall be a reference to Subsidiaries of Borrower.

Taxes” has the meaning set forth in Section 8.4.

Term Loan” means the term loan made by Bank to Borrower on the Closing Date pursuant to Section 2.1 in the original principal amount of Five Million Dollars ($5,000,000).

Term SOFR” means the Term SOFR Reference Rate for a tenor comparable to the applicable Interest Period on the day (such day, the “Periodic Term SOFR Determination Day”) that is two (2) U.S. Government Securities Business Days prior to the first day of such Interest Period, as such rate is published by the Term SOFR Administrator; provided, however, that if as of 5:00 p.m. (New York City time) on any Periodic Term SOFR Determination Day the Term SOFR Reference Rate for the applicable tenor has not been published by the Term SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the Term SOFR Reference Rate for

9


such tenor as published by the Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such Periodic Term SOFR Determination Day.

Term SOFR Administrator” means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term SOFR Reference Rate selected by Bank in its reasonable discretion).

Term SOFR Reference Rate” means the forward-looking term rate based on SOFR.

Trademarks” has the meaning set forth in the License Agreement and shall include, without limitation, “Halston”, “H Halston”, “Halston Studio” and all derivatives and variations whether currently existing or hereafter developed.

U.S. Government Securities Business Day” means any day except for (a) a Saturday, (b) a Sunday or (c) a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.

1.2TERMS GENERALLY.  The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined.  Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.  The words “include,” “includes” and “including” shall be deemed to be followed by the phrase “without limitation.”  The word “will” shall be construed to have the same meaning and effect as the word “shall.”  Unless the context requires otherwise any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), any reference herein to any Person shall be construed to include such Person’s successors and assigns, the words “herein,” “hereof” and “hereunder,” and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, all references herein to Articles, Sections, Exhibits, riders, and Schedules shall be construed to refer to Articles and Sections of, and Exhibits, riders, and Schedules to, this Agreement, any reference to any law or regulation herein shall, unless otherwise specified, refer to such law or regulation as amended, modified or supplemented from time to time, and the words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights.  All terms defined in Article 9 of the Code and not otherwise defined are used herein as therein defined.
1.3ACCOUNTING TERMS; CHANGES IN GAAP.
(a)Accounting Terms.  Except as otherwise expressly provided herein, all accounting terms not otherwise defined herein shall be construed in conformity with GAAP.  Financial statements and other information required to be delivered by Borrower to the Bank pursuant to Section 5.1 shall be prepared in accordance with GAAP as in effect at the time of such preparation.  Notwithstanding the foregoing, for purposes of determining compliance with any covenant (including the computation of any financial covenant) contained herein, Indebtedness of Borrower and its Subsidiaries shall be deemed to be carried at 100% of the outstanding principal amount thereof, and the effects of FASB ASC 825 and FASB ASC 470-20 on financial liabilities shall be disregarded.

10


(b)Changes in GAAP.  If Borrower notifies Bank that Borrower requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if Bank notifies Borrower that Bank requests an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith.
ARTICLE 2
CREDIT TERMS
2.1TERM LOAN.
(a)Term Loan.  Subject to the terms and conditions of this Agreement, Bank agrees to make a single term loan to Borrower on the Closing Date in a principal amount equal to Five Million Dollars ($5,000,000).  The execution and delivery of this Agreement by Borrower and the satisfaction of all conditions precedent pursuant to Section 4.1 shall be deemed to constitute Borrower’s request to borrow the Term Loan on the Closing Date.  Amounts repaid in respect of the Term Loan may not be reborrowed.
(b)Charges to Loan Account; Clearance Charge.  Bank will maintain an account on its books and records in the name of Borrower (the “Loan Account”) in which will be recorded the Term Loan and all other Obligations; provided, that the failure of Bank to so record the Term Loan or any other Obligation shall not affect the obligation of Borrower to repay the Term Loan or other Obligation.  Borrower unconditionally authorizes Bank to collect all principal, interest, fees, indemnification obligations, reimbursement of expenses and other Obligations or amounts due under this Agreement or any of the other Loan Documents (including, but not limited to, costs and expenses relating to Bank’s attorneys’ fees), in each case, as they become due from time to time, by charging the Loan Account or any deposit account maintained by Borrower with Bank.  All periodic statements relating to the Loan Account (if any) will be conclusively presumed to be correct and accurate and constitute an account stated between Borrower and Bank unless Borrower delivers written objection to Bank within 30 days after receipt by Borrower.
(c)Interest Elections.
(i)Upon the expiration of each Interest Period, Bank shall continue the Term Loan for a successive Interest Period.
(ii)During the existence of an Event of Default, Bank may, at its option, convert the base rate of interest on the Term Loan from Term SOFR to the Prime Rate.
2.2INTEREST/FEES.
(a)Interest.  Interest shall be payable on the outstanding daily unpaid principal amount of the Term Loan from the date hereof until payment in full is made and shall accrue and be payable at the rates set forth or provided for herein, before and after default, before and after maturity, before and after judgment and before and after the commencement of any proceeding under any Debtor Relief Law.  Except as otherwise provided in Section 2.2(b), below, the unpaid principal amount of the Term Loan shall bear interest at a rate per annum equal to Term SOFR for the applicable Interest Period plus the Margin.

11


(b)Default Rate.  
(i)Upon the occurrence and during the continuation of any Event of Default and at any time following the Expiration Date, at the sole discretion of Bank, the Obligations shall thereafter bear interest at the Default Rate plus the interest rate applicable immediately prior to the occurrence of such Event of Default, to the fullest extent permitted by applicable law.  
(ii)Bank may assess the Default Rate commencing as of the date of the occurrence of an Event of Default or as of any date after the occurrence of an Event of Default regardless of the date of reporting or declaration of such Event of Default.  
(iii)Accrued and unpaid interest on past due amounts (including interest on past due interest) shall be compounded monthly, on the last day of each calendar month, to the fullest extent permitted by applicable law.
(c)Payment of Interest.  Accrued and unpaid Interest will be payable monthly on the first day of each month during the term hereof and on the Expiration Date.  Any accrued interest outstanding after the Expiration Date will be payable upon demand.
(d)Term SOFR Conforming Changes.  In connection with the use or administration of Term SOFR, Bank will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document.  Bank will promptly notify Borrower of the effectiveness of any such Conforming Changes.
(e)Payment of Fees.  Borrower will pay to Bank the following fees, as and when such fees are due and payable:
(i)On the Closing Date, a commitment fee of $50,000 in immediately available funds, which documentation fee shall be fully earned as of the Closing Date and non-refundable; and
(ii)All other fees for financial services and products offered by Bank in accordance with its internal policies governing such fees.

Bank is hereby authorized to debit Borrower’s deposit and/or operating account at Bank for payment of the foregoing fees.

(f)Late Charge. Borrower shall unconditionally pay to Bank a late charge (the “Late Charge”) equal to the greater of (a) five (5%) percent of the payment then due or (b) $200.00, if any such payment in whole or in part is not received by Bank within ten (10) days after its due date.  The Late Charge is in addition to the Default Rate, if applicable, and shall be payable together with the next payment due hereunder or, at Bank’s option, upon demand by Bank, provided, however, that if any such late charge is not recognized as liquidated damages for such delinquency, and if deemed to be interest in excess of the amount permitted by applicable law, Bank shall be entitled to collect a late charge only at the highest rate permitted by law, and any payment actually collected by Bank in excess of such lawful amount shall be deemed a payment in reduction of the principal sum then outstanding, and shall be so applied.

12


(g)Computation of Interest and Fees.  Interest and fees will be computed on the basis of a three hundred sixty (360)-day year (or, in connection with interest on Term Loans accruing interest at the Prime Rate, a three hundred sixty-five (365) or three hundred sixty-six (366)-day year, as applicable) for the actual number of days elapsed.
(h)Interest Statements.  Bank shall provide written statements to Borrower with respect to interest due and payable hereunder to the extent that Borrower is not then utilizing Bank’s “Stucky Netlink” system (or any other electronic transmission system approved by Bank); provided, that any failure by Bank to provide (or timely provide) any such interest statement shall not affect Borrower’s obligation hereunder to pay such interest as and when due.
2.3ADDITIONAL COSTS.
(a)Increased Costs.  Borrower will reimburse Bank, on demand, for Bank’s costs or losses arising from any occurrence, after the date of this Agreement, of the adoption or taking effect of any new or changed law, rule, regulation or treaty, or the interpretation thereof, or the issuance of any request, rule, guideline or directive (whether or not having the force of law) by any governmental authority, in each case, which are allocated to this Agreement or any credit outstanding under this Agreement, provided that Borrower shall not be required to compensate Bank pursuant to this section for costs or loss incurred more than 270 days prior to the date that Lender notifies Borrower of the event giving rise to such costs or losses and of Lender’s intention to claim compensation therefor; provided, further that, if such event giving rise to such costs or losses is retroactive, then the 270-day period referred to above shall be extended to include the period of retroactive effect thereof.  The allocation will be made as determined by Bank in good faith.  Such costs or losses may include, without limitation, costs or losses arising out of any such change in law related to: any reserve or deposit requirements (excluding any reserve requirement already reflected in the calculation of the interest rate in this Agreement); and any capital requirements relating to Bank’s assets and commitments for credit.
(b)Compensation for Losses.  In the event of (i)  the payment of any principal of the Term Loan other than on the last day of the Interest Period applicable thereto (including as a result of an Event of Default), or (ii) the failure to prepay the Term Loan on the date specified in any notice delivered pursuant hereto, then, in any such event, Borrower shall compensate Bank for any loss, cost and expense attributable to such event, including any loss, cost or expense arising from the liquidation or redeployment of funds.  A certificate of Bank setting forth any amount or amounts that Bank is entitled to receive pursuant to this section shall be delivered to Borrower and shall be conclusive absent manifest error. Borrower shall pay such Lender the amount shown as due on any such certificate within 10 days after receipt thereof.
(c)Temporary Inability to Determine Rates.  Subject to Section 2.5, if prior to the first day of any Interest Period, Bank shall have determined (which determination shall be conclusive and binding upon Borrower, absent manifest error) that Term SOFR cannot be determined pursuant to the definition thereof, but not due to any of the reasons set forth in Section 2.5, Bank shall forthwith furnish notice of such determination, confirmed in writing, to Borrower and thereafter the base rate of interest on the Term Loan shall, on the last day of the then applicable current Interest Period, be converted from Term SOFR to the Prime Rate until Bank notifies Borrower that the circumstances giving rise to such determination no longer exist.
(d)Illegality.  If Bank determines that any law has made it unlawful, or that any governmental authority has asserted that it is unlawful, for Bank to make, maintain or fund loans whose

13


interest is determined by reference to SOFR, the Term SOFR Reference Rate or Term SOFR, or to determine or charge interest rates based upon SOFR, the Term SOFR Reference Rate or Term SOFR, then, upon notice thereof to Borrower, the base rate of interest on the Term Loan shall, on the last day of the then applicable current Interest Period or, if necessary to avoid such illegality, immediately, be converted from Term SOFR to the Prime Rate until Bank notifies Borrower that the circumstances giving rise to such determination no longer exist.
2.4REPAYMENT; TERM AND TERMINATION.
(a)Loan Repayment.  Borrower shall repay the aggregate outstanding principal balance of the Term Loan in quarterly installments of principal in the amount of Two Hundred Fifty Thousand Dollars ($250,000) each, together with all accrued and unpaid interest as of each such payment date, commencing on April 1, 2024 and continuing on the first day of each quarter thereafter until the Maturity Date.  To the extent not previously paid, the outstanding principal balance of the Term Loan and all unpaid interest thereon shall be paid in full on the Maturity Date.
(b)The unpaid principal amount of the Term Loan may, at any time and from time to time, be voluntarily paid or prepaid in whole or in part as provided herein and subject to any additional amounts due and payable in accordance herewith.  Any payment due under the Note or any other Loan Document which is paid by check or draft shall be subject to the condition that any receipt issued therefore shall be ineffective unless and until the amount due is actually received by Bank.  
(c)Expiration Date.  If not sooner paid, all Obligations hereunder shall be due and payable on the earliest to occur of the following (the “Expiration Date”): the Maturity Date; or upon acceleration following an Event of Default.  No termination of the obligations of Bank will relieve or discharge Borrower of its duties, obligations, or covenants under this Agreement or under any other Loan Document.
(d)Time and Date of Payments.  Each payment due under the Note or any Loan Document shall be made to Bank at such bank account as Bank may designate by written notice to Borrower, in immediately available funds not later than 3:00 p.m., New York local time, on the day of payment. All payments received after such time shall be deemed received on the next succeeding Business Day. If any payment of principal or interest shall be due on a date that is not a Business Day, such payment shall be made on the next succeeding Business Day, and such extension of time shall in such case be included in the computation of the payment of interest.
(e)Application of Payments. Unless otherwise specified by Borrower, each payment, other than payments made pursuant to Section 2.4(a), received by Bank shall be applied as follows: (i) first, to the payment of any and all costs, fees and expenses incurred by or payable to Bank in connection with any of the Loan Documents, including all Bank Expenses; second, to the payment of all accrued and unpaid interest hereunder; third, to the payment of the unpaid principal amount of the Term Loan; and fourth, to all other Obligations owed by Borrower or any Guarantor to Bank or (ii) in any other manner which Bank may, in its sole discretion, elect from time to time. Each prepayment of the Term Loan shall be applied to the installments of the Term Loan in inverse order of maturity and shall be accompanied by accrued and unpaid interest to the date of such prepayment on the amount prepaid.

14


2.5Benchmark Replacement Setting
2.6.
(a)Benchmark Replacement.  Notwithstanding anything to the contrary herein or in any other Loan Document, if a Benchmark Transition Event has occurred prior to any setting of the then-current Benchmark, then the Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to Borrower by Bank without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document.
(b)Benchmark Replacement Conforming Changes.  In connection with the use, administration, adoption or implementation of a Benchmark Replacement, Bank will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document.
(c)Notices; Standards for Decisions and Determinations.  Bank will promptly notify the Borrower of (i) the implementation of any Benchmark Replacement and (ii) the effectiveness of any Conforming Changes in connection with the use, administration, adoption or implementation of a Benchmark Replacement; provided that any failure to so notify will not affect Bank’s rights hereunder. Any determination, decision or election that may be made by Bank pursuant to this Section 2.5, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its sole discretion and without consent from any other party to this Agreement or any other Loan Document, except, in each case, as expressly required pursuant to this Section 2.5.
(d)Unavailability of Tenor of Benchmark.  Notwithstanding anything to the contrary herein or in any other Loan Document, at any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including the Term SOFR Reference Rate), then Bank may remove any tenor of such Benchmark that is unavailable or non-representative for Benchmark (including Benchmark Replacement) settings and (ii) Bank may reinstate any such previously removed tenor for Benchmark (including Benchmark Replacement) settings.
(e)Disclaimer.  The interest rate on the Term Loan may be derived from an interest rate benchmark that may be discontinued or is, or may in the future become, the subject of regulatory reform. Upon the occurrence of a Benchmark Transition Event, this Section 2.5 provides a mechanism for determining an alternative rate of interest. Bank does not warrant or accept responsibility for, and shall not have any liability with respect to (a) the administration, submission, calculation of or any other matter related to the rates in the definition of “Term SOFR” or with respect to any component definition thereof or rates referenced in the definition thereof or any alternative, comparable or successor rate thereto (including any Benchmark or any Benchmark Replacement or the effect, implementation or composition of any Benchmark Replacement Conforming Changes) and including, without limitation, whether the composition or characteristics of any such alternative, successor or replacement reference rate, as it may or may not be adjusted pursuant hereto, will be similar to, or produce the same value or economic equivalence of, such Benchmark or any other Benchmark or have the same volume or liquidity as did such Benchmark or any other Benchmark prior to its discontinuance or unavailability, or (b) the impact or effect of such

15


alternative, successor or replacement reference rate or Benchmark Replacement Conforming Changes on any other financial products or agreements in effect or offered to any obligor or any of their respective affiliates, including, without limitation, any swap agreement or hedging agreement. Bank may select information sources or services in its reasonable discretion to ascertain any interest rate used in this Agreement, any component thereof, or rates referenced in the definition thereof, in each case pursuant to the terms of this Agreement, and shall have no liability to Borrower or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source or service.
ARTICLE 3
REPRESENTATIONS AND WARRANTIES

Borrower makes the following representations and warranties to Bank as of the date hereof, each of which representations and warranties will survive the execution of this Agreement and will continue in full force and effect until the full and final payment, and satisfaction and discharge of all Obligations:

3.1EXISTENCE AND QUALIFICATION; POWER.  Borrower is a corporation or limited liability company duly organized or formed, and validly existing.  Borrower is duly qualified or registered to transact business and is in good standing in its state of organization or formation and in each other jurisdiction in which the conduct of its business or the ownership of its properties makes such qualification or registration necessary.  Borrower has all requisite power and/or other authority to conduct its business, to own its properties, to execute and deliver this Agreement and each Loan Document to which it is a party, to borrow hereunder, to grant a security interest in the Collateral to Bank, and to perform its Obligations.
3.2ENFORCEABILITY.  This Agreement is, and each of the other Loan Documents when delivered to Bank will be, duly executed and delivered by Borrower or Guarantor (if any), as applicable, and constitutes the legal, valid and binding obligations of Borrower or Guarantor (if any), as applicable, enforceable against Borrower or Guarantor (if any), as applicable, in accordance with their respective terms, subject to bankruptcy, insolvency, moratorium or other laws affecting the enforceability of rights of creditors generally.
3.3COMPLIANCE WITH LAWS.  Borrower is in compliance with all laws, regulations and other legal requirements applicable to its business (including, without limitation, all applicable federal or state environmental laws), has obtained all authorizations, consents, approvals, orders, licenses and permits from all applicable governmental authorities, and has made or accomplished (or obtained exemptions from) all filings, registrations and qualifications that are necessary for the transaction of its business.
3.4AUTHORITY; COMPLIANCE WITH OTHER AGREEMENTS.  The execution, delivery and performance by Borrower of this Agreement and the other Loan Documents to which it is a party have been duly authorized by all necessary organizational action, as applicable, and do not and will not: require any consent or approval not heretofore obtained of any Person; violate or conflict with any provision of Borrower’s organizational documents; or result in a breach by Borrower or constitute a default by Borrower under, or cause or permit the acceleration of any obligation owed under, any indenture or loan or credit agreement or any other contractual obligation to which Borrower is a party or by which Borrower or any of its property is bound or affected.

16


3.5FINANCIAL STATEMENTS; NO MATERIAL ADVERSE CHANGE.  All financial statements and information of Borrower furnished to Bank are complete and correct and fairly present the financial condition of Borrower as of the date thereof and for the applicable period then ending.  No Material Adverse Change has occurred since the date of this Agreement.
3.6NO LITIGATION.  No litigation (including derivative actions), arbitration proceeding or governmental investigation or proceeding is pending or, to Borrower’s knowledge, threatened in writing against Borrower or any of its Subsidiaries which could reasonably be expected to result in a Material Adverse Change.
3.7OWNERSHIP OF PROPERTIES; LIENS.  Borrower owns good title to all of its properties and assets, real and personal, tangible and intangible, of any nature whatsoever, free and clear of all Liens, charges and claims except for Permitted Liens.  No financing statement or other public notice with respect to all or any part of the Collateral is on file or of record in any public office, except filings evidencing Permitted Liens.
3.8EQUITY OWNERSHIP; SUBSIDIARIES.  All issued and outstanding Equity Interests of Borrower and each of its Subsidiaries are duly authorized and validly issued and, if applicable, are fully paid and non-assessable, and free and clear of all Liens other than Permitted Liens.  
3.9SOLVENCY.  Immediately prior to and after giving effect to each borrowing hereunder and the use of the proceeds thereof, and giving effect to all rights of contribution, the fair value of the assets of Borrower is and will be greater than the amount of its liabilities, as such value is established and liabilities evaluated in accordance with applicable Debtor Relief Laws.
3.10REGULATIONS T, U AND X; INVESTMENT COMPANY ACT.  No part of the proceeds of the Loan will be used to purchase or carry, or to extend credit to others for the purpose of purchasing or carrying, any margin stock within the meaning of Regulations T, U or X of the Board of Governors of the Federal Reserve System.  Borrower is not or is not required to be registered as an “investment company” under the Investment Company Act of 1940.
3.11SANCTIONS; ANTI-CORRUPTION.
(a)Sanctions.  None of Borrower, any Guarantor (if any), any of their respective Subsidiaries or, to the knowledge of Borrower, any director, officer, manager, employee, agent, or affiliate of Borrower or any of their respective Subsidiaries is a Person that is, or is owned or controlled by Persons that are: the subject of any sanctions administered or enforced by the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”), the U.S. Department of State, the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”), or located, organized or resident in a country or territory that is, or whose government is, the subject of Sanctions.
(b)Anti-Corruption.  Borrower, its Subsidiaries and their respective directors, officers, managers, and employees and, to the knowledge of Borrower, the agents of Borrower and its Subsidiaries, are in compliance with all applicable Sanctions and with the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”) and any other applicable anti-corruption law.  Borrower and its Subsidiaries have instituted and maintain policies and procedures designed to ensure continued compliance with the FCPA and all other applicable anti-corruption laws.

17


3.12NO OTHER LIENS.  Borrower has not granted or suffered to exist any Lien on any of its assets or properties, except in favor of Bank and except for Permitted Liens.
3.13FULL DISCLOSURE.  No representation, warranty or other statement of Borrower in any certificate or written statement given to Bank, as of the date such representation, warranty, or other statement was made, taken together with all such certificates and statements given to Bank, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the certificates or statements not materially misleading.  As of the Closing Date, the information included in the Beneficial Ownership Certification is true and correct in all respects.
3.14INTELLECTUAL PROPERTY.  
(a)Borrower owns all of its Intellectual Property free and clear of all Liens, charges and claims except for Permitted Liens.
(b)The License Agreement is in full force and effect and no material defaults currently exist thereunder.
ARTICLE 4
CONDITIONS
4.1CONDITIONS OF INITIAL EXTENSION OF CREDIT.  In addition to the discretion of Bank, the obligation of Bank to make the Term Loan under this Agreement is subject to the fulfillment to Bank’s satisfaction of each of the following conditions precedent:
(a)Loan Documents.  All Loan Documents and all other documents relating to this Agreement will have been duly executed and delivered;
(b)Assignment Agreement. Borrower and Holdco shall have entered into the Assignment Agreement and provided to Bank evidence reasonably satisfactory to Bank that the Assignment Agreement shall have been submitted to the United States Patent and Trademark Office for recordation therein.
(c)Secretary’s Certificate.  Bank will have received a certificate of the Secretary (or the equivalent) of Borrower, attaching and certifying copies of the resolutions of its board of directors, managers, members and/or other equivalent governing body, as applicable, authorizing the execution, delivery and performance of the Loan Documents and certifying the name, title and true signature of each officer executing the Loan Documents;
(d)Lien Searches and Filings.  (i) Uniform Commercial Code and other searches, the results of which will be satisfactory to Bank, will have been completed and no filings describing the Collateral shall exist (unless such Liens (x) will be released or subordinated to Bank’s Liens or (y) relate to Permitted Liens) and (ii) all Uniform Commercial Code and other filings deemed necessary by Bank will have been submitted for filing with the appropriate filing office;
(e)Financial Information and Projections.  Bank shall have received all financial information of Borrower requested by Bank, including, without limitation, all financial projections for the

18


current fiscal year, which reflect pro forma compliance with all financial covenants set forth in this Agreement;
(f)Licenses and Approvals.  Borrower will have received all licenses, approvals and certifications required by any governmental authority necessary in connection with the execution of this Agreement and the Loan Documents and the completion of the transactions contemplated by this Agreement;
(g)Fees and Expenses.  Borrower shall have paid all of Bank’s fees, expenses and charges in connection with the preparation of the Loan Documents including, but not limited to, the reasonable and documented fees and expenses of Bank’s attorneys;
(h)Deposit Accounts.  Borrower shall have opened its operating and collections accounts with Bank and after having been given access to such accounts, use “IDB Access”, Bank’s cash management system;
(i)KYC Requirements.  Bank shall have received, at least five (5) days prior to the Closing Date, all documentation and other information required by bank regulatory authorities or reasonably requested by Bank under or in respect of applicable “know your customer” and anti-money laundering legal requirements including the Patriot Act and, if Borrower qualifies as a “legal entity customer” under the Beneficial Ownership Regulation, a Beneficial Ownership Certification in relation to Borrower;
(j)Representations and Warranties.  The representations and warranties of Borrower contained in this Agreement and in the other Loan Documents shall be true and correct on and as of the Closing Date;
(k)No Default or Event of Default.  No Default or Event of Default shall have occurred and be continuing on the Closing Date, nor shall either result from the making of the Term Loan; and
(l)No Material Adverse Change.  There shall have been no Material Adverse Change since the date of the most recent audited financial statements provided to Bank prior to Closing Date, and there shall be no pending or threatened action, suit, investigation or proceeding that could result in a Material Adverse Change with respect to Borrower or any of its Subsidiaries (if any) or any Guarantor (if any).
ARTICLE 5
AFFIRMATIVE COVENANTS

Borrower covenants that so long as this Agreement is in effect or any Obligations remain outstanding, Borrower shall:

5.1FINANCIAL STATEMENTS AND INFORMATION.  Furnish to Bank:
(a)Annual Reviewed and Audited Financial Statements.  Within one hundred twenty (120) days after the end of each of its fiscal years, (i) reviewed consolidated (if applicable) financial statements of Borrower and (ii) audited consolidated financial statements of Parent, including balance

19


sheets, statements of income, and statements of cash flows for such fiscal year, setting forth in each case in comparative form the figures as of the end of and for the previous fiscal year, all in reasonable detail and accompanied by a report thereon of Borrower’s independent certified public accountants, which accountants shall be reasonably acceptable to Bank, together with management’s discussion and analysis of the fiscal year’s operating and financial results.  Such accountants’ report shall be unqualified as to scope of audit and shall not be qualified as to going concern, and shall state that such financial statements present fairly the financial condition as at the end of such fiscal year, and the results of operations and cash flows for such fiscal year of Borrower in accordance with GAAP consistently applied;
(b)Quarterly Financial Statements.  Within ninety (90) days after the end of each of its fiscal quarters, a quarterly income statement and balance sheet as at the end of such quarter and the related statements of income and retained earnings and cash flows, and internal management reports of Borrower, Holdco and Parent for such quarter, and the portion of the fiscal year ended at the end of such quarter, all in reasonable detail and certified by the chief financial officer (or other Responsible Officer acceptable to Bank in its sole discretion) of Borrower that they are complete and correct and that they present fairly in all material respects the financial condition as at the end of such quarter, and the results of operations for such quarter and such portion of the fiscal year of Borrower in accordance with GAAP consistently applied (except for normal year-end adjustments and the absence of footnotes);
(c)Compliance Certificates.  Simultaneously with the financial statements described in clauses (a) and (b) above for each fiscal year and quarter, as applicable, a Compliance Certificate demonstrating in reasonable detail compliance with the applicable financial covenants set forth in Section 5.2;
(d)Royalty Reports.  Within sixty (60) days after the end of each fiscal quarter, a detailed report regarding the Guaranteed Minimum Royalties compared against actual royalty payments received in respect of the Trademarks, certified by the chief financial officer (or other Responsible Officer acceptable to Bank in its sole discretion) of Borrower that they are complete and correct, all in form and substance reasonably satisfactory to Bank;
(e)Projections.  On or before November 30 of each year, cash flow projections (inclusive of royalty projections) in form and substance reasonably satisfactory to Bank; and
(f)Additional Information.  Promptly following Bank’s request therefor, such additional information regarding Borrower and its business, operations, asset and properties as Bank may reasonably request.
5.2FINANCIAL COVENANTS.  Comply with each of the following financial covenants:
(a)Guaranteed Minimum Royalty Ratio. Maintain a Guaranteed Minimum Royalty Ratio as at the last day of each fiscal year set forth below shall be no less than the amount set forth below for such fiscal year:

Fiscal Year

Guaranteed Minimum Royalty Ratio

2023

1.15 to 1.0

20


2024

1.15 to 1.0

2025

1.20 to 1.0

2026 and thereafter

1.25 to 1.0

(b)Fixed Charge Coverage Ratio.  Maintain a Fixed Charge Coverage Ratio as at the last day of each fiscal year, commencing with the fiscal year ended December 31, 2024, of no less than 1.10 to 1.0.
(c)Minimum Cash Balances.  Borrower shall maintain at all times in its primary operating account at Bank a cash balance of not less than $250,000, as evidenced by the account statements provided by Bank.
5.3EXISTENCE; CONDUCT OF BUSINESS.  Do or cause to be done all things necessary to preserve, renew and maintain in full force and effect its legal existence and its respective rights, licenses, permits, privileges and franchises material to the conduct of its business.
5.4ACCOUNTING RECORDS; INSPECTIONS; APPRAISALS.  Maintain a system of accounting that enables Borrower to produce financial statements in accordance with GAAP.  Borrower will permit any representative of Bank, upon reasonable prior written notice and at any reasonable time during Borrower’s normal business hours, to inspect, audit and examine such books and records and to make copies of the same, provided that Bank shall not make such inspections, audits and exams more than once during any calendar year, unless an Event of Default exists.
5.5COMPLIANCE.  (a) Preserve and maintain all licenses, permits, governmental approvals, rights, privileges and franchises necessary or desirable for the conduct of its business; (b) comply with the provisions of all documents under which Borrower is organized and/or which govern Borrower’s continued existence, and with the requirements of all laws, rules, regulations and orders of any governmental authority applicable to Borrower and/or its business; and (c) maintain in effect policies and procedures designed to promote compliance by Borrower, its Subsidiaries, and their respective directors, officers, managers, employees, and agents with applicable Sanctions and with the FCPA and any other applicable anti-corruption laws.
5.6MAINTENANCE OF PROPERTIES.  Keep all properties useful or necessary to Borrower’s business in good repair and condition, and from time to time make necessary repairs, renewals and replacements so that such properties will be fully and efficiently preserved and maintained.
5.7TAXES AND OTHER LIABILITIES.  Pay and discharge when due any and all indebtedness, obligations, assessments and taxes, both real or personal, including without limitation federal and state income taxes and state and local property taxes and assessments, other than any of the foregoing being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as (a) adequate reserves, as shall be required in conformity with GAAP, shall have been made therefor, and in the case of any tax or claim that has or may become a Lien against any of the Collateral, such contest proceedings conclusively operate to stay the sale of any portion of the Collateral to satisfy such tax or claim or (b) the failure to so pay could not reasonably be expected, individually or in the aggregate, to constitute a Material Adverse Change.

21


5.8NOTICE TO BANK.  Promptly (but in no event more than five (5) days after the occurrence of each such event or matter) give written notice to Bank in reasonable detail of: (a) the occurrence of any Default or Event of Default; (b) a violation of any law, rule or regulation by Borrower; (c) any termination or cancellation of any insurance policy which Borrower is required to maintain; (d) any litigation pending or, to the knowledge of Borrower, threatened against Borrower that, if adversely determined would result in liability of Borrower in excess of the Notice Threshold Amount; (e) any dispute or claims by Licensee with respect to the License Agreement exceeding individually or in the aggregate the Notice Threshold Amount; (f) the occurrence of a Material Adverse Change; (g) any change in the name, jurisdiction of organization, or organizational structure of Borrower; or (h) any change in the information provided in the Beneficial Ownership Certification that would result in a change to the list of beneficial owners identified in parts (c) or (d) of such certification.
5.9INSURANCE.  Maintain insurance customary in coverage and amounts for the business in which it is engaged, including, without limitation, general liability insurance, in each case, in form, substance, amounts, under agreements and with insurers reasonably acceptable to Bank.  The insurance policies must contain endorsements acceptable to Bank naming Bank as sole lender loss payee with regard to property coverage and as additional insured with regard to liability coverage.
5.10DEPOSITORY RELATIONSHIP; COMPENSATING BALANCE.
(a)Maintain all of its operating and collections accounts with Bank.
(b)Maintain with Bank deposit accounts (including without limitation the accounts maintained with Bank pursuant to Section 5.10(a)) having average monthly balances, in the aggregate, of no less than $1,000,000 (“Minimum Compensating Balance”). To the extent and for such period of time as Borrower’s deposit account balances at Bank, when aggregated with Holdco’s and Parent’s deposit account balances at Bank, are less than the Minimum Compensating Balance (the Minimum Compensating Balance less the deposit account balances is hereinafter referred to as the “Deficiency Amount”), Borrower shall be subject to a deficiency charge, payable to Bank on a quarterly basis, calculated by multiplying the Deficiency Amount by an interest rate per annum equal to 4.00%.
5.11COOPERATION.  Take such actions and execute and deliver to Bank such instruments and documents as Bank may from time to time reasonably request (including obtaining agreements from third parties as Bank deems necessary) to create, maintain, preserve and protect Bank’s first-priority security interest in the Collateral (subject to Permitted Liens which are expressly allowed hereby to have priority over Bank’s Liens) and Bank’s rights in the Collateral and to carry out the intent of this Agreement and the other Loan Documents.
5.12INTELLECTUAL PROPERTY.  
(a)With respect to any and all Intellectual Property, maintain and protect the same and take and assert any and all remedies available to Borrower to prevent any other Person from infringing upon or claiming any interest in any such Intellectual Property other than the interest of Licensee.
(b)Notify Bank promptly of (i) the filing of any patent, copyright or trademark application by Borrower; (ii) the grant of any patent, copyright or trademark to Borrower; or (iii) Borrower’s intent to abandon a patent, copyright or trademark; provided, that Borrower shall not abandon any patent, copyright or trademark without Bank’s prior written consent, such consent not to be unreasonably withheld,

22


delayed or conditioned if (x) such patent, copyright or trademark, as applicable, is not material to the conduct of Borrower’s business and (y) such abandonment would not violate the terms of the License Agreement.
(c)If requested by Bank, (i) execute and deliver to Bank security agreements, financing statements, patent mortgages or such other documents, in form and substance reasonably acceptable to Bank, necessary to perfect and maintain Bank’s security interest in all existing and future Intellectual Property owned by Borrower; and (ii) furnish Bank with evidence satisfactory to Bank that all actions necessary to maintain and protect all Intellectual Property owned by Borrower have been taken in a timely manner.
5.13DIRECTION OF PROCEEDS.  On or prior to October 30, 2023, direct Licensee pursuant to the Payment Direction Notice to remit directly to the account set forth on Schedule 5.13 annexed hereto or such other account as Bank shall direct all royalties and funds otherwise payable to Borrower pursuant to the License Agreement.  Prior to the occurrence and continuance of an Event of Default, all such payments received by Bank (i) shall be applied to the next regularly scheduled payment of principal of and accrued interest on the Term Loan until paid in full, and (ii) the balance, if any, shall remitted to Borrower’s operating account at Bank.
5.14INTEREST RATE PROTECTION.  Borrower shall enter into one or more Hedging Transactions for no less than the notional amount of $5,000,000 in respect of the Term Loan, in each case on terms and with counterparties reasonably acceptable to Bank.
5.15Post-Closing Deliverables. Within thirty (30) days after the Closing Date, all insurance policies and other documents, agreements and actions required by this Agreement and the other Loan Documents will have been completed and will be in place with Bank named as lender’s loss payee or additional insured, as applicable, on each such policy.
ARTICLE 6
NEGATIVE COVENANTS

Borrower covenants that so long as this Agreement is in effect or any Obligations remain outstanding, Borrower shall not:

6.1USE OF PROCEEDS.  Use any of the proceeds of the Term Loan for purposes other than for working capital and other general corporate purposes of Borrower (including without limitation for making cash distributions to the members of Borrower), or in contravention of any provision of this Agreement or any other Loan Document.  
6.2OTHER INDEBTEDNESS.  Create, incur, assume or permit to exist any Indebtedness of Borrower, except the Obligations and Permitted Indebtedness.
6.3MERGER, CONSOLIDATION, TRANSFER OF ASSETS, TRANSACTIONS OUTSIDE THE ORDINARY COURSE OF BUSINESS.  Cause, permit, participate in or suffer to occur or exist, any of the following: (a) any merger or consolidation with any other Person; (b) any substantial change in the nature of Borrower’s business as conducted as of the Closing Date; (c) any material change in the existing executive management personnel of Borrower; (d) Borrower’s entry into any joint venture, partnership or limited liability company as a member or partner; (e) any acquisition of all or substantially

23


all of the assets of any other Person (or any division, business unit or line of business of any other entity), or any assets outside the ordinary course of Borrower’s business; (f) any sale, lease, transfer or other disposition of any of Borrower’s assets, except pursuant to the License Agreement; (g) the creation or acquisition of any Subsidiary; (h) entry into any other transaction outside the ordinary course of business (including any sale and leaseback transaction); or (i) any liquidation, winding-up, or dissolution of Borrower or suspension of Borrower’s business or cessation of operation of a substantial portion of its business.
6.4LOANS, ADVANCES, INVESTMENTS.  Make any investment in any Person, whether in the form of loans, advances, guarantees, capital contributions, or other investment, other than Permitted Investments, or acquisition of any Equity Interests or Indebtedness of any Person.
6.5DIVIDENDS, DISTRIBUTIONS.  In any fiscal year declare or pay any dividend or distribution (either in cash or any other property in respect of any Equity Interests in Borrower) or redeem, retire, repurchase or otherwise acquire any Equity Interests of Borrower in an aggregate amount in excess of Borrower’s net profit for such fiscal year, in each case so long as no Default or Event of Default has occurred and is continuing at the time thereof or would result therefrom.
6.6LIENS.  Mortgage, pledge, grant or permit to exist a security interest in, or Lien upon, all or any portion of Borrower’s assets now owned or subsequently acquired, except (i) Liens in favor of Bank and (ii) Permitted Liens.
6.7AFFILIATE TRANSACTIONS.  Directly or indirectly enter into, or permit to exist, any material transaction with any Affiliate of Borrower or make any loan or advance to an officer or Affiliate of Borrower, except for transactions that are in the ordinary course of Borrower’s business, and are on fair and reasonable terms that are no less favorable to Borrower than would be obtained in an arm’s length transaction with a non-affiliated Person.
6.8ORGANIZATIONAL CHANGES.  Change its name, chief executive office, principal residence, organizational documents, organizational identification number, state of organization, organizational identity or “location” as defined in Section 9-307 of the Code, in each case except with ten (10) Business Days’ prior written notice to Bank.
6.9CHANGE OF ACCOUNTING METHOD.  Modify or change its fiscal year or its method of accounting (other than as may be required to conform to GAAP).
6.10SANCTIONS; ANTI-CORRUPTION USE OF PROCEEDS.  Use the proceeds of the Term Loan or any other extension of credit by Bank, directly or indirectly, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person, in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of the FCPA or any other applicable anti-corruption law, or to fund any activities or business of or with any Person, or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of Sanctions, or in any other manner that would result in a violation of Sanctions by any Person.

24


ARTICLE 7
EVENTS OF DEFAULT
7.1EVENTS OF DEFAULT.  The occurrence of any of the following will constitute an “Event of Default” under this Agreement:
(a)Borrower fails to make any payment of principal or interest due and payable under this Agreement or any other Loan Document when such payment is due and payable;
(b)Borrower fails to pay any other charges, fees, expenses or other monetary obligations (other than an amount payable under clause (a) of this Section) owing to Bank arising out of or incurred in connection with any Loan Document within three (3) Business Days after the date such payment is due and payable;
(c)Borrower fails to perform, comply with or observe any covenant, agreement or undertaking contained in Section 5.1, Section 5.2, Section 5.3, clause (a) of Section 5.8, Section 5.13 or Article 6 of this Agreement;
(d)Borrower fails to perform, comply with or observe any covenant, agreement or undertaking contained in any Loan Document (other than those referred to in clause (a), (b) or (c) or elsewhere of this Section 7.1) and such failure continues for thirty (30) days after the occurrence thereof;
(e)any statement, report, financial statement, or certificate made or delivered by or on behalf of Borrower or any Guarantor (if any) to Bank is not true and correct in all material respect when made or delivered, or any warranty, representation or other statement by or on behalf of Borrower contained in or made in connection with this Agreement, the other Loan Documents or in any document, agreement or instrument furnished in compliance with, relating to, or in reference to this Agreement, is false, erroneous, or misleading in any material respect when made;
(f)Borrower shall default beyond any grace period in the payment of principal, premium or interest of any Indebtedness of Borrower (other than the Obligations), when and as the same shall become due and payable (whether at scheduled maturity, required prepayment, acceleration, demand or otherwise); or if Borrower otherwise defaults under the terms of any such Indebtedness if the effect of such default is to enable the holder of such Indebtedness to accelerate the payment of Borrower’s obligations, which are the subject thereof, prior to the maturity date or prior to the regularly scheduled date of payment;
(g)any final judgment or order exceeding $250,000 for the payment of money which is not fully and unconditionally covered by insurance or for which Borrower has not established a cash or cash equivalent reserve in the full amount of such judgment, shall be rendered against Borrower and such judgment shall continue unsatisfied and in effect for a period of thirty (30) consecutive days without being vacated, discharged, satisfied or bonded pending appeal;
(h)any non-monetary judgment or order shall be rendered against Borrower that could reasonably be expected, either individually or in the aggregate, to have a Material Adverse Change, and there shall be a period of thirty (30) consecutive days during which a stay of enforcement of such judgment or order, by reason of a pending appeal or otherwise, shall not be in effect;

25


(i)Borrower or any Guarantor (if any) makes or proposes in writing, an assignment for the benefit of creditors generally, offers a composition or extension to creditors, or makes or sends notice of an intended bulk sale of any business or assets now or hereafter owned or conducted by Borrower or any such Guarantor, an Insolvency Proceeding or any other action is commenced for the dissolution or liquidation of Borrower, or the commencement of any proceeding to avoid any transaction entered into by Borrower or any Guarantor (if any), or the commencement of any case or proceeding for reorganization or liquidation of Borrower’s or any Guarantor’s debts under any Debtor Relief Law, whether instituted by or against Borrower or any Guarantor; provided, however, that Borrower or such Guarantor (if any), as applicable, shall have sixty (60) days to obtain the dismissal or discharge of an Insolvency Proceeding filed against it, it being understood that during such sixty (60) day period, Bank may seek adequate protection in any Insolvency Proceeding, or a receiver, liquidator, custodian, trustee or similar official or fiduciary is appointed for Borrower or any Guarantor or for the property of Borrower or any Guarantor;
(j)any execution or distraint process is issued against any property of Borrower or any Guarantor (if any);
(k)any indication or evidence is received by Bank that reasonably leads it to believe Borrower or any Guarantor (if any) may have directly or indirectly been engaged in any type of activity which, would be reasonably likely to result in the forfeiture of any material property of Borrower or any such Guarantor to any governmental entity, federal, state or local or Borrower or any Guarantor ceases any material portion of its business operations as presently conducted;
(l)Borrower shall become unable to pay, shall admit in writing its inability to pay, or shall fail to pay, its debts as they become due;
(m)any Lien in favor of Bank shall fail or cease to be, or shall be asserted by Borrower or any Guarantor (if any) not to be, valid, enforceable and perfected and prior to all other Liens other than Permitted Liens;
(n)Borrower or any Guarantor (if any) conceals, removes or permits to be concealed or removed any part of Borrower’s property with intent to hinder, delay, or defraud any of its creditors or makes or suffers to be made a transfer of any property, which is fraudulent under the law of any applicable jurisdiction;
(o)any material provision of the Security Agreement, any Guarantee or any other document relating to Collateral shall for any reason cease to be valid and binding on, or enforceable against, Borrower or any Guarantor (if any), or Borrower or any such Guarantor shall assert in writing or take any action to discontinue or to assert the invalidity or unenforceability of any Loan Document, or any material provision of any Loan Document for any reason ceases to be valid, binding and enforceable in accordance with its terms;
(p)Borrower or any officer, director or owner of any of the outstanding Equity Interests of Borrower or any Guarantor (if any) shall be indicted for a felony offense under state or federal law, including without limitation any violation of any anti-money laundering, bribery, OFAC or bank fraud, or should Borrower employ an executive officer or manager, or elect a director, who has been convicted of any such felony offense, or should any Person become an owner of any of the outstanding ownership interests of Borrower who has been indicted or convicted of any such felony offense;

26


(q)a Change in Control shall occur; or
(r)the License Agreement for any reason shall cease to be in full force and effect.
7.2REMEDIES UPON DEMAND OR DEFAULT.  Upon demand or following the occurrence and during the continuance of an Event of Default, Bank may, at its election, without notice of its election and without demand, do any one or more of the following, all of which are authorized by Borrower:
(a)Declare all Obligations, whether evidenced by this Agreement or by any of the other Loan Documents or by any documents evidencing Bank Product Obligations immediately due and payable (provided that upon the occurrence of an Event of Default described in Section 7.1(i), all Obligations shall become immediately due and payable without any action or declaration by Bank), at which time Borrower shall be obligated to immediately repay all of such Obligations in full, without presentment, demand, protest, notice of dishonor, or other notice of any kind or other requirement of any kind, all of which are hereby expressly waived by Borrower; and
(b)Exercise any or all other rights, powers and remedies available under the Security Agreement and each of the other Loan Documents, or accorded by law or equity.

All rights, powers and remedies of Bank may be exercised at any time by Bank and from time to time after the occurrence and during the continuation of an Event of Default, and the same are cumulative and not exclusive, and will be in addition to any other rights, powers or remedies provided by law or equity.

ARTICLE 8
MISCELLANEOUS
8.1NO WAIVER.  No delay, failure or discontinuance of Bank in exercising any right, power or remedy under, or insisting upon the strict performance of any one or more provisions of, any of the Loan Documents will affect or operate as a waiver of such right, power or remedy; nor will any single or partial exercise of any such right, power or remedy preclude, waive or otherwise affect any other or further exercise thereof or the exercise of any other right, power or remedy.  Any waiver, permit, consent or approval of any kind by Bank of any breach of or default (including any Default or Event of Default) under any of the Loan Documents must be in writing and will be effective only to the extent set forth in such writing.  By accepting full or partial payment after the due date of any of the Obligations, Bank shall not be deemed to have waived the right either to require prompt payment when due and payable of all other Obligations, or to exercise any rights and remedies available to it in order to collect all such other amounts due and payable under any of the Loan Documents.
8.2NOTICES.  All notices, requests and demands which any party is required or may desire to give to any other party under any provision of this Agreement must be in writing delivered to each party at the address of such party set forth below each party’s name on the signature page of this Agreement or to such other address as any party may designate by written notice to all other parties.  Each such notice, request and demand will be deemed given or made as follows: if sent by hand delivery or overnight courier, upon delivery; if sent by mail, upon the earlier of the date of receipt or three (3) days after deposit in the U.S. mail, first class and postage prepaid; and if sent by email or other electronic transmission, upon receipt.

27


8.3COSTS, EXPENSES AND ATTORNEYS’ FEES.  Borrower will pay to Bank immediately upon demand the full amount of the following (collectively, “Bank Expenses”): all payments, advances, charges, costs and expenses, including without limitation documented attorneys’ fees (to include outside counsel fees and expenses, and all allocated costs of Bank’s in-house counsel), appraisal fees, consultant fees, audit fees, and exam fees expended or incurred by Bank in connection with the negotiation and preparation of this Agreement and the other Loan Documents, perfection of Bank’s Liens in the Collateral, Bank’s continued administration of this Agreement and the other Loan Documents, and the preparation of any amendments, waivers or other agreements, instruments or documents relating to this Agreement or the other Loan Documents, or in connection with any “workout” or restructuring, the enforcement of Bank’s rights and/or the collection of any amounts which become due to Bank under any of the Loan Documents, and the prosecution or defense of any action in any way related to Borrower or any of the Loan Documents, including without limitation, any action for declaratory relief, whether incurred at the trial or appellate level, in an arbitration proceeding or otherwise, and including any of the above incurred in connection with any Insolvency Proceeding (including without limitation, any adversary proceeding, contested matter or motion brought by Bank or any other Person) relating to Borrower or any other Person and any of the Collateral and other examinations, appraisals, evaluations, audits and inspections.  All of such Bank Expenses shall (i) be reasonable under the circumstances incurred, (ii) be documented and (iii) bear interest at the then current rate of Interest accruing with respect to the Term Loan from the date of payment by Bank until repaid in full by the Borrower.  Borrower’s obligations set forth in this Section 8.3 will survive any termination of this Agreement or repayment of the Obligations and will for all purposes continue in full force and effect.
8.4TAXES.  All payments made by Borrower hereunder or under any note or other Loan Document will be made without setoff, counterclaim, or other defense.  In addition, all such payments will be made free and clear of, and without deduction or withholding for, any present or future taxes, levies, imposts, duties, fees, assessments or other charges of whatever nature now or subsequently imposed by any jurisdiction or by any political subdivision or taxing authority and all related interest, penalties or similar liabilities (collectively, “Taxes”), provided that Bank shall have provided Borrower with an executed IRS Form W-9 (or other applicable tax form reasonably requested by Borrower) that indicates that Bank is exempt from U.S. federal backup withholding tax; provided, further, that, in the event any deduction or withholding of such Taxes is required, then, (i) unless such taxes are those described in clauses (b) through (d) of the definition of Excluded Taxes, the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section), Bank receives an amount equal to the sum it would have received had no such deductions been made, (ii) Borrower shall make such deductions and (iii) Borrower shall pay the full amount deducted to the relevant governmental authority in accordance with applicable law.
8.5GENERAL.  This Agreement will be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; provided that Borrower may not assign or transfer any of its interests, rights or obligations under this Agreement or any other Loan Document without Bank’s prior written consent.  Bank reserves the right to sell, assign, transfer, negotiate or grant participations in all or any part of, or any interest in, Bank’s rights and benefits under this Agreement and the other Loan Documents.  This Agreement and the other Loan Documents constitute the entire agreement between Borrower and Bank with respect to each credit subject hereto and supersede all prior negotiations, communications, discussions and correspondence concerning the subject matter of this Agreement.  This Agreement may be amended or modified only in writing signed by each party to this Agreement.  This Agreement is made and entered into for the sole protection and benefit of the parties hereto and their

28


respective permitted successors and assigns, and no other Person will be a third-party beneficiary of, or have any direct or indirect cause of action or claim in connection with, this Agreement or any other of the Loan Documents to which it is not a party.  If any provision of this Agreement or any other Loan Document will be prohibited by or invalid under applicable law, such provision will be ineffective only to the extent of such prohibition or invalidity without invalidating the remainder of such provision or any remaining provisions of this Agreement or the other Loan Documents.  This Agreement may be executed in any number of counterparts, each of which when executed and delivered will be deemed to be an original, and all of which when taken together will constitute one and the same Agreement.  If more than one, the liability of Borrower under this Agreement will be joint and several.  Delivery of an executed counterpart of this Agreement by facsimile or other electronic method of transmission shall be equally as effective as delivery of an original executed counterpart of this Agreement and any party’s failure to deliver an original executed counterpart shall not affect the validity, enforceability, and binding effect of this Agreement.
8.6INDEMNITY.  Borrower indemnifies Bank and its Affiliates, Subsidiaries, directors, officers, employees, representatives, agents, and attorneys (collectively, the “Indemnified Parties”, and each, an “Indemnified Party”), and holds them harmless from and against any and all claims, debts, liabilities, demands, obligations, actions, causes of action, penalties, costs and expenses (including reasonable attorneys’ fees), of every kind, which any Indemnified Party may sustain or incur, or which may be asserted against any Indemnified Party by any third party, in each case, based upon or arising out of any of the Obligations, this Agreement, any of the Loan Documents, or the Collateral or any relationship or agreement between Bank and Borrower, or any other matter, relating to Borrower, the Obligations or the Collateral; provided that this indemnity will not extend to damages asserted by any Indemnified Party that a court of competent jurisdiction finally determines in a non-appealable judgment to have been caused by such Indemnified Party’s own gross negligence or willful misconduct.  Regardless of any provision in this Agreement to the contrary, the indemnity agreement set forth in this Section 8.6 will survive any termination of this Agreement or repayment of the Obligations and will for all purposes continue in full force and effect.
8.7CHOICE OF LAW: FORUM SELECTION: CONSENT TO JURISDICTION.  This Agreement shall be governed by, construed and interpreted in accordance with the laws of the State of New York (excluding the choice of law rules thereof).  Borrower hereby irrevocably submits to the jurisdiction of any New York court or the courts of the United States District Court for the Southern District of New York sitting in the Borough of Manhattan in any action or proceeding arising out of or relating to this Agreement, and hereby irrevocably waives any objection to the laying of venue of any such action or proceeding in any such court and any claim that any such action or proceeding has been brought in an inconvenient forum.  A final judgment in any such action or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the judgment or in any other manner provided by law.
8.8CONSEQUENTIAL DAMAGES.  No claim may be made by Borrower against Bank, or any Affiliate, Subsidiary, director, officer, employee, representative, agent, attorney or attorney-in-fact of any of them for any special, indirect, consequential, or punitive damages in respect of any claim for breach of contract or other theory of liability arising out of or related to the transactions contemplated by this Agreement or any other Loan Document or any related act, omission, or event, and Borrower waives, releases, and agrees not to sue upon any claim for such damages, whether or not accrued and whether or not known or suspected to exist in its favor.

29


8.9SAVINGS CLAUSE.  If at any time the interest rate set forth in any of the Loan Documents exceeds the maximum interest rate allowable under applicable law, the interest rate will be deemed to be such maximum interest rate allowable under applicable law.
8.10RIDERS; SCHEDULES.  This Agreement may be supplemented by one or more riders and/or schedules.  In the event of any conflict between the terms of this Agreement and any rider or schedule, the terms of the rider or schedule, as applicable, shall control.
8.11RIGHT OF SETOFF; DEPOSIT ACCOUNTS.  Upon and after the occurrence of an Event of Default, Borrower authorizes Bank, at any time and from time to time, without notice, which is hereby expressly waived by Borrower, and whether or not Bank will have declared any extension of credit under this Agreement to be due and payable in accordance with the terms of this Agreement, to set off against, and to appropriate and apply to the payment of, the Obligations (whether matured or unmatured, fixed or contingent, liquidated or unliquidated), any and all amounts owing by Bank to Borrower (whether matured or unmatured, and in the case of deposits, whether general or special (except trust and escrow accounts), time or demand and however evidenced), and pending any such action, to the extent necessary, to hold such amounts as collateral to secure such the Obligations and to return as unpaid for insufficient funds any and all checks and other items drawn against any deposits so held as Bank, in its sole discretion, may elect.  For the avoidance of doubt, Borrower acknowledges that pursuant to Security Agreement Borrower has granted to Bank a security interest in all deposits and accounts maintained with Bank to secure the payment of all Obligations.
8.12CONFIDENTIALITY.  Bank agrees that material, non-public information regarding Borrower, its operations, assets, and existing and contemplated business plans will be treated by Bank in a confidential manner, and will not be disclosed by Bank to Persons who are not parties to this Agreement, except (a) to Bank’s Affiliates, and Bank’s and Bank’s Affiliates’ respective attorneys, representatives, agents and other advisors and to officers, directors and employees, (b) as required by law, rule, regulation or by any court, governmental, regulatory or self-regulatory authority, (c) as agreed by Borrower in writing, (d) if such information becomes generally available to the public other than as a result of a breach of this Section, (e) in connection with (i) any litigation or adversary proceeding involving claims related to this Agreement, or (ii) the assignment or participation of Bank’s interest in this Agreement, provided that the related assignee or participant is informed of the confidential nature of such information and agrees in writing to maintain the confidentiality thereof, (f) to equity owners of Borrower, and (g) in connection with the exercise by Bank of any right or remedy under this Agreement, any other Loan Document or at law.  Bank may use the name, logos, and other insignia of Borrower and the maximum amount of the credit facilities provided under this Agreement in any “tombstone” or comparable advertising, on its website or in other marketing materials of Bank with the prior written approval of Borrower.
8.13PATRIOT ACT NOTICE.  Bank notifies Borrower that pursuant to the requirements of the Patriot Act, Bank is required to obtain, verify and record information that identifies Borrower and any Guarantor, which information includes the name and address of Borrower and each such Guarantor and other information that will allow Bank to identify Borrower and each such Guarantor in accordance with the Patriot Act.  In addition, if Bank is required by law or regulation or internal policies to do so, it shall have the right to periodically conduct Patriot Act searches, OFAC/PEP searches, and customary individual background checks for Borrower and any Guarantor, and OFAC/PEP searches and customary individual  background checks of Borrower’s senior management and key principals, and Borrower agrees, and agrees to cause each such Guarantor, to cooperate in respect of the conduct of such searches and further agree that

30


the reasonable costs and charges for such searches shall constitute Bank Expenses, and pursuant to the Beneficial Ownership Regulation, it is required to obtain a Beneficial Ownership Certificate.
8.14WAIVER OF JURY TRIAL.  EACH OF BANK AND BORROWER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).  EACH PARTY CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT IT WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER.  EACH PARTY ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE WAIVERS AND CERTIFICATIONS IN THIS SECTION.
8.15NO ADVISORY OR FIDUCIARY RESPONSIBILITY. Borrower represents and warrants that (a) to the extent it has deemed appropriate, Borrower has consulted its own legal, accounting, regulatory and tax advisors, which advisors have been selected of Borrower’s own free will, and (b) Borrower is capable of evaluating and understanding, and understands and accepts, the terms, risks, waivers and conditions of the transactions contemplated hereby and by the other Loan Documents.

[Remainder of page intentionally blank; signature page follows.]

31


The parties have caused this Agreement to be executed as of the date first set forth above.

BORROWER:

H HALSTON IP, LLC

By: _/s/ Robert D’Loren______________

Name: Robert D’Loren

Title: Chief Executive Officer

Address:

1333 Broadway, 10th Floor

New York, New York 10018

Attention: Robert D’Loren

Email: rdloren@xcelbrands.com

BANK:

ISRAEL DISCOUNT BANK OF NEW YORK

By: _/s/ Mitchell Barnett ________________

Name: Mitchell Barnett

Title: Senior Vice President

By: _/s/ Ender Cetin_____________________

Name: Ender Cetin

Title: Senior Vice President

Address:

1114 Avenue of the Americas, 9th Floor

New York, New York 10036

Attention: Mitchell Barnett

Email: mbarnett@idbny.com

Term Loan Agreement Signature PAge


EXHIBIT 5.1(c)

Form of Compliance Certificate

Attached.


SCHEDULE 5.13

Account Information

ISRAEL DISCOUNT BANK (IDBBANK)
1114 Avenue of the Americas
New York, NY 10036
ABA #: 026009768

A/C Name: IDB BANK FBO H HALSTON IP LLC
A/C #: <REDACATED>
Ref: H Halston IP LLC


EX-21.1 6 xelb-20231231xex21d1.htm EX-21.1

Exhibit 21.1

Subsidiaries of Xcel Brands, Inc.

Name and Jurisdiction of Incorporation

·    IM Brands, LLC, a Delaware limited liability company

·    JR Licensing, LLC, a Delaware limited liability company

·    Judith Ripka Fine Jewelry, LLC, a Delaware limited liability company

·    Judith Ripka Fine Jewelry Digital, LLC, a Delaware limited liability company

·    H Licensing, LLC, a Delaware limited liability company

·    H Halston IP, LLC, a Delaware limited liability company

·    Halston XL MD, LLC, a Delaware limited liability company

·    C Wonder Licensing, LLC, a Delaware limited liability company

·    Longaberger Licensing, LLC, a Delaware limited liability company

·    Gold Licensing, LLC, a Delaware limited liability company

·    Xcel Design Group, LLC, a Delaware limited liability company

·    XCEL-CT MFG, LLC, a Delaware limited liability company

·    Q Optix, LLC, a Delaware limited liability company

·    AHX Beauty, LLC, a Delaware limited liability company

·    The Beauty Solution, LLC, a Delaware limited liability company

·    Tribe Cosmetics, LLC, a Delaware limited liability company

·    Xcel Acquisition Co., LLC, a Delaware limited liability company


EX-31.1 7 xelb-20231231xex31d1.htm EX-31.1

EXHIBIT 31(i).1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES OXLEY ACT OF 2002

I, Robert W. D’Loren certify that:

1.    I have reviewed this annual report on Form 10-K of Xcel Brands, Inc. (the "registrant") for the year ended December 31, 2023.

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer, and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer, and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 18, 2024

/s/  Robert W. D’Loren

Name: Robert W. D’Loren

Title: Chairman, President, Chief Executive Officer and Director (Principal Executive Officer)


EX-31.2 8 xelb-20231231xex31d2.htm EX-31.2

EXHIBIT 31(i).2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES OXLEY ACT OF 2002

I, James F. Haran certify that:

1.    I have reviewed this annual report on Form 10-K of Xcel Brands, Inc. (the "registrant") for the year ended December 31, 2023.

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer, and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer, and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 18, 2024

/s/  James F. Haran

Name: James F. Haran

Title:   Chief Financial Officer (Principal Financial and Accounting Officer)


EX-32.1 9 xelb-20231231xex32d1.htm EX-32.1

EXHIBIT 32(i).1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Robert W. D’Loren, the Chairman, President, Chief Executive Officer, and Director of Xcel Brands, Inc. (the “Registrant”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K of the Registrant for the year ended December 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

April 18, 2024

/s/  Robert W. D’Loren

Name: Robert W. D’Loren

Title: Chairman, President, Chief Executive Officer and Director (Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to Xcel Brands, Inc. and will be retained by Xcel Brands, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


EX-32.2 10 xelb-20231231xex32d2.htm EX-32.2

EXHIBIT 32(i).2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

James F. Haran, Chief Financial Officer of Xcel Brands, Inc (the “Registrant”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K of the Registrant for the year ended December 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

April 18, 2024

/s/ James F. Haran

Name: James F. Haran

Title: Chief Financial Officer (Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to Xcel Brands, Inc. and will be retained by Xcel Brands, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


EX-97.1 11 xelb-20231231xex97d1.htm EX-97.1

Exhibit 97.1

XCEL BRANDS, INC.

Clawback Policy

The Board of Directors (the “Board”) of Xcel Brands, Inc. (the “Company”) has determined that it is in the best interests of the Company to adopt this Clawback Policy (this “Policy”), which provides for the recovery of certain incentive compensation in the event of an Accounting Restatement (as defined below).  This Policy is designed to comply with, and shall be interpreted to be consistent with, Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 promulgated under the Exchange Act (“Rule 10D-1”) and NASDAQ Listing Rule 5608.


1.Definitions

For purposes of this Policy, the following capitalized terms shall have the meanings set forth below.

Accounting Restatement” means an accounting restatement of the Company’s financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

“Clawback Period” means the three completed fiscal years immediately preceding the date on which the Company is required to prepare an Accounting Restatement, as well as any transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years (except that a transition period that comprises a period of at least nine months shall count as a completed fiscal year).  The“date on which the Company is required to prepare an Accounting Restatement” is the earlier to occur of (a) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if the Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement; or (b) the date a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.

Erroneously Awarded Compensation” means, in the event of an Accounting Restatement, the amount of Incentive-Based Compensation previously received that exceeds the amount of Incentive-Based Compensation that otherwise would have been received had it been determined based on the restated amounts in such Accounting Restatement, and must be computed without regard to any taxes paid by the relevant Executive Officer; provided, however, that for Incentive-Based Compensation based on stock price or total stockholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement:  (i) the amount of Erroneously Awarded Compensation must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total stockholder return upon which the Incentive-Based Compensation was received; and (ii) the Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to The Nasdaq Stock Market (“NASDAQ”).  

1


“Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company.  An executive officer of the Company’s parent or subsidiary is deemed an “Executive Officer” if the executive officer performs such policy making functions for the Company.

Financial Reporting Measure” means any measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures; provided, however, that a Financial Reporting Measure is not required to be presented within the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission (“SEC”) to qualify as a “Financial Reporting Measure.”  For purposes of this Policy, Financial Reporting Measures include, but are not limited to, stock price and total stockholder return.

Incentive-Based Compensation” means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.  Incentive-Based Compensation is “received” for purposes of this Policy in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period.

2.Policy Application.

This Policy applies to Incentive-Based Compensation received by an Executive Officer (a) after beginning services as an Executive Officer; (b) if that person served as an Executive Officer at any time during the performance period for such Incentive-Based Compensation; and (c) while the Company had a listed class of securities on a national securities exchange.

3. Policy Recovery Requirement.

In the event the Company is required to prepare an Accounting Restatement, the Company shall reasonably promptly recoup the amount of any Erroneously Awarded Compensation received by any Executive Officer during the Clawback Period.  In the event of an Accounting Restatement, the Board shall determine, in its sole discretion, the amount of any Erroneously Awarded Compensation for each Executive Officer in connection with such Accounting Restatement.

4.Method of Recoupment.

The Board shall determine, in its sole discretion, the timing and method for promptly recouping such Erroneously Awarded Compensation, which may include without limitation: (a) seeking reimbursement of all or part of any cash or equity-based award, (b) cancelling prior cash or equity-based awards, whether vested or unvested or paid or unpaid, (c) cancelling or offsetting against any planned future cash or equity-based awards, (d) forfeiture of deferred compensation, subject to compliance with Section 409A of the Internal Revenue Code and the regulations promulgated thereunder and (e) any other method authorized by applicable law or contract.  Subject to compliance with any applicable law, the Board may affect recovery under this Policy from any amount otherwise payable to the Executive Officer, including amounts payable to such individual under any otherwise applicable Company plan or program, including base salary, bonuses or commissions and compensation previously deferred by the Executive Officer.

2


The Company is authorized and directed pursuant to this Policy to recoup Erroneously Awarded Compensation in compliance with this Policy unless the Compensation Committee has determined that recovery would be impracticable solely for the following limited reasons, and subject to the following procedural and disclosure requirements:

• The direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered.  Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Company must make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to recover and provide that documentation to NASDAQ;

• Recovery would violate home country law of the Company where that law was adopted prior to November 28, 2022.  Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of home country law of the Company, the Company must obtain an opinion of home country counsel, acceptable to NASDAQ, that recovery would result in such a violation, and must provide such opinion to NASDAQ; or

• Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.

5.No Indemnification of Executives Officers.

Notwithstanding the terms of any indemnification or insurance policy or any contractual arrangement with any Executive Officer that may be interpreted to the contrary, the Company shall not indemnify any Executive Officers against the loss of any Erroneously Awarded Compensation, including any payment or reimbursement for the cost of third-party insurance purchased by any Executive Officers to fund potential clawback obligations under this Policy.

6. Required Policy-Related Filings.

The Company shall file all disclosures with respect to this Policy in accordance with the requirements of the federal securities laws, including disclosures required by SEC filings.

7.Acknowledgement.

Each Executive Officer shall sign and return to the Company within thirty (30) calendar days following the later of (i) the effective date of this Policy set forth below or (ii) the date such individual becomes an Executive Officer, the Acknowledgement Form attached hereto as Exhibit A, pursuant to which the Executive Officer agrees to be bound by, and to comply with, the terms and conditions of this Policy.

8.Administration

This Policy shall be administered by the Board or, if so designated by the Board, the Compensation Committee, in which case references herein to the Board shall be deemed references to the Compensation Committee.  Any determinations made by the Board shall be final and binding on all affected individuals.

9.Policy Not in Limitation

The Board intends that this Policy shall be applied to the fullest extent of the law.  Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company under applicable law or pursuant to the terms of any similar policy in any

3


employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.

Nothing contained in this Policy, and no recoupment or recovery as contemplated by this Policy, shall limit any claims, damages or other legal remedies the Company or any of its affiliates may have against an Executive Officer arising out of or resulting from any actions or omissions by the Executive Officer.

10. Amendment; Termination.

The Board may amend, modify, supplement, rescind or replace all or any portion of this Policy at any time and from time to time in its discretion, and shall amend this Policy as it deems necessary to comply with applicable law or any rules or standards adopted by a national securities exchange on which the Company’s securities are listed.

11.Successors.

This Policy is binding and enforceable against all Executive Officers and their beneficiaries, heirs, executors, administrators or other legal representatives.

12. Effective Date.

This Policy shall be effective as of November 8, 2023.  The terms of this Policy shall apply to any Incentive-Based Compensation that is received by Executive Officers on or after October 2, 2023, even if such Incentive-Based Compensation was approved, awarded or granted to Executive Officers prior to such date.

Approved and adopted:  November 8, 2023

4


EXHIBIT A

XCEL BRANDS, INC.

CLAWBACK POLICY

ACKNOWLEDGEMENT FORM

By signing below, the undersigned acknowledges and confirms that the undersigned has received and reviewed a copy of the Xcel Brands, Inc. (the “Company”) Clawback Policy (the “Policy”).

By signing this Acknowledgement Form, the undersigned acknowledges and agrees that the undersigned is and will continue to be subject to the Policy and that the Policy will apply both during and after the undersigned’s employment or service with the Company. Further, by signing below, the undersigned agrees to abide by the terms of the Policy, including, without limitation, by returning any Erroneously Awarded Compensation (as defined in the Policy) to the Company to the extent required by, and in a manner consistent with, the Policy.

EXECUTIVE OFFICER

__________________________

Signature

__________________________

Print Name

__________________________

Date

5


GRAPHIC 12 xelb-20231231xex10d7001.jpg GRAPHIC begin 644 xelb-20231231xex10d7001.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" @ $# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#[]HHHH ** %** /_]D! end GRAPHIC 13 xelb-20231231xex10d9001.jpg GRAPHIC begin 644 xelb-20231231xex10d9001.jpg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
X4==N/E!/7/%=C^R=^SO\1?'GAN]\8^"?'7_" M J\IT];A+/SI+I$/S%6SPH;(X[CK3YI2LF!QW[3W@.]^ G[15_)HJ_8D%U%X M@T5U7:D>7W;%]ED5T_W:^T/VC_'MC\4OV$M?\5Z:P^R:KI5M<;1SY;&>,.A] MU8,I]U-?/?[3O[,/Q1\.^ YO&WC#XC#X@QZ)M!BEL1#);P.X#N&W?=!VDJ0> M,G(K@_AE\5EG_9.^,?PXN[@.UM;Q:SI:ENL3W,0N$&3_ N5? '_ "U-5K%N M-K70=$6/V9_@+;?'_P #_$C3(C':^(M.%I=:3?,#^ZE_>[HVQ_!)@ YYX!'2 MN%7XF^(?#'PL\4?"/7;2=+=+Y)(K:9OWFF7,<@,D8'>-^HQW.X<,:^F/^"83 MJ^I?$78P;Y++ 4]/];78_MU_LOMXUTZ3XA^%+(/XBT^+&IV<"X:_MU_B '61 M!G'W_ $RKY6\+>%-8\6N]OHFE7&K7%I:- M>31VR;FBA1W)KZF_9;GCE_9#^.+(X9"I(.?\ IE63_P $V7CE^-FJ M)N5@=#P5ZY^>IM=10C2_X)]_'#3/!'C"[\%ZM!:VT/B.0/9:MM"R&X X@D?N MK#E,]#D=Q7Z2Q]??'-?E?^VI^SXWP4^( US2(VM_"FNS&>U>%L?8;L' MG*SY&!]'4445U$G#?$*[\*VD>G'Q1!#,DLWEPM/'O",5.2?[HP.36QIGAS0X M=%>RL;*U_LNX&XP1(OE.#C)P."#Q7&_&_P %7WBO0[233$$UU9R-)Y!."ZE2 M&"D\;NA&>O->)^%/B!KO@29HK2=A#&Y$EA=*2H/<8."A^F/QK\QS3/H9/F#?GI;L?2W_ KCPN>?[!L/_ =? M\*U-.T'3M(3;8V4%JO<0QA/Y"O-O#?[0>CZCL358GTF4\%B#)$??)B\-C\,^7$J27 MG=K[]B74M*L]8MFMKVVCNK=L;HID#*?P-8Q^&WA8_P#,"L/_ '3_"NF4Y'6 M@BO:JX3#8A\U6FI>J3//C6J4U:$FO1F+IOA#1=&D\RQTNUM9?[\4*JQ'U K9 M=5>,H5!4C!4C@TH'M2@8-;4J%*BN6E%17DK&R^ /PUTVY2YM? 'AJWN$.5D328 RGU!V\5 MZ!16G*NQ)R?BGX8^$O'+6C^(_#&DZX]HI2W.H6<<_DJ>H7<#M_"M3PWX9TCP M?ID&E:%IEKI&FPY\NTLH5BB3/)PJ@#K6Q1562U J:MI=GK>F76GZC:0WUA=1 MM#/;7$8DCE1AAE93P01V-<%%^SU\,8"WD_#[PW'YD30N4TJ$!D;&Y#A>5.!D M=#@5Z1119/<#E_!OPX\*> 'N3X:\-Z5H#7043MIUG' 90N=H;:HSC)^F372S M*'C96 *G@@]*?2-TI; '?"6C:%>M'Y37&GV$4+LG7:64 X]JZ>]O+>TA:6> M=(47DN[ 5P/B'XY>&M$5TMKAM5N5X\JS&X9_P!_[H_.O-Q>8X/ QYL144?F M=5#"8C$NU&#EZ(ZWQ5X5T3QEI$FG>(-)L=9T]F5VM=1@2:(LIRIVL",CL:X7 MPAX:^%WA;QZ+;PSX;T/2O$:6SAKC3=/CB<1DC!M1.NKK]Q UM8I"Z1>8"&E+X^8 ]%P M.O>OAZ7%JS3,(83+:;E&_O2:=DO(^FJ9 \%A98C&SY96]U76K/H16&!14)MV M))RO-%?I'OGQ^A*Q'IQ7#^-?A7HWC;,L\36M]MP+N /[ ]F'L0?PKN,Y6F] M>U2WMQJ]FO26U M'S@>\9Y_[Y)^E<-&TEC\&:)XD79J6F MV]WQPSK\P^A'(_"ORO,/#ZFY.IEU5TWV>WR>Z/NL)Q;4BN3&4^==UH_FMG^! M\S:7\4O%FC@"#69I$' 2X42C\R,_K74:=^T-X@MB!=V5G>*.NPM$Q_F*[+6O MV=-%NBS:;>76G$]$+><@_!N?UKB]5_9X\06A)L[RTOU[!@T3?^S"OFI9;Q=E M3M2FYQ79W7W/_(]>.,X>QO\ $@HM]U9_>M/Q.BMOVE(6 %SH,\?J8IU8?KBM M:W_:+\/28$UO?6[=\P[@/Q!KR*^^$_B[3<^;HDLJC^*WD5Q^0.?TK%N?#FKV M61/H]_"1W:V?^8%9?ZS<4832M!Z=X_Y6-/[%R/$?PJB^4O\ .Y]$P_'WPA)C M=>7$?^]:R?T!JPOQS\''_F*8^L,@_P#9:^8)(Y(N)(I8B.OF1E?YBH_/1>K@ M?4XI1X_SF#M*DOG%E?ZI9=+6-1_>O\CZE/QR\&X_Y"H_"%__ (FJ\OQY\((# MMOY7/^S;2'_V6OF'[5$>/,7\Q3U/F<*K/G^ZI-/_ (B!G,M%1C]S!<)9?'>H M_O7^1]&W/[0_AF+B-;V<]MMN1G_OHBLFZ_:3LU!%MH]W(?\ IHR)_4UXE!HN MHW9Q#IM[*?\ 8MG/ZXK:L?AKXKU @0Z!=KGO+MB_]"(I?ZV<2XG2C2?RBV+^ MP,EP[_>U/ODE_D=M?_M(:Q-D6>D6MMGHTTK.?R KF=3^,GB_4E8'5%LT/:V MA"_J=QK2T[X!>*;UO](-GIZGJ7E+M^07'ZUU^E?LW6L95M2U::Y]4MT$0_,D MFM(X;C#--)RE%/N^7\%J1*MPY@?A2D_1O\]#P_4-3NM2?S-0O9[QCWN)6?G\ M?^2/+?!?P M+TKP\\=WJC#5[Y3N 9,11G_93G/U)KU*WC2, (NU<=J=CG^M.48//6OU; 9; MA,LIJEA8L<84444 %)BBB@!:*** $(!ZBF MF)"/NC\J**AQB]T.Y&UK#(O,2'_@-5Y-)M'Y:WB/U0445E*A2EO%%1G);,:F ME688 6L(/KY:_P"%64LX4(VQ(OT4445$,/16T5]Q4IR>[)!"@/"C\J>% [44 :5O&$5LC.XM%%%:""BBB@ HHHH **** /_]D! end EX-101.SCH 14 xelb-20231231.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Trademarks and Other Intangibles - Schedule of Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Debt and Other Long-term Liabilities - Net Carrying Amount of Debt (Details) (Calc2) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Debt - Net Carrying Amount of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Debt - Xcel Term Loan Remaining Principal Payments (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Commitments and Contingencies - Company Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 40904 - Disclosure - Commitments and Contingencies - Future Minimum Payments under Employment Contracts (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Income Taxes - Income Tax Benefit (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Income Taxes - Reconciliation of Income Tax Rates (Details) link:presentationLink link:calculationLink link:definitionLink 41004 - Disclosure - Income Taxes - Net Deferred Tax Assets (Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary of Significant Accounting Policies - Rollforward of the allowance for credit losses (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40204 - Disclosure - Summary of Significant Accounting Policies - Trademarks and Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40205 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Summarized financial information (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Investment in Orme Live, Inc. (Details) link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Investment in Unconsolidated Affiliate (Details) link:presentationLink link:calculationLink link:definitionLink 40305 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Significant Contracts - Schedule of License Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Significant Contracts - Qurate Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 40503 - Disclosure - Significant Contracts - Halson Master License (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - Stockholders' Equity - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 40704 - Disclosure - Stockholders' Equity - Black-Scholes Assumptions for Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 40705 - Disclosure - Stockholders' Equity - Outstanding and vesting options target prices (Details) link:presentationLink link:calculationLink link:definitionLink 40706 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) link:presentationLink link:calculationLink link:definitionLink 40707 - Disclosure - Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40708 - Disclosure - Stockholders' Equity - Stock Awards (Details) link:presentationLink link:calculationLink link:definitionLink 40709 - Disclosure - Stockholders' Equity - Black-Scholes option pricing assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 40710 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Related Party Transactions - IM Topco, LLC (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Related Party Transactions - ORME (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Subsequent Events - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Trademarks and Other Intangibles link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Significant Contracts link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Trademarks and Other Intangibles (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Significant Contracts (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 40206 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details) link:presentationLink link:calculationLink link:definitionLink 40207 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 15 xelb-20231231_cal.xml EX-101.CAL EX-101.DEF 16 xelb-20231231_def.xml EX-101.DEF EX-101.LAB 17 xelb-20231231_lab.xml EX-101.LAB EX-101.PRE 18 xelb-20231231_pre.xml EX-101.PRE XML 20 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2023
Apr. 03, 2024
Jun. 30, 2023
Document And Entity Information [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-37527    
Entity Registrant Name XCEL BRANDS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 76-0307819    
Entity Address, Address Line One 550 Seventh Avenue, 11th Floor    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10018    
City Area Code 347    
Local Phone Number 727-2474    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol XELB    
Security Exchange Name NASDAQ    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 17,934,000
Entity Common Stock, Shares Outstanding   23,492,117  
Auditor Name Marcum LLP    
Auditor Firm ID 688    
Auditor Location New York, NY    
Entity Central Index Key 0001083220    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false    
XML 21 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 2,998 $ 4,608
Accounts receivable, net 3,454 5,110
Inventory 453 2,845
Prepaid expenses and other current assets 398 1,457
Total current assets 7,303 14,020
Non-current Assets:    
Property and equipment, net 634 1,418
Operating lease right-of-use assets 4,453 5,420
Trademarks and other intangibles, net 41,520 47,665
Equity method investment in IM Topco, LLC 17,585 19,195
Deferred tax assets, net   1,107
Other assets 165 110
Total non-current assets 64,357 74,915
Total Assets 71,660 88,935
Current Liabilities:    
Accounts payable, accrued expenses and other current liabilities 2,127 3,870
Deferred revenue 889 88
Accrued income taxes payable 372 568
Accrued payroll 109 416
Current portion of operating lease obligations 1,258 1,376
Current portion of long-term debt 750  
Current portion of contingent obligations 964 243
Total current liabilities 6,469 6,561
Long-Term Liabilities:    
Long-term portion of operating lease obligations 4,021 5,839
Deferred revenue 3,556  
Long-term debt, net, less current portion 3,971  
Long-term portion of contingent obligations 5,432 6,396
Other long-term liabilities 40  
Total long-term liabilities 17,020 12,235
Total Liabilities 23,489 18,796
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value, 50,000,000 shares authorized, and 19,795,053 and 19,624,860 shares issued and outstanding at December 31, 2023 and 2022, respectively 20 20
Paid-in capital 103,861 103,592
Accumulated deficit (53,849) (32,797)
Total Xcel Brands, Inc. stockholders' equity 50,032 70,815
Noncontrolling interest (1,861) (676)
Total Stockholders' Equity 48,171 70,139
Total Liabilities and Stockholders' Equity $ 71,660 $ 88,935
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 19,795,053 19,624,860
Common stock, shares outstanding (in shares) 19,795,053 19,624,860
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues    
Net revenue $ 17,755 $ 25,781
Cost of goods sold 6,918 7,980
Gross profit 10,837 17,801
Direct operating costs and expenses    
Salaries, benefits and employment taxes 9,910 16,802
Other selling, general and administrative expenses 13,361 16,280
Total direct operating costs and expenses 23,271 33,082
Other operating costs and expenses (income)    
Depreciation and amortization 6,954 7,263
Gain on sale of majority interest in Isaac Mizrahi brand   (20,586)
Loss from equity method investment 2,060 1,202
Gain on sale of limited partner ownership interest (359)  
Gain on settlement of lease liability (445)  
Gain on reduction of contingent obligation   (900)
Operating loss (20,644) (2,260)
Interest and finance expense    
Interest expense 113 1,187
Other interest and finance charges, net 268 16
Loss on early extinguishment of debt   2,324
Total interest and finance expense 381 3,527
Loss before income taxes (21,025) (5,787)
Income tax provision (benefit) 1,212 (431)
Net loss (22,237) (5,356)
Net loss attributable to noncontrolling interest (1,185) (1,338)
Net loss attributable to Xcel Brands, Inc. stockholders $ (21,052) $ (4,018)
Loss per common share attributable to Xcel Brands, Inc. stockholders:    
Basic net loss income per share $ (1.07) $ (0.20)
Diluted net loss income per share $ (1.07) $ (0.20)
Weighted average number of common shares outstanding:    
Basic weighted average number of shares outstanding 19,711,637 19,624,669
Diluted weighted average common shares outstanding 19,711,637 19,624,669
Net licensing revenue    
Revenues    
Net revenue $ 9,156 $ 14,737
Net sales    
Revenues    
Net revenue $ 8,599 $ 11,044
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Employees
Common Stock
Executive Officer
Common Stock
Consultants
Common Stock
Director
Common Stock
Paid-in Capital
Employees
Paid-in Capital
Executive Officer
Paid-in Capital
Consultants
Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Employees
Executive Officer
Consultants
Total
Balances at Dec. 31, 2021         $ 20       $ 103,039 $ (28,779) $ 662       $ 74,942
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 534           534
Shares issued in connection with stock grant           $ 50 $ 281         $ 50 $ 281    
Shares issued in connection with stock grant (in shares) 33,557 178,727                          
Shares issued in connection with restricted stock grants (in shares)       50,000                      
Shares issued in connection with sale transaction               $ 33 97         $ 33 97
Shares issued in connection with sale transaction (in shares)     20,064   65,275                    
Shares repurchased in exchange for withholding taxes           (357) $ (85)         (357) $ (85)    
Shares repurchased in exchange for withholding taxes (in shares) (240,000) (53,882)                          
Net loss                   (4,018) (1,338)       (5,356)
Balances at Dec. 31, 2022         $ 20       103,592 (32,797) (676)       70,139
Balances (in shares) at Dec. 31, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 161           161
Shares issued in connection with stock grant           $ 10           $ 10      
Shares issued in connection with stock grant (in shares) 7,300                            
Shares issued in connection with restricted stock grants (in shares)       40,000                      
Shares issued in connection with sale transaction               $ 45           $ 45  
Shares issued in connection with sale transaction (in shares)     66,668                        
Shares issued on exercises of stock options, net of shares surrendered for cashless exercises                 27           27
Shares issued on exercises of stock options, net of shares surrendered for cashless exercises (in shares)         61,225                    
Contra-revenue related to warrants granted to licensee                 26           26
Forfeitures of restricted stock grants         (5,000)                    
Net loss                   (21,052) (1,185)       (22,237)
Balances at Dec. 31, 2023         $ 20       $ 103,861 $ (53,849) $ (1,861)       $ 48,171
Balances (in shares) at Dec. 31, 2023         19,795,053                    
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities    
Net loss $ (22,237) $ (5,356)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 6,954 7,263
Asset impairment charges 100 274
Amortization of deferred finance costs included in interest expense 22 156
Stock-based compensation and cost of licensee warrants 242 620
Provision for credit losses 787 413
Undistributed proportional share of net loss of equity method investee 2,060 1,202
Loss on early extinguishment of debt   2,324
Deferred income tax provision (benefit) 1,107 (965)
Gain on sale of majority interest in Isaac Mizrahi brand   (20,586)
Gain on sale of limited partner ownership interest (359)  
Gain on settlement of lease liability (445)  
Gain on reduction of contingent obligation   (900)
Changes in operating assets and liabilities:    
Accounts receivable 869 2,117
Inventory 2,391 530
Prepaid expenses and other current and non-current assets 1,034 566
Deferred revenue 4,356 54
Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities (2,936) (1,426)
Lease-related assets and liabilities (525) (244)
Other liabilities 35 (224)
Net cash used in operating activities (6,545) (14,182)
Cash flows from investing activities    
Net proceeds from sale of majority interest in Isaac Mizrahi brand   45,386
Capital contribution to equity method investees (150) (600)
Net proceeds from sale of assets 459  
Purchase of property and equipment (100) (265)
Net cash provided by investing activities 209 44,521
Cash flows from financing activities    
Proceeds from exercise of stock options 27  
Shares repurchased including vested restricted stock in exchange for withholding taxes   (442)
Proceeds from long-term debt 5,000  
Payment of deferred finance costs (301)  
Payment of long-term debt   (29,000)
Payment of prepayment, breakage and other fees associated with early extinguishment of long-term debt   (1,511)
Net cash provided by (used in) financing activities 4,726 (30,953)
Net decrease in cash and cash equivalents (1,610) (614)
Cash and cash equivalents at beginning of year 4,608 5,222
Cash and cash equivalents at end of year 2,998 4,608
Supplemental disclosure of non-cash activities:    
Liability for equity-based bonuses and other equity-based payments   (283)
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 56 $ 1,032
Cash paid during the period for income taxes $ 99  
XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of Operations, Background, and Basis of Presentation
12 Months Ended
Dec. 31, 2023
Nature of Operations, Background, and Basis of Presentation [Abstract]  
Nature of Operations, Background, and Basis of Presentation

1.   Nature of Operations, Background, and Basis of Presentation

Xcel Brands, Inc. (“Xcel” and, together with its subsidiaries, the “Company”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the “Halston Brand”), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the “C Wonder Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the “Isaac Mizrahi Brand”), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party (see Note 3 for additional details).
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a 30% ownership interest in IM Topco, LLC and continues to participate in the operations of the business; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting (see Note 3 for additional details).
The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch in 2024.

The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024.

The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop.

Prior to 2023, and for a portion of 2023, the Company also engaged in certain wholesale and direct-to-consumer sales of products under its brands. The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Consolidated Statements of Operations, separately from the Company’s licensing revenues.

Liquidity and Management’s Plans  

The Company incurred a net loss attributable to Company stockholders of approximately $21.1 million and $4.0 million during the years ended December 31, 2023 and 2022, respectively (which included non-cash expenses of approximately $9.0 million and $8.2 million, respectively), and had an accumulated deficit of approximately $53.8 million and $32.8 million as of December 31, 2023 and 2022, respectively. Net cash used in operating activities was $6.5 million in 2023 and $14.2 million in 2022. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations) of approximately $2.1 million and $8.8 million as of December 31, 2023 and 2022, respectively. The Company’s cash and cash equivalents were approximately $3.0 million and $4.6 million as of December

31, 2023 and 2022, respectively. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.  

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions were executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to develop and launch in 2024 and beyond. In the second quarter of 2023, the Company entered into a new master license agreement for the Halston Brand, covering men’s, women’s, and children’s apparel, fashion accessories, and other product categories, with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 5 for details).

These restructuring initiatives were substantially completed as of June 30, 2023.  

Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Further, in October 2023, the Company entered into a new term loan agreement in the amount of $5 million (see Note 6 for details). Subsequent to year end, in January 2024, the Company entered into a sublease of its offices at 1333 Broadway in New York, NY (see Note 12 for details), and in March 2024, the Company issued new shares of common stock for net proceeds of approximately $2 million (see Note 12 for details).

Based on these recent events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Annual Report on Form 10-K; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of December 31, 2023, have been alleviated.

XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2.   Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of Xcel, its wholly owned subsidiaries, and entities in which Xcel has a controlling financial interest as of and for the years ended December 31, 2023 (the "Current Year") and 2022 (the "Prior Year"). The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). All significant intercompany accounts and transactions have been eliminated in consolidation, and net earnings have been adjusted by the portion of operating results of consolidated entities attributable to noncontrolling interests.

Investments in Unconsolidated Affiliates

The Company holds a noncontrolling equity interest in IM Topco, LLC, which was entered into during the Prior Year, and a noncontrolling equity interest in ORME Live, Inc., which was entered into during the Current Year. These investments are accounted for in accordance with ASC Topic 323, “Investments – Equity Method and Joint Ventures,” as the Company has the ability to exercise significant influence over their operating and financial policies of these affiliates, but does not control the affiliates.

The Company recognizes its share of the ongoing operating results of these affiliates within other operating costs and expenses (income) in the accompanying consolidated statements of operations. The Company’s investments in unconsolidated affiliates are reviewed for impairment whenever there are indicators that their carrying value may not be recoverable; if a decrease in value of the investment has occurred and such decrease is determined to be other than temporary in nature, the Company shall record an impairment charge to reduce the carrying amount of the investment to its fair value.

See Note 3 for additional information related to the Company’s investments in unconsolidated affiliates.  

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.

The Company deems the following items to require significant estimates from management:

Allowances for credit losses;
Useful lives of trademarks;
Assumptions used in the valuation of intangible assets, including cash flow estimates for initial determinations of fair value and/or impairment analysis; and
Stock-based compensation.

Cash and Cash Equivalents

All highly liquid investments with original maturities of three months or less are considered to be cash equivalents.

Accounts Receivable

Accounts receivable are reported net of an allowance for credit losses. As of December 31, 2023 and 2022, the Company had $3.5 million and $5.1 million, respectively, of accounts receivable, net of allowances of $0.8 million and $0, respectively.

The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.

A rollforward of the allowance for credit losses for the Current Year is as follows:

($ in thousands)

    

Balance at December 31, 2022

$

Credit loss expense

 

787

Write-offs

 

Recoveries

 

Balance at December 31, 2023

$

787

The Company recognized credit loss expense of $0.4 million in the Prior Year, which was related to the bankruptcy of several retail customers due to the 2020 – 2023 coronavirus disease pandemic. The Company wrote-off approximately $1.5 million of such customers’ outstanding receivable balances in the Prior Year.

Additionally, on October 17, 2023, the Company and one of the licensees managed under the Halston Master License (see Note 5) entered into an amendment of their respective licensing agreement. Under this amendment, the payment terms of the $0.76 million outstanding balance due to the Company were changed such that this receivable (and collection thereof) became contractually contingent upon the licensee’s future performance. The licensee is also required to pay interest to the Company on a monthly basis until the outstanding balance is paid in full. The Company recorded a non-cash charge of $0.76 million within other selling, general and administrative expenses in the Current Year related to the restructuring of this licensing arrangement, in order to write-down the previously-recorded receivable to zero, which is not included in the credit loss expense and allowance for credit losses amounts set forth above.

There is no earned revenue that has been accrued but not billed as of December 31, 2023 and 2022.

As of December 31, 2023 and 2022, approximately $0.04 million and $1.7 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the Prior Year, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During both the Current Year and Prior Year, the Company paid less than $0.1 million in fees to the agent under the aforementioned services agreement.

Inventory

All of the Company’s inventory consists of finished goods. As of December 31, 2022, inventory was composed of jewelry, wholesale apparel, and home goods. During the Current Year, as a result of the restructuring of its business operating model, the Company sold all of its wholesale apparel inventory and substantially all of its remaining fine jewelry inventory to its new business partners and licensees. Thus, as of December 31, 2023, inventory was primarily composed of home goods and related items for the Longaberger Brand.

Inventory is recorded at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of its inventories in order to identify obsolete, slow-moving, or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventories, the Company

will record a write-down to net realizable value in the period that the decline in value is first recognized. Write-downs for inventory shrinkage, representing the risk of physical loss of inventory, are estimated based on historical experience and are adjusted based upon physical inventory counts.

Property and Equipment

Furniture, equipment, and software are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over their estimated useful lives, generally three (3) to seven (7) years. Depreciation expense for the years ended December 31, 2023 and 2022 was approximately $0.8 million and $1.1 million, respectively.

Leasehold improvements are amortized over the shorter of their estimated useful lives or the terms of the leases. Betterments and improvements are capitalized, while repairs and maintenance are expensed as incurred.

Costs to develop or acquire software for internal use incurred during the preliminary project stage and the post implementation stage are expensed, while internal and external costs to acquire or develop software for internal use incurred during the application development stage – including design, configuration, coding, testing, and installation – are generally capitalized.

The Company’s long-lived property and equipment assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on a discounted cash flows analysis or appraisals. The inputs utilized in the impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurement.”

The Company recognized impairment charges of $0.3 million in the Prior Year related to store fixtures purchased for an apparel program with one of the Company’s retail partners.

Trademarks and Other Intangible Assets

The Company’s finite-lived intangible assets are amortized over their estimated useful lives of three (3) to eighteen (18) years. The Company re-evaluates the remaining useful life of its finite-lived intangible assets on an annual basis, based on consideration of current events and circumstances, the expected use of the asset, and the effects of demand, competition, and other economic factors. No changes were made to the estimated useful lives of intangible assets in the Current Year or Prior Year.

The Company’s finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value, based on a discounted cash flows analysis or appraisals. The inputs utilized in the finite-lived intangible assets impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in ASC Topic 820. No impairment charges were recorded related to intangible assets for the Current Year or Prior Year.

See Note 4 for additional information related to the Company’s trademarks and other intangible assets.

Deferred Finance Costs

The Company incurred costs (primarily professional fees and lender underwriting fees) in connection with borrowings under term loans. These costs have been deferred on the consolidated balance sheet as a reduction to the carrying value of the associated borrowings, and are being amortized as interest expense over the term of the related borrowings using the effective interest method.

Contingent Obligations

When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired is greater than the consideration paid, any contingent obligations are recognized and recorded as the positive difference between the fair value of the assets acquired and the consideration paid for the acquired assets.

When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired are equal to the consideration paid, any contingent obligations are recognized based upon the Company’s best estimate of the amount that will be paid to settle the liability.

Under the applicable accounting guidance, the Company is required to carry such contingent liability balances on its consolidated balance sheet until the measurement period of the earn-out expires and all related contingencies have been resolved.

The Company recorded contingent obligations in connection with the purchase of the Halston Heritage trademarks in 2019 and the purchase of the LOGO by Lori Goldstein trademarks in 2021, but no amount has been recorded for the contingent obligation related to the sale of a majority interest in the Isaac Mizrahi Brand in 2022.

See Note 9 for additional information related to the Company’s contingent obligations.

Revenue Recognition

The Company applies the guidance in ASC Topic 606, “Revenue from Contracts with Customers” to recognize revenue.

Licensing

The Company recognizes revenue continuously over time as it satisfies its continuous obligation of granting access to its licensed intellectual properties, which are deemed symbolic intellectual properties under the applicable revenue accounting guidance. Payments are typically due after sales have occurred and have been reported by the licensees or, where applicable, in accordance with minimum guaranteed payment provisions. The timing of performance obligations is typically consistent with the timing of payments, though there may be differences if contracts provide for advances or significant escalations of contractually guaranteed minimum payments. With the exception of the Halston Master License agreement described in Note 5, there were no such differences that would have a material impact on the Company’s consolidated balance sheets at December 31, 2023 and 2022. In accordance with ASC 606-10-55-65, the Company recognizes net licensing revenue at the later of when (1) the subsequent sale or usage occurs or (2) the performance obligation to which some or all of the sales- or usage-based royalty has been allocated is satisfied (in whole or in part). More specifically, the Company separately identifies:

(i)Contracts for which, based on experience, royalties are expected to exceed any applicable minimum guaranteed payments, and to which an output-based measure of progress based on the “right to invoice” practical expedient is applied because the royalties due for each period correlate directly with the value to the customer of the Company’s performance in each period (this approach is identified as “View A” by the FASB Revenue Recognition Transition Resource Group, “TRG”); and
(ii)Contracts for which revenue is recognized based on minimum guaranteed payments using an appropriate measure of progress, in which minimum guaranteed payments are straight-lined over the term of the contract and recognized ratably based on the passage of time, and to which the royalty recognition constraint to the sales-based royalties in excess of minimum guaranteed is applied and such sales-based royalties are recognized to the distinct period only when the minimum guaranteed is exceeded on a cumulative basis (this approach is identified as “View C” by the TRG).

The Company’s unconditional right to receive consideration based on the terms and conditions of licensing contracts is presented as accounts receivable on the accompanying consolidated balance sheets. The Company does not typically perform by transferring goods or services to customers before the customer pays consideration or before payment is due, thus the amounts of contract assets as defined by ASC 606-10-45-3 related to licensing contracts were not material as of December 31, 2023 and 2022. The Company typically does not receive consideration in advance of performance and, consequently, amounts of contract liabilities as defined by ASC 606-10-45-2 related to licensing contracts were not material as of December 31, 2022; however, as of December 31, 2023, the Company has recognized approximately $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet related to the Halston Master License agreement (see Note 5).

The Company does not disclose the amount attributable to unsatisfied or partially satisfied performance obligations for variable revenue contracts (identified under “View A” above) in accordance with the optional exemption allowed under ASC 606. The Company did not have any revenue recognized in the reporting period from performance obligations satisfied, or partially satisfied, in previous periods. Remaining minimum guaranteed payments for active contracts as of December 31, 2023 are expected to be recognized ratably in accordance with View C over the remaining term of each contract based on the passage of time and through December 2028, subject to renewal or extension upon termination.

Wholesale Sales

Prior to the restructuring of the Company’s business model and operations in the Current Year, the Company generated a portion of its revenue through the design, sourcing, and sale of branded jewelry and apparel to both domestic and international customers who, in turn, sold the products to the consumer. The Company recognized such revenue within net sales in the accompanying consolidated statements of operations when performance obligations identified under the terms of contracts with its customers were satisfied, which occurred upon the transfer of control of the merchandise in accordance with the contractual terms and conditions of the sale. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Direct-to-Consumer Sales

The Company’s revenue associated with its e-commerce jewelry operations and the Longaberger Brand (prior to the restructuring of the Company’s business model and operations in the Current Year) was recognized within net sales in the accompanying consolidated statements of operations at the point in time when product is shipped to the customer. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Advertising Costs

All costs associated with production for the Company’s advertising, marketing, and promotion are expensed during the periods when the activities take place. All other advertising costs, such as print and online media, are expensed when the advertisement occurs. The Company incurred approximately $1.0 million and $2.6 million in advertising and marketing costs for the Current Year and Prior Year, respectively, which are included within other selling, general and administrative expenses in the accompanying consolidated statements of operations.  

Leases

The Company determines if an arrangement is a lease (as defined in ASC Topic 842, “Leases”) at the inception of the arrangement. The Company generally recognizes a right-of-use (“ROU”) asset, representing its right to use the underlying leased asset for the lease term, and a liability for its obligation to make future lease payments (the lease liability) at commencement date (the date on which the lessor makes the underlying asset available for use) based on the present value of lease payments over the lease term. The Company does not recognize ROU assets and lease liabilities for lease terms of 12 months or less, but recognizes such lease payments in operations on a straight-line basis over the lease terms.

As the Company’s leases typically do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

For real estate leases of office space, the Company accounts for the lease and non-lease components as a single lease component. Variable lease payments that do not depend on an index or rate (such as real estate taxes and building insurance and lessee’s shares thereof), if any, are excluded from lease payments at lease commencement date for initial measurement. Subsequent to initial measurement, these variable payments are recognized when the event determining the amount of variable consideration to be paid occurs.

Lease expense for operating lease payments is generally recognized on a straight-line basis over the lease term. The Company recognizes income from subleases (in which the Company is the sublessor) on a straight-line basis over the term of the sublease, as a reduction to lease expense.

See Note 9 for additional information related to the Company’s leases.

Stock-Based Compensation

The Company accounts for stock-based compensation by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.

The fair value of stock options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected life of the awards and the expected stock price volatility over the terms of the awards. The expected life is based on the estimated average life of options and warrants using the simplified method; the Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The risk-free rate is based on the U.S. Treasury rate for the expected term at the time of grant, volatility is based on the historical volatility of the Company’s common stock, and the expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant, based on the quoted market price of the Company’s common shares on the NASDAQ Capital Market.

Non-employee awards are measured at the grant date fair value of the equity instruments to be issued, and the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant.

The Company accounts for forfeitures as a reduction of compensation cost in the period when such forfeitures occur.

For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant

performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

See Note 7 for additional information related to stock-based compensation.

Income Taxes

Current income taxes are based on the respective period’s taxable income for federal and state income tax reporting purposes. Deferred tax assets and liabilities are determined based on the differences between the financial statement and income tax bases of assets and liabilities, using enacted tax rates and laws that will be in effect for the year in which the differences are expected to reverse.

A valuation allowance is recognized when necessary to reduce deferred tax assets to the amount expected to be realized. In determining the need for a valuation allowance, management reviews both positive and negative evidence, including current and historical results of operations, future income projections, and the overall prospects of the Company’s business. A valuation allowance is established if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company applies the FASB guidance on accounting for uncertainty in income taxes, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and also addresses derecognition, classification, interest, and penalties related to uncertain tax positions. The Company has no unrecognized tax benefits as of December 31, 2023 and 2022. Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2020 through December 31, 2023.

The income tax effects of changes in tax laws are recognized in the period when enacted.

See Note 10 for additional information related to income taxes.

Fair Value

ASC Topic 820, “Fair Value Measurement,” defines fair value and establishes a framework for measuring fair value under U.S. GAAP. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of the Company’s assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of term loan debt approximates fair value due to the floating interest rate structure of the term loan agreement.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company limits its credit risk with respect to cash and cash equivalents by maintaining such balances with high quality financial institutions. At times, the Company’s cash and cash equivalents may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are not considered

significant due to the collection history and due to the nature of the Company’s royalty revenues. Generally, the Company does not require collateral or other security to support accounts receivable.

Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted earnings (loss) per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants using the treasury stock method. The difference between basic and diluted weighted-average common shares results from the assumption that all dilutive stock options and warrants outstanding were exercised into common stock if the effect is not anti-dilutive. See Note 8 for additional information related to earnings (loss) per share.

Recently Adopted Accounting Pronouncements

The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively, and is effective for fiscal years beginning after December 15, 2024. The Company does not anticipate that the adoption of this ASU will have a significant impact on its consolidated financial statements.

XML 28 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities
12 Months Ended
Dec. 31, 2023
Acquisitions, Divestitures and Variable Interest Entities[Abstract]  
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities

3. Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities

Sale of Majority Interest in Isaac Mizrahi Brand

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.

The purchase price paid by WHP to the Company at the closing of the transaction in exchange for the 70% membership interest in IM Topco consisted of $46.2 million in cash. The Company incurred approximately $0.9 million of expenses directly related to this transaction, including legal fees and agent fees, of which $0.1 million of the agent fees were paid through the issuance of 65,275 shares of the Company’s common stock, which were recognized as a reduction to the gain from the transaction. The Company recognized a net pre-tax gain from the transaction of $20.6 million, which is classified

as a component of other operating costs and expenses (income) in the consolidated statement of operations for the Prior Year.

Pursuant to the May 27, 2022 purchase agreement, the Company was also entitled to receive an “earn-out” payment in the amount of $2.0 million if, during the period from January 1, 2023 through December 31, 2023, (i) IM Topco received Net Royalty Revenue (as defined in the purchase agreement) in an amount equal to or greater than $17.5 million and (ii) IM Topco generated EBITDA (as defined in the purchase agreement) in an amount equal to or greater than $11.8 million. These conditions were not met during 2023, and ultimately the Company did not receive any additional “earn-out” payment.

Additionally, the purchase agreement provided that, in the event IM Topco receives less than $13.347 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on the third anniversary of the closing, WHP would be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP for such period, as an adjustment to the purchase price, payable in either cash or equity interests in IM Topco held by the Company. This provision was subsequently amended in November 2023, as described further below, and was subsequently further amended in April 2024 (see Note 12 for additional information).

In connection with the May 27, 2022 membership purchase agreement, the Company and WHP also entered into an Amended and Restated Limited Liability Company Agreement of IM Topco (the “Business Venture Agreement”) governing the operation of IM Topco as a partnership between the Company and WHP following the closing. Pursuant to the Business Venture Agreement, IM Topco is managed by a single Manager appointed by the vote of a majority-in-interest of IM Topco’s members, and WHP serves as the sole Manager of IM Topco. The Business Venture Agreement contains customary provisions for the governance of a partnership, including with respect to decision making, access to information, restrictions on transfer of interests, and covenants.

Pursuant to the Business Venture Agreement, IM Topco’s Net Cash Flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective ownership interests.

The distribution provisions in the Business Venture Agreement were subsequently amended in April 2024 (see Note 12 for additional information).

The Company also entered into a number of other related agreements on May 31, 2022 in connection with the transaction, including a services agreement with IM Topco and a license agreement with IM Topco (see Note 11 for details), while the Company’s employment agreement with Mr. Mizrahi and the Company’s services agreement with Laugh Club (see Note 11) were transferred to IM Topco. Further, the Company’s licensing agreement with Qurate Retail Group related to the Isaac Mizrahi Brand (see Note 5) was assigned to IM Topco as of May 31, 2022.

Management assessed and evaluated the ownership structure and other terms of the May 27, 2022 membership purchase agreement and Business Venture Agreement, as well as considered the Company’s continuing involvement with the Isaac Mizrahi Brand through the aforementioned services agreement and license agreement with IM Topco, and concluded that (i) IM Topco is not a Variable Interest Entity under ASC Topic 810, and (ii) the Company has significant influence over, but does not control, IM Topco. As such, on May 31, 2022, the Company de-recognized the carrying amount of the Isaac Mizrahi Brand trademarks of $44.5 million and recognized the fair value of its retained interest in IM Topco of

approximately $19.8 million as an equity method investment. The fair value of the Company’s retained interest was determined by applying the Company’s ownership percentage to the implied enterprise value of IM Topco, which was calculated based on the price paid by WHP for the 70% controlling interest, as the May 31, 2022 sale transaction was considered an arms-length transaction between knowledgeable market participants and the most relevant and reasonable indication of value to utilize. The inputs and assumptions for this nonrecurring fair value measurement are classified as Level 3 within the fair value hierarchy defined in ASC Topic 820.

Investment in IM Topco, LLC

The Company accounts for its interest in the ongoing operations of IM Topco as a component of other operating costs and expenses (income) under the equity method of accounting. Based on the aforementioned distribution provisions set forth in the Business Venture Agreement, the Company recognized an equity method loss of approximately $2.1 and $1.2 million related to its investment for the years ended December 31, 2023 and 2002, respectively. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for all of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal to Xcel’s share of amortization expense.

Summarized financial information for IM Topco is as follows:

    

For the year ended

December 31,

($ in thousands)

2023

2022(1)

Revenues

$

12,119

$

7,791

Gross profit

12,119

7,791

(Loss) income from continuing operations

(1,961)

316

Net (loss) income

(1,961)

316

(1)Represents financial information for the period commencing May 31, 2022 (the date of the sale of a majority interest in IM Topco) through December 31, 2022.

During the Prior Year (subsequent to the May 27, 2022 transaction), the Company made a capital contribution to IM Topco of $0.6 million in cash, which did not change the Company’s noncontrolling ownership interest of 30%.

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which the parties agreed to waive the purchase price adjustment provision until the measurement period ending March 31, 2024. In exchange, Xcel agreed to make additional royalty payments to IM Topco totaling $0.45 million over the next 11 months. As a result of this amendment, the Company recognized a $0.45 million increase to the carrying value basis of its equity method investment and a corresponding increase in current liabilities.

The provisions of the membership purchase agreement were subsequently further amended in April 2024 (see Note 12 for additional information).

Investment in Orme Live, Inc.

In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s consolidated balance sheet. The Company accounts for its interest in the operations of ORME as a component of other operating costs and expenses (income) under the equity method of accounting; the Company’s proportional share of the operating results of ORME were not material in the Current Year.

Sale of Investment in Unconsolidated Affiliate

The Company previously held a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016. This investment did not have a readily determinable fair value and in accordance with ASC 820-10-35-59, the investment was valued at cost, less impairment, plus or minus observable price changes of an identical or similar investment of the same issuer. This investment was included within other assets on the Company’s consolidated balance sheet at December 31, 2022, at a carrying value of $0.1 million. During the Current Year, the Company sold its ownership interest in this entity, and recognized a gain of $0.36 million related to the sale within other operating costs and expenses (income) on the consolidated statement of operations.

Longaberger Licensing, LLC Variable Interest Entity

Since 2019, Xcel has been party to a limited liability company agreement (the “LLC Agreement”) with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC Agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

XML 29 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trademarks and Other Intangibles
12 Months Ended
Dec. 31, 2023
Trademarks and Other Intangibles [Abstract]  
Trademarks and Other Intangibles

4.   Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

December 31, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

27,431

 

41,449

Copyrights and other intellectual property

 

8 years

 

429

 

358

 

71

Total

$

69,309

$

27,789

$

41,520

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

During the Prior Year, the Company sold its $44.5 million of indefinite-lived trademarks related to the Isaac Mizrahi Brand (see Note 3 for details).

Amortization expense for intangible assets was approximately $6.1 million for both the Current Year and Prior Year.

Estimated future amortization expense related to finite-lived intangible assets over the remaining useful lives is as follows:

($ in thousands)

Amortization

Year Ending December 31, 

    

Expense

2024

$

6,115

2025

 

4,177

2026

 

3,506

2027

 

3,504

2028

 

3,504

Thereafter (through 2036)

 

20,714

Total

$

41,520

XML 30 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Contracts
12 Months Ended
Dec. 31, 2023
Significant Contracts [Abstract]  
Significant Contracts

5.   Significant Contracts

Qurate Agreements

Through its wholly owned subsidiaries, the Company has entered into direct-to-retail license agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements (individually, each a “Qurate Agreement”), pursuant to which the Company designs, and Qurate sources and sells, various products under the LOGO by Lori Goldstein brand, the Longaberger brand, and the C Wonder brand. The Company was also previously party to similar agreements with Qurate related to the IsaacMizrahiLIVE brand and the Judith Ripka brand. Qurate owns the rights to all designs produced under these agreements, and the agreements include the sale of products across various categories through Qurate’s television media (including QVC and HSN) and related internet sites.

Pursuant to these agreements, the Company has granted to Qurate and its affiliates the exclusive, worldwide right to promote the Company’s branded products, and the right to use and publish the related trademarks, service marks, copyrights, designs, logos, and other intellectual property rights owned, used, licensed and/or developed by the Company, for varying terms as set forth below. In connection with the Qurate Agreements and during the same periods, Qurate and its subsidiaries have the exclusive, worldwide right to use the names, likenesses, images, voices, and performances of the Company’s spokespersons to promote the respective products.

Xcel Commenced

Qurate

Agreement

    

Current Term Expiry

    

Automatic Renewal

    

Brand with Qurate

    

Product Launch

LOGO Qurate Agreement (QVC)

November 1, 2024

one-year period

April 2021

2009

Longaberger Qurate Agreement (QVC)

October 31, 2025

 

two-year period

 

November 2019

 

2019

C Wonder Qurate Agreement (HSN)

December 31, 2024

two-year period

March 2023

2023

On May 31, 2022, in connection with the sale of a majority interest in the Isaac Mizrahi brand to a third party, the Qurate Agreement related to the IsaacMizrahiLIVE brand was assigned to IM Topco, LLC. See Note 3 for additional details.
On August 30, 2022, Qurate and Xcel amended the licensing agreement for the Judith Ripka brand to terminate the license period effective December 31, 2021. Effective January 1, 2022, the agreement entered a sell-off period, under which Qurate was allowed to continue to license the Ripka brand on a non-exclusive basis for as long as necessary to sell off any of its remaining inventory. The sell-off period ended in 2023.

Under the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based upon the net retail sales of the specified branded products. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes.

The Qurate Agreements generally prohibit the Company from selling products under the specified respective brands to a direct competitor of Qurate without Qurate’s consent. Under certain of the Qurate Agreements, the Company may, with the permission of Qurate, sell the respective branded products via certain specified sales channels in exchange for making reverse royalty payments to Qurate based on the net retail sales of such products through such channels. However, the Company is generally restricted from selling products under the specified respective brands or trademarks to certain mass merchants.

Also, under certain of the Qurate Agreements, the Company may be required for a period of time to pay a royalty participation fee to Qurate on revenue earned from the sale, license, consignment, or any other form of distribution of any products, bearing, marketed in connection with, or otherwise associated with the specified trademarks and brands.

Net licensing revenue from Qurate totaled $6.0 million and $11.4 million for the Current Year and Prior Year, respectively, representing approximately 34% and 44% of the Company’s total net revenue, respectively. As of December 31, 2023 and 2022, the Company had receivables from Qurate of $1.5 million and $0.9 million, representing approximately 43% and 17% of the Company’s accounts receivable, respectively. The December 31, 2023 and 2022 Qurate receivables did not include any earned revenue accrued but not yet billed as of the respective balance sheet dates.

Halston Master License

On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet as of December 31, 2023 related to this contract, of which $0.9 million was classified as a current liability and approximately $3.5 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 5.0 years. Net licensing revenue recognized from the Halston Master License was $1.6 million for the Current Year, representing approximately 9% of the Company’s total net revenue for the Current Year.

Additionally, in connection with the Halston Master License, the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the Current Year was approximately $0.03 million. As of December 31, 2023, no portion of this warrant had vested.

XML 31 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Debt

6.   Debt

The Company’s net carrying amount of debt was comprised of the following:

December 31, 

($ in thousands)

2023

    

2022

Term loan debt

$

5,000

$

Unamortized deferred finance costs related to term loan debt

 

(279)

 

Total

 

4,721

 

Current portion of debt

 

750

 

Long-term debt

$

3,971

$

For the Current Year and Prior Year, the Company incurred interest expense of approximately $0.4 million and $1.2 million, respectively, related to term loan debt. The effective interest rate related to term loan debt was approximately 11.6% and 9.8% for the Current Year and Prior Year, respectively.

Previous Term Loan Debt (through May 31, 2022)

On December 30, 2021, Xcel, as Borrower, and its wholly-owned subsidiaries entered into a loan and security agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”), as lead arranger and as administrative agent and collateral agent, and the financial institutions party thereto as lenders. Pursuant to this loan agreement, the lenders made a term loan in the aggregate amount of $29.0 million. This term loan bore interest at “LIBOR” plus 7.5% per annum, with “LIBOR” defined as the greater of (a) the rate of interest per annum for deposits in dollars for an interest period equal to three months as published by Bloomberg or a comparable or successor quoting service at approximately 11:00 a.m. (London time) two business days prior to the last business day of each calendar month and (b) 1.0% per annum.

Upon entering into the December 2021 loan agreement, Xcel paid a 1.75% closing fee to FEAC for the benefit of the lenders; the Company also paid approximately $0.5 million of various legal and other fees in connection with the execution of the loan agreement. These fees and costs totaling approximately $0.97 million were deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, to be subsequently amortized to interest expense over the term of the debt using the effective interest method.

The December 2021 term loan was to mature on April 14, 2025. Principal on this debt was payable in quarterly installments of $625,000 on each of March 31, June 30, September 30 and December 31 of each year, commencing on March 31, 2022 and ending on March 31, 2025, with a final payment of $20,875,000 on the maturity date of April 14, 2025.

The December 2021 term loan agreement also contained customary covenants, including reporting requirements, trademark preservation, and certain financial covenants; the Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the consolidated financial statements.

Extinguishment of Previous Term Loan Debt

On May 31, 2022, the Company used $30.1 million of the proceeds received from the transaction related to the Isaac Mizrahi Brand (see Note 3) to repay all amounts outstanding under the December 30, 2021 term loan agreement with FEAC, consisting of $28.4 million in principal amount, a $1.4 million prepayment fee, and approximately $0.3 million in interest and related expenses. As a result, the Company recognized a loss on early extinguishment of debt of approximately $2.3 million during the Prior Year, consisting of approximately $1.4 million of debt prepayment premium, the immediate write-off of approximately $0.8 million of unamortized deferred finance costs, and approximately $0.1 million of other costs.

New Term Loan Debt

On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.30 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.

In connection with October 2023 loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.

The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.

As of December 31, 2023, the aggregate remaining principal payments under the October 2023 term loan were as follows:

    

Amount of

($ in thousands)

Principal

Year Ending December 31, 

Payment

2024

$

750

2025

 

1,000

2026

1,000

2027

1,000

2028

 

1,250

Total

$

5,000

Interest on the October 2023 term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month.

The October 2023 term loan agreement contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount.

XML 32 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity
12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

7.   Stockholders’ Equity

The Company has authority to issue up to 51,000,000 shares, consisting of 50,000,000 shares of common stock and 1,000,000 shares of preferred stock.

Equity Incentive Plans

The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 4,000,000 shares of common stock are eligible for issuance under the 2021 Plan. The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-Based Compensation

Total expense recognized for all forms of stock-based compensation was approximately $0.22 million and $0.72 million in the Current Year and Prior Year, respectively.

Of the Current Year expense amount, approximately $0.02 related to employees and approximately $0.20 related to directors and consultants; all of this expense was recorded as a direct operating cost in the accompanying statement of operations.

Of the Prior Year expense amount, approximately $0.41 million related to employees and approximately $0.31 million related to directors and consultants; approximately $0.62 million was recorded as a direct operating cost and approximately $0.10 million was recorded within other operating costs and expenses (income).

Stock Options

Options granted under the Company’s equity incentive plans expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s stock option activity for the Current Year is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

200,000

 

1.51

 

  

 

  

Exercised

 

(87,750)

 

0.80

 

  

 

  

Expired/Forfeited

 

(578,020)

 

2.96

 

  

 

  

Outstanding at December 31, 2023, and expected to vest

 

5,148,540

$

2.03

 

4.26

$

Exercisable at December 31, 2023

 

1,398,540

$

2.88

 

1.66

$

Current Year stock option grants were as follows:

In April 2023, the Company granted options to purchase an aggregate of 100,000 shares of common stock to a key individual. The exercise price of the options is $1.50 per share, and the vesting of such options is dependent upon the achievement of certain revenue targets. None of these options were vested as of December 31, 2023.

On August 23, 2023 the Company granted options to purchase an aggregate of 100,000 shares of common stock to non-management directors. The exercise price of the options is $1.51 per share, and 50% of the options vest on each of April 1, 2024 and April 1, 2025.

Prior Year stock option grants were as follows:

On April 20, 2022, the Company granted options to purchase an aggregate of 380,850 shares of common stock to various employees. The exercise price of the options is $1.62 per share, and all options vested immediately on the date of grant.

On April 20, 2022 the Company granted options to purchase an aggregate of 125,000 shares of common stock to non-management directors. The exercise price of the options is $1.62 per share. Half of the options vested on April 20, 2023, and the remaining half of the options will vest on April 20, 2024.

On April 26, 2022, the Company granted options to purchase an aggregate of 100,000 shares of common stock to a consultant. The exercise price of the options is $1.58 per share, and all options vested immediately on the date of grant.

The fair values of the options granted were estimated at the respective dates of grant using the Black-Scholes option pricing model with the following range of assumptions:

Year Ended December 31, 

 

    

2023

    

2022

 

Expected Volatility

 

89 – 90

%  

57 – 93

%

Expected Dividend Yield

 

%  

%

Expected Life (Term, in years)

 

2.75 – 10

 

0.67 – 3.25

Risk-Free Interest Rate

 

4.0 – 4.7

%  

1.6 – 2.8

%

Compensation expense related to stock options for the Current Year and Prior Year was approximately $0.1 million and $0.5 million, respectively. Total unrecognized compensation expense related to unvested stock options (excluding stock options with performance-based vesting) at December 31, 2023 amounts to approximately $0.1 million and is expected to be recognized over a weighted average period of 1.05 years.

Of the total stock options outstanding at December 31, 2023, the vesting of 3,500,000 options is contingent upon the Company’s common stock achieving certain target prices as follows:

Target Prices

    

Number of Options Vesting

$3.00

1,000,000

$5.00

850,000

$7.00

700,000

$9.00

550,000

$11.00

400,000

As of December 31, 2023, none of these 3,500,000 performance-based stock options have vested, and no compensation expense has been recorded related to such options.

The following table summarizes the Company’s stock option activity for non-vested options for the Current Year:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

200,000

 

0.68

Vested

 

(135,000)

0.68

Forfeited or Canceled

 

(12,500)

 

0.89

Balance at December 31, 2023

 

3,750,000

$

0.05

Stock Awards

A summary of the Company’s restricted stock activity for the Current Year is as follows:

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

113,968

 

1.01

Vested

 

(108,968)

 

1.08

Expired/Forfeited

 

(5,000)

 

1.62

Outstanding at December 31, 2023

 

333,333

$

3.69

Current Year stock award grants were as follows:

On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On April 17, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On May 15, 2023, the Company issued 50,000 shares of common stock to a consultant, which vested immediately.

On July 20, 2023, the Company issued 7,300 shares of common stock to an employee, which vested immediately.

On August 23, 2023, the Company issued an aggregate of 40,000 shares of common stock to non-management directors, of which 50% shall vest on April 1, 2024, and 50% shall vest on April 1, 2025.

Prior Year stock award grants were as follows:

On April 20, 2022, the Company issued an aggregate of 50,000 shares of common stock to non-management directors, which vest evenly over two years. Half of these shares vested on April 20, 2023, and the remaining half shall vest on April 20, 2024.

On April 20, 2022, the Company issued 20,064 shares of common stock to a consultant, which vested immediately.

On May 31, 2022, the Company issued 65,275 shares of common stock to a consultant in connection with the transaction related to the Isaac Mizrahi Brand (see Note 3); these shares vested immediately.

On May 31, 2022, the Company issued 33,557 shares of common stock to Isaac Mizrahi, which vested immediately (see Note 11 for additional details).

Additionally, on April 20, 2022, the Company issued 178,727 shares of common stock to a member of senior management as payment for a performance bonus earned in 2021. These shares vested immediately. The Company had previously recognized compensation expense of approximately $0.28 million in the 2021 to accrue for this performance bonus.

Notwithstanding the foregoing, each grantee may extend the first anniversary of all or a portion of the restricted stock by six months and, thereafter one or more times may further extend such date with respect to all or a portion of the restricted stock until the next following date exactly six months thereafter, by providing written notice of such election to extend such date with respect to all or a portion of the restricted stock prior to such date.

Total compensation expense related to stock awards for the Current Year and Prior Year (inclusive of the amounts detailed above) was approximately $0.1 million and $0.3 million, respectively. Total unrecognized compensation expense related to unvested restricted stock grants at December 31, 2023 amounts to $0.1 million and is expected to be recognized over a weighted average period of 1.06 years.

The following table provides information with respect to restricted stock purchased and retired by the Company during the Current Year and Prior Year:

Number of

Shares

Purchased as

Part of

Total Number

Actual

Publicly

Fair value of

of Shares

Price Paid

Announced

Re-Purchased

Date

    

Purchased

    

per Share

    

Plan

    

Shares

None

 

 

 

 

Total 2023

 

$

 

$

April 20, 2022 (i)

53,882

 

1.57

 

 

84,000

May 31, 2022 (i)

 

240,000

 

1.49

 

 

358,000

Total 2022

 

293,882

$

1.50

 

$

442,000

(i)The shares were exchanged from employees and directors in connection with the income tax withholding obligations on behalf of such employees and directors from the vesting of restricted stock or the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.

Restricted Stock Units

There were no restricted stock units outstanding as of December 31, 2023 and 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

At December 31, 2023, there were 3,103,941 shares of common stock available for award grants under the 2021 Plan.

Shares Reserved for Issuance

At December 31, 2023, there were 8,368,546 shares of common stock reserved for issuance, including 4,771,255 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,103,941 shares available for issuance under the 2021 Plan.

Warrants

Warrants granted by the Company expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s warrant activity for the Current Year is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

1,000,000

 

1.50

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at December 31, 2023

 

1,116,065

$

1.67

 

8.46

$

Exercisable at December 31, 2023

 

116,065

$

3.15

 

0.57

$

See Note 5 for information regarding the warrant to purchase 1,000,000 shares of common stock granted during the Current Year in connection with the Halston Master License; the Company recognized contra-revenue of approximately $0.03 million in the Current Year with respect to this warrant. There was no compensation expense related to other warrants recognized in the Current Year or Prior Year.

Dividends

The Company has not paid any dividends to date.

XML 33 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings (Loss) Per Share
12 Months Ended
Dec. 31, 2023
Earnings (Loss) Per Share [Abstract]  
Earnings (Loss) Per Share

8. Earnings (Loss) Per Share

The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the years ended December 31, 2023 and 2022:

Year Ended

December 31, 

    

2023

    

2022

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(21,052)

$

(4,018)

Denominator:

Basic weighted average number of shares outstanding

19,711,637

 

19,624,669

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

19,711,637

 

19,624,669

Basic net loss per share

$

(1.07)

$

(0.20)

Diluted net per share

$

(1.07)

$

(0.20)

As a result of the net loss presented for the Current Year and Prior Year, the Company calculated diluted loss per share using basic weighted-average shares outstanding for both years, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of basic and diluted loss per share excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

Year Ended December 31, 

2023

    

2022

Stock options

5,148,540

5,614,310

Warrants

1,116,065

116,065

Total

 

6,264,605

 

5,730,375

XML 34 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

9.   Commitments and Contingencies

Leases

The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.

The Company's real estate leases have remaining lease terms between approximately 5 to 7 years. As of December 31, 2023, the weighted average remaining lease term was 3.83 years and the weighted average discount rate was 6.25%.

As of December 31, 2023, the Company leased approximately 29,600 square feet of office space at 1333 Broadway, 10th floor, New York, New York for its corporate offices and operations facility. This lease commenced on March 1, 2016 and expires on October 30, 2027. This lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property.

The Company previously leased approximately 1,300 square feet of retail space for its former retail store location in Westchester, New York, which was closed in the Prior Year. In the Current Year, the Company successfully negotiated a settlement with the lessor resulting in the termination of this lease, and recognized a gain related to the settlement of $0.4 million within other operating costs and expenses (income) in the consolidated statement of operations. The Company had recorded an impairment charge of $0.7 million to fully impair the right-of-use asset for this lease in the Prior Year.

The Company also previously leased certain office space in New York, New York, which was subleased to a third-party subtenant through February 27, 2022, and the Company's lease of this office space expired by its terms on February 28, 2022.

For the years ended December 31, 2023 and 2022, total lease expense included in selling, general and administrative expenses on the Company's consolidated statements of operations was approximately $1.6 million for both periods. The Company’s total lease costs for the years ended December 31, 2023 and 2022 were comprised of the following:

($ in thousands)

    

2023

    

2022

Operating lease cost

$

1,337

$

1,474

Short-term lease cost

 

62

 

55

Variable lease cost

 

233

 

217

Sublease income

 

 

(104)

Total lease cost

$

1,632

$

1,642

Cash paid for amounts included in the measurement of operating lease liabilities was $1.6 million and $1.7 million in the Current Year and Prior Year, respectively. Cash received from subleasing in the Prior Year was $0.1 million.

As of December 31, 2023, the maturities of lease liabilities were as follows:

Amount

Year

    

(in thousands)

2024

$

1,552

2025

1,552

2026

 

1,552

2027

 

1,294

Total lease payments

5,950

Less: Discount

671

Present value of lease liabilities

5,279

Current portion of lease liabilities

1,258

Non-current portion of lease liabilities

$

4,021

Employment Agreements

The Company has employment contracts with certain executives and key employees. The future minimum payments under these contracts are as follows:

Employment

($ in thousands)

Contract

Year Ended December 31, 

    

Payments

2024

$

4,292

2025

 

2,150

2026

2,150

2027

2,150

2028

2,150

Thereafter

 

4,837

Total future minimum employment contract payments

$

17,729

In addition to the employment contract payments stated above, the Company’s employment contracts with certain executives and key employees contain performance-based bonus provisions. These provisions include bonuses based on the Company achieving revenues in excess of established targets and/or on operating results.

Certain of the employment agreements contain severance and/or change in control provisions. Aggregate potential severance compensation amounted to approximately $2.9 million as of December 31, 2023.

Contingent Obligation – Halston Heritage Earn-Out

In connection with the February 11, 2019 purchase of the Halston Heritage trademarks, the Company agreed to pay the seller additional consideration (the “Halston Heritage Earn-Out”) of up to an aggregate of $6.0 million, based on royalties earned from 2019 through December 31, 2022. The final royalty target year for the Halston Heritage Earn-Out ended on December 31, 2022, and the seller ultimately did not earn any additional consideration based on the formula set forth in the related asset purchase agreement. As such, during the Prior Year, the Company recorded a $0.9 million gain on the reduction of contingent obligations in the accompanying consolidated statement of operations. As of December 31, 2022, there were no amounts remaining under the Halston Heritage Earn-Out.

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and thus $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability. The $0.2 million of additional consideration was paid to the seller during the Current Year.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. Accordingly, as of December 31, 2023, $1.0 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 3), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024.

No amount has been recorded in the accompanying consolidated balance sheets related to this contingent obligation.

The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details).

Legal Proceedings

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation pending against the Company as of December 31, 2023 is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

See Note 12 for information related to certain legal matters which arose subsequent to December 31, 2023.

XML 35 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Taxes  
Income Taxes

10.   Income Taxes

The income tax provision (benefit) for income taxes in the consolidated statements of operations consists of the following:

Years Ended December 31, 

($ in thousands)

    

2023

    

2022

Current:

 

  

 

  

Federal

$

22

$

300

State and local

 

83

 

234

Total current

 

105

 

534

Deferred:

 

  

 

  

Federal

 

727

 

(509)

State and local

 

380

 

(456)

Total deferred

 

1,107

 

(965)

Total provision (benefit)

$

1,212

$

(431)

The reconciliation of the federal statutory income tax rate to the Company’s effective tax rate reflected in the income tax provision (benefit) shown in the consolidated statements of operations is as follows:

Years Ended December 31, 

    

2023

    

2022

 

U.S. statutory federal rate

 

21.00

%  

21.00

%

State and local rate, net of federal tax benefit

 

6.36

 

6.10

Stock compensation

 

(0.14)

 

(6.14)

Excess compensation deduction

 

(0.27)

 

(5.32)

Federal true-ups

 

0.18

 

(5.09)

Life insurance

 

(0.12)

 

(0.52)

Change in valuation allowance

 

(33.16)

 

Income tax (provision) benefit

 

(6.15)

%  

10.03

%

The significant components of net deferred tax assets (liabilities) of the Company consist of the following:

December 31, 

($ in thousands)

    

2023

    

2022

Deferred tax assets

 

  

 

  

Stock-based compensation

$

712

$

712

Federal, state and local net operating loss carryforwards

 

8,127

 

3,175

Accrued compensation and other accrued expenses

 

451

 

748

Allowance for doubtful accounts

 

231

 

Basis difference arising from discounted note payable

 

11

 

11

Charitable contribution carryover

 

1

 

Property and equipment

 

169

 

497

Interest expense

 

31

 

Total deferred tax assets

9,733

5,143

Valuation allowance

(6,537)

Total deferred tax assets, net of valuation allowance

3,196

5,143

Deferred tax liabilities

Basis difference arising from intangible assets of acquisition

 

(3,196)

 

(4,036)

Total deferred tax liabilities

 

(3,196)

 

(4,036)

Net deferred tax assets

$

$

1,107

As of December 31, 2023 and 2022, the Company had approximately $28.6 million and $10.9 million, respectively, of federal net operating loss carryforwards ("NOLs") available to offset future taxable income. The NOL as of December 31, 2017 of $0.3 million has an expiration period through 2037. The NOL generated during tax years beginning after December 31, 2017 of $28.3 million has an indefinite life and does not expire.

As of December 31, 2023 and 2022, management does not believe the Company has any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its consolidated financial statements. The Company will continue to evaluate its uncertain tax positions in future periods to determine if measurement and recognition in its consolidated financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.

During the Current Year, the Company recognized a valuation allowance in order to reduce deferred tax assets to the amount expected to be realized. The change in the valuation allowance from December 31, 2022 to December 31, 2023 was approximately $6.5 million.

XML 36 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions
12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

11.   Related Party Transactions

IM Topco, LLC

As described in Note 3, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

Services Agreement

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year.

In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.

For the year ended December 31, 2023, the Company recognized service fee income related to this agreement of $150,000.

License Agreement

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.

Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the year ended December 31, 2023, the estimated amount of such shortfall was approximately $325,000, which the Company recognized as royalty expense in the consolidated statements of operations.

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which the parties agreed to waive the purchase price adjustment provision until the measurement period ending March 31, 2024 (see Note 3 for details). In exchange, Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities.

Isaac Mizrahi

Isaac Mizrahi is a principal stockholder and former employee of the Company.

Employment Agreement

On February 24, 2020, the Company entered into an employment agreement with Mr. Mizrahi for him to continue to serve as Chief Design Officer of the Isaac Mizrahi Brand. This employment agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (see Note 3 for details).

The employment agreement provided Mr. Mizrahi with a base salary of $1.8 million, $2.0 million, and $2.1 million per annum for 2020, 2021, and 2022, respectively. Mr. Mizrahi was also eligible to receive an annual cash bonus (the “Bonus”) up to an amount equal to $2.5 million less base salary for 2020 and $3.0 million less base salary for 2021 and 2022. The Bonus consisted of the DRT Revenue, Bonus, the Brick-and-Mortar Bonus, the Endorsement Bonus and the Monday Bonus, if any, as determined in accordance with the below:

“DRT Bonus” means for any calendar year an amount equal to 10% of the aggregate net revenue related to sales of Isaac Mizrahi Brand products through direct response television. The DRT Revenue Bonus shall be reduced by the amount of the Monday Bonus.
“Brick-and-Mortar Bonus” means for any calendar year an amount equal to 10% of the net revenues from sales of products under the Isaac Mizrahi Brand, excluding DRT revenue and endorsement revenues.
“Endorsement Bonus” means for any calendar year an amount equal to 40% of revenues derived from projects undertaken by the Company with one or more third parties solely for Mr. Mizrahi to endorse the third party’s products through the use of Mr. Mizrahi’s name, likeness, and/or image, and neither the Company nor Mr. Mizrahi provides licensing or design.
“Monday Bonus” means $10,000 for each appearance by Mr. Mizrahi on Qurate’s QVC channel on Mondays (subject to certain expectations) up to a maximum of 40 such appearances in a calendar year.

In addition, on May 31, 2022, all 522,500 unvested shares of restricted stock of the Company held by Mr. Mizrahi (for which all stock-based compensation expense had been previously recognized in prior periods) were immediately vested, with 240,000 of such shares being surrendered for cancellation in satisfaction of withholding tax obligations. Also on May 31, 2022, the Company issued 33,557 additional shares of common stock of the Company (valued at $50,000) to Mr. Mizrahi, which vested immediately, and made a $100,000 cash payment to Mr. Mizrahi

Laugh Club Services Agreement

On February 24, 2020 the Company entered into a services agreement with Laugh Club, an entity wholly-owned by Mr. Mizrahi, pursuant to which Laugh Club provided services to Mr. Mizrahi necessary for Mr. Mizrahi to perform his services pursuant to the employment agreement. The Company paid Laugh Club an annual fee of $0.72 million for such services. This services agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (see Note 3 for details).

ORME

On December 4, 2023, the Company acquired a 30% equity ownership interest in ORME, a short-form video and social commerce marketplace that is planned to launch in 2024, for a purchase price of $150,000. ORME licenses the technology utilized by its marketplace from KonnectBio Inc., in which Robert W. D’Loren, the Company’s Chairman of the Board, Chief Executive Officer, and President, owns an approximate 20% noncontrolling interest.

XML 37 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events
12 Months Ended
Dec. 31, 2023
Subsequent Event  
Subsequent Events

12.Subsequent Events

Leasing Transactions

Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and shall expire seven years from the commencement date in 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year.

On January 26, 2024, the Company, as lessor, entered into a lease agreement for the sublease of its former corporate offices and operations facility located at 1333 Broadway, 10th floor, New York, New York to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of this sublease is approximately $0.8 million per year. As a result of entering into this sublease, the Company recognized an impairment charge of approximately $2.1 million related to the right-of-use asset. The loss recognition will coincide with the departure date. February 29, 2024 has been determined to be the date of a fundamental change to the use of the 1333 Broadway premises.

Public Offering and Private Placement

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,421 shares of the Company’s common stock at a price to the public of $0.65 per share. In connection with the Offering, Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares of common stock, respectively.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1,735,000.

 

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 178,953 shares of common stock (the “Representative’s Warrants”) as compensation. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

On March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $265,000. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,063 shares and the total net proceeds received was approximately $2,000,000.

IM Topco

On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 membership purchase agreement and the Business Venture Agreement. Under these amendments, the parties agreed to the following:

The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025.
If IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco under the second amendment (which totaled $375,000 as of December 31, 2023).
On and after January 1, 2026, WHP shall receive 50% of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to $1.0 million.  

Legal Matters

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the March 31, 2021 asset purchase agreement for failure to pay $963,642 earned in 2023 in accordance with the provisions of the Lori Goldstein Earn-Out (as described in Note 9) under the terms of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to Ms. Goldstein’s failure to make all of the QVC appearances as required by her employment agreement, the Company was not willing to pay the amount due in a lump sum, but instead would make the payment in four quarterly installments. Failure to amicably resolve this dispute could adversely affect the Company’s cash flows and the availability of Ms. Goldstein’s services.

XML 38 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.

The Company deems the following items to require significant estimates from management:

Allowances for credit losses;
Useful lives of trademarks;
Assumptions used in the valuation of intangible assets, including cash flow estimates for initial determinations of fair value and/or impairment analysis; and
Stock-based compensation.
Cash and Cash Equivalents

Cash and Cash Equivalents

All highly liquid investments with original maturities of three months or less are considered to be cash equivalents.

Accounts Receivable

Accounts Receivable

Accounts receivable are reported net of an allowance for credit losses. As of December 31, 2023 and 2022, the Company had $3.5 million and $5.1 million, respectively, of accounts receivable, net of allowances of $0.8 million and $0, respectively.

The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.

A rollforward of the allowance for credit losses for the Current Year is as follows:

($ in thousands)

    

Balance at December 31, 2022

$

Credit loss expense

 

787

Write-offs

 

Recoveries

 

Balance at December 31, 2023

$

787

The Company recognized credit loss expense of $0.4 million in the Prior Year, which was related to the bankruptcy of several retail customers due to the 2020 – 2023 coronavirus disease pandemic. The Company wrote-off approximately $1.5 million of such customers’ outstanding receivable balances in the Prior Year.

Additionally, on October 17, 2023, the Company and one of the licensees managed under the Halston Master License (see Note 5) entered into an amendment of their respective licensing agreement. Under this amendment, the payment terms of the $0.76 million outstanding balance due to the Company were changed such that this receivable (and collection thereof) became contractually contingent upon the licensee’s future performance. The licensee is also required to pay interest to the Company on a monthly basis until the outstanding balance is paid in full. The Company recorded a non-cash charge of $0.76 million within other selling, general and administrative expenses in the Current Year related to the restructuring of this licensing arrangement, in order to write-down the previously-recorded receivable to zero, which is not included in the credit loss expense and allowance for credit losses amounts set forth above.

There is no earned revenue that has been accrued but not billed as of December 31, 2023 and 2022.

As of December 31, 2023 and 2022, approximately $0.04 million and $1.7 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the Prior Year, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During both the Current Year and Prior Year, the Company paid less than $0.1 million in fees to the agent under the aforementioned services agreement.

Inventory

Inventory

All of the Company’s inventory consists of finished goods. As of December 31, 2022, inventory was composed of jewelry, wholesale apparel, and home goods. During the Current Year, as a result of the restructuring of its business operating model, the Company sold all of its wholesale apparel inventory and substantially all of its remaining fine jewelry inventory to its new business partners and licensees. Thus, as of December 31, 2023, inventory was primarily composed of home goods and related items for the Longaberger Brand.

Inventory is recorded at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of its inventories in order to identify obsolete, slow-moving, or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventories, the Company

will record a write-down to net realizable value in the period that the decline in value is first recognized. Write-downs for inventory shrinkage, representing the risk of physical loss of inventory, are estimated based on historical experience and are adjusted based upon physical inventory counts.

Property and Equipment

Property and Equipment

Furniture, equipment, and software are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over their estimated useful lives, generally three (3) to seven (7) years. Depreciation expense for the years ended December 31, 2023 and 2022 was approximately $0.8 million and $1.1 million, respectively.

Leasehold improvements are amortized over the shorter of their estimated useful lives or the terms of the leases. Betterments and improvements are capitalized, while repairs and maintenance are expensed as incurred.

Costs to develop or acquire software for internal use incurred during the preliminary project stage and the post implementation stage are expensed, while internal and external costs to acquire or develop software for internal use incurred during the application development stage – including design, configuration, coding, testing, and installation – are generally capitalized.

The Company’s long-lived property and equipment assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on a discounted cash flows analysis or appraisals. The inputs utilized in the impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurement.”

The Company recognized impairment charges of $0.3 million in the Prior Year related to store fixtures purchased for an apparel program with one of the Company’s retail partners.

Trademarks and Other Intangible Assets

Trademarks and Other Intangible Assets

The Company’s finite-lived intangible assets are amortized over their estimated useful lives of three (3) to eighteen (18) years. The Company re-evaluates the remaining useful life of its finite-lived intangible assets on an annual basis, based on consideration of current events and circumstances, the expected use of the asset, and the effects of demand, competition, and other economic factors. No changes were made to the estimated useful lives of intangible assets in the Current Year or Prior Year.

The Company’s finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value, based on a discounted cash flows analysis or appraisals. The inputs utilized in the finite-lived intangible assets impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in ASC Topic 820. No impairment charges were recorded related to intangible assets for the Current Year or Prior Year.

See Note 4 for additional information related to the Company’s trademarks and other intangible assets.

Investment in Unconsolidated Affiliate

Investments in Unconsolidated Affiliates

The Company holds a noncontrolling equity interest in IM Topco, LLC, which was entered into during the Prior Year, and a noncontrolling equity interest in ORME Live, Inc., which was entered into during the Current Year. These investments are accounted for in accordance with ASC Topic 323, “Investments – Equity Method and Joint Ventures,” as the Company has the ability to exercise significant influence over their operating and financial policies of these affiliates, but does not control the affiliates.

The Company recognizes its share of the ongoing operating results of these affiliates within other operating costs and expenses (income) in the accompanying consolidated statements of operations. The Company’s investments in unconsolidated affiliates are reviewed for impairment whenever there are indicators that their carrying value may not be recoverable; if a decrease in value of the investment has occurred and such decrease is determined to be other than temporary in nature, the Company shall record an impairment charge to reduce the carrying amount of the investment to its fair value.

Deferred Finance Costs

Deferred Finance Costs

The Company incurred costs (primarily professional fees and lender underwriting fees) in connection with borrowings under term loans. These costs have been deferred on the consolidated balance sheet as a reduction to the carrying value of the associated borrowings, and are being amortized as interest expense over the term of the related borrowings using the effective interest method.

Contingent Obligations

Contingent Obligations

When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired is greater than the consideration paid, any contingent obligations are recognized and recorded as the positive difference between the fair value of the assets acquired and the consideration paid for the acquired assets.

When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired are equal to the consideration paid, any contingent obligations are recognized based upon the Company’s best estimate of the amount that will be paid to settle the liability.

Under the applicable accounting guidance, the Company is required to carry such contingent liability balances on its consolidated balance sheet until the measurement period of the earn-out expires and all related contingencies have been resolved.

The Company recorded contingent obligations in connection with the purchase of the Halston Heritage trademarks in 2019 and the purchase of the LOGO by Lori Goldstein trademarks in 2021, but no amount has been recorded for the contingent obligation related to the sale of a majority interest in the Isaac Mizrahi Brand in 2022.

See Note 9 for additional information related to the Company’s contingent obligations.

Revenue Recognition

Revenue Recognition

The Company applies the guidance in ASC Topic 606, “Revenue from Contracts with Customers” to recognize revenue.

Licensing

The Company recognizes revenue continuously over time as it satisfies its continuous obligation of granting access to its licensed intellectual properties, which are deemed symbolic intellectual properties under the applicable revenue accounting guidance. Payments are typically due after sales have occurred and have been reported by the licensees or, where applicable, in accordance with minimum guaranteed payment provisions. The timing of performance obligations is typically consistent with the timing of payments, though there may be differences if contracts provide for advances or significant escalations of contractually guaranteed minimum payments. With the exception of the Halston Master License agreement described in Note 5, there were no such differences that would have a material impact on the Company’s consolidated balance sheets at December 31, 2023 and 2022. In accordance with ASC 606-10-55-65, the Company recognizes net licensing revenue at the later of when (1) the subsequent sale or usage occurs or (2) the performance obligation to which some or all of the sales- or usage-based royalty has been allocated is satisfied (in whole or in part). More specifically, the Company separately identifies:

(i)Contracts for which, based on experience, royalties are expected to exceed any applicable minimum guaranteed payments, and to which an output-based measure of progress based on the “right to invoice” practical expedient is applied because the royalties due for each period correlate directly with the value to the customer of the Company’s performance in each period (this approach is identified as “View A” by the FASB Revenue Recognition Transition Resource Group, “TRG”); and
(ii)Contracts for which revenue is recognized based on minimum guaranteed payments using an appropriate measure of progress, in which minimum guaranteed payments are straight-lined over the term of the contract and recognized ratably based on the passage of time, and to which the royalty recognition constraint to the sales-based royalties in excess of minimum guaranteed is applied and such sales-based royalties are recognized to the distinct period only when the minimum guaranteed is exceeded on a cumulative basis (this approach is identified as “View C” by the TRG).

The Company’s unconditional right to receive consideration based on the terms and conditions of licensing contracts is presented as accounts receivable on the accompanying consolidated balance sheets. The Company does not typically perform by transferring goods or services to customers before the customer pays consideration or before payment is due, thus the amounts of contract assets as defined by ASC 606-10-45-3 related to licensing contracts were not material as of December 31, 2023 and 2022. The Company typically does not receive consideration in advance of performance and, consequently, amounts of contract liabilities as defined by ASC 606-10-45-2 related to licensing contracts were not material as of December 31, 2022; however, as of December 31, 2023, the Company has recognized approximately $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet related to the Halston Master License agreement (see Note 5).

The Company does not disclose the amount attributable to unsatisfied or partially satisfied performance obligations for variable revenue contracts (identified under “View A” above) in accordance with the optional exemption allowed under ASC 606. The Company did not have any revenue recognized in the reporting period from performance obligations satisfied, or partially satisfied, in previous periods. Remaining minimum guaranteed payments for active contracts as of December 31, 2023 are expected to be recognized ratably in accordance with View C over the remaining term of each contract based on the passage of time and through December 2028, subject to renewal or extension upon termination.

Wholesale Sales

Prior to the restructuring of the Company’s business model and operations in the Current Year, the Company generated a portion of its revenue through the design, sourcing, and sale of branded jewelry and apparel to both domestic and international customers who, in turn, sold the products to the consumer. The Company recognized such revenue within net sales in the accompanying consolidated statements of operations when performance obligations identified under the terms of contracts with its customers were satisfied, which occurred upon the transfer of control of the merchandise in accordance with the contractual terms and conditions of the sale. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Direct-to-Consumer Sales

The Company’s revenue associated with its e-commerce jewelry operations and the Longaberger Brand (prior to the restructuring of the Company’s business model and operations in the Current Year) was recognized within net sales in the accompanying consolidated statements of operations at the point in time when product is shipped to the customer. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.

Advertising Costs

Advertising Costs

All costs associated with production for the Company’s advertising, marketing, and promotion are expensed during the periods when the activities take place. All other advertising costs, such as print and online media, are expensed when the advertisement occurs. The Company incurred approximately $1.0 million and $2.6 million in advertising and marketing costs for the Current Year and Prior Year, respectively, which are included within other selling, general and administrative expenses in the accompanying consolidated statements of operations.  

Leases

Leases

The Company determines if an arrangement is a lease (as defined in ASC Topic 842, “Leases”) at the inception of the arrangement. The Company generally recognizes a right-of-use (“ROU”) asset, representing its right to use the underlying leased asset for the lease term, and a liability for its obligation to make future lease payments (the lease liability) at commencement date (the date on which the lessor makes the underlying asset available for use) based on the present value of lease payments over the lease term. The Company does not recognize ROU assets and lease liabilities for lease terms of 12 months or less, but recognizes such lease payments in operations on a straight-line basis over the lease terms.

As the Company’s leases typically do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

For real estate leases of office space, the Company accounts for the lease and non-lease components as a single lease component. Variable lease payments that do not depend on an index or rate (such as real estate taxes and building insurance and lessee’s shares thereof), if any, are excluded from lease payments at lease commencement date for initial measurement. Subsequent to initial measurement, these variable payments are recognized when the event determining the amount of variable consideration to be paid occurs.

Lease expense for operating lease payments is generally recognized on a straight-line basis over the lease term. The Company recognizes income from subleases (in which the Company is the sublessor) on a straight-line basis over the term of the sublease, as a reduction to lease expense.

See Note 9 for additional information related to the Company’s leases.

Stock-Based Compensation

Stock-Based Compensation

The Company accounts for stock-based compensation by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.

The fair value of stock options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected life of the awards and the expected stock price volatility over the terms of the awards. The expected life is based on the estimated average life of options and warrants using the simplified method; the Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The risk-free rate is based on the U.S. Treasury rate for the expected term at the time of grant, volatility is based on the historical volatility of the Company’s common stock, and the expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant, based on the quoted market price of the Company’s common shares on the NASDAQ Capital Market.

Non-employee awards are measured at the grant date fair value of the equity instruments to be issued, and the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant.

The Company accounts for forfeitures as a reduction of compensation cost in the period when such forfeitures occur.

For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant

performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

See Note 7 for additional information related to stock-based compensation.

Income Taxes

Income Taxes

Current income taxes are based on the respective period’s taxable income for federal and state income tax reporting purposes. Deferred tax assets and liabilities are determined based on the differences between the financial statement and income tax bases of assets and liabilities, using enacted tax rates and laws that will be in effect for the year in which the differences are expected to reverse.

A valuation allowance is recognized when necessary to reduce deferred tax assets to the amount expected to be realized. In determining the need for a valuation allowance, management reviews both positive and negative evidence, including current and historical results of operations, future income projections, and the overall prospects of the Company’s business. A valuation allowance is established if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company applies the FASB guidance on accounting for uncertainty in income taxes, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and also addresses derecognition, classification, interest, and penalties related to uncertain tax positions. The Company has no unrecognized tax benefits as of December 31, 2023 and 2022. Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2020 through December 31, 2023.

The income tax effects of changes in tax laws are recognized in the period when enacted.

See Note 10 for additional information related to income taxes.

Fair Value

Fair Value

ASC Topic 820, “Fair Value Measurement,” defines fair value and establishes a framework for measuring fair value under U.S. GAAP. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of the Company’s assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

Fair Value of Financial Instruments

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of term loan debt approximates fair value due to the floating interest rate structure of the term loan agreement.

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company limits its credit risk with respect to cash and cash equivalents by maintaining such balances with high quality financial institutions. At times, the Company’s cash and cash equivalents may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are not considered

significant due to the collection history and due to the nature of the Company’s royalty revenues. Generally, the Company does not require collateral or other security to support accounts receivable.

Earnings (Loss) Per Share

Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted earnings (loss) per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants using the treasury stock method. The difference between basic and diluted weighted-average common shares results from the assumption that all dilutive stock options and warrants outstanding were exercised into common stock if the effect is not anti-dilutive. See Note 8 for additional information related to earnings (loss) per share.

Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements

Recently Adopted Accounting Pronouncements

The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively, and is effective for fiscal years beginning after December 15, 2024. The Company does not anticipate that the adoption of this ASU will have a significant impact on its consolidated financial statements.

XML 39 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Rollforward of the allowance for doubtful accounts

($ in thousands)

    

Balance at December 31, 2022

$

Credit loss expense

 

787

Write-offs

 

Recoveries

 

Balance at December 31, 2023

$

787

XML 40 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities (Tables)
12 Months Ended
Dec. 31, 2023
Acquisitions, Divestitures and Variable Interest Entities[Abstract]  
Summarized financial information for IM Topco

Summarized financial information for IM Topco is as follows:

    

For the year ended

December 31,

($ in thousands)

2023

2022(1)

Revenues

$

12,119

$

7,791

Gross profit

12,119

7,791

(Loss) income from continuing operations

(1,961)

316

Net (loss) income

(1,961)

316

XML 41 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trademarks and Other Intangibles (Tables)
12 Months Ended
Dec. 31, 2023
Trademarks and Other Intangibles [Abstract]  
Schedule of Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

December 31, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

27,431

 

41,449

Copyrights and other intellectual property

 

8 years

 

429

 

358

 

71

Total

$

69,309

$

27,789

$

41,520

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

Schedule of Future Amortization Expense

Estimated future amortization expense related to finite-lived intangible assets over the remaining useful lives is as follows:

($ in thousands)

Amortization

Year Ending December 31, 

    

Expense

2024

$

6,115

2025

 

4,177

2026

 

3,506

2027

 

3,504

2028

 

3,504

Thereafter (through 2036)

 

20,714

Total

$

41,520

XML 42 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Contracts (Tables)
12 Months Ended
Dec. 31, 2023
Significant Contracts [Abstract]  
Schedule Of License Agreements

Xcel Commenced

Qurate

Agreement

    

Current Term Expiry

    

Automatic Renewal

    

Brand with Qurate

    

Product Launch

LOGO Qurate Agreement (QVC)

November 1, 2024

one-year period

April 2021

2009

Longaberger Qurate Agreement (QVC)

October 31, 2025

 

two-year period

 

November 2019

 

2019

C Wonder Qurate Agreement (HSN)

December 31, 2024

two-year period

March 2023

2023

XML 43 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt (Tables)
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Debt

The Company’s net carrying amount of debt was comprised of the following:

December 31, 

($ in thousands)

2023

    

2022

Term loan debt

$

5,000

$

Unamortized deferred finance costs related to term loan debt

 

(279)

 

Total

 

4,721

 

Current portion of debt

 

750

 

Long-term debt

$

3,971

$

Schedule of Maturities of Long-Term Debt

    

Amount of

($ in thousands)

Principal

Year Ending December 31, 

Payment

2024

$

750

2025

 

1,000

2026

1,000

2027

1,000

2028

 

1,250

Total

$

5,000

XML 44 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity for the Current Year is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

200,000

 

1.51

 

  

 

  

Exercised

 

(87,750)

 

0.80

 

  

 

  

Expired/Forfeited

 

(578,020)

 

2.96

 

  

 

  

Outstanding at December 31, 2023, and expected to vest

 

5,148,540

$

2.03

 

4.26

$

Exercisable at December 31, 2023

 

1,398,540

$

2.88

 

1.66

$

Schedule of Black-Scholes Assumptions for Fair Value of Options Granted

The fair values of the options granted were estimated at the respective dates of grant using the Black-Scholes option pricing model with the following range of assumptions:

Year Ended December 31, 

 

    

2023

    

2022

 

Expected Volatility

 

89 – 90

%  

57 – 93

%

Expected Dividend Yield

 

%  

%

Expected Life (Term, in years)

 

2.75 – 10

 

0.67 – 3.25

Risk-Free Interest Rate

 

4.0 – 4.7

%  

1.6 – 2.8

%

Schedule of options vesting upon achievement of target price

Target Prices

    

Number of Options Vesting

$3.00

1,000,000

$5.00

850,000

$7.00

700,000

$9.00

550,000

$11.00

400,000

Summary of Stock Option Activity for Non-Vested Options

The following table summarizes the Company’s stock option activity for non-vested options for the Current Year:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

200,000

 

0.68

Vested

 

(135,000)

0.68

Forfeited or Canceled

 

(12,500)

 

0.89

Balance at December 31, 2023

 

3,750,000

$

0.05

Summary of Restricted Stock Activity

A summary of the Company’s restricted stock activity for the Current Year is as follows:

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

113,968

 

1.01

Vested

 

(108,968)

 

1.08

Expired/Forfeited

 

(5,000)

 

1.62

Outstanding at December 31, 2023

 

333,333

$

3.69

Schedule Of Common Stock Repurchased

The following table provides information with respect to restricted stock purchased and retired by the Company during the Current Year and Prior Year:

Number of

Shares

Purchased as

Part of

Total Number

Actual

Publicly

Fair value of

of Shares

Price Paid

Announced

Re-Purchased

Date

    

Purchased

    

per Share

    

Plan

    

Shares

None

 

 

 

 

Total 2023

 

$

 

$

April 20, 2022 (i)

53,882

 

1.57

 

 

84,000

May 31, 2022 (i)

 

240,000

 

1.49

 

 

358,000

Total 2022

 

293,882

$

1.50

 

$

442,000

(i)The shares were exchanged from employees and directors in connection with the income tax withholding obligations on behalf of such employees and directors from the vesting of restricted stock or the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings (Loss) Per Share (Tables)
12 Months Ended
Dec. 31, 2023
Earnings (Loss) Per Share [Abstract]  
Schedule of the basic and diluted net loss per share

Year Ended

December 31, 

    

2023

    

2022

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(21,052)

$

(4,018)

Denominator:

Basic weighted average number of shares outstanding

19,711,637

 

19,624,669

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

19,711,637

 

19,624,669

Basic net loss per share

$

(1.07)

$

(0.20)

Diluted net per share

$

(1.07)

$

(0.20)

Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share

Year Ended December 31, 

2023

    

2022

Stock options

5,148,540

5,614,310

Warrants

1,116,065

116,065

Total

 

6,264,605

 

5,730,375

XML 46 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of total lease costs

($ in thousands)

    

2023

    

2022

Operating lease cost

$

1,337

$

1,474

Short-term lease cost

 

62

 

55

Variable lease cost

 

233

 

217

Sublease income

 

 

(104)

Total lease cost

$

1,632

$

1,642

Schedule of maturities of lease liabilities

As of December 31, 2023, the maturities of lease liabilities were as follows:

Amount

Year

    

(in thousands)

2024

$

1,552

2025

1,552

2026

 

1,552

2027

 

1,294

Total lease payments

5,950

Less: Discount

671

Present value of lease liabilities

5,279

Current portion of lease liabilities

1,258

Non-current portion of lease liabilities

$

4,021

Schedule of contracts with certain executives and key employees

The Company has employment contracts with certain executives and key employees. The future minimum payments under these contracts are as follows:

Employment

($ in thousands)

Contract

Year Ended December 31, 

    

Payments

2024

$

4,292

2025

 

2,150

2026

2,150

2027

2,150

2028

2,150

Thereafter

 

4,837

Total future minimum employment contract payments

$

17,729

XML 47 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Schedule of income tax benefit for federal and state and local income taxes

Years Ended December 31, 

($ in thousands)

    

2023

    

2022

Current:

 

  

 

  

Federal

$

22

$

300

State and local

 

83

 

234

Total current

 

105

 

534

Deferred:

 

  

 

  

Federal

 

727

 

(509)

State and local

 

380

 

(456)

Total deferred

 

1,107

 

(965)

Total provision (benefit)

$

1,212

$

(431)

Schedule of reconciliation of income tax benefit computed at the federal and state and local statutory rates

Years Ended December 31, 

    

2023

    

2022

 

U.S. statutory federal rate

 

21.00

%  

21.00

%

State and local rate, net of federal tax benefit

 

6.36

 

6.10

Stock compensation

 

(0.14)

 

(6.14)

Excess compensation deduction

 

(0.27)

 

(5.32)

Federal true-ups

 

0.18

 

(5.09)

Life insurance

 

(0.12)

 

(0.52)

Change in valuation allowance

 

(33.16)

 

Income tax (provision) benefit

 

(6.15)

%  

10.03

%

Schedule of components of net deferred tax assets (liabilities)

December 31, 

($ in thousands)

    

2023

    

2022

Deferred tax assets

 

  

 

  

Stock-based compensation

$

712

$

712

Federal, state and local net operating loss carryforwards

 

8,127

 

3,175

Accrued compensation and other accrued expenses

 

451

 

748

Allowance for doubtful accounts

 

231

 

Basis difference arising from discounted note payable

 

11

 

11

Charitable contribution carryover

 

1

 

Property and equipment

 

169

 

497

Interest expense

 

31

 

Total deferred tax assets

9,733

5,143

Valuation allowance

(6,537)

Total deferred tax assets, net of valuation allowance

3,196

5,143

Deferred tax liabilities

Basis difference arising from intangible assets of acquisition

 

(3,196)

 

(4,036)

Total deferred tax liabilities

 

(3,196)

 

(4,036)

Net deferred tax assets

$

$

1,107

XML 48 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of Operations, Background, and Basis of Presentation (Details)
12 Months Ended
Dec. 31, 2023
May 31, 2022
Longaberger Licensing, LLC | Variable Interest Entity, Primary Beneficiary    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%  
IM Topco, LLC    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Ownership interest   30.00%
ORME    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Ownership interest 30.00%  
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2023
Dec. 31, 2021
Nature of Operations, Background, and Basis of Presentation [Abstract]          
Net Income (Loss)   $ (21,052) $ (4,018)    
Non-cash expenses   9,000 8,200    
Accumulated deficit   (53,849) (32,797)    
Net cash used in operating activities   (6,545) (14,182)    
Working capital, Net   2,100 8,800    
Cash and cash equivalents   2,998 $ 4,608   $ 5,222
Reduction in payroll costs   6,000      
Reduction in operating expenses   9,000      
Term loan debt   $ 5,000   $ 5,000  
Total net proceeds from the sale of shares $ 2,000        
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Accounts Receivable (Details) - USD ($)
$ in Thousands
12 Months Ended
Oct. 17, 2023
Dec. 31, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]      
Accounts receivable   $ 3,454 $ 5,110
Allowance for doubtful accounts   787 0
Credit loss expense   787 400
Non-cash charge $ 760 760  
Earned revenue accrued but not billed   0 0
Accounts receivable, assigned to third party agent for collection   40 1,700
Accounts receivable, collection agent fees   $ 100 $ 100
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Rollforward of the allowance for credit losses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]    
Accounts receivable, allowance for credit loss, beginning balance $ 0  
Credit loss expense 787 $ 400
Write-offs   (1,500)
Accounts receivable, allowance for credit loss, ending balance $ 787 $ 0
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Property and Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Summary Of Significant Accounting Policies [Line Items]    
Depreciation, Excluding Lessor Asset under Operating Lease $ 0.8 $ 1.1
Operating Lease, Impairment Loss   $ 0.3
Minimum    
Summary Of Significant Accounting Policies [Line Items]    
Estimated useful lives of property and equipment (in years) 3 years  
Maximum    
Summary Of Significant Accounting Policies [Line Items]    
Estimated useful lives of property and equipment (in years) 7 years  
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Trademarks and Other Intangible Assets (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Summary Of Significant Accounting Policies [Line Items]    
Impairment charges on finite-lived intangible assets $ 0 $ 0
Minimum    
Summary Of Significant Accounting Policies [Line Items]    
Estimated useful life of finite-lived intangible asset (in years) 3 years  
Maximum    
Summary Of Significant Accounting Policies [Line Items]    
Estimated useful life of finite-lived intangible asset (in years) 18 years  
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Revenue Recognition (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Halston License  
Summary Of Significant Accounting Policies [Line Items]  
Deferred revenue $ 4.4
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Advertising Costs (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]    
Advertising cost during the period $ 1.0 $ 2.6
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Income Taxes (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]    
Unrecognized Tax Benefits $ 0.0 $ 0.0
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details)
1 Months Ended 12 Months Ended
May 31, 2022
USD ($)
shares
May 27, 2022
USD ($)
Y
shares
Nov. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Gain on sale of majority interest in Isaac Mizrahi brand         $ 20,586,000
Derecognition of trademarks $ 44,500,000        
Loss from equity method investment       $ (2,060,000) (1,202,000)
Members contribution       $ 150,000 600,000
Fair value of retained interest $ 19,800,000        
Disposal expenses   $ 900,000      
IM Topco, LLC          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Ownership interest 30.00%        
Company's noncontrolling ownership interest   30.00%      
IM Topco, LLC          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Ownership interest 70.00%     30.00%  
Members contribution   $ 600,000      
Royalty expense     $ 450,000    
Increase to the carrying value basis     $ 450,000    
WHP | IM Topco, LLC          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Ownership interest       70.00%  
IM Topco [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Loss from equity method investment       $ 2,100,000 1,200,000
Isaac Mizrahis          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Shares issued | shares 33,557        
Business Venture Agreement          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net cash flow distributable to members (in percent) 100.00%        
Net cash flow distributable to members $ 1,316,200        
Business Venture Agreement | WHP          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net cash flow distributable to members (in percent) 100.00%        
Net cash flow distributable to members $ 8,852,000        
IM Brand trademarks and other intellectual property rights | Disposed of by Sale          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Amount received in cash   46,200,000      
Legal and agent fees   100,000      
Gain on sale of majority interest in Isaac Mizrahi brand         $ 20,600,000
Earn-out consideration   2,000,000.0      
Amount of adjustments to retained interest   17,500,000      
EBITDA threshhold milestone   11,800,000      
Royalty guarantees   13,347,000      
Adjustments to purchase price payable   $ 16,000,000      
Number of consecutive quarters for royalty payable term | Y   4      
Royalty payable term   3 years      
Shares issued | shares   65,275      
IM Brand trademarks and other intellectual property rights | Disposed of by Sale | IM Topco, LLC          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Ownership interest   70.00%      
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Summarized financial information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Gross Profit $ 10,837 $ 17,801
Net (loss) income (22,237) (5,356)
IM Topco, LLC    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Revenues 12,119 7,791
Gross Profit 12,119 7,791
(Loss) income from continuing operations (1,961) 316
Net (loss) income $ (1,961) $ 316
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Investment in Orme Live, Inc. (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Asset Acquisition [Line Items]      
Members contribution   $ 150 $ 600
ORME      
Schedule Of Asset Acquisition [Line Items]      
Members contribution $ 150    
Ownership interest 30.00% 30.00%  
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Investment in Unconsolidated Affiliate (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Gain on sale of limited partner ownership interest $ 359  
Disposed of by Sale | Unconsolidated affiliate    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Carrying value   $ 100
Gain on sale of limited partner ownership interest $ 360  
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) - Longaberger Licensing, LLC
12 Months Ended
Dec. 31, 2023
Hilco Global  
Schedule Of Asset Acquisition [Line Items]  
Ownership interest 50.00%
Variable Interest Entity, Primary Beneficiary  
Schedule Of Asset Acquisition [Line Items]  
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trademarks and Other Intangibles - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets [Line Items]    
Amortization expense for intangible assets $ 6.1 $ 6.1
Trademarks (finite-lived)    
Goodwill and Intangible Assets [Line Items]    
Proceeds from sale of assets   $ 44.5
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Trademarks and Other Intangibles    
Gross Carrying Amount $ 69,309 $ 69,309
Accumulated Amortization 27,789 21,644
Total $ 41,520 $ 47,665
Copyrights and other intellectual property    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 8 years 8 years
Gross Carrying Amount $ 429 $ 429
Accumulated Amortization 358 298
Total $ 71 $ 131
Trademarks (finite-lived)    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 15 years 15 years
Gross Carrying Amount $ 68,880 $ 68,880
Accumulated Amortization 27,431 21,346
Total $ 41,449 $ 47,534
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trademarks and Other Intangibles - Schedule of Future Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Finite Lived Intangible Assets Future Amortization Expense:    
2024 $ 6,115  
2025 4,177  
2026 3,506  
2027 3,504  
2028 3,504  
Thereafter (through 2036) 20,714  
Total $ 41,520 $ 47,665
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Contracts - Schedule of License Agreements (Details)
12 Months Ended
Dec. 31, 2023
LOGO Qurate Agreement  
Current Term Expiry Nov. 01, 2024
Automatic Renewal 1 year
Xcel Commenced Brand with QVC April 2021
QVC Product Launch 2009
Longaberger Qurate Agreement  
Current Term Expiry Oct. 31, 2025
Automatic Renewal 2 years
Xcel Commenced Brand with QVC November 2019
QVC Product Launch 2019
C Wonder Qurate Agreement  
Current Term Expiry Dec. 31, 2024
Automatic Renewal 2 years
Xcel Commenced Brand with QVC March 2023
QVC Product Launch 2023
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Contracts - Qurate Agreements (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Product Information [Line Items]    
Net revenue $ 17,755 $ 25,781
Accounts receivable 3,454 5,110
Net licensing revenue    
Product Information [Line Items]    
Net revenue $ 9,156 $ 14,737
Sales [Member] | Customer Concentration Risk [Member] | Qurate    
Product Information [Line Items]    
Concentration Risk, Percentage 34.00% 44.00%
Sales [Member] | Customer Concentration Risk [Member] | Qurate | Net licensing revenue    
Product Information [Line Items]    
Net revenue $ 6,000 $ 11,400
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Qurate    
Product Information [Line Items]    
Concentration Risk, Percentage 43.00% 17.00%
Accounts receivable $ 1,500 $ 900
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Contracts - Halson Master License (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
May 15, 2023
Dec. 31, 2023
Dec. 31, 2022
Subsequent Event [Line Items]      
Purchaseable stock   19,795,053 19,624,860
Deferred revenue, current   $ 889 $ 88
Deferred revenue, long-term liability   3,556  
Licensing revenue   17,755 25,781
Contra-revenue related to warrants granted to licensee   26  
Net licensing revenue      
Subsequent Event [Line Items]      
Licensing revenue   9,156 $ 14,737
Halston License      
Subsequent Event [Line Items]      
Additional royalty payable term 20 years    
Total purchase price $ 5,000    
Warrant term 10 years    
Deferred revenue   4,400  
Deferred revenue, current   900  
Deferred revenue, long-term liability   $ 3,500  
Recognition period of deferred revenue   5 years  
Contra-revenue related to warrants granted to licensee   $ 30  
Halston License | Sales [Member] | Customer Concentration Risk [Member]      
Subsequent Event [Line Items]      
Concentration risk, percentage   9.00%  
Halston License | Minimum      
Subsequent Event [Line Items]      
Royalty payable term 5 years    
Halston License | Maximum      
Subsequent Event [Line Items]      
Royalty payable term 25 years    
Halston License | Warrants      
Subsequent Event [Line Items]      
Purchaseable stock 1,000,000    
Warrants outstanding, exercise price (in dollars per share) $ 1.50    
Number of shares vested   0  
Halston License | Net licensing revenue      
Subsequent Event [Line Items]      
Licensing revenue   $ 1,600  
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Narrative (Details) - USD ($)
12 Months Ended
Oct. 19, 2023
May 31, 2022
Dec. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2023
Debt            
Unamortized deferred finance costs       $ 800,000    
Repayment of principal         $ 29,000,000  
Prepayment fee   $ 1,400,000        
Interest and related expenses   300,000        
Loss on early extinguishment of debt         2,324,000  
Prepayment premium       1,400,000    
Other costs       100,000    
Unamortized deferred finance costs related to term loan debt       279,000    
Term loan debt       5,000,000   $ 5,000,000
Swap contract with IDB            
Debt            
Derivative, fixed interest rate 9.46%          
IM Intellectual Property            
Debt            
Cash proceeds from sale   30,100,000        
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Swap contract with IDB | IDB            
Debt            
Derivative, basis spread on variable rate 4.25%          
New Loan Agreement            
Debt            
Face amount of term loan     $ 29,000,000.0      
Percentage of closing fee     1.75%      
Legal and other fees     $ 500,000      
Deferred issuance cost     970,000      
Quarterly installment payment     625,000      
Final payment amount     $ 20,875,000      
Repayment of principal   $ 28,400,000        
Quarterly installment amount $ 250,000          
Unamortized deferred finance costs related to term loan debt 300,000          
Term loan debt $ 5,000,000.0     5,000,000    
New Loan Agreement | LIBOR            
Debt            
Stated interest rate (as percentage)     7.50%      
New Loan Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate            
Debt            
Stated interest rate (as percentage) 4.25%          
Xcel Term Loan            
Debt            
Floor rate of LIBOR (as percentage)     1.00%      
Interest Expense       $ 400,000 $ 1,200,000  
Effective interest rate (as percentage)       11.60% 9.80%  
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Net Carrying Amount of Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Oct. 31, 2023
Debt Disclosure [Abstract]    
Term loan debt $ 5,000 $ 5,000
Unamortized deferred finance costs related to term loan debt 279  
Total 4,721  
Current portion of debt 750  
Long-term debt $ 3,971  
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Xcel Term Loan Remaining Principal Payments (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Oct. 31, 2023
Oct. 19, 2023
Debt      
Total $ 5,000 $ 5,000  
New Loan Agreement      
Debt      
2024 750    
2025 1,000    
2026 1,000    
2027 1,000    
2028 1,250    
Total $ 5,000   $ 5,000
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Equity Incentive Plans (Details) - shares
Dec. 31, 2023
Dec. 31, 2022
Stockholders' Equity    
Shares of common stock reserved for issuance (in shares) 8,368,546  
2011 Equity Incentive Plan | Unexercised Stock Options    
Stockholders' Equity    
Shares of common stock reserved for issuance (in shares) 4,771,255  
2021 Equity Incentive Plan    
Stockholders' Equity    
Number of common stock eligible for issuance 4,000,000  
Shares are granted available for issuance (in shares) 3,103,941  
Shares of common stock reserved for issuance (in shares) 3,103,941 3,103,941
2021 Equity Incentive Plan | Unexercised Stock Options    
Stockholders' Equity    
Shares of common stock reserved for issuance (in shares) 493,350  
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Stockholders' Equity    
Compensation expense $ 220 $ 720
Operating cost 242 620
Other income   100
Non Management Directors    
Stockholders' Equity    
Compensation expense   310
Director and Consultants    
Stockholders' Equity    
Compensation expense 200  
Employee    
Stockholders' Equity    
Compensation expense $ 20 $ 410
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Aug. 23, 2023
Apr. 26, 2022
Apr. 20, 2022
Apr. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Other disclosures            
Compensation expense         $ 220 $ 720
Operating cost           $ 620
Authorized number of shares         51,000,000  
Number of common stock shares authorized         50,000,000 50,000,000
Authorized number of shares of preferred stock         1,000,000 1,000,000
Contra-revenue related to warrants granted to licensee         $ 26  
Employee            
Other disclosures            
Compensation expense         $ 20 $ 410
Non Management Directors            
Other disclosures            
Compensation expense           $ 310
Employee Stock Option [Member]            
Number of Options            
Outstanding, beginning balance (in shares)         5,614,310  
Granted (in shares)         200,000  
Exercised (in shares)         (87,750)  
Expired/Forfeited (in shares)         (578,020)  
Outstanding, ending balance (in shares)         5,148,540 5,614,310
Exercisable (in shares)         1,398,540  
Weighted Average Exercise Price            
Outstanding, beginning balance (in dollars per share)         $ 2.12  
Granted (in dollars per share)         1.51  
Exercised (in dollars per share)         0.80  
Expired/Forfeited (in dollars per share)         2.96  
Outstanding, ending balance (in dollars per share)         2.03 $ 2.12
Exercisable (in dollars per share)         $ 2.88  
Other disclosures            
Outstanding Weighted Average Remaining Contractual Life (in Years)         4 years 3 months 3 days 4 years 9 months 3 days
Exercisable Weighted Average Remaining Contractual Life (in Years)         1 year 7 months 28 days  
Vested (in shares)         135,000  
Compensation expense         $ 100 $ 500
Unrecognized compensation expense           $ 100
Weighted average period of recognition           1 year 18 days
Employee Stock Option [Member] | Employee            
Number of Options            
Granted (in shares)     380,850      
Weighted Average Exercise Price            
Granted (in dollars per share)     $ 1.62      
Employee Stock Option [Member] | Non Management Directors            
Number of Options            
Granted (in shares) 100,000     100,000    
Weighted Average Exercise Price            
Granted (in dollars per share) $ 1.51     $ 1.50    
Other disclosures            
Vested (in shares)         0  
Vesting rights (percentage per year) 50.00%          
Employee Stock Option [Member] | Management            
Number of Options            
Granted (in shares)     125,000      
Weighted Average Exercise Price            
Granted (in dollars per share)     $ 1.62      
Employee Stock Option [Member] | Consultant            
Number of Options            
Granted (in shares)   100,000        
Weighted Average Exercise Price            
Granted (in dollars per share)   $ 1.58        
Employee Stock Option [Member] | Five year expiration            
Stockholders' Equity            
Expiration period         5 years  
Employee Stock Option [Member] | Seven year expiration            
Stockholders' Equity            
Expiration period         7 years  
Employee Stock Option [Member] | Ten year expiration            
Stockholders' Equity            
Expiration period         10 years  
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Black-Scholes Assumptions for Options Granted (Details) - Employee Stock Option [Member]
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Stockholders' Equity    
Expected Volatility Rate, Minimum 89.00% 57.00%
Expected Volatility Rate, Maximum 90.00% 93.00%
Risk-Free Interest Rate, Minimum 4.00% 1.60%
Risk-Free Interest Rate, Maximum 4.70% 2.80%
Minimum    
Stockholders' Equity    
Expected Life (in years) 2 years 9 months 8 months 1 day
Maximum    
Stockholders' Equity    
Expected Life (in years) 10 years 3 years 3 months
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Outstanding and vesting options target prices (Details) - Performance Shares
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Stockholders' Equity  
Number of options vesting 3,500,000
Vested (in shares) 0
Target Price 1 [Member]  
Stockholders' Equity  
Number of options vesting 1,000,000
Share Price | $ / shares $ 3.00
Target Price 2 [Member]  
Stockholders' Equity  
Number of options vesting 850,000
Share Price | $ / shares $ 5.00
Target Price 3 [Member]  
Stockholders' Equity  
Number of options vesting 700,000
Share Price | $ / shares $ 7.00
Target Price 4 [Member]  
Stockholders' Equity  
Number of options vesting 550,000
Share Price | $ / shares $ 9.00
Target Price 5 [Member]  
Stockholders' Equity  
Number of options vesting 400,000
Share Price | $ / shares $ 11.00
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Non-Vested Options (Details) - Employee Stock Option [Member]
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Number of Options  
Beginning Balance (in shares) | shares 3,697,500
Granted (in shares) | shares 200,000
Vested (in shares) | shares (135,000)
Forfeited or Canceled (in shares) | shares (12,500)
Ending Balance (in shares) | shares 3,750,000
Weighted Average Grant Date Fair Value  
Beginning Balance (in dollars per share) | $ / shares $ 0.05
Granted (in dollars per share) | $ / shares 0.68
Vested (in dollars per share) | $ / shares 0.68
Forfeited or Canceled (in dollars per share) | $ / shares 0.89
Ending Balance (in dollars per share) | $ / shares $ 0.05
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Warrants (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
May 15, 2023
Other disclosures      
Purchaseable stock 19,795,053 19,624,860  
Compensation expense $ 220,000 $ 720,000  
Halston License      
Other disclosures      
Contra-revenue $ 30,000.00    
Warrants      
Number of Other than Options      
Outstanding and exercisable, beginning balance (in shares) 116,065    
Granted (in shares) 1,000,000    
Outstanding, ending balance (in shares) 1,116,065 116,065  
Exercisable (in shares) 116,065    
Weighted Average Exercise Price      
Outstanding and exercisable, beginning balance (in dollars per share) $ 3.15    
Granted (in dollars per share) 1.50    
Outstanding, ending balance (in dollars per share) 1.67 $ 3.15  
Exercisable, ending balance (in dollars per share) $ 3.15    
Weighted Average Remaining Contractual Life (in Years), Outstanding 8 years 6 months 16 days 1 year 7 months 27 days  
Weighted Average Contractual Life (in Years), Exercisable 7 months 27 days    
Other disclosures      
Compensation expense $ 0 $ 0  
Warrants | Halston License      
Other disclosures      
Purchaseable stock     1,000,000
Warrants | Five year expiration      
Stockholders' Equity      
Expiration period 5 years    
Warrants | Seven year expiration      
Stockholders' Equity      
Expiration period 7 years    
Warrants | Ten year expiration      
Stockholders' Equity      
Expiration period 10 years    
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Stock Awards (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 23, 2023
Jul. 20, 2023
May 15, 2023
Apr. 17, 2023
Jan. 01, 2023
May 31, 2022
Apr. 20, 2022
Apr. 20, 2021
Dec. 31, 2023
Dec. 31, 2022
Other disclosures                    
Compensation expense                 $ 220 $ 720
Non Management Directors                    
Number of Other than Options                    
Granted (in shares) 40,000                  
Other disclosures                    
Compensation expense                   310
Consultant                    
Number of Other than Options                    
Granted (in shares)     50,000 8,334 8,334          
Employee                    
Number of Other than Options                    
Granted (in shares)   7,300       33,557        
Other disclosures                    
Compensation expense                 $ 20 $ 410
Senior Management                    
Other disclosures                    
Unrecognized compensation expense             $ 280      
Restricted Stock                    
Number of Other than Options                    
Outstanding, beginning balance (in shares)         333,333       333,333  
Granted (in shares)                 113,968  
Vested (in shares)                 (108,968)  
Expired/Forfeited (in shares)                 (5,000)  
Outstanding, ending balance (in shares)                 333,333 333,333
Weighted Average Exercise Price                    
Outstanding, beginning balance (in dollars per share)         $ 3.71       $ 3.71  
Granted (in dollars per share)                 1.01  
Vested (in dollars per share)                 1.08  
Expired/Forfeited (in dollars per share)                 1.62  
Outstanding, ending balance (in dollars per share)                 $ 3.69 $ 3.71
Other disclosures                    
Compensation expense                 $ 100 $ 300
Unrecognized compensation expense                 $ 100  
Weighted average period of recognition                 1 year 21 days  
Restricted Stock | Isaac Mizrahis                    
Number of Other than Options                    
Vested (in shares)           (522,500)        
Restricted Stock | Non Management Directors                    
Number of Other than Options                    
Granted (in shares)             50,000      
Other disclosures                    
Award vesting period (in years)               2 years    
Restricted Stock | Consultant                    
Number of Other than Options                    
Granted (in shares)             20,064      
Restricted Stock | Consultant | Isaac Mizrahis                    
Number of Other than Options                    
Granted (in shares)           65,275        
Restricted Stock | Senior Management                    
Number of Other than Options                    
Granted (in shares)             178,727      
Common Stock | April 2023 | Non Management Directors                    
Other disclosures                    
Vesting rights (percentage per year)             50.00%      
Common Stock | April 2024 | Non Management Directors                    
Other disclosures                    
Vesting rights (percentage per year) 50.00%           50.00%      
Common Stock | April 2025 | Non Management Directors                    
Other disclosures                    
Vesting rights (percentage per year) 50.00%                  
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Black-Scholes option pricing assumptions (Details) - Restricted Stock - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
May 31, 2022
Apr. 30, 2022
Dec. 31, 2022
Stockholders' Equity      
Total Number of Shares Purchased 240,000 53,882 293,882
Actual Price Paid Per Share $ 1.49 $ 1.57 $ 1.50
Fair value of Re-Purchased Shares $ 358,000 $ 84,000 $ 442,000
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Restricted Stock Units (Details) - shares
Dec. 31, 2023
Dec. 31, 2022
Stockholders' Equity    
Common stock, shares outstanding (in shares) 19,795,053 19,624,860
Common stock, shares issued (in shares) 19,795,053 19,624,860
Restricted Stock    
Stockholders' Equity    
Common stock, shares outstanding (in shares) 0 0
Common stock, shares issued (in shares) 0  
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Earnings (Loss) Per Share [Abstract]    
Net loss attributable to Xcel Brands, Inc. stockholders $ (21,052) $ (4,018)
Basic weighted average number of shares outstanding 19,711,637 19,624,669
Diluted weighted average number of shares outstanding 19,711,637 19,624,669
Basic net loss income per share $ (1.07) $ (0.20)
Diluted net loss income per share $ (1.07) $ (0.20)
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 6,264,605 5,730,375
Employee Stock Option    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 5,148,540 5,614,310
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 1,116,065 116,065
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Narrative (Details)
$ in Thousands
12 Months Ended 24 Months Ended
May 31, 2022
USD ($)
item
Apr. 01, 2021
USD ($)
Feb. 11, 2019
USD ($)
Dec. 31, 2023
USD ($)
ft²
Dec. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
ft²
Commitments and Contingencies            
Operating lease expense           $ 1,600
Weighted average remaining lease term for operating leases       3 years 9 months 29 days   3 years 9 months 29 days
Weighted average discount rate       6.25%   6.25%
Cash payments for operating lease expense       $ 1,600 $ 1,700  
Cash received from subleasing         100  
Leased office space | ft²       1,300   1,300
Gain on settlement of lease liability       $ 445    
Contingent obligation       5,432 6,396 $ 5,432
Gain on reduction of contingent obligation         900  
Contingent obligation       17,729   $ 17,729
Gain on reduction of contingent obligation         900  
Plan            
Commitments and Contingencies            
Aggregate potential severance costs       $ 2,900    
Minimum            
Commitments and Contingencies            
Remaining lease term       5 years   5 years
Maximum            
Commitments and Contingencies            
Remaining lease term       7 years   7 years
Main Headquarters Lease            
Commitments and Contingencies            
Lease expiration date       Oct. 30, 2027    
Office Space Lease            
Commitments and Contingencies            
Term of operating leases sublease       Feb. 28, 2022    
Leased office space | ft²       29,600   29,600
Office Space Lease | Minimum            
Commitments and Contingencies            
Lease expiration date       Feb. 27, 2022    
Office Space Lease | Maximum            
Commitments and Contingencies            
Lease expiration date       Feb. 28, 2022    
Retail Site            
Commitments and Contingencies            
Impairment charge         700  
Gain on settlement of lease liability       $ 400    
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale            
Commitments and Contingencies            
Number of consecutive quarters for royalty payable term | item 4          
Royalty payable term 3 years          
Contingent obligation $ 0          
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | Maximum            
Commitments and Contingencies            
Royalty guarantees 13,300          
Adjustments to purchase price payable $ 16,000          
Halston Heritage            
Commitments and Contingencies            
Contingent consideration     $ 6,000      
Gain on reduction of contingent obligation         900  
Lori Goldstein Brand            
Commitments and Contingencies            
Contingent consideration   $ 12,500        
Contingent obligation       5,400 $ 6,400 $ 5,400
Royalties earned         6 years  
Contingent obligation (Lori Goldstein Earn-Out)   $ 6,600   200    
Additional consideration is payable to the seller       $ 1,000 $ 200  
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Company Lease Cost (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
Operating lease cost $ 1,337 $ 1,474
Short-term lease cost 62 55
Variable lease cost 233 217
Sublease income   (104)
Total lease cost $ 1,632 $ 1,642
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Future Minimum Lease Payments (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
2024 $ 1,552  
2025 1,552  
2026 1,552  
2027 1,294  
Total lease payments 5,950  
Less: Discount 671  
Present value of lease liabilities 5,279  
Current portion of lease liabilities 1,258 $ 1,376
Non-current portion of lease liabilities $ 4,021 $ 5,839
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Future Minimum Payments under Employment Contracts (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2024 $ 4,292
2025 2,150
2026 2,150
2027 2,150
2028 2,150
Thereafter 4,837
Total future minimum employment contract payments $ 17,729
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2017
Operating Loss Carryforwards      
Operating loss carryforward available to offset future taxable income $ 28,600 $ 10,900 $ 300
Change in valuation allowance 6,537    
Indefinite Life      
Operating Loss Carryforwards      
Operating loss carryforward available to offset future taxable income $ 28,300    
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Income Tax Benefit (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Current:    
Federal $ 22 $ 300
State and local 83 234
Total current 105 534
Deferred:    
Federal 727 (509)
State and local 380 (456)
Total deferred 1,107 (965)
Total provision (benefit) $ 1,212 $ (431)
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Reconciliation of Income Tax Rates (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Taxes    
U.S. statutory federal rate 21.00% 21.00%
State and local rate, net of federal tax benefit 6.36% 6.10%
Stock compensation (0.14%) (6.14%)
Excess compensation deduction (0.27%) (5.32%)
Federal true-ups 0.18% (5.09%)
Life insurance (0.12%) (0.52%)
Change in valuation allowance (33.16%)  
Income tax (provision) benefit (6.15%) 10.03%
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Net Deferred Tax Assets (Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets    
Stock-based compensation $ 712 $ 712
Federal, state and local net operating loss carryforwards 8,127 3,175
Accrued compensation and other accrued expenses 451 748
Allowance for doubtful accounts 231  
Basis difference arising from discounted note payable 11 11
Charitable contribution carryover 1  
Property and equipment 169 497
Interest expense 31  
Total deferred tax assets 9,733 5,143
Valuation allowance (6,537)  
Total deferred tax assets, net of valuation allowance 3,196 5,143
Deferred tax liabilities    
Basis difference arising from intangible assets of acquisition (3,196) (4,036)
Total deferred tax liabilities $ (3,196) (4,036)
Net deferred tax assets   $ 1,107
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions - IM Topco, LLC (Details) - IM Topco [Member] - USD ($)
1 Months Ended 12 Months Ended
Nov. 30, 2023
Dec. 31, 2023
Dec. 16, 2022
May 31, 2022
Services Agreement        
Asset Purchase Agreement        
Due from related party       $ 300,000
Reduction in service fees $ 600,000      
Revenue from services provided   $ 150,000    
License Agreement        
Asset Purchase Agreement        
Royalty guarantees     $ 325,000 $ 400,000
Additional royalty payments $ 450,000      
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions - Isaac Mizrahi (Details)
12 Months Ended
May 31, 2022
USD ($)
shares
Feb. 24, 2022
USD ($)
Feb. 24, 2020
USD ($)
item
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 16, 2022
USD ($)
Restricted Stock              
Asset Purchase Agreement              
Number of shares vested | shares       108,968      
Isaac Mizrahis              
Asset Purchase Agreement              
Base Salary       $ 2,100,000 $ 2,000,000.0 $ 1,800,000  
Initial cash bonus basis for Calculation     $ 2,500,000        
Subsequent cash bonus basis for Calculation     $ 3,000,000.0        
DRT Bonus     10.00%        
Bricks-and-Mortar Bonus     10.00%        
Endorsement Bonus     40.00%        
Monday bonus per appearance     $ 10,000        
Maximum appearances eligible for Monday bonus | item     40        
Shares surrendered for cancellation | shares 240,000            
Additional shares issued | shares 33,557            
Payments to related party $ 100,000            
Value of shares issued $ 50,000            
Isaac Mizrahis | Restricted Stock              
Asset Purchase Agreement              
Number of shares vested | shares 522,500            
IM Topco [Member] | Services Agreement              
Asset Purchase Agreement              
Due from related party $ 300,000            
Revenue from services provided       $ 150,000      
IM Topco [Member] | License Agreement              
Asset Purchase Agreement              
Royalty guarantees $ 400,000           $ 325,000
Related Party [Member] | Isaac Mizrahis | Laugh Club Annual Fee [Member]              
Asset Purchase Agreement              
Related Party Costs   $ 720,000          
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions - ORME (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 04, 2023
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Members contribution     $ 150,000 $ 600,000
ORME        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Members contribution   $ 150,000    
Ownership interest   30.00% 30.00%  
Related Party [Member] | ORME        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Members contribution $ 150,000      
Ownership interest 30.00%      
Related Party [Member] | ORME | Director        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Ownership interest 20.00%      
XML 94 R75.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 12, 2024
Mar. 19, 2024
Mar. 15, 2024
Mar. 14, 2024
Feb. 16, 2024
Jan. 26, 2024
Jan. 12, 2024
May 31, 2022
May 27, 2022
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Subsequent Event [Line Items]                        
Lease cost over the term of lease                     $ 1,632,000 $ 1,642,000
Term of sublease                       104,000
Impairment charge                       $ 300,000
Purchaseable stock                     19,795,053 19,624,860
Common stock issued                     19,795,053 19,624,860
Total net proceeds from the sale of shares                   $ 2,000,000    
Disposal expenses                 $ 900,000      
Business Venture Agreement                        
Subsequent Event [Line Items]                        
Net cash flow distributable to members (in percent)               100.00%        
Net cash flow distributable to members               $ 1,316,200        
WHP | Business Venture Agreement                        
Subsequent Event [Line Items]                        
Net cash flow distributable to members (in percent)               100.00%        
Net cash flow distributable to members               $ 8,852,000        
IM Topco, LLC                        
Subsequent Event [Line Items]                        
Ownership interest               70.00%     30.00%  
IM Topco, LLC | WHP                        
Subsequent Event [Line Items]                        
Ownership interest                     70.00%  
Subsequent Events                        
Subsequent Event [Line Items]                        
Lease cost over the term of lease             $ 500,000          
Term of sublease           $ 800,000            
Impairment charge           $ 2,100,000            
Term of lease             7 years          
Additional consideration is payable to the seller         $ 963,642              
Subsequent Events | IM Topco, LLC                        
Subsequent Event [Line Items]                        
Ownership interest 30.00%                      
Subsequent Events | IM Topco, LLC | If Royalties Receivable Less Than Specified Amount                        
Subsequent Event [Line Items]                        
Ownership interest 17.50%                      
Subsequent Events | IM Topco, LLC | Twelve-month period ending March 31, 2025                        
Subsequent Event [Line Items]                        
Threshold royalties below which the equity interest would be transferable $ 13,500,000                      
Subsequent Events | IM Topco, LLC | Year ending December 31, 2025                        
Subsequent Event [Line Items]                        
Threshold royalties below which the equity interest would be transferable $ 18,000,000.0                      
Subsequent Events | IM Topco, LLC | WHP                        
Subsequent Event [Line Items]                        
Ownership interest 70.00%                      
Subsequent Events | IM Topco, LLC | WHP | Business Venture Agreement                        
Subsequent Event [Line Items]                        
Net cash flow distributable to members (in percent) 50.00%                      
Net cash flow distributable to members $ 1,000,000.0                      
Subsequent Events | IM Topco, LLC | WHP | If Royalties Receivable Less Than Specified Amount                        
Subsequent Event [Line Items]                        
Ownership interest 82.50%                      
Ownership equity transferable 12.50%                      
Certain payments owed $ 375,000                      
Subsequent Events | Warrants                        
Subsequent Event [Line Items]                        
Purchaseable stock   178,953                    
Warrants outstanding, exercise price (in dollars per share)   $ 0.8125                    
Warrant term   4 years 6 months                    
Subsequent Events | Public Offering and Private Placement [Member]                        
Subsequent Event [Line Items]                        
Common stock issued     3,579,063                  
Total net proceeds from the sale of shares     $ 2,000,000                  
Subsequent Events | Public Offering [Member]                        
Subsequent Event [Line Items]                        
Purchaseable stock     3,284,421                  
Common stock price     $ 0.65                  
Net proceeds from the sale of shares   $ 1,735,000                    
Subsequent Events | Private Placement [Member]                        
Subsequent Event [Line Items]                        
Common stock price       $ 0.98                
Net proceeds from the sale of private placement shares       $ 265,000                
Subsequent Events | Agreements [Member] | Private Placement [Member]                        
Subsequent Event [Line Items]                        
Common stock issued       294,642                
Subsequent Events | Chief Executive Officer | Public Offering [Member]                        
Subsequent Event [Line Items]                        
Common stock issued     146,250                  
Subsequent Events | Chief Executive Officer | Private Placement [Member]                        
Subsequent Event [Line Items]                        
Common stock issued       132,589                
Subsequent Events | Director | Public Offering [Member]                        
Subsequent Event [Line Items]                        
Common stock issued     146,250                  
Subsequent Events | Director | Private Placement [Member]                        
Subsequent Event [Line Items]                        
Common stock issued       132,589                
Subsequent Events | Executive Vice President [Member] | Public Offering [Member]                        
Subsequent Event [Line Items]                        
Common stock issued     32,500                  
Subsequent Events | Executive Vice President [Member] | Private Placement [Member]                        
Subsequent Event [Line Items]                        
Common stock issued       29,464                
XML 95 R76.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure    
Net Income (Loss) $ (21,052) $ (4,018)
XML 96 R77.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
EXCEL 97 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 98 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 99 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 101 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 254 438 1 false 92 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation Nature of Operations, Background, and Basis of Presentation Notes 7 false false R8.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 10301 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities Sheet http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities Notes 9 false false R10.htm 10401 - Disclosure - Trademarks and Other Intangibles Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles Trademarks and Other Intangibles Notes 10 false false R11.htm 10501 - Disclosure - Significant Contracts Sheet http://www.xcelbrands.com/role/DisclosureSignificantContracts Significant Contracts Notes 11 false false R12.htm 10601 - Disclosure - Debt Sheet http://www.xcelbrands.com/role/DisclosureDebt Debt Notes 12 false false R13.htm 10701 - Disclosure - Stockholders' Equity Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 13 false false R14.htm 10801 - Disclosure - Earnings (Loss) Per Share Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare Earnings (Loss) Per Share Notes 14 false false R15.htm 10901 - Disclosure - Commitments and Contingencies Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 11001 - Disclosure - Income Taxes Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxes Income Taxes Notes 16 false false R17.htm 11101 - Disclosure - Related Party Transactions Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 11201 - Disclosure - Subsequent Events Sheet http://www.xcelbrands.com/role/DisclosureSubsequentEvents Subsequent Events Notes 18 false false R19.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPolicies 20 false false R21.htm 30303 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities (Tables) Sheet http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesTables Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities (Tables) Tables http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities 21 false false R22.htm 30403 - Disclosure - Trademarks and Other Intangibles (Tables) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables Trademarks and Other Intangibles (Tables) Tables http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles 22 false false R23.htm 30503 - Disclosure - Significant Contracts (Tables) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsTables Significant Contracts (Tables) Tables http://www.xcelbrands.com/role/DisclosureSignificantContracts 23 false false R24.htm 30603 - Disclosure - Debt (Tables) Sheet http://www.xcelbrands.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.xcelbrands.com/role/DisclosureDebt 24 false false R25.htm 30703 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.xcelbrands.com/role/DisclosureStockholdersEquity 25 false false R26.htm 30803 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare 26 false false R27.htm 30903 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies 27 false false R28.htm 31003 - Disclosure - Income Taxes (Tables) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.xcelbrands.com/role/DisclosureIncomeTaxes 28 false false R29.htm 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails Nature of Operations, Background, and Basis of Presentation (Details) Details http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation 29 false false R30.htm 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) Details 30 false false R31.htm 40201 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails Summary of Significant Accounting Policies - Accounts Receivable (Details) Details 31 false false R32.htm 40202 - Disclosure - Summary of Significant Accounting Policies - Rollforward of the allowance for credit losses (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRollforwardOfAllowanceForCreditLossesDetails Summary of Significant Accounting Policies - Rollforward of the allowance for credit losses (Details) Details 32 false false R33.htm 40203 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Property and Equipment (Details) Details 33 false false R34.htm 40204 - Disclosure - Summary of Significant Accounting Policies - Trademarks and Other Intangible Assets (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails Summary of Significant Accounting Policies - Trademarks and Other Intangible Assets (Details) Details 34 false false R35.htm 40205 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails Summary of Significant Accounting Policies - Revenue Recognition (Details) Details 35 false false R36.htm 40206 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdvertisingCostsDetails Summary of Significant Accounting Policies - Advertising Costs (Details) Details 36 false false R37.htm 40207 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails Summary of Significant Accounting Policies - Income Taxes (Details) Details 37 false false R38.htm 40301 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) Sheet http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) Details 38 false false R39.htm 40302 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Summarized financial information (Details) Sheet http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Summarized financial information (Details) Details 39 false false R40.htm 40303 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Investment in Orme Live, Inc. (Details) Sheet http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Investment in Orme Live, Inc. (Details) Details 40 false false R41.htm 40304 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Investment in Unconsolidated Affiliate (Details) Sheet http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Investment in Unconsolidated Affiliate (Details) Details 41 false false R42.htm 40305 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) Sheet http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) Details 42 false false R43.htm 40401 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails Trademarks and Other Intangibles - Narrative (Details) Details 43 false false R44.htm 40402 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Details 44 false false R45.htm 40403 - Disclosure - Trademarks and Other Intangibles - Schedule of Future Amortization Expense (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails Trademarks and Other Intangibles - Schedule of Future Amortization Expense (Details) Details 45 false false R46.htm 40501 - Disclosure - Significant Contracts - Schedule of License Agreements (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails Significant Contracts - Schedule of License Agreements (Details) Details 46 false false R47.htm 40502 - Disclosure - Significant Contracts - Qurate Agreements (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails Significant Contracts - Qurate Agreements (Details) Details 47 false false R48.htm 40503 - Disclosure - Significant Contracts - Halson Master License (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails Significant Contracts - Halson Master License (Details) Details 48 false false R49.htm 40601 - Disclosure - Debt - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails Debt - Narrative (Details) Details 49 false false R50.htm 40602 - Disclosure - Debt - Net Carrying Amount of Debt (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails Debt - Net Carrying Amount of Debt (Details) Details 50 false false R51.htm 40603 - Disclosure - Debt - Xcel Term Loan Remaining Principal Payments (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails Debt - Xcel Term Loan Remaining Principal Payments (Details) Details 51 false false R52.htm 40701 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails Stockholders' Equity - Equity Incentive Plans (Details) Details 52 false false R53.htm 40702 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails Stockholders' Equity - Stock-based Compensation (Details) Details 53 false false R54.htm 40703 - Disclosure - Stockholders' Equity - Stock Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails Stockholders' Equity - Stock Options (Details) Details 54 false false R55.htm 40704 - Disclosure - Stockholders' Equity - Black-Scholes Assumptions for Options Granted (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails Stockholders' Equity - Black-Scholes Assumptions for Options Granted (Details) Details 55 false false R56.htm 40705 - Disclosure - Stockholders' Equity - Outstanding and vesting options target prices (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails Stockholders' Equity - Outstanding and vesting options target prices (Details) Details 56 false false R57.htm 40706 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails Stockholders' Equity - Non-Vested Options (Details) Details 57 false false R58.htm 40707 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 58 false false R59.htm 40708 - Disclosure - Stockholders' Equity - Stock Awards (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails Stockholders' Equity - Stock Awards (Details) Details 59 false false R60.htm 40709 - Disclosure - Stockholders' Equity - Black-Scholes option pricing assumptions (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails Stockholders' Equity - Black-Scholes option pricing assumptions (Details) Details 60 false false R61.htm 40710 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails Stockholders' Equity - Restricted Stock Units (Details) Details 61 false false R62.htm 40801 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 62 false false R63.htm 40802 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 63 false false R64.htm 40901 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 64 false false R65.htm 40902 - Disclosure - Commitments and Contingencies - Company Lease Cost (Details) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails Commitments and Contingencies - Company Lease Cost (Details) Details 65 false false R66.htm 40903 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments (Details) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails Commitments and Contingencies - Future Minimum Lease Payments (Details) Details 66 false false R67.htm 40904 - Disclosure - Commitments and Contingencies - Future Minimum Payments under Employment Contracts (Details) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails Commitments and Contingencies - Future Minimum Payments under Employment Contracts (Details) Details 67 false false R68.htm 41001 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 68 false false R69.htm 41002 - Disclosure - Income Taxes - Income Tax Benefit (Details) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails Income Taxes - Income Tax Benefit (Details) Details 69 false false R70.htm 41003 - Disclosure - Income Taxes - Reconciliation of Income Tax Rates (Details) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails Income Taxes - Reconciliation of Income Tax Rates (Details) Details 70 false false R71.htm 41004 - Disclosure - Income Taxes - Net Deferred Tax Assets (Liabilities) (Details) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails Income Taxes - Net Deferred Tax Assets (Liabilities) (Details) Details 71 false false R72.htm 41101 - Disclosure - Related Party Transactions - IM Topco, LLC (Details) Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails Related Party Transactions - IM Topco, LLC (Details) Details 72 false false R73.htm 41102 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details) Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails Related Party Transactions - Isaac Mizrahi (Details) Details 73 false false R74.htm 41103 - Disclosure - Related Party Transactions - ORME (Details) Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails Related Party Transactions - ORME (Details) Details 74 false false R75.htm 41201 - Disclosure - Subsequent Events - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails Subsequent Events - Narrative (Details) Details 75 false false R76.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Uncategorized 76 false false R77.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Cover 77 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 25 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:WarrantsAndRightsOutstandingTerm, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, xelb:AssetAcquisitionRoyaltiesTerm, xelb:ClassOfWarrantOrRightExercisableInPeriodWeightedAverageRemainingContractualTerm, xelb:ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm - xelb-20231231x10k.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - xelb-20231231x10k.htm 9 [dq-0712-Presentation-Base-Set-Order] Role '41201 - Disclosure - Subsequent Events - Narrative (Details)', a level 4, Detail role, appears before '995410 - Disclosure - Pay vs Performance Disclosure', a level 1, Note role. https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd 30, xelb-20231231.xsd 315 xelb-20231231.xsd xelb-20231231_cal.xml xelb-20231231_def.xml xelb-20231231_lab.xml xelb-20231231_pre.xml xelb-20231231x10k.htm http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 104 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "xelb-20231231x10k.htm": { "nsprefix": "xelb", "nsuri": "http://www.xcelbrands.com/20231231", "dts": { "schema": { "local": [ "xelb-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] }, "calculationLink": { "local": [ "xelb-20231231_cal.xml" ] }, "definitionLink": { "local": [ "xelb-20231231_def.xml" ] }, "labelLink": { "local": [ "xelb-20231231_lab.xml" ] }, "presentationLink": { "local": [ "xelb-20231231_pre.xml" ] }, "inline": { "local": [ "xelb-20231231x10k.htm" ] } }, "keyStandard": 361, "keyCustom": 77, "axisStandard": 34, "axisCustom": 1, "memberStandard": 35, "memberCustom": 51, "hidden": { "total": 33, "http://fasb.org/us-gaap/2023": 25, "http://xbrl.sec.gov/dei/2023": 4, "http://www.xcelbrands.com/20231231": 4 }, "contextCount": 254, "entityCount": 1, "segmentCount": 92, "elementCount": 761, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 722, "http://xbrl.sec.gov/dei/2023": 36, "http://xbrl.sec.gov/ecd/2023": 4, "http://fasb.org/srt/2023": 1 }, "report": { "R1": { "role": "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "longName": "00100 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical", "longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_3PuS6JGquECEOruNy3Q6EQ", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_3PuS6JGquECEOruNy3Q6EQ", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "longName": "00200 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R5": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity", "longName": "00300 - Statement - Consolidated Statements of Stockholders' Equity", "shortName": "Consolidated Statements of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0K7QSFrU-EWBfx4sQ7bdZg", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0K7QSFrU-EWBfx4sQ7bdZg", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "00400 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AssetImpairmentCharges", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R7": { "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation", "longName": "10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation", "shortName": "Nature of Operations, Background, and Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "longName": "10201 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities", "longName": "10301 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities", "shortName": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "xelb:AcquisitionsDivestituresAndVariableInterestEntities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "xelb:AcquisitionsDivestituresAndVariableInterestEntities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles", "longName": "10401 - Disclosure - Trademarks and Other Intangibles", "shortName": "Trademarks and Other Intangibles", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContracts", "longName": "10501 - Disclosure - Significant Contracts", "shortName": "Significant Contracts", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "xelb:SignificantContractsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "xelb:SignificantContractsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.xcelbrands.com/role/DisclosureDebt", "longName": "10601 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquity", "longName": "10701 - Disclosure - Stockholders' Equity", "shortName": "Stockholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare", "longName": "10801 - Disclosure - Earnings (Loss) Per Share", "shortName": "Earnings (Loss) Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies", "longName": "10901 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxes", "longName": "11001 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions", "longName": "11101 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.xcelbrands.com/role/DisclosureSubsequentEvents", "longName": "11201 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "20202 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "19", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "longName": "30203 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesTables", "longName": "30303 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities (Tables)", "shortName": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables", "longName": "30403 - Disclosure - Trademarks and Other Intangibles (Tables)", "shortName": "Trademarks and Other Intangibles (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsTables", "longName": "30503 - Disclosure - Significant Contracts (Tables)", "shortName": "Significant Contracts (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "xelb:ScheduleOfLicenseAgreementsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "xelb:SignificantContractsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "xelb:ScheduleOfLicenseAgreementsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "xelb:SignificantContractsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.xcelbrands.com/role/DisclosureDebtTables", "longName": "30603 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables", "longName": "30703 - Disclosure - Stockholders' Equity (Tables)", "shortName": "Stockholders' Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables", "longName": "30803 - Disclosure - Earnings (Loss) Per Share (Tables)", "shortName": "Earnings (Loss) Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesTables", "longName": "30903 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesTables", "longName": "31003 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "longName": "40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details)", "shortName": "Nature of Operations, Background, and Basis of Presentation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_vZwMEKQorkqoQNuPvPiE4Q", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "longName": "40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details)", "shortName": "Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:OtherNoncashExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R31": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails", "longName": "40201 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable (Details)", "shortName": "Summary of Significant Accounting Policies - Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_17_2023_To_10_17_2023_0UtbvSpTuEmnBnurJpHDCA", "name": "xelb:RevenueRecognitionMilestoneMethodNonCashChargeWriteDown", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R32": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRollforwardOfAllowanceForCreditLossesDetails", "longName": "40202 - Disclosure - Summary of Significant Accounting Policies - Rollforward of the allowance for credit losses (Details)", "shortName": "Summary of Significant Accounting Policies - Rollforward of the allowance for credit losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "As_Of_12_31_2022_ufvg0Lpz1Uu3i4lnsRy5yA", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:ReceivablesPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2022_QFBeyjaujUOgNXfyXiDZbg", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R33": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "longName": "40203 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)", "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails", "longName": "40204 - Disclosure - Summary of Significant Accounting Policies - Trademarks and Other Intangible Assets (Details)", "shortName": "Summary of Significant Accounting Policies - Trademarks and Other Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "p", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "p", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails", "longName": "40205 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)", "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "As_Of_12_31_2023_srt_CounterpartyNameAxis_xelb_HalstonBrandMember_hucMk3DuMk6_Ou3OeHOwlQ", "name": "us-gaap:DeferredRevenue", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R36": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdvertisingCostsDetails", "longName": "40206 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details)", "shortName": "Summary of Significant Accounting Policies - Advertising Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AdvertisingExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:AdvertisingCostsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AdvertisingExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:AdvertisingCostsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails", "longName": "40207 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details)", "shortName": "Summary of Significant Accounting Policies - Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "p", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "p", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "longName": "40301 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details)", "shortName": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2022_QFBeyjaujUOgNXfyXiDZbg", "name": "us-gaap:GainLossOnDispositionOfAssets1", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_5_31_2022_70_oibkptk-02nNJ90MKOg", "name": "xelb:DerecognitionOfIntangibleAssets", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R39": { "role": "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "longName": "40302 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Summarized financial information (Details)", "shortName": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Summarized financial information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:GrossProfit", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_srt_OwnershipAxis_xelb_IMTopcoLLCMember_Snmb0IB7nkGFIzNetMBy8A", "name": "us-gaap:Revenues", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R40": { "role": "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "longName": "40303 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Investment in Orme Live, Inc. (Details)", "shortName": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Investment in Orme Live, Inc. (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R41": { "role": "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "longName": "40304 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Investment in Unconsolidated Affiliate (Details)", "shortName": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Sale of Investment in Unconsolidated Affiliate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "xelb:GainLossOnSaleOfLimitedPartnerOwnershipInterest", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2022_srt_OwnershipAxis_xelb_UnconsolidatedAffiliateMember_us-gaap_DisposalGroupClassificationAxis_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_NXjGaT3idkSSnm1hp5EQuw", "name": "us-gaap:MinorityInterestInLimitedPartnerships", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R42": { "role": "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "longName": "40305 - Disclosure - Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details)", "shortName": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "As_Of_12_31_2023_dei_LegalEntityAxis_xelb_HilcoGlobalMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_PSSKmKqXC065N4zjsm6tDA", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_dei_LegalEntityAxis_xelb_HilcoGlobalMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_PSSKmKqXC065N4zjsm6tDA", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails", "longName": "40401 - Disclosure - Trademarks and Other Intangibles - Narrative (Details)", "shortName": "Trademarks and Other Intangibles - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "us-gaap:AmortizationOfIntangibleAssets", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "us-gaap:AmortizationOfIntangibleAssets", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails", "longName": "40402 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "shortName": "Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails", "longName": "40403 - Disclosure - Trademarks and Other Intangibles - Schedule of Future Amortization Expense (Details)", "shortName": "Trademarks and Other Intangibles - Schedule of Future Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails", "longName": "40501 - Disclosure - Significant Contracts - Schedule of License Agreements (Details)", "shortName": "Significant Contracts - Schedule of License Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_xelb_AgreementTypeAxis_xelb_LogoQurateAgreementMember_-yFy1DNPnUWXBGvCnGm9Yg", "name": "xelb:CurrentTermExpiry", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "td", "tr", "table", "xelb:ScheduleOfLicenseAgreementsTableTextBlock", "xelb:SignificantContractsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_xelb_AgreementTypeAxis_xelb_LogoQurateAgreementMember_-yFy1DNPnUWXBGvCnGm9Yg", "name": "xelb:CurrentTermExpiry", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "td", "tr", "table", "xelb:ScheduleOfLicenseAgreementsTableTextBlock", "xelb:SignificantContractsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "longName": "40502 - Disclosure - Significant Contracts - Qurate Agreements (Details)", "shortName": "Significant Contracts - Qurate Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_xelb_QurateRetailGroupMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_OF1gYb1o70iOD2_05SVWdg", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R48": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "longName": "40503 - Disclosure - Significant Contracts - Halson Master License (Details)", "shortName": "Significant Contracts - Halson Master License (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "As_Of_12_31_2022_ufvg0Lpz1Uu3i4lnsRy5yA", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_5_15_2023_To_5_15_2023_srt_CounterpartyNameAxis_xelb_HalstonBrandMember_EA6-UUgsd0aV585Qbqgknw", "name": "xelb:AdditionalRoyaltyPayableTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R49": { "role": "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "longName": "40601 - Disclosure - Debt - Narrative (Details)", "shortName": "Debt - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:WriteOffOfDeferredDebtIssuanceCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:WriteOffOfDeferredDebtIssuanceCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "longName": "40602 - Disclosure - Debt - Net Carrying Amount of Debt (Details)", "shortName": "Debt - Net Carrying Amount of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:LongTermDebt", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R51": { "role": "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails", "longName": "40603 - Disclosure - Debt - Xcel Term Loan Remaining Principal Payments (Details)", "shortName": "Debt - Xcel Term Loan Remaining Principal Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DebtInstrumentAxis_xelb_NewLoanAndSecurityAgreementMember_JzrJGfw840aaYkJA0BG39g", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R52": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "longName": "40701 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details)", "shortName": "Stockholders' Equity - Equity Incentive Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "longName": "40702 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details)", "shortName": "Stockholders' Equity - Stock-based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2022_QFBeyjaujUOgNXfyXiDZbg", "name": "us-gaap:OtherIncome", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R54": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "longName": "40703 - Disclosure - Stockholders' Equity - Stock Options (Details)", "shortName": "Stockholders' Equity - Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2022_QFBeyjaujUOgNXfyXiDZbg", "name": "us-gaap:OperatingExpenses", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R55": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "longName": "40704 - Disclosure - Stockholders' Equity - Black-Scholes Assumptions for Options Granted (Details)", "shortName": "Stockholders' Equity - Black-Scholes Assumptions for Options Granted (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_22NqCfJtE0GYq1wmk_TdFg", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_22NqCfJtE0GYq1wmk_TdFg", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "longName": "40705 - Disclosure - Stockholders' Equity - Outstanding and vesting options target prices (Details)", "shortName": "Stockholders' Equity - Outstanding and vesting options target prices (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_iBSVrnEv00iXxFk23S-CHQ", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_iBSVrnEv00iXxFk23S-CHQ", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "longName": "40706 - Disclosure - Stockholders' Equity - Non-Vested Options (Details)", "shortName": "Stockholders' Equity - Non-Vested Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_fZ37nQKXu0qmH8VNuNSEag", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_fZ37nQKXu0qmH8VNuNSEag", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "longName": "40707 - Disclosure - Stockholders' Equity - Warrants (Details)", "shortName": "Stockholders' Equity - Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "As_Of_12_31_2022_ufvg0Lpz1Uu3i4lnsRy5yA", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_srt_CounterpartyNameAxis_xelb_HalstonBrandMember_AVacTx7HD0iTKmdgevxDbQ", "name": "xelb:ContraRevenue", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R59": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "longName": "40708 - Disclosure - Stockholders' Equity - Stock Awards (Details)", "shortName": "Stockholders' Equity - Stock Awards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_8_23_2023_To_8_23_2023_srt_TitleOfIndividualAxis_xelb_NonManagementDirectorsMember_719G7fUyUUCSH-3E5ERQLQ", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R60": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails", "longName": "40709 - Disclosure - Stockholders' Equity - Black-Scholes option pricing assumptions (Details)", "shortName": "Stockholders' Equity - Black-Scholes option pricing assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "Duration_5_1_2022_To_5_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_-7lv312MzkSGQNcLWr2DXA", "name": "us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "xelb:ScheduleOfCommonStockRepurchasedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_5_1_2022_To_5_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_-7lv312MzkSGQNcLWr2DXA", "name": "us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "xelb:ScheduleOfCommonStockRepurchasedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "longName": "40710 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details)", "shortName": "Stockholders' Equity - Restricted Stock Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "As_Of_12_31_2022_ufvg0Lpz1Uu3i4lnsRy5yA", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_yvouhQ_sv0y8wQ9hhnlebA", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R62": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "longName": "40801 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "shortName": "Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R63": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "longName": "40802 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "shortName": "Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "longName": "40901 - Disclosure - Commitments and Contingencies - Narrative (Details)", "shortName": "Commitments and Contingencies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2023_kOBGUDwHvU-nZkbyPOzZHQ", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2023_kOBGUDwHvU-nZkbyPOzZHQ", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails", "longName": "40902 - Disclosure - Commitments and Contingencies - Company Lease Cost (Details)", "shortName": "Commitments and Contingencies - Company Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:OperatingLeaseCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:OperatingLeaseCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails", "longName": "40903 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments (Details)", "shortName": "Commitments and Contingencies - Future Minimum Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails", "longName": "40904 - Disclosure - Commitments and Contingencies - Future Minimum Payments under Employment Contracts (Details)", "shortName": "Commitments and Contingencies - Future Minimum Payments under Employment Contracts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:ContractualObligationDueInNextTwelveMonths", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:ContractualObligationDueInNextTwelveMonths", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails", "longName": "41001 - Disclosure - Income Taxes - Narrative (Details)", "shortName": "Income Taxes - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails", "longName": "41002 - Disclosure - Income Taxes - Income Tax Benefit (Details)", "shortName": "Income Taxes - Income Tax Benefit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails", "longName": "41003 - Disclosure - Income Taxes - Reconciliation of Income Tax Rates (Details)", "shortName": "Income Taxes - Reconciliation of Income Tax Rates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_Standard_pure_9o0k879uoEaoitIGfM5Pxw", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails", "longName": "41004 - Disclosure - Income Taxes - Net Deferred Tax Assets (Liabilities) (Details)", "shortName": "Income Taxes - Net Deferred Tax Assets (Liabilities) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_5i4kPZcNPEihnKx3SC31UA", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "longName": "41101 - Disclosure - Related Party Transactions - IM Topco, LLC (Details)", "shortName": "Related Party Transactions - IM Topco, LLC (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "As_Of_5_31_2022_srt_CounterpartyNameAxis_xelb_ImTopcoMember_us-gaap_TypeOfArrangementAxis_xelb_ServicesAgreementMember_Gn9mRDNtEUacjmbWLgaZLA", "name": "us-gaap:OtherReceivables", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_1_2023_To_11_30_2023_srt_CounterpartyNameAxis_xelb_ImTopcoMember_us-gaap_TypeOfArrangementAxis_xelb_ServicesAgreementMember_AC9KJY4PNkSKNC0QVrr5_g", "name": "xelb:ServiceFeesReduction", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R73": { "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "longName": "41102 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details)", "shortName": "Related Party Transactions - Isaac Mizrahi (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_Q-p7K2D7q06zM9smnwakXQ", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "unitRef": "Unit_Standard_shares_1GhGaespAki3VopulNzAVg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_srt_CounterpartyNameAxis_xelb_IsaacMizrahisMember_ABqPFP68lEqp3IEuS41N-Q", "name": "us-gaap:OfficersCompensation", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R74": { "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails", "longName": "41103 - Disclosure - Related Party Transactions - ORME (Details)", "shortName": "Related Party Transactions - ORME (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_12_4_2023_To_12_4_2023_srt_OwnershipAxis_xelb_OrmeLiveMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_RelatedPartyMember_ySLG2yG2kUWjEvz4ALAmlQ", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R75": { "role": "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "longName": "41201 - Disclosure - Subsequent Events - Narrative (Details)", "shortName": "Subsequent Events - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:LeaseCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_12_2024_To_1_12_2024_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Ft2hIeWXfEOmEBH5KnZQ7Q", "name": "us-gaap:LeaseCost", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "unique": true } }, "R76": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Uncategorized", "order": "76", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_kSxL78OsAE2QeH9oKt10Kw", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_ifT55wY8DkiX_MEd7yuRHg", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Cover", "order": "77", "firstAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_Kw-V_0hcQkyMCeQ5JhDy5A", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_Kw-V_0hcQkyMCeQ5JhDy5A", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20231231x10k.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable, accrued expenses and other current liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r26" ] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Rollforward of the allowance for doubtful accounts", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r965" ] }, "xelb_AccountsReceivableAssignedToThirdPartyAgentForCollection": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AccountsReceivableAssignedToThirdPartyAgentForCollection", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of outstanding balance in accounts receivables which is assigned to third party agent for collection purposes.", "label": "Accounts Receivable, Assigned to Third Party Agent for Collection", "terseLabel": "Accounts receivable, assigned to third party agent for collection" } } }, "auth_ref": [] }, "xelb_AccountsReceivableCollectionAgentFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AccountsReceivableCollectionAgentFees", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of fees paid to agent for collection of accounts receivables.", "label": "Accounts Receivable, Collection Agent Fees", "terseLabel": "Accounts receivable, collection agent fees" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r783" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable", "verboseLabel": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r287", "r288" ] }, "us-gaap_AccruedFeesAndOtherRevenueReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedFeesAndOtherRevenueReceivable", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Fees and Other Revenue Receivable", "terseLabel": "Earned revenue accrued but not billed", "documentation": "For an unclassified balance sheet, the amount of fees and other revenue, excluding investment income receivable, earned but not yet received, which were recognized in conformity with revenue recognition criteria based on estimates or specific contractual terms." } } }, "auth_ref": [ "r937" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued Income Taxes, Current", "terseLabel": "Accrued income taxes payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r111", "r167" ] }, "xelb_AcquisitionsAndDivestituresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AcquisitionsAndDivestituresAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Acquisitions, Divestitures and Variable Interest Entities[Abstract]" } } }, "auth_ref": [] }, "xelb_AcquisitionsDivestituresAndVariableInterestEntities": { "xbrltype": "textBlockItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AcquisitionsDivestituresAndVariableInterestEntities", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for acquisition, divestitures and variable interest entities.", "label": "Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r876" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r117", "r821", "r1042" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Paid-In Capital [Member]", "verboseLabel": "Paid-in Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r465", "r466", "r467", "r707", "r949", "r950", "r951", "r1014", "r1046" ] }, "xelb_AdditionalRoyaltyPayableTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AdditionalRoyaltyPayableTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Additional amount of time that that royalties will be payable.", "label": "Additional Royalty Payable Term", "terseLabel": "Additional royalty payable term" } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r882" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r882" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r882" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r882" ] }, "xelb_AdjustmentToPurchasePricePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AdjustmentToPurchasePricePayable", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount payable as adjustment to purchase price previously received by the company.", "label": "Adjustment to Purchase Price Payable", "terseLabel": "Adjustments to purchase price payable" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Value", "negatedLabel": "Shares repurchased in exchange for withholding taxes", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Compensation expense related to stock options and restricted stock", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r75", "r76", "r432" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising Costs, Policy [Policy Text Block]", "terseLabel": "Advertising Costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r179" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdvertisingCostsDetails" ], "lang": { "en-us": { "role": { "label": "Advertising Expense", "terseLabel": "Advertising cost during the period", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r473" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r846", "r858", "r868", "r894" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r849", "r861", "r871", "r897" ] }, "xelb_AgreementTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AgreementTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Agreement Type [Axis]" } } }, "auth_ref": [] }, "xelb_AgreementTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AgreementTypeDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Agreement Type [Domain]" } } }, "auth_ref": [] }, "xelb_AgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AgreementsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents agreements.", "label": "Agreements [Member]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r882" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r889" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r853", "r862", "r872", "r889", "r898", "r902", "r910" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r908" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Allocated Share-based Compensation Expense", "terseLabel": "Compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r463", "r472" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRollforwardOfAllowanceForCreditLossesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance for Doubtful Accounts Receivable", "periodEndLabel": "Accounts receivable, allowance for credit loss, ending balance", "periodStartLabel": "Accounts receivable, allowance for credit loss, beginning balance", "verboseLabel": "Allowance for doubtful accounts", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r209", "r289", "r339", "r342", "r345", "r1037" ] }, "xelb_AllowanceForDoubtfulAccountsReceivableWriteOffAndExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffAndExpense", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs charged against the allowance and expense for expected credit loss on accounts receivable.", "label": "Allowance For Doubtful Accounts Receivable, Write-Off And Expense", "terseLabel": "Provision for credit losses" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRollforwardOfAllowanceForCreditLossesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Write-offs", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r344" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Issuance Costs", "verboseLabel": "Amortization of deferred finance costs included in interest expense", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r125", "r393", "r561", "r943" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization expense for intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r6", "r59", "r64" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Dilutive securities", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r263" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AreaOfRealEstateProperty": { "xbrltype": "areaItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AreaOfRealEstateProperty", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Area of Real Estate Property", "terseLabel": "Leased office space", "documentation": "Area of a real estate property." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r508" ] }, "xelb_AssetAcquisitionAdditionalConsiderationPayableToSeller": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AssetAcquisitionAdditionalConsiderationPayableToSeller", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additional consideration payable to seller.", "label": "Asset Acquisition, Additional Consideration Payable To Seller", "terseLabel": "Additional consideration is payable to the seller" } } }, "auth_ref": [] }, "us-gaap_AssetAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Axis]", "documentation": "Information by asset acquisition." } } }, "auth_ref": [ "r1012" ] }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionContingentConsiderationLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Current", "verboseLabel": "Current portion of contingent obligations", "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as current." } } }, "auth_ref": [ "r1012" ] }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionContingentConsiderationLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Long-term portion of contingent obligations", "verboseLabel": "Contingent obligation", "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent." } } }, "auth_ref": [ "r1012" ] }, "xelb_AssetAcquisitionContingentObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AssetAcquisitionContingentObligation", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Contingent Obligation", "label": "Asset Acquisition, Contingent Obligation", "verboseLabel": "Contingent obligation (Lori Goldstein Earn-Out)" } } }, "auth_ref": [] }, "us-gaap_AssetAcquisitionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Domain]", "documentation": "Asset acquisition." } } }, "auth_ref": [ "r1012" ] }, "xelb_AssetAcquisitionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AssetAcquisitionPrice", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of purchase price of asset acquired.", "label": "Asset Acquisition Price", "terseLabel": "Total purchase price" } } }, "auth_ref": [] }, "xelb_AssetAcquisitionRoyaltiesTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AssetAcquisitionRoyaltiesTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Royalties Term", "label": "Asset Acquisition, Royalties Term", "terseLabel": "Royalties earned" } } }, "auth_ref": [] }, "xelb_AssetAcquisitionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AssetAcquisitionsAbstract", "lang": { "en-us": { "role": { "documentation": "Asset Acquisitions [Abstract]", "label": "Asset Acquisitions [Abstract]" } } }, "auth_ref": [] }, "xelb_AssetAcquisitionsContingentConsiderationAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AssetAcquisitionsContingentConsiderationAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum aggregate amount of contingent considerations.", "label": "Asset Acquisitions, Contingent Consideration, Amount", "terseLabel": "Contingent consideration" } } }, "auth_ref": [] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Asset Impairment Charges", "terseLabel": "Asset impairment charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r6", "r65" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r165", "r205", "r231", "r268", "r278", "r282", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r510", "r514", "r546", "r655", "r732", "r821", "r834", "r972", "r973", "r1028" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r199", "r212", "r231", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r510", "r514", "r546", "r821", "r972", "r973", "r1028" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current Assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets", "totalLabel": "Total non-current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r231", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r510", "r514", "r546", "r972", "r973", "r1028" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current Assets:" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r840", "r841", "r854" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r840", "r841", "r854" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r840", "r841", "r854" ] }, "xelb_AutomaticRenewal": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "AutomaticRenewal", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Term of the license arrangement renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Automatic Renewal", "terseLabel": "Automatic Renewal" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r905" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r906" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r901" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r901" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r901" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r901" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r901" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r901" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r459", "r460", "r461", "r462" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r904" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r903" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r902" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r902" ] }, "xelb_Bricksandmortarbonuspercentageonrevenueexcludingdirectresponsetelevisionandendorsementrevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "Bricksandmortarbonuspercentageonrevenueexcludingdirectresponsetelevisionandendorsementrevenue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of bonus expressed as a percentage on net revenue excluding revenue from direct response television and endorsement revenue.", "label": "BricksAndMortarBonusPercentageOnRevenueExcludingDirectResponseTelevisionAndEndorsementRevenue", "terseLabel": "Bricks-and-Mortar Bonus" } } }, "auth_ref": [] }, "xelb_BusinessVentureAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "BusinessVentureAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Business Venture Agreement.", "label": "Business Venture Agreement [Member]", "terseLabel": "Business Venture Agreement" } } }, "auth_ref": [] }, "xelb_CWonderQurateAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "CWonderQurateAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "It Represent the C Wonder Qurate Agreement.", "label": "C Wonder Qurate Agreement" } } }, "auth_ref": [] }, "xelb_CapitalStockAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "CapitalStockAuthorized", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of capital stock authorized for the company.", "label": "Capital Stock, Authorized", "terseLabel": "Authorized number of shares" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r43", "r202", "r793" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r44" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of year", "periodStartLabel": "Cash and cash equivalents at beginning of year", "terseLabel": "Cash and cash equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r43", "r135", "r228" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r135" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "verboseLabel": "Supplemental disclosure of non-cash activities:" } } }, "auth_ref": [] }, "xelb_CertainPaymentsOwed": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "CertainPaymentsOwed", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of certain payments owed per agreements made.", "label": "Certain Payments Owed", "terseLabel": "Certain payments owed" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r880" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer", "documentation": "Person with designation of chief executive officer." } } }, "auth_ref": [ "r954" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ClassOfWarrantOrRightExercisable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercisable.", "label": "Class Of Warrant or Right, Exercisable", "terseLabel": "Exercisable (in shares)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExercisableInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ClassOfWarrantOrRightExercisableInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average grant date fair value of warrants exercisable.", "label": "Class of Warrant or Right Exercisable In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercisable, ending balance (in dollars per share)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExercisableInPeriodWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ClassOfWarrantOrRightExercisableInPeriodWeightedAverageRemainingContractualTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The weighted average remaining contractual life of the exercisable warrants.", "label": "Class of Warrant or Right, Exercisable In Period, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Life (in Years), Exercisable" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrants outstanding, exercise price (in dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r414" ] }, "xelb_ClassOfWarrantOrRightGranted": { "xbrltype": "sharesItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ClassOfWarrantOrRightGranted", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were granted during the reporting period.", "label": "Class Of Warrant Or Right, Granted", "terseLabel": "Granted (in shares)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in shares)", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in dollars per share)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life (in Years), Outstanding" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r881" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r881" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingency", "verboseLabel": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r33", "r93", "r656", "r718" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r147", "r363", "r364", "r784", "r968" ] }, "xelb_CommitmentsAndContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "CommitmentsAndContingenciesLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Commitments and Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies" } } }, "auth_ref": [] }, "xelb_CommitmentsAndContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "CommitmentsAndContingenciesTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from commitments and contingencies.", "label": "Commitments and Contingencies [Table]", "terseLabel": "Commitments and Contingencies [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Capital Shares Reserved for Future Issuance", "verboseLabel": "Shares of common stock reserved for issuance (in shares)", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r34" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock", "terseLabel": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r824", "r825", "r826", "r828", "r829", "r830", "r831", "r949", "r950", "r1014", "r1040", "r1046" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r116" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Number of common stock shares authorized", "verboseLabel": "Common stock, shares authorized (in shares)", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r116", "r719" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued", "verboseLabel": "Common stock, shares issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r116" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Purchaseable stock", "verboseLabel": "Common stock, shares outstanding (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r16", "r116", "r719", "r738", "r1046", "r1047" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.001 par value, 50,000,000 shares authorized, and 19,795,053 and 19,624,860 shares issued and outstanding at December 31, 2023 and 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r116", "r658", "r821" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r886" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r885" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r887" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r884" ] }, "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net, Classification [Abstract]", "verboseLabel": "Deferred tax assets" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Net, Classification [Abstract]", "verboseLabel": "Deferred tax liabilities" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r50", "r52", "r87", "r88", "r286", "r783" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r50", "r52", "r87", "r88", "r286", "r692", "r783" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r50", "r52", "r87", "r88", "r286", "r783", "r919" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentrations of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r95", "r182" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r50", "r52", "r87", "r88", "r286" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r49", "r50", "r52", "r53", "r87", "r164", "r783" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r50", "r52", "r87", "r88", "r286", "r783" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r190", "r237", "r510", "r511", "r514", "r515", "r597", "r785", "r930", "r931", "r932", "r971", "r974", "r975" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r190", "r237", "r510", "r511", "r514", "r515", "r597", "r785", "r930", "r931", "r932", "r971", "r974", "r975" ] }, "xelb_ConsultantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ConsultantMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Consultant" } } }, "auth_ref": [] }, "xelb_ConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ConsultantsMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to consultants.", "label": "Consultants" } } }, "auth_ref": [] }, "xelb_ContingentObligationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ContingentObligationPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for contingent obligation. This accounting policy may address the amount which the Company may owe additional purchase price consideration for the acquisition of the Business.", "label": "Contingent Obligation [Policy Text Block]", "verboseLabel": "Contingent Obligations" } } }, "auth_ref": [] }, "xelb_ContraRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ContraRevenue", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized through deductions from gross revenue that result in net revenue.", "label": "Contra-revenue", "terseLabel": "Contra-revenue" } } }, "auth_ref": [] }, "xelb_ContraRevenueFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ContraRevenueFromWarrantExercises", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "The amount of the reduction of revenue from warrants associated with the respective agreement.", "label": "Contra Revenue from Warrant Exercises", "terseLabel": "Contra-revenue related to warrants granted to licensee" } } }, "auth_ref": [] }, "us-gaap_ContractualObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligation", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation", "terseLabel": "Contingent obligation", "totalLabel": "Total future minimum employment contract payments", "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments." } } }, "auth_ref": [ "r947" ] }, "us-gaap_ContractualObligationDueAfterFifthYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueAfterFifthYear", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, to be Paid, after Year Five", "terseLabel": "Thereafter", "documentation": "Amount of contractual obligation to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInFifthYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInFifthYear", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, to be Paid, Year Five", "terseLabel": "2028", "documentation": "Amount of contractual obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInFourthYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInFourthYear", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, to be Paid, Year Four", "terseLabel": "2027", "documentation": "Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Due in Next Fiscal Year", "terseLabel": "2024", "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInSecondYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInSecondYear", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Due in Second Year", "terseLabel": "2025", "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInThirdYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInThirdYear", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderEmploymentContractsDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Due in Third Year", "terseLabel": "2026", "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]", "terseLabel": "Schedule of contracts with certain executives and key employees", "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation." } } }, "auth_ref": [ "r948" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r128", "r633" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Revenue", "terseLabel": "Related Party Costs", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r129", "r231", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r546", "r972" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses", "totalLabel": "Total direct operating costs and expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r126" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "verboseLabel": "Direct operating costs and expenses" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r191", "r235", "r236", "r381", "r402", "r595", "r795", "r797" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document And Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Current:" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r922", "r946", "r1010" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r158", "r492", "r500", "r946" ] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State and local", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r922", "r946", "r1010" ] }, "xelb_CurrentTermExpiry": { "xbrltype": "dateItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "CurrentTermExpiry", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Date which license agreements is set to expire, in CCYY-MM-DD format. - date item type", "label": "Current Term Expiry", "terseLabel": "Current Term Expiry" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r51", "r286" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r24", "r110", "r111", "r166", "r169", "r237", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r562", "r804", "r805", "r806", "r807", "r808", "r944" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Gross", "terseLabel": "Term loan debt", "totalLabel": "Total", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r24", "r169", "r395" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Face amount of term loan", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r90", "r92", "r378", "r562", "r805", "r806" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate (as percentage)", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r30", "r90", "r397", "r562" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Stated interest rate (as percentage)", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r30", "r379" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r237", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r562", "r804", "r805", "r806", "r807", "r808", "r944" ] }, "xelb_DebtInstrumentLondonInterbankOfferedRateLiborFloorRate": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DebtInstrumentLondonInterbankOfferedRateLiborFloorRate", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Floor rate of LIBOR under the debt instrument covenant.", "label": "Debt Instrument, London Interbank Offered Rate (LIBOR), Floor Rate", "terseLabel": "Floor rate of LIBOR (as percentage)" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r31", "r237", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r562", "r804", "r805", "r806", "r807", "r808", "r944" ] }, "xelb_DebtInstrumentPercentageOfClosingFee": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DebtInstrumentPercentageOfClosingFee", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of closing fee paid under the debt instrument.", "label": "Debt Instrument, Percentage Of Closing Fee", "terseLabel": "Percentage of closing fee" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Periodic Payment, Principal", "terseLabel": "Quarterly installment amount", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r31" ] }, "xelb_DebtInstrumentPrepaymentFee": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DebtInstrumentPrepaymentFee", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of prepayment fee in a debt instrument.", "label": "Debt Instrument, Prepayment Fee", "terseLabel": "Prepayment fee" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r31", "r68", "r69", "r89", "r90", "r92", "r94", "r150", "r151", "r237", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r562", "r804", "r805", "r806", "r807", "r808", "r944" ] }, "us-gaap_DebtInstrumentUnamortizedPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedPremium", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Premium", "terseLabel": "Prepayment premium", "documentation": "Amount, after accumulated amortization, of debt premium." } } }, "auth_ref": [ "r89", "r92", "r977" ] }, "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]", "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan." } } }, "auth_ref": [ "r72" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails": { "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r946", "r1009", "r1010" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Deferred:" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Gross", "terseLabel": "Deferred issuance cost", "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r91" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "verboseLabel": "Unamortized deferred finance costs related to term loan debt", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r91", "r977" ] }, "xelb_DeferredFinanceCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DeferredFinanceCostsPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and Finance Costs.", "label": "Deferred Finance Costs [Policy Text Block]", "terseLabel": "Deferred Finance Costs" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets, net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r478", "r479" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income tax provision (benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r6", "r158", "r187", "r499", "r500", "r946" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r113", "r114", "r168", "r486" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Income Taxes and Tax Credits", "totalLabel": "Total deferred", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r137" ] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue", "terseLabel": "Deferred revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r936" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue, current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r935" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue, long-term liability", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r936" ] }, "xelb_DeferredRevenueRecognitionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DeferredRevenueRecognitionPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Period of time that the deferred revenue will be recognized over.", "label": "Deferred Revenue, Recognition Period", "terseLabel": "Recognition period of deferred revenue" } } }, "auth_ref": [] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails": { "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State and local", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r946", "r1009", "r1010" ] }, "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsCharitableContributionCarryforwards", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Charitable Contribution Carryforwards", "terseLabel": "Charitable contribution carryover", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards." } } }, "auth_ref": [ "r79", "r1008" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r487" ] }, "xelb_DeferredTaxAssetsInterestExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DeferredTaxAssetsInterestExpenses", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from interest expenses.", "label": "Deferred Tax Assets, Interest Expenses", "terseLabel": "Interest expense" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1007" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax assets, net of valuation allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1007" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign", "terseLabel": "Federal, state and local net operating loss carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r79", "r1008" ] }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Property, Plant and Equipment", "terseLabel": "Property and equipment", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other", "verboseLabel": "Accrued compensation and other accrued expenses", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other." } } }, "auth_ref": [ "r79", "r1008" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "verboseLabel": "Stock-based compensation", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r79", "r1008" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts", "verboseLabel": "Allowance for doubtful accounts", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r79", "r1008" ] }, "xelb_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBasisDifferenceArisingFromDiscountedNotePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBasisDifferenceArisingFromDiscountedNotePayable", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Basis Difference Arising From Discounted Note Payable.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Basis Difference Arising From Discounted Note Payable", "terseLabel": "Basis difference arising from discounted note payable" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "terseLabel": "Change in valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r488" ] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Intangible Assets", "negatedLabel": "Basis difference arising from intangible assets of acquisition", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill." } } }, "auth_ref": [ "r79", "r1008" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense", "verboseLabel": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r6", "r272" ] }, "us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationExcludingLessorAssetUnderOperatingLease", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation, Excluding Lessor Asset under Operating Lease", "documentation": "Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of depreciation expense." } } }, "auth_ref": [ "r361", "r583" ] }, "xelb_DerecognitionOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DerecognitionOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of intangible assets derecognized.", "label": "Derecognition of Intangible Assets", "terseLabel": "Derecognition of trademarks" } } }, "auth_ref": [] }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeBasisSpreadOnVariableRate", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Basis Spread on Variable Rate", "terseLabel": "Derivative, basis spread on variable rate", "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Fixed Interest Rate", "terseLabel": "Derivative, fixed interest rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "xelb_DirectResponseTelevisionBonusPercentageOnRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DirectResponseTelevisionBonusPercentageOnRevenue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of bonus expressed as a percentage on net revenue through direct response television.", "label": "Direct Response Television Bonus Percentage On Revenue", "terseLabel": "DRT Bonus" } } }, "auth_ref": [] }, "xelb_DirectorAndConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DirectorAndConsultantsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "documentation": "Person serving on board of directors, and consultants.", "label": "Director and Consultants" } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "DirectorMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Director", "documentation": "Person serving on board of directors." } } }, "auth_ref": [ "r954", "r1041" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r197" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disposed of by Sale", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r7", "r20" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "terseLabel": "Amount received in cash", "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r2", "r97", "r103", "r145" ] }, "xelb_DisposalGroupIncludingDiscontinuedOperationEarnOutConsiderationBasedOnTargets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DisposalGroupIncludingDiscontinuedOperationEarnOutConsiderationBasedOnTargets", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of earn-out consideration receivable based on targets, for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Earn Out Consideration Based on Targets", "terseLabel": "Earn-out consideration" } } }, "auth_ref": [] }, "xelb_DisposalGroupNotDiscontinuedOperationExpensesForDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "DisposalGroupNotDiscontinuedOperationExpensesForDisposal", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses on the sale or disposal of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Expenses for Disposal", "terseLabel": "Disposal expenses" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r812", "r813" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r840", "r841", "r854" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "terseLabel": "Document Financial Statement Error Correction", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r840", "r841", "r854", "r890" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r875" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "xelb_EarningsBeforeInterestTaxesDepreciationAndAmortizationThresholdAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "EarningsBeforeInterestTaxesDepreciationAndAmortizationThresholdAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of threshold earnings before interest, taxes, depreciation and amortization for making adjustments to retained interest in investment.", "label": "Earnings Before Interest, Taxes, Depreciation and Amortization, Threshold Amount", "terseLabel": "EBITDA threshhold milestone" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings (Loss) Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Basic net loss income per share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r221", "r246", "r247", "r248", "r249", "r250", "r256", "r258", "r260", "r261", "r262", "r266", "r538", "r539", "r652", "r670", "r799" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Loss per common share attributable to Xcel Brands, Inc. stockholders:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net loss income per share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r221", "r246", "r247", "r248", "r249", "r250", "r258", "r260", "r261", "r262", "r266", "r538", "r539", "r652", "r670", "r799" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Weighted average number of common shares outstanding:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Earnings (Loss) Per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r47", "r48" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "verboseLabel": "Earnings (Loss) Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r255", "r263", "r264", "r265" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Income tax (provision) benefit", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r481" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "verboseLabel": "U.S. statutory federal rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r232", "r481", "r501" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "verboseLabel": "Change in valuation allowance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates." } } }, "auth_ref": [ "r501", "r1006" ] }, "xelb_EffectiveIncomeTaxRateReconciliationFederalTrueUpsPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationFederalTrueUpsPercent", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from federal true ups.", "label": "Effective Income Tax Rate Reconciliation, Federal True Ups, Percent", "terseLabel": "Federal true-ups" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Life Insurance", "verboseLabel": "Life insurance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to life insurance expense." } } }, "auth_ref": [ "r1006", "r1011" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Percent", "verboseLabel": "Stock compensation", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement." } } }, "auth_ref": [ "r1006", "r1011" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "definitionGuidance": "State and local rate, net of federal tax benefit", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r1006", "r1011" ] }, "xelb_EmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "EmployeeMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Employee [Member]", "label": "Employee" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Employee-related Liabilities, Current", "verboseLabel": "Accrued payroll", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation expense", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r464" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period of recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r464" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "xelb_EndorsementBonusPercentageOnRevenueFromThirdPartyProjects": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "EndorsementBonusPercentageOnRevenueFromThirdPartyProjects", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of bonus expressed as a percentage on net revenue through third party projects undertaken by the company.", "label": "Endorsement Bonus Percentage On Revenue From Third Party Projects", "terseLabel": "Endorsement Bonus" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r838" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r838" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r838" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r915" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r838" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r838" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r838" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r838" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r916" ] }, "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]", "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan." } } }, "auth_ref": [ "r72" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r16", "r194", "r216", "r217", "r218", "r238", "r239", "r240", "r243", "r251", "r253", "r267", "r332", "r338", "r415", "r465", "r466", "r467", "r495", "r496", "r519", "r521", "r522", "r523", "r524", "r526", "r537", "r551", "r552", "r553", "r554", "r555", "r556", "r588", "r682", "r683", "r684", "r707", "r762" ] }, "xelb_EquityIncentivePlan2011Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "EquityIncentivePlan2011Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2011 Equity Incentive Plan.", "label": "2011 Equity Incentive Plan" } } }, "auth_ref": [] }, "xelb_EquityIncentivePlan2021Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "EquityIncentivePlan2021Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2021 Equity Incentive Plan.", "label": "2021 Equity Incentive Plan" } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r325", "r326", "r327" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership interest", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r325" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments", "terseLabel": "Equity method investment in IM Topco, LLC", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r275", "r323", "r933", "r963" ] }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Fair value of retained interest", "documentation": "Fair value portion of investments accounted under the equity method." } } }, "auth_ref": [ "r934", "r1015", "r1017", "r1018" ] }, "us-gaap_EquityMethodInvestmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesTables" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Summarized financial information for IM Topco", "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information." } } }, "auth_ref": [ "r324" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]", "terseLabel": "Investment in Unconsolidated Affiliate", "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change." } } }, "auth_ref": [ "r322" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r883" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r846", "r858", "r868", "r894" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r843", "r855", "r865", "r891" ] }, "xelb_ExcessCompensationDeduction": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ExcessCompensationDeduction", "calculation": { "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxRatesDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of excess compensation deduction during the period.", "label": "Excess Compensation Deduction", "verboseLabel": "Excess compensation deduction" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r889" ] }, "srt_ExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExecutiveOfficerMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Executive Officer [Member]", "terseLabel": "Executive Officer", "documentation": "Person with designation of executive officer." } } }, "auth_ref": [ "r954" ] }, "srt_ExecutiveVicePresidentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExecutiveVicePresidentMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Executive Vice President [Member]", "documentation": "Person with designation of executive vice president." } } }, "auth_ref": [ "r954" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Asset Purchase Agreement", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r541", "r542", "r543" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r541", "r542", "r543" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement, Policy [Policy Text Block]", "verboseLabel": "Fair Value", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "verboseLabel": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r11", "r23" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r340", "r341", "r346", "r347", "r348", "r349", "r350", "r351", "r394", "r412", "r527", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r669", "r803", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r959", "r960", "r961", "r962" ] }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]", "terseLabel": "Trademarks and Other Intangibles" } } }, "auth_ref": [] }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of finite-lived and indefinite-lived intangible assets, excluding goodwill, in total and by major class.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails", "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Useful Life", "presentationGuidance": "Weighted Average Amortization Period", "verboseLabel": "Estimated useful life of finite-lived intangible asset (in years)", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "verboseLabel": "Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r203", "r358" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five", "verboseLabel": "Thereafter (through 2036)", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "verboseLabel": "2024", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r142" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r142" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "verboseLabel": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r142" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "verboseLabel": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r142" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "verboseLabel": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r142" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r355", "r357", "r358", "r360", "r634", "r638" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r141", "r638" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r60", "r63" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails", "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r141", "r634" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAmortizationExpenseRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAmortizationExpenseRollingMaturityAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Rolling Maturity [Abstract]", "terseLabel": "Finite Lived Intangible Assets Future Amortization Expense:" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r850", "r862", "r872", "r898" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r850", "r862", "r872", "r898" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r850", "r862", "r872", "r898" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r850", "r862", "r872", "r898" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r850", "r862", "r872", "r898" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 6.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "Gain on sale of majority interest in Isaac Mizrahi brand", "terseLabel": "Gain on sale of majority interest in Isaac Mizrahi brand", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r943" ] }, "xelb_GainLossOnReductionOfContingentObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "GainLossOnReductionOfContingentObligation", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on reduction of contingent obligation.", "label": "Gain Loss On Reduction Of Contingent Obligation", "negatedLabel": "Gain on reduction of contingent obligation", "terseLabel": "Gain on reduction of contingent obligation" } } }, "auth_ref": [] }, "xelb_GainLossOnSaleOfLimitedPartnerOwnershipInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "GainLossOnSaleOfLimitedPartnerOwnershipInterest", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 8.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale of limited partner ownership interest.", "label": "Gain Loss on Sale of Limited Partner Ownership Interest", "negatedLabel": "Gain on sale of limited partner ownership interest", "terseLabel": "Gain on sale of limited partner ownership interest" } } }, "auth_ref": [] }, "us-gaap_GainLossOnTerminationOfLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnTerminationOfLease", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 9.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Termination of Lease", "negatedLabel": "Gain on settlement of lease liability", "terseLabel": "Gain on settlement of lease liability", "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term." } } }, "auth_ref": [ "r567" ] }, "xelb_GainOnReductionOfContingentObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "GainOnReductionOfContingentObligations", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Gain on reduction of contingent obligations during the period.", "label": "Gain On Reduction Of Contingent Obligations", "negatedTerseLabel": "Gain on reduction of contingent obligation", "terseLabel": "Gain on reduction of contingent obligation" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0, "order": 3.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on early extinguishment of debt", "negatedTerseLabel": "Loss on early extinguishment of debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r6", "r66", "r67" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Trademarks and Other Intangibles [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "verboseLabel": "Trademarks and Other Intangibles", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r140" ] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "verboseLabel": "Trademarks and Other Intangible Assets", "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined." } } }, "auth_ref": [ "r14" ] }, "xelb_GoodwillAndIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "GoodwillAndIntangibleAssetsLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Goodwill and Intangible Assets [Line Items]", "terseLabel": "Goodwill and Intangible Assets [Line Items]" } } }, "auth_ref": [] }, "us-gaap_GranteeStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusAxis", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Grantee Status [Axis]", "documentation": "Information by status of recipient to whom award is granted." } } }, "auth_ref": [ "r431", "r433", "r434", "r435", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r459", "r460", "r461", "r462" ] }, "us-gaap_GranteeStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusDomain", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Grantee Status [Domain]", "documentation": "Status of recipient to whom award is granted." } } }, "auth_ref": [ "r431", "r433", "r434", "r435", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r459", "r460", "r461", "r462" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gross Profit", "terseLabel": "Gross Profit", "totalLabel": "Gross profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r127", "r231", "r268", "r277", "r281", "r283", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r546", "r801", "r972" ] }, "xelb_HalstonBrandMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "HalstonBrandMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the Halston Brand (the \"Halston License\").", "label": "Halston Brand [Member]", "terseLabel": "Halston License" } } }, "auth_ref": [] }, "xelb_HalstonHeritageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "HalstonHeritageMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Halston Heritage [Member]", "label": "Halston Heritage" } } }, "auth_ref": [] }, "xelb_HilcoGlobalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "HilcoGlobalMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails" ], "lang": { "en-us": { "role": { "documentation": "Hilco Global [Member]", "label": "Hilco Global" } } }, "auth_ref": [] }, "xelb_IMTopcoLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IMTopcoLLCMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to IM Topco, LLC.", "label": "IM Topco, LLC" } } }, "auth_ref": [] }, "xelb_IfRoyaltiesReceivableLessThanSpecifiedAmountMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IfRoyaltiesReceivableLessThanSpecifiedAmountMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to the event where royalties receivable less that specified amount.", "label": "If Royalties Receivable Less Than Specified Amount" } } }, "auth_ref": [] }, "xelb_ImTopcoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ImTopcoMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM Topco.", "label": "IM Topco [Member]" } } }, "auth_ref": [] }, "xelb_ImWhpLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ImWhpLlcMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM WHP LLC.", "label": "WHP" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Intangible Assets, Finite-lived", "terseLabel": "Impairment charges on finite-lived intangible assets", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r943", "r966" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r122", "r173", "r268", "r277", "r281", "r283", "r653", "r665", "r801" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "(Loss) income from continuing operations", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r160", "r231", "r242", "r268", "r277", "r281", "r283", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r539", "r546", "r665", "r801", "r972" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Undistributed proportional share of net loss of equity method investee", "verboseLabel": "Loss from equity method investment", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r6", "r123", "r172", "r273", "r323", "r664" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r812", "r813" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r12", "r20", "r25", "r97", "r98", "r99", "r100", "r101", "r102", "r104", "r105", "r106", "r146" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r232", "r474", "r482", "r484", "r490", "r497", "r502", "r503", "r504", "r701" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesIncomeTaxBenefitDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "totalLabel": "Total provision (benefit)", "verboseLabel": "Income tax provision (benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r177", "r188", "r252", "r253", "r274", "r480", "r498", "r672" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r215", "r476", "r477", "r484", "r485", "r489", "r491", "r697" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income Taxes Paid", "terseLabel": "Cash paid during the period for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r42", "r45" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r788" ] }, "xelb_IncreaseDecreaseInEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IncreaseDecreaseInEquityMethodInvestments", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "This item represents the change in carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Increase/Decrease In Equity Method Investments", "terseLabel": "Increase to the carrying value basis" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Lease-related assets and liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r920", "r942" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Liabilities", "verboseLabel": "Other liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpensesOther", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other current and non-current assets", "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r356", "r359" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r61", "r143" ] }, "xelb_IndefiniteLivedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IndefiniteLivedMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Indefinite Lived [Member]", "label": "Indefinite Lived [Member]", "terseLabel": "Indefinite Life" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r853", "r862", "r872", "r889", "r898", "r902", "r910" ] }, "xelb_Initialyearcashbonusafterreductionofsalarybasisamountreductioncalculationofcashbonus": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "Initialyearcashbonusafterreductionofsalarybasisamountreductioncalculationofcashbonus", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount which should be taken as base to reduce the base pay for calculation of initial year cash bonus.", "label": "InitialYearCashBonusAfterReductionOfSalaryBasisAmountReductionCalculationOfCashBonus", "terseLabel": "Initial cash bonus basis for Calculation" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r908" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r842", "r914" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r842", "r914" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r842", "r914" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Trademarks and other intangibles, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r58", "r62" ] }, "us-gaap_IntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntellectualPropertyMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Copyrights and other intellectual property", "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights." } } }, "auth_ref": [ "r22" ] }, "us-gaap_InterestAndDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Interest and Debt Expense", "verboseLabel": "Interest and related expenses", "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity." } } }, "auth_ref": [ "r13" ] }, "us-gaap_InterestAndDebtExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpenseAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest and Debt Expense [Abstract]", "verboseLabel": "Interest and finance expense" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r91", "r176", "r219", "r271", "r560", "r747", "r832", "r1043" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt", "terseLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r132", "r391", "r398", "r807", "r808" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Income (Expense), Net", "negatedTotalLabel": "Total interest and finance expense", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r175" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid during the period for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r223", "r226", "r227" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "verboseLabel": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r211", "r794", "r821" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r178", "r201", "r210", "r352", "r353", "r354", "r632", "r798" ] }, "xelb_IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Isaac Mizrahi Brand trademarks and other intellectual property.", "label": "IM Intellectual Property", "terseLabel": "IM Brand trademarks and other intellectual property rights" } } }, "auth_ref": [] }, "xelb_IsaacMizrahiSaleTransactionWithImTopcoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IsaacMizrahiSaleTransactionWithImTopcoMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Isaac Mizrahi sale transaction with IM Topco.", "label": "Isaac Mizrahi Sale Transaction with IM Topco [Member]", "terseLabel": "Isaac Mizrahi sale transaction with IM Topco" } } }, "auth_ref": [] }, "xelb_IsaacMizrahisMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IsaacMizrahisMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Isaac Mizrahi's.", "label": "Isaac Mizrahis" } } }, "auth_ref": [] }, "xelb_IsraelDiscountBankOfNewYorkMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "IsraelDiscountBankOfNewYorkMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the IDB (Israel Discount Bank of New York).", "label": "Israel Discount Bank of New York [Member]", "terseLabel": "IDB" } } }, "auth_ref": [] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Salaries Benefits And Employment Taxes", "verboseLabel": "Salaries, benefits and employment taxes", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r941" ] }, "xelb_LaughClubAnnualFeeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LaughClubAnnualFeeMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to annual fee paid to Laugh Club.", "label": "Laugh Club Annual Fee [Member]" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lease, Cost", "terseLabel": "Lease cost over the term of lease", "totalLabel": "Total lease cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r572", "r820" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "verboseLabel": "Schedule of total lease costs", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1024" ] }, "us-gaap_LeaseExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseExpirationDate1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lease Expiration Date", "terseLabel": "Lease expiration date", "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r571" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "verboseLabel": "Schedule of maturities of lease liabilities", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1025" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r580" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "terseLabel": "2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r580" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r580" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r580" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r580" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: Discount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r580" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Remaining Lease Term", "terseLabel": "Remaining lease term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1022" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Term of lease", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1023" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r27", "r231", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r511", "r514", "r515", "r546", "r717", "r800", "r834", "r972", "r1028", "r1029" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Current Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r121", "r171", "r661", "r821", "r945", "r964", "r1019" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r29", "r200", "r231", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r511", "r514", "r515", "r546", "r821", "r972", "r1028", "r1029" ] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent", "totalLabel": "Total long-term liabilities", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r24", "r107", "r108", "r109", "r112", "r231", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r511", "r514", "r515", "r546", "r972", "r1028", "r1029" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "verboseLabel": "Long-Term Liabilities:" } } }, "auth_ref": [] }, "xelb_LiabilityForEquityBasedBonuses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LiabilityForEquityBasedBonuses", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The aggregate amount of noncash, equity-based employee remuneration classified as liability.", "label": "Liability For Equity Based Bonuses", "terseLabel": "Liability for equity-based bonuses and other equity-based payments" } } }, "auth_ref": [] }, "xelb_LiborLondonInterbankOfferedRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LiborLondonInterbankOfferedRateMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "LIBOR London Interbank Offered Rate [Member]", "terseLabel": "LIBOR" } } }, "auth_ref": [] }, "xelb_LicenseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LicenseAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to license agreement.", "label": "License Agreement [Member]", "terseLabel": "License Agreement" } } }, "auth_ref": [] }, "us-gaap_LicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicenseMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net licensing revenue", "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark." } } }, "auth_ref": [ "r979" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "xelb_LogoQurateAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LogoQurateAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents the LOGO Qurate Agreement.", "label": "LOGO Qurate Agreement" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtAndOtherLongTermLiabilitiesNetCarryingAmountOfDebtDetailsCalc2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt", "totalLabel": "Total", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r24", "r169", "r385", "r396", "r805", "r806", "r1036" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtAndOtherLongTermLiabilitiesNetCarryingAmountOfDebtDetailsCalc2": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of debt", "verboseLabel": "Current portion of long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r206" ] }, "xelb_LongTermDebtMaturitiesFinalRepaymentOfPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LongTermDebtMaturitiesFinalRepaymentOfPrincipal", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Long Term Debt Maturities, Final Repayment Of Principal", "label": "Long Term Debt Maturities, Final Repayment Of Principal", "verboseLabel": "Final payment amount" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months", "verboseLabel": "2024", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r237", "r389" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2028", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r237", "r389" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four", "terseLabel": "2027", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r237", "r389" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three", "terseLabel": "2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r237", "r389" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two", "verboseLabel": "2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r9", "r237", "r389" ] }, "xelb_LongTermDebtMaturitiesRepaymentsOfPrincipalQuarterlyInstallments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalQuarterlyInstallments", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Long-Term Debt, Maturities, Repayments Of Principal, Quarterly Installments", "label": "Long-Term Debt, Maturities, Repayments Of Principal, Quarterly Installments", "verboseLabel": "Quarterly installment payment" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtAndOtherLongTermLiabilitiesNetCarryingAmountOfDebtDetailsCalc2": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt, net, less current portion", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r207" ] }, "us-gaap_LongTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebt" ], "lang": { "en-us": { "role": { "label": "Long-term Debt [Text Block]", "verboseLabel": "Debt", "documentation": "The entire disclosure for long-term debt." } } }, "auth_ref": [ "r148" ] }, "xelb_LongabergerLicensingLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LongabergerLicensingLLCMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "documentation": "Longaberger Licensing, LLC [Member]", "label": "Longaberger Licensing, LLC" } } }, "auth_ref": [] }, "xelb_LongabergerQurateAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LongabergerQurateAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "It Represent the Longaberger Qurate Agreement.", "label": "Longaberger Qurate Agreement" } } }, "auth_ref": [] }, "xelb_LoriGoldsteinBrandMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LoriGoldsteinBrandMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Lori Goldstein Brand.", "label": "Lori Goldstein Brand" } } }, "auth_ref": [] }, "xelb_LossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "LossFromEquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Loss From Equity Method Investments", "terseLabel": "Loss from equity method investment" } } }, "auth_ref": [] }, "xelb_MainHeadquartersLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "MainHeadquartersLeaseMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Main Headquarters Lease" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r286", "r811", "r978", "r1038", "r1039" ] }, "srt_ManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ManagementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Management", "documentation": "Person or persons designated as part of management." } } }, "auth_ref": [ "r954", "r1026" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Maximum", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r365", "r366", "r367", "r368", "r428", "r631", "r679", "r709", "r710", "r770", "r771", "r772", "r773", "r776", "r786", "r787", "r802", "r809", "r814", "r823", "r976", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035" ] }, "xelb_MaximumNumberMondayBonusEligiblePerCalendarYear": { "xbrltype": "integerItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "MaximumNumberMondayBonusEligiblePerCalendarYear", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "Maximum number of Monday bonus eligible per calendar year.", "label": "Maximum Number Monday Bonus Eligible Per Calendar Year", "terseLabel": "Maximum appearances eligible for Monday bonus" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r881" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r881" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Minimum", "terseLabel": "Minimum", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r365", "r366", "r367", "r368", "r428", "r631", "r679", "r709", "r710", "r770", "r771", "r772", "r773", "r776", "r786", "r787", "r802", "r809", "r814", "r823", "r976", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r36", "r170", "r231", "r328", "r369", "r371", "r372", "r373", "r376", "r377", "r546", "r660", "r721" ] }, "us-gaap_MinorityInterestInLimitedPartnerships": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestInLimitedPartnerships", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest in Limited Partnerships", "terseLabel": "Carrying value", "documentation": "Carrying amount of the equity interests owned by noncontrolling partners of a limited partnership included in the entity's consolidated financial statements." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Company's noncontrolling ownership interest", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Ownership interest", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r901" ] }, "xelb_MondayBonusPerAppearance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "MondayBonusPerAppearance", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of Monday bonus paid per appearance.", "label": "Monday Bonus Per Appearance", "terseLabel": "Monday bonus per appearance" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r909" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r286", "r811", "r978", "r1038", "r1039" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r882" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r225" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r225" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "terseLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r135", "r136", "r137" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to Xcel Brands, Inc. stockholders", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r124", "r137", "r174", "r198", "r213", "r214", "r218", "r231", "r242", "r246", "r247", "r248", "r249", "r252", "r253", "r259", "r268", "r277", "r281", "r283", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r539", "r546", "r668", "r740", "r760", "r761", "r801", "r832", "r972" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net loss attributable to noncontrolling interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r86", "r162", "r213", "r214", "r252", "r253", "r667", "r939" ] }, "xelb_NetProceedsFromSaleOfMajorityInterestInInvestingActivity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "NetProceedsFromSaleOfMajorityInterestInInvestingActivity", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of net proceeds from sale of majority interest in investing activity.", "label": "Net Proceeds from Sale of Majority Interest in Investing Activity", "terseLabel": "Net proceeds from sale of majority interest in Isaac Mizrahi brand" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r192", "r193", "r194", "r195", "r196", "r241", "r242", "r243", "r244", "r245", "r248", "r254", "r266", "r290", "r291", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r362", "r465", "r466", "r467", "r493", "r494", "r495", "r496", "r505", "r506", "r507", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r544", "r545", "r547", "r548", "r549", "r550", "r558", "r559", "r563", "r564", "r565", "r566", "r584", "r585", "r586", "r587", "r588", "r635", "r636", "r637", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r695" ] }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items." } } }, "auth_ref": [ "r46", "r192", "r193", "r194", "r195", "r196", "r241", "r242", "r243", "r244", "r245", "r248", "r254", "r266", "r290", "r291", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r362", "r465", "r466", "r467", "r493", "r494", "r495", "r496", "r505", "r506", "r507", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r544", "r545", "r547", "r548", "r549", "r550", "r558", "r559", "r563", "r564", "r565", "r566", "r584", "r585", "r586", "r587", "r588", "r635", "r636", "r637", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r695" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "xelb_NewLoanAndSecurityAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "NewLoanAndSecurityAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to new loan and security agreement.", "label": "New Loan Agreement" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r881" ] }, "xelb_NonManagementDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "NonManagementDirectorsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Non Management Directors" } } }, "auth_ref": [] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r850", "r862", "r872", "r889", "r898" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r879" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r878" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r889" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r909" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r909" ] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Additional royalty payments", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r15", "r70", "r161" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "verboseLabel": "Noncontrolling Interest", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r81", "r415", "r949", "r950", "r951", "r1046" ] }, "xelb_NumberOfConsecutiveQuartersForRoyaltyPayableTerm": { "xbrltype": "integerItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "NumberOfConsecutiveQuartersForRoyaltyPayableTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of consecutive quarters for royalty payable term.", "label": "Number of Consecutive Quarters for Royalty Payable Term", "terseLabel": "Number of consecutive quarters for royalty payable term" } } }, "auth_ref": [] }, "xelb_OfficeSpaceLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "OfficeSpaceLeaseMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Office Space Lease" } } }, "auth_ref": [] }, "us-gaap_OfficersCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficersCompensation", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold", "terseLabel": "Base Salary", "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold." } } }, "auth_ref": [ "r940" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Expenses", "terseLabel": "Operating cost", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Operating loss", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r268", "r277", "r281", "r283", "r801" ] }, "us-gaap_OperatingIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLossAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other operating costs and expenses (income)" } } }, "auth_ref": [] }, "xelb_OperatingIncomeLossBeforeOtherExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "OperatingIncomeLossBeforeOtherExpense", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before the inclusion of other expenses.", "label": "Operating Income Loss Before Other Expense", "totalLabel": "Operating loss before other operating costs and expenses (income)" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r573", "r820" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r1021" ] }, "us-gaap_OperatingLeaseImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Impairment Loss", "terseLabel": "Impairment charge", "documentation": "Amount of loss from impairment of right-of-use asset from operating lease." } } }, "auth_ref": [ "r1020" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "totalLabel": "Present value of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r569" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations", "verboseLabel": "Current portion of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r569" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current portion of lease liabilities", "verboseLabel": "Long-term portion of operating lease obligations", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r569" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Cash payments for operating lease expense", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r570", "r577" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r568" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Impairment charge", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r943" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r579", "r820" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term for operating leases", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r578", "r820" ] }, "xelb_OperatingLeasesSubleaseTerm": { "xbrltype": "dateItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "OperatingLeasesSubleaseTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents the sublease term.", "label": "Operating Leases Sublease Term", "terseLabel": "Term of operating leases sublease" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforward available to offset future taxable income", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r78" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r77" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Nature of Operations, Background, and Basis of Presentation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Nature of Operations, Background, and Basis of Presentation", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r96", "r159", "r693", "r694" ] }, "xelb_OrmeLiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "OrmeLiveMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to ORME Live, Inc. (\"ORME\").", "label": "ORME" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r204" ] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Domain]", "documentation": "Other future obligation." } } }, "auth_ref": [] }, "xelb_OtherExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "OtherExpenseDebt", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount other expense incurred on debt.", "label": "Other Expense, Debt", "terseLabel": "Other costs" } } }, "auth_ref": [] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncome", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Other Income", "terseLabel": "Other income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r671", "r741", "r777", "r778", "r779" ] }, "xelb_OtherInterestAndFinanceChargesIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "OtherInterestAndFinanceChargesIncomeNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The amount of other interest and finance charges (income), net incurred during the period.", "label": "Other Interest And Finance Charges (Income) Net", "terseLabel": "Other interest and finance charges, net" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Other than Long-term Debt, Noncurrent", "verboseLabel": "Other long-term liabilities", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r32" ] }, "us-gaap_OtherNoncashExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "label": "Other Noncash Expense", "terseLabel": "Non-cash expenses", "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other." } } }, "auth_ref": [ "r137" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r881" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Other Receivables", "terseLabel": "Due from related party", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r208", "r727" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r848", "r860", "r870", "r896" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r851", "r863", "r873", "r899" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r851", "r863", "r873", "r899" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "xelb_OwnershipInterestTransferable": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "OwnershipInterestTransferable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting transferable should certain conditions be met.", "label": "Ownership Interest Transferable", "terseLabel": "Ownership equity transferable" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r877" ] }, "xelb_PaymentOfDeferredFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "PaymentOfDeferredFinanceCosts", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with finance costs.", "label": "Payment Of Deferred Finance Costs", "negatedLabel": "Payment of deferred finance costs" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Shares repurchased including vested restricted stock in exchange for withholding taxes", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r39" ] }, "xelb_PaymentsOfCashToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "PaymentsOfCashToRelatedParty", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of payment of cash to related party.", "label": "Payments of Cash to Related Party", "terseLabel": "Payments to related party" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtExtinguishmentCosts", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedLabel": "Payment of prepayment, breakage and other fees associated with early extinguishment of long-term debt", "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest." } } }, "auth_ref": [ "r4" ] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Payments of Debt Issuance Costs", "verboseLabel": "Legal and other fees", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r41" ] }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Equity Method Investments", "negatedLabel": "Capital contribution to equity method investees", "verboseLabel": "Members contribution", "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence." } } }, "auth_ref": [ "r37" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r134" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r880" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r880" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r879" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r889" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r882" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r878" ] }, "xelb_PercentageOfNetCashFlowDistributableToMembers": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "PercentageOfNetCashFlowDistributableToMembers", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of net cash flow distributable to members.", "label": "Percentage of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members (in percent)" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails" ], "lang": { "en-us": { "role": { "label": "Performance Shares", "terseLabel": "Performance Shares", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r115", "r400" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Authorized number of shares of preferred stock", "verboseLabel": "Preferred stock, shares authorized (in shares)", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r115", "r719" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock, shares issued (in shares)", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r115", "r400" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock, shares outstanding (in shares)", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r115", "r719", "r738", "r1046", "r1047" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r115", "r657", "r821" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r938" ] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Net proceeds from the sale of shares", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from long-term debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r38", "r698" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Net proceeds from the sale of private placement shares", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance or Sale of Equity", "terseLabel": "Total net proceeds from the sale of shares", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r3", "r698" ] }, "us-gaap_ProceedsFromLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLeasePayments", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Lease Payments", "terseLabel": "Cash received from subleasing", "documentation": "Amount of cash inflow from lease payment, classified as operating activity." } } }, "auth_ref": [ "r581", "r582" ] }, "us-gaap_ProceedsFromSaleOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Intangible Assets", "terseLabel": "Cash proceeds from sale", "verboseLabel": "Proceeds from sale of assets", "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r133" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Productive Assets", "verboseLabel": "Net proceeds from sale of assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r133" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r3", "r19" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProductMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net sales", "documentation": "Article or substance produced by nature, labor or machinery." } } }, "auth_ref": [ "r810" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r284", "r633", "r673", "r674", "r675", "r676", "r677", "r678", "r790", "r810", "r822", "r921", "r969", "r970", "r978", "r1038" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r284", "r633", "r673", "r674", "r675", "r676", "r677", "r678", "r790", "r810", "r822", "r921", "r969", "r970", "r978", "r1038" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Professional Fees", "verboseLabel": "Legal and agent fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r832", "r1044", "r1045" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net (loss) income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r198", "r213", "r214", "r224", "r231", "r242", "r252", "r253", "r268", "r277", "r281", "r283", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r509", "r512", "r513", "r539", "r546", "r653", "r666", "r706", "r740", "r760", "r761", "r801", "r818", "r819", "r833", "r939", "r972" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r8", "r654", "r663", "r821" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r8", "r183", "r186", "r662" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Type [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r144" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives of property and equipment (in years)", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRollforwardOfAllowanceForCreditLossesDetails" ], "lang": { "en-us": { "role": { "label": "Provision for Doubtful Accounts", "verboseLabel": "Credit loss expense", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r222", "r343" ] }, "xelb_PublicOfferingAndPrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "PublicOfferingAndPrivatePlacementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents the public offering and private placement.", "label": "Public Offering and Private Placement [Member]" } } }, "auth_ref": [] }, "xelb_PublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "PublicOfferingMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents the public offering..", "label": "Public Offering [Member]" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r877" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r877" ] }, "xelb_QurateRetailGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "QurateRetailGroupMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Qurate Retail Group.", "label": "Qurate" } } }, "auth_ref": [] }, "xelb_QvcProductLaunch": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "QvcProductLaunch", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Date the Product Launch, in CCYY-MM format.", "label": "QVC Product Launch", "terseLabel": "QVC Product Launch" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r365", "r366", "r367", "r368", "r426", "r428", "r459", "r460", "r461", "r607", "r631", "r679", "r709", "r710", "r770", "r771", "r772", "r773", "r776", "r786", "r787", "r802", "r809", "r814", "r823", "r826", "r967", "r976", "r1031", "r1032", "r1033", "r1034", "r1035" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Range [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r365", "r366", "r367", "r368", "r426", "r428", "r459", "r460", "r461", "r607", "r631", "r679", "r709", "r710", "r770", "r771", "r772", "r773", "r776", "r786", "r787", "r802", "r809", "r814", "r823", "r826", "r967", "r976", "r1031", "r1032", "r1033", "r1034", "r1035" ] }, "us-gaap_ReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Receivables, Policy [Policy Text Block]", "verboseLabel": "Accounts Receivable", "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable." } } }, "auth_ref": [ "r955", "r956", "r957", "r958" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r843", "r855", "r865", "r891" ] }, "xelb_ReductionInOperatingExpensesOverNextYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ReductionInOperatingExpensesOverNextYear", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense for operating activities to be reduced over the next year. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Reduction in Operating Expenses Over Next Year", "terseLabel": "Reduction in operating expenses" } } }, "auth_ref": [] }, "xelb_ReductionInPayrollCostsOverNextYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ReductionInPayrollCostsOverNextYear", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees to be reduced over the next year. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Reduction in Payroll Costs Over the Next Year", "terseLabel": "Reduction in payroll costs" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r427", "r592", "r593", "r712", "r713", "r714", "r715", "r716", "r737", "r739", "r769" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r233", "r234", "r592", "r593", "r594", "r595", "r712", "r713", "r714", "r715", "r716", "r737", "r739", "r769" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r592", "r593", "r1027" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r427", "r592", "r593", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r712", "r713", "r714", "r715", "r716", "r737", "r739", "r769", "r1027" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r589", "r590", "r591", "r593", "r596", "r702", "r703", "r704", "r744", "r745", "r746", "r766", "r768" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Long-term Debt", "negatedLabel": "Payment of long-term debt", "terseLabel": "Repayment of principal", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r40", "r699" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r235", "r236", "r381", "r402", "r595", "r796", "r797" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r844", "r856", "r866", "r892" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r845", "r857", "r867", "r893" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r852", "r864", "r874", "r900" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r47" ] }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings", "terseLabel": "Shares surrendered for cancellation", "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation." } } }, "auth_ref": [] }, "srt_RetailSiteMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RetailSiteMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Retail Site", "documentation": "Locations where products are offered for sale to consumers." } } }, "auth_ref": [ "r791", "r792", "r835", "r836" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r118", "r152", "r659", "r686", "r691", "r700", "r720", "r821" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Accumulated Deficit [Member]", "verboseLabel": "Accumulated Deficit", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r194", "r238", "r239", "r240", "r243", "r251", "r253", "r332", "r338", "r465", "r466", "r467", "r495", "r496", "r519", "r522", "r523", "r526", "r537", "r682", "r684", "r707", "r1046" ] }, "xelb_RetainedInterestInInvestmentAdjustmentRevenueThresholdAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "RetainedInterestInInvestmentAdjustmentRevenueThresholdAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of threshold revenue for making adjustments to retained interest in investment.", "label": "Retained Interest in Investment Adjustment Revenue Threshold Amount", "terseLabel": "Amount of adjustments to retained interest" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net revenue", "verboseLabel": "Licensing revenue", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r269", "r270", "r276", "r279", "r280", "r284", "r285", "r286", "r424", "r425", "r633" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Policy Text Block]", "verboseLabel": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r189", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r789" ] }, "xelb_RevenueRecognitionMilestoneMethodNonCashChargeWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "RevenueRecognitionMilestoneMethodNonCashChargeWriteDown", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration written off during the period for the milestone or milestones.", "label": "Revenue Recognition, Milestone Method, Non-cash Charge Write Down", "terseLabel": "Non-cash charge" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Revenues", "verboseLabel": "Revenue from services provided", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r220", "r231", "r269", "r270", "r276", "r279", "r280", "r284", "r285", "r286", "r328", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r546", "r653", "r972" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "auth_ref": [] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Significant Contracts [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RoyaltyExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RoyaltyExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Royalty Expense", "terseLabel": "Recognized royalty expense", "verboseLabel": "Royalty expense", "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property." } } }, "auth_ref": [ "r130" ] }, "us-gaap_RoyaltyGuaranteesCommitmentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RoyaltyGuaranteesCommitmentsAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Royalty Guarantees, Commitments, Amount", "terseLabel": "Royalty guarantees", "verboseLabel": "Threshold royalties below which the equity interest would be transferable", "documentation": "The amount the entity has committed to make for future royalty guarantees." } } }, "auth_ref": [ "r639" ] }, "xelb_RoyaltyPayableTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "RoyaltyPayableTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of time that royalties will be payable.", "label": "Royalty Payable Term", "terseLabel": "Royalty payable term" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r909" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r909" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Sales [Member]", "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ScenarioPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScenarioPlanMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Plan", "documentation": "The scenario under which facts represent plans as distinct from actual." } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Scenario, Unspecified [Domain]", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r254", "r429", "r917", "r952" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r47" ] }, "xelb_ScheduleOfAssetAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ScheduleOfAssetAcquisitionLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule Of Asset Acquisition [Line Items]", "label": "Schedule Of Asset Acquisition [Line Items]" } } }, "auth_ref": [] }, "xelb_ScheduleOfAssetAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ScheduleOfAssetAcquisitionTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule of Asset Acquisition [Table]", "label": "Schedule Of Asset Acquisition [Table]" } } }, "auth_ref": [] }, "xelb_ScheduleOfCommonStockRepurchasedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ScheduleOfCommonStockRepurchasedTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number of common stock repurchased during the period.", "label": "Schedule Of Common Stock Repurchased [Table Text Block]", "terseLabel": "Schedule Of Common Stock Repurchased" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of income tax benefit for federal and state and local income taxes", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r157" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]", "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]", "documentation": "Schedule, table or text reflecting equity-based arrangements (such as stock or unit options and stock or unit awards) with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability." } } }, "auth_ref": [ "r10", "r71", "r72", "r153" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of components of net deferred tax assets (liabilities)", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r156" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of the basic and diluted net loss per share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r953" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of income tax benefit computed at the federal and state and local statutory rates", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r155" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r325", "r326", "r327" ] }, "xelb_ScheduleOfGoodwillAndIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ScheduleOfGoodwillAndIntangibleAssetsTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Schedule of Goodwill and Intangible Assets [Table]", "terseLabel": "Schedule of Goodwill and Intangible Assets [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "verboseLabel": "Schedule of Trademarks and Other Intangibles", "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class." } } }, "auth_ref": [ "r57" ] }, "xelb_ScheduleOfLicenseAgreementsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ScheduleOfLicenseAgreementsTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of license agreements expiration terms.", "label": "Schedule Of License Agreements [Table Text Block]", "terseLabel": "Schedule Of License Agreements" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-Term Debt", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r431", "r433", "r434", "r435", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r459", "r460", "r461", "r462" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]", "verboseLabel": "Summary of Stock Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r17", "r18", "r73" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Activity", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock Options Roll Forward [Table Text Block]", "terseLabel": "Summary of Stock Option Activity for Non-Vested Options", "documentation": "Tabular disclosure of the change in stock options." } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Future Amortization Expense", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r63" ] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r1013" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r837" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r839" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expense", "verboseLabel": "Other selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r131" ] }, "xelb_SeniorManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "SeniorManagementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Senior Management" } } }, "auth_ref": [] }, "xelb_ServiceFeesReduction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ServiceFeesReduction", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "A reduction in a fee charged by the company in relation to services performed.", "label": "Service Fees, Reduction", "terseLabel": "Reduction in service fees" } } }, "auth_ref": [] }, "xelb_ServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ServicesAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Services Agreement.", "label": "Services Agreement [Member]", "terseLabel": "Services Agreement" } } }, "auth_ref": [] }, "us-gaap_SeveranceCosts1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeveranceCosts1", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Severance Costs", "terseLabel": "Aggregate potential severance costs", "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation", "terseLabel": "Operating cost", "verboseLabel": "Stock-based compensation and cost of licensee warrants", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period (in years)", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r815" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Other disclosures" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Expired/Forfeited (in shares)", "negatedTerseLabel": "Forfeitures of restricted stock grants", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r451" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Expired/Forfeited (in dollars per share)", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r451" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r449" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r449" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r446", "r447" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Other than Options", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r446", "r447" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)", "verboseLabel": "Number of shares vested", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r450" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r450" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "verboseLabel": "Expected Volatility Rate, Maximum", "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "verboseLabel": "Expected Volatility Rate, Minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "verboseLabel": "Risk-Free Interest Rate, Maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "verboseLabel": "Risk-Free Interest Rate, Minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Stockholders' Equity", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r431", "r433", "r434", "r435", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r459", "r460", "r461", "r462" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of common stock eligible for issuance", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r817" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "verboseLabel": "Shares are granted available for issuance (in shares)", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r72" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Exercisable (in shares)", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r440" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Exercisable (in dollars per share)", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r440" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Expired/Forfeited (in shares)", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r986" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired/Forfeited (in dollars per share)", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r986" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r442" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Granted (in dollars per share)", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r452" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]", "terseLabel": "Schedule of Black-Scholes Assumptions for Fair Value of Options Granted", "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year." } } }, "auth_ref": [ "r74" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r438", "r439" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r438", "r439" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]", "terseLabel": "Schedule of options vesting upon achievement of target price", "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Number of options vesting", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r454" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r459", "r460", "r461", "r462" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r443" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Granted (in dollars per share)", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r442" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Five year expiration", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Ten year expiration", "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Seven year expiration", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]", "verboseLabel": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r430", "r437", "r456", "r457", "r458", "r459", "r462", "r468", "r469", "r470", "r471" ] }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedPaymentArrangementEmployeeMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Employees", "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires." } } }, "auth_ref": [ "r433", "r434", "r435", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r459", "r460", "r461", "r462" ] }, "xelb_ShareBasedPaymentArrangementTrancheFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ShareBasedPaymentArrangementTrancheFiveMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Fifth portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "April 2023" } } }, "auth_ref": [] }, "xelb_ShareBasedPaymentArrangementTrancheFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ShareBasedPaymentArrangementTrancheFourMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Fourth portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "April 2025" } } }, "auth_ref": [] }, "xelb_ShareBasedPaymentArrangementTrancheSixMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ShareBasedPaymentArrangementTrancheSixMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Sixth portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share Based Payment Arrangement Tranche Six [Member]", "terseLabel": "April 2024" } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Share Price", "terseLabel": "Common stock price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "verboseLabel": "Vesting rights (percentage per year)", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r980" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r816" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesAssumptionsForOptionsGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected Life (in years)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r458" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable Weighted Average Remaining Contractual Life (in Years)", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r72" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Options", "verboseLabel": "Number of Options", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Forfeited or Canceled (in shares)", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited or Canceled (in dollars per share)", "documentation": "Weighted average grant-date fair value of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Ending Balance (in dollars per share)", "periodStartLabel": "Beginning Balance (in dollars per share)", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "verboseLabel": "Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Outstanding Weighted Average Remaining Contractual Life (in Years)", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r154" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested (in shares)", "terseLabel": "Vested (in shares)", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)", "documentation": "Weighted average grant-date fair value of options vested." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Balances (in shares)", "periodStartLabel": "Balances (in shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedTerseLabel": "Shares repurchased in exchange for withholding taxes (in shares)", "terseLabel": "Total Number of Shares Purchased", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Short-term Lease, Cost", "terseLabel": "Short-term lease cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r574", "r820" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r138", "r229" ] }, "xelb_SignificantContractsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "SignificantContractsTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContracts" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure about significant contracts.", "label": "Significant Contracts [Text Block]", "verboseLabel": "Significant Contracts" } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r16", "r35", "r194", "r216", "r217", "r218", "r238", "r239", "r240", "r243", "r251", "r253", "r267", "r332", "r338", "r415", "r465", "r466", "r467", "r495", "r496", "r519", "r521", "r522", "r523", "r524", "r526", "r537", "r551", "r552", "r553", "r554", "r555", "r556", "r588", "r682", "r683", "r684", "r707", "r762" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "verboseLabel": "Contract Terms", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r238", "r239", "r240", "r267", "r633", "r696", "r708", "r711", "r712", "r713", "r714", "r715", "r716", "r719", "r722", "r723", "r724", "r725", "r726", "r728", "r729", "r730", "r731", "r733", "r734", "r735", "r736", "r737", "r739", "r742", "r743", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r762", "r827" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r254", "r429", "r917", "r918", "r952" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r238", "r239", "r240", "r267", "r633", "r696", "r708", "r711", "r712", "r713", "r714", "r715", "r716", "r719", "r722", "r723", "r724", "r725", "r726", "r728", "r729", "r730", "r731", "r733", "r734", "r735", "r736", "r737", "r739", "r742", "r743", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r762", "r827" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r847", "r859", "r869", "r895" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Shares issued in connection with stock grant", "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Shares issued to consultant in connection with Isaac Mizrahi sale transaction", "verboseLabel": "Shares issued in connection with sale transaction (in shares)", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Additional shares issued", "verboseLabel": "Shares issued", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r16", "r115", "r116", "r152", "r698", "r762", "r780" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Shares issued in connection with restricted stock grants (in shares)", "verboseLabel": "Aggregate shares of restricted stock granted", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r16", "r115", "r116", "r152" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Shares issued in connection with stock grant (in shares)", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Shares issued on exercises of stock options, net of shares surrendered for cashless exercises (in shares)", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r16", "r115", "r116", "r152", "r443" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Issued for Services", "netLabel": "Shares issued in connection with sale transaction", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Value of shares issued", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r16", "r115", "r116", "r152", "r707", "r762", "r780", "r833" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Shares issued in connection to restricted stock grants", "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited." } } }, "auth_ref": [ "r16", "r152" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Shares issued on exercises of stock options, net of shares surrendered for cashless exercises", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r16", "r35", "r152" ] }, "xelb_StockRepurchasedDuringPeriodAveragePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "StockRepurchasedDuringPeriodAveragePricePerShare", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Average price of shares that have been repurchased during the period.", "label": "Stock Repurchased During Period Average Price Per Share", "terseLabel": "Actual Price Paid Per Share" } } }, "auth_ref": [] }, "xelb_StockRepurchasedDuringPeriodValueVestingOfRestrictedStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "StockRepurchasedDuringPeriodValueVestingOfRestrictedStock", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingAssumptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Value of stock repurchased during the period related to vesting of restricted stock.", "label": "Stock Repurchased During Period Value Vesting Of Restricted Stock", "terseLabel": "Fair value of Re-Purchased Shares" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Xcel Brands, Inc. stockholders' equity", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r116", "r119", "r120", "r139", "r721", "r738", "r763", "r764", "r821", "r834", "r945", "r964", "r1019", "r1046" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' Equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balances", "periodStartLabel": "Balances", "totalLabel": "Total Stockholders' Equity", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r81", "r82", "r85", "r194", "r195", "r217", "r238", "r239", "r240", "r243", "r251", "r332", "r338", "r415", "r465", "r466", "r467", "r495", "r496", "r519", "r521", "r522", "r523", "r524", "r526", "r537", "r551", "r552", "r556", "r588", "r683", "r684", "r705", "r721", "r738", "r763", "r764", "r781", "r833", "r945", "r964", "r1019", "r1046" ] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Stockholders' Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r149", "r230", "r399", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r413", "r415", "r528", "r765", "r767", "r782" ] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Sublease Income", "negatedLabel": "Sublease income", "terseLabel": "Term of sublease", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r576", "r820" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r557", "r599" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r557", "r599" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r557", "r599" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r557", "r599" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r557", "r599" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Event" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r598", "r600" ] }, "xelb_Subsequentyearscashbonusafterreductionofsalarybasisamountreductioncalculationofcashbonus": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "Subsequentyearscashbonusafterreductionofsalarybasisamountreductioncalculationofcashbonus", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount which should be taken as base to reduce the base pay for calculation of cash bonus in subsequent years.", "label": "SubsequentYearsCashBonusAfterReductionOfSalaryBasisAmountReductionCalculationOfCashBonus", "terseLabel": "Subsequent cash bonus basis for Calculation" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "xelb_SummaryOfSignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Summary Of Significant Accounting Policies [Line Items]" } } }, "auth_ref": [] }, "xelb_SummaryOfSignificantAccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "SummaryOfSignificantAccountingPoliciesTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "", "label": "Summary Of Significant Accounting Policies [Table]", "terseLabel": "Summary Of Significant Accounting Policies [Table]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Supplemental disclosure of cash flow information:" } } }, "auth_ref": [] }, "us-gaap_SwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SwapMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Swap [Member]", "terseLabel": "Swap contract with IDB", "documentation": "A forward-based contract in which two parties agree to swap streams of payments over a specified period. The payment streams are based on an agreed-upon (or notional) principal amount. The term notional is used because swap contracts generally involve no exchange of principal at either inception or maturity. Rather, the notional amount serves as a basis for calculation of the payment streams to be exchanged." } } }, "auth_ref": [ "r163", "r726", "r731", "r736", "r753", "r759", "r774", "r775", "r826" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r888" ] }, "xelb_TargetPrice1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "TargetPrice1Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the first target price.", "label": "Target Price 1 [Member]" } } }, "auth_ref": [] }, "xelb_TargetPrice2Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "TargetPrice2Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the second target price.", "label": "Target Price 2 [Member]" } } }, "auth_ref": [] }, "xelb_TargetPrice3Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "TargetPrice3Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the third target price.", "label": "Target Price 3 [Member]" } } }, "auth_ref": [] }, "xelb_TargetPrice4Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "TargetPrice4Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the fourth target price.", "label": "Target Price 4 [Member]" } } }, "auth_ref": [] }, "xelb_TargetPrice5Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "TargetPrice5Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the fifth target price.", "label": "Target Price 5 [Member]" } } }, "auth_ref": [] }, "us-gaap_TaxPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Axis]", "documentation": "Information about the period subject to enacted tax laws." } } }, "auth_ref": [] }, "us-gaap_TaxPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Domain]", "documentation": "Identified tax period." } } }, "auth_ref": [] }, "xelb_ThresholdAmountOfNetCashFlowDistributableToMembers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "ThresholdAmountOfNetCashFlowDistributableToMembers", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold amount of net cash flow distributable to members.", "label": "Threshold Amount of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title of individual or nature of relationship to individual or group of individuals." } } }, "auth_ref": [ "r954", "r1026" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsOrmeDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Relationship to Entity [Domain]", "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r880" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r887" ] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks (finite-lived)", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r80" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r908" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r910" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r394", "r412", "r527", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r669", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r959", "r960", "r961", "r962" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r911" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r912" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r910" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r910" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r913" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r911" ] }, "xelb_TwelveMonthPeriodEndingMarch312025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "TwelveMonthPeriodEndingMarch312025Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining twelve-month period ending March 31, 2025", "label": "Twelve-month period ending March 31, 2025" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r508" ] }, "xelb_UnconsolidatedAffiliateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "UnconsolidatedAffiliateMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfInvestmentInUnconsolidatedAffiliateDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to unconsolidated affiliates.", "label": "Unconsolidated affiliate" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r907" ] }, "xelb_UnexercisedStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "UnexercisedStockOptionsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information relating to unexercised stock options.", "label": "Unexercised Stock Options" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r475", "r483" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r54", "r55", "r56", "r180", "r181", "r184", "r185" ] }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityOwnershipPercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)." } } }, "auth_ref": [ "r84" ] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAcquisitionsAndDivestituresInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Primary Beneficiary", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r83", "r510", "r511", "r514", "r515" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableLeaseCost", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesCompanyLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r575", "r820" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsTargetPricesDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Warrants", "terseLabel": "Warrants", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r824", "r825", "r828", "r829", "r830", "r831" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrant term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1016" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted weighted average number of shares outstanding", "verboseLabel": "Diluted weighted average common shares outstanding", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r257", "r262" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic weighted average number of shares outstanding", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r256", "r262" ] }, "xelb_WorkingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "WorkingCapitalNet", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of net of current asset and liabilities.", "label": "Working Capital, Net", "terseLabel": "Working capital, Net" } } }, "auth_ref": [] }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WriteOffOfDeferredDebtIssuanceCost", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Write off of Deferred Debt Issuance Cost", "terseLabel": "Unamortized deferred finance costs", "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt." } } }, "auth_ref": [ "r132" ] }, "xelb_XcelCommencedBrandWithQvc": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "XcelCommencedBrandWithQvc", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsScheduleOfLicenseAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Date the license arrangement commenced, in CCYY-MM format.", "label": "Xcel Commenced Brand with QVC", "verboseLabel": "Xcel Commenced Brand with QVC" } } }, "auth_ref": [] }, "xelb_XcelTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "XcelTermLoanMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Xcel Term Loan", "label": "Xcel Term Loan" } } }, "auth_ref": [] }, "xelb_YearEndingDecember312025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20231231", "localname": "YearEndingDecember312025Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining year ending December 31, 2025,", "label": "Year ending December 31, 2025" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "835", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "44", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482943/710-10-55-8" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "83", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "(m)", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479092/842-20-40-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-5" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-7" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-13" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483119/928-440-50-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r917": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r918": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(S-X 210.12-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2E" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 105 0001558370-24-005326-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-005326-xbrl.zip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�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

  •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

    ;DM"=.:H=P1OLTX 1A;^ZB;06#[F/$"'XT8P3/&,&3I'HKF^8J]A]) MXP&NU8@I7V$?!L6N]/R#!83M/04\%OYUP5BH(+<8?!ZT1- =M+64E63"&5AN M'9%:U&=A!'=*G^KKSY-O07.Y0IA5Z3T3V"/:'4U!_;5^#W=$=<[CLEG8S4V& M4*W<@]RC@9W@3)^6;:VJW4UY<+)PBF3,W7$R5;7PES WPC^#YS)S@HTT&4!V MO7+.'"5\H&H W(!*=UP5 \WEW)OC(MJPUCR#6N#)%X)&B0R=[CXPLO6[\]"= M!.S]R,8/'4=W'S*QII9"TJCIQQ&PVV^UOR5Y;Q@9.?D6EH!(O8F'O>=O/[$T MSN\3>%I^L&X"+&WFZ=$GW"_S/2:QU89&#=H)8:6FL!RUT69-^/!ALTW4\+'!@.H:!"[ MFAP=Z,.CQ^3ORT)!34D,,^?VF/8!/!:6M^D[P@GFG60#->Y7&F]3W+(3"*O? M2LLU6)3'K2:T6=^[$S[5SFN&M!"G6*T^%8C'6H!^JAT]7=S41CJ/ZO.$:TNZ MB>T!D(H9B3C2W0X^V9]A!U".#7(K4>GR1;VT5K9E:'A0'33<%HM16/UXYHE/ M(P!PW[.5CM5CH08?$S=0U29O=^_=27*P)^07V#D($6:W,'"C6^@J4@$(VGDX MO6&3U',A9EI\)0U.27'H42D2SU%\7?!L__SP/&"R2W=2>2\-/;6+VO")%RD: M3&B&E0_TGR5V-M5N6['X1\JJE@2&C^*NP8-8- :K_A!]%G2OP/Q"U-B@2C X M[M&?,MDK!_+ P[Q[Z*:#Z4QYRW6T6/^DQWEO+5,C&A 74A% ^ _/RO:QA6'7 M=26>R^E!_*'R.7_@OA77BYM3R\^WT]F174A'4R&=@^SN:/=BT):7/;6*S18U M8B-;/H@7$]L; DO#+E)_?G#^X(&_>-0*14#?58FC#DX9-2]@9'_JF<*]7DW# M,V!/64FWH%T[X(H9T?_09WT_CM84K1_>]*GZ\YWS1X_]G- 9O2PQ=$.Z.3%5 MZ>O@I\0"Z<_WSQ\^//J[T(G<_Y+OH$#_9]\3]5 ME6:X%8]ND4%QU)XX:D8!>)R0%$-ZI^11R4,"BIL"28!:UI5)I,@ M$U[:EONW_\.WA["+)[>^;T6/H185P0JIW^VWTLH559(J&42V4O:1XRZB2Q#V M;H.ACPMJ/P0TK(QN0A/6G::8#K#[ IL.RW7A'A+4QH3OS!6,H>W%AZX0.@3@ M5 6'R5X.UVB/-RQ'E&H;;32Z2UBF] A@5Y!O+!,O9T\JD/6=Z'1\%X&)$Q<5 MPO]NJ5'$QCM;CJYE26U\Q@TJK/H";Z0^F&6Q*43@'+"?5G4-^F4F;9F,]?,$ M3IJT0Q!N=;Y_DOSB=JYLX ^TBKP'ZDDR,>QXK+'-15W)5V16W& N%+I"0Q94 M@F+9<@>?X6,LSB+],YN*$S7LG&46WK#CKBW>6!\3443#4!JBX'W04)?TMZ8F MOJ30F%:I;&/ZSJ)*Q=(G9M13:=!&',ER69\)S6F/#FI]!,9643/)AQ:A@<"X MNT7<0BETWKG(+H#0+'-5]S:J(4&'!\)!=5V;+I'9[/M]XKM]1YR:&5=8'_I? MN=9MO/!F>X;?MB8JYT-+@^WXM!H8T^^-$#G MCK-"8/&(VCAW(T%_GM6.6W T];9N!WMHFNN4)77Q($<^F=O2X4\Y6@LV+3=U MI78HVC %Q4C==KZG57B;=^R;KH)*,]IEI."VO#IDEZU6TJ:>OFX<]GK5/NK8 M( QX$!\NWAM@5&N7Y=(DWFB_\ ,8!-_X,<8X'\\QSCG&^?'$. ,39=6 FRIR MCR_D*FC_9%E:-!81: H?5_=18"=(FO>FT'K0\TJ?4M4HS.'3**BF6QL M*1(^?M"W(=NY!78[LA!*D/RD4O80]VL4Q)/PV92)\4 MG_)@XY\>WAU8#K;*;95JC>#--'*N(IIS>6"AWFP_,*@2!I_=)\61B8VM0MI9 MZ6RO?7\WZ]&"/WQ.&K_PPSED&6LBOW5 QHK$1;%^72 MS]&UZI_/0RB(6[")P2\*'K7XI#,,&1J>=VB<(&O(ZF%E$L,%M@LB-HL3_5"& MT*1=_SZOJR]EHMY6RCK:AA MA^!MU.F1._9R;NP9-Z5#R]$AU>$FP'6C%M?PV@4%#Z+V=:FX-JFIG]H>:AUK MC!3OF[WCG_#6V=U2R\F(!0Y7VKTQ*_%GE+7P=@Y$"?^DTS];[,_PO^Q6(0.V M%9-*7IF',Q"">.6H6^"K#JX];.&S)MO7)6S?MVY7NJY+?@0%-&OR-/G)796X M_7^KUQ5L@J#9P8X^T8^8S_U7Z4 4O#F92/[9]QEEM4*O1^>6ZPI4Z(M]3.N] M2MQ@K]BVPD+)0<@'^8,V%IBR7=9P<.E"$G3#B[07[SMG6C=C4=\KY9_J+/P$ MJ%UXLH2KA)XS=+[0M:%,[#=PGR\Z>I>4%>VZ99=HM1M@7RS M#24J4#RR5"X0NG<&-N ;A"XE^P O VI2H'_1]0NLZV14_%=8%?=/[QKTY&^J MXDQ=?E$FG[AH0!NIESWIY")L-3=\E'BH'%:=?M..9!/EQQT^,SMLM=)IU2>] MWJD=)SI^FM):PQFY%79"M2HUK0\7)^VO\:E-L6QJ[I?N+K*SHEH!]0 #)]T9 M9X97F"FM09Y:_%;X )2]K _0@]\Z%,D MP0YRI3<2'2J?15;"0JCQ;7;IVH%FHWQ):87#F<,;QCM\^$+9BR/.,61#MHVN MW2E4OCNF IHN6BZA3G HS&S#>#;@PKDV3KJ"6W>_,4)4?K51'VH]J0G%:G"; M_.]3K8#8T-P*%WH%#QFQG,3)]0=>G;0Z'S=!]X>\V^W.2WC@0K\_A^U+)Y)S M[ _6_$UX=*J>S3S_"WW=X+?A-W&;]>CYY8Z^X6>U2_:H8_M@#?Y;_!EJCR:# M4$S]D4VX!1+BV^H.F^C$IZ2 2-1.^H+3G3(,1JY09VXY,VK!,-(2VUEK,B). MN*^*7WMT*A6L=%\5;O=.H__7Y,18O>NMFGI]-.[HNW=F?_3LCSZI/_JMG#!< M4 <3.96\^$9R&\E?(-E4PO8X=3.G(HM5WV%>8;84#YS4TIM '-GI&W;;:)F@ MSV'0#$HJWM10_[3F3AR5J ,E29WEI(>X;F\5T>E(/P6Y)P+H-HU9(O>2+++__J/>_?O/UEB &"&:'J)QH8^&;+N [S%;)>UR"\\X*NW0- M&R::FD85U/B]2;)05Y=J8L%F))M?HO>2NIUB?2\.1;XBM%^BZ7U6&^6()XPY M)9)I)8K5JJS10X-U^+$Z#\="(NUDFLM7;IFA\TW=ND21P_TT*=BP)O7(8EID MZOWUJ:A[HAPB154H^/.:*YRPA)^43K1WBM7*-90]@*5*/1@@Y95U^8OBQ^&+ M41TLY]SV1&"KOBSW_H17_C# BD&5PQ^YW"X,ZN\X

    ]\F&0D>"I4##Q 0>$N1(;+I$"98>@KA*M*3Y)J"TS VN?=&\X*[(NLB> MFI3U@T=E91?#M-Q-F?(S.J#T ,SE0;X,-; 4R:1O^YN&$,8O!$S=)T3LT9TQ M6!)WG7\ 3PW]5>]@0/[:F-(-L 6_,FD]*N.G\1O-)4F?Q? ( NU*<31);@[] M;558*K*2<8%: 5QZD8^0-N1F%J]BS?VI S/3##YN@*DKB)T8W@'TQPY&&V,) M!(PC>=$1;V!?72#%32"DJ;Z0_.B/63U.W(1N,!Q67V=( YV;^L= =%?[*D13 MZ+2JRT[,_DS0*D&3>IK>% GA;N*F0@,VWDT];"Y--LMA$.5K$E (J*\3Y'N: MG2IM*"8KJA>&NAY28DV1QJ&N5'ZBA\$*5(AR=0--/6^L/SU^']P\O#]S$4]N M3$W2O#;FIJR24 @WR%/#MTS22G>O(: [@CT.X"&('Y MD/BQO.$7*%O9W7WW9]DP5KFQ">C2]L' J^$I).H\N[(,F/*5-(2."> M\#^P$@? :>TLX )=$.D% =!+2G"LK;E@D,=>YZ1J0/#6-RL9TI!S?/VKN)3M MAS0#:^V4"*\GEKUI'YY].H!&+MB3^A*GD!;^BGOU:H&$I""OWW%L/3B)I,R1 M:HO:>Z[;S9IS4\K)48(RZ59UN>"R,EP8/DQP">],DOYK8U$T6PR"J^ :W@HU M6SFC;X6AK\(/UZ-) Q%#I\D1*YB7>70MZ//?3)IY;Z;,BG&25W:NZ]29V'.6 MR/R;J+9^V (IOT"U72\^EGI#W!!MMP K,=[_!>7A@PGG*T?@BJ'V79M,GQ0P MQ=CE!97X/-4U,%E$TP?_XA"O-1KDM(@6)"'II?Y1)2)D)W/#T:#$"PCXJJW1 MTW(72P,J,$WVN'^ IY)M$#5G3%.7W/!EOV $%\PGH['(7C&50*5+4DV%8#A\ M0=J"C -E''SQAD8*8>5O!IE6&#T)R_,!86-PAAK208>B;:&"-D;=7I4*[P+ZV?J2*LZ-FYH$I6^MT+O(C34'KC( M.@BMJ\TZO2G/F;Y^DY'W7!\&:?>< WXR_\EU*'G#/3?1Q':9+:V7E< LV>?R ME!X2KA?2&@(1HPGEZ#5$P4NK6%T6S+/R-8:FUZRF.$O/79IY M[ICG[G0]=UN-2C":4C' 3[(FDHS(_S>@;RQUD?AO2JPQ)K\:S^N5"R*PI M.FM:P+-^%0W B]:[QDNSP?#]<3:Q4XBKWZ%87**>2;RQ,<(S8IDM<]O6.;W' MX!9N:Y."^@ U:?&O,;T1F"2+W:7:T^KLQ%^B^=X/&QP==K"ZN:&'F8W\$B]T M'U!"P%68%54AM2]@'41EV;G'-=,3V">P,A!HJ> *-)XP2"L';79!7(E*S6>9!V$5B$BE2F]ZP@50OVRCE"Z@8B ;E6WE6QKV?@?3]1; MU=W=52!3(#(5%I%(-*=N^(K5RJ"QBEW:B9^?&\;^1C+TX]\[A(&A2$Z&*Y-Z M$<=OPJ0@2\9Z*M582OC*.,$7SD-+!M+(-Z@;N-,T13OM*'X!JSZMM1XP+PF9 M2!+R-4![1Q#P2L&$)*9PI%O:5J'+")9Z;*)<&V8D6/+2_>V"NZ3E&_VT00]@ M5,M=AT2*3;M=!S"1Z6VE1,0"B<&P:B\PQ<,M:Y= '?>9!_XCZ=86BP4,'*^1 MRE-'LZ&M5RP-[YT44AG5KU"Z>7.)!(^U*+ &#;DL*::"KR^V[_K\$O^!NJ=@ M]-D+$UZC#7B"D,!@R@N!+%KS-03*TQ'H@H7P(>P'=U(A\XQLF\7Q1#-HKBL( M.=#0P>*.W\^&%/1<@R#97QV1.+PX!N3EC=&\H!%:MWZ%\*I@<#FXV,,YO^7CB06/EUIS$'N>:[[<>#=8VW/'HFVA-(D!K M1#C.=<@U@2#&)<-M#@Y(N@J!A'L" 2#8(BX481[F_RMH*W_$5#N#/,$,0,04Z2GD%^2)$0W;&\)L!'27,$8*"\"2G MWEV!)P0$]Q42%N3Z9CU%V/W3+U';6S7-:D$PX#6)-%AR^:$)->\1%J!5?:0A MM_F,SXT,,U!.D.2"N1U:W)*WY,Y6W5KHTFA16SH1:?*Z5M_6FVYE.RD;^D#" MXLS 6RB6?F3'HJD&0RBO.3",U>'[T1+(ZQ0"GLF)%;A7."RO(PR=#)[1B+Y M7=]X4A*V3YNBN#D((45SO71TBKGXKZ$Z^;QDR2WD(9N '1#G_CLK8=%F(R I M4/5GO0(HG()7[S)" ^SQJ=$G343BC=T>?L$N*H$<"9@ :T\8AJ'[>6"N.56X M;6GD%0YRJVKA::&L 7Z303HWN,4VW2VL0DN(7D#Z5-@0LC]0Y2!P^LUOW)H\ MM*F 3H:ZNW);1=Q>2K1+PWHGY>VN?%OM] A@<&'D#88;I&NA MH[O-95>!V(3P$>>E9Y\,;[N'5P Y: M;)@T5?8[]@4$4W<&$M;G5;G!N=LSQQ"V9,7_X_"X#FP@;5FU6_M*DE(B$D4;P,OPB0O5V65Q RX MQX$V"M82#-ONR8@\TKNC]1(IQK>O]5)K?Y,LVLT(,Y>HFS_DA]]LF 6]/E*. M>P2;!H.UVF)K_:1VM$L*=DHR2"-X&LBS5:K]6 !^C;%O1@(3U^E9GQC=.-TA MY@>\VR&2%$Q'5WV=/ 5V+,FF 9WGC#&F24B?J::A4S]%W0#CAO<5K5) ))]5 MEYD@A53UON;FM^![]?P*(#71ZGA^D@DMPV2 M*X2Q@-R"7D.JB#HX#JB?8Q5 M?/JRO9*W=! %(.+$Y8,>90/7E:YXUFJW1YUAV'.28[C6I2XHXD160LM:_SI_ MV5N2#'&C2@J(+[ ^R=7TG6"=:+?2.,6($#7_@BOU/1;KZ'[E>6F$7,L!L \W MQ,6B;!^VC5\W!D)LKG7CA=V[IT2"6]T;@+?_!TXC_)B#5"T2;J'8N7RH:T$# MU3;/X;"-?GY;KP7O825Q6 ZY9+A1#R& )>'G-,WU1&&^A257PXAWU(8OF MD^'CB_AST =IFT2%JAXZL:*Z6HU+9;<(^5IE0[(=G?(V_SE_W:M]0BRC2H4';S?$0VJY';FT/IP]K8E% M^T$&<^,\\6%+V]I2[6#40#-Z&#XI(2 RZ 77AE0Y%;*0;*0$>V'XA^QM!._0 M39V@:W-]LH0E2\"H@(Y9FC%7C/G*0TK2/2GUPY0B,#_=$NGI!K4CG&W&=<->!1Y:KCM?EB;P+_["%23N,+/TS *> M&"'OIDC[KI_T/W-I!%K(- H.+C4H4JQJX1#AW_&JZN.CA$+*8>_-R/UI&X_K:2DI*PD$AGE!S4C MT2? ^Y3*-B!+4+4)B\+GT0"!@?X%I9,E\!8X M8,X[86",V1XD7E2H: "H\9EE=@T;! V,8<"^3PJX3V099^8@2/#,0< JMM3TC+F)YETMY>.B=VDG.H)""44*9'8XB?I2T_X;GIA5Q:F M>DT0*FB:FKD\%C]9D>CT!?UW_T]_*]QJ+[3V:G W7$&R)7+NM)^ AV($'Z+$ MKC6QT"_OE^#Z 2)=:(1[D>E]>O2$@+_DV(;W 85]\LD:BO $18/XL4V";--; MF/O"& 5'6_$)(0+!5=)<$D.IF3M+)G:13OUWD(JZ[_,HZJ?X=>G -]3ELI4] M&\14P=V=<"%\L;VM75[B(G.F^_N/;0+DG@V4GCU<[J*$[P,YEP1ZM2PN@!P3 MA9+SQ(V/WMQ.D8D/TP_6!?HZ%GJH',_ \13(Y$<11A=*04@\!H@>9L/G )J^ MY'M7K-?N6K7+4K50K!?QCVKKKGA5:K:*=\5"O9TKE_+9?+[6?I]X[ 7-]KF2 MOK*,WJ&!5U_-;;*1I;T>P:ASJ9KC@!#-_:SGL[4<5RK\XOY77>"I]2K8W_!# M1$1;V'>PCX)#+.2Z+:,;$[JB^]>HN2BGTC4K6Q0:Z#ICW-HQ_G;^ M@].E,=@SD/HK"[UX#1->7U)^$!FZ*IEF=YALQ(51PHD6\R_]^\6L=*GWK<:/ M?Y/I]/_^9VU!__[-4/CC=Q1@(T2^7M]B0CA3/'1C7$F(Z_MP+1_,LUD+F=U6 M2AF('A%$$V<*HB7B>_35[P- :4"5QRRBYKL!&;R>$KPFSQ1>F]!)YQHK$,BT M:*.O@X,L><60OL+SA-%7,1 ^)1!.G2D(YR5K>*D9<^O@D LSJ*,TIE^'\V?M<%EL!4OO\%W3U7.V2"ZR?6VV HSO@R!:JK5+UBKLLW55\E\<'$*H6 M+289U&"(/SUG0 P\U.]P^[J"N/@AB]@\P6 +0^KJ@CZ&KI/?;8)VQ/[S>R^X M-E%U$IA)PRS#Y92#7N;OPLB\Z@H2V+5I".:>NCP;-2?#&DIN703W$^(H5DUJ M[54OR4!]2])$JLKN5-Z%,HU\:P(V9MC:G\.CP1OOD5US*:MM^ MK#YTG]O(BH2/#GG8-,H:2F#!5=*@]95_R.T.H>'S'R =NO) E+ L0W%./\RY MK:N^RDN6G24>&HFUDOAC2IDF352O_J%]VSW64>K@;<)C62+XS]+*BK/OG&O#_S?W\03RH/_ZF MN5&D](C;Q('6?5$#KEGR/I>0>/6FO7>JI$HU%L5I 7EO9225H>\VR+)6;:LT M:>X']0<"FCG3T?R>5)Z+T$VE[!B*+7QX8T B<)1OZ49%?'2\(F*7&0 M>>(F>]++W75(T,E4P;?C;Y2NGFN19.?5M^[5T'3KN5NY@*25T*8%]##IJR!M ML$<2>?Q:,J0?JF.2=TLDAGT^1/;0+9"W$T_Z)B)"O\]*X*R](1%_#H7F(6$N M!ZU@3?P87@G-]O=AA.2;K$$82"$1_*E)B_B1DF$#C'(TJ9)N*T(2)&%;'H]Q M7 I[G'A=Y$R$>3822)N__7O MXWKX5&&/7NDVMWDRZ8Y&R03-H]ZD%'[^'4T)WJ1#;]EPL _$'/G423=H 6;W MQ9]7G]W-F/-1P,TO=B_7K<\A(X7D5A#QR*)5JA%-TMT)>]XQA4'N;^ R$D2; MS24 =E%"[]95)R4':+XPJ9L?&+Q*EUY SCW)NB\+%F: MF@!C(@N1?NN]98#MK:7X;;R"M'B#+F54]%QKV!6^^,ZJ'@>"B4'F#Q#5Q%9**" 5_/E4)!=8@>RNA]'WLK@02 !T= M?T'43P3-,21:Z(Q\+;E9WJ0L0C"EW-4>?&:QD[&Y+-1$ZZ\RS$WY9^UK5^:A MT],D11LA5^B0[%_"A=O\CIUA/!C/_E/X&V/Z MS-!FKD!!A##:U$N&>OR8:Q+:8SF]9\I(2+T@6KMFP3T[RL#%07+J_J:\B@3A MUZ 8B+)L28.B"BHM4S27ED%\7+4"#2/#D%VNTP9 )#694EZ7_>*I(T!O NMQ M:I! ;E^.UX41#UJZE\E(SL<4 M'BU[-0<)4%1\KN-7F*]C"??8!8__5]V]IQVDE"N0VK$3V@%*_4RBNE:>V2ME MJ^INX=I]A&:M/0NI (7%!H<8K4Q0O$AM%(PED&=/"&_0W ;#B7#A=S2"^@5^ M,C:I5>06-O+J2VWT-8)>K[+J-A250A7RM2IMA*0,#-=8*6/Q&/2+M0H+;EU8 MJ(QA!^O0 %#12@L(^5\'*Y53"QVA2X@(D(&" #J^ +?I"FUQ;*W84!^O&D^G MN 7H?U%U6WSQ]!4%]"=+_UNMP ^8,-W'?E%0+JGBX-7!M8K%;U\E]+ JD MW^\YO@O.+^FRDO_(2L[2#RDP/R3S0[[3#WD$+J-Z109!-28$BDHAFX6F@O5W M:-%JMQX2:= V6]7Y(-4RL.J$*'$&)*>*(B$FQ!00]C#U"Y&^9"!6SE3I,ZOK MO(WW8GI%Z5TH#X8&7EE% >/'RO9/1GPF2PXK#ATD[.^EUK1L9JB4ZYD\B%V) MZO:>:33(+]:-$5NKF$FJ1O!,EB8JZ5GJ^7N@& Q&OIY*1(0 L_ ?]M4-:E6V M+&<\"?8 44W_$&B#NI59(VA<"32W\]JAD)J# :MEL%!4R!3$#*3[3Z_@P&\4 M QXEA:AW/I6_(,5,ZX6N38"0D;K/-,EU>6?#^;K2/>#?E6BA)54VH/*X.H;#JBF;0=\J8 M9O<"5DM:,\:$V)"O!%@L&P MB*@F+?%!_^JK"Q3:02G -3Q>3XG4>ABF.RP-W_TG^,4?;6(S4A&61\(5AZJ- MHJ35!6:0OC8@RLO(]2S9I_'$H"=X7/+9"&AE< M,[C&9-"U)1)9E:IV =V*NCE=T/>^I]VV@IZ0 +\S7>?PJN"NIP\2"DV\0Z2! ML,?_5_P+O*:NG8L(= QP&>#N!%P*>1!B$)"U-@GSF@@7E)Z(US@(E]180>2' M=8"DH@UQ9KU*A(I0F[VDH*GC]=!S07JOVXR!.P/WU\@?I,PT]7(B)4"J_\<3 MMHD,X>K%Q/^P(5"O*UE>I$I __ 0"JLIT&/.;>ZSLN_MG:K_@O!(R#%<8KNS$%3=H H1U,"ZLQTX08".](P"A\)?_P+=^M=X5;0[J MM_LZF?<0OGO=[S3P=A$=BG"3FK(K9X2[ Q('!>^FK\+XUJ>NFZV84UHRU[6/ M$<0*]@PT9,\YLG,"BEA!$Y_?+]5:=Y2 J4^WP'"QHC>>%R?P#/2-<$B_B)5Q MT%=TJ"X??-M&"6'/$W)*;)%GF'ZZF&Y!&PGBP0-/K:0M(2R'A&4%&"38FC$, MVJLFC$'#G^.*: J4X@=GO:>S_Y8^[('2<$]'S*TI3+T 9^$(OX2>$RA:5B&^ MH^5WQ"8G29MRE70;X[ *6)F%]L[,*WXPKWC\]UYQ63)-DA=#8_8 ]OOTRC1R M9?;ZE1GN_/Z5D8[<%G%)_!6/!1IM[DBS@!KS7N?J0'1T(*AOX*@DBCCBRHWN M&RP(!@(A#YBS*QZ"10%"]5P-"RSBX.;U&!J$"05*V*NF[(PA^%4F'P1MXQNG M8-&F&88-[_-?HJ&+0"1'F.]I;<%N&!!I)4%,)3M/A,7@? N'V5M]9*Z13.V[ M_.0]>$F\)QX ?K1C+<1&;3E> R2(/5$58SX%D[2SWT$ M8Z%K>Z)//9NKI_);Q!3U'@@".DLAB% ]XG7T% ;(V##5P8#H_[WEJJ_12M?W M=&^:LN0^N$KWV(B (IVAUF\?-H"LE=4W%(A6;@X_=,NU>.#W@8X$K1O6\P%7 MA)ID'% 4\P+&%9#J^HY&^LY9W$\WHW''VU=)C72O7+!B[9D%%XDLN(@%%YU/ M<%&I'T(M2%M0?;F%Z*3YG&^O=-F.RQQ).LA*DI9ZQHQ*H '!V!ZB("FD$X!X M.-!)?SL\O]MC3/%2H=V'>\M5Z'68R$V&PB+=SD$NN<9OHCO:H"R?_L]G*C0@ MENP2,0[ P-P.A) [0-*%_+2"H P4DD0$G".80>'+<6XD"#41T%;,H2S*" MF_OR\H\@8*@)^0_P;LV+G7W%Y*0GLVO+H,U7 SL(6BL"=DQH-$M:P4+N*\@( MP<:#Q&Q)G6#:QB!Z75YS6->LYW/173QT QDC)(D??[@*!O0ZWA%)PK/]N=VO MQK0G4;!W8K!AXE;[+R8AK>:5 'F%&7?04+##G(S3 M@ 'MZ0$MC6$-A]F5BV W@$6V8H8=6Z6=D=?=!X1'^S.>DB^+@>7I@>5>6OH; MUY4'?\#D39.TA]QIJ&/TD0'BP;RJKP50Z[7 >4*PR1S^)P>:KF5YM_[LZOT[ M? [!OMR>8X4T\O9=.6Y1.IGTZB:^P%UOH@8>5U/:?-])1 3\IMKP=J/+XVF[ M9[E4JH6O3+O_L?[S*3V>JOB#0(>G6?GJYK+K)&^+S6@C;?:4*6_:V1__5B10 MK;ARN;[9Z.E33B/X^D]XG555#>9EE WSB.^ M*\51K"NA'HK'$OT>'^<_K;+Z[TJ;O;I.>"^XQXT&>Z>QE;T]^SZJ4MN;5_F3 M..L,QZ+%P$%PA]:L0^*KHD46W;_P1J2_/WGE'XL92,GTI%@LV97ZR50WGN#C M7?RGW(TEQ(R8[(F91,+##/I$2^[.4J+4%O+2E.]D9H_1$I*SC\DL2">;(X69 MHT_G\>X5OS2;FOUXG78PR<8C$YLC2_/;YNTP5FN,5/$FBV97(TDPYUVAN_7V M:L8VB_JLXHS&8K1:0.;T[KG:!(9N;6C<:.Z_:>YP^7;_^R-?==CI^5RKF*Z.7ZU@*W0CW\VYF>^3C*&>FM/8#/UH^%!)\7>RWK02^ M=WY[:--"[=++P)RTA63;&I8-?OFRQ!P77YY:TJ+= M EW:VA?3C9K=]%)EI].*@LT[U<[C20>&G+WE[%>?LE*K8[#S5QR*N=V\D$ M;ROD4AO/K<1\T.DD^=M&0[K-5A)3NXX/*^16=7-2 M>-:0RQJ-Y69JE"HEBTDC5;>5QXKQG)[#T"U(?:RE"[-:_ZG'CY]-Q9FW\NW! M0P.&;H'J$-U?/EC73F&TU!/W[:?VJ*[*6:Q>;"\@=M]\&;3CS0P_%7K297J< MO3&<1E<(N5A]I-:>\NF.7E0'5U?CQ)7@S#!8"R$7>]];M*KZ3:G5OKH>W"7G MA7AR:).A6]NZT^\?[-O&N-X6]'SE:C#7ZQEA#D.WMK7(WD_50:X]+T[O^)=! M/Q>-]A$>&@(N'30VRZEL]G%TFUW("_7Q*?X(LX: 2\\JZ\:B-UBVK_C21&H] M=1>V..@*(3 @I1YO"FI47_!1I7VMF-:#]-C%0T-@(/]@9/OWC:MA41T-XMW[ MYKTV@RL(0>TYJO'W1AX/["PDL?EL6S>CY1R&)C>'UBYO[WK+6^&Y'1U?F86^ M=/?P5,7G&@)9C?M.+2>GXED>/<2>U+O*_?/S'5Y "!U09\+-4VI0CX[R(T<7 MK]7VL)K"%#@$7%ZBZO3%B#Y51OG!,S][U&ZLK)@%W75K:+>;QY>UO#>+TWZF M'Q6<[A6R!UTQ!%QRLVQ!,.12@6\^\$WY(56[P4H)#-TZ@49\FG.BU>>'D7H_ M?VSEJYWLK8#7&@(#OLU95+TI\ M_7+V(FK3!PQ9>.C6 J21N9AWZR6!;SY?/A4*@VI%E?'0$,A"S:+R@F>MCI:3 MVV*S+RSCJ0$>&@)9LAR+#Q2C_UP<2ZF;\JWX?#F\QML*@8&[B?$RS#2UE]&4 M?\K>CZN)[,T]YIAA%RM4R]/GXM6@?569=3I\OC(5;K/=^.;%=N-*,B4F^G'\ M55_IQM/]=#>M]#$-D(24S, K:8_DW,>=6>MI/E@7Y97FH/5A?/ M&@*VS5*],N\\3^.\H_9'XCSUI-VT,2B$P.++<_;^69MJ2OOV=JSRM5L]?XNE MHW@(+/*JT>K=%$;M=CZ:Z8[J[6P_:>&A(:0K4U\L>]'ATP,_M:\?6JW6?')] M.^@F0NC1U=#N+IW2E=U>WHJ]JEFXU2M\%H9N,1HGN\R*]U)*;B.AAR;ECMRL M%%$Q7VP.;CV!M"\9:JQKULX^)6SQ35O;%N0;--[JSM;S'4?_;XK M9#)]PPG,:W]A/,6! >V7CRET^->$BECSB+005M.>[%(01/\01N= MOYBVSB1=KW(/N>C?Q.OW[17Y.2#$'WF[(0#^)Y+=Y^[F35SN4YB:J_)]_J4&L)F8V'83-@:Y M#')W*P3G ;FG)6R_C8?DW:Z(E)?\.B?QZ2/Q[]LAVU[+X+GR! : YP. '[OG M3R3MQQ1$_+#T))D^#\E2)-\??H&<_IFDT1#FLY2Z3A!RCR"M;9&>O[ZHJL") M:TD67FK7I4G+:G..KM(,GC;^I=NT,:1+IM)M-PM=M=]*).:/Z<)(?>A6BDIJ MZ=Q=#WZLY?UDK6ZM'TST2:CQ4?U)KM:+ZE"_78C-O!AK9W]P"I+5L:19__U\VZJXCW4 MH_K!6?B2\%/B#S_^]LY(Y!:36KZ-;FX'V>N8]-2YA%A9\<>_0B2327L)0]Y! MG*OZS]#Y0]'YU/2GST5GH>OT9P.^/'F)M1U1C6NZ=;=,+#\?G3M1YR9U4QFD MVDMY8;[$IOQQ;FSQSL<%#I#L?CZK(=LTT(>2EI#R@QX%P)_#13OYQGSGG?R-&]F_2S_-^KW S$B[+4C37LW.& MD.V2)(-$)!;C#\OP3\C>4-*AQ*!A+IE"\I44DD.+!M]8*SFXM."C'"9)(;2H M7K;O^M>E28*7GAN9A-I1'YXN(?,52P=Q*%'/+ D,<9DYX0A"Q6\0MZEU!U+J M/C[F:XZ:C;=NE&(Q.L"(FP0C8#J>^!I6@[J))I(:*'Z^JC\NNYYIR8UR8DK+ MNZG0<4/[/E:6.)FPQ2\F6+B86:2(F=45TF.0AHGLUGWJV:>ZEA,SW?;8'@S$ M%JK>#G+9;HI8(S[2<\'0^NN@]?'W=C)H?7"QXWUH/4OP25XV7O)%H?F4*_0? M6V*]#V5QL#02B\03J2]HTG +PK8,6](^2AAA6M(.+>G+TK9P\P*M4LQGT0:N(17CBPH^9D8OZKAAZ5SS/N_U3)V/?: M\H='>&S6;0V)US[V(3!0_Q9;_O#0B<\#]7-5Q#U/ 30D)VV0%)+*,('N1X<- M,60B^5=S6K)H@P,[!2@2UC5)M[.Z4O3P,-R)F4H\"]<9F2^,HM>EGI58WEXU M'@=0SQJKUTGQ T,3&29_-4QFX0<']@.\"9/KYEEO).N9.O:]5T66F) L&/D0\,= MOQ=@?T]<9BD4GX?+EX7L\H8ORG_/W][D>+5\D\MK+=)T"X216"2QEX(QI&9(S:P?'YE\\2ZD M;O7NL[8U>GQH3WMB]#KWV"E?67-8)]1R2$62R2^2E@'6('O)C9$]-!0L?,R0 M98-Q"/_*E2I#Z"')Y8\8JE((KV/2#$T9FC,[" ?)GB\'HT'_4$KD$ M3^$,K"6PZ9APKF7R3_#.&>0SD\)'<':/9Y5TV1BCEK3P+0LAS+WP4I7OVS=6 MC5_.\D*YG.AF&E',W.,TG"+&'SBA\FCA%,1YP>(F6*HWJ^#P^?$3J\SNJJ'+ M._.@DH_/CZGF8I+AU:N'DK&,YQM#,!B0$I*QO29-ALD,DUG1AH^/GG@E)H\* M"4N&7LGD;,QZNB\^S+! +-^DXI%,['SB+S8P?%.@V8/N]*&HAOHV M60U+=V?NW;.)TF"5'4[RWK\GJ+/*#B?9UYXJ\V??W?Y-,+]U#*AHTCU>X'EKP-!R&M5_L\_B]>+_'L/ZCP- B%:0.W2219:_4ZV/:T5!N.Y MG.K=W&,M@!9MC$62R3!#)R,CC(Q\$ADYS;,X#S+R06:%L)(65S?JDB^4!D6G MHMU*2:-3?! )&4G^^#>=CF3$,&-"[UP,"B<@8C-%ZEML^7-L!B>U9P;9WV++ MGV,B8!:!WPH=954B.U?=#E%-VY!'0_P=,JW_X6A2Q7<1\;]LF/3W*HO@[^]@ MNV20^S4A]]0"]7="[FGI0V_C,&Z; "[ :5A1_-,5%C^<5YP@>C$ _#8 >-04 MZT/2]Y.($::Y2%E9QNNP+6XB+:6>AB*<),NF@_8VG]56[(!):%])0OOKBZH5 MYQX%[")IG>)H5E>R%$D#M1#'YF#"DY]MYP;8'78$471,B M,8'%!S.L/D>5Z]Q#>_\(J^_-=*&^:";C?"T;4Q9*;SE\5.: U@N&.XL^>+O6%:<-0XW=&.WG?+K1*]?E5 M2L<4A91(2ZK?8R-UM4Q=2D,^@U !5) M%,X7S%CVK1'$]J"2<,E+UPE/FZGG:6Z:Q8$'KMO',BL&PDEDQ_JQ:^SNP M,G[)%^.=^FS MA03?LF@*IN0P&\=)BR3K+3L]VK?<3?F$2D:(55O2RZAC79>GF:RBF5>#KD#* ML\4B0F*?KL.H *,"S-1Q>B+0FZG 0)&NJ_U8QFHON_-RZEH8=\UR%J@ *6TO MI@XL 9V0N*,9^B!J(W.,#[MWN&8UWPN%SUO;8C:0]Y.:,D:?%L:> D:>W?2E M/5!$B6G&O$\*P\D TY<4J?Z2^,"NN@P/SPR5#3:ZF!>G(X:A8$V;70%4ILMDXPS"P C$JP^^UE: @Y'))Z2^=2MV;C- MM&N2+EGU/FK$>4(DDC_^%>+BN1L(UGK2?&0FZ7!]H67B-XW8R M+D0'MZ*<;(^;-P]"X7)6R,6R72%#NLM$XDD64,$0F37".ZH,\BI$;HXS?,M M9I/OI%,OJ>?%=1D]S@&1DX#(B63LZ\1@_/.[PGG@D@"CZL<5-F**UPDDOK-2 M>0QR&>2>G/-_)^2>A1Y+S?UEWZO]R9%]WQ 7O]>6F;_\(P+T]G90K$^*RY=Y M<9SBG<'4L6^F";VZ;, *L9(;C_#"/MF8X3/#YW/RNY^9

      ?)YE7UXJC_?C M47LL]SOW:!(M-29S6"%D%T;2XCZCU9GINI]5+HFI!2R6^#05X3,76#:*PNPE M; WMN9.^-YQ&6Q4+C\E;.UX9/V-!A91R%".)Q+XP8D8 & 'XDO:$CX@L/+Y= M :+E(YR.\ \-69;O,G?M#4P!.4D%A 72GRJ?#0;2[V6RZFTZMYQ;S\X(E>S< ME1B-+^+Q;%<4*9/-I)@U@"'CJ6GU7RR:/M2\SN+IF7S+%-RS8[QO#9'=RYP= MJ3Z]M%^2MVWI)M6HM1JMXJPWZ(JD;F B$A=9Y4!&(;Z]!GQF-OZ#4HA$?S'D M'VI/UFAIM',OSW4SVFP2"D$"W<3,%TFUKY&63*OL>A9*SR)P62C]D8(. !<# ML:1["929JO&EJ[35+TY3PU3[MBS6>1!A2(7".$O59]C\U>+IOXQQ8BV'[6-9 M[[<7L[]=YBY+[S]6^MM>=BT^S!NUO+.%6D!OU2$%SZ0 M93,J\-VHP$EN]V2HP$?FSNVW.SI/=X[<46^+S4QNF4I+S=PL2J@ %/ 3(H*8 M.%.S@B_/E)D!@:DP]MA_:Z%%\,86F\QFKPQ'JOV&.FVQ6&1AO.# M'V2BB!^P)LTYWNQW#2X^:J2_OYD#EY9A '@^ 'C4Z/:= ,@4(2;U,:F/*4(, M)1A*,$7H:RE"3=N01T/\.S*M_^&*4P=VS!2@;RI_,@6( 2!3@,Y/ =J;LU(W MO?)4%A#["/?7?B=?09VI"B(N/FLHF#Y ML"()&Q]P$\GD9O"2R&N=O>[1Q*Z&5Q*R)MF1*MX;$T>KOF3O_]S?6ZI>OL'A MNWYNY)"LK&,/#1/C@1)Z7OW.D_[,Y_GB2+AM/#;J6:G=ZF5_!QH'V/UK ./# M=S^I#.-*O)6>=UGTL\S2 _K<\S\/_7P$R] @XR7]3A,/?(TZU+ >3 M%3"@&XYMP8EAJL9TQ3/6%;]8.7=RJ:\/?UF[\:B%Y*BZB-(+_G5-_NE>3P:) M^WI4'_#2Y'&F5":UZT("8/V3U!OV[>S*XRB!?;T6%/:\XGQ7ZJ-SA!Y#LMD] &=FWH!WLPC3K*#=W3 M'+Q][GOB9+4+NI6WR]O)Z&.S:]YTLNVH: M9X7+^\E(\8=7BO?N\[I7N:ZV& MT>6G?4'MM9ZR-\E&X[5ZQ6M 8TWW>,7X,]1/ H?_*O'\0=7NQ[&!_=2^$NS; MY9TUG<0ZYZFCR?N[,;I/C,>@ER7XUZLFKX*Z$/4%5):3 M@,!/N(82T=+"K299.X^:15GBF[WJ57;*/SR]S.=8.L9)(1Y))\/ _/50'38V M7'@RD_WL?&[9E5'MME\::T->SU>.H;E0L\&&Z/0N> K?*+^HY'.)SDVEV$'- M\DQ;=NOI M6NO[ABK>V>ISK"[Q^_.& E2<",8AR4.MQ_*XH29*2EN0ZCG^(SR]U[!0Z..Y?7-^/,=- >MT;Z3:EE1TO2 ' P^1L< M/'.7K:0J457G9&FBVI+&C+K,J'LJ'I63HDF'+YN,#PO6*6F @B4]3Q$PA#3U MBS=7R\MR+U;,*_/GV7-KAD;M;#=.:B+'>!$K=A_8LH A\E=#9%;=^+#5C5^- MR'/1>'Y>)$>ST7363XF%J)*N7 X D9,4D1.9?>7-3\O3LU>JR,JR,W8T\ ;@ M8^VKLFHSI>4/J,]7+5ARTC6'@!;]/#.IX@[9DJHCI2B9.CXJ*X"(!8J'F"[A MS>)IPVHARHNHK2:>Q/95MGT7YV/1V"*+)0U2NCB!!8WX=B&BOQEB,\0^KTI$ MGX#8!Y0S1)5@/B#-!@PA7+5! MH9NXTALWQ7'A8=:]SM]49O?S;IQ49X;P#=80BJ$P,WT<22AY%0HW8\WG:E$L MM-K-NT3G?F&7+GD["RB,98\4'TG'SK6T\H;1 PI,XY&FH6GXG9R*[\%$%C-\ MG*=^=()'P@PFAY="*JINF/C>2BZV[M.BU*HQ?T'%>JK8',G344]=5)TIIF2D M3G,LU W#K",,^P];R.0[8__!!9BW8+_,\_5I89I(\&/=F8O"8)KLS^: _=!X M,K5=W_E\#2B^S22L9@M3KUCSFX-:4$Z7I'TY"TM)ES4'3K!NF+"#K&V;:L^Q MI9Z&6L:Z A.@B9ND,-^^?;AN15-ZNY:/9Q)#YUKA9U@02I,6E^E(+,4"4AC9 M8#VSOHI5YT!D(W;?+C0?VI/**-^L+WJW:N(QG9X#V:"6H)BXK\_-:5F"3H\N M?%LU\7MM^#SS^(-58?V'=2YV18"U"&K M*Z]R!#>:J=1C5(VVBE>92NQQFF\WAJE&-\&#U2 5BR1#ZQ,P L,(S"<1F-,\ MB_,@,!_9;_.U!&:L9^MWK7MMT59?C*N\W6G8%4I@DC_^3:X_ MQ*[Q\13@E2A^\.)X,@(3S?K"F@AQDBP;8_S:)42O5 T;6=2*9QO0M(P8UTA" MSZ6J2[JL$O<0_H"T-KLXX%)_0S/?0R45=?;O_^(?WD2RAB03:,+0?9N/WO!6 MER+P_'\?CA'L/'\A'@@DHGM.) *K)C__7W#Q*QH5E0W-,']YA"BPJR$])('0 MI &*]DPDC:)2'[_XEZ3-I:7E[C*5N1 ]K_(OGY;!,7 Q'M@#%_@=CF/K+,?2 M(AHX,9<$1C74MW^YCWF?$?KE?VA8)&_NEXDT"6K,P.QK\Y*+P9K3+R%V 2%6 M8_RGN[%X["*5^*"KV@CP$@,$5N*&)A"__VK5\J'\''[?6ZBG!;2%,_JD#R!@ MC@^GTFM@=?VHPTY0(M2PFY+3BA3O);J]>*+?C2=CO6Y/Z:6[:45&&(#X3)I/ M_*!O_10"LY U^S^A;)-TGW>"5+<-$$)81XFL=XD9$S4C7$CT7L"1/ MS!@,[_5%N3K*M:]2=\]#U.M67LKS+A:#-D=&F\U;G2]E:NVKZHTI/PWJ<7/2 MZ K;(V/)7.?65"[G_/B^FYJG,L@R[6Q7W![9+0@&9N,S?H\S0^Z\2Z_.5*_C_::3V*ESCNC95E[>-(> M,Q(6G+9'2H7"PKE^*M[P2265?BH;G9<<7F=B>YUIX2Z5U^-FNGW[6,X/&M-N MLE^'.;?6*<0[\4[2KCT7\Y?HR;@OWA7C_48WN?WVNYJ4F#C7DE%LCB;=*LJW MG&HCVTUMCZP;\G!FW B98C/>38Q*J6I4;P^ZZ>V1<['.-V]BT6KQULX9461F M;K)XG9GMDRSD]?-DI]G4XTZ[9EXGN[5> MMF_@A6)I>6MHM5%];EQUY^FBJMT_8FRX311O!]V8&+( 5)4ZBWBATJ[ER@_3 MRUSC-HH//Q9RHZJ<'S^E6]ELN]9S4*D\2"I*HH'!;'OHXC):7*3N'A _SD3' ME^W'^WGJ!6\KY%0+Y=;-0K"7DV+'[&:UN=G+=S6\@)!C?>Z4ZE?6V&H6.U>Y MJ3%OFK>3!ADJ;@XM7VH-M=%92J/:\LF\;[W<=$882V(A5_"8;N9:HXF4X9/5 M%P4U],E3XVJ.]8_MH:/[=.(E+LYG&/X:K7%)+L^+5PT8FMPOB M55R0AG?M[$.BAF<-N=C6(GK[N.BG^3:JFZU\?]*>9U)9&+HUJYAM=M.7M;M% ML7:=K,XJDM"YJ^$%A,# J)2>J/6D>LE/XW?9:#'I-!O+ 0S=.JR;>B=?RC^. M;MICJUOFR\E8-CK :PV!@<=Y?='@X]T].=X1G#8&!2[4HJB.M MH163+UIG*G7Y&YW':PV!@6MSG'I6$T^-8J>H+T?SKM43%3PT! :LFWQCI"_G MXDBZNW[.STM/C60!KS7D8I/1XF,R6=->BM->1>U,TT^IL3Z H5LG\&)6']1% MO]7@HUF'4WT!XON-5Z &'*NQE17A$*^^# :EV8W9R[%:2?>X%6=K\RG.3MY+Y"A6V0X61HT.R]9 M0QP)-70YO,VK-ZJ3[<9#SE6RY_F4U9UGV[>-< C"W.DOX\3D M;ECCU4E?60JWF2=>Q$PHY JZW9SCU)K/]Z/;67X0OXX+';%/RN!Y0XEB[JM! MU"Z#52!-FECHE_=+4, K<'5&$!VEJG,O:ZC!.PVKH*RK0/:IO=6=[88%4Y> MX^])7J3C^]Q: 5$_,+F!)^QKQMP38KR_HV"S^D75N3D^@=^J4?[W4@]+I8Z- M_@&-ZJ/4W-?8.V-O\*ZM5. _M@"GA2/>@BNADA=O7(>D61R15U!T+=ARY?+0)Z! M_-M _G322MZ,$EXK#^I"$V,1+PN'H<6W1POAO6@1$R]2R;-&"PA_/%@&/*=TI1^7?H1G2'7102#ZIB-A/"GD%%?\;[IM:^TZK M+>\&??LR8'VX[.=O#*W'"=A_#[2>EDB]OT8=LCE-QV:V43F M#"-#=J%:73?OH%LFV($J1)/NWA<&[5PQ.WOAF[G+6;;<+98KO3^IXDT0[M(T MQA#_"WONJ/8P[UCXTI#IUUG(6A;"_U-:TB(LSZ%LUWNE='?U25 S#OQ>&?VRZ_&EAN+"&X<);,3SQF)T@(S,3^4ZB>ZT^ MIU*F5CTVAG?J+?0\BSI]OMFXRU:N+Z=2.3OHDG+]L7@D)6Z7ZS];O3=$0K'P M<5A?1ALX#3)V>A64/DAEVJGHGHYQZ]QD(O=+EV)>W><%17UI/A7'N;MN^7F1 M?RZGCTTQZ_)M*=V[K+VTA8?\U3 7Y6O-JWF7] E(1Q*9?96E&'UA].4 I@E& M7]XKD:W3EW[S[K$6O;5F14E_R>7UC#Y0U6/3ERMY<%/(I19I/F\.[)OFY6(V MB -] 8DL%N'C\<-*9)\O?KG-DD#^8G:AL](:#RT[?1M"M2D(C9J+-OYT>F/$MK4A7,;M'D.WVE;/."'$O/YUW:=" 5227VM4]AB/MM M$/<[VWP:ESFT?):5M4GT=)(56[S>G#;)E6=F(OCZEF M0EE$H>P36%7X2'JOAYTA-$/H@!#"$/I3)([]"#V2Y99S52QK?,U(IL>-H10W MXEF,T$EB)DWS9VUM^7R\)AO^WBK7WB,XP=#\3S^"$\TI8:C!4./81W"B"2S' M:'CTR3KY[_(H"ZJ)9)LS:"EF?8!%&LNF+8[08@*1P=:Y9 N?JK1_MM+\48,? M/BH;D@'@^0#@49WXATQP/"%G=%/22/N "-=#.L+:HTOLQQ/-6$)I?LZ6%BS? MX*Q3[(_A@?XV=IT/-M26I9YA9G7E#FKQ(:5(A; 0$X_>-[-&KAE=\&@\E,NI M[K4ZK0S(RB#Q,1/;YT9B2,V0^KCJV6DA]0<;:U^-U$_UUNV3DIQ(Q6;M(69T M9XO<]4T#5@:&VV0DS0OG[ARF8DC-'D(C':1I^)41;H!E$5/2B"@B*6-55RW; M)+5( VHHTP"^G09P?&?9Z="H#Q8\FA07KR@F8F*57(_%B)C.PG3B1O0UC)L+*,HKS&9,T6+*5HL?O_DA!R(TX4( M79? 62$4CG_)"L5QQ4KQT719NIP\3(J.-("^@EB<$<2(D/I <8;A.XO;/X'M MG@X]^(2X_=_0@_[]LM#)C V)SPLWB?1E>EI*OC2 'F")1Q0C?/I\3#(G%A?R M!56X5X0"?:/]?G@0P8EMF 'T%]_OAPXY6/'>W\M.W,0*?'O&H)?P,T6P,VPBC'3?(J/]Z*]]NW] M95*+1<6FJF2[L91;,B:QKZXFPW"&X:<<4/^U+,?OQ/#G?O]!'8N%6EL::[<+ MM5U)F94Y8#@I_B(DQ2_H/J>"RI6DZAR^9^AG .7PQM*S86*8YU1H;H@L&__" ME2Q)DKF*^F)*0Y7KF1@(F*+"%)5SU]W?2!IATS'AZ[0 //J=,\@_T3A_@/:? MYRT) %\K&Y95TPNJ-3$L%=Y=ZT,Y7-N*A<@ L>SS9?&Q7%^.I@M!+'=R)CZ: M1C=&"L )?"21WNY9]O=9VB;@6+B^:8PY-'6 U8^1/304S.AGF-]#MB%37YCZ MP@P4GV>@6""M]PO0$LIY%PE25@A.EGR4# N"05.UD3>N'CNCZ9A'OKV, M#0"S(: _(APZX?"$#1*:.L8@JG 3R;1UB"Z8XY_64)WX%@JFD#&%[(N;(CY# M(?M(V6:EC34Q6M?Z98K4=8K3-0^E2RY&AU#$.^VJVQ]EI3*/6M>=X<21I*HZ MQRL%64=,;/=._)N1!486OKB=YK<6RC.R2OA\']FVADC-(^#^2+(0E@$D>K], M?6'JRWD8)LZ88V^;4%O('*NZ1$VH94#)$ XMB6KKJ9!XKO'+6EU>M(J]EFUG MNT(,.'0\OMT"\' <^GN!]O?$YI,R1AR"T9Z@SFTBZ'$,E JS7J \> 6$$??P M%@X;NOCMQ6Z\QAIK9_WV6C- MYZ)A)7P>>O+-TU"=%%6S,>W'<@^EQ+C1%4B-P0R_[*[[9E!]K?8,DM^_[SD]YJ?V:YA-L\D^C-V,'VO M:OQ?P!KMXUZ)%) .1N+T7BS>)X0>;IB)&K7SK-^/ZII:N^A,+Q^3BWF78$6 MC.,CR?AVUAYS&3.,/A?7[QGKRN_$Z/Y+XUJN-V+1=C*1=!K7J5FI#/XE4O)- MB @AT:[GHB.? ,8R;>%;;)GIP=]AR]\4LID>_$F2U=XB<%X0)RE[TU=U29?] M?C&LZAL3LL]+;?Z0=J<,GBP/JG'BDKR&8G//)@L>(*RX!=N=_TU MLHL]>XN'3VY9_0+JA27:Z%8L_B@LD]5B-)M.]F^3*#-^&70%4NTL%MM7"8FA MY;=!RY.*QCUO,^CKT-*ZCP^48L[J%J7)P_0JEU!+1F<.:$DR@F/IU)?-"*95 MQ=4PM5(>XH>@;;J.6!HPD\[/1:_\&G(%B7DDR.F1L*RN7%+,S%/$I)Z=*@JC M:,O[F/UR4UNH_+34,B8]J7#]]-SH"FGBH4VF63\OAN#GJGY_#0GE#Q&\W,XI MJ4FY]C#*SZNERF/YNI?-9@'!25?2L^G/]?MB:OA&D61J2PY?$'ZSHUI#+X%9 MP>(\:*G;& M:TG]Q\G3_0Q)_)6ZO-:*RVEQVL'L/T/CM41A7]N$<[58K/4D#S59'-J9P929 MTTL'96_A["H@#B:!-SSI86R&(Q[4:Q!_^\5"S,\>TE%?M9DT MSOQJS.M^OBH_%MA=EUJ.(G2(+/Y4S*O/TLM0*29S8T=[ZGQ'FW/WX==/ @OOOZCZGAKGG.U-^3A9K\737+#R-NZVG;%=,$K>[$!'$4.\: MHR&,AAR!AIR@4_^X-.2#K0&OHR%/JM2[U3.HR8^O[Y,I,];7TW5"0XB#7DQL M5R/8("&G90;86Y+ DZ,XR;9-M>?84D]#G&UP^EI@@Y^>R%2E/Z"!+#O[C,H3 M? &9"2/W*L@I&T#PEO'VN*7EXV(R[+3;>MLI=(;:=55--Y*#KDAK/49B:=:T MG5&+;UO+X0M(1P>E%C6G'>L]/M4,7E('XWZWO9S-BEF@%J0$I2ANEVS[,S_* M.1BKMH2L!QEI7,[$<&%%.'SX%W@20QX-\6/(9+:M4_ _BYC(*(8#%_;_L_>E M38KSR-;?[Z\@>N[S&2B^.(R1C;&QP0O;KW\EFUJA MJZJ[JPI#Y41,/Q0((Z4RCS)31ZES;$"_J%?__4X:\E;*RN?+(L[!ZF M=3::FTK:%S3!6#'*7*LT]&UU([.9NZ,FW#&+!7)>@"V?ARUO(;X MIS+U7L) M6Y;*8H?:]YE4BHN_4S&O>(8:UB.>&E;@HRFY.2E*9),U*%Q\P$]\KQV^STV O"*3I(?4 MI+%-1B+X40G_(R=3RIH:&46!$K5BYW::;] +JG-2GG^HB]%?Y#E88.Y"L9XD M\ YOA9)=M71*58E5@_8Q/ MF;JP7?JQ7(I $I7#TKE?6V*2LYR2Z%UP9NUJFY_F-:O!I2.6 ]?$Y1^ M/R'^H:"T761OW=EZO##+:L[)^8U.09)S!)3X;S^I[PQU7>R&8:CJV %4<$<5 M'26P-"?8!72T)YD(+^$$OD?V/DAO(%J#: WR#*"Y5Z6YD&?XC#S#YOEZ\\M5 M!ES]RW3U/WY]B:_3_(?5E@[>,UV>E17D+7.FP0Z<96"U]KG!NU/5JJW2;_C/ M=_YA+C+75N@=BEKH2WOB@[7>^=7/W>EL(;OI+BH57ZBK3#TSZ>ZY3;XCI]@P MQL_>I&GZAC]Q=!.L'ZS_TD+FS[?^WX^=/]?Z%\O;XJWCR4M)')'7[H&&_.H!B"CJG^^W?OQ2_DSJD3L=C9F<3[[O=?CO M?SWN_$/XDE0=RW%_W$'BHU'-(B$Q(3KJ*#EQD6(F%0W_\ _%VB@[[S#*=/8[ M>X>V/^Y1E8@A05/?6>Z?B4>OB3B.9+E0MLE'$CN <=)"FO_C\+6[]T(DO7_3 M\0R" C]<9&&T6R/R]"?/#2<&!SD_&/H["306^,_#P%)X">0^:*J>A3GLP\3\ MGY*8N02@_]$7"R?=@%=SS/V0X^-HQ*1\8CGW>JJ\15>?BOJ4!)40E&5^FDZG MLUQ&5J8\)ZR<:8X]PHBH1)TI8!1@$8C.@)WCY@))DWGN/F%SAA>GI_R2B MWM\/[_S]_Y=A)_R9$W@1!0UM582-("*KX4$I__[DOO[:WWX*W^&%S&]<% Z& MHB$NS:0I5IZD%&PHZH21L]2$E1F-YNA,)LMSVIVA*/=G(V_G++^4RYQ0Z,X: MC-1HK]1UCOAJSUN.9G5^5JZ6!"H09TME'&3'R,G)S'%+FVWE:W1G8$F%7C>? M2W%,KEK1<M*YK#4 MIW@VU7#Z+'DHS3YONE[)@T)WJUM"/=,2I[5RORMO-S)[W--2KR*5EGE&H,2\ MF*]G%&;.FJ1EZGG+M+_<]-:E7<$L-_W"LI<6/;6MXY9'8YI;Y1V.';V]P*^+ MMM3(5LK**H=;'H^)RL_43&ID'::&E*%&7. M\>;CY:T2/I5_WG17*#7,,6M,!ES(*1'99RN8QOF>29-'TT>K\J9!>H)$C)H%>> M=[IVQAQM2-.CB=J4J62C/%LUA+(^E8>WR62EW-C(F>,Q#95VQ;.:-D49M992 M7THSP<3"55*4A1O34M MM]E^^//'/1U**2=/L4I-JF]TCUW-9TEOL<%J;/1KU=E.WSJ<6=W#;XWV_=U44IZFN+.-$FJ M+Z.V1[V]S16"5FDWLR7%;ZWS*37C]',=$LH=];:(VH-L8#==*J#;VKYEZ)-9 M+6QZU-N]T:>7>3XH4^6-R]<&LV5>KVQ(T\SSIHHLZNFE6LP(0:;<<]+[7J99 M#I]Z/+!^/[6ZG5FL*8A]K;%J6]DERN;"MD<#H]C*0*1:]:K)C/4N3W*6K&5 G[N"=N:K[O38;Z<\4QD3>F2IFZGJW2' M-#T20IDJ9-,[R97->J-0Z;4*O+AHA4\]'IGHKDIR35_73:7,[N8V2Z_-^PNE1QL5HC7UW.!SH5MCWJ[ MK#JK@]W:\GO1ND]E!W41&U]#9W&B\;G?"MD>]M<8R M770L=XSMO-D3;8;69E6\&IXP7I;1@OUP4IR8S+J?FF<]C5*HL.E1;^G%=,$W M&K<] =';]8KM^FQYT"%-3V"B.Z=N:WJ^)O% M501>\2KIEM*^Y3SGFV'-:@2?C#IQ0\')JU4OQ_E"F1%#:O3S4UYE*$%H5=ILK46/Y+ZV"E@3MC";=&8.'W5UZGDNCM3 MZ#HW-]6P \?SY?*CW5S?92FS[.J;YO* MINPQN.T)6^C(*J7,:5N6"O7).M4>^>F:E"--CP:6SVPK+6FSZ DB.\JERNF MW/Y%FAX-S"L61+OJ[.;FKB_49T)WI3678=/C@:D-W=::T][ 1-)>4/JZA<:5 MJ.WQ*I)LYO>FLVQ(NW:9WENRNZB5=')E^-' ^.R\I:\R3L\<-O:EX3S3+PN# M\';QXVE0"JFR8ABWE)'>]GQ]449JH4.:'FG7:K@07;=J%NG8D!(;B>VMI-)Y+NU26HK*&FBX3!_6$ MB66[@^D,1Q]ILR>GQU8WP_>\0OC4(R$$IYRK!!DVVVSL;+'03.\$/+$ M@B.MF\UN):=+S$[U-IM)#IM$)VQ[)(1@)XKIS3JUI>HUWME,Z6HNI81=.!9" MM=_J%9(SOB09^4HI.:,GJZT4EK8_=OW7(EUN,_Y6*IL[6A$M8R:*&]+T2 AR MR5WKMSNJ0:&!-L\66LF\SH=-3RQ.-)=:2KF.1O%)3S90L*[V@JCMT<@83^\. MM]W DE8CE=4W3+U'46$=OF-7N:JJD[&ZDJE%J9-TV:K+WV)'B3T!']D."OH^ M/\I+]5YMFQ4;TY)9"Y]ZPK%<-4Q]4+D="XS-+]KIRL[I.>%CCWN[&RIT:KO) M^P*C#??N^K9YJXHZ.2E]U-NMH;2+269-4V5]D95N9_-J'?L3[ E,**V88;TT M];L2FHPT)YW:F&@9/O6XM_DE2AE3)EN5F.Y&*"@ES:)0U/:HMTXP2]4J2:HD M,7W;SJF;O>6.=#EU A.L(@1VGA\TA7S IX1@ MU1PN4Y45[YCA4X\&)@Z"L='823X5;"N5=$.S#76S(4V/+&>:+/B[^NVD*R1Y M41&ZG9MFKV2M5B M;DGS#7^9(TV/S*;1G4J]NDF/3'&RRI"H;UE MM(Z]%8>SL ?'\:67+ZS4WMZAJ=6FD9^F%9YC@[ +]P%F=*;O+G,;;6JICF4I M2P_]N'OQ.!U"$IV')"=)]ZE1FO!I6O71IM3O(9\3_O!= M4P6'PKF)8;S O82 MSWFAOF=8F)?XS0OWG7JQ ;,"^ 8S,L3''N1?0CS9E^QW%N8EAO,".!;/>8&X,I[S MPG^GP%X^;EY^Y]#[JWN4%R&!#T7O2Y* ZECDS?_WC::^_:$X6.Y[)AVG2Z:. M#C.<$.!;#\9$A8![[W^]T#4IT<<$#1]_R.6W9/+'QR _U(,'(8$MO<%Q/8<$ M[GZE@(Y?Z4^^. MQI;"7)-W5PAK8D4'GD._#ARZ7ZL-\Z=JD_[.T!]>&NT=M:*M&-.D88,N?( N M8!_VX\ODO:,NY%0U6 06*2, ^O !^D!3W_D7:8AQ4XBG]SB#3EQQT'+F2!;" M$@A+SH47IXK-/A; XX*Y[USV.3K'<3TQ1E3#[U(6BG>9^+]W"[COV:L*-',+ M)[!]4((_B!NO1PD*RM+P%0NTX \BQNO1@B+2#-4 +/BC./%ZU*!*OHX\T(/? M#8JNBU_0=XY6A-=CH5.% LYY0\CQF/.*I=@J2BAAQ*NTO0-PE2/?O= MU#U>8W[O""A.=Z1$%=U/-)*LAFHB-E+8A/WB)2Q9,)"[%R:OJ'IEPJQ7Y1-Q#Y3$IUROU*@B(Z* M7PE0D-L-#:W/<9O;3-$T1G)3F*9W0;=R?I1(LK\#$H_X@5%/JK9J!602VHY+ M))#S?=>8!&%AHK[S=$/ASBV\1Q;V'EDT[I8V^:XR,HA0SUOI6[.?DL)S8 MB=L2 5$^\@40Z+@W1#L0CAH&H?TD,'5-*%.3WH#E>\*5IC MI=\J2[WJ/!<_5&I-"\MTPV1WICCJ!F);[4KTCO@[&>SO4.P-Q8*S\WG;0C1 MT^GSV_&"IB,AO78#]&=C4Q?YBF&CZ=VMS@=0:E$S.5T2U984T/UUI<0L?*O4 M.3\H/;MD^@&=,E-ESS)&FQ:&DPU?[W"!:3K$9R*U/YG,33I]C$[_!GCZR$,> M()03ASKB!4]Q]YQ.X\ !H^217#';Y7)5,E:,DK>& K-",72<^DZNM^ES0U:H M#^6\W] K?D4ACA,I-,?<6IBU63J>^2PWG7 MT+.+&/@MSS&!7A2&H\!0&6'AH\'M<,5:I4R(">EO/].IFVSJ)5@ $EV\MDQC M+X'72B:_.\/T]4#HW"(!I7BM+O#U2^"U"KQ@%E]0*6)]0.$3<_Q@%I]N%A!-G"7QZ.1LPB_@K!;A9GW/L\Q,D\ ?IJ'@E M8=>5$[D M(E/VP'1^DITF"DXS[S%>V'\!BBYH^%?4\&O>8?R"U,]BX(9N@4S+X18C(_>= MAPU'YEV9H*FMQXSPHY)4[[8R+CK#:D];_CFA(3>=!YY/^N3UG5_\V-M M* T]8\K;("?SA"/*L:FK8CI<6+SY^831W^9&OJ.W&3\F**S%7X"$^&EK\660 M"4'#K\[;C+U0OB0/[C4OM5/*H]U<">:2J+=&VFYD%,>3/S_Y> ;/4FZ._455 M%\:4T=E7JFY =TUY@SU+0IA[V;4$MAQL30!;#I0"V'+ E@.S@&U<8,M=AUE< MF$B +0=LN7@83KPE &PY8,N!68";!6RYF++EHN*("A[9(#<@-R@G# M)FE)&T5)S8WASP[<.=U5;-\C&<;$Q+$#+[%4=F'^$/8&/C*'=25I\-\H+?I6 MOD:9*"1"A+811!P-S_5EX4Z314TS5.0>B!E_6WA06#9D=<+.1,'8<=FB0!G9 M8J7S%^5)R;.KH?WA\9+#Z&$:/3+,\-_\\\1[V74\[T05T\S.+&QDNK,S_K^,HDS M4&5'X(S!AD*+H;BO6<.1W/W+JE318)ZL]>$^^>D]]J=+_<,6.KM?-)-)D^]1 M/",ODG3+U@9:!R_U&5(AC[ZJ9?["TAMGJN9Y45("4B>L>5!9$LB@8!G@(@,9 M]+-=9+FO"1UNL6^;2&WUJJN\T\\9L7!K=\56=JXE:U/3&"_7XWR^V%R).G9K M"3/T9;\6F*&P#0?,4% *8(8",Q3, B@+P R]#K.X,)$ ,Q28H?$PG'A+ )BA MP P%LP W"YBA\6:&NF@9N.J,)/ 2FNLLGA)$T19_9.LH)(,2BBBY7P7W,N$K M6P1\T"_$!ST2TILO1P1"Z*G[Z@D=I>2X?64[?# K_,9I1N@),NC(US0U76TR MPJ)?EG8]II_Y]C/#7==: M?V%Y#:"$ B4T-K839R4 2BA00L$RP$^^8$KHA?K)[\P)?5_?5EBDNK*[6G<% MGLO*"@%\$*!%PIF 80%X(5>AUE/-"'RJ&3@T7J;[C>J9XRLNZU7*'&>6FRZFXFPL39$9(0=2MU0%'55-<3B M;+1 #@5R*%@&;'I?,#GT*BWCPH)D(!D"R3 VMA-G)0"2(9 ,P3+ W[I@DN$; M+ -X;[#) +PW4 K@O0'O#&_#>XF$X\98 \-Z ]P9F M 6X6\-XNA?>F.K876'YX%_8K=V5#OAKH;O&@NVV1-9$+#YK[3I2WRC9;\VY3 MRXZT<\O;LI"\=2?+S0=1WJ+WR?EQY*X-]22_+2GD2ER]4U(H)5EJCX;[V:QD MY&0Z1?AM#'5#\2G@MP&_[=QIQ;A#%^RWPGXK\-MB?<_?NZSH+]<]3'']<;!< MEE82O]+&RV W[B\\_>_N"SQ>W,/K G^]MC]4@UD6K%FP*M*W5,\9T1VV.T_J M>YVL[9EO/UGVJM;U"TM8 <1.(BQL9TX*P%P$(&#")8!/O%5<1#C[A.O"^GQ MK%(KCDVF4 \RS"KOM+:=L_FQ?7F'-+D]],U5VEJN][14OY5"/Y94-7S1D05R M)^RD ;D3E +(G4#N!+, U@&0.Z_#+"Y,)$#N!')G/ PGWA( 0.\$LP,T" MZW)4,HY^=5<5@7ZV?D\:Y9S/9#)];:D+0&K/IP4ZG5Y0NTSRA M#B BOSSUW<3BF/=G,EF$NBWAIINY%1'$_.=UBH M*%IZ+5FG2U)O,AX-NC6GT!,VQ"TE),L7_5(@6<*.%I L02F 9 DD2S +V/T' MDN5UF,6%B01(ED"RC(?AQ%L"0+($DB68!;A90+*\%)*EB78)M%A:S@ZA5TIH M0EX?F)3QJ*!Y3^$@/Y97/#1M*SM"YL3H.2OU.U35OI[/DK-4N:U0R MG^IF7$ZOB_./HF4^C(OT#]E>**>RZWBG")ILI5-0A?2($0IR7LMHZYW!5',R MG2$$39:]X;CK8G[$V9:!H D$3;",N.Q>O^8-_<\_:)YZCQD'HF6\UN^769OE M5KU-Z1.U;Y:%6TW;E><;>?>7K,UHD,?[X^$0)R\OY0\[Y72N6IYPHN-2JV%; MK J!W6;2.EG*,]]^,7EL7X? +G:P;^<7 &1$Q8L,]"Q/RT!1L(E:#A M0*@$0N4Y7-FUOM)I;GT[->+>F;; MM>VV'[J?A*CYHO\)1$W8%0.B)B@%$#6!J EF 0P"(&I>AUE!,U7;0,7'5&$G@)S7461WQ-M,6?VCHB^<*0L3ES M+-+1A*]LP^];BA\Q/=?(\\D'CH;?]7S74,D'$5_O0G<8/FV[*(X4S:/1)OX% M',WWY6B&C9;K6 MP?(+[T%/43<4=9Q9A[JU5\30_#2< J8E:#@P+2]G)8[E_G2,J9:YZ3SP?-(G MKQMYMGWG=Q?FA^WNU7C9Z??X7=],BD5^-%2:J[*DDX697&)^XM3$12_*%Y:, M +XE+-M?:MD&OB5H^'5K./ M+X1O>64.[3L3+M_7":WU^*'/I]N"R4Q-NB6/ M,IE-(71"PQO(7_9"@74)6US N@2E -8EL"[!+( . *S+ZS"+"Q,)L"Z!=1D/ MPXFW!(!U":Q+, MPLX!U&5/690OY"<8[\Y^L>LI-;.WMV9Y5%7W:TIL>M2? M$\W?AA^9\:V0]$1L"&+'W#@L4J@TTD/\2'W[2=^P+.#'57O?L1<*L L_X7[L MMX$%LQ_OZ\JZ.J *[>IPOVL6A7*]$X(%*:YXPW(\4/U@7^6]KQ5RW"ERDU'C M'_1RF_ 1D04=>2^R"A,"*7O,\04=>2QZ#A,"*7DLE M@XZ\EGX&"8$5O99%!1UY+14+$@(K H_N;Q.+UR^AU_-N=Z**+ZTQKUB*K:*$ MXI'JCT!DO'(BX_N7@U/D3J,=/:&9U(W&?ZZ+MF, M\Q("A-!+08JW[KN= 29^_ZHT4J,#N5[4DZJM6@&9A+;C$@GD?-\U)H&O3"S4 M=TXS#D[L[2&IYQ;FR^20ZJ4F4I:3\T5MK1-HX;[]9 !2/MEOOTY(N0P&;KP@ MY>7JE)F:.%3Z/=TRZU*M5.P7RNQM\)RY4.P-EV4 8ZZ<\@P,YP_C"_TER/R"TIR:]N;2:M%#%%.M"VIYQN]W M2N?\Z/)+AE);Z5,%OXT8(9"TF6ZM&6NH; C,$#HTR]RDLU=6$S?>. -\:,"9 M-Q.@<]92YJ1Q>FD.Q\EB-5M59G0Y!J'2+]%F:OH&T].#CKEKM>?Y_6@V9[S0 MJ2'D:3[](AL2H ;"I@NF0)\A;-+6.M58[FDI8(V497O='?<7A?@_+M3)FY*: M5IFQR62W7'&7*\Y6K<@'27_[F:9N:#8+U]##3N_[LJ2_L@1 !Z#^Z>?4/XVS M!, *H [7YY0[C;,$P H^IYAIG"7P.;5+XRP!L (H5?HYI4KC+ &P O"(H#)I M7-*ACV\12J M>8T>W^[ND81Z^MP%V< 0\X MJ:#A5Z_AU[S7]P4IDL^K';%/JAVQ[\J8'/=IOC<54BT3)46KO>+SR=3^SSE- MCZY2[#N_^.7P:,?D^4V*780'X6$UZ"%W;:BHC:?%F7:1ZNAV^)2!8@7HQ :C M7:\.C7RAH K#&5HMK?S$8H*-S/ AEY*G@4<)/,KKY%'"4@L,ONMF\(&&@S,) MQ+$/=2;-WK:1SHA>3F ZJ))UZCY-U?^\3O<9',#5J%?==^E63>A51J7!5ML, M%E6=.("$8?:R!PCT,MA"B"&][,*NC/CJ2@%\,[AO&\P"MEOAOFTP"V"DQ861 M!F9Q44H!%#6X31O, IRH,W'6SF$65T!BLWU72;IHC>S@"7UMH[BN8OM>0B?_ MB=ZS#)6PW! D[S_T@IB8Y[=A!^?J"&^Q%PH0Y4 )X#Y!(-A=+L%NBZS)C\C= MZD;>5LEU%L/(RQ*VR%4-#WDG=D?K>I+KSRUV(1CS E(=U5L:4UUF,H0>QQS7 MY 'TN1YV7.R% JPZ4(*SL.IB+Q1@XX$2@,<*++[/9?']L9>IY*GI>)TK3*E= MC0]8OV/8HM$A7B;AX+WH9@(%#W9$@(('2@$4/*#@@5G [C%0\, L@(('%#PP M"Z#@ 07O_"(!LP G"BAXL:7@11?E)@S/"R*6W=1PD>H[+G[/)CE$&T49R(WA MSXYJR$7T/ \2^%^9D??^UTN_E6!1#LFAB/ L@HA4X;F^7#QH\(%!\;=WSG+< MIE@J>=5;JJ[6V5QZ[2W]F?X75U.39U=#>\/C)!>DA"?5(T/LWAM8V"RWP9)K M(5_42HZK(<,/W$?Y\X>KK&=*9=@II:NJ65^7.8YQ-\M-)B>S%+G*.D7=4!3< M.?NYJ400"C H00E@/_I*&)1@&<#N W8?6 :P^^(@%&#W@1* -W6Y[+XCRP 2 M&^PI (D-E )(;$!B [. _5<@L8%9 (D-2&Q@%D!B Q+;^44"9@%.%)#88DMB M>T2.23@:L-2 I78DI,2_SD=3^U/FF5KLLY,ID_6$58UMF3I[NV@8N;]@GI&A MY9]?G)(CI[/UL'_YW4.3MK(C;X4,M*C?51N;51#>S2+Z,^3V9XHM1A<,'PP0 M3:MVQ&8[P5'K&7.GD>PV)I+2D:2JNI=+S5E'9AG"4>-.4M3^#28+'#7@J,&N M*NRJQB!_");QI94 .&K 40/+ (X:<-3 ,L"; HX:<-1@RP X:J 4P%$#CAJ8 M!6RO D<-S (X:L!1 [, CAIPU, LP(D"CAIPU.[E<%1H375L+[!\Q?9/55H# MXMK7)*[%N[P:N>!#+MPKKO=.)=;$AMI!6L LA-5JY5>JZXI8FG8^J,1:]'[) M<7O(71OJR7IJMS;%LZ6>.S![^J#2TM!JQ:#^[T^>$5_^0I;KKQA3-I/"A3?7POMX%;9UZC?OUSLE<5] MH%@!^O7:_G#76'&RN54&[5660E8]Y:R;XGPCAVM[YMO/% ?K.O )SYWNC3MZ MP;I^=7S"U](7__,/FJ?>8\:!%P@:?A;/]=,T_#+X?7'W0#L5=UC)%JF\4%A2 MQ=J8R'9:^QWBZHDB+?&/F6L%[/56"=>([FA]D6W$8B3L(\%Q$E0 M"B!. G$2S +V_($X"68!Q$D@3H)9 '$2B)/G%PF8!3A10)R\'.(D6BPM9X?0 M*[1)R-T#:S(>K,E[,L51<;V'TGO"0:G?Z]+:<9Y7 XZ[-8U!OI71C=Y@P7T4 MH_)T7<&RZWBGN)6"O+V=9JD;%JZJ!6KE^=., M<<]@ >]M)EU^/@U-:73N; MH;3712E9759N2QEQE^MVB%-*")XO>J5 \(3]-B!X@E( P1,(GF 6P$T @B>8 M!1 \@> )9@$$3R!XGE\D8!;@1 '!\T((GHZ=0%ODJH877>8<,3J=Z)[9FX2- M_/#=Z#M>X+K(GB(7?U%SW(2J>#,+>=[#(V ? %B@7_K.YQ>)F^3#PQ7.PL%B M3EW=?&O-:I5E2=@(0\8HE*0Z/]HD-S*;"I^L<4R'RKXRD+R]Q"WJ*1$- CK]%G M%^/QHD,<3\*A?-'S! XE;&D!AQ*4 CB4P*$$LX#M?^!0@ED AQ(XE& 6P*$$ M#N7Y10)F 4X4<"ACRZ%L(3]A.9X7LB#]&4KLD.(F"#5RFB@B-=RJCH[)L_1- M]((D$2\TB_]I!0$N@^4(6S)7Q[C[- T'YAQH^+47=;D$!AQH^-51L3[12XD? MI>IHM(E_Q9KDV46^8MAH*BBNC>5T=POELGU;7JSR@[2@;#N]9(I=N04)=/TMY\,?4-Q MS-%6^K\!.JZ'J_:E;V.^-.AH.39YN.M8%A93%?^,BSS_ ""I-4%"8$6OY8!!1UY+)(.$P(I>2X>"CKR64P4)@16!1_>WF<7K ME]#K>;<[4<67?IA7+,5644()2S8"X?#]"8=/#8'%AC!U@HF%/L,2XE!W,>?) MHO:>A1;K6Z6WJ8T'NC#,3^U%B][=#JKZ7Q1:#,1SMZDL]P-Q;%0H.GLKYSFIAP8NN0 M[>^D]:X@V%0@-M-N?G5;MSHA+G'??C)P(>_9J0+G-LN/QJ-?TJ_*Z]7&[F!2H7/VSJ]1K45FCLZM)JF5=Z%3$YK-1#; HO M"V=O,CP- '5N&O6Y[?2C >J7%.MS#_R\1*B_1*A?D*YSBQJRQS5S*"Q446=< M86?D]C%PFWY)O2HVV?7<&J99:64Z8BO3JV2KDQS!*$+8YC!&I;) N/SD'8KX MV>I'@]0OR=SG'OA%@]2+].Z%B=!"[15K@E(7:]F9E4NS^E\68?Q0J$+ZB#%F MJ8Q(\?WD[6UG/2C6%WH(52$U_)0W!4@%\=Y[QWN_H(V?>^#QBOP66EF(8HZE2P>AD5VV+$L?K9D_IJ[<-NA."2OK;SU3FADZ_%*.% M.V#_&_[H!Q0141'I^&/%>6;XT2?W>XS,VZT?^OJLKSV$$HJJXH54L7=89Q(M MQT=>M#OF.XF"8X?;MWC9G29*AJW8JJ%8B?MUV/O^CEW]M1##AAM$[!LCE35] M,]A/C?7/_\/_W#U(M9#B$K";_>?IQ+#D5P\+'T7]\_U6LU_*GTG=8?4]/''I M1[T.__VOQYU_0-^DZEB.^^,.8A^-:A8)B0G15D?)B8L4,ZEH^(=_*-9&V7F' M4::Q[WFW6__C'J6)&!(T]9WE_IEX])J(XTB6"V6;?"2Q [@G+:3Y/PY?NWLO M1.;[-QTOS'+]<)&E^,8:D:<_>6XX,;ZS_,%@)X0H!O[S,+ 4_3W-?=!4/5M# MV8>)^3\E,7,)X/^C+Q9.>B'D-09+C.O6?QYKZ^&M;S_[!"S)7GN!K!_8U[ O^=Z 43SY@:BFN0*R$GD8RB,184 M;U:RG(T7FW$\@WHJ1;76:.6^Z[,NNME[VFN5AE M&=$N-5NNL)'#_;BG+=%Z6%E4JYF^A,1.QY@U&MK [.AU2I=J2K5 MNQU*G[0S6S>5DU/'+1?[X6+27J335&^9%[5.=LRIS :W/.YGS1O45SG%-8?: M.*L-F76.L7 T>=Q/+D/GG<; $81"=C:SF7YIM5*7:?JXZ;I36>9J[?U*"E959[C= M99>TK).@X%A0DY&;RO1+E)!<:()4VG8R93ULRCYOFFTHGM\)J+F@H"G],WV5DKGZJG\;!.Z(E%Z7RN,R@R M)H=C);^S// MRI&F1QUH,T:SGS<*#4JDDFFSL1W2N3U^ZHGYKZD!CDD%+7;4FR=G0"YL> M/360O,+.R';24L^=%'*K=)=JK[%<3^C5T$$.[W4Z;6&Q*K<,M;++IBMATR,) M5(9&UILO.I(@)K/C>E9@NHL&;GI"![,.[9E<)YN5"E:OQ(N-+:4EL;!.*&%R MV.OUQK5<3D*5M7D[$'>!R>=P]'CC;DM[#5LV<4,+% MH-8Q*P.K8"8KKF(%.FIMOE MNKNG"E.SWA^JCZ_.-J9V72>9@6.#,8>53&,[ MZ4F%>JJ=3PZ1/!QU2-,CU;:ELMR2)I445?9JTJK5&&G[JB8E=UM*9VGJM M9JF"M%]G2EVQGBQL9/;$Q'H#O9'S)V8K+ZVL;:]4F9CB+)O7;EL.H^?"ID?#\AN6G=D[\HQ: M3>15:\YMY0:#)7#"8LL#.VTV@WR/8FH+1(D=JYGDPZ9'L\6+ZEK>EH?(3*X[ M0[;*^#5K%EZC>/14=E<(*KO&IHMUY78EYUPNZ<]RI.E17P73D71CM2F:2G*R MF"\5HV;4< =.:-8^54P:*#W<4JLA)^]7@[+ \1O2].BINDCG46/J]Y(8?_CYY*)]O+U$2>[\VZIJX4QB[NV]@*<-,C"11:07JUFJ@+83<> MU[I*LC/8^KCI"264%N7;6R-G5:@>33>7&X>?L7@*<-.CIV9<_'$?S<;28F[KB8EUA%1K756-ME2>2TE& M5$=).\B1ID>^$#\3I[/MSA]20UO:\[5Z:;EUPJ<>.4.W8D\1VEU)-X-!NM'- MH,4R7\'.T(G9JLO8M7&9ABLQ^FVVW1#2*2;5D;D34U"7;3'II*FJR;!TIDKW MM%U1S9&F1WW5B\TU:K=G30KUROU;9C:EI7L.8-=-#L5VRT':BUL>C0LMV%UNFGL[U/(RG>WQCX];9?# MID=]76UZLPDJ+TM44.FV&# M=: W3^\'\Z8]E9@&S>^;./CH!6'3HPZ(_J0QS7>J/4K9WDX=D1<8C\S6@YL3 M)D3OLS518EQU+$M9>NC'W8O'X1));AP2&R3$5Z/4P--4RJ/$^2&/3?@< MHK_PA^^:*A,<4 <^^HQ$SUMVF.C?V&%Z2-_]Y:8+\YUYL68+S,MYYH5^Y28S MF)'$ )#%RI[U@/PZ5=VWTY(0_\_5P.^*LZ]#LB"-DWQ 7V$IKK+!+.$I%" MT+:>()S6-?9L'[&+WL.X8B:KM]C;>Y[C^?S+US[52?RKM-3GJ\9[7,QX"IO? MVY"5'>VX\_.]W7R@O MR,"_QD4EZ79E6/5Z_%@H\]GMRD\Q(F()$9E]Z9H2 $ @8_8^_AZ(, \ 0%& M[I3R:#=7@KDDZJV1MAL9Q?'DS\MMO T$\I:>K<_UDDFM]%)QE,P($U,G(,!_ M^\G=L!S_!@RX[/P#_Q9ER$WG@>='QW]\)^$B/+&J8:&$?7?A.WZ7O%9):B+P MT#1AV"?S$C\N.\RZ&%2-BWJ=)_H\1V[B^3&QOT3@3]QU 1,"$X),Q<5G*HIH MB1=F(W2RPM/&RH*4T]A';Z#M$MD>@@CF*T4P'[2PGA$"L-9QOQO)7'8VX[%9 MX]<6"BODV-/<(^L^$=FL*JVZ-$I/#*J\TNOM^3S3V4JZS)/T!G^3Y5(G*N$ M- T7&Z&(X;0\,$YCC^$!M8H5SG>:$^D M7B)_W1>#6@.W)XHC5]P_"G;GZX MJIS'V_RIG.D>F])4[FR93BCC1P>YZ>I4U=7 (8 AGS!%$X,,>2# MG;0W8XB5#%B_U<[MS(+#N(6"WM^R,L$0[)8QZ3?$:U>7T7KLQY*R%H]WTL88?G8:,_).)2'A7P7!+60[[I(G^N1T8O:H3ROK1>(J9^Z M]")KH'&]X?)F,*WJFW:M1=M,1\Y$-!Y(<@$>0)+KLOVGW\.#DMXWC79*\LW% MK4^WNSM>KO8V$UTGF"#X5'\' ";J2PZBB3^GC_"S $, 027[%TW-Z,(;UV8&U54VV9?*DVKRJ"E"D(NAS6 ME^5/WOM\[8FOMNL0L,!3CJ6=4%TT-2*>]?OO/@):?GD90)+KT_RK+;(F/W*6 MY6Q(_KKDN$4GF/A:8.54%:]4OM=%*C+6I.3NT,7S)6I:SIX*42[[!'32E4Q! M[9I62BHKRV*OM+M-&<,-N?T!^U_IS/$1-H /@(\/.=,.\/$)KM5[PP>G9&%]U(B::)I>LLHVLJ%2OA$1^7 M),ON#\+AURB\U#*Q0/[,(9N2:^3YZ-UW(B'RC4'D>PEB@8Q:'#)J55MU%HB< M1RZYSB*Z][89(D0U!(CP<.U+1Y53;;/2RA7&CM#C@];:L[==9I(CMW>15-L- MQ0/+#" G)F*!!%P<$G!_#3E,TRO4]_Z*,HWVJ* T-D8J)6X(Y)#-U!O')NB=J1;SJO>A*E'3>K_"5K(0$FMKG4I4\6N1( M;PF[_89E/HS??EFYIN(=Q=T(G;>$KVQ)QNFP&_BO";*19OCO7H@.0I@81'8Q MI%% XNCLB:,[1(BBN;ZR/:3S\Q$4G,#:\4;WA6'!'PJ%A;-GQ\K\=H3":];) M:<0;FOKX;4' $\"3B\@*_:Y0+KTLYNMH\DL73G6S;F==Z:>%PG ^JIA\?M\R M-P16L N7Y;D/*Y498W>-^,0D&>1A69'DST*9.R[9_+L_AX@_KWJ*HB::QMY5 M9D9BXF(-@8@8(F)($$&"",SA:A-$7\VS($LAR0Z)=M'P[BY8%;6P_(%'G_ G M^*G)K +3MY_NK;?^9E6,;""*E(BNO;R$TX M&_RO-S.6]VX'Q'-7&,]=@ECBF#.*'1)_)+G\ 89[&"U$K1%A13N""O$.*:H' MH#A5'K#49E/-5&;47K/,.AZ M\R7(]RUT1YFQD.(A[-4HD<9 - C1X+4E1[Z*#W(<#?:1NS#L0_F6!K'T$S[' M(M@S8]0?4A*S6N6&NUD^:0VPSQ&6*T^EWI);!I D+CPE-'Y78?+S(NX:!JH M=T4B">CA3H:NQ00/-$0>B% @0H%\2/PV:D!AP(XN-M*/G4__D:?.R5HKVMV[ ME5;4"O?KK'B_S)XLT-K2@Z">JNU-!6N*4ABB@"IU9#JL:YT]41O_HFDC;[I. MM3!3L."\9W>DAAME807&NTS(1]R7^L5QY L6K/V$2;_(:T_!$KZ:)7QL=']& M2_@*P?Y=B1MR^_BAQ@U$(U<8C<00-ZXB@K_L_82JK;ID[Z"(HO]6[>.25R^1 MUW?6?C_V5847:;#0L49_IC4 -@"V/(E3\3$$%L^OD[*7V%+ MRYF)FIQ;5R5C71=JS6$G-64V!%O"L\TT_8;S=A>4XGB;NT9*S-B^XP*; \*V M6"V=T-/+N2E70[W,2I1QV9IJ$<, MZ'!129T+1(=/]Y;>B [UK*GG*VZV;.X4@W-X2:O1?9V@ W:3./;#[GF(2XCQ MUJL?T%(QIG?WET8;0HX_0VY"#5R7T%K(.UA.R?N_PYTC"%@A8(5D6#P@^-,= MM -J'(HY>"+!BY>PV)&*S)RE4UVI)]5HAJJYJ_2R(S-T5"*&8M]0C@OP!? % M$F)?P\7[77PQRW2AHOCNG!K6D=D6QJX?U',$7XBOQW_8-:PQ=NSN*_NY"+O+ M =Q,?UF1[R7( ')E,7#%[NR\&YGYJ?L.S:ZR$"U/DY*N[22SM7G%2F+GBPD/ M.]VP;[FE&L "P )29Q?O5[T.%GN_FW:72!J8]53'&I=+O6&'9,W"PLD<5$U> M/N&&+94=V:V]22BJZ@;H(8WV\ YNXCJ6]?#&0Z5E]/@!1VFW1ZQLB(4A%OZ2 MN;;?%<,.-;89@CN)0B5>6==ZS3$-&4T;E&F4&4F\KA>JV:O+IO;Y*YJ;9YBA'H(.<$4@=Y_&^9J7KT-.%3%L< MHMZ)XTZ1FXR^_X->;A.>8QG3Q#^H\']?+"H^K3IGEM&%[:Z<)U?W -9/XN3G M *TT@XK8G6AY8>@&@U8^/Z7'" /TH>HUT.$ F&()3*?3=3$&)G ?7X*E7SJ0 M*2;3]'?]1F N%D-J& C4[6C8(?A$',@3U^=>=/+N\ N37ZE%^/<&$=W"G;:F MN'$+^0E5\6:)P LW=1^7UL(261_H$3DDEW(3F=H#_N8. -2Y/S-QP4 M)P>D.8_;!T@3%Q_O?9!&IA8KE]NV,H+AVH++E0<+B@^1ANS0IF[H#',E:<(+ M !V(RF-#DKD$L9R#K'>YI5=!?\"L8LM'N[@ZKI>2H2$N4D*SG(V7T%QGD3#L M-?(@07.Q;(D8AD671:J*)/#><@#=_YJZ?UFLH!=U_Q)BV+^ENI#]BJ7KX'Y. M#^OAW?7N"V7NN-@^[F]S)[L954]1U$33V+O*S$A,7,6>@E<.7OF7"7;A4K,+ M5ABPH]A$MQ?(&_O(:\WP*MP^+,(EO ;W\!(L:LW# EP]K+]1B4OO429_=VJC M,"LMZ[M>WC$+]90FEE9BR2 G]<,RX"GNALU\Q;)'!65I^(H53K!K3()007PG M@58!<7$6R)\YTT,J ,%9JPL+@RY!!A>7%KATWD5;V2V0[7M])Z=B*W>1$-IZ M,S3U"$G#ST]@J)TOBOLZVHZH@.8;R;PBMA:-G,R&%<1I[BV710)@ &!\L5S* MI=,G_@(P*E;9XEO]H"0,\_;>E":95F?<(8"!G2[^ V^7O99D$Q0/AQ#X[,X9 MA,!G]MB.0F#\3GC3]QKE0H X ;TN=SNO#);M@E0HEZ?TA/<=N[TA721E+#FX M4@] )B9BN98\VZ_RU5>7-&H'KCI3O-!!P6[+$@]F%U;E(5FC)?$%(>P#ACV< MY8E1B/C9.:7V 1;:EF+[.7LJW"'#"4]E*X_VDPU#9Z6AM]&*S(1+#^K84PD+ M;M-O"A(!7@!>X #/U\E _0Z\:)-=<>*7^K(4N'LT" JV)QDAO)"CV?Q;S@=> M=@[J\ M_=%I[>3@SE9CL/IX0#*$1%-F ZC]7F<+ZQ1',Y\2-T\5_YHN.IJQN MZ964%/3T1DK-9O16E]FH'C<%J2P IG@"T\55_XDA,)WG;/C;@*G>;4V&LW'5 MI9*9U=).]_HM4PJ!B7#*4C<<\X8KU6.7'KP _(&P'<@@G\,>N]Q3W%]<,\ Z M/H$J=7&'L2\X)_/\?+9FV(JM0CHF!E'/UXIJ8L<(^C.A?,S!;C :,)J+8+B\ MJ]'$+H;]:XK+$S8NVB)7-2+"B^<[JIEPEB28A_-0X+-?7$1[@3G S^37$O,6 M(^L6#F8_/9'Z:S17@[G>L20IV9)7NFI1@\Y$E]FP[BR3ABOB 2DN/KJ//TDV M+F[EVYR*WDQQ\6^Y:'D@T(:WFUL!Z60B/&$]39 #[:ZADI>1IV'8V/W K6T= M$41+; Q_-G.L\#OAI>@0P5QA!/-W8CG*'L%I(2@\ X8%J0&@E[Y$+RTY;O=^ M;1:U@K-8.'88$)P( ';T:,FFJ?)6,LJI%L-Q#9%S<0"0CO;^/ZX6?(P=G*=9 M$\NQ]:2/W 6>EPD<"8( "%(E5Y4JJ7I>H-@J1LH&MO0^-O0BMO,34-EV%)M; MMYM3JM=5D\GLN%#79 R5F?!B[AOJQ!$?0 M "TB7?.UTR<$M(YLN4Z0AUT73 M ^D!80CTH"P*!&A >(A'@/9!7D=8 _0 Z)6/(! *<* H& $]Z&5-!&@RZ? MZDG*,.B/U,TV\&;8V\B&5T53QXSL=S].##@".'(1B9[S>R27X7Y )N."8Y,8 M L'E92T^:$L$5/^KJ3Z4;OW,G8TN6A[V-EY-TC6'NY'.C18C8>=F9EE:XR0D M=>146*J5R9[,TEU;I8S?=@R6[IV ;Q(3%RFFHJ.P$IKCSY";T!#ND^)YCFHH MA-%!N!L)I+C6+H$5 H\I,+S9YS@9$)-K?>]\$:=+>++D_RI]F2I8E<'DUFJ8:-S,98I^I2\VL!]&$S^,ON'HMR0P M+R@9<_B%OZY.]J\@XM/^^^,/QGYQY(%RD1=6C?;KT51^4=6G=(<,+U;U$02K M1^_;G"^44TS#H;RLAW88@<-ZM*F;-/.&B^( 80!AH"#MU3IVOX4O6&+X\2> MIL]N)]-.O]2B5F,J;4^GW7QS$ (-3W:J;[(<>R4IMPL '0C/8[-U?PEB.0#[J M^SQSNZI4=!Q#\1&UAJG;Q Y@0Z)F\\)GU@<&4R=8&*A"SB:\-\?G*#Y?&%<5IS$ MRIR1,MMCM=46C)E=W[*] DM+\ H*S K,"E(QUY.*^9U#3[U@N;00J?"C6(FIX:F6XP5N>'4T]FB2 MT1FH^^/A/^#HT^4<1K@$&7SX<:@+$ (8 QC#YYS6^3PA7$+ ^[>%=1N&$HDC MO.B8[&GXN^0DO"=YXMB!1XKIWM?6??+Q795C<.'C4:WS*R M%PPN)@;WEC*X\3*XWQ78I1[B#>_ONE_52XXKA(MVGJS9^6A%?^G$;:I>3NO9 MYL"E4'>G36VA4NXZ&YD+2^$RF8\KCG8>R'F+DQ1],VDAS0^[!/$4Q%.07(#D M A@#)!>^:G+A?9/T88)>LYQ-PK C!P=[%N^;IH<@)P8;@S&L+'3Q]PQ'0GEO MT8#1@-'$:.?\4XTF=O'KKS6 ?\M@PV,+2\68)J:!2^I+^#.46(9ENL*DOV'[ MR$4>W+$+G&(XMO!U[FNI'LR^C9&AA4Y=3]H)!M-2>I31S;+C[$:&-U;TZ4;F MPEJ?'-S( @ "AQ+B#" ?7";T=0!937@MRY@:3:T4/R=M4(K)+3L$0,)[]2CV M2@I ?+B#ICH+E/"5+0*V!6S^GAV)OP;;XM*].X(9?0(9!)]/@'-=&P\JW7ZR M0"F"X$@%OY?KB+K,<<2[RV8_W+L#Y 'DN7[:R7ORO$)7Z']]!0_M TZCJ(CX M0@E%Q0B-?W9'/+Z6XR,ORD?Z3J+@V&'= M.\5'T\3A@D/%2N UQP\WT+SO[]C57POQH>&?R&]J>$M+V9$U!/WG]WIH&39* MSJ+=P[=VD?H-F)X:ZY__A_^Y>XIJ(<4E #3[SU/%8R\$R_LW'<\(MWU=9&%':8W(TY\\-YP8WUG^8.CO)*Y:X#\/ TO1W]/< M!TW5L]6/?9B8_U,2,Y?X=O_HBX63BDE>8P/ /IOU9$O\\-:WGWT"YF0+O$!< MQ<=L>N4MNOI4U*<)R$YG/9BAJFN:R"LM_ MBW[U?:1V1 !X!1%'!:&1R'=SK6+O)L+!:JOP/8'_3O2D?*]:K.:Z5:$7RB0: M4PB9?><>'A_0\5T'\MJJ\Y0"\>PRMM]#]7O"P\?W/%1ELBR>9G(\'481J6@Q M06XT$I:^29"()3P70O)*]]V. H96L,#=4=\E^'D:TXBNKMC&/GS2@S#Q'SE[ MVG:11Z@EY$]1.Z$4Q7O&21_W*F\YJGD(A2:RZZ5V9LO<%"21J];625:<)VNY M*'XS[ !-<_X+[632C/Z60#C$6N+N^FZ W@U]CJ;CUW-(?T\\WM=L*?Z!7B,N M421^[R:1OU\M;L()S"N>X9%&CP7X,4HX#SS?T'8OC&"D(BN1=W&_O#L0L-7O MB7^1-9RA_D,^#E_2_R%]OTGXCH["@TD;PY\E#-]+>,'$,Z:&XAH(#Y;DT0[? M+42^UN'K_T[@02N)!<)-HXIN6#A$;Q-+UYD&*G[2P3E+(%O'*^:4W*5('C=% MA#M]D[ ,;%,>7L5N$G@\)O+#EQ9&72PVO+HNPK_)HSTG-'/\//Q\%7^,X_!0 MXA,R4/QD9;E4,&3?X.#>\3<8W6^(;X@\SXE&H6%O*#%'&V2YNYO$C*0"=<>9 M/CZ8==3]Z*=)AQ5U%1C1PD!^=+K#-A599_0-R]!0.-%1?[SOB7/-?B%P7:R! MUBZ:N$PX3OA" S/#T5)VC?$LIB8[!(-++9$&9N*YR,\ M:='7_O5(%9XU"/7M3B^BGZXHEN<[A^]Z3[Y\]]&);]6"*5'#KK$TE2=?_1:] M%7[EVZ%Q(3%T\.R[IW[C_K,3/])PL#YB+-;OOOIL: ^?GOARU5,4-=$T]JXR M,T[]\M,&)Y[0=S;(K1B6121=F+EX @R$&QJV::'=B1X5\L\?\Z"U6%F76,5] MQ=T]5;XPQ+WW;Z/H'ONVEK+TT(^[%[\94YSTZIX$B(\\S%!W22>2.()Q O^' M9FS1])0Z/_*_[KSF:$%]NF5Q:)8AG_WOXP_^:A#/,BAA]W#W7\BA9(Y2(/_S MCRR?SO[G>7+F69[DR+7]J_7L#7YQJ.K'=GJ3>&* -XE'IA6IUE/C26!D36QF M6&5V"6=CDU.MN\?H\OW>WSY*L( 2@A+>ZPE>Y&WL!GA'&!QIF3_#+I4>N2!W M&O79O7WC?L42.X5RUJ',3#H;.(+B&'ZUK#6Y]G;S>QL6GNO+CT,: ?O*I+Q* M;FMX\L%EEP?8$R,J?+=7'#;:M5T#Z_DNCVRD&=@[G(+ O,;&R>G>WS? MJ3;QX;";K*/[+94D$P42+<5UY8R[[M9GFCTPD2MLF+R]S<^;G6\_N>-[#>8D'_YS%DAH[78=*]%[X4HK&+5$?',1MNB8=. MU,O%R$DRGO>_3':XR>-=M%",Z/ZKX^[-D!5"MX*;&BXI/N#ZN\2_/(3"U&F" M#1]#X(*(EAPPP&Z%87G_!H '@'\3P#]Q$HCJ1H@_/>$X/\7\IK)+''(BS/>$ M:#]YXTDH0RZSP=]SGFDQCD.5.?9U\,O'YJ@D;+2Q=DER@2[)&-V'ML2!4?S$ M1O%"5$/A(V?AHW_555>9(A*FXKAP$OC8U+!QA./\I54>PMW)DZ$J5[.X1?5; MN7MJU"\6GFJS[RQ5YV&M8:5]M;VJS"=F(6,V!Z4A[];RFS]=:YJ&'<[[W5IS M8I7)[]H*B8I/KS:&-*#'E8E-F?6FLBCOO,Q K>6^_63CO]I4FXE0M@]KQ5VV MS2/Z3$P#NP9+K/IWNNCRL1:0JOPA=PK_]]<_2[X? MT:VBTC:)!?)G3EC(__ 4\OF%+3,4K#+Q6V4.:9 H[XB!'6M[\BX!&"H!EGBH MW(D)\C<(V8DP&1I&M,_3+"30M;%RJE%:\CX9O[3P^]%R8"GXX]GAT]0+VGEZ MA^VN+$*T^W2&7.#CE1G#JD- A$CN8]:!9U'-B85 Q.MLPUBCPS(@3;R57NR+ M%K62!+\UW]7S2^])M>]JJ_29"\&:V;VG366Q.+P1/\%#L M-H4$&=E-XDFNG;S_*&>7\&:.B^<>#RBQ-J;(.9G:CC+A6 WQZ]!'P=K^DE*> M)\_\6+>6822*?S.AXV#4#4,:%ZT17H;NO1ZR/-RG^\G20-:40_+TKDWH0V$! M!U@<>#X46X]VG:*="3R$0".?NGA6#W$163?P7]\3C[IS\R21$/TF(EL 4X.4 M>L>N&WKX20QBSL(VDNJ,"-AZ8:\!?Q/QV :3H!J!=-#,F/I.@LGM*7P M 4JT'7V_#1*$N;03(PZ5*"RJBB6%+$2X%XY-NJH;Y(0WV0I)1ELA1'F6RS N M?-;!F] UO5M,)ZZAFDG\*\D%5C;%?9!2E-I#R?N!'09-]G@[^7<;RW]J-O]ULJK#W[D>I&$ZC+:*R0! MA)?XUD)^],O?PJ]_*S@86G GHDTJ$O-\NW/AGFR!/^S-/M^D]!!V__"'V"PU MK)XGMX,>+/)@KV?*H;0,+"_.24>)Q%9,PPUB2CNA]?&L.DE MCD^H?L+HGD$D1@NR,1<&BWBF+<"/DA&E.:7Y/;<3E(+AA?H^:[7S=7U M;S]3WX]]EGL1/3H@0VY:\\BU:U@U[Q@JB2-RR@V&!V^)PG4*J^"_GJR TX?R MX&B[)(OM]6FM2+9:6XY-1BE$@SPY'3ME,['Z^P(M&%I-I(N;RE+60L%KT9TZ@6X/0B2>1+DA'B[<5R3**VJ M+,/@]%]JQ#7#!N$A$FHCCP2-T7O6H7AJ2+Y#6^(IW/D<=TT>A6\64CP<,D^P M,QV%+_^^7!@/:\<.(UD5(E$]/MC]>(*,85WL3;6);:Z:^>7*GMD;OH'QA_EL M!_>C@/HW9%$UUT.S4"W:9EUH#"A:V2;;O= U>$P7B$^^B4D5,RJO(PF(G2OL,CATZ%1R5L9_MXGZT<_'^HEM+2)3416IG+NCV MSE'^/WMOVIPXLJT+?W]_!5%GG[A5$<9;S-#]WHX #!@/#,9X^D(()$!&2*"! MP;_^YEJ9*:5 4+;+-E2U(NZYNZM*2#FL7+G&YSD;-IQ*&YRU;1B872).^UD" M30*_7R]6(>K%.IY>K$3F2WNQCK\S*FIY>O_(7]OE]/7-S!_2UOKS5D&BF5D) M!DU$[VV.8DU/!PFWO\I6DLEMB3)&ID*$#])OIF7'+%DCYCKDSC&G@OZKW#== M)S3)P+F1'-.K3H%;38Z-3'0G3'B/<>K%Z;\L0'\6C(/N"H.>L"HV6(>8-F7X MRQC+A[PLS&M*!&$$53;DCQ $'6"M&61[A[*N4W1FZC1A)9@9L]T9N#^QH4O[ MR_S44']-?J@-,3R *2=6GD.3.+*?9OJOG[P9K_N6IL2FIJ+JD%.$XCB6@O8? MFNFNS1N_\,G36)TFE(::93NQN2M;#J2IPK)I?75$9PHI;\O%+&QP>,$IX&ED MM7 FEFKX Y%'ELI25K :ST0*G-B"_!G>N9WW[9,OQLG-.-")G^E_#VJ;C,W< M+_TN1EEP$>##X3G6L/'0[Q71J)(]\2V;N@ZGHJ^C\#G@!K,\O_+?_G_EV 7M M*HO=^B_G!0 7MW=>LQPOT=UJMI"]5!W/5M.!D!^'_<@;F)#)Y:MR&JM"9I3W MPMD:.3A$L!WR.YL:ELRK45?JP"5"BC) 3N S.-YI!$6$C9T64/K)4$$N4$_2*@:A+-*,-0V5+"(9(O3MQ6K$])O1RC*OCN*B MQI<1JM0T6Y HMECD$9KR]?+R/.%+VZ2P6HAL4!]+1+TTO!Q067B>L7).48D2 M-&>X/\&*"_RKOKHFR^$=(%LE2ZCL/T$ADCF5;0>;!^D\?#GDN[[1IC,P%_10 MD8>X%)S$EF;@C^C)CC5=L?R_%;HCB9N"7H78&QEH)H.4-]%6CCIB_XK+*T-< M2"%*U%H3RU?&6(Z0\*:O]]H]8?Q>M05\CM<[*"#H#LZ13,S"V%#9JVRWK3Q.[I=CN[2:$4/:*#T'@4AI5(!L9%+1T-NIPL8EENCT"S;1<* M:\C;;*)P:$4-V$FF0(SP;NQ19F#L&BS28,33KJ74)P3>H'N8N/106C\"X M%P(G-"S"C#5U!:C MX8PI5(ZO7V@P!7L (5I+C5!R%K+39'YIGB(6K+C09PP1>WDF, M;OYFI^.SH;4ZOKM0]!K?6B;Q[\G>;0-F:6<5LV.:ZJ@BKQ?/Y;L7XS8W&VT# M9H4_=RR 61+@90Q=HUR12@Y^T$+95 .W80U0M;01C81 S;(J"D M%]OEQJ@MQ(9F__->UQ-5'[P7@PR!;G]8/?%&+HBB.3&<*OIOZ#W\\#(1[!'L M^Q ?H*'>GR^,K\%FEDJ]!0U#7J:E@!W!0EJ^2,Y\$: =3+!J$"*;.3YH&5A- MO.$")\\"Q5Z4LGO:.8W5BL66%_)E5M[FEX4-PP" J_-L'^TTN5%'4,0(QDDG M_G ":PT-1JX^PCDS\)T.^*1T_^ [E16]=>$^F!+[40Q#=RIE/J;36)%_;"QOZBJKDW)LK.E&8@'ALH5V*4J*\D4KQ,%)-^?@%#_)41# M5-O5'6;O"AOMR>IFU\2.WGN&[ON;5TIDI:A2(JJ4B"HEHDJ)?TVEQ'YK]PVV M]@?.. M5KA4YB6C.YW;S;CQ6'$>GD>?:=^_UV"N&PMRP7(;E-A%@8NZ. 0/&&RD8VA- MAS9*>QNAAP&5[,0TX4W>T)01B 8*K7.T+?F10LT:(3! (1_9 IXS6>8H8P? M0@/8!BP7?P>@E9A9;2IGNMJR.(N=,LR.G($4N/@RLSA7:M'WU05\2NA$*AH+4Y)(< !@;);/B)9HD- M,89HT\^8J\BR>9 C]Z2+@C I)H*B.=Q=H6/P'CI<-[,HA )^&\(K0T27)RA- M@X9E0BW@S3GC9GHE#4*L#%. Z-)Y"2S*=_;#2R"(1!F! VL'.LC]/C=X.$7A@ISM-2%IBZY6)(7:1:MLQD3+XMM/];\@$@K1$"PNHQ791#!&+!T M06P!JC,VE=>XV7T,.H( @6K].Z813Q0"S1:&Z/S&V,\MCO*"[-%?E M3>&0.I!&8&2Q)N,UD2UX"*0(KA*\P;S@"A$IH$SUL>&-5]^^QJ#\^#$!RPR 7I7Z'W; M^@W]BI\%>,VT.=I\V-@X/D=0RPMV OV1GP0_&#+0M8Q=@OY6[-BP4//@V55& M\,!IK([ 1U[J!12T"9;TFE@%MJUA](>7[_%O\:56Z3[#EOKY%"B'=%P6IB(: MB^P;[J5F#=PIU#\-5#$[! M.^/7M@$9:YK!?8\5XFW<4^%**JDZI=3DTH>B*+AW^GA=/\-HI@,"J6#U\7_"MB$L&0XQ0D,.BC@^',;1A >\/7?LB+# ]"W"M$\.(G![$JU'MO[=]_FC]-M:/ MW+U#EP)W41/>0XV-5N\5TB?#4'<4:(B\0:@M^\)2X4%R@9$ M)8!.,12]ZIY][V.@^K8UW*W_#7HJ1'/H:UNSD2OG4S=0^A/VKP.U2?$^UH> MOTFL%%SHT[!DP0Z@S$W?YK/-?=;*N]' NRM,-RI;=O*F41Y-YJN'4CUYUZ]T MBD?I!91Y:0W^AS"U0UWID'@9C&=0- MD U:T(\QTRW+9[,\?T?29K-8_]-!#SX<+X(OE[]Q $9#0]#A66N+RX*U6JE6Y2RL_O,8UW)U\A"??LG MLP?<)=B#>R) J(L"?.()K6^L?UYE^.?)&A]]U;3.3+?O$,-Y>Y5#U[8WSJJE MRV(O)R6OL\E,*_=@9GNC;_](?QK"V2^L43G1JYV7ZU)WTAD4%BU=3V5>AK!& M6RNTV?D=7CFS5?OYN]72)*):FJB6)JJEB6II_KQ:&DKF?3OH52^[Y:12*8PG MV47F8>VTE.E2;Q,W1F)\WMZ39CR7.TL9T)4W'ES7JO%[P[7;O>3VD_>IEYO[ MOFR9$_=YX4ZFUN-M^PF>3&X^F<^4K>Q-ZVHI)6]GZV2Z>E5M5.#)U.:3FOM\ MVVEGVL+7NI[:\_W:8'=P-]VI#F]P_#8J*;:;O#=B^]_>3S M[8L[-[IK9;*^O5(JY_$[*3\;D2>WOMZ[&UR4]M]LC'-2K=R=YY:72OV^]GM M=^8R&6<\.2_5NN[4M.>MFU1#;X[(DWP]WUX9E7Q3951J=_757D_S8(F /9[9 M1LZ>AI[<&9A[L074NCO8B\#S2C1_QG!L3F-5!F@33-'P]_'4FO]Y7G(_U@"^ M )AVD'=&'="LTM*"")DY'&*&CGS-0+@= FJP3R.X1._+08+HTZD&U.6TW[K80P)T\6!;Y&*:/X#"!Q1KQBLC#7 M@?05B(GIVE 4CT-GK!<;[\(LI1?SH!E8+/FVA5ALG_>.L8R4OU!B&UA@\-Y/ M &7#!-YMOU@D,%+$_YB:Q)"G920 J4&+BF@0=W.$B//!1 =J2/QJ%-; QL// M_@K9.URR4R'400:L4Z<,>7.)3!"3!*5"'LF:P?K(]LDT=CIC:4K@59 '\X)< M4"OA =,<+$U7C$&U&YG!DGA-/$FZ;VH_9?7U+DL>U$B:Y6 M&<<,\/MH689$[KJ-G+HV^NUN]MXU.CES7IM>?E886+#0I=.@+1W.FP&_E%[? M%_<& MDD^?%G+_*R[&!D>98$\)[X>R,4@0\27A?XY#1N,OZM(MR2+\U)42$C?>HW+? M!@02]2M<*"(+@A,5+@6)UTN!X!AO%QP]W;]\B+E?[9&^X(AW_]# MS59BL /(W0\O^O&Y2OW3)RUVF8O_?V!NQ%H!04 &X7<>QN1I*GG0W?]ID.G5 MAR8?%K-\[2GZA9/CA=+_^I_!0"5.Y:,8B64JDG)RC MKRO9RK563F3K>:/2!O"W;__D\KFM@H(_S("XYV%]^^.TT9%-,;(7/D5G14;# MY^_9#>T$YHABD:GPSI-X8(?W2X_E\3CW7W=&CTS5[O'*4]$M^^FW;/ (I,@1 M4$S .3Z*\_ZY;OO!IWY03^,]5=UO<2W>6+'L.QGZK/K<*]6<]F2]DE>M13)K MN6THBWJ=D_%?S&(?!!IC\V0?.WYS*#:-(A9J>-&73V@K^&(RY5>YNF+=_#(Y M;!:O,M6K2?(Y4ZZT3.6^OUY";T%Z+VGR)B:4#^VTR7LD&Q/+G3D#+)FR 0@' M6_,!==RO_.(-__ +LBZ2A]"$I:T#TS(->:%9K@W8%(A>0_934:?:(,B(M;1, M5I/VM8P4G[RMKU,SZ+DWB>,>NM-NZKQYF2]E>MWDP\(Q!YW+AC4D.YW8U[L$ M6X8XW7RC&)A-S'0=0)%0*(;3=C'8EHA\'3C5;Z6@MDK,/&0A[(CR.342N3"* M'$I/Y@%V,'(M#WT$$-45-4BO=4UYN*X8#Y? ./5C@PO"B!$A-!1>NDE!JOSF MF3!2N=-8EWT0JMSXK^F89_*:HJ&HUI0#?GWBP91ZB9P?7/3_)'6=_J(SNW4K M4Z-DN-;%[/RL'+0 TJ\GBT&7E2].D\& ^;3 M2 G']_M&A2S6B)K#'[&^.B"SIKASM)85N;,\8""L018ET .]8C6N,]7")27C MHQJ;/XCED%#*RJ!-\.*8R0*2X,94L-@9&Z/)$"A7#D!+4S"\L.70@#Y1HW T MKJX'+PP*7Z8R0,,X-E,S]+(OL ;>$?@^B&RNVW:_,BV^9">=[GCU^'1^D=2' M[9_)9@"_SU81)_*$8XZSBFDH/+<="PMU?*0G=GL$RF;W<5!YW!."2O*I-9$ M!]T@^#$M6U?(5!EKDKK0L-P[[LF"<"+(#UY4R^0&CD;Q%UEEO(?8$69,>JQI M.VJ#.=P5(#-!'?H82&47ARMNOL5Z<#+!HVL:C=OJ 0=RKMLU0@I;K9<5:F2 M:Z]H*$V0-E_V]_6,OKCWL[M$O)&3U'NID!E>G)TU)FT/2/=X.HL_:P'&%;LX MOV^]#"O-SL"RJ_-S/=DC5XYAAOB?FZ<<,._QK."7Z'T"B),4_9X."5%+$<.2 MJ 2/8_$G#6R'*^\/)XD1 \^UZEXCZ"\^CH(:0&P 45,56[-V[%F*2W9D?OV:C4OLE M<=FU3*E3>TP6.[.+^^5\!/[7=K1G#T*"8 K]'WN'&\:83F4VV!@2NSDPX#@P MTA*W 8VVF6L!U9A#_YWQ1=D"'=]KP*"I@T%OQX!GPCY.2:7(IV:FS9G=//O2 M-#AD'X8&*8L3_JM': S3UX9:X%:V&1V7L!!]=2SKE*+%-G4XG5[OC?",H0XU MST=!,]B;;-"OPO@$]#\M@75[K,T\3]A;5&$XM >-_H5J>XX.-K?1QBSXXW?$ M\.'S&H*71BU-CR,$G_OA&]/XY_]C!U9LR*P??RV"/72G,4;T#NVTVU84#%3< MO@ ?-%C).$@$ /Y-8R8[3JY_.NEY5=7P,$EJ>.'4]793E>XM?5 <-RVKE5Y^ MN%'PE92F[U^,;K8UDZ7;[(545F;GC:#YKO0O1JG\W4)_/S/EZDKWLQ/.] MAVY#JRZWNY/#GSM>1"MOXH<$3]O!::WQL=$V9IL"!@_!C1P3Z1F9IK*37SIY M(OP<8M6 VF=BO^TP]JPN5=U:GVPSO5/U/B;JE;_^+)RQX(12#U+<65]5;SBJ M@(/;=XF3"IIV@Z)[ V&=;!/XD/Q7VQST_G0HOKM(;2[\D)POF79X#Z'[ETU5 M^#5#7@<*5F]H8"K [U M5"!PQJ@! FR>4)0_?$1HVL?X%3V'\$+(AXQ4&L@*AJ8HLC4D@?4U(Q?@G>A3 MWKG$-Y@O.N.W\X(=&N!9DKG%3.AP4@%XV8:FJ:FYP& ,&3J&9Y8 30T!,) N MG +NQ6FL/@SY:^S/)F\DFIHQ"_C-Y :Q)74R6:!, U13?S^%,0;%_ ]%8$I& M"$P1 E.$P!0A,/UY"$QOQ^Q)O0FS)[W[&WMMZ8,8JTC8S6EP ND%,]0NX$D# M>K_[O [$==,1FX4S^A##8ZA92 ?!RU9.8_?>^SG4-[=3[#&Q,"?DGH"HT8R8 MG2IE7*7A%7L"^FHV7ML(Y(.I"H079S\_P=N;0]S:F/ M1>1]1+35W0 T\=4LN*.D\^ MVNUQ_VPN'R7N-9\:9<7E\SJ4WU9U+4.C3%$J'\L)"\H-G:7,;$0D$$%C&HUC MBFT]&+A(%4+^00'Q)>K?X5%C>0IL+R\"ZRY%"&*/@>#97-0AFP@K%\?#-*74 M;@+]FB_BKL!><")P(0XMHJ3M7I7^?X/STGD5Y=],ZSRXHFUQ.#\Y7I M+.Z6H;W)'R 6^TP11 OW=#O^3^Q[ZH=WK[YB,O95(S+U(L[ M<4:'F R4AQF;D\G]$-BVB>\M"@=/MKZ5EMLCWP8?]6M+Q3XITL=UG;@\E15# M4[LB)\RTBL ?@;'O)H\Z7$$M76CH[^QNI&22+XN7[F7ILJFNQI0]3J:NNJURK3W?SI3K(8;KGM8#8!\N#XJ2 2Q2X02RB.@7N M3:J(55^C$K,#H.4MOT(L7,'&6!0@4/T%;%<04BJI#OR]!UFX]5UR[>+=^ () MI>58TQ'37M98= JB6\0/HRT6EE=(@@EGS: ,B =;SC+R52+\'ME6P)85GX$GH?I!"*[ \#/EX^2#(T/O2WC9O@I'Y][@@-,? [.6%L'43 M(BL:Q,YFHOGFF4P>S]YK6$4I"QILDH#C&.1Y8PB2/H?<:\E&3V.W)B_=H^E/ M803>=HBQ/ AIS>R?$ 5"^!3M/B(2."]67$6#E1JZ2AZU$5T&'1*E.H2LB=6G M(DV/QU+G/PF4KEAMMH?<4*7T2@S5$Q^DHPX 5MKN%-[F&L"%R.F&&:BH]ST, MC\+3@<>$\2@F*Q?SUG\G#2H="(LUL^4_":=5)0]-B>)T+:K@\-?T7?VUD(G? M^R$Z8W4U4%7%WF!=%6!+8^'S\C%&+;2>9,TF-RT-7VO&S"6O((=)#8 ;,E6)_"J_'%YEO0,JM[4P1TTU [+:=8"6=V MI2>ZS6*Z-T@L+WI/]2+8N:DW-,"(U:D0+B'R2H8*%.)0^D*6UV8:'(KJ6>Z. MZ/Z1)4\9%Y1?Q+]Y7;!>&9Z..PR_4\TT%0AT%0VE[C'2H4%L;_Z9!E6\6(I\ MX\Q;\I6C=I/Y>&DFK11[/ FA?0I_[GB3Y+<>UR%>*UAV&?/7(D87XPC.O%^* M#[2 *K,\MG@%=]CW>PSZX6N""Y/9\UWO!L[5'E*^2?2 M@MX^^7\&X)IC]OK$MQLXPKS'8LG1W)FQBFTFHHE*C4@*A$[E+&"NG'@.#B4[ M1N&#TV9%2;ME?'OJ8=T)1+4+ MO6Z_V:F/?(S(Q_AB'^/D4YR,G\CZ%_@@Q#_P_8+3SP9.>[LQ+;VEL<0WGYO# M32NOBDN-*^W9U9)@5\^O>M93_.9^W-5N[?.!84+/FN> ; M^(#URA/=6A_<@IZF3 MY#5!D[G0S0%1V>@ W+SHG*!!3I7TUEJ$NT^_?[59*JHVBZK-HFJSJ-HLJC:# M^K&W5)ME=G]C;U#J*TN9L)'G3!VJD&.C JMB8G%7"9-V/[XI5Y:SA;2^*#?/ MJI>YY[OFZ!@#:7Q6[!S"Q6X?1>#,SVG2E.AWOYEA9IE#U;:IC8+-3>@&JMC4 MA*U-4 >(#1?D'W^@NVP:!FOBPX@ON3\ML7DOE$H<8-V4#>KCV"K[[%A> MJ+2K6N$K97*F-D&+<;@+>ZRJ#F]$45P&Y&$&W37JQ/C>FLG*J/Q!^656?94Y M>"PRB#EUALWA(6?Q:@";%ZYH$ 88T3,6 >E4_9/ MC1^/D,]H> MF]<^XS]+_9@O:X8ZCIW$^I4Y!)NY+ONE;13*E<-\R3XJ-Q83]H9$8UP8X,2B M[[Y*MPB2?JKCZ"J#0*+!P/7AMJCK-]?2$AST?_TM&[GDTD"Z5C&NBH%!'X0) M+PL&_^:OJ3<['^L-S"7'WG<;^0!-4S\MS@O@V>H"GDC<=/%.T2Q.J8JE]?0: M\08Q@#"K?RN29TU]<1PU/KYJV"&&(88 :A"6).:+P<':SLGHL%A*"&Z05R2E M1,&O^=KX[56SUH0H[95I:;$:N2-L1X4 YL8;DL21H/ L7+ ]]!9O$ESWA$YF M,QZ#C:E &!N;RL_DVXZ X<4"J'5;E@>Q:^W%DL<:;>ID@TD>[K!XP:?"+P2? MPK?[,+EZ!OY3M5)B=B91&< M,YGX&V34N^HX0--':L?M[=A33,P1V8YAS;U5L3WXA-U8XM/"IJ0:+Q1I9,[U5RQ2)\"NVF9SWSF(E2$7 #S!=6\HE=T#21)K!= MV^MI'X[GKI^(L!G^S<[G$G+#G\9:%(V&6D#.>L8:R@$D$F.[J+?9?6H.F,.+ M@ ?"#3N#&F\/I\:'&341^A=[O[WA(-P>#,6B,HTR"CA_4W=*QB7#8JE0^\I@ M+!W3'8U9ISJDHONB MO6Z#N3KPSA6.25'9A;!@=@Y9*R)S6!0(M0R0X_$IYX/8F,(\^=3Y4$YC]WR< MD!N=B;@^.T!:?4@FA7S5TOHTV4AA6T_8G# ?1&YSM-C$F5&#U71UMJ=P09.W M0\ 3TDH#)[;#"MYMT=DBD\$N'+=8?5L.0+L1O19/2/%,)I[-;,(N>><3.B=] M-$=/PEER7V8=!\@=_SW!BW@PJ=ZWB1&+9>9HD%@QUP8+"F4;-_%[4G@^7,80 M*!(/IPU0%2 %/B0)'IBX]^8X]24LHPU*O(1!9>3Q;R T_[7T1@!"64BU MH$J&0<1U>4TL^+^&VDI5PK2T$.GEZ2,:50[R>]#'4I"_^?9?\1]^:1(;E HX M/#+\/:0*^2U.A._:CTVFA@W2A*\N!/-M :_(1:BM\#MV3YB 8HF*)=1:$4FG M)1HQSRJAM\INE.8Z["@P)P_U+Q2YPIWH#0FDFADU'NB;9BQ, MI.!"@R5093(BYEH2W4/M=J(/ MB6YQR.GQ[@@:;>#!!&9"[:K!%;4$.;/B-[Y3K&OH(90I0JQW0#% Q.9ZIY&= M+_(9LHL4BM!C(?9I[):L.$-XN2'N+?'PU%@-RFD\@_#VIL8+T?^&W? 2+C_E MB/C]<]WI*-<=Y;JC7'>4ZXYRW9"]?DNN.[O[&WOC.@DN8_N9?'8 MF(EG121K'3129[)-'<1H?2!V4U1 M>$+F)MB[%-H1?-'0-VUDMMA7%0TJYP=^EL4 XW?,,I+A'Z1^ *_*9G@LD->D M-!MOL73+&Y8N,5=_G.ZV4M1=?14 ?(-N%#F9]F87D,6?Y($_ M#9TVB'.X8H=!()KFY8']*GLR/"&*E,[$4V)R)FPQ663,\>->.]!+A=B5N%9" MU)2O6OAV0^"31@LWPY>L4\E@L2D([X3--M!(LF?*R5^=O<1*]L3NX MGJ3.W.M)MM=T4TWUO+G4V[\ $4/+L)CC'MI6_&!K=[.;A3NO)$<7M79ZIJRO MUJ-O_Z3W\>IA4QLK\1+S$UNB\?.,^T:Z\J=Q99$&["@2Z=Y)@^8@W63A'I:I MEAW'TOJNPREZ7,./KP+; )$*BH'L__6N7 *8,PO9T@*)%/\N.)I["8WG M('7/C[#$!XS:G+';0EVI4QKO1V8@[YWL<&]H:$W!!: Q>XR.T]&)/?P&J[2# M! UH ';;8YIPUY2]13G9L5AH=7%B)/9*.VB^VPQ3)G0RCY_&?<3OVR$ M(_MJF&T6LK;4TO!-/;^?E1M]&*CSCM ^\XZ54UB8) H.E PR?P*)!03 M4)=D.R':N') ]X*6PUHB1'G&=3Y4PO7> PGO@+EXJ+-,NXIVDW6%U%QQX'%$ M0J<]/#-VLX8VW6YTA2+N#YI+,3P-/CJVSU%D\1R@AS6$P54/58C7L/3A]B"O MXDCI6(O$K"414F0T>:O]S!*TO6 /]J_ZRXH>PV9"8 %> U<6/;Q4E6"2&03<-_JXC!^9Y/MX_U^+ EQ4 M,#8'CM+>SIGZZ+(U2=KK97?>:\H79^6"5CL/874)?^YXZ^"$^1^VQ0;876AK MR^8)9[(,5_<&?9=W*F5_%B23X,?]+[$747^+5J,$ MKWNOW>B/ J05Q*Y"%R7489X4U.10J24SW;J'@)>&HSSQI4BI[,2P$^@=LWTD<4$2 M0K]HT:/!_66FW[??B*W\F:C$(2IQB$H4N*0V_V- MO2;[(7P2 )975<0JW>F/%(QQ45KF]6FWTWX\NY4OE%$B<91D) %I$@L>9I8: MQY('!BYOQV(Q4:2^;.QO\E/>I=S% #XG_;-I+RRQF2Q S^/)3YGBW\>^[X00 M2R>]>D^Z;A[V,(L'$ LLV$ @?"+H7/BPZ$*1O4SSUW%S&(>"6@YR?-/L^A^B M^(L!1B&,J?+$-Z_$Q0BAC@8<3HLU*GL6)ITKK B#%A!:21%WT+$W"O"GX) Q M0#SZ:R_)\-U_H_>6'Y109CJ%7-_-0H$.B%S0'LDIJ6/X ?H:LE915\?3V-W/$6\ M<8QP=9B<4=10AHP+(*(KV! 4E^\\9B1.PI%7K,V][VHZ,F!HADWL"DZPIJ-U MX,FW/98MJJPLU1S^X @+/.#$?'%,_6Z,4G;\&6T()"7RT" %+#;GG\8Z?B,5 M=FAL/8*K;:M^]CQ0CB>&P7D(#&%DM^3?AP[UWA2LJJ$I841:8&&S@S+C!$BG M?/[F3?UJAUVYRILT[8YL("HF:$O#K;;=/CL-WS7Q@A-0'5A?'+WR?KQB"&+- M)'__20BFD"ZNQV_>P<^XB [2L=^!DUV"*P5&I6(UBVDT4>DBXC[X;L1] @+# M+7S]QG1QMDA6VI7L6'^PU8&^MJNC$'S]T.>.-UW1<8@3%,=%B8FK<@29RN#5 M8N- J4$P$ 8*57O\S')=%\2YV?E+.&F&H%NV8+98)>8&A(J\!(839@3X-<\6 MQ&\A)RY4"-+3[#7[';3D*V11/-N&YAW!J:$ZU<=I9[:7P@!ZL =?P!DBF-R3'!!G?@\UJQ,G L0H(0.K\L M/;0X[R^X@4C] )D5@@)S&%5_&V#['/3?DR _C^X](\YA84(L!_VVP(5A!U]" MES?X%6VC#]3?31G@R$>J-YC0_1=(/M&0Q\H4BAKW=^#.8[C@=OBSE(N-;?;N MM0@=@D)[1L%. \,36U,]4]G+EK.,(Q0)&XY(2HE7*+UL\?)FU[7I8TTQ?]=[ MYTP&:CR.C0 \OO&A1>X[-"LWU[-[VB'/66BCK>DCW/CU"^Q -S"+'ZL(^.$Y M$7=V\\T""["X_^&5$V!E(O$<$9J3;6%2-'#'#$4X EO?VWPE_3[C2<,7>>@; MWNMFV!=T..OP!JI*-.&\\--DL6YCD:9V&_$L7&]P;&"Q MN.4FUFS;/T,?9-R>WNW#+P?OAB6NC+H \?]#L]_9*/L=9;^C['>4_8ZRWY#/ M?DOV.[\'S'Y?!.@@YHAXL1+?C-Q>WVV&S>5#QJ*3PHR-,*@N$5WK-%81@K,T MZ$YM@&"3.G9#<^JW%8+'>6F0#2, 74B*R[711D9- 3)B'_.+3 )AO?SF5Q7+ M4OL'#;)X\='<*^.CNP)3IP P@+7NW7]>Y2AKT/*& MT^>YP_#/GC O735D&C"!&:#UC0_*2XZHR"# 5$1,RUT+ M#MEA;( M *AEV!:BA'N,G6S'CB)T(6 G(X:>!Z!L;E$3N 9SXS$>%-!YO)8=*C 0594& M/GPP%Z ,ML?0M(FU\R)VO64B> OJOA"5([YE\[>(D0[+S U$;#TQ:#MQX)C0 MOXEI77#OEEGUL4]#18_X6SL&KX*(]=N M2374H>:$L\$_/>I3CF5Z'[1G L/TZOBR]7E>)(=/3Y?=!>%T?UR].T?XS6\E*XA0@_!Y9\>(58('ZH2]5L5M\$S5%V@(4\/!4#JI&Q07R^;0%:F?X%S1T-BIY0J*^ MS$HZ@N*/A/1*[T:\ @Y3[U&5->L.\A77_K5 79M=#L[S1?/)GG8;C/L@@>B=&6/8&FV1 M;20J=X*21N]TM#/\'U&@!$S$UHK%%KT^?Y[L\VV(';Z0I0YU/*F^]>O]6"0J MXJA2VU6=/@ \ Z]2=K'1A*T@WG->=A,WXQX&U7W/H1:OK?J9VH[[MH9": M7S[<%L;=3CKY4GIMEB;J-B10V'#O'4B_]F M#T_M, >K;&*A*'W5C69/RL2A)XX*^2_O.+U8-_9TOIQ>3*9JU9"D0?N^JH24 MBX8_=[SEHH&YHV30R<=@]E]9@Q!VC.AM/#,AT<"PUCB:F'#E #C+UBP&=!90 M^,6I;A!X K0\O @>V74P@T?0/YM!GQX+ QG#D? QO%E9#)C2 >[Z2G\= V_* M8=AKF'7QR 'Q-5#)& /R1FSV"JR0YK@LSE!T,-43O(?]RJ6=GX>6&,9@P?PV M1(NCQ4)TQ;?'8-]1RDD=O[0ZHM<5'T155]$U1=1]454?;&WGF*O MB700,U^DIQ,,66!G8/ZR6$NR M,7UQ)&U5TZ^L6[/2OCI*OY3/*/;]RK3M'[$6@#["U [EC99DFVR=Z@U+QV'- M0#;&B"M%B[!=UE2#!?Y@60*0(@O>LM_X25 TGOVV TC:(3C]6DB;"GTF?I?- M1DF\Z]B0S8'/;>'&G; N6_ZW0O " M,_[".$"@7(&-BZ(]<+9;.'O"2'D2V8YU9Q2XA"4NBAT?C:5AG@+Y>S:>2)W$ MOH6&&#'?D4C\S>,?H/.A.9QF1%+)[(^_Q 2($"EA3Q)Q#GWQ-P2J(<*%N4ZD MI.CR >7CB0)EI%W0/"?\W8GX1"$N9>"):^*MPQ\W_C$A,2L4_CNQ^:K TTDI M+B7AB:K:MUPH1(*_H_%&X:DD>^I:MHCNA+_XP4XZJ) +V<"?\G0LT63D_,// MF>D".5V' 8,*[7G0((@%J5ZE!HLCZ'3Q@O4@.R*ICB4K-+U$+2+?Z/%*4K#T M1@00 /U(J2$>1 M%(9EAKJYM)%5P%\##XW[*SN! KY%"'OM*]V- PSV%9I0T'AU;&?;I_ ..IEC M7_FZX5=F^"PW6%&FL97U%4HJ+A6\;+)8QLMU:RXM$=U:GX**5[VF0_])8O\A ME0DTQYWRO/.VWE&\I]"P] T.(),>F19+? 1 AS 1R**?)[1DA2I$(%PBTP^6 M^G+6$%!HH$?(0=4UAK5"8YU(CQ:B!SF4$I88*JI#K&^>AJ0EP^QE"!*F3O%3 M6'0HC%T;LG^; E&-#'%A^ *MUO0J[J@.@X7!2K?0T7C4,('909[Z!'T%LDK$ MH'8-A>@D\JP\&D&C/?,J>(W/=\[:\"-TX>@[T?0S#. 9X&8YR^"*[\4U$/>% M?.:96/^VHK&$-R_EW#]K3TE3=#);75 /&B\+7J;C\[QQ:6%K)&3!8/FPA!?_ M@5<5 H<&R0'+#4866C,VK#":&5^3>ZVN+(RFD4G-'!=!VW.&C MH[OOC(!]EK\ W%E_%0=$4%A]W9F&S;+8RELT% Z Q>OU*NP<>O["TUFZENO6 MY]/)/'=A+P;E54F;A\#FAS_W^8G%U_D2>\*G.P MB>TH+AN>#''M3L@- '_R M8/>Z1D FB\,A:E^5E9-[2&->921?:L#,_*P [?O1,'=;*1U61G0M/YL8\/-F M1%:A;LOR(':MO5CR6*,D'0=&%6PRYR1'.?%.8@\#E5P/LFY"+ &48_T:ZLH& MYDGLZJKL^6?\;WW(3+*+Y"]Q3O;FLR7^V EM6E@2M0]IW*6!+#]]6U,TV?*+ M&[B"]%Y[?]X*OI/\A?].V7\'YH;)/\9JNMD'LT"&Q/$"%"N%1XA#*@\N0XLB MPWM=%;1,R"<5Q &5("3 MP__M)&;2I>;T@R>Q[]J/0" 988J X8W#B-ILAY!8X,!#7!JEE-3",^E$_4U''AEM8Z1(Z?3*\G"R3&JO M8$J3?*[@FA79U)QZ;7B=::V68?7AF5XR1TOB@?&P,QBKBJNKS6$%=^\:0W"^ M;MG^6U4-,B/6KW$B1'88+R*+$?6(73HS;5FO6:8[*P=:!_#7H<_1/ZA*H!:Q&AD,.H5>F'T\*=?I#-_

      \YV)M(TJ9M=M=8N M/FCM;__DM@DR_M?GT/+.*"]B0L7"A1H.)U$17^F:@]'GZ0M:G8B5I>1D@[(* MHO/Q,E"0!(&J22PBI43*:!1[8$?1>8S.XZ>?QZ>6^VR.[H=2UW6>KW*CVN+B M%BA>0\]CR$%$*XB?0U;:I2).T.JW;=V4+JL=6>[?=A.CYO+; M/^GL:7(O(Q $:@_+.^4+(G%0_3\L=#E_K.R5O-C+:4)E-G==,=3J:]Y -9:NFTL)?+V2,Y4I!T M$:\L.DV+Z;+('!["29RVS+(:^S>0UR*$N%JL$FU&T8LE^YZ MLJ];?K_TU\C60^U#TZ"SP7DVAT6,.R5"56]1RBSKBV)!ZF:E^-/9DU9*68GB MMW^2TAX^1B[04-[&]G)G$\%OUC*0CUH&HI:!J&4@:AGXU[0,[$]COB'IF3Q, MJP!:41[!$59S88;$)YU@%-T,<-U@##-@(_S@%23A3+T;U/4\*.LS"A\,_"28 MDU(#^;Z0)%:PN6$)2P:U*%B"HG/<-H12 (0#EHZ#^M^XZ3J\P(KP-_-][Z-$!/6ZKB8$Z.1OUK[N!BFANUHM3>] A#>([W;"^H!O:%[1) M9.F(F1[O4/U@@" <&!#:@N$D(<:^"LU"%+0N"G =U7'YH 7'I<;E>*C\'J0 MNN&G7XH*J''X+R95M[PVKH@"$WHZ,@6UFY]?)XS*-)E3C6E+EI,Z.1V)W&E( M"((?#R^?[TDW+;B&RZQ2JM^>%2.)CB3Z51+-6^Q**M2-9UK9FZO+TN$M%.G.9WBC:GA/)J[UF4 M%^HK :*:70I4O\,Q<'6'IWT"_9RL2<"W=C4RO7YED> M>QUU6NA4M=:P6TY?SF[B)5M3SR+!^ES!VDRI[(!@Q?N@@>W%S2&8^>H 6TG; M1,;(M0#99B9U+8J)=:M:T]#4RN-:J=^;VOU2TC(W=TZQOZ]5!>$1L VD;4.+1;;"80N*^GTDYHULKGC#4+H*P-#<#F686P4%YW M@A5X%#>PKX;&.;P,F4>U.(-_CF[%(U=>\>QK35G? ;LU6\QN:D&9)I/-T LQ MWGIR4%X]JU5IF6P.HA4OLRX:A406-_1P&D$@CI&2]5E)H;O+*P&FE MJL_KPB$9*%>N[(V:Q_:"-:8G'($0ZT4UVDD%WP'0=4X6R MDQ<*\L:IO,KNR M9F&ODQLC@[9'ETYL:-XD'6QC1F,;_$D*-J_$AJZ% ^FK9+(G#,A@XU7\&>&5 M13(C'5NH8M]M#_TXN0>?X,?!;/$0M-:MP.O>1H)@#!:6"*2 QV&%?@2R+FR) MX"'@XD1'_HK1WEXQV-.U]ZZBYPN(!='?X7/,L2DQLH;8'7D*.NR\GWB]'B.X M6#WF"B_J'7@EAMH!FI45E@;X2C9G-C2!"X*_D"GFS6X*-;9[:"?^AS6.%HP2 M#%URQDB'Q8>_LZ#$W].BC-V3P,M UHC?.B B1L22W%4"<@)/*=#5YV5*@446Z^DV MX?U [>'!G34!IO[C""TUL]6_^'_\_0$Y]$"KNI#/ MQ\V 0<1U)!G^:ZBM5"5L?X1T(J]1H*E+QR+_I_!)L,?R\&__%?_AER9!3H,# M3#9L3#@\,OQ ZZ)A8N.B, !6[, &^EW[\?__UU'$,04?V"XB^ #4EWT5"$/- M N82GM3]ZL]_=#.)X&BE$H*CQ?^@J%KO"BJ L>]S+=B(T_OQ[$H?;)BIM^N9 MVAP6 0")]N_YO^ J@&D 3P&P-ZR;EWEYY.BERF5YI-6-C'3^\!PP&Y.OM1K] M9HGFD.@24"6@2,")XZ7%9#'"PQ("3!=2?F1!%WJ)@D--YK.\MJ^7Y/'* M/)\G5[/GBCN\>.JWVT[A0@GT#DBOE>2-H/Q;Q%D,WEP4'^UY7%^.NM/;1=/) M/,IE9;[\]D_^))])GD@A,GTP,?CN@5&;HA\%O2(,,GZ@60-W"L!J VK;V2H2 MY1"S:LL\\(MOX!+Y+UQ[_\7UBJ[QK[W&C^X>MP$=1OGW7.2_KM:TXG+IM)W) M0U>]Z77GJ7BID5T?[((>%W.+F[/N;;TR;3=;N;/$RFC8RR.\H &X@=_0".(0 M7=&[KNA?E]%N(WU?J9V]/$OS27DN]8=FJ;HJ'O+JG4JYC.Z4>NFN>]]8C1\S M:C9] ]FYDU0B>Y+\@Z_>F(BB[Y2R\)0)M,:\=XT#,AU[$"J8M!!394=H3D,3ZF5U!_M\I M(A\ IMT.HPO(V!RVK&WH3OV4L*M]W=+&.,6$-UYB^OB*]$NYX9!)&Z M\REAJ1.XU R0\ A.IWI)JW(WGCOM77J00AQ7N?-7^\:^94,Q;-E MW>T'1O6#B@V/&S,(/C\(7J7)G7#&&Q^!:>-C;1>1&[&*4H]AHC'861X.B.0/ M+/.#%K/; )L7'!.C;16W]RO!8:X%$"JD9&7I')5R93,,95\=^5Q3K@JH?=:AB)"^ DY M.=!8L2UT/D+7SN/!\Q*4JY;6N05KN3G@^2[(N34CLQ3X-!/2#A@LL+ #((S& M4'<1$QY2-"II+CV_X30+!/ M[+[@AG5.ZIE:?S)S)G$I:30N"M+U9?.]:!8BN7=S2':)6.D:V3#:HAJ:D>_> MN%WGRGBYZ$[3C0Z"_N)VT)O7[5&Q8ZPFDWES-E5#L9?J29M/7E;M M]/KQ4A]+Y5&\6[.1^3)S.:3 MY>52.]-GM]*DEK[LMJ]ODM7[WK*7WOYZ35:7\]O,P[BBWLS<^])3R6Q?CLB3 M6U\_NWM:MIKY]*V4'6[9?9AIJ\$WJSR5COKQSI6;K M4I)50%)6)_!9V,=?RUZ_;1$NL8((7#&-P?8BECRO M:]M\@>_1S;P\!?=EM2F%JT?5.;. M!2;]C#VZ?,.YM8 MHY\-%\H%Y9/@0L]GPXE\D7NYD"['YL/T<2T]M^;+MV:'/@@-,ZT4[Y2V=#Z8 M$%]C='4?OR_/4KO0:9D#J(ODVB>\9C 06K(!0UQ$8UH&W6](YA!WG]BYQ@B\ M:^%)7F4Y,)@8F!%AU3:O$^"DPL%]#;KH#O8+T,%E6!QRAY"S MO][0K5/<&:98E46A/KHTE#])/CW?57.5^Z19Z+I7#Y=7&8 9"T-X!&GY:J"ZMZQJM;=TKI3TT["B)GKI MM'9QGNC,WH_:]OY5G257+_>S5KPT64OW3^>USM2YK4 =PS[D7"' 3D^\IZBX M%4%I;VA.: M&@_F64O)$R*OIZ]-8U;2$AA>?/%([54]/1,;3/K:6@ZIAP3]* MC "!3Z^AG&N+'R\)PWVVS81BKC\$0*31WO$;EO @.F%YK%4@KA MI!LFCCQ.W^0-'9->NLYM1* MSVG,GZ_GYUAZ@IIY;2T]C 8)Z:IQ)L+AC[()"Q= MW-_<)HS'547.FL/Z_*5V\9C>!9".73W&9U%I;%P$G[#RXZ5$I# SU*5LXKDU MR"[.M.;EH58^KS;;Y"BIL)6'8_V#VJ\A%S><9CQ( MK*/4.\9(_\7+H^ =?I(4J8SAQ@\YVJ>?RF+U$U]ZF^7V93I[NG4;";F2O$[? MM^*=Y23W^%DLWF\R.#ONE/PC*EJ14-0GEX.=$7-YO] T0X<(P7T6V(<8XH"& MQH.I!,DO=6%YA.U4C6/QK[*W)5CQCE<)LU%B0[,^["W9Y*F4_%\Q1+I1-R-$ M/87W0YH1KE >-N5_1IJNOVCB!1JO?YKP$&J7O$?EOFT"C_57)#JD4RFSSX/" MW[V>2%-(7VW6(^W8A5UE3F1?$M&^1/L2[+I8&7[&W?HIS;S%Z_+:U?B4]7%(62!?Z5,IM"W-/+6FQ^<7MH2LUKZ* MG*H01*4Q5*\(YXUGY"@/Q-:,HQ/RTQ/RQB5ZWQ%A<1'>+SQ;Q;"(+<:+.7^C M(R3F'#[B\!QZ:=Z]$-__0Q6I9K#BQ+'IVL#%_2.X+-&Y>M.Y2K[J7"6RIX7< MX87G \\5A)TCP?D2P?FS%+)72FR[P;'AUW*GF; *<4B]\O)Z]&IXY^QF6ZHY M U67(#J-O/[7E;W7S?#7_PP&JCH<'E1,&?:__6%G[LCF]X7'\ ]:M?]\P,18 M5/8 ,Q,T"V;.Q*FF-J?ZVCSX1Y9'>>GE/6GNCC'M2_52SIC4JO67ANI^E>ZML_B>1)(K%- MOORGROVA8BM'M@P?=?Q3T?$/J^-[S?$O7%IW_6FU/I+<\2AU;8\NK$QG^1G' M_]&I&\7S4J?5;5XU6O)U:EDW%]!JD_WV3^XD5]@N@/R=@T4U"VIM9I8YU)S( MS_AS8F-O]"8.'S+\:=+Z#U2&1V(+H0YHH0H(T8?W\7:SZ%A*OU*6$X4K_2GQ M4"?F4.8KS*&C42219CBL9MB;!?X#-<.1F$G[-4->/[MT+P;G_4D\D3J_O[[( MW:Q4:"#^-$OIR/R"[] $\H/W22!#C8# X_=@_:E^T6]B:QW6Y_I]E.SQ1:>V M5BKV_=]AD@5[S,J>4O$9G#R"IQ;%4BPZ(DIIPS2$5F>.KO4-D;+(4$*4>:&6 M&Y[=)22&[K* 62LJ4J>,D9! M+#BDY@5\60XM@^!P ;[:4$CJ'QZX^B8L3W(/B\5703Z@WLR^ZK"QO_* &%YY M^ X 7G%&^91@DUID3ZW8(_3U?/?Y,SBX8P"?7T#O^Q'$%YO*B@J8:?(,L.,H M?B#'+Q/9"SX!V%U@^>)L],CRQ?_P27@R#]W9;?SEIG-3*=N%;KQX\7B7GKX? M+:LEKRD"BED'4E! M9'O,D3D53:'8_V-@F H% 34"88@0TAG$EO\DK$YQ.U]C0:2K;>>N=K,J5MQ\ MP;SH:P]6]_S=X)O7FH'ZB\=>0I!^2NM@F(8^$H[_H^Z$6N8"ZJ"P:,+'/(32JP*(%#>>=ZD>$?.'<[9_E8B>0J< M2,41KQO .6T&HCLMI0!1 S_C?^>HL8*W%P>7"(CF*/,23Y^)[O$R#CI!4;> MPZ^;]&FL#D!(] PP0#7_ZU-YHHIT09:YEG5RI\W8V0UH.L<$$$WRA<^#_ MX MX8E>2OI4 *TS=>%>3ZK+P62^:)65?/NI][0*FN3IMY06TL6K4-2I4+762*:& M@ZM$=2[%GTK.J#2YN,CJ(U!KZ3T4&=#&CIMND!4#YJ$I6;RQC3AY,H#[N3J3 M3L!DXO*Z&RXSVL 0QI.Z,0#H7948;/B_=>,M]]53:=6^+=L]:U+3"^&*]$E_T*> MTS49+3>B?[Y2 7^0.W<@_%T!J9:I__V,3MN<;4-*N/6[<+>%XTV@P_5:#.6F M-55C5^1:.R%WS^#TBW?QMQ(Y:J!X/N*6@>*['>IG(NTFWQ3\AOV%[65*./M\ MW;DRRJO.I-9M/U=Z5],*PB.^\Q;]);5R15\5I/KO.]1O='58_O\%"G"Q0&F3A M*2+HQB7([1KAQL,_,8XYAE!/T+EQ1XQ@",;M'0&'TY,Q4@ M='+,-\[[=?IO3Q$'2,8115Q$$?>K,?2((BZBB#LVBKBW4X1]$>G7NYRB#DL5 M!9VCKA$P0XK#(5E7\I^1E[1WL*)]-K/4A6:Z-G&NQZI.:;NG&JPFA%<-L+I" M34P9[/; ZLM\]44RKT F/PL*26R8" &;5">7!C+"Q6#<+)")NX1D*$F%RB3 MX!##$(@U9REH>")S,I FD16-)Z1X*A//%*CS)WP&!H1O((-UT(8\B>G CJ.1 MM= L&N>;Z2XQ[BSBSQCP'WU@;\8!T$@R]60H(0X<*N#D(;8\_,(F"Z?+EOA% M+]%)G'C-MEW5VIX\C&JO!6Z^U0*'V87JO^0)_),SRL[@B?8.\#, M16.N5>],LXF.DW7D2B\S6[,W:;[F#=N*('JT7/%:Q#N-]]47-V> MM=UNYVZB&L;D<::=85P[A#6(N=VG,2%E*WH>P0@(66D%O;#P0XV^H8K,)R>; M7-)R;"1KQJ=F:-]6-GA$HG.6NEX-*B_#267=2_;7@TJBF"R,WA?4HU&'R4HM2?C*U D>=49 M 7WT.O^;J:N >K*YB8C.O+=\4>C\PPRD*],8R4061V2?KLA%9=ADGY!X+W8G M6QK>8%QF8I3<*';\\SKV?>IH<.D2HZ; LL%CZ3AN_<5_NK3X<2N-)#B^Y-T!AQHHQJN?@BU=7]&; V6X_6@H\&ON. MU$- O;G0%%?6B5$G\VE>,_N$#Z("C[)?C\GFVY\0*GX=RZ"ON/"@:*H=N"KX M>>+'B9ZFED54N;4NJ89*+AC8(($J+.3Z$K;(VR$_&;MX6EY7+MNF-9F;[8;; M6K2T2OK==%3A(WXU'=50&[W;-@>FKJ[_)WB[5 MA4H,$X\"#@I##%E?LP0MNST<>"?R4Q$G@%XV&-9"R]?C*\:G R>&&2[T+'@G MS X:0G!.!=='H#IVQL1$]F/(0'M,[ 7DZ_.BQW"?H>39<*:0O(F8TDS+>O.E MAI3'3BM^6AT.*84@I]*E90E75Q@\MY JT"/4G5')(GK%$ZWMR02N6S(F6]!, M, )X1K#F<&KH7IR(N6Q@-Z203B?!VYT>9U@THM=X%CWP3;\TU+OLX24Z$7.N MNS8*Q'RR:707+;_,5-1'GK]S..X_' X=S:^9[21D,]]U!-+7><:O\XT[0(GN73'5F CXX. MOS.")N-<>ZED0A[F"U)/32=RO70^+_4*_72_E\VDY&0_G\FH*E#$05A8YC7_ MBPNU,+ZY,R^[\GVIO\Q+ZRMENH0[8^O)GGZ6S3=&E]U.93Y[JFNI8?^^W4MN M/YEMJ[7D\R*N5>+U^G"=Z]O9\561/)G>?+)J2I>C=>JE--'*]U5[K8W6XXMB M+Q7R]>DJO4QW'KG32KW8F7:=]I$K4VD3&JN+]3, MDCR9VWRRE3@O/$MNL57)YAIW5^V18\BK$7DR(6T^JDXFB_&@=J-UD_?+:E?* M]UJ2#!B/6T^ZES-S?'M?L[I:]6DE)^1)_N$1X."VIF0]]7O%>F7>D=9/^=Q: M*TA&?PKOW)K20YQ\[R9QMJRXV>>KNU1IO6A+\,ZM*5E*;G49+_1G1!U(ZO5< MO2WESN"=VU-*IPO9XGH^FDKR37$ZZLI+I7(YZF6VIV3=I,_RYU/+D=11W:@6 M9D;OQ2KVLMM/9MQ<8R"W9LN*.LVWIU?W2?NF#*UE6T_VI<[YI5-S;B4M?^;H MJV1!:XV@UV1K\M?C4D_.I15[4NZWB]WEV*K @N:V)W]K5]2.5%4RE7*J/'U* MUPHWSQWX^L;D>P,IDU!E1>JED^EL+ZTD\[U\?D@$MY!*R<.LFDZJ_]8#Y5DX7%6GU2NJUVY'790Q@GIMM!Y M68R[Z_J@\7B?74^4FV7807EJ+.87SPE)KG3TM'IWV\RV,_UVV$&97'7RU7RN MXG:S^7Q-;S1T^_PJ_*!D[K(/]KQR_ER))YZ?EH9\5[_I%\,.BG-F3(STZ'G9 MU9[LC%'+2XTS*?2@+!X,PWJIYRJ25AFJJ9133.?.1V$'I=.4!K7FP^-XLKY\ M2-6JEYU9[FP9=E ::GPX;%6>K$YO MRHOZ\S0?>E"DBY?+R5TK?DE.7S&^M!Z6UK,>>E!N9LY3;7$UR73G;D,9:P]7 MEPMM&7909K>WM?;J,K7L)B_G^MWE]:6F-(IA!R7S,LGFFM=6;C(].[_KE!() M^2&]##LH8].XRUW<7'Z"*: M:1!_TDVH4MXF0;T_:\^4^I,]E)KVZ"&W[&3B%XOBMY@7L"HZ>Y[#W$_BDRA3 M=WCT816"Z=-8@$9G=W9/;*;TNZFDZ>Y?$3RMC/,>$!6Q&2T+T>X+XG$ M:287;X+])I+N+=/<*-(8HLNF".<%\B17:D^Q(I MLN/>^1(KL2/>%*+*]8(_1QOS2QKP1C/:GH;'C !S$-^7?L"R?ZF7_ M\IKDW[XD^_IYQ-1 ($WP,A&)SDUT;J)S\PE>U&^\*,?IP;QSXEO'Y<]Q8'Y17_Q;G9,B MF: \4G\GW^2C=WI@ZB#I__=;_ML[IYU.G$I9CACC53+-5C'LN8AQ+)K?1RJV M6M+I?T!577#Y(NWX[SPS_Q;M. 6,L1>L,OU=5.0A3X"G2I/O5:6)Y&GB]T_;\>M;Z?;,6 M.F2_#S4#]E/7%JKR,?3 R>.;,(_>?9CI]_73>Z-<[^X6WP(1XB!A=4-1J30 MY<16.W]I?0V4EPB:%@ 7\Z6)DV%7.TY;=QHC*5MOKM6"?9&U^LL 4!!168._ M%->"XE!;-39[T:L[A]&UU:&K7VE#U6.[/=-?:K.'3/)FLCXKUQ_[1OH^,UH" MP=ZW?Q*9V%J5+7N+R_8/%?2OI\:F=0!'M@P?=]YI)\DPY[ MM\*P,3 =0I(]T-RD?1_/MB?KZ5E]/M#F#YEXFZB-S+=_LOF3?'X;5.S#+,PC M.RZ1UHBT1J0U@I@W?I)"]#-#]$CI+KYX64T?S>ZZKY?OM+J57YT5B1[)?_LG MF3M)I[8AT",]$NF1-]031GKD]]4C#=4)T1F/X[Z5=-O/AM1I#:K)CJ04K2=P M61*);_^D$R?I=&&/TOC]BHW*YFS-D) #D%RJKJL4,1EX[,@6KK@GRTF'BP\SNH%'*KJ3H9=Y.7_4=]_J#VU$KQTR(,(^7*>)G8 M\GDW'L]'"R%_O9-PX+D>YTW_1?KBZZ(- MF?%SV:U52MIDOFAT2JORR$D]MHD*R9 +/[GOMO]3DEF1_HCT1Z0_/B[N<*6M M!\[Y5Y"ZN>F"4Y+_]D\KD(XT2:91WAALBC?(G:93P",2R>';= MO33&V(&ER 6FF"Y Y!_#;;U7\_SGHQH,=R8@#[XV;[K= M]R[6IU_]&2T]:3T-&JV*-C8N5ZE..97H?FG40#$+#;5==+6*>I?LU:LW#^KR M'CACH$:A<)*2P@(''U@)&RF=2.E$2N&(5J[06*9G]K1R;]S.Y;94 M2:QND?&1%D1DDF'5F%N-&?]%*JR(ONN3Z;MVXO]$C%['">\=$10=Y[Y$C%Y' MNC'1@3G.?8GX(XYT7R(BG./CU_5TPS8A%K5\3:%;%V':4X1=1*88Y'Q-H5B=;OX]-& A:Q M=D6L77\8QE#$VK6S8SOY\9CXE^?G^4'JH:A5U+/J[*)VUS22I?:G86KW:M7D M^9G3;G37\W(I:4Y*L^N[4<3:%?%F1/P['X/J\(4ZXNL0L;+ZW>2I.4M6)-5H M666Y5[KJ58L1:U>D-2*M$6F-UT-:U7///>LI67RJ))/=_/C&RH]G4INQ=B5. M4NELI$1B-.&M7[B23 M2D>L7;]O B)B[=H\N1^,>9\9W-KYU:"SEBX'4_DBZ5XT2HG/8^U27]3SE'T] MU*6D\E!X+K2NUW8C8NV*.#(BUIU/NNF_2%]\7;3!:.F/2']$^N,]<8?+RK53==;/9Y)[5IH.[$&W-;]I4]:N9"%B[8HT M2L3:%6F4G;SA_?'DX>FEMY"RB\3-^?KQH6G7BHRU*Y&*:+O^;-JNK^Z4.OZ" MB=?VW?_18K%5?!:QXAP7/T7$BO/+]_EP,9*N9B^)KIO2TKIAWZPSZR\-!F?MW7UY:*7KVC/ MB5*J>Q\?/M2"LIYY@ZRW+)/H&\6N6N:T0\2Z.=PLF;7/]* M:5Q=2LU^*Z^.[I/%='M$A#U]NBWJ,2(#.JRU.8QIWCK0UIR8X_?L($XV_)6) M>U>W97D0N]9>+'FLQ4H65-A\MU4UUC =-9:".9)9.[*FVS].8U\E?!L->C%U M-5,-6\71:-[2Q61=N<]1X&*X? MM+.G_NC=\B+._96R4GI,)L^=1:YIO/6HA48"%2O4EG M=97+-^UB)=E6SPOFI9.0+I=?N1 9:QXO5[3N8T5+WS7KX]+54M;(0F1/P\+2 MNPX1"!K1RV.JWUS+4@T'-1Z6H/D*\/0+3\0'W1V["[#>N[G!/>L,QJKBZJHY MW'/%5UW'M51Q>ROTB-_"[7Q+1E32S<&$7?[]WGIU>UF]U.9-Z7+4711G_Y[KP6.);S&5R,N,#-6Q7/43S-OWIA@WB[\V_XQH_P*GP4 G MD@=6[_COH!BD8!"?06JP,QR>3'.KWC,4IS/_&A/^& MY=A:2V N%58L0%[*?A;D+^5_^1/>";8QCCG[*YDX!:K4*?DCFU@Z01R23]JJ M30M.$/NK;__@Z00+HVPBV:OMR;'\ MD8;IEGNS+QU#AO50KES%2C?%QEF'8336&^73&/ESK-,M=>IG]>)-O=+Y'%T= M-J#]L$3$LK+I,(D11E82,^1HE!&-*1L#3=9CY&9VU"E=XOXG&?UO'OD6(&8, M[@6\$@.@F%\STO>HVKVJ-*@)P@ZXC/=1+Z/FTG(RG>QE^RFUE^YGE5Z_( UZ MPWPZDRQ(0W68''ZCAT+F[NN\-;UZEM9ZMC*?9O\?>V_:I*JRK0M_O[^"F.?L M-]:**&LC]FN]=T:@A7VO:.D7 @$!05 :47_]S4P:L2FKT]*JR8E[UYZE*62. M+L<8.?(9R50SWY_&>1)LM/CA2&/>LY9>'.ZI%<*2U2SZ6S7+O8%$8P\>F;*',RY MBMY=T\.RE!B39FU1SSA,XOB9UKA2L&?M69G:B'@U)[!5-HO#D4?/U#N5;:9N ME$DJ5G@N:VI,B,4=D4D>/[.V+=4'@M#BE;E%R]*371"5.KP/=3R267:9K5-^ MIM.5_JQ:&')X2H8UD4I'LSO:A7MYUYKRTRN>.1^+,P*>3$1I+J MR<[,HF>#:EXGP4B?2F"W][P8-];Q/)[A4V?!5\;F%&^9XG/&Z:5BU17I>3(O M_NJL__-5CBH%/ILC>S9%;A[&GHKE0H'H7JQZ'-_!YD_($3= # N&:B)FHSI[ M#/["Q&00_IG 95=5W3'_^7X>^??KO(Z>DDT^YJ)>>.>1&V_4HS!]%JA1&?+E+ON"/:2)BS-48\\Z:SU?WE1\*I'K>.$3@PXFS.GJ'^&\O Q^3!V^ M*^XP2II3&IP0]D)#C>^B0:_2X1/PB^?Z\PUVY0L:;5UHE=(Q.GK M%% >'V@VP;3Z#K3Z#3!'Z51-=S/V5+;G^)- ;>I)G9,J<6;*DDR"2?SZG7Z( MQT_5-7W.PMW8G*6^PV[_A5K=.;1HU*XG-GE-BR2W;6[$+P7F#>$@\I_!SFYK?T MMS*1OQ7Y6Y&_=0SR)=$-#S M;AVN;.1P10Y7Y'!]:^L&QIZP;G&R[]2S3KZF;-IX;6[8ZI](>9.1(J]AE;UQPI M0V(VWQJT/&YOZD-EM9ZU80EQ CHY#YGX#W;ETJ[]<_'/?J8O=T?GE3?'+KC= M\>7-E_ZG&L33R R]:3\^G69Y@BJQ1 &?SGMRG'&8'#HNB#^DB'/-L/9 &6Y0 MMK]?XOCQ(O[_'MS(./7)M[J5$-Q@F>N;9VADH,^4*"F>J/=Z,3CR:)X&,'NU M1+LIX2V])V^VS8:=[)^\-Z54F\DZ89L=>L,):J&7+"5B67AB=_1,KB#$)PVV M8"LMJS!-J%RKU>V0IVY8;:?C)Z$@2S6JU",DJ[S.T/H6]IGQGWFMF^1K09W\ MTP/R+4_!=J%9\+(I-!SF\;WPN9:Q>MO:4J-*,;71GXY7FM0EC^^%GQYWU7OA M1S5J+V.KI!ZQO8J_E^OS+UG MD1TH$P)&BH;@7VR]#9)-WPO*(5*-(^FJNL%T1Q. FV)/3)F764,6S'UD&XDU M,52SY=Y/TS%>-@3.BEEZS$#@*!@@!KK5Q@;+PQS9DC!OU5UW5 F\>8']!:TM M@?_K?H?^B/_[]P.LZH1XSV#C!5,RA*E@&.[]./!V.)LC"F)_R1HOKV3>9L$J M'C"!Y22,Q?8>OQN^>]'"-DP;R@IX-I H3MI;+"^8@)" O!>K_<04[<-3G ; M,)F"JH)O5X!.NFW"YDN\#<4->&C>/;UZJ]3")ANLKALR5@)B85J"K&$3B"[C M$K:N:R([$0P1_,+[&#X:30,;ZNA)Z/-'K!^:&D)Z44T=O%18P;<#0BU8P]K ME9@R$!Z(T'&:!:> ;SSX$4!/?;$8K?0T#QEC5-M7D ?FZQ[Q3Z@*\M!+-" WAR8@ZA#&<7\ M]-).D.*9?\''@BK 31ZXFG,!R#,4$_A\6(+=&130!,J]YM_H'SY98$,M0Q,L M0$9+,+\,U^10.=LAT3PFW:%.BH Q'D\]YL E0<5FIU/@XH!/7%8):T $VC6 M ^;HALJ#",/C'_PM(/4O,)GQXY_P<]MTWWO L0@LBEY5U4] M:0N0EQZ XA@K8"8P[T\NZ&OVL-,Y51=U[QUG&IWYHH?LU@.< /BO9X*0#/\7 MP38!0P+&\U 50TM[0.@V0)PV"-!+,.;H_BSP[^$70.@GX&?.(U;1X#:J"6[0 M@E3IM!6"D^5W\& FV,0Q,$U9Y\%*#O@2MK& A2OA#>R!](6CH'< 220K@B: M> 3\&\0O(OS?E0X6[]$-O!K%.AHT6$"13G'57.B*8(*1IJZ9AR)@P&^0'0ZX M_GA5Z!S7X?%PU>^/]R2(6_/=SXII>@$XG'7#JZ._AJ8'V#2]!X(N++_?$EGGZ,1[>@[Y Q MD<+<)U_BB<=L!+-QAXP!"A/M_'?(ETAA[I0QD<+<)U\BA;DK_)-70\J;0H%\ M2='#:[[HSZ? JV'2SR=!) 2O&N:?3X+7?(:?3X'K"\&%D5B>.4%U#[(+^GPN M:)S 7PSA)Q*&;R8,[O'/IU!Y/'_HNP)@!<K/D2'2!BL H3;GDJDK:()SP:;D M5]Z%(^&Y*;U0$S"71+#HP_W7J7T\DJ!(@D[2J^U6S;A$JK.VQDD7\0#OZRX0 MJG(\K(;"_NH,"I>YZ@FWZ+O'*;S!A2C/X;M[RGR\6@S6@S&!2/4W"P&UJT0? MUW51=X4N&. UK8QMBIOX4[.MT-">[QSJ,$D28CF]73\MJ327 M)_!B+A5/#,5?OW5-B$&=.A1_KQ;V8G[3_?,ZTH)[UX*0I,-T;9"H1;[_$'C] MG147V'ZI[FR=9JVH*AO6'"6?^5FJ@8O ]J=!I+DP9!5:_?AUK'XD[Y&\7U;> M@61[\8D;F01B3B23THBR@'^_ _[P_:LK MAS!W4&?P8F?U@W-!OVW0M MI2X(19XH+9T4S;J]=7[]MAS]2^*&2%;_%%E]EW^T1IMYGNOSA>6 2ILIIBSK^"@A M7NIPX3EC=NOE>*>!#XEA3TN/!RT5(0T!5][O&>C[\M'I0I1G^BX:\<% 81,G MLLU>;L+1I75KTW=&\40Z37Y=H'#_[(X4X1LHPKNBD,6PU4Q+C>$3/E> [2>> MND)2=, 6 **0!FMP$$.;2$1G#)'(?Q.1?S&^T8DY1S7BS0Y=J@^)++ED)B(! M 1A1?'-.QO>@4@]'?2MLT7> _7PNQO(G%_K$TA?H3S2'F,IN=-OZ9RJO!?[4 MZD/73]UY^H38CS.]8;".[M=_PU]\:@T'&HNF!Z9_1F>S1SKY__U/+IW)_7MH M# X4]^A:RP4@(C7H"*E[$)'>1[]^MS2LP6Y\GYYXP.338&,^&!Z+S=F9;@"Y M!=>,"'D\AE;X0$1*"#)L1G()V-%.&V MBD#:(J QEL!]70A!YD''"0.;"H(@A#+J@OQ!J+T %Q&)W6G,2B39(-Z6-=;# MMO-Q2MV0 0/;N8=T=QAGQQ\Q*OBRRFHV:VRP0%WW\"L#:%0688/&].G4>_Z# M!X+I@HQZZW)!/%7=<=7)A^J%__9G!Q\?7@8P"2P&=KM8 !2(35A3-EV-,S%5 MAP0Q,6 _!-.$,X5XH& N&)P+1(L$-@3"#QK"G)4U2#Y96X%IZ\;&11@]F#CF M4AR8&+@EG]'@$(S!H5[]\D$ ;@"C20=8K$=PC8%\ ?+I$_ \WP3.607(!;MQ M01T]F^BC;2(.+($0 $ZK&Y?Z#_!_(-#I0G=-,80/]?!PH>$.T!=G ,$QSV%4VN%?W 2X*./7HF(@" ]'S @W"X(J,6N?4S6(^\0B5A(##E5 M8 WHW4L'MC\!1>,:Q$,7VL"6]G^W#2_H?OH)X$C(5P-!"),L0O&8R_IA)78E5AQ8C%$:QF&3 MH.E_^JW"R8O.K^YE"*84Z@.$('<1OCVSR?Z^- IY^,+)N7@1WDG)G3V[@QT)4UWFL $ TJB2T#( MN!7!-JYQ,O L>Q9,M;LDGER2MI^9N>]!N)/WW(@$,FK0:?CBF7XD7W+6E.Y; M@E,*?M#OXWR/ J_WP(T0\$_!.+N[*(3#!WNC! AF[7D 4T.?(S<);EDG0-]W M6VP(/QGMMBY$NH>9#_R]^4*P9 MN;M/ )P2.*P@_#I', 8U,,+='S/5G.! & M /?-W]1/;,CA"<]9$/<%D>0"NL$F D4/7OO@^H@'F,]''L)*9H-7[U;I>BM@ M[P91JPHAW.&&#_X2!>25 F\*$@JZ* ;P: U]PZK69L^_\N;O.E%G7"C3!LYS M,!O?Q4&?^J]_Q,K GP:OVB>!'.8J#)J!RP MR6=X"8.- -0<.? >:>8@2,: M5P+G!#V[6T'(DZJI^X''NR4&FT!96-HRC&=0=.%'!/ 18)((+!R,8T,LA<&I MO'"5?BH((=Z"#WPG%9@2S2>][YX&H.T/2-3!^N"LD..'G&[D_,$#)?AV7H;\ MF]B6)\-PQ Z5?@*>#[CY@-#E!1?1_S"ELO,H'1EBUINFSLEH:]DE7 +.AY@, M3;C+_:_C*MP*@2[LXEV?CHB 'GDMV&L.S/5_+]QBZ[7$L6E83 ,FI J>YV_N M$L?NU-R&'ZC?AY\S!K_Q,L(MH^>V D"_\OIN,1[LNS?<_Q1X '!_<^?3E4TE MO\D+&B=!SNS]O ?-Q>L_#K+D=WL:[+QB+@HM^I!IX%^;.H^)TJ8,,Q\/_X/KL.6HZE0X>DF;52*LZL MV!:/V9-%2VU6MA+9^?4[_7C<;0P#\JE"L8""?&U9(?9DA?BC9,5Y,I6X+F5D M/%VMS>NQ=GY3+#@WEQ4U(]*4P%;S^'#*+4AV&V/*1?'7[WC\\;@=9R L?EIM M#Y %MOY$8M0&FX*Q^^PAM%/"5CR&L ?"- ;!-'^ MCI-5BA!3O[O%'^%K8A M,#D=5[*9G*U3K"Y;E=*TD6JOG>L;J[N1J%8Q+HXF<3V#RZTG@L%3O<&0W[,^ MQ#L$ZN@M;>"N@ ]848@'DA,C0J(3XPJ5A*;0%B[7&T]U8;3&YZSSZW?B6'#^ M@^3BVMR]A'FY'^YN19V;$R,<3S=B>:(N*&.QW_DZ[A*C3I.V)5S$BMZ<(*]@2L7<\WG MLRZ]A1UU%/T2H2(Y#B9SS6ZPT"M(V*3+]*K+YE.!+LT9O:=D&JE.]>,[TO&< M@9/J;1 GMQZCR]8K ^ >*P6C]C29,WUYTX=;SV/J:]V4 QY_D>'X$A['5MEX M;["(Y^BYV6QOD^S30BN37\?C=G*K9,CW.37>7-(399E5EK+>&-9&DR]T%Q;TJI9:V%-+*;#U7B&9P^UF&VXH MB3_)7?@25J>'[2W'SNHMJN4(O6)]2:K-S!>RNK*9Z'.^G%@H@B75DZE-IS_4 M :OCF;?[#JQ'J-!F?^@]P%SM*[[#KL/ESF/@91[3="OH+ F]"B\#Y2=2P,L- M&YZ(VA8:N@$NS 18)_?["0)&RQH/"&ML8JK HEH%V!%90*43K/<(+MPV%$QX9[U@<9R^]XG[DX=7 MADU94T)^+@?+=727#9PDJ[QQ_##T^[V1$G@8F+QLJ+(FH.HH6!>(AGG_5F2_ M42LZ)7'SZ%ZN/-Q %]BYN6VA[LDN/]QB%M?JGB8V?,Q*YOW3 ;!C+T!TIL'' MFI)_O.-VUD7G _ UX%-T-+Y?4_. [=KR^N<4HLVBEK;@\7-9D^?V?/<8?SQX MH!GJ]\UJ&FP-ZP]'+7S1R9%WC!'J.@Q;YK+86PJF4TP\%7B*NS^@]U" .Y9@ MH+K*)B#XSG_P"(;$-I3([,(S,33*=3[6<)[>]\,Q75SK\R=966ID=9GNEW.4 MV7GS)9JN>P33=ND+;Y:%-NCE?#TU4\[2H 1&C6^;Z1S5K8CP&@V@R"8V!2I\ M^CH-K)B#B@[4WD1ZB0Y; /5E"QZ^WYA^+I^][ZE9IS14GO4GNB6MM3C?[=9& M,GD9^B68'&O;%;)+UTJ]#3ZK9J$!3OGJ5,KL$6:HRV'%.%2<(J+4>;6$-T LDZ0QM@=,'F M,X/GX, 8!.88V;N@W_&N8A,9=-;"@'$VX5Z' [=K8WJ_@$X;;">]@)EHW[8( M&CJI1)W@_Q1!C8^RNM%(ICE\4[ IHUS<;E:H(:;5D.:/WI[)S*3&J8O M4$0&SWMM>*CMU:7N[\YP$[C:B=*UM>*="1)714Q3L$@.;"UN!4P;$%0XF1:I M/L\6 SFQ7>!VFTQN8H5)6E*!EJ3.GM!983&&__Q3MJM2ICAJIA/KAA)3L_* MJPV2LOS6[>K!*[%V;8A7QP"=)M4KC-TOAP!$= V=>50$ #T:C;.AWPJS40;< M\6"%)72CIGL*<. 7R$.\I(ZPI!],Y M=?/#?]I^.0H:[JIJV"5')M:K=T8+WU6[G)Y5V#T#CY5TS3L///V0P$:X9N/+ M(N.CZA?HX@$JV:KE4_U%#_6KQG!XD9SCOK!J$BBT)MR Y83VBY%7%!0>A^ M1H;=.V?"@C31WBTGV0P>_P"'NV;C3^/?N6P^X2S%,MN(L93\-!@KK-ZVMC9Y M/IN/[K1P*KPEAFJG4)S%N2\)N.B%J'N9_C^-\$U=X\[0?KL%SO&R6-S@:<'8 M)&Q24XL]H$*)HKKOW6[C.\JU+/9I8$Z&O1I=T-M,LCS=D,G1[2OJ8L/: M>"6V#(V*)3(I7&DN6H.Z X^JTV\NDL+\6JB[.MM\%S/OICAF51KU3&:K4$HA MVV.FJW*25\6]8^U*LWC5(ZYB+[4IE7J3*5W8$OH:'[&X7N_\^GV\$;Z].N:D MQ'SE.=(NQZ-N7KQW_E)(L%]<;]JN6^5'*F=LOKLQ?R(T[3GTFMDF*VMJ6)JT MZ^IJLMU:;\IL^?P? I;"RGQ2X[LP3#1;MF5"?0-*>A"+,M-XB]MFGRV\D!^) MU+PHRIL.8+PE:*=C4,=]]EZRQ%[ /]^H[Z;$ HO!Q$M2B17,!:G(B8&^L-7F MEAR<]'$^04I? 8/[5!7-M P;AD5["NH1S/M5,E^4&T-GU<.)I;.*3VT^! [ G7$0TP1:Y/).$%H4VK>7@_FE>?:3.] ^_R XSC\ M_\=6VJ7J2[K)H1D I0-3@(D7%EYA 39!1J<<,O>66K,G&1Z&H*W78V&B;??2 MU=+2I@I4R[";FT0G376^"0O?53( ?<[6U'M%RT!*17D$1&FQX$O3^]:,G^1L MKU^K<^,8=W>Q_32/=S3D M7U2QX#5C.%* V[()]@$3>O3RAR CI4^GIF!9[KU]SA!0+E9W)5?253#] M("D.#[TLY)>'D#@6K,S'H*EG%_ $WEW5[BZYZ_3'PNZIP:.@8#]R]A<=RAN' M=S$7V>"J\=V7A0XA7S3YUM2PZWV&W%%/^GV=,$^ZG8(E+1V)'\ZHEC:V>:DT M%TM$!\;;^''1E.]W'E;5!MF.ARML.%=S,=]IO38K0ZPI,4N1JZVG<3/&3+K3 MSKD-"#D$@%\O. 1HV\E#LP%W!J![:)4D?*>(%#"_V0UINWE#$N@ 3R$=VTW: M;,$#]K[$:BV4_#0'P"()?"4((4_8O$XR/M%C5*Q!%S;/EE!4DUQN T)]33]A M\73#MR1[>@C+I%?H53MLA/ -W&]6,_/=H!P2$91#!.4003E$4 X_#\J!11L5 MD^-8'D],XDPJGITP22Z.,UD\G6/B/)O+I7/Q')$E?KE*P?KXCEPA-9W;LM/& M;7V@=C-D+/_<$:'G<#A2+*XG[:26)_!YOSV>461BCC^)#,'@AR/QEI;(EFUV M3)4 6PI,._6L%D@P\NB9;:+[5%PU"R,E)BWPAII,6V*S T:F#D?&2K/)GP?/I&)4/O-< MMY162IBT1^5D;#8;J=;UI2$:+-'CUS$].M6:NX6>+I#+>UQN9B4=^(+B[MP4BF(4HM MHY-5"OUR?JD4@45B229]_,PIS9:E&8LW@,^]DN(9)M&?M3M@Y-$SQ:=6E>[T MG^?*?&!QF=ZVPPS+#I,Y?J;38?MLALDD\=Y:8#>-)W6-4R08><2C!-5L:J,> M;2LMVMK2HE-/YOLB&'G,HY*ZG97[=(L::G*VU%.L$3V%S_3G^?$C#J6WKF>R M+9.DB(Y0SNDU*X[7G$,'%?:9@)FI)V%B]<&C\RJ(]W[YN"K-Q:3>U(SGI#*? M6*6GF%WN%EGR5P HQY/6F7$>_@HF -]T =X)7%GA8GOSD4E]^;P^_8CMM11_ MV2R'P0X7AA!#<(?05D\L# M,\K5YTN,D$-FK0FN*N.(6LARRIBWP%M=N%5>4 M;.7S2CS9259A#N@JQ'[-.^^?2'W!A#0'HH@-.J ($@$\I"4Z3P3C#1GALKA) M"K>D$0)%?K]:_'>@C+IS@UZLY\'"S9)S?%O<@ M0]_4GR63>,R=[:@3VMY#SXA5C_GFG6MV3\J^@U)7]59O M)BO94XF"=Y($1&_PP__[*_7KH^1)/&;C_M%*$%TNUAA*5F/^HKLC[.EOT'ZFUMW-'7Z6)[XU?:H>^\5+/*?71VK&_OMU^[6JM6S$I M%*#.-H536W6&6S^)PZ4D4[5A/5M0EGUM@L-",;!5$YGC.XM_?X=(-5+P&RMX M^O9+O1,_[0I\ 0L_K-KQ+=0\*?M4CYINO_(_9RD\@HNYV<[J7-(UN M1C<5(KU=R5+2[D[&'28#=_/$0RX3Q=215?C"X^F;K_P27L!_T778R_/BHT*Z MCZ1X"\CXXOL:7>]A8+K&B]]A\POK!4)Q@SUS;@J%YH-H[1?\['"YGCE!A4:X MKK.:C[!ESOJ-R2S+XZVL,G;&G6$JPWV\66S%HPGEDN0T:#Q3QI.VO69H5LNP M8GJDV5+"@>AG9T#C;]'&_@/D9)Z=1*]F9&8XVR?U<;-E]\G$QZ'$WT)."Q]7 MR];S6ZZ2R56L]$:H];'R^S\UG7!*8FLB7_/S;8AK&3=-C%4FPUYAB$TE;_\9I&PGZ2'?D7\??OVECNT2QS- M"JX+<:NI^)%HTFBQ19"/69-&$' M,QYC76A)5WX00BML.V,B2/(5!'[U&],@4!+P'E9U/W07A7!8 N T&6B!;-EN M'QZ$NPD'& )<$GP?!+4U'[&V;9BV!TV-P"/=U>XP9A'NK3L:F[.P56[(?GN= MAE@1C!>AE=]AQ5RO=0<.;4W\55L#Y R*+*GQ/8]OI+\JS_3,LLFG^F!:5^C8 MJ;_8NSPGS 6@AC$&BU M=[^ORV"Q=5WC=0V9]0FK*2U@TV%O#C#0WZ7-L:@Y1EZG>LHBS4R?&MU5^0J[ M"8(EY%_;2BB&,LMQXGFN% ;-FE2L=G+- =A*,B?ZM?P' 5=#2.JY!^Q\BI>\ M #3_V+]=N&BHAN#O0"J"QZ*]BA?0Y7 3JBX/S0A0:Z]3 M:_@7L/V?L(3HV,@N $9A<\!]"?6$78"@5C8EMX%E7M5U2'H1@T]QN^$:+CRF M =O+NHUIL:6M(WQJTVW_@?#4]WR^>/P?',?8Q_DC]I?+9LP"NP-8E*-C$]L$ MRS9-U-]QOZ.C"EL_AK\/^CM"AD"I=F>.3.1?D[^OV&%CIPQ>;/!&U3CA%676 M>,; A42-&L9*U4K!J)A&\=UR['6P";_U90U""E8$W#3@7Z<%NF]HSG-2D@84 ML2ANJZ0]'=DQZ'.>,%HA@;Z9ST-#N'>TG;O8Z)[,!(X"9,_1C@?9@2#1=RTK M[DA87K>C)9.=C.)\G*/3+5FLQ?2M:"7VMK4W0Y;O3V)G[EK3@JK#GD5%X273 MMRJK!ID=BQ3+QAFMP4];S2V2E,PIV\>YC\.F D*NA_Y1X%I/! U8O:!=G^>, M_+N7: '+TCV>?5%6Y9;\>Y=;XB&3FRXB8<6$[IY7*'ZZR1A/D@NU;CPKF_PJ M,T@5,K,D;#*&GVLR!GBS MLV#!94X FZ79+?62$-:#!#KM<.-!% ME%$P!?<1KN,+KZ2@ICG'K9-^AL?Y%MT\5_Q?,G3S-&/GZ5F/88JQ'CZ,$09; M5&?SVM3MW)H#*/Q%0 M. ;<#T XV$,NN*($OCQ.I)[JF8'R2K;I=Z$XD9.:"Y:D\S?;F/I'N]".$# ? M!E8*1 V:@4$)('#HV+Q) IJ4X\PM0!BO 70,L0.$!$$>;2%VSL7ZAOPW@SP M4'6#0D%659$5^#&A&?[6/2Q\FMB -$5-"[O"(K"+ 3T[/LDJ(8J=;,] #&-Z M=KH1%#S=RN%%+EMDQHSSZW>:.'WK%7+*;Q+<8 WP#Y@WJ=J:@)(5/6%A^:D+ M9.A"C3L"?W:#5CC0WX;"5HL'U3N!>T(:#J6/2O MI2T;+GC_PZX+-89Z'QHKY$>YF2N_(=,N>Q4\>M_-@R8.N1+SA2KO&FD#586^ M@"ISR/@%/PZW;CI8$S*$?H=Z^'LWZ#4QKS,C2O^Y^U:X,<%NAF;0F. KN_-= M"/+X!I-]4\:96D/)L653\FW3"SGH&R_FWBG?TO9R\_N'TK9YA9;D06"4"@Z# M0%R4.CH9JFA >86@JT?>=1Q[T&\$YG_7?/))-F%,"#P@,[\!?RQTDU6!;VLO MS*!C*QRC>V#V+:"_;M/YW;92,5F6:\A;@Y5DU%^J[]L@V.01-66"B1!5!ED-/JV _8'H+:FETU *Y&@OT^N.GW>#IG"#P)FS\!5NBMJ;@ MW:PFRL!BP=:S+T1C M'M-PKC;@X?9N2^H=IMBY$[OWXG\,?CZJ9P. 8YOO#> M"5NV"<#]#?43!N98,SW6[_5Q$S!$-LRC&X8(A_UE@L <-FS!$G_#<0;<*5V[ MBW+"9OE=*/.RKE?.Z)7,BK M#BZ4U;+ +:=K)O&9YL4[-_7D!;.PK#!BA1VDRGB3)NJ5;H%/%UO2"GHEV7/5 M$F";6P0!AG;$YJJI-.#(2[D.N4QDXGA5O/]ZG8J;67X1 QGJ\*$ M,_BZ,-OFYAR=KA'%5%7LR]0$-9@\0[=%\%B8GWCX@N[U7T3"PX(2(.V0H.?J M2B8%K2.5[NA*V[63]")[$S4QA(D$TU:M M_2TLW$T3&!/3=.,K&.P*1RX$"HZ_O-[JL$"H4\P+FQEKS^B6V'R>;I[EI_'D MXX:A!/QELZ[#GN4M;=]MWZ2F'1F+$O35E7#YRG* M'#*U>M(L.*^8#U\P0V9DX;[#%749A/F\#&-$QX"%J/IT>ONBP9=ZX'R0VD.X MLM9T"B7633 >IJA/TIM*.WK">4[*"BNOB4:LL5T7&RB1>5RA$Z:W_2K:T9=: M\>O2&&V$R,?U#/>+;L.:I)K/YBP[5@K4@FSSF5)5WZ*$_WD/TTWO([I]PQ#X ML+#XNW4734;=1:/NHI]:PU'^)>HN>A[B@--V4X*34?95)N\J13X M5$'LG.H5FNNOMG5URXSHUKH]JTC6AG_..J=ZA:H=0ZP]9[NV4MJJV4*MOTEN MM,ZI7J'U]7J=W."9.BY/1W-IV9N/1BGQ5 =0:EZK->F!4*6(1;>YVAJTE,ET M3G4 K4N#1'F&M[I@ET\P@PHO$SVRWF>-&@8UJ'FK>WTYC1A"./ MGCF;S89*/BU5\7FD>5F61N*I;IW#SIC!\3S;4)9%46 *54<@%^*I'ISX M9*6(17S]#"+BIZ%>(Q;M-D^>ZJPIX^WYO-[LV7B:[M8MMK&I=IX=)GN"\C#1 M9B[S;6K9'.<[%VZ7IH&#B;!+/K5NI=3H+YID+UG[0R/Q\ MRTNOE>4W*;J&$[EIKOM$876+LW28Q(OG7%OT@)6Q,G!%+4#Z2MLK;89!BU>R MZ!=;ATJ!C&\M:N[1F5[J/(*)1R!)U[1N,>'PUKL%[.'%=-@ MP8]12AA6(.=938&/A$09Z882E%Y7GO+^M-Y0_0Q&'U<]>WG2W26OKRZ"QIEX M[FT765Y/6#9*RWJAK9>KE*P,=:T@LA.R<:D ^@7\Z+TK29W::E&I*0M%+K6< MZF:\DM(6")Y3K]1!A[+;*-N]5Q>-BE;0.8<%R\(VJ(+H(1SC^4FF\!6]HQ*E MX\K!0_F CYJ#YT^\U\'31 >(&_P1QRZ@FF,+VP#;',QG]6Q8EHIJF,Z]%A6] M(15RWPV/.U"F"Y[]RY:?YVJP7BNF^AFR^MGRJ3!V:EA, M*S,I62\S@R&U3 _I01'O*$T9Y1P2+\LI)K$K6+\H:%]8084R& 9\K=>\]\<5 M3U6.5<;?H9"G?.H*B[\E(?*4L;H,G%VXQ/U[.:$O7MR[CK>LHUWJQ$6A\/;H MBS<6R+?_,F@-INQ*1Q7]2*WA=-&V>/ *5R-,25Y@?IX>:ZL"+PJ[I^Z]]/#+ MEUYYN"D*V/%TSY,4$\$.[ITGPOTS1(] @L!+(1V!3;% '*:Z1XFN_,E&Z+X< MT 1X-/K@V3%+8C7_^-([R?6X,MF\PF8P&30-86]X <.KX\(U9^ M7_)#:AW2V:LG?QM-X,6,^8ZS_E>HZ"5,X8LOYI9UD#L#YI8\HL.< YU3U M&/Z=?*/"QUTJ=[?+P63N)?>\/M^H.JQ9:^.R4[7H%)]NR*UW5[Z==L_:J.9) MYKP2\?,U;XZY(I)5LARCTQ:>:!4410+? MP^M&:#?1;7@'2F-5ZXMOZZ8#O2"1O(:J0/W :S_2,( -E#5(GMT1OE\P\)+F M'WC)++S_I:JZ8_Z#UKJ7%K_(P<6^!/8X"?@UL/YE5WRY7]N TI]]\-:\JG/* M+S^X%Y_5S+A9UG6<'6D]UJ@NLI4^4$@!R.H"O #(M'"Y_.XNC8P_G@LP\9C.15V'[X\O M\8@O]\D7_#%-1(RY&F->AQ)]QXYR'PVYOZAI[G7L_]6;P;[5LFZND&AZQ'NOX^J/'RK&2G-M93FY_0 ]Q)VGU>I^T(QAGF] MBPG_G:WM%@C-=TB&2P P>R'34U%1NS>C!CT[?N.?L)V47:Y,*OFJ\]* MB27QLI%.IGL%T>WW&#]Y8/K#/+ETY,G]:$_N!F2(_+Z?8C(AHNP)HUF3EEG> MH8T,O>FDU,:V+#-WW,G1%W39.M2&- MQ5L=,2$-<'D^R8B--5MZ8D2W<=D?X1QF(^?PZL[AK7N2?F7,?(?+CTSIA4VI MO#KE,NI]ALHUEYVU(HP&W:>*C4LYJ<-D75-*_(PL81J]H@^O:D4^XV>LY*T[ M-'[5T[Z;X,18Q:MVE&PZ0\IBJZ^CZ,'H+ZN8S84WWXJA[YXM'US8U=-'%PR.& M:,OHYOFN:1BZ+.C=BBL*/&H6UD7 R\+QY?C7.@#IFM?_QZ<'[+-C26#9\-JU MHV/T8^\1*Z%YH35Y>@2[J>7]WCQ/1[U[IJAQVLL]>_Z^:N^J2][2>K%WE?]% MSV5=R^=PRY";:WD]D(I3A<-F6:?-XGL2B>>]5%^7.K]_)1^)L9ZM'[%"Q3E[B\[Y[ M33R^(>K8C:Y8OF2^ AODP;N;7XSN'GHRE _PE6BSZ*8L,%[0CLUM8 /U#;R* MAZ';9P_^P*F\AF#T$EBWB_AN &G=C=G]G&--*;A>KPHK0840$!"YV,3@-6-Y M*D-P!8T_;Z;=^X:W!**_-?9\!OV4D*8H502'Q14DI$:FSU,ORTG^V\MSG8;A\Q MY!6ZY9)G3=GL 9EE^986GOOI#62<2102S7I[3M?RK(K26X7W^-%NV@IF<4>.$3,74196K)Q,4+9"P]W'R5$_I M/;:8$-SF@"^NT40;CFM@.=6]KGR.?SO[ %P"9(^ 0F <3Q $S9\E?N%[>T0 MUOPQ /X,@X=],P_BN^&4IB*Z27E!EI;5HEA)+8&<0K/7IF:IB?#\;X:*JDA<56,SE:3^1@ M!?;1,P5SO)QU6I,M'<-[&6>RX;;5$0E&'CTSDQ1Z33PS:5.RW9ZL4OID5*N* M8&3N<&2%U>.;.C&8TO:XONUEJ4FQU'*8U#$&*D'_0ZI+9]I $(X_F&<^M:-W>+C1JOJ;2CIET6B,) MCCR:YU-%G<1ZJU5&28^5\G2B5LK5),FD3V"UZLL,%S3LI/*)\BZLE3;XPX;W\1J6UCT$#]Z M_59>=P0SGG]2A$*3=(K=MCA9=4Z!RO+-_#B9,,MMI9"/Y:VMM4TVRN(I4-E, MJM(8I M/>8486I)IV$RC,R"AOWXT5&#'M2+;:G1Q62. J8*A1Z1B M"H/>JM+@>OA0YS>"VF3B-HV&'M.JT!V6!ME&4E9:9:YJ& -U2^<<>/QQ-+2_ MZA;,4EM0*$*LM]>LE)C'!1$./381J_ZSYI0G8["F9Z7:P.4GFT=//9ILOMF* M=Y<&/L)[5DS=#,J%;D+HP*'!9*\.*F3IG"*!;4DP3&II \,/M]5=#[%C-*'2 M\U:?+L=;@>I1XR%3&J7\5'HW/^& MR>"!P6$N.6Z9?/1S9A"BB[4M24>P=Q".TC1M ;,7\-]O#,9-B041+!,O2256 M,!>D(B<&^L)6FUMR\/E6,6]+HJ/.&@47W!51G'07M17XD\!I@TZQJ)#YIQ8N M9&R!&R23A7X5!-4I5.EU&CO-7>=A;YUO1"1?,P'SY[J&R-1#TWJ%6/*Z6*2G MZ527&LKX+%^>;I@\/%EP0>;.$0L2B$-O V(.7H<@4-1=5A M@'&$9JBO9%Y *'"?*'J&P1HK4^G,@>,_0/FXJGKAF>@!U'N 9/T"(X0>(K(AR]!/8 MKPJ>#(6 4$V;X^"QKY>C\QX!WXCI"S@6ZB):',NAHR2,A#@ LMK+Y"I6;N5L3"%!U5IZGIAQ M1:N5%C]N%I AR,-* $@(03.1VT0:!LQSHU:JF]T0#Q^ A 4%P.L"\VE-WV1) M:I4Q^\PT;9:>SXB4N37+Q%P!>U7R_=87,%0 R@7[FZ(TO.RU]0J=A06:X>:) M@S]]<3>#_#V"SW5/RC:8=U#F"9:+7HDJ)C8+=R(L7+?YCS<3?>'*\E]RH*/@ M"6 -,5C>@([__GZ F,- [CG+MX/'GR#I BJU$ S$-;@6]TU($= YH_OWX7+D MTV49A_8DKX,?(]S/G3+KQ@.L+G'/,,#7P6 >.+>&X)VR>LCPEA"@@J/!MT3H MWAT5(N+%W"(6ESZ(%=ZYK\>=!PQ\8^QLUB'Q_X8F"W6"5C6,YU>VTW)Z31R5=+E%R3DD)_+-:Z<=0P M$&9]7^J% -7H#INN?A'-5CK74!+Y5@QG"TNFEYC),=5&'7(S9VCFNSZP58B/ M)0=KX1$Q40_6W61._J?"F9W907II).]KI+ M*S\IC?)(AO 3,A3JZAY$#'?0WO05XONN#ZGQA5T'SS_7!IJ,0[?*R MFA&7C,;>1)T3S05A;ZBKS!PVX'[E8$: ,&N,%[C+!UXH2S*"\$V/D$/*HYS'2'X15 EAIJUNN/! M^V[F%'J&8=)]9Z F]Z4@1GF@<>)FS!-^=B97"36213(]()UL; M%*DAJ[923PU<;BAH.TZ>:>![)^;AG4QHZEJ#!3J/Y#H(DSR62!:?U";TH@8= M_]Z@/B7GU^ M6CI+V?X\(V6K%-Y3BYV-,1^VZ@S:O.)G>IGMD1.6X\$P&75EVJ>GN=]?#X;Z M8")_7]0A_7QTBK7<"/UFFZ&7('@]E2&X68Q=\FH!\^"0P"AG:@5-_V#_&M,_ M#@0_CO^+"3)BT%YQ3,P4N)B\CKF5,?^4T?\P4V8[FY0DLD?+FUR'%9WA$YT0 MS\*A?X)IYZK*IF"-094.^I^'MRR@]S0?ZV*U;U,ELIY[)DBP7<$Z+"87T!GB?M7QZ80R>@,02DX2 M$$J/]Z1:9MLD>ERE06W21EIOV/'Y)D?N&27(EW]XVX!M$$Q!.YG GKR>P)X< M)K I*.EHL-NO*GSP%><)JU0DGZC"JJ43=F[ +9)@8[ $#760,@]O/&)30Y][ M-]@LE"Q%"O@ 3"V8$N\UFH+?+UAX\=96@9N*ACQ^<7>DT^P)L=@D8:@/3,,+ M_9*:6L%\SM*9G#)/)/#>II N3AWRN,+A]+BK5CB\5BI-8J8]GWL=%D_9Q'!B M'V,].@2'!(=\B?3E7OD2[?OWR)=HW[]QN]7WI5^^4V.XZQCP^^@Y&]#D MZ&#K2XCT6M;ASH@4"E+:/+:%GA3FWLK,8ETZ=,AX+UU)1VB MOP3^0CUL(QF)[&UD;]GW =9'WGYD1")O/Q*<:/>)=I\[$I-(EWZ)Q.DJ_/#__B)^?=A9^5:^2I29C/S9UV2D MBY!_P 0C(8D\VLBCC3S:>Y"%R(A$'FTD.)%'&V7?;F]FOIM#"[OR0!0/&S8- MC\0D,BJO&Q51- 21M0[,2N2V18KR'=VV"VN'"Z3MHDKHT\BD1B;U#4)#K06# MD\W(48LNZY?X?]>VCOS@*5\R*K%&D/M23&_3>_WT9P [_%[ MV-G[$9\+V=B?(TEM0^:^S7Y]/W+T&5_NYPC/7[*VPR4T_X[$*#)'GY2H :O: M[T[86?IBWQ<,PTYRG"!,IS=U#UOA_DL65F4U&\*!>CW&+Z8Q=[9J7^HOY;Q] M_>I"MWZB$=3SXD3@"\_U1E MVMN2OK"8Z<[(\+\7JTCZYN;D"383$5#/!L^@)-IV+UTM+6VJ0+4,N[E)=-)4 MYV8&A;B-.?%K8[V* C]AC:*<$T9FS(P?]^/XJ?;E8INU%^+AM6)5&KRBY'7F^0U;FJP/*^Q*T MRT>/UVK#0Q#-96%:M2B\-%K&G;G"]/GB#8-)).)FQ>NG4S)TTSSAZ2GV-)%? M-KDL)4SGK6>+KY<';9+)PG"2>*$;_(_0FEOM63_"4GS-[97;!X:WLQ47C1/- M=YF*=\:*2F?92HY6<4*1Z^/QA%1F>7[E L"8L7X8^JX%>:/,!\7#@QOOY2+ M+>CVO(E,^]V;]O?+XW<^[G)C#M^07B[JN)L%_@DG6T?+Q?[Z@X,3^(:*:=H" M#Z8,^."Z#LC+,,/]*P.A/^$Y;&;;-#N8"1LJ+?R0S>-+PJ+;QD +V1#X_Q9U8RK(T0G, MO=W'B**@KSRB\;3 !G0A-1[I!GI"X-*<<%MT-B&/DL,B3974G$9EGI.]CDTR M<1P5 &:R#SAQS;#IC]SF;JR/7[GGW;'IB:*G+[0\[PRF"I8D67&Q:E.E-IY> MS^?)F$4[T"JABL%<.CH%NN\;4-$I4;2;_+C=Y,\Z97)?<7"IZDG@A!VB32+^ MX/X#;F4/&!B&">N%P %#CUDZMA),ZZ?F2*Y_.+4O[0D@[;QN3U3A6SI/%[B7 M]7%?2>-3?:O6(45:KN%X,I90UL+(N>][66RF+M76]&1&+;L;FIQTLY,J(3+Q MN'LQ*Y[,/J22?TY2^8Y2DC?7RYO5C-]\Y;WTO_WG'YZ]I)D6]P^4M.Q*@1G[9YJH>7 MZUKI&<]:60?JD7O[BXAN?T5;?;35O[#5?]_[8_@B5,O)0@J?C[)_1*[LJ@>< M=R^L4:3\9K\TI!S/ MM#17/9J\=\WZ\T+9E_7CI5 VOH,4$[>%6K:=VM+I7KVO3B=,5IJ*D"@PE 6B M?+U0-MJ+H[WX+BS&"Q'I?RVH4;^/Y?_P;UY>_?[_P7_\F7,J4')(*KNO&/S[+0JB07 MGY1 W!.%V,006"7&3L&+_V%5A]V8OC2 F,^7AG\"KD,R8''\,9'Z#Q;Z-R3' M$2WG[#H6HI@G+#%5F%K_>#_S/T.,#C[431D:QW\,007F="7 I^\]%S'&TA?_ M$, <0I >,AF\1BD@&WJ?_IMPHG ?3AOX'H@4U%W>NL MX'WTZWG>]5GBIDMT+U+CC#5R9TO@V0;@FF.TU+AY1$A2LLK),HRAJK M<3*K8B#RM]RK2@$R[^UG?I2*0F"ZJ-0#XK1]\4P_LL6>-:7[EN"4@K/(K6&$ M5#J3P2<$P\73:2;)Q5-,-DXDF_7*5@?4V^(% M0VQGAIJ4Z\9(!AWA[X\D24'!AP:5H5H9G"J.S84DUD2&.!Y9(:IY-2M;4WQ> MF]8:S$Q*,R8+BJK*'2;!X(+IV)^J:](!XP\>GN-G#=RZUR,I3;,R*85?L,R0Q*,3!S-LQ,K)M/51H]F M&\MUCA_$.J4E?.;1/,VG>3M!;$8SNL7,8LP@4RL)93@R=3B2GPOQ@CTI%BC6 M62I]NU*1XUV121ZOB*&+;&J@YC;*9C DZR,U,ZS3<.31B@B::2SSAJ4I:3)7 M*U;4W"K^W $CCU:4RRZ+N=2L:N&%-)^I$F+9XA,.&'FTHOJF[60UH]G'B71+ M'ZL=+MV)P[?#&;U>3D0F=;RB;)I?=]DD$5/F6\HF M&\MFG,YVP,BC%?7J7;*8;>AS7*:'BY),$<#Q)\'(HWG2F5+?3L75))TFNLFA M51BE!@V'21^_W9HVFR.A(F9P.SD:%VM/0E&?=<#(H[>G$FLCD<4S)L[BCCDO M5,@5513!R"-Z.J4L7T\N8BNE1Z2&/6UIM]<5^,RC>:XSY'0\MWF9[HU32V9( MM-5""L[SB)Z%1;W<$2NK 26,A6:A+8_G70&$'LIU.R'=!!X9C/-DS4:AD_N["5-ZWNK3Y7@K4#UJ/&1*X]2F+'48.#3N9D[ M+T"P9+TVFOCUXCN:6L%\SM*9G#)/)/#>II N3AW2>\<53.W,-BUYNCEC:_=] MSCCTTH[-;_@8:0K^#SAXIRWRP;*_9$6N9T0$GE'!-@RPPV"PI0)X.PB_,1V% MOIB(T(LP1S $C#5!P*VJNF/^51UH(*U$77&JS&NGF-)]D0.$LW3"^/\M'\ MB[EM5WILFFS@Q)0B^/QL\)21R+N&WVNRA@$\B55)5SNQ#KU12=N9#1.".NK\ M^AU_$7SOC5S'7'Y"2>'T^5S7/*T!(L5BBK#!Y( UCU@?R*#@)5*Q!]6+.=])YKX)C!N21"[7:L;E8;Q(;RA&GB@5P3);#@)Q^XP8 M+@3#%46WWAS*%*PSA_7I0,1,FY/",L8+8.4\-/3V @@.',URDBRL$ 60, N& MQ$3@N@:-'-GTI#'L$*S@HX#^-X/GC$_;MY)U=UZ$RW@3=@B>! &G0D4 M['_0H]COQW1+-V):GVI"K2V7R GZ%*R4O.Q?@H;%YP :,]_GPO9R,;R6!W\G+ M$#@F;M,)6L9[I7A!BA5YMMEW7H2*?9=0[KL:US%GP'@*3$['E6PF9^L4J\M6 MI31MI-IKYR>(T@>,V4=< O2?@>L&=J$$F4"<8 89+#@0FQ@1DAO&'$E%G#&7 M2KJ'=SNS5COV) )[=L(W_<][?8+ _D!G .\%UCHE4Z],-WU!9+(?0U_DGJ\ M>^< Z*%NO"=G(GC'2 M9GV\E!,S=+F22 FQ;Y#FP%>Z.!-;JR>ZEAZLRYR@/')+<4.2EKR$5('W<> M.\POL*JZ9\Z!O9#G[@-SO7Y9.2;:R* MY P'(H$7'&.RUC/3!B^=S6+)U,GP MZXR]^V1 =6=F[XNEXSO9/4DE:HZJ%I=4K]1H*2MS,L[GQ5?MWB-69M7I*5<6 M&H\#$Y/896$-OS 4DT[\WI&!(?7]X;U')._ 7J;OVS],AU4B_29/ -88V2IX M[V=U(O-4L$BIT2@HZ45CJ3[/EA:7^08)JV+?*;>JJ5:"[CFCI9RP9\TI>R9A M=?9\BPNH>2]6\KY%XCN9R>9@2FJ]NFY1M3%#6?$VJ5@Q-X-T?)?C8N[AQV\4 M*+UU/9-MF21%=(1R3J]9<;SF7%?-#HB*OGP"BRJRLC%@55M 5:)]L(2\"J3E MEU_)4J/9JI@KE+M4C.'&/1O'XZLNF*L ^+ L[4,6_BRBA:HN%,P81#Q@1F; MAUKKFWN4Q("II#FJSV0M;W?%^.7:HF-^KQ3XN=[<,_ZW>T^+N MLEZ];^"6DR<>TV<;%(4J1T//U\$SIX"!/DG\OV/PWL(_;O$Z//=\M6C M@JMUUS5T%R',A\EP:JF1[;@WV_$JBX_6[[^D !8P,63PT+*@K@2X*/@"5C-C MWEOVH=/W8=0O11\W:/DYQL,%@KN(>7@M;HAD!SGP/TIVB&AK>=?6F$VFE.N:&E4[5F/&7D9ZUMN>S\^IV["L*GZQW=F57\SX5[9WD> MSA]N'(D]A2,^K' %O4*8/88?*R4^LUW6*JE%MWX+"-T+&4>U.=0'7>4ICL>( MBK'J<]0:=T38&_1VQO%/YM4YXRBF$D*.% 8L51(8,AO;;ARE20+C>*4N')G[ MZ\_^G^^<1PH\>[<^3..QD2RHEVAJ??/L\H5=^;O:FH[!'N\W'7,C[^*G\NOJ M*9#K&[P[,^"!#:S+4P'["T(+/V"RAD&48_,2C<>C1,?-%? 3U:^PQKD+W:G= M[0_7>_UD37,[5U4=I,J>%,B5MM6B,K]04] -ZC)_K,F-/<9L,IL46,9+)"O\E)0$_PQW3F M$C;I#;2^B$W*FM-\*I-1!7S3JRZKSVN=(QKD?=':DEIB9F2-57KS-"U0JEDM MMFA@_Q./Q)']_ZGQ_8>[+'R_;$!7-I58T1 $K */?.'=29@!BK(!]YT-^#DG M0XE;I3ZAY$/!]^7^U21UK9'/S\GXG%/L?$9KM:;97G8#=J'DXXF+GC_O".^^ M&'4N0VV*5IM):8,1/9322XDMM-=B1X2,.CY.B-)IWR.=]G-.>^Y+C\X9O$YU M:B9KE5Q-*:R*=-F1SU<5Y75ELGB M#NH4>+TSN7O*1[_4\NI;76[^FLF&Y1,3UO#?\.*YBNZA6_H>Y!X$V3-KF-8B*P!Q D IYVD^EG%'V29&? MF0;%9S9VM_Q.T.KKN3^QU#O, :FJ.@MHN4"[9 V5.AX_7YW@[G\KB,VJ8 M[]7IA4@V^WD'YCJ.H48Q("(JI"IDQK5)_76&]ZM(O>86,58KLIS2HW*UCK&P MD]4J"4F=>I'4#R&0!G7SB/5UBU4!J0V!TT4-:"&\B'1>PVS- _'85[6_A#6G MVM".'GR!X!P6@H%(HG%"#.5W?$#ZOT_VQ3[<3T,7B08*YD33HM(4_<8@B9K(HZ&OR_HIM74 MK9$ UNHS^:0\J>59;QB3%E7:KIK33(M6Z,:2?(/JRB:2$\X3D D4ET"=L.X= MO^IUVJ/O@B[7+P!8C0=L6UZL.B-ZCD_8);=2C9A]+0"K4+M8$%+MQ5DO7S+% MWVYWOBE$4RK]F$A&6 UGI> F&!J)QUR$;7*/?,D]IB,PH+L!-_'LU\^Y0MQW M/0,$J6E>Z"[Q:[;DWFCP\L7SRY##5>&?(S.NIPO#!\]!P[QV+9^ZH.VKUDUK MR]Y FJO 5\H:O*_]_BQPPMVU1QI>=P;VQBN8K$1,):XL([I\W:OSC+VYQI# MG 3FA8VD\4Y64=M;'1?X*L?,U74BQ3D, 5LY)QY/A3\7LT(_I>3IT];GWM7J M?E,1EU6J[Y&V $IK.C.)S?%"3"$ZY68VS[,Y$"X#I25^_8[#I,4+O0(_9_[O M2RB_NZTGO+&4T&Z/X\[24&KE1GW!]/7YF+B.K5\5\%8A,YTO%%:<+L:Z*>D6 MT6$2T-:GKFOK_TC#?E\*\[VM^-O5Y=M8\?R,F:S6?(;$:WR%+W<+J5FY[P!U M!%8\F[J.#;][7^.[F_6$-W8AI:>5LJY7:7E#QX R-3I+P;F*62^"Y3-/A<)8 MF3_9QK/4$VR:$9DD-.N9R(6/7/AO;_S?KE3?QOAS%;67J=/M)3[,9L8YKI8I M+YX=V&4(*&WDP'\#2Y_TQHIC@E?E^*""][K%^'8]R OII^LX\'6J7G>JRG:" MVQF"BSM);B@:))."ECX7.?"1 W_'-OSMZO)M;'AGT<=-9YV(XW*=&E&]0G.: M:XI '8$-3T4._/CP>>?"1!__MK?_;M>K;6']+&PZGSNBY3]F=[90=TH/T MQG" U@+KGWR;!Q]=VOE8F2V)^D*>**&]8G_@#UVW>4EEBMU"*[W,;PUJ*"2J M65%/C>/RV1):5$L.5 %6!IF"=C%@C#T]<&6]-77G>K)>-ENA))8=STMT+\,- MBNFI]+1LD+]^ ZH+)TIE43VT*=RO\?I1Q*N;Z0D!OMZ88\ M6\Q\?*MFOVQ=8E>"UW+7;<6KZ:>O]TBLB4T$04,7-PS8<"=\I<[F)/^1[DT" M.!&W>MIF/=.(*K]"]6V<*K &W+^E?_>M4P(_*GV]\HY,)/TM.;!!F$6T?!E'I?>^*0,5Y5IR^$,@D M@J ,HO[ZMPK0=EH].G4W'\X^K:N$JAR>RLS*S#*MITTNT/E\&+GWC=XU?VIDL*]4ALLI2>MNE(A(^*Z"-!_@?9^1N2XXB6,*]XAV)[ MJ<7AS_:SBS=?OI*#&#+&,6=/./:8V,^NCF./2?)"K#K<''9,2!X96Q A_M6I M9TXF)L*_@18 J=?W[MP*OX*9=S"#&X!7)DC%MK?['7_./>\H?^LEBQ!,JY]A M*DBZ1=>R[?#RJF(M\XB STB;3;>+V2+=*C+MR^S*IR;T?^9]J"0'Z[5WKA%*]Y'@ ME(+S_I;"H3PQDA.RS,4Q/L'%^=&(XT5(!VRE^.-)>C;,N@3,FXU*5UFZRTZ"#^OC\R*7%ELKV.\RQ>(/N](K8N5'(P4G_T3&F4(RL* M[[6TF$M5.ZMA!9T07A">W1_9H489P3#E&MLK2U4[)6IBK-P$(X^>J4LJZRP6 M-9*9K^*IM-YO>R2M!+&!_9&K)-WKX"G/T>J"[LYB,:>T+#2YY/'('-^(5;-# MU=!B>7;AI3J#YGRB<*GCD6*KE$:',9G2>%G08_,,6RK4%(XZ'FD4J%*6J.H4 MFDEB"]F8ZD0G!D?NKXBC@-3%"3[."2(.EDL*,D<)(XHC!8R7<30N8.31LT>I MM,)2$Y)EYA4*55!E,(A[RBF9JF;&2FV5=I)H+"W%JCV[NDB7E2 Q:G]D2:TQ M.$$-;4V=\QVOD1[9O=A)Z6L7&ZEB/%/2M$2S@9)J-C[BA.8IZ4NGJ'8/2\U( M-&,6VG&]VYNS2>^4]*W45K679] >VYOU.FD#=L-C3DK?L-M*5&?U9)V))1W4 M';0+'^4]%'QS)16A:7)QCQ+L4T3%U9#^I3T M3;BB/)TDTCU&R@VXFDSR:7/:/"5]ZF@\FHS-'J#20D[C\[*X)IKT*>FC[+)4 M:GCI&%IO2 .Y$2O,J]E=Z3NP-C=U9_G^VI3GP[7$M)EAC\L/R55AW.3@4/Q7 M6-WG G/<>6TT\:ENNV^LU1/&DNCJ$O#/GJN1[9:IZSG3\IV>T\5UN;I;D_A% MI<'.>]BBD5_U,5)4+E1<]UK0H3.6P@I'6 09ELJY4S &/,(^64"YZY @T&]9 M@/W/[\L!R!T+.PF\VJ[CZ>L5,'_10L)D_)$@HKJH$Z)PXX(UW'?I(K[<&U^ MKXU%C+E#QD0*4^ZJ%?-<-^PH7M+^/W/=RMBEMD,402<1:) ,X?I(B?@_1AZ4B^N(?>6V5[+^S^]KF;QB-,O+@&?(8" M1WR_"DDBI/QIB@=>:I;26"TDA%O@"47J1A3J /IGPFT_M;"\8/ MQ,Z\Q6^.DK*\$Z'GUT#/5UVQ(P)L7I(!*QA9*GAH0=(7$EP5? %OV+'P+2_Y M:F?&TN_3G"P\L?XJ('L_\G,VR/T^L@1OC0D(YM\='>K4]0LJ@\/9.R/# MO\]R)^!M-HES8LI9RJ\OB2KO+JH^!Z9LSA;"Z)CO[D%';WLUW0F8H=WY1!#L M#*]-G4$I-A\S+7T)TVU)>-T->GQ_TM?T%1/^*WR*P+.7^[?:KVYE?"7UOWX% M[&+?9<#:@^(CM8$LC*:/K0Y*=.Z4&;>!" MSA[3 $1\VR'QTI6U7SRT$9@309'[=W6YOGD8XVB]R%\_W.BX<-\-:'6LRJZ= MSQA5)C^F"[U5<3IV4%C;"1N^$^1)J^/O[ZI?44CC1F3XN0&0+V38?!J,/F+0 MR)JKHG$:ZS#SFH-FYYF^XN"P^O=2!LTMK9><:=6D@&GM'H46CDWHZN M(S/F)J>MBKQJV2R6B=K4J/",UG.S3CU=7"M>&78#@)8-?O*HYGR&S<_: MOD,KYL8Z>;UXRZU7&IDM-P:?CU@RI4ZWD6RL\I;6EKJU(K[6%Z@#>^/XEDR* M^KZA&?0PZ^2H#5;P1Y2!\JG0S3XJ$0"51-.%?3Z^(BQ=H7'GGU'($,F.4V[2 M"JN6430>([2E-/CL;2!725')3"HYKD6MEPS>J<[TZC'R5KWIZ+ 3W2KL M6W[4B<[:+A )FM+M=:,[V78.46V$M\.6=W;4A"YJ0O<]FM%$/;6^&5^B)G1W MRIA(8>Z3+U$3NOOD2]2$[I)L^4K']2\2X?O4N4==0J*&2_16OQTO'P^28FP,L+*$P+BG]XB\/@V@LL[UXS[ M:2/V57/YSZP[05K65P'6^Q&?J O=D2A]_RYT.Q>/1YWHSID'_)42ZJ[0B>X@ M=RA,I6OWVCB?6Q9IK8L0P8(44#3-+UKZNN.V/)ZHQY MXW3R[XE<.K+7G#O#AA!#ZQUBC:9[I?0XHX1]Z0CB ?PO2OG]627<45>Z*W:E M^RC"7*6US-OQY2-IO*8ATK71.L.C4D:G'#S)6:1-![WJB,=7=Q MXOH%>]6=1HAF;)8LX]GD'$VLJY0]-3Q>Z]^E#;+?F.H$#DAE+E6C]+BFM4=4 MNES(FVUYU@R:UV$8\4"]V*GA"^M1U+PN:EYWV6+ICV+'?5@7GV]IURXT>*)1 MZR90E<]G&HM.S$HVFT%+.^P1/;^)<3>F?-32[LO'0X[6>W^]8+ZZ;1+HQPNV MR;K8Q"V/6/58?IC.)Q;KEJ)8G_W?;/^1:N7]33 M+K)CSH@I6^5XP901LC7#M0:&PZC+&I>.5VTV.U:"GG:7[M7[(ZV6J*7='8!/ M9,]<"7M<0*L/->D551EOE8M%;3Y,FNU",X9552]H;8<])O#O&Z)!3Z6R1.WM MHO9VMV]O=QJ15@O3'3X&N4EZ3&H\-71K1]V@/O9[W(E@U3:N+W0X:J]B4 MZ^2HG"LI8;.[*.\E:G5WY<28FR_\]D;4E3#J/JRF3V7.##!O)6?:S::FIE/, M1-::I5P0& M+\ (E]=]G5Y*^HC+ +5P=?!6)]3E];#D5;'J-(_R>/;-4'<&2MQ&].(*_HE00&-8GDJ,&T&[,UDU86_[PBO!M&D:' MHL>@>1E7-;FC\8Q3'PG)U1QO?U71PW)C+AEC)1K-N,OTM$<9GL" +3?Y0+Q3 M\@Q$"NETGX)'NPH8AD"A^Z/H@47PBF))"I@M7.0%13'% <';B.+SAU=$$;A$ M5=[@ [G(JI8D.*9EAX*9Q*A\4F97+)MI%V($0S*M9N6K;L?MV"HAS&IU39,T M;^!01CO#X@ 3X^_&1# L-MT2#1$W5'N @P-)?2.?9ZXE<92):JDDY9H,;ZI. M,2]7R<;2NQZ77_;X,_[B=[W]S;_ G K54)[?;OO)1>9)J' W?5(BOX#Q4C7?>1"S*V5[B-&_ ' PYMWIQ\G*CG3M<+' M5+AIHCTO8GTFTZ+7&$%8*W[X61RZCJQT!B/=3)<(A4W0J@KL3KU?L=XO*^3- M-KH& %3K*P1? G*%AB!^Z]TX'MJ">. 0;SY<3OE.1V8UDDJG7*LV0^NH=G\B%?SYQW\V=!$I(5D -<"]O]% MWG+%QH;+V"[+L:NSW$P.6VFO;-MLWIM/\ZBY;#1'WAZ/8[8D/(FN!=L8VY)Q M-B;OPF/ 1VR'?=,>354SH]Z:D2:Z)1C*@%*A9^!X)K("^&(?1IL?D;TH-IQU M3%W&@GCU4\'_/\YL84+;X*LB6I?ET:@F#MVXU7RQ&\I[D2CX"!\$9@>(J.^U MJ0J_^O6[P.OR-G;N_U]X>8@M;40Q=&#, [0B0DO@]=7*LPJ1'Z.Y!IJQYD:A M5RP7Q(QWB]5">+6D*:\:,(EB?+SV4YM9N-[X[0.E+^X3=[&KYV4OR;K47.&554#4O/4(3M#9:I1:$33:\7[\!7]'$ M-XRN$MAMY)7,Z8+6R;->,M9U8!D/(MKT>9YH:JN+7ZL;K:R M:TAXUA:XCLBFYFRL1_4UJ:&8:?RKQBMF1J9G9*HYCIF6=5:;U =+7:)__4Z0 M#WCR^+JU-THXHAKPDR$%DN*ISMB7* =,R [%Q[_/ (@5^"G\)Y^;2,A.)&W! MK>HO6Y*0F@G,:.+O?T[N<9'NO*0[;P\.H\-^+YL4TF5V7LO8A)Z?#>;+KVK! M]UMDSF IQV;F'=R1ZREU2?$>3/YZ(,GD>V1Z3RC_#-L[@HIA_M5L,(T'/IS7 M 0D=7M7MOQ^WJ0Z0C:KA\F'^AG_7Q3!W>T_$_>]>1;/.?X*5MIO6T27+:655X#0KNYSLI4BRX[827 MP8N?>-WC5_8FK79$S_#CU[:VSSO\]]$^5N7\.7&B2":?4S3 5)M^A:MAWF3!=K MF4<$?$;:;+I=S!;I5I%I7P;_3TWHY=;S ;L8)H 0:#% 2LF_*TNIQJ\(:@ M% #B.SX./K<%O?W,CQ+4?:_1=QKAEG+EF7XD<_5%*-U'@B,%WU%@#'LD-SH% M=Q4NSB?1%!HG.8'@42XN"!3'DRC.B1B.)7B9QY.B_"M0$W[;H")#)-?57J_" ME$VGRS;02=%0FQS&)0]'UF*946G(#S@V5C>SU;(Z2:51C\./1U;=/%TND84% M&UL3V5EULBS.8PI''(_L.D-]LFCG;,"X!1T3QZFZ)#2!+W@TXULUIL5.H:V-KN)G /C#R:9]G,$/'U=)36 MZC9CU:?=J2.T85\!]'!D/#OR' .?XYK+X%7.55JZ6P@[$.R/; B-M&/IV1++ M]X?FH%,K$@73 R./5I2QQ>2\-IMDV#+OCGJ+P= 9Q>$SCU8$V+:V\V10R;6 ML9>Q&M?,T 8<>;0BNI9/IXE)?ZCE1VFC-F4S/-.#\\2.)NHI/;J$II9KK;V0 M>ND)ONHW,)JCCI>D57$S2Q(2RTI'IF3>)49>D&2[X$PC>BZ(>3C0S;/S#R: MP3.REX+W81\M/IN,KZG$K%5&5\V\U9SG1OB*A"./V*E@FB 0NN5I^+JH36KS M3(IJPKD,$KF2IKGS^KR3(F@EL_1@>OC14]O.W.0=;8VQ^7E)B+66 M5KU&-.'0HZ<6&[E9NT-:&HNK@ZY9EW6OFP)/)8Z?JJ\F-L&S=!+-\_2$B!.+ MDN$J<.@1J\153D=GL]E8X[5J12]54_%*R7_JT03RXV0AF:EH AN+KI,P,.B=FU?9B8:)$GO[U&TNF'I+XN[QI'IGZ!(+_9OOD M1G:.QW@;F05S#SQH9"99/HD,04)&IN':"##F#.AY&U"NL$>D\TI$" [8"MZ8 M%Y&9)2U4T[6!RVY)@JD80.!AG_EGJB+2$O[M>T'\;&:92\ 1W\?_]QM%%I;& MJ'*')+U!*JNI?:[*B,F5VRJ'WWWS.F[0 O:""!A6Z(O)6MQ(YLH7I\ MADJ=+*LE%KGDK% KC7"A^>LW^H@?=SI! )+I/FH:/J! $?"E2A L5_)EQAFK M]K'8W"PP"&@ (Y_;&F X:S U23'!IP<@S<(XR'"0)* (*R!ZP.D6@V&J90.5 M, S@F5@VK/: \JCK2* 9IN5+8'#P!T1Y@T*AKHU6B*TN S<.:""8 G3B?!RV M)#_. E!:@L^:@ND@CD\$. /9M>"8S4QL%\P0NJY!!!>\9R8)CD_TMT[%!9N7 M[O^3 1X:9G! 8OB/E9: N?KQ;)\G^@ 7 ]00J /\E6>I#I@:8I@.$$\?2. < M)3V,-(.IG6_N,S\I!?QB^ZR;B9*O8Z>!:B>.OI,Z8X<* ? OJ&P*Z.MGV$"' MWD^XV?GN+]40=-<&XK8A!S^%)R]V&+^$>2TCL*,'VE3@-:H1",?V MH'['5#HVB3;+]G7#DAS8P ^::+LN/A"NC;G[)N/C:OF\YZM8#VBX.?,,&CP( M@,+\S):>-G_LS@T>$8:G"_ D0@@.V/8/)'<:0(2GD<<'OHZU>>OFK")8UMOZ M))'D8Y)ZJ6?;SMG)SO,AS,E >C8DV7R.P>X73\'Q+6>7ZE>C+S3% B+W.3G E+=5-Y=UG'Z@6+SFLWQ_ M_'S%._C"\!E9YM%&$EGFD9Q$EGEDF=\+32)%^>J6N9\/:4<6>6211Q9Y9)%' M%OD=D"2RR",YB2SRR"*/%.5'6N2-33U*$"[G(^,\,LXCXSPRSB/C_!Y($AGG MD9Q$QGEDG$>*\C.-<]YRHC26R"Z/[/+(+H_L\CLBR<7M\C-O)'Z+F6 G"9(C MS[>;?%_9$$P=?OE_O_!?'\95ZK+D.;.8T(+C\GHD&Y'Y&<:&1[HJZ*O(]+P& M6%"/J6CAROACGV"UYWI=-^2F1_13@:V5^_33E0CW/GOWU?P?AYQE?# M4H4011N\*D9"$EEA@5%N&*9K"-(9)2(RP[Z/&=:28MLW?ZZL:A<(@LJDJ#W2M"Y#+7O(TRS3>VY;^U'$G4=3-JYZ?8[ M"%%#YXVO8O#=C^BS'UT[\$09)D^;9.A+KO0<"_GU0' MS%_X!]X<90#D5<^'O'>V^HT*G,V4.U[>#77@,%_ [^6_2P_BD!X(] DQ_"P4 MN4=^?^@RYS/D%-ZA7%Q%+8)\PCM^,V[? 0)@9>(=R M<16E\+,"[W#QGU2*KW0D[=^HM+F\$EZX]14B"=S26[/\):+\^WP&Z*V7^7,E^\RVY0]FY#V=-E_3;+PURR\-48%]>.M5 MWL0:C#RC>PP'W( ,?XR>_C Z1.+P8LST9Y'AC\'3GT6&2"E>C*W^+"I$$=67 M(ZH_BPQ_"JU^22I\I8!J\ IZ9JDPGOH 8ZHX\I?Z][<(67PFS^:;U.U\P"7\ M7W4)9FGD+%Z ]^LAKJ$Z+4G^OU\L^(-K.[PA\I;(V7XB#8?EQWE>LF>TIA)= M<^;JM37=57XA I@">*W_PZQK\?!17)S#."AA7,<$?Q-H\,&U8PK/SSC: \_M MK&82O53M[;V8@E:58+DVER8RNCOD&A56(IE95C$G(C7R?B&B M)*A37K?_[U>QEON%R*8UY9W_^Z4NG2?#G8JF$P[XA1C\%- U?,M3D!8$ZTQR MIM7AESW5&8]-'?("?.'_:QKFPV;,Z4PR;'\YOQ ;L!H\!/V%J.+__>H(7"RN M]GL)ID&B[KQ?:_<9,\.F/ X#R_[UFR0>4BG\?_^[3]\OD0QYAUO&[7L\G3FY MXBNA0%9=J*+$L>WL!@>(AMM.E/)SE\DP= 0[@;T"!I:2/GOS' MMJ39)O4=S!;PH %H:8HTX"BO2'Y)&OC&QX,3ZL_RLX322\UIINY@\5YUUI2I M-@W5G_SU&RAI\GLJ_WF/!NY+#Z+(_]=N)77>[(_[DLTW6FH0I56Y0Y+>()75 MU#Y79<3DRFT5[L%,BQ'GP.C:73,N\5F7S3 MR*(%U:4F&=].P]!?OU/Q!Q1%7\#J;W%(4N57"(%=P.6[LW5&J>'7<_#('>0@ M.0+[.'+$DOJ"P/#J6FOGFS6ATK/P;)^^N8.W&C?KTQS5$#3)IGIYD1B(W7*3 MPW#HX.%Q]!7@^%Z:=4<'2K?6P"@)_TY,35Q1V:"UV2F-VG' MX[)5SL3S'MQGH&=,D*F+N,;W44V"1]'8KU]-O*4O2M2.A#QN/X6WS( M_SH\$(X+\'[B@H7(JUUQ^V,+7G*K'-O(!_09WX@-HKKX_.0?T:,Y^-^ C^.@ MLQD $4J:_C,S;142\LF2="!J"VGKQJ'_@2O%[_PM>O/FOS]/M+ ) #/0 M^9DM/6W^^.<,6+9'JN ;?_I0%. <8CJ_,EWG25:7DGA*.G9H%ZXP%)3]V,:G MIGJ HOXLP"Q?V"Y21]CH']SO@_,!>/XQ"?J]TPT^P@>!60%,T?>Z4X=?_?K= M&0,.^V8QXDF6A$A+@"B&(HF(;)E31)K.=',E@7\%"(J(JB4)CFG9B&I O#2D M &T]X+\B#GB2:@CF5$( MQQA5LA^WJ'($CSM:O2/G861KHWL!TM;<*>"K<"Y(W1&'L,W@KCCX[18/[ HX MJW![?=Y$$'\70>"N:ONH>07 /YP-8"D05%]:SQ\^HFVN+G]VJV_WVCB?6Q9I MK8MF2<1@PRIC3J6GXKPAB1W77L>'J@/@= MNG8UWK*X44:4!_4QGF$EI=J:]R9+NI1OPKZ3%R88\2&"K1:F.VYR]@)=I;PF M-1X;NC1Z,7_DW 2KS0;ED3MKFVB,$M.*0A?<0A40S#!/F#X'7QRC$B0K@+KG M=R*\#;$I"V *+GB3RD5L$ E_\/_ZL>PIVK8KB2W@\([Y]"GT# M"B'T@E=UWR)C_8T)3A8&B'ECY;OUR7]LA)F[P,Q%B@9LO NL0'\A-P-JVMD* M?!!UV4C] YS\U3#\6>8A-6I $'V1AXX4%Q!L2R\X I */>:0RV\E2T13+EN MIO&)D'/JB<_&_8\B^[1E08MK"J:07CT/:? K^)6OI\&UEW4Y$(6M).1,*P]^ MZYS6FVF"R'*M5(_%*Y:YJ/7[-7=!__I-/& H\4#%L6/U"8T<^VD@+?:P-F;43Q;O4&0)ID+:!!"R8/<88'W/[Q*D&J<:TQ%&H-1AT;Y271 MSA 8^XF,S1U$S_ SR*R _!OJ U'-N8YK21L.G)19UHKG!PV',M#$6+%3XK(Y MM[L ZU,/1"+U0,83;Y99:Y?K:OC.!PCWNNMOR#?;:GW<80UI*5F":H<;;=W? M@^P0=]Z)5]@&KUI\+ZEU5X:%MF?>,EL83HKKQ(MVYS68JDO9&%%?)DQTE6TM MO4:S9YEUP-3X0S*)/> D^4>F;IDXX<-WDH/MOC7/9,5J,F'5&=>HY3FEM"Q2W"?J;<\C M!VN;9X>T%&MHB70&F])*,68H4 XHXH$X<=ST9BG89_PI;N,;;E_%R,8_S+BE MK6..T-($U"5*\V:ZWZ[(]"<,CO,P;BGQ7299%>O:O(2)(RMAY_4.?55G\M:6 MVWD(B?42'0=OXB@3*SB+&6,/*^U*\R63[(]*L6^3;3:X/]MC\#F0TJKA\N&3 M_6C33D1*T"7>@J=#XX.P+ %ME_WP]-E-I_V;0O#XYG!K:SDEJ6 =S_'I_WE3 MD'QG56&\'/?#LHH4&UD2K\5X&;SXB=<]?F5OLB!VSG:?MD==A&_+H8\$^1]D MY^_GR-U>=&\9VZ%8&.2-Z9+L/(4_VWQG!4'\\,NC./ZO/T4-<>PQL7^T$,<> MD^2%6'5HTNZ1P H.[ZG^7RISNUG?MHCVH;&KCS3 MCZ05O BE^TAP2L%Y?XO@9&F$Q:5$G),DGN+BPBC.C>*I!)?"!9&,\RDRCI._ M J7@-Z>W8JS-JW0,5UA)TY7NC"=[?*;)85SR<.30SHS,V&A!:+U)PN$PK]F0 M,C2''X\<3(?SM3@;S5AI-E5B'9ZRAI3"$5S\<*0UKB7$]%!/:O-14ECC;2&U MGGI@Y/';M>DTFV"K>0WG#(4@67HI2AX7/WYFB=7B-;LZX+5$PG7PN*GI,[,) M1AX]L[7*-6> *@K#3];]V'!K"N,FY&9/-]>>.:0Y M$B9*[H_LJ,Q:;:NS-9M?&DLV)C)Q1E7 R*-Y9N(SVIBMYX2V(JK6HL%FU$G, M R./YCE=IJH6:1E=-F&1,9*JJ2SCCSR:9UCAR M1J!LJ[<><%HBTR[+!:S5HED:C#R:Y[+/C^4>91%LS*Z62A4W'J,(!8P\IE(K MCM9JZ7Q&BQ6&(C7.IYHI9>* M+3.U1 \%-K?+E6FY+K9HCCH>F5128PX=8"MM[N&Y1=]:$(M\$XP\8M)4+V3P M1(+#M(3&2-EV3HLMDQX8>:3&\B3.H'J*'*,K.Y[URFT&92T/+.CX]0LGW\8I MCJUKO99*H*FXR^&* H<>O5^IS=0$-J,7;)ULT<5BI=F8 #:!H4<3 &804>'[ M!,:VLV0K2[FS;''5A#7V1Q/P,G4BOD*5+)J@:P-": S&+=D?>L336%%RUZR4 MJ[*\O9C,APU2BS?]H4=,97)])3U3^BPZ]7*+1(7*CT5=V13Y[X\%9JENCR=4 M02O'T[$NA:4929H?<;'!J1V/#&-"H^JA22MC&?.;)%K;NHN_+$']G;PRQ&7 M[Z]->3Y<2TR;&?:X_)!<%<9-#@Z-G\U8^U38M!?&5&X5(MV\?^O(CU:[9QV( MM)RIEH3P#K+@+1CA01SX\LWEBBD2<7492S8R9\*_O]Q M%78F&OFL(:!EKS^J#"PVD>\W;Y&*(0-K8&M5^/_W\)8%]*DEE>MA]32;R:7J M+;FWC*6Z-UF +2TDXW %P#O]W[V,AA<3[8B]1+O73BM#43F(EH6Y;WLC_W#R MXC\5/$(82QW@Q$B;1BACUQS%EV03S8,7"-I@1;$][_B 4W2M/QQP^N\;O7[2 M,SH\Z6&@=/N#@VR^G>A!A9H-9X182:/\*&$7VEZK@XV57[^!QX2L@+UI'Z:. M/&?00#< ^E>^2CT@H@2F%&3F&/Z_SWB8V^3JO!4,.><9SFO)?#1BNU/PS6IS M GMXJ!D&>1$8 5G XTTY3/K)^$DZ3J#Y T !1+7A0;MLPL0>^^F*B]C3M8_G M(+XCXRZ8&XP A-X_=#2$P'_>CS?LI.B&P8;C>(YC;=ZZDU3XZ\UU@:E'ZL7. M43NNT<[S82*5##BU(>+$/5L27V_"%>B0BOMPA7R)]N5>^O-P^-N++;?B2?,02 M$5_NCR\1CMTG7U*O5$U&?(GT)>)+M._?.U^B??^B?'EO6Z;7PB\W(T+J'42X M*(#?E )'AR_7NKGLNCW0C[(I(C'Y F)R^YM9;BT4KVUFD:+\]T^ M39+4^Z7DI:RZGO])$K?I>E[H6,;/ ((2(;/!*3:".)-I)(42(; MW+?!PU:LD0D>(6>$G)$)'FT9D0D>B$:&9V1X1A;%=S4\?[10I%XCP$N;Y.8BF-$/-Q^_6(SJ M$CS_&58A;*X$VXBYO/Y5F!WYD=<$ D6Q)(5W#J @,H8BM;A_8^C,NA TW ZV M"U..X#*"RR,18<+^LU]%."+#Z:.+KZCRE^%R! %7%(PB,*A5PU:%R&*Z<[5X M#?PVW<,._WLVTV?_/DULMD3\]JS7N$[SW,=-V_YP7P,1S\+Z,T';]Y$"_W;I M'R4"G[%UO@_?_U*-YWYK]M\_2@(B$#@0!O^JX7/8/L_=^Y_^)0B2),LW-8?J MNQ?W&2(27C7B-^?C':3$&R[L5Q@V*C^;_-\9%Y0_QREXGNMS/E M.EJNG]=X#G53V>5LP(O=1NHS-W3IO&W7Y? E=:L%*?+"M9BPR?A$S?9JJ4Z, MF4Y6L70]A]7&)FSSC?_ZC6&)!S1Q?'?3=]6&#]T+<(84DSLCP[_/ECGRQ?$@ MJRY44>+8=G:#"$3#;2=*^;G+9)BZY=961#/!-*^*"/@;\ #>GO0J&!3#]L.; MW,+PD-B_;3++.U*.5RU_]S^!&K%99E"3F)ZK\74\.96+,<%18"-_\M=OXA'[ M.9!Q;B?BSA7F#;W*RZ/R;#R*KWMH+$$6F$_XI\0Z_H%[(/]L-(6">L(.TKK)+MYN=].LV_*F/2VC2GW)XU*^ M]_2 HBC\W^6,H9^XY7P++;]Z8OV-?*'KZOGG7*-0RS_C%F&+O#%J$8DUN\HK M8HY+KTQ:@7 W")@C'Y3)#BS#W1+K3A:&W(+F+LU0R-H_]+0_H>U':[PBQ_C M!#[$)D/O?%[$W2SP9Y[0'/FUWXN=4:#F$F@;2?4W8>==1L'OQRB\,[9'8/8# MP.RBUN1M34=XR;#XWYQIR9(:!:+O+:?Y#K;9'PFN-^;X-9$V$NZOSLB;YUY_ M(>LQ0K,(S>Y%";YE2#)XQ5YFN8-D)4%Z+C0GL(?@CRBK_#,QRWU9)X"LBZ8+ M4_?O0=AOD';^OI/4J4V69KE\K9 M*!=C-;9!IUB3?A-#C9VDDDC\&=2X?MO]:*O6&['9B)K-4MC69,F6POO$ZSZWG MA>9-LMM3C_%$E-T>[8[1[OCM\N/1V4YNRZ8D^1J.Y+?8C4Z=7-R]O'Y3%_'/ MUMR.=)\PTIAN=L+FFH;#SIME.DLW1^5>LPE7%E=@8N^>(7RM]A#3YVKW;NRO,%]RZW[ M*EZF.9%9C48SM3AV)9KV;N*^H95 M5[M$.)#(X%^VAZ3X[,W=+\\SV1UT4!TP:>&X(^N[UO-&M&E+$E(S'0DAX=Z, MJ$:P0T.+ O:#M_S#2F;Y+ MHKCLY;.?.B@SIU/3:#NFH+7]);]P2%8#,^&*M;4Y'>2[@E;7I\V4E:HMVLGF MR[7%'V86$K !,65 <3A1\'LP4T0)"B,1T;4V8I)Q+4L"8@([! )I@APRI(#% MGNJ,_3$A[9$J;P/F(!55D Q;^B?XO3D%\UL!X1-,Q0#:(?I,MOB8)2TDPY7@ M)/C9S#*7@(Z.I*\^(X7_?J,80CM:E3LDZ0U264WMOOEDFZ MRPN=9;*01=5.>2HJTF*9'35WY2P6?[-5[=.Q%9!Q*U2)':&RY.K*:0T*)CH? MYEAV4-"P44+Y]1M -W%6>0(0J4-R P$Y$AI?3("TS8#80+1QQJJ]09]'I#.6 M+ A&]A7 YZ-X_KXV3X26'+%>K]K2RC.R',NNU)$]>!%8H#T+N>X! \"6 MC$-DH77=%("BB#ZNI %LBU#'@,;YA-!A_24X=-)K-3%&B389[0I3,JE[ S/T0* M)@@42H>K@ IE I6S-AIE[R+M*74$1D$#^-J6_^D1.;_A\]VLM -S'\XQ-'J# MH(PAVE>D7F=G3P4V&V*8#C+C51&!7XB;"4&Q$(%\/ ;V.!!&J*"JX?*!-'XI M3O.;4$^1*\<:&4I9:/6"SJPZZV&.8&@ ,@1XUW_YG9'55K'5-?!R >U-E#I3 M3& 4:].<'U/>']FHD6G5&+ >(VE\TUN+J*WP38XX'MFL<=-!#*,36CF.YDH3 M96 5BQX821Z.)"6=L@5\A#&)>,D9KBK4=)RFN3B''HXN=::L]UI=UB^FMT[-XIBYZ.=Z#0X_>;R0%JK5N8;"R:ID/Y M3SV:P*I:$1P!DT@F@=8SZV(^U9%3"DPY.9H 2?!%M)N-&VQ;&"8HHT,;*Q1, M@#@A)H:%$=0T4=#4"4.E:A19S704./28^V[)08IK %E5>Z"AQZ-($% M7N89;4[DM'97SI;7!M69+F@X=#.!8&NLN5, *L*[+ >MO:PD4W6;9O"F5*#, MLH.A9>]PBV=X"UZ7;#,2U",4>9]I4A74-66<42Q,' M,R^P8@!(2B+MO#".@\.P7X@$;(09>*]C ?/[K!O2V[:?U".R62KR5\6T[;\1 ML&3$7_.5=R39!&:5Y_N,_B$VL/!YWQ Q!(#O@>4"_#QHC!B0[[P##!#8C!N MOCE5#?]S.&#$VT L_']4=1?:.(;D(#I8'S(#R_-=5]\F7ZO*A.*;A^FA#S :KZT"" M'8OHJ"M,:FUJ)#()M9X0QEPEJ6/-8Q$]/>ZB(GJE;3^0I/ Q8314 '+&SVSI M:?/'[MQ@L>ELZ20)]I2T,,-)./-\$SY2!#FU(LOD<@X'AIY$E\5H,NC3_S$Q;A>+Y MY'L ZD(Z>&9(:?_%FZ'\R#:AL!TL]&97$6%OEX+_@J5M__NIL#K^2!$17^Z/ M+]AC*M*7>^0+\9A\L557Q)@(R"*^1$!V]WR)@.P^&8-'?+DD7]Z9!_^JX_*5 M4XK>M'%^^06^M@/=]P*W-_+%/WHC'X$_XEL&/A:[[YOO"2#-0V9^A/WP8.KB4)%XON1B1Z/=#ZM8W+2+LB[8JTZPZU M*[)B7K)B[JS%4VV3S,<[CJ6.W"#-RS&1OB#IB%\K93\@14-X#(K2QD"0),M& M_O*+&4S7A@/^/ALJWQEU[A^%?*"^[,*V HO8=OJ@*;NGY; ,PY3%>7=:S]5% M@8+%$@3PBK$'E,2/RJZ^-$Y\8B>.H"""@FM4PC9S:6DUX=T)6U=J?7G55[/# MD7)Y*!A0:,ENJ)TB6V:FPT+2J>5F-JQQ2OSZ'7] L=2%D.!&0G /%L,7#*'] MP*.5+V(_1B2*'/U(NR+MBK3KCK0K"J-]H3#:*RE$VZK:\YX0WAL1[AYL;N4B M?VVJW8.W_550.U++2"TCM;P[M8PB15\H4N2WY$"\L/LXP@?MQV&K$MA!Q)2W M_3*?FWC^K#S]-RSPSES/;^I+WN1^D<\?"*+O. 0XN 2@YBMA73YJH^LK[8D+ M 0IX@TL/G-D,G;:99K--*;+3]+@4/";$J()/[,DOX0?2CV"T*+XA#"R#)M& P-LT]WV4U62]TR)2QED/V;- M=^VU?N0"C>\5$SJS97)GJXO$^AIB?8CX/[0LR9WX#U1[8N M^!1ZW;@<]'[OYZXI]V,.:4(0>?7*PX[ +>=#S6TQV8&" 2SI/]42^8E'H/#&<$[FJL_8$ M'URN=&QT9^!R9=/V2RXU"EI%)_\_>O_[SJ(=Y;E$TA[%F^[)) ER;H^O]HM" M2M_,Z[M=;XZ;+_VLS3N"VZ;]UAVAYT8TW':BE)^[3(:I6VYM13033//<82'\ M'9[;R;LNCQMY/#MJ>I69<8N&M];RR;C(*#2AU!/^S;8P"O2('L=_OG1+GP@S M(LSX>ICQ_FC/13W(]+X:MNEJB2:>]YA3E\CT?,Q*_?J././I#F_]\[[A. M=ND? MNS7@\0U=MD1)H8=WE_[/WA6M6W,[)IBZ:3UM%'EG5>'5L+C/4T6*!3? \C)X M\1.O>_S*#E>9I!Z)#48\;;$ D@'!T$>"_ ^R\SOW$0;,L8Q9T\X]IB @@0^A@N+8X])\D*L.I!7;$=:>61L M03SY5Z>>.=4[PO\;B!X "OV?W2X;X5>_?G?\SNZFC&0@/.T6[_&!=)]G#4<= M/E[J%@*FU<\P%23=HFO9=GBU7K&6>43 9Z3-IMO%;)%N%9GV&6?XRH1>ONK' M="0[F*9C0DKZV< \](1RJL$;@LKK2-L!7TP#$H_.2=O/S/SH'D,$&I\(;XC( MWAU6UYGI1\#W12C=1X)3"LYO=KQ<71YJ)9S,,_E.>^A6\NM4LJEP.(?_"I1A M.Y*?6-GDDF13&L[F!DJI.EU,Z29''(\D^Q:U3@Q=GNT511V/ETDF:<*1\<.1 M2H.UZ;Y4G*"]M&:,\$2E,]&:7)Q##TH#BZXS.E#!E-DTJ7&([$NQ*T"A1#=)@YG%P*/;KC[\:=85)K4V-1":AUA/"F*LD=:RY_=5_#WYV 9&:N+:C MRJL79&I_;\7@;O1&,;O.9&D;X1%@0[JZ7[_EC*6=LS?P/=09$=I]_C]E7,L" MWR#^]<108QN6"OX)?GP(!IA3L( 5 @PPP=5].!+# ,W^<1[BVF [1$9['79B MF]SRXXQR?PI0Q9 5>)G]@/ VXCJ BFOXCYMWA+_S3%<7D9$$INBH,?\?@>[! MRT3V)_%X14)_*:GH %8*@)6N$R@4 MYJZZ -8^V(/_E$VK-]SQ("V?=NVL)8$EU=JLLT>/GFW>WMI)F %&+.,J>9 M9S+6Y4.WJ /FE=8!C7YM,"T]J^!*::+$V41]B+.=QMQ9)X$K)P%_:0:FX%BN M= F+_)(R&USELS'= U\L=7"XWJ M8[_%L39O#9^&!&))O/?M'L4^"%>( ( MKUK_(:7]%V^&\B-@YP'MNX;5_TJ3N.!W;Y>"'5_NTSX[^F+ +N++;?B"X8]) M/&+,_3&&>,0COMPA7S#RD<(BQER,,>\]S7YMP[\9$5+O(,)%M]:;4N HF/1. MDFQOC2<^>FL\<9V\\,_V-3X/Q2+MB;3G$MISPTX6J?. MHMJ;NMU1I%'?3*/>WAW]!@0+?;#OHV,P+'>FNVI>F][O\O>F5#VSA9Y__>>A%![[ZTVK]]3)CPGX;*2+%F6 M),(S$,FP_=_0L&&SXF'!_SD Q9//9#QXP2X ML^V)D>I_;*.,5/\PC?1^5!^O-T?*))]=:_-"BR^+W=:@RMRAZK=$E(J#1^>U MU=H!C"XO9D49YN'$H>HGL/@#@;VD^E_/J>QMF_;_DQ3ZE.+*111MYTC4JU9;%*(>4#1@57RNII_BRA+QW1X_;M&5\[75O2/49"[ MKKJ[!Y/C]7K;^\""?+M"VEX'RZ(]P;?N(!3\0?$N@%-_UO MJSE_#")$FO/I8M7[T)R50*49C*)XMMU+5AL)M^8F! ]HCN_;)PGT@4B^NH]N M2CQOD/.]GX;U\0SP4]6IERC->>M*KEIL\>F"LZ"\BDN,*#$A)BE.QG&)BV,D MQ8TP"N>2@B@(/,^30+@/"[(Z:1M-EIG^B*V/VIK&TPF]5_" 4AV5;M'=@KQ, MI/II=LKQS70MWUX7AG#D48F9RA?:M=ZZ2+%MMEWMB':F+*DT&$D>CA3J\?;2 M79%3U!7J%:F_! 2B: X_?CLU3 _KQ?QDA+8;3G[AH-6JL6Z>*H4C)[E6K-2V M\UI]:"23XBK9S.3AR*.WB]-8?LITQRLT+^=T,38Q>ZL6S1'';U\V-$H37&ZH M):KM;C>V:O.<=[(4KMQ8##I2+5MFI\.60W=Y5] KWJE2N&Z*8E-KJNZQO6JU MK4U6BWC:A)XR<3BR2F4H<9 A#3:3GFL5E$LP)D?O%,T]SS.I4%B2\\JH1*R& M=:_0'I13X4:\/Q*5]%@*K1F:UF:T6&T=K_=F;!.,W%#ITB4R "^GJN-[2K0A M9GQ=5R1# +":56U!-VWW5/E+C>H6<6&0D1D<9>LMHSPMMUKAY@# 0A)IYX5Q M8>G?98IECHZ7#XND\>V.2#TBNP?T.[3P"ZCVJ''NBN>@_EH%KHLJO&?.%0EX MM^>';.SNU@ZJ-S'C+6<%Z/7,F06DT%$3WY^>7 5H2KP,>P^+F!Y^@ M\$L!&%^\:OC%9C-(:\0#'CS"(XYD36'9&88C4S##L8V T;IDVX_(P5N%H+I1 M7R&&Z8!?;F^G@!9;LODT@*5T MCB=)!L+/9I:Y!':0(X&UO@ %M,W5Y5W=MRV':\$(B1_A@)^JX#53=QI&-\:" MH!+5+B9I,6J8&:'ITCCA-O<,L9@M"4^B:\$RSD/0J "N2%)]PW-?)%N;I?B? M.F A 5C4>,OB'%(J,ZCK."@_2TP*:J5$DA0-;*M#BP-R\9,+Y9<["TT,^T:Y M%B>:6KXH=6V4P--&7SFY4)B);TO&I]=J]8NKLFFG^IJ$,DTIDUJ9>+?YZW?:$63T/?JX[K7'8X/MMO#*H*EV5[ZTRYUR_9 MBQBOO,+630RX8<&-S%DU=-YP@#W$;#:I((KL@\Q2TD?@Y[(J2&T8+/!Y%\*- M*<4!=AO2@,TDNCW;UBO%TN(S_B[8..IR"^P>C+]Y;.9WZ,+Z='C5P\(AH)=6M9-TWKP!61@6MKS7_[6K@*[23"MF>GK8_"\0'U#\\ T@&' M"[XG!7=UL)<'( ;+T(&9!1@/N%OE+6$<6&2^B& )_QG2' M;^9T%8!90>)%2"R M?8NN_-64\/:2F/$9&*>E\HW9K6*M[^[/,%>+[X](_(K MB&>G=ACP1 :NSI]Y%OQ@%S%Q@XIGLI5R$YW;A*Z.&ZY&UH!ZUP7']/4(]?4H M>;RQ[!#8@N:6%1;];W0-[+4S?H7 P!1\,3!1+-_V]:O0 "_ OZN&8 7V"C#9 M-J:;PR\W? 6/ R:=:3L^7^##9R%A;XK&7[9'LO.3E^69VD-,9!9X $V\ !$L"W-9#0-CH-YRH9&W_S3'!#X!G&/9[ M,9 >L'*%,?B/M(<3WE@5QOX6#5U*P 8UD);GOB2/2-$XZEVROS?8K@ Q99= MV(/"D!3347TYY1%;O8FX*^@Z^ [(;!G"K27PE="@PGX")M^&#G_WZC!,$N@*K<(4EOD,IJ:I^K,F)RY;8* M'TQ_> M^^<:QSZBVZFPPJYT><*@I6A;:FVOY[+(UFYO#/8&,D>^0QSR@4,6T M[;K1>:9K7?8Q;2N3B5WSN%K*H=8"EYC\,CM ![PE-W4:=@Z,'TLD0 O=;R(" MF HX$<#-LZ\9 $^X.4@&A*F_ &*94^GO#;>%W8Y;]J;/EK_?;?>D?0=SS =" M8,%R(1X(-?A:M?Q?"6, .M(UV/ZGP_ /LSW6QQLC53;6[#PS7>FI:CKOT%,0%C3HK":""Q351B.DS=K1MH?,J,S:8O M"L<-9+>B +0P (" +SZ3_;./F"G'8 ,:'DXA[(2TW?^.X>8>=B= =_/$%K79 M9_1$+AX2XP%H1'P3XYD (D!WUJFJXP_8T&]%ELX MERUM4Z)-=G54@*FCR:5'9.OZK'EFXVHJ5+%BHY%N,OQ U=SJNN+Q=>"LYZ21 M!3;#%8(G'\)V=_O6U*HY?WZ3/S[ M7.M?)T8.VJDE3+;.NX($3QS8WIOE$#[Y "WM=JBI!X$C=U%D%D3?Z+'E$H'KKM_?W?A\Z]WV" MZ^[M!*?5TWDVZQ46;,P8:J-5H[X>%IIGVII?VG]K]4FE;JS654:R*7DHXUW3 MK#5A!_?$G_??;7\_\!K5%/>-)W@HBB7_L?=_G$^!3-@^GXKW.-3,*&&V?DT5FAIO:[+YLI2IT5/E*-SK2_:5RU)/*:B MOFIWV(X(?R2BOFIWR!?L,9Z*^')_?*$>\1?O#HCX$N%8Q)<(Q^Z=+U34'O*. MNA"&YO&-F[!\N.7*7_\.@J*F:P.GR_[[3+U[7L/TVR[ZSZUY#A:_;:*&?[2) M&H;>NISW?AL\14*R(R3?3$8^U\=I ZKW54I4W\]N]2-:9U.#.UOK+>XXA.;F MG9'A'+<:!G[G=VD^K*6/$A\/=,%B[C743V_HN(S,5C%8A64+S0Z?O MC%M$E6-@,0KA)\,0Q^?-D7I'ZOTF=^RGJ_?[2S[/K][#);.HCHQ,BBFK1C[+ MB@R-KSV@W@FHWO'D<6;19PV4FW:5')N6$_/S_B]@COQ$JO1;F_(?9< MV+3P%0TF:;R$/2F"7MA&>).>]C%3FK2S!9YM8TFFDT@DYYBF #T%-@)YQAY)]QG!Z/*6ZF>A M1 &,'^+AG-FN^.ENSH5-C8U^OH1@&C9:))EY;(3&)NM5NE8@;(OPN#BT-'"" MB$(8D8)'<8Q[M5'>HN!,;%7-FI5:!>TY9D,M$?%%&X,*#DP4''LI1OD%@QAA M#CP2U&M%;M%G@.G&G62O:89\J::Y?CH\?H[51\+]W87[SEN_'ZT=^>MK;\B; M#:CH[S\G=F.4X\LYG*")QH1+OQD7/A)O>GOU"1Z"1>(=KH\I)K.D*T/!3=?UQ>SU HVJO53+!+Q MEW!AKSOV8>WZ#;IEG[$_ME\]L%,C(0![R8+B/C[HPDW >5RB2.*/V;MX?*.M M6_E,88>5#_^S5^"QU3]8GFQ:3QLEVUE56%B"^_JF2+&@?H27P8N?>-WC5_;& MJ*4>B8U+\[354T@&!$,?"?(_R,[?D!Q'M(2ESSL4VZM^#G^V7P"]^?*5.I:0 M,8XY>\*Q1UAK/04?PX7%L<2%6'39.V-EK>&1L08W_5Z>>.5G< O\&H@DS:;;Q6R1;A69]F4Z5IR:T(OYZS73D>Q@FHX)*?G<0"+G]Q56 M@4O4WK:2V*:ZWW[F1_?:[_=3N/),/V(ZO0BE^TAP2L'#YONCU BG )!QDB#S M7)R098X7P59)CN(RBO(D@8I'#>CY9&J=28FNA\9D)EZNT:F*5VB>:JD_3.'VLXVI&F&)8PN7+S5*-\M.^UVF6^C-;9?Z#:8575@%)H3 MNV-X'H>AQT,+GCZT38&+,QFVD]$$5!B;,<#X$]V!X?N$Y_#DG&"XI,H)V#Q%!='A3A'H1(._L(PBA!3(QX3#Q]>FAOMDKNH M*J@[3JT:ZIHLKQ(G!9"UBRTFWLOQK.0*+9')YY+)RLF;&NA^*FN3XWP+B%4] MFYJ.*K,8[IT2P)[%BQ8>YUUM;JT+*UW%2T*J>4H TZR&611J%MEZ>T[1W'+0 M;6#**0%4^IE::E2N)]B5'4OR&;6DI ?>*0%L.F:;,I/T L79;BTOI^E4JMH, M;E0^8*R09N+]1+3SU+**5$5 M\>QDME!UAZWS_*+>'+J]=5PY):HMA\NAL^6JI^6[>&R"BW%25$?,=,07 ME$:64><3DZ[ET+H^;IX2U85N)_'1<-A@^-:"J3LKCRBQ]$E1S;3I=L$LF7.M M7%ZXA-3I$M+$'[JAT\%5+2_?U+"Y@>$=]S7@ES!93QKK&=X>(S->#2X,X/U+ M>^R]QE"P%] 4>"NN==C.<5NCI:N\O^NH4M#CZ=J-.M\0L_EX5Z?-Y88GVSIA M:JNL"TY*U!(<(=#3AEOU8%O%%]LZ04/AVDTMW^"^7HA$F7EEG+;%#L/4&^.B M,%XT8LX -L9]J?.D>MR?UB?;Q?4Z'U9"#Q7Y-+"/5MUD>\FF=;P ^8 ^ M8G_DP]6ZVYTO;'#Y/F7'=U140OQ;57D'WI.V^D,/LT)U[BW<1K?-)H:'?,$BOMR$+U/P%/UYB8^)6[8K.B8]C/B2@.Z.Q1LVM&B>_+]@ M=_^_T(<8^*>_OP-[WIE]\NKN5X;:%_;M!T"2G_/MV9_GJAX=L'M>&^ M4G: >Q@_FX#?V=I>V!"NE)QTAT1Y2^[1*:/TWHN=SAP#_,"M9.],''HA_K0) M &9=J08FU/$D?2%537C#[ZD:J)38MW"3:K#MP7299TOTU/"4H)T"]D"2K^89 M?2G#%S"#_ H[\ETF2WZ_-;_/?XYPZ5RX!(WCCF>>2GLTIMY@C:Y*['S>)M$U M+N+40@EJKB\#1W>VPP*V)'Z$2?5SC:@W5[%%EM1](=;8DDX5KEE]L5)0J_VD M5M:SG)>T,@4MIG#DMS6ADI$)]1DTNN,"VS]%Q[$]X/J,>77KU4=@%H!9SG2M M$UA6*5IJE1RL<';>99CN@%"K/.MMRM%PZHR=/>_3_MJMPIV%)(OLL6]MCUW' MKXP,MYM@W:GNQ5A1K:73F0ZJ0#1:+?REZ#A'I"LJHM M!$=RW\UR.[!2(D/N.B2*;+L[PCO6$$/]ED1F^?_9>\_FQ)5M8?C[_16JN>>\ M-;O*^$ID9K\U5001#"8'VU\H(34@4, *!/_ZIU>W) 0(IS$&>W3JWCT&%+I[ MY2SB2VD /H#YC966P)6:&6Z^Z>;:/)><))K#UC!-VB>G#K. OYEZUS20"88@#SDZL/^>1#=Q7G!VUS68LMY48G M 95B1/.+IC+?2O-S"V<6ND' >%)N]ZV).-0'0WWP:S ]A^8#>)^EJ?ERZIZ] M8R/+34[4QVS6RI&"5NK:2Z2_N^Y7U[6(^)D\\<+V?REL\@*[3GU2SMO9]_D7 M)1IOB42'$M7F[VY\+,K#8>NQ/!K) N$Y@IQJ_8Z(L&\;=HL_6!K8K( M@W[)%EZT>%@YL;-X7ETH.G'4,MF)@6B+'R:L-G81VS2L7]!<"C#/%I3&".^$ M/*XH R)#%,^M->Z(4R39"CI2<[QF9]&&DBC,6;EY<\N-RR6E%6F=H^88(FQ0 MTZ^K^/@VS%0P&;1% ]'9K-[8QN> &%769-56O< =9EF8WT+],NFIZSY<""A5OE2,\TN1,?X?%A*!2/AU M2JTM??%:&_DL%8N'6_R258EAD?4W@TM89'VA<#ESW?5W!\SK?0_'(/1)OM@W M5@Z>N;[L8MVV8EZD(O^&L>ZECC?E;LT6+?Z-7W!\6 MDWP!)2GL5O"]E:0S'$.H4GTN@^M.9>,8?Y.+FT1Q/EWWYM%\>MA4YHW<;79" M"X)/P-_"S@9?DV3_QCV'2M<)>1+T)["F1YB2_9!,#\5:>=E['*!:2<^W;RI= MIX+WKU"ZTJ'2%2I=H=+UI1FS1A5TFRGS]\FY,%%BU8P2 M%_M/65I;&[]*QPX'O7T/G2RYV+:-VDM##\AL#WM*A55EGQ![//O6_SX>&< 2 MUXEV:[Q,*]7Y8W2TM%1=CE1$K^0V=96*OMAPX*N5E[VV7.4,XPTK&@.83A#, MTLE0P^<8-%X@F4,OC/0EHC,0G:HEV Z7^O=/*Y?(/7#1 AD$]30114:"B=\Y MTC7;9!:&#@>L:[3("1H2>M^XTWGII?AA]$9=\R^4$<2IC)8P^]1 2Z39".[# MBX(.05#ZC$Q +]F\ M!S9A6SCH'J>)MVK 8;I;$:>"-D&PP$/P*3,#Y='2J@9"S'MX\0 M\4DBS:03GNED9#@KG1$6^"%KS!TLI&P^?=BQ:9"'6F3K'1%I@B'KV;5L#AT> M-72_;"J"=DN2_X923)T:N=2PRS=&4MP:]7/14O?]DV<[[B'E==,RNE;DR;VQ&S0>^;1ELM(6-V.M#SK<=C;PSA]3+661@Y]>?5A^ZCX,!";K/ MEKK2)%1,/8"F6S'!$.[!_'% MSS^DQ-:HW6FUD'O.'7_KO-+9WD_>#9 M:V'G9ROQ:&*PBN+%SAOU_+BH#ZO2O9S]\3MY'>09>S=T7(YTM96NAKX1%#+P M&%O!FCMDG""N-<5ZSV1Z,$ YZI0HRX" ]/Z-(VV9#>1HXV,+QG07!1E$LKCQ M3P?/OB)ZA0_9L9QVA9(D2XRF6V2E#*&08X2PHSP %&U%P ^TX&],J,[@=%)_ M!AH1 '!+IYX(QK(4:TVV.+UB)-L O6%WW/HNN1I(!",%/^XB">C(]/;W$E!N M9FEB:A:[9:OS=%J,]G*K^_G;92\AH!+6$M$ 2:)GW;, M2&EAW:\:2SXIUFJ-T;TXLK4LC( /,D;^F':8"5'<7 QRU@ML4]R*1]U;LNDB MFR"*%%$ CP!;P<5'T,]T]1YXB*.C4DTN<'YYE*"=@>B$UT"CI/@]8Z_ A\37;TM..=$RA5]19FB@A$>#/CIO[MV4PQ$Z"FJ,H^F]$?C MKO_!$^#IZ'ZIY?_L5)1Z1ART$-"-7Z[7P+"K^Z&PLSEVG$B<"U;YFY?.>"7Y&I-K9^N%CE-]5*GG,RGB.6X)H*5Z!E@V]J7\Z\\V&PB M6@(PPT]>Z7N[S9;8%3S_0K4?$^/^:C;*_1UJIJM=V>#.'2 MZ.>TOCFU05G3#9DIX2M-"V$A>CIS\JU>MR"[+[LP9(6AV,D=V'Q[6_DCBT\P MI\^8?4<.[=#H.YFB&:>*)@>*IO?WRVHF+-Q;=\[ ;WS93+5&@W_L"":/YG+K)C6ZO9O.V-GDQV\N>ITXZ@)ZSN#RF18[ M%!0QD1B1UQ'*6WZ5R3_#WKC_,%3O]=Y<[D=5?G,[6J74UK,UHW_@77E.+IOR MVB-%\@\#AP5(0ZU K,C*.E28JEBDB+!%C(^ #-1\/(*HS$H E5D&MZ7B-ZI, M;%>Y/2TW@,8A N/7O]I*NLO-N69EOK)9M9;-FOUL=:#+$_ P)%^#M8"=DCP> M8Y,#O,@C9*T0>IJ8/79[B&M7F$"8[@B#QKWR+QYEV^MA!DZ0JP M!FPG0R+^:X_A3FR9?H-_SW;R3,<>8<57%IDTFX@DV//Y58]:;3N'Z8N1/'L^ MF%.#FG;UR?[YM[L)CJ*_NM;+U=AM)M&SNT665SOQMAW[(%=;UI.+.^R[*6Q( MWT"]0\1G($$L*W>WP_9C7.Q%H_7:4S0IWU9DXC8XK*;T;'\,J:,^)V!<#DL? M^86WZ]&RS1!J?PRU]#Q3G,E6FNL)BZ><.<^N[6+Y%5 #<(P$A;(0P=R3*VX3 MY:U\ 9!]-+3VHOA_!)YD11J,ZJVG^[F0LYJY2#T_$=#[0U_'QN' M4D7@)]EAG,OW-@7#ZBC]IV7AD0B;PW%['I0.P:+HVB2";3!U"QBJ.WQV=/(/ M #6\D87'V;PPYX7IRN)1?6W>UCY;^)M22KE'#PV93[;L>2.1*"6:Y=4?\CJ0 MSF[>@6.F^%19=U8#^,G/%F;/O4WB'@MXQ#Y;^GX1_/L#/MZ/M(OMD6;K)HWU3+[6%>R+9>!C^-N;AA MC@L3Z'\$*'Y0E.]S-^T4WUA)_>P@$ENIH[?K6R<2Z'QOL%XM!;G/5A-LL_LT M[VZJ_6" MXJYD%VCP16!48:9#:W;,+3$(D6FYDL,BKPBF*8]E4?!(/O Z^@%)C7%NT\&GBT^) M##,E+G[\M1< WGM9 Z*^^!15V2(QFBU3(0!PSA^>Z$.^ 3[FBDH.TGE<=<+5 M.ZI86[&/MW9&K99&I;;V?LNA3?,_2K: 7VHA9/I7>-R+FE^OE=;3LE>8-]1$ M);I0+6X5 0$0NXX=YRBR/U%IZTB%?!- K5=BA6PA=(K@QWSVELQ=IL?\Z6./$T,Q"G?R.Z O5(O[L =_,\ >^C9;")M M1Q6HV_!0DJ1A.@G!+8P!F"^81=UP<,)5!#"_]W" ]>' 7'QZ46SZ#=<"Q;AN'."!N7[5U-#\Z+V6@V30DWKQB=,46GEC+^A[ K:W588=M M2D\LJLM6:Y);=#;ZZA":V#X+@F80O#PH%=?2D_A0SQ?82+N%.@7U3D5@.V)C M":$(>/KW<_E=SS\&$6AIF!!]PB9Q1;C^2K<5"71P2%"V%"IO'$Y/4]#N1*2< M*%05LOL==I]\M0$@@;H!J^GJ32?"V<001P[F!'+ZP:9[-]:E>Y:/EF%':!6P"_Q9(D7:>\0U@S6V.N9GQ.BD M!JQ4"Y.Z5@.E,PG1DR0JY446":5/+ M>H]\;P7\2)=ZX^=3UT_+ KXRB;\LVO=(_(AD?UTUF)^V-\O&)J7T40X?H99L M%6X78KK1@FRC0]IV" @&)(T@=.A9AB_F1[IFOCE%B*0Y^@P4V0Q.NSQ?^*_[ M!C(T[9&)^0/^ ?.<,?2' 2W&H6R(:Y*D$J [GT'%18G"*R%+D!7SGR]D0->P MXJXP34,7L06(06:>V30N@IYAX><17,+_[EJJ(XRA*JDP6^K*DD)$(5L0%4%6 M:04<3-AT/ $.(A,'(E2 B%B/I2E (]N4-2S2"&\GURQDS7%IX5T)$\)X?1%B MP'];L9P,8F(K.V_&1&0BY[-9D9)@N MILAS<'#C\Y@*4"4HX^(Q$ M:Z]ZSRLS=(_CBM00T-Q#=R-7;FW>;C+T%;S$PBG3VN(VM4CNQYBMSR4(JD^'=BE%%ONV!@V>AC=7#] ?9='\E#_^C\Y'?F M<%[(,KY:5GXLS,H/L_+#K/PP*__[9>5?B$00W-8<=[WK^1$?R=8ZD9C5 MN!&'68@G_Z TZ5W9G^;$/M\4$+OI%5&\>_?()6.M873([E^Y2-W8+EO"8OK_-J+WH:CTMLL-41L#/C!]>J57:"?7IIJ#. M'V-25D6&NAB,X32_%96>46<.5!^M,WEB=E![)9'N- M5:JBQ%?3Q<2 -N@';^^(@]XBVT&;>52,H)*N%*O=1G:8/+RR5=Y8@\T(9>>- MH9:_[]![ZN#*3;+.EY_,5(DO M:8-AOI:[&PK3%K1D.01G,W:3UC:),KM9%^5)L<&7TW8+2JD/+DT*=V*U]Y!3 MYT)[,=/[\?1#N9N%4/?!I=%28;,H5C8/+)H^IE:MAUY=ZY-+#TX_R1;KJ9%U M7YYO9O&FM>KK$[+6 #19]\QLI)T4>_/JC5&Z:TX;#5T-1.=['?#I]M&>R[%> M1$R.N5E,"$32:F*"E,6L6&>CI4R^D:W?".LV7!G?OW(T?9QW9OPLPJI\==WI MVD).5EM!2-K(W>A-(5J-SCM/@[@1>S3Y:3R+KXSM7VD+G4(]68G;#WATEG+&;P>^>RDEL)B:<:WU$F08A?S'4;6CNQ1"P2$K=4 M"MC[P^-=.]W,KGKR[#XOU5?3=F$:B,ZMVXF4O>L..3YZDT1W"ZW9[NFK('2N ME2,#.3:]J_>BV-JQ>XVB,7YJX2L/8(060ZEU/UYF>E&5;[#9E#"V%]E Q$\_ M=B4M'3/CBN]ZVB@=>A*ZS!A8A-/]L(F']^/]O_8 6:\0\HHUMG\-Z1^8DV+K@29/IJ2UC[7'0_1TA# M8]GZQS%]W4N05]0=7,>]Y[N@V6GFMA""SFF'%F5DEZ?&J(XX19*M( C7J@M= M@Q4VQAZ>\6MH"(1R=*]=&@+<1[A^=E[,9LUROY?,R9WR72'UE!VN3H1"X=#Y MEX?.[PQV3,6NT^$H[><'CYYI]'PL%L+E\N#"7O.:G7C_W>OCC]AH,] MJ5 X&VJE@]P0;SP2;S!ZXKV#T:.QZU3R.PU&AU).D^%)=B3%ZTQ2$ M("OVS ?V[N/Y^1_J%=)M3)>2^<_N65PNE?W1IOWN._]_#S;OT5/TO?3$L=>I M\PY+^6!Z A=>B"0?CR3?#$>B'\)4+VRHRG-[=EH'_/I0VKBP _BX$5+$ KRP MW7W^S!SJ.+JP87]'H/YAL \Q^^_ [,L;8_E*S'Z?K#KGV+,B@M8(RE=0R2X0 M5U]R1WZ-*60O!2&^P4"Q]R86O'>^&-7H'.(ZR#D(F#06&5LY?LBV$NPC-^=R MPBS953.M89P,C#UL6A72Z]]-K]]];/U+C1Y;Q1S:S 1[UFM,ZG?CS9U<>!A- M/I%>Y:C919ML]6:N#EMK.U=KJK4[H-?DC]\Q]L_&.U^T/4O5!I*C3^L!=?$# MU8>+V>9Y.=2+ T&_Z7SHHU;MN7=_4L M;#79#NKG&W$>*@ABM#+N5"I,R#/^=I[QFA'*?SG/^!P%ZLT\HSU_:BZUY7(U M[YB1;J"@ ZM1T=AAK\6OZ6JAKZ 3YIVNDZ$!]R>L[B_A:_'S;_6B MF-CG*#Y'"D4"N%<\86?3L1(V O,I:Q-/WT?B-:$U3)+I\.SA=)R0Z$.B?Y4R M$Q+]9VLNKR?ZFF(M[LMJIL)V:G<%+=E/Q5K)%29ZK+(D3J"R_/7F36CEA>'A M"TA\N*QC"(DB)(H+R)DXR3%\/=/^A=9!8X1U#.EC\_N^)&2_<.#V@^WZ+Y#, M%"+H7XN@9TXO>"6"?G%[ZC0)>!>SO5 E_-0(^5_E$SJQ(]C5V!S:?+UO*'6W M*.L+*?(T1](L%^G>/@V-'/3]BOWXG8JFPAAX2/5?R[Y[DY1F?GYM5_"KR1X? M!WYT /WWBEPS7^O>RGPC>C_,K^>QF]0-M+$$WS";.:#_?[ZFT7O:',"_DG'] M)<&M,*)]%D5F)R_G]>K,4$Q9S7:YJO)19;5N%">E1Y1R^XC&TL]E.8<\(.0! M7S/ _6W5FE+L_UFXN M3)VG"7R2XO?1*A]] M[-1OXCS;10LR70"R_ZXX-G3WA"PC+'GX_GK5,SSCN*.HNA*J=ZQ\ST8S6NV^ M&:\8KP%_44^16G@#D#H;WX8?9B#!.[I-O0SO\2>-W']:4X M^S;_)CWH];XAJRI6.JN>J??4^QN]F!_,5W(-F8]Z<#_:;*=QX5N[P M^JXTT%C!WVV'U;\P+LJ9GOG7(\, MAJJU[V:MN:(T6:%5$.?VL-A*UB;A8*@+&0P5O\ZDPD$$ =CANR\0,4X^4(4+ MX7*!<,E<<^$@M0N$2_0ZE0CAGE,N'"D5D)(5Q.!)>W^IQ?4L/..BKG MDPITGU=XOL>PH-B[AP5QUUSL.PVN(,.":(2/3 RB?[YJ;-#)F-[7Q;&0WUP< MOWEQ(L[! ;Q^F-MS(W,^KD:>._^PK4N=IO2\L1'BSO?#G>A7D4$?O/6/F-M' MI=>?:Y_QWPP'@S_\P\7(Q6Z:O^,"$*NX\Z<8GR2U8V 8:9G1V MGDYE;)T7=-FJE,:WB>9Z]=')!?$W!!M?$W3)NCWX.RXB[USLQ2,C42\@.2K4 MFO7[WEJ8-XIWL4AKLK123]EA;!C%?(Z[?K87_Q]*S LCA_]^&8._ M *H0.NO4JE=;67,YV>]58J/1:":O,%7$3T@55!>X-*KXFE9E8(TMD>97C(8L MB*:[(AZB\DXH_BL8DI\MUO\N;G5^&1Y<9X;,(#:U>8P-HL5V<33/WT_L0I5K MUNP!C-'!PCMY'3NL*?L*UFZ(X-];'+\%P3M+!P0G#NA&+X89^CI_;X7HW&X0EL7YQB'5]#ZKQN!F0*^W@?7TT^#?F[AWS/EK5Y#/4G MG:@*PUVP<&>ON<-6Z1]3#W2!EGE()]]."?A .EE-QHF'?*3_Q)>ZD]ABI&[6 M0V."Z83J"*>ADXNTU3]9;SBGDL"O162:.UH"XR#4!^H+WXCI_64<[C2:P!HI MHU\4]?PLJN BWK-\JM'E!G9SJ%9Z:E(28M%X)A]?P[@C(L\#VEM^G#P/\?BK MXO%I)/4?X7%[^)!-/,S*QERVFC<3+=):;N(PP0?+V\1U[+!P]>/D[5\D7"]& MM=CIL\U ?5;$7IBA2?X538WOXD^G_.L59H8[DAYC;6]A-I$!^2]!3"V;6$_K MPUD[VFNL[S?U^WRFO\ZUABG'V$[_-5'P[TT WTR"_P$%')?O*K?,S*6&'N\] M)GN-T:W2:D?N)I@4B'Q_O@US:$]_47NZ)H^A3-W$R*N)'Y?Q]HTXV5_&MB[3 ME0YH6G&Q]%DNUFKQAK6PEC-66$=ZK5$[P<4?)\.T(]!/8Z6$UO;71OK+](N_ M'NFSF8:25]O-*2M8^41F&KU)Q.* ]'% ^D1HFG]'TSP_%;0)"&]F*2@V=84+ MT!?F0R7YQ6SZL\R4[]D,] OK Q3/*QJO"=!;:9N]>YP?%N][/66Z[.7FPKUN MWCW.I$E\" -EL!(0BUUSSS9=#^WZ[T,PAXXOTK\K^A$'$IJNYY7^E6USM9]> M=[5_PI3NUU9B?ILND5]*MN7Q>F3-QD?;\+KZ/2O+W+--K[^P17NBLJQ+)H&_(RO\" 4<%CGT;LJ)::8L]I"YJ#TV M[^;L1%D!XF.KEL/G%/N>6>#[E5=?K?/K"=N\'E_9:U6=O3.DO9I\':E$!0D& M(,GTW]W-QN"EIVA)=;1(/QIWL<-#C71\O\_4_^RTT_)T46@ZJAN_7*;FVY73 MQBM*,'N"(K1;ES#&+_XE*"MA8[H:7N;:ZS3TR^.+< P,)KY8XK^,[V\XCH.S MA(:FOA/;Z6GJW+;;UM3]\H6N80Y@+'T!_9# &:+BC\[&XIB $R<"U1[5!OC'J8SD$+>K9- M15VWD--.RM+A)+,:"2DAK6G;8CG[/2 M][#69UGI+B<((G#!E?MUGB]%5S>Q'%^U(Y6'7GUF+(LMT%=^4&+PKHS-(AF3 MJQ9&O4BC$R]4> L]1K+#Z)#=OU)>]M+E99]=LXWU;#@HEC;=R!JN/'CFK7*C M-R.)K,EN!DWSMEV?/C6X%;XRL7]EQAR6)LW;PHSMB+PNW:@26V&A5OS@[;4\ MUS+0IC6:#RI&9KQ89>:/^.WQPRO+VJSZU-W8MVRIG4Y'X]5R9BQ/:&'G[I6# MN_Y0&E>F=38Y,W/-O)06TVVX\F"=>DPU9M79LC5/INNE5-]J+^U4:Y@X?+L2 MM2:+R+18G$?+]W>/F+)TB;.;BR MG7FH;>X7O>Z\DY]'ZY-<)]-*9O&5R?TK[]=(3J5+>F/>:"]O,S&E715O6L/T MX3,7T9(\Z>8F*F\GRK5&:J,U$WQKF#F\DGM0*Q&AM6GQ:%7I-![FIMGNK>AD MZ=TKLVUVK&?GS1D?633O:]K-M#\16J!M'CQTHMK9IF@5R_/2F%U)Y?0T]G"S M@BE$!Y=:TW+]X4G.].?1N(WTQYOKH46^>:J4YWCHQ%NEF[G>KU MR 0N/5C D]7I1IKI3I&/6)'):E&Y6TQ5O*T -&T,NA&C?;<4>=6:]R.=IVCY MH8P/*P!3C(&N\8922_+J(&O(ZY0TMA%>:P"J2+G'Z&PNS>N]QYM4)F<-%O5Y M#:\U .DWBU;O7LRF^RFOQPJM4Q M01*)=P^2B%VGDM^I-_>K1D:\;P;XF0_IW4?R\S]TMJ1NFX(FF?]\6-O[$U/6 M'VWZ>%?[T1$:BKZ7ACB69@!^&QKZT-D((9)X2/+-<"3Z(4SUPO)FGYG6X:8_7=@]GE*(#X L]\GMLY9 M\$<:Y$9&T"CQX]OD7I2U_"G(^Y*_\?1[_L^'"9ZQ2&\KB;2*SNTX6Y M?#>\Y:74QFZ7)[M)ZUESV!C[?!#K35Z>:M5UK)./<;VL/TL]$GM# MFOI!R@#^P_W.*<7V=TO+:E*.UAB9SW8NI0GM,2^??5BO\;/TS51@2T\/T7X7 MU=%-%'J:QW[\3@4T)@C)^N\FZT\H0[@DLHX.[?%RPM863US/CLEQ13/;F\3F MXLE:TK756N(F"I]4&H8ZRDP>"FT@Z^1+9/W%#>>=!H%7C+DWP7#V&#XK3":?$PGP0NT,<[%\2[L&#ZP;N\"K>?OI_,T7%*M84K-^PDU M@.?%X@_=[/(A*_*/:CE6YU>VG(Q#ZW6LRJ2ON(">QB&UA]3^93T*WT\5>A.U M/SXT./&I7BJRC[-V:6Q4GNPG'@I(L(83N^)2AQ7H7]G+DA5%P][SL!"U1K>F MR& $YV=$-F 409P+,VUFT&Y=6LUE.%BK6:Y_-< M=PE#%["&$D]PH;,E)./0XW(Y'I=C9%RJ&_>1KCTO\(UIO[($XV=4(^Y M,%H(6<)?Z6K68IJ18QI18\0H4>4TU*I@$" M>]5:*T6]?)?HY1_PK4CFHO,':,6/!387^AU"0@_]#A_F=S@KH3>,Y-,T^UC6 MYRBU5'.5L68/&D#HR1<(_5MX)O)3K,;0#C, :4,>V0132(H'U/J&ADAHB(2^ MB8OQ36SI->\CUQ=$WI[GU\J VV1ZF30_&6:(,A/Z'D*2#WT/%^U[ M:!J0@6EM2/X">K3E!;2]#6V.T.8(G0L?+6%=6FLJ@F9A2X-WR2U KB9R[7L[ MFY@I;,2JJ[.U=3?39F2F!PC6Y.&HW9!D0Y(-W00?G9[P%I+MU!N107ID]MED M5A\HC5+[4:I,@&2QO1_//)?Q_"T,_@JTC4"FY28^ALK^R97];>')\LUG622-[K+&$>0@A>_AL M7\&Y=_\7^1+H*[JZ)2A!I+'B_P*CD"6.9-HZX,GQ+]%3M0*]W>/-+(U&,K M&+N'E:?D52)VZ"_^F*GM(4<).4KH6_DVOI4KVD9KS"Q/J('\75@?6ENAW^42 M](@Z"@HS/YC)YF.DJS1ZG4%9UN-K[J%N3& (;XPTV\DD0Z]+R ="K\OW\;H$ M\X':O57JE6\:]SW;R&O%SL-F- .?2_PO\+F<"_M#Z^ERD\\OR-]R4?Z4D$I" M*KD C>&[4LG7@\!#90V2_\,*+ M"_.LKV=]AN7,I6DXO,9,BE MCOO/)CMJO9XM-^/+%K 1J!"] M8F//LI&OYVD(2%K8<2F$%M:WC$I^M 85\KE/4)27HI-@-!/IZO\]99.:/"%D=,POR"DDI!*POR"+VOUUY$5-H$XJ140PZHQ MC/I2T$68 ?\YD:E_AFW^85U1B-DA9K_&MKUXS/ZBMJV7,N^S;8.SY_.UJIDV ME:74VRAY+A.];413L2Q>'!G.<,6Q+[9K_#_2*_VW>UG=5O&YBR< U\PV+7F\ M\6/('KG27SS'211?\4H*_H3%$JJ"-3FXE27Y%@4D(G6$#.I"BG%7##@W21=J M0) KQIHB!D:!"MJ&F0H2(RP6AK[&P+>0LF'^UL0;$/05T]23%#?K^,=A MLB5''^J2>->+",:"FU;CV5AZ\N-W-'U]Z'9A,- 4=P3YB0_F591[PH,19D_3 MNZF8;/0>E=EC>F":]UP.'PS'7A^V1'8/YHHQD+E ^,LEQITK0+\QPMQ84&CM MK+L$1L%KH/-)W$4P/W_4&S7SQS^,L!1DA4PSL73\A#'F,LS8MFP#@8Y+?I") M9^V:Z6+4Q7=AO?<8IG,I^.6TL.)2PU*3U6YJB^X#7VVV;YOKFCH9)#X-5ITI M^R0_54N(%\P*6Q-&CYM(;/7C-WM]6)GDX? 4'QIF;&B]D U:S8Q?*NO8D)AB MZVXRQ8<72VV/>((T6!,V-"3; !!B6-"#WB#!,)D1PEQ(@Q^$L86,LP$#L?GE ZJ9N?)EE(8;/)W M Y%K?1;TS+F86>0+V?9<4/MF?2KTQ/4R2UC0R^"3O0TQBCQ&A#-).I8IFFY1 MV*+KSY(_KQH8EO$BQFI=N*A#G0HXUWS<@6\ \5"29P#GBW@<8*YDWD#0O=PF^'1RJ" M.(=%FW@_^,%4F]F03$7O!0SP?%O"C\1OEBT3\(]$3 A!X/,7-!&>A9]@D6V9 ME'#&]3T^KUW%S7?:0E"#"H + M,8P A[#^;N.O EQ'\"L\5E!A[!KI+RX"XN"O,< -A)>)7T&QA$(<'@QW!+V3 M) &[S(!Q^$ 4'K;_98Q9 :E_:2-W\CIQE/U38H%?':XB4,/I+R2?XRM[K6]%DI>__W_\'_<^4<'D!=Z&Z;^[ MFXO!2QR7"LO^]R0N Q%! W!W5]&XZRSQK+ITPK=J\M__\2]^ZYZ/B+JB&[]< MMX=O5U-:B!8E'I )BHPP8<\C1&_[)2@K86.Z/N[,=<)=Z7CKCX92!% ',"GK[S7 (8 M2U_\BG+74(R 96+$V5B_,DK_7!6NLL)@@C\2XFO'6_DCJ:!-38BCX?+8ZFI?GVC#P2"I*1C6IFL(FDEU !.&XBHZZ/U=_,*< MHHMSQ]DZ&B;Z]E31DEIRGC<4?4M9ZY;@B7<3\8A+64!5Z) M9=CHPZ!R@._''9<<=\U0&J#_=4Z"(4?!^,_B7*[58\Q=MO 3Q,.]_OA=N66Z M^D+4KYA:+7]^Q["$86S((WRH6'\'CLG$]CS!>-E8(\?FGT:&"NM8[\16B.R. M'L*W;;>TFLKB% Q)073F-8/:C!5VR3'UP";'H%.1-=4E6@5(+L2/_#2[[P"& M\G$ _OC=0<92QE8QDYT8"-%1C?+9(-;0F%MAXYE0NZ BS)M $LL[@3'=E0ON MRK'%;DU]X%K8AFD+&G&04-#Y'X=ML*6,\8-QO1+X;[Q*(H9,>['0#6O[CI^R M)BJV1/Q^IBF;%C'\R/O@F8['EYC]8_(-02"!>(@9;.8A8+;8MAO9IJPATW3< M&)3>,2Q@]%YYDW#&N8)GAL+8$EU MS+=]/D:5K-#Q+7K.R,T"-<99PX 5PTJW-[BHYF&:X(X4T># MVD1XJ.W8I^Q;O)+@O&EC#4->@I:Y]46R/EMTINO82/BT![%\&6(]X8Y%VE4@'\MJ3"&,99^^B14R^8SU9O[>+,^[U3K>;;5 M-XS$ MPS7#?1R)*U'/J -G9HQ?M^M99(CX14AC5'S@4_/*%Z+ C[BQE0WC:-AG$T%% MG:X7*(BAF'G@&3OJY_-MW0F(;1DG>/%D/_*?@"N^I.5^$NJ6>]TN.QVU5;XS M:-],A(384(0WH^Y6Z5XBK"<'<\?BTG[,MW@UWVMPG3BO:'9!Z4),-!&,L>=C MBL_K-C5\CIJ)SJ/:O%&;49RUOD&9\9CV!*,1(0<_C_>>B*^W\3^NEE,Q!4%D M;N4G0YC*C&4($L*+GIN,$^_'EV#LUQ"E'4_#H[DB*'J[;J6XI? MR_MZRIQ#6_M<:E(U']AFM#WF&^OY6FPFDIU8=/5N+D4.:U-RC]'$V*W*%E& MLR1T$\B_S'Y,8[D1I_!5.V%H8JH^'K2S/W['CTA<:GU_OHKW3N_3YZR,'X]I M@LL6R[FDGY$=?-AR^^ MHBOW:%G84O,.Z0:P&Q)3WO8*JOE M?<;(MCZ9,XZT^_L[J<@-MU4[+PUCBOH Y8RR:".2,5P%^$W\(WG20:N.. MZ'9E^4XZAB\) P-\ZRLY6RK$13':8,/>.>TK9E!N4JW"H]==S5&CQK[+>UQ" MC:8<0E7)D\VIO 5$NM(NTR.DO<6RD !LNM/(!;62I"=="7O_H4!!ID@P7[( MBPF7-"EQ6K)"KO8G[3@I=WB=H,C="O@Y+FN(,S]-S%*I;Y9P4PEA154Q_[EF M*ENUSF''VV6IPAR6()'H"E;:7$3T'&1^)FU!WQ!X]5=W;!QA+H_+943,M]19 MKS-,3CJ56V3;W+M=:/4=7[@[J;NBB08&*2IBT="Q1Z8LR8*QX8G'NV*";>)+ M_/ SG5IYK$_+C9S.;X26R#_%YWGU9H75L2/FY-:UP7&.4^.:R8*3'B_#5JRM M:NXB_C,Y0B' /Q_@\XZDM:5)@9L+75&8/4T2D[G5>@;@LO,F-RV+9$P#N4*V M%5:@2/=%#'7(N-L-L,)TG3.<)TWF^7SK/7GKJ\TDJ;O+)&U)5HI^3,O0!R1]^W_*9 MDS]V_=R@+8+9@LEH0CO-#4#9ZL MEN@^EY*\440CP\9*(A.-$R[ /A?ST)SSINZKW;C'K7'MP0YLPJFL@G+HKRV! MN" TW&;R4QE!,0[)WFB,QUAC-EP([F)!#BO8)*L?HT/@N[&Y*L@:]5 BX@#U MRL3\WJ]K)B"TC38* M.5/N>&GH@@AOO #"Q:BT =J\\E5@^NNTKW?9" 0:%%-G$.92LE.&[<0_B%<5 M/QGJ_01SRHQTS3:9G\!L07V,LO_FX!OR-_?O/XR]8%Q7+*TG>X1;\5-FS^3EPI5;Z=7CZNW@QQDA)5H?%SB /!L9%3 M(^:YE]&DCRG')AX=>EC>;Q@K1%L1Z&7>_8'H8D4+F7BR6D_UU-RD\M@JU!Y; M]16@R_%2,D:!M$N_U'"QYK2T>9&0 G<>1E(L8TE5^VFA-;,L:W;[U-7F:E^* M)6K-;+ZI8P$4>X9A'H46YQ$WS=D@A$C"3;()MK*C5!7:7<;)<;JBUU!--&?( MXCR"'Q&YU0U+,/R_\9JD&R;5/.ACB28% 14= W_C7BN3""^),'M5RD1CA&1O M0]K-#!XA15_](IH5:>_B.;QH^QY15Q1A8:)?[A__?H";9Z?*P^=R(HH9+"*B M"!O=MGZ-Y362@G0UG\7KNM&H0;+;-\ZY+ V__9__AS_:Q%X[)+(\O/QG^CZE M#WH<_7__FTFF,O_N=UK::X1T8.#^D6OJ94>9(SP .?T"!$)EFDDP'/1]H"!@ M-C2@'B!57,OZLY?_2A:YL TTS.CL/)W*V#HOZ+)5*8UO$\WUZOP\,OI:%EF0 ML3* UPGQ Q-UO11^ K@F,L#Y)$Q00W/8C,?Z(E$?[WLPU-QC5YEQ[*.YR)6$ MV/VBM%A!>YD#UO??TZF@RY:(;<-N2U5 MU0-%?LAZ+Y?U$HB9>$LJ 1C1+!<>Q]4UAS6AM5.213F-RVBV? 8_ 6UU.N,Y M/OV4C]ZQC[5PVRNJMR^33/NYLTD0]CS%[3'B;M1? JZ\8[^@( M%W99/;!QWX%Y+PFY;,AE7^*R!\93R& OE\'Z@'5,G86DGRX$#4@Q>M/09YC% MFL',LZ87FD(J.>JR:G_Q,,M7N?L6!PE>%\8\/::)B7^;Y;QP]D9YIB7,D>8J MGMN^9MB:US7$8"S&,@GYPBF0*VGJ"B0J X[[/8RT3@0.FL9YMB$8KQKF0&DF M>=\F"4#Z'N5=#S"\8A09KQ&9)G%T_A]^*P;PQ"F]T9 ,52T[R]?V%N95/M.D M=U(I:#@5/I?$Z]F0U5\BJ_<;8+M<_ES$_1VUBG3T_ZE;JQ5#U\+]\N6'.=6T=3D4F@NG$V?"9535M<)H6GPJ[V^XRD M#]$H'-J8 -]"%7FI8$;*AGYW*LKR]L MI?Z4[1_COMOB58S"KZYD#4!A-\\^"]V)(=F>7.Y^VT90Q0S]/SN0%N;5^'HE8:NO>'AOI]Z"]&POOP 'D!!-)_FBX+^<_M]E>TJ1%+&2]3L*] MAA=ID]1/TN&DB_E>8T'X61]!Y*NBT2;0@21ST\EWU(G:J+/)%+*GV>8F_QC' M&GH"0S$1E)%OD[QZJ-TB<*/:LWM,-'UN+TF.F2)%VN?9/X&OTXPFP!5R7P2B M>A*&^/84O.HQZ,L_@EK)!=;59=TVE9UR#AE^D*$+#FT4_ ^S@D:]LJHB2:;5 M@G395U1E_PJX64;I4D[CEXC-)V>-&[2XU9;<'^#9'C83G#*A7 -)=60UQO2+ MHFYTA?4 'Q)D06*=,K@3Q-Q(FG6I/DCQC7S7R"TV U$ RRX:/U+)L2WH)&@S M0F!#U/5MMED9Z]^@@S**=DD,E"SL8! M)_(CHDPV^U<"GX"< INV4Z8\@<(<2P7R4S"H*U4VQQ;C#SEV,$@MQ#[;*:,4 M1.EC5XG$X>P2?^G=ED=@HE9U+9@__"3%/!(C6*=+MOA$P+REONH(6*!Q,GH> M*E-K$UNU&W5]/N@M"Z.!D*PK*PR5(Y54I'>8CP&[];L.,_,*==W=]_,A &#].4-N[<)65L0PT4J?]0BR55$L,]P@1) MSIC;#V 7(&'S]R.+?;Z1CP"^L;QBCYCS]BO\:L<:E)+_GIZ*6P!5:S] :DSD'+O/<#_/NM( M0OGNV(>%($O^16V3/L>T!.3D;J6HWS;_$\/F2 ]=7QDQ;!-VF24[+"+TNB>8 MN8W_ESV[:?N#\[19Y 8IJ>ELSLN<>MLLB;FD5-O-48R_06[F=1-KK/L)-O[< MPJRD<;-RE!=[C65*>BISFX=1A(P$2D6/)Q<"3E$UU<$>IR8D /W#BI"OQ5'W>XMMJN 8V54@OK*UFW#!4,B3Q-/HP9Q:6 VXP9^W(RM([ MYOI!6V;?FK/CJL.WLD;T/;=!C[>;;?Y.;H-?CWS=WW82=5*=XF">NED_L(UL MR9;ORV,AF6E!V_/#1!VWT8[NOF1'RP3Q(HQ_J1I5 U6!%N#L0H::0=V17/%]IN-G;3$U\,16C]Y M1H39=&JEZ*84G?<&,W[Y%,_6LJKR[BZ!KJNKJV[P=CI/5GL1,]Y[K*]2RCR_>JX+-""%VTC3=+INBE,-JZF3#6-;,AFJ!XX" MZ./D1PJ2AU6E?7ES,C:,-/'Z:FOZM'5\-!8SN&8*3NR_IF,DW^$D7E) ?BK( M^'B\+I\Y'>/$E=,D@%\CT29-39W25.H&;6*TQM@+C<0PNI.!H[X>E!?"F>"J MKFPIJ#&N:%@&RQ(VY,G5\ LM5]&-DV!E+_4X*$:M48U-\M6;9+FJEZ=/D[.Q M,6E>KJ8FQE2>-S;1M""CW(H;PC#K(#9V9+#+MS!MO]3R!0+ 87R4YD;1L3!, MI\71,)X91X=I(2$-QU$I-1I+8R$MB#^H173JR5/;*EA^2=CDP9RI\7BRLJJI M9IF-1$KCITQ=:B[8R6'SGN#K+F7.U X )=G$3'?S2]8P/:#("/9+40!F+&O6 MKZT3Q+&\#ZR:TR3/.%HU%[VFAA#!G"V(& JC4YK)[VZ%].-W#0DDCW9W:-=9 M&R!M&WAO0P"9*T?'>JXKCV]\/>F7"/H8])H6=6.A0P(>3*LG;E*,.[2;L\4D M$BS3 4>M-66R3MTUQ^$/8T77L9B%3=[KQGS[E^-SI>\@NJ(F4C]K%JM\"NT- M2]1)4A9(AWPSSS %1ZP"'X![/8&V1^8'^3][OSLRKS#MR+E*SQCQ24E.:;EV M/;'(97?$7,1$XB_)-E:Z(9E(VV2V4[A[>G32.)FW#*8AA3=PX(P- MNVX$C7*&9 !G("T.H!$#$/#^O!*TTTC::X-OVB/ZD].NU>FL=L@[@+)]8]/& M@D@'TOMX"A>+Q9BEI MIYA4('F0J@*&M(<-)@]OBY])(=&DCT+<#W]&(0-N],!BG%[,JYG6X.Z&[0GS M\?LII.,<2X7,: HDD^A-::R,D?0XS\=8-=L3XB@R)F1RO!65;_3:7@]H@I&. M3J_O@N9X0VB-D?&7V$($^(I33!L$54,X;ILV[0BLBG=:-=T,[N]R7Y7*L[O; M5*ZG5FZG>;74*V?'+S5OVAGAA1@2'(KHXP@4/PDP5I[2IH)?ZL+/&4BD@&<) M&CE*R#^>"&@>)J6!^+L^5'F8J6#2U%)?SQ;\\A$MSI(H:\+X-;8Q;&&_X,&B M$X6<-3IU6?#G#F>"9%55-C^VA?1'*J=-3!585VK 1!(RP9*X/.0E[+D)#AB: M1G-63_8VKOGK?\?D?^X +9@5P"5>H[B2 KZ5(1/==2^#)6\(\B12QIJDK3)Y M80&'PY3P"QI4/SVZEZG-LR"4^@BGY M?Z6-XSL"N*Y(*N36QT51T]V@1(#UV?L*IJ.7\6C 7QMFP,; MY)3+4=SN(!_R7)4P"W'R)RQX%LK&EWDC>E1YO/\PW#KF]BK23? M^KJ0?8LCD0"S"0<9"$5MDTDH["UZFJ-.41>SF594YHBVD0S0RD'-(&=*QHX$ MCCOQ+O,WX)T5V9!!F>7.F('>PYJI#C$5R7+L! M-TK8YL:KR]D&47 QR]F^K@\(YGFVX>:<.WRX@(U*15]XBM_I09+7DW!S,DST44Z=W(ZLUQ.C-Q9-7T430+*=SP_!(C.+SP9:)9.^3 MA>:RRR:'K?[]S5+6YMHG@:T]J51N"NI:FS^FK)Y<&>;&%O\LV(!"SPTZC_* MJWA,Y>R ;%22-PUV9:?94G.*NLV["=+93P+D8)4O&5I%%-B\V,[RQ6@K%Z&S MU()+ZH*K9/9:U%[X$)K/61D8?B*V_$ACBO&.[&5TDX8%))LBI"<35U7 M1(\W3>*[(JXLTG5C.^#04^2=TD;(\-V0]+_=WB)7M(3QD_P/F-PSGO]A^^%\ M!+PV1A/;3J_C\\&T5*^:JUBO(+R[SJKI !Z:U[@3JL#;[A%U("'?R95QH:JO MLZPMY>+V333WT)\!1[Y*Q8+'(IZ83/W1N%AR)RF5D"5D#WXB.?86& ./T&-@ MY25\M6L]>WT85@(4/-/I?%Z&#VW'<$(1MX?F7IKHMJAZ!\T'=)$?(MU,2RI4 M8X.G_%R^R?>'MFVFQN@/*CS?;,NFFG7+[%7OQKRPKMC1W("?V@)T $FEKS*) MV&OE%/.\:X18N5%"C"*;9&#L+;!AM\"_RSFD22]K[T71^-;E M,I+[&-Z;CPU M^$BI/[+RI7GIOD]=^5STT+Q^'>A]L 6P.RE@ND(:;T'QOV!85_YQ\#LZ#(1C M(_(Z0A687V7RSU"9KNZ'W"/J\]&A+$S6K7E_.9^[$_N(7@6_L_J(7H FC]4/,;JQQ9Y:TMA,83,N\IN/ M5,.?@69CDIE,\Y5EA4^V"M9B(W8RT38TTA*_)%++LO MQ)G6#2O6F,7Z:78S-O,/*VT4BTTGH IG M):P(HY C*J))-9]8Q&.N0!O([! MUQ><@=KR]X#3GVFQ.<"0!@V:?#]U+[6 Y.-7R?AA9X)KK-3Z_);4%^EVD(&TE G)L4/(\VGN M^5<^V8D8]SL1+X/DU:I03>KLCQ/U7!\)>+_1+G3MC MP<\WE<=)3>2>-CDRRRYYQ)E(J-Y3IQU-^RC5@R..M,_3G"'VRN8P1'W-7+A] M]]6GV:?#)@UADX:P24/8I.&O:=+P;(G;9T:&?6/*/!WYF-.3QJ,\Q^E.!FRP ME#VQ*GV^#+RL)AW1G.[B.;5?>$JU^&CV46KF[N7B\OZ3%.7'I]C\QLS->#9R M;YOU1D&JYLALT*M$*G/%)H_'IUP0.N:27WUVIOA2N^CSE.*$7RF^1$"GS+OI MM%HOS7I"OMJI\&.EE,Y^K(ILT 72/@.!$"_+F_MRJ5]HLM5F^J[QU.+5[ J\ M(: <'U&0+UR9O=0&-5Y_N3,O]J*.L>'6EW+1P)*W0;E)W:G>Z>V6&6!ZDFCD MQYU'*6R8:(IV_6-40FFD78IGT6TK$5R>Y<5;^OA;*%K);CM4]MS);7"G]S*Z M2'?@$'FB5SLSUA5%7\%:4&",R?D0;K"FF[.O1.Q M?IZB0,*O!"+L;:RS*LXM$+2D%SCQ=$029)@.6EBT&Y53 IJXI'E7(;I>&+I6 MQELI8.@;0:'<%S-L,I[>FN+E?)>95]1$B7O5]^#M[XA3)-E;A6Z_<=3AMPCM M-2V^):=7J^5]78P\N[^#;5X!T^?V^NX**4MTB]4*X)$LCQ@'!?DAP MP>K5T&-/NAO-&V+E(5H9;IZJ?] L+&O2U3QUDKJU##E[K2Y3 M3R>_RKCMJ@-MXFP"+0WZ_RU\T^\=GMN_[VN@XBPA^"&>V:B/9973^T!G\\/^IO;VC"7X5JD M5]>AH#K[?'3J$=2W>?&'%*9O%;LK.@F ]"4%ZO2RDH,;GWJ$N=)M18+S-VB3 M+/ Q?Q?B_"09]V66,!D H%P-^ R9LQ>?\DION)%38?TA=E/I"^/]MAUSY+?83<$;0TZ*8*<^18#:X-[YCI M\IC>-X;Q6=ZE;O&SD] +$FAO )CM!OT8$V$LE[:1/^:G,_X+C!KHP_--W6@A M_;Z1?E^7DT,L_CS%/V_PZ>I(,DZGT5_=%9OEUOPQ>=>_CZP&RVP#C)A4<.;R MV>280"SX??=:[)]KYH*B>6P8S+NH8%Z#%M_2V@JW[S'%G"1)^W"XO9,]]FTT MI0OWM'Y,AAQC*2=0 @H.>O%ZR)E2[>ZF] A&EI/1I.V=^]X5G#XE\.P'[V&R0*&!&V^M8@Z?N M]*E_ORY#'.0"(Y+7#*U@>$8E"B[E(5E(7AG1I>:V$L)@;@4+.BV'^:W!(]\Y M;ZH#=*XS$6&7-=V0F1(^1'L[20(">_2Z>WE M=0&!F)G_"\C&PW8NY-H;4. #-6VT,0I-E/5EAW"TRWM03A^\&PQH2(R%1B/" M"=/VHT-NVY!_^^'/>-_:[HNMU&@SF4>2B\*X7ZH;F>:;F]H1QI6%0R+#^VBE M3M:3AE!3)4O._(PFE;%=O8,4!1G!_2K+4R[#U4HU7KWM%;DFMQCE%UBUR"1C M@37)#!(,9_ YJ8#"_PJBB T22/3?EIQZ29M>0O0N@C$\?DRD85O,3XP=$H(F M.B/Z6#)Q//./S_L!G?F]YPC;I.BN#\DD'=.+IEO0D'%A6[1__U9?>&X%!&%) M48@XE=%RNSD:)'!Q_-:\]MU-;I)L@HL[OW@!!1^R$G\/6!'.2EK]/%2@($A] M(5-/0.%Q1IZ.-@SI&:DN%)U6>GL[OCH@*]@P=$9SNLD#4?CV#BX#1<"(GD^/C[,/*#*1B"CIX([H8/^-L9B=UO!(RSQ>P3* M0$F;H\!#QMQP"8-CKB]G%MY%\?V/G@OLSHG#+.&M;A$R6,XI WZG](=M'TF0 M_I RR,NK*,^$%>674U$>8S^UHOQ/2W:=T9I2 K%BE..&<3:=P?_)C(?I6&P\ M3+*C-!HE8LF8@)S1FO2.BH743)X,N3&A*EO"MM"VM1V(^*P(FJ-STY<97!F/ M74>#*KU/.K@2#I.:7!G_!$OG>(EXQ@)OYX2I%D7/V"(=,+%JZWQTRY2WY?+X M5FC^@27RY_;B-ISV,IH. G]_]:2II8VU4MTP=YQ CIY#^F;393N*WO:@8FS\ MY^@?^C=T3T036Z%%YYU(]4/+/O]8B#LDQDJID1@7$L,12K'#>#(>PR0FLD.4 M&J/,*)5A$T@Z)+$L&?BH*Z8 M;FZB"0;*L<3B6@JG@Z)ZVW$E=VA+N=@G9E6 M[M%^4I^.ET;J"%;D >.AV]AM4$Z8J^ M&5NC$B3,JGC',$^/VDWT>JBWWY;M6?A0G>H0K+N[$5*W#6V'SWN*O6$K3CD_ M+->\:?1P,* 9JU7Q&2"JEQR#M@B MN>&LG@ MX#;( CR8;(%]S71@ST= ?N7,#I -1A/ 97J%S2F-6N 25C T8I\)IJ[1IMDF M?B0QUK?OW!Z%;S85>1FCCV:TOZ!Y?8*"\5.340.+H>>@1W\[@!R#EH)B4^3! M^(#_IG+Q.(4HR )!#_2WWK=?_'.3+J@@/@UDR/] 77'B^%LEN2WP,ZV MV$#ZB6'"0 [IO7+?CEY@;0_NV%*N7!<**=!U'80K;*&0H][ZA48(D\VG8.!Q M=+L]I)(L'0[;)JP.#I143T!4*N_2#PR+W2(8O1+3W!2S!#$Y,GW:.1O1?S9C[VP,]VRNM\?XTJ6$^;M2:"OS M1ILKJ#/T)5#9"_ 4D3)R?4P=:2(A?N0Q!MW'&!8>6]^^U/\[Q6SJK@.J&.F8 ME0**N]VW,5OV"YCM,!CJ2M<@Y D>.X=+O\"@Z6A)1?;YPX(.P_6=+0P8?$JE MX\ZEIM=;B\)M[1SSPC:P">G8(WONW EF>P866QOX!2KE)7*)8XPX!Z40%]Q7 M$P^]0/R 4]PZLJ&Y!F"">YB['-*O.NCO$S8PZP?P'$8,T8#WEB&[3(I-^]-36)^.@(M MW^@T7$'FDU>P5]_I;.E[[*UK*S.$$3Z% Y$V)>-'#L3:ZT_0];N_*-R>EVW; M(W=D6S;@(L+=0(<09:2)E*D)H-V.\,)3\+,P;6''0MCNU@ GT9H[)\?J[S:G..+-<+H5(4)#COMVKV $9#IUM,D[=XZ^OP Y=O MHW[FKW,?B>?$)F.J7CZ?X_U.B.N8?;U[_RSIG&'^YIE[!_DCHK;FII6-9?PO M>#$.E/0BOIGAV$CUP#6QXY+H\/E#-X3#TP5_>%7E5*UTL3R M#Z+0?F^0PV+)&08]TCO"YY*K0]X3\I[OS'L*VY%C*D8,&LWSTJQHBA716 -I MFD':!"NE1.,'=_H"$9\ZI5:_B366,:W]-*E)YY2>0M84Y'/4:LU_@%X=^X'P M._* :V: ?!T!(3,$V ,DH9"! 6XV#64-=/Z8;^TQ-T5L(<@2T06!Q=&2)N\^ MLK*K8RE ='O;3)WM+811TXFKF.?2;PAOVEI!OG?LM5#!/^YKVE'O(O+ (\<- M>Y2P#;TD;1L=!D?4KF<9-SR:7(4M7=UP#[>LK[!Z:ESM'8:WD"-KF#JV \P_ M5)"[4=I*FCSD4+]E*C0Y"51@0R7.1.KLQ6( @]ZL*M72;IC@JQ+S%FZ M%VK"P/I50:*VDO.]DTH$"_!D#CFF+5:1K4V%I;MDLEB7IGRNE=T3/K+JTXNQ M][LNOF=J2X8-4ULN)[4E^:4R6R[6SB_I1&#KQDHPI+UT3?!M"+3BP1,3PF*! M[["\@3Z,)$._;D\-P)LS%?/:[PT1.J"]'.\9M1-M\UP=IQ I#3* MLB#VX@3SJ7U[S-#<:I@&FL@F[5Z]($WB#[3-;>3A#4&; =I&_ORV),CH*_RM M0:7U"G_PQ/0?KQ0$/3+ ."?G096H\1M M:^*]6X#:8C&VZ5<\2.0](+3N (KX'?:A? )WYM,ZDB^%[AQ1UU>FR!&% MGW'0QG$U'6+\:Y'UYVY*P4Z. .07.,-UN)@0(7D%]*.3:D"_^L>=E$WB(KII M$>U>\]LD8QD*1=P" (KA4Z*D4Y>_E\L/J3[@TS>WL8(-H\ASL%Y(V]5=_ MMOV/'$_]4:E_22&5S(@9=C@21[%AG(LFAJ.DE!A*\;@@Q%.Q*$ISAZE_N0;8 M9)5M$M,PEHYGSI;TY\NCR[D5@O2_9)V,;Z&?R9AVIL$%5VIQ[)"#XJP85&IQ MT6',^51=1?I#=BJVYIO;/&HE;J:%32*[6U\UTK&6)&AC03&16UZ%1.D7$!+' MCA)3>;4]F+53-5OL"JT?O^L'$^S.M(6Z MKKV\B\;-,B]+#67 J_-))+E^ZBOYN]6/W_JE[,*_A:ZA:M;!#E*QA_OS!(7 3:J)FJ=VE<,]W2ETUMLR/IO?01A7M;^)\ M$V_>KQ4X7#(M2BDAG>"&8Y85A_&H) Y'HQ3FD@DIR4IB*L&FHP$U"-O<]K:K MD!:QE8,7?8-EF"G)XH=RS#>=R?'<:/H$< U<6JXTD\G[TZ2?GWBWS?/S#I]Q M3I]QCY_F:YD8G[Z@ZLRQF66:GX=@@DPK$%-X//R^)R$K7,IJ&K.G[T^=4TCMU5 MTPK;K,.#W#-JNN9U VO1X%@O@7H-NO4G%PSY\E6<4"FBX17'*052$_+\)\C) M]G==?UZ6VT&J)MV:EW+I)&*1A#G8*5A@^OC:=R3;^PS/^?9<$B>^%UH5'.:( M0M<0T_GDM*XQ2([>_V/O6YO;QK%$O^^O0&6ZMY);M"+JK62GJQPGF4YOTLG& MF>[93RF(A"QV*%+#AQWOK[_G' DJ)=E1Y8H"5-;O;%$$<#!>3]5'C691-/X MNDR->Q632Y 2N-+*ZVN=[-LT4W>A6L*GH0! M[-O8)'Y,>^2AT17DT!2,>T3=Y=[0QZ[\Z^AJ]J2+NNK1;Y8!:.7.7XR89(E> M5;W-52'U(CH]%_B6AU-O:?4;G<'/)D3F8MF&<]QX/Y(NELEKD.B_SS!\_D+& M/VX "'?&'8P4@N)1/DKC,,_$+N(-S4:SNR915_[NOF7=ZK_5'($5M[ R^:#1 MZ]A[J=^]M!O=OKV7^MV+I9=ZWDNOV^BU[<4\VL50AD@U?6X#>:\4%*WGS+XS M@$C@,YW%-?^X#&,K![W3&MS\Z*:99?YW2^"0 M+%%<)W_PR+*HR"*8NC'@RF?/EZ^^_+NX^]5^-S-5REWN,)4BU2Q%W\# M6UB,QX\)A3N%S>=X!!MF?S;8:Q7B?!\G(MH !=9G11,YU.RL&L-_[&B*!^[^ M: 8VDYEOGK6]5HDPSS)+!*E'\ SK]2I:@[WN-9RL7F>[F/ @@9=H#^(K[0Q\ M7;H7BR+>5;U !);A1=D/L;-] N$W],&RMPWV*[:FW X.'S["WN5[J"TS:F^5 M&1W.16YF >^"IRQO+X/,XCQ- QQ%FF&2(9;7)+?.RHY"](,R\U&]YYBTIDN1 M3=BK/($=74U2*SU/05GJ=*RR=)C*4JG__(&QR$+Q07U)#W!@K\6U".-94:N% M_3[2/+FE/PJF=["ZT@>>? /E\!)8>'QJ O;H-*76B6I*#PX?//Y!M-UU3%J. MLJ\"$?JZ&L&*O2/7Q.QHAE^["-,"689?85;J$6ZOIN@WV(5$U$)6= ME%O 7HE1E@C@89'($^Q6$L77'*Y$58\$<21$T>,$6Z1B':4<:RFH7SWV&J-^ M$P#)1/9'H]+S=E>NC"W'TK4[27&&WT1P?T4OBW@:!6=8HQ^)D,U"GF'1*,[= MA ^\3#>/4P^DLO3D"J_'@7T&WKW___H*^PVYT:3Z"RPYX0EV) M>7D1Q@44/3 ]/5B4FMRUFLTA'D0BQ*]RX$ 0Y8+:;-!^<#O&TKBR,;9#;G-G M](=)3=0D#KN/HGB8&RBBCO5;'@F-Z/OQ;'MX6GPR<51A',RH+SN,8=&1< MQ._B^P4\^XHNSE%E;I'70-A?A?&(!K#27,MR?JCJV6^,?= ]B[()51W!05(] M/D9U(,:*KO-L@ATCC*Z@<>:P@^Q&YMIN9+8;V3)4W54WLGM)]C_Y-4UF_17X MN<->86NQ5R%/@<%^X%=7@?@0QYHH\:,$(7 9\A&[ *0$YGM+S"/[/Y!*N*OB M+QP&"XSE'R@YV#FU'0!X7\3QMT!792+=7TYB3)#ZOC?-YJT2#RTI'IJ]53RS M8$TT&X!/8]4MO50%TD*JD&Q;RE/_>7%12!A=2$MEGEPVV0^Q[#*7K9E!EF:W M2V0:NZ&&0!.A&ZP58Z]6JB:.*>N)@V$35GIIJNM3"1+N<-A7D&BME!XDD51M MJ.P O7A<4MH^SJB3?)EG0L1S_M_LGQ$V3TT1"(G 1EN;P4)V\A$:$*L4JN*J MLACA[(%&+K#S_TCN336I*P%+G9^DOM:<@XX< ;9*X9/[0 6?^I&)[V#"X0,_ MN8TFZ/]A",?!$30 UD'7852Y7(*N5(.6H@I>:!7NYNP+!:4"-^2<-- ^86.R M*Y-JOU:=KT.G_*FE-T?KP*E2.9-[O8K*PS0V-HU:&XU8E^(^H?>_C;')6L@C M',=N#*W!!N/8M3"E>0_R>=()7H/-A',^]L8 UNGD\JRJO?F2-$X\\3M C^"[ MU)* W<7Y#+168 X=H^6*NM%'.;34< U"T!*)!BP M5_./XH7_+S+;\M$#,H#G$V#G[-[2LEU,ZMO$EJ6WFI;4V_7&$ZD9\&C5B%JT M(@:(>ILLK3MOKTK@<0HYA^DMJD'#2INB,-/(BOG #2-F[7B]\CLE2/07N-@: M82N! A:_+U3/@\)@7"F?&@I>(",'6EMHL,).^RN64\I@56<9L#A-@,+.YZ 1 M709^)&X!O=-O,?#!_U.=-:1\_]2X("/+Z%GI2PH@DO,*XEO>R;+!5#MY[ D) M>BH-^"Q"-0\,EMN&ANV4*C9J^U('^*G;;+*ITIMH4D'A M]9".W)_:U0=H! P/"[U5MC\FO:F4\ILHETJ['^,L/X"LGL_'9\!0P.Y2;D@_2_33.$):H@G_(P1 \=J38&7&B>U'4< M7JNYO,S4/6F[09*2>4%];XV);5- :@_0XQ9@HP:,F3-S7P%#Q/\B;I7JT=+] M?1!)@OK0^UL 3*'USY+@&GF)%])4 O2VS!K+P*"&$=S?&N3R**TMOP&JZ0'Q##JN:BENS*T/O!EJ29 M&15OO>1#\[P%N- E?0'RIN*-E O,O5G& I9[^V&Q+PE.AP2)'-]$%(#UTHT&Q48Y$]!>0 *DOV4".G^@/=R#$08B%5ZI&/@8U?*&46[EP); MDHE D/S6>%V5L(LX^@58M!^;+WO/;Q31577W(%H)V55J_0$A_7PRI43[&SET M6W7V6HGY053QNKL#,L=(&6IUSVC8S#5.*9&*5\5-0[-P0+?"^+"*-27B.HCS M% ?*5.CB']+A_JO@OO) RE=\TN("%=[7Z)-#YHZCR@(UU)PJ?FY$&D_EH,\O M?QB"&CWQ!EUJ$,P3I?1(7(0<9'*!@Y<@>W6?:!D7**1#3-KS#2.,!M+TD O? M *E),C3LS"HJ*>M4P<6;\*!TYK2=9K-Y-@M!6TUI911CH7\#M*KD7M5LD.&> MUIV'JZ@VKX,4]7)Y-/9GLFT_>A;[SR7E;X-J_2@EO6G,K/'K2>/<-9>U7 MP%0,_0*OT X1KEO9TP/%W8-ED&1S4X=#4!:N).:F^8SZVVO;H]0A^ZIIG9S4 M))WRY/'0#!4H#9' 8,0*.A60$"&&F>K9K_9=L41QK24O60J;)?-X%X%S.0', MNHECL(^X]XU?X;'G9-D4MA04,(+E\C%'Q4H";P(W?R;@O3B\5IQQGY1&/M/C MIO%?TO$S*Q8H9DF9ODV<&CU"TQ&CR.E49*CNE-.E%Z.K4VG'+P$'FKZPB_)L M9&$..PCEE>;-VD'&5?\HVNKE#[41/E1(4"Y+'-M3\R)&MU6/%@ <@20QH[GD M%*7W_B#CCBT;=[1QQX.).Z[C#!4V*6F<' K HA*A)YP"$7>7$/%&3J@;98;3 MC!?ME:N$(Z23)A>S<^^M]X)LXDE% M];V<*-V7PC\H?$P_SEN5RJ*TV<^DYZD61^CA85^$-XF /UW=%@/RS+ M >YR[ =.VOW&X#:_%9+M5PS'_C?\YTR.I8>%KK3R(96<\UFBEX*==I2NFLKM MSH?)1GD0%@Z)#)1J8^1."J2%$R;YC%,:HA[I(S4<.>DH13C3/!(Y"L@/TB2? M$:YG^H3X.SD!G2;OIA,^HQ5CGY=VGLJS40IQB XW6%@8&CQ0NFRH#F!RBKNL MY%B1>URG;)D.Q@'.0Z\F]R"*!VH@/3I;"LU@!"_V><99&H^S&]RW5NL* M#3Q!1XS2P5O+W(WHD4H5T1:[1903TUD8WTK!?8%*(-V>N3-CQDQX:UP@_GH1 MW7##VEPR+*C+C,^*\382Z0IC"CO5(Y[-T)OD M+.+,TU8YY<25IDU5);D KN0%H>)X,T( &1E,%0H4"[,O//V&;?.5I2]#"D5R M6$FAN,K'A(,(4/0%:ZJ\Q$MICMWJ=1M@[Z<9SN%,-=E6W[,DY@E__'< F \< M$3 I#"BJ5,R#.\\Q!5%2WK-EL+IG^/#5^2K?!:"UQZ_B;?+;!1ZYFML6\-#7 M]#^R1[;'U;R"_0B!=Q$;@TDU06^#)S2_]HJ.[5=%QW;TDF)SD!#-*C,WN8P5 MCQ)*ULNCX-^YD$W "V;W[\IQ:72Y%@PTOFTDPD @MR,&%X:+;U?S5L'XR]78 MN3$U)@?S+;MUR$EPE029:F7"?:1VW#=%%ZXF3&2( #1Y-?)AV90&PM[*L]#+ M?3&%O1'*^X:KS0-2!SL+^29@TR28%0XOR<]IX)3XC@[!%/@+$AC[*_>OEF0R M()$'TJ%8I)&:DQIU"K."2[5UO2^ V00S"4!CK_2&.?CJ_'$-OA>'HV5LD @. M&Q @,J^%F4 <2,_5MRB^"85_59CXL P^K+P%ANO6L/UU/&0NAED8L#03L7QS M-779C$?@<\:><&9:D3,[*^U_V@F)V<7^_C2,LY(NNY@>ZQ23_C 4B[P4C7O2 M^I4N(1.!DVD>ZM"LRLE&]#+S;U/-XB4?O9'3TR*NCBFA)PPK6:9E'PX^K0I0 MH+\"-1&"6A6/"FV.O/MY1&%ZC2X*2Q2SPPL'$,;& XICZ*F.DI8/!U[+?=OJ MN"7EI3(,&*(W=@Y\ZUS6)3=44$MT+!88:Q&YI.1#%5NAGQLAR\.!Y'(WJX(D M4G(B)@J:%:Y5IF=(\\53T6G%CC W$S/%4C:72X_^SL71AI_,O#^?N5MFZZO:R"4:$,T,IT*BK M$+;DG=+ T^CKD/L@\( O8Q:U^A''[ R$&&@/B5=XMF-,YP%;:D\ZZW^#=O1& M&EEB;QKJ_:\.U(6 _0,M@@PN3U]4!,9!+4 +& >UJEB(]-2'(1^I (+2'V:3.)/EA\A8SD'D M 0!$,(*=8[)9QO[@$:JZ;WE 7H3+#&>NL0\"=-Z0OH^O0.E_A[?"'5*ZA1Q3 MH^,)\NSX]M=@RF)>#6=_8-1/,1;X-V=_O$3,9C)G'8X0%7.F/2PG MX,JU-T3S/J(;"#G8JA/XP?N/__B(SH'J13JT,_$=5#;B> @-.36.MOD_?UP4 M3BDYL!QHG;B95H!#^J>"JI:I707 MJ$PDN"G<4KJDSF<9#C78VW+H(95^!92@9IP(3CJ5IR\/!.(NQCP@CV:G8X'[ M#8YE1Y5?3OLC5T5DO$'E3K1:LN6 A#G\JR/_=8/YEB.QYL5S;T-GI"#>#&I/ MB/:T""C! !7G6W9%]'"38- M8E&63#*.M,I MNA%!/F>RDX'[,25[4M4+@FX#5DCI6)M80RD@8]GDZ K&#[THF,Q;HY$+- ISK^Y&GP3 F6 M!JB Z-@(T24%)";8%7 R&3$HXDZ88);.<7$CV5QE1Y$340YHS1+N"_3NF/E4 MRVL/XIM(X"S7F5H4T$5Z:^EE< (=!7_W"4P.W&$9"L<\]>_(PW%O/PT:9?$! M$'*DBDR+O&/Y.K2_Z!]%;(!G(4E%X "G (])2P2F8)+ M.N'R4BAM;18&FW[KM<:(5CYJ=[ZLEN\$:#H!9E>)- ((M%CV2^XCU@,9WWSZMV7 MU^?L*<8&Q)CRX-3&[I8JS[0D7KR0E4Q3PIL"7,2?='2 !O::!*%@HTG!/'Z0 MHOB3@A;>EZQ&;X0A115B[]M.NY^LE=!WBF6RF:^ ,"J!.5/8+>U&"89TLNDO%=+DU>6?D!&DLQJ M6J;FMH;*\,=KQGH%!VLV_U*7NU*2HO0A]ZZ113$?BI2I,?E,E0>O/R/&LZZ+ M6AYCX'9R)3)YYG1G84VL5_SJ>F9-?2 Y*6?R)A.'VAI4^;J_O'QK?^\BC2175'@^:_)Z7 M5?FZM^='T@CEOR])ZY3__D-@ .KJOE-,E]+97OL(;P"TG]J-9G-KU%*S-KH5 M=KLI@]T*W=3]VC?J']UO]YQ!9W&.SL-(H5X ^*F[3;P_222OUX5N.!2JY[3= MQ8&^Q\K<^Y:Y6^:^8CB VW7Z@\5!1D?!W(>6N9\><^\TNTYKR8#D8V7NKFNY MN^7NRVFA->PX_79_.2V<\!B1^P3>+\6U+-_;6Q'A^*[L!"-WBEI,J@2=A: 3 M9CK$><8\GJ>"^FKEM7.GWY"BO_,8T%.Z+(GYGO'?,@3&6L,P(8Z,0? M1^;ZW)4\$&5!%LKT*QTKQ8R2/)KQP*_DME"=51%"G8LAFZE&OJ[*XBS,IW!G M^52GDY1I!]2@QLP/BE0NF^[7N_!&G;H>QM&52B2[B8V)(F6.PL)/BTY*&!CT MRRPTA-!9-1OJ7.7'8*[.ZH!JG(?^//A@-VP"+(N2V0@E*?L,\9?JS>;2,>![ M K&*C\\0^K*-6LM(S%G=A%KN@:JMYS9BYN/)@HQ@AE (EDI*'I2P4ZG03Y5VQ\7&4/Z#4464#7A!-.QJ)84V\6IE*XT MVW"/N*M*Z->3K7OPK'Y1'X3I11AQ#F+*(6OW3$"N1H]])15=3+!V0:<()W&X MPP#R.PEGK'/('LS@D#MA)S3"!YY1$\><2U31+R#[U>RK'E>2!U) MEU#B6KYS$ROJ+!*?D-_5CQ7-)=^4^]X&5W$8["I/V4\N-G\ZR,J)CJVW M9LL+&I*1ZB6)&ZI5D//C$Y1QA3U/A.ROO2:,:V#3#L4 !:LR_[,:/"TKN56%@L$>E0[AJ+1P0+3 !S:;8G:F[F\\ M$G#3E&2&:8.8M*A_A.\$692KYA7+4MJK"OQ3_$-GMD8>!DGA8BM-53#'%70> MO)ZGZG*PLXPOE3Q?\&SR3#?05FOC:)&_XD0UB)&%YQA^+997,S8RU0S1GSO( MR[DDV'+[E%PI[1NJ<% "C3),([\H-UC<0/D*!"0HKK*QQRU-FUL\>)E-ZR.* MDV@?B65/-M@_,8]OB;[AH-Z)F@-U1M$9?-8L%UE,VI5%9,A* 4*NMK;EL?(&7;Q5U1 MBK29W"GSKE';J7Q@T[:IU0 MRIDE&;32WBHJG)3A55[<7/D1(8WQQJ>J FIS64=35JKF1\5VF/L>MHP5:E2C M8IH-@(E2#LID^2B\+0II].%- 4N.C#3X?F;*AHV/^6RE$P%+E] HGN'O,UH> M"YL5E\O3@L/.V<<(_J(="WQ-FO(L">9D@^3XV)6.J\*VFTAU<\#Z %AX&M-P M7GBVS.P'>!:<4A'XF%;T<,J2V?<"H#81H5_TT\+C UM',XI^A]!,:((K<>:B MRYN>@2"H=;PBZ40;+)AB> ;_.*,6'>A5H+X@SZ0,$M$5*.IT:BP:B5,YLE1^ M3'/+\J32]EAU2D-LH)$J.%\AHVN&+<1%5R1X4XKE?WIX!;G5 #K8SX V(JW" M0GOR8Z,A3B%0I7TWGD>(*B$UV'F8QH[61>:H[,?)ZBYT3%)"?4BHH+HG.M23.@SP7THOE'Y-B84%A'07G'F]1U># MC1<&VDH/#U*G'YOMBG>_XR7IH9N>":"<2@0&Q'4T,_$-MHCVN=%S$;CG M6559Y$9KN5AWS9#%0J$>\V: 1]4FB,VAXE0+0(V+%V(IN[PGL"9!(DIM0$%$ M,6GCHPTX\YRPN&-=Q=/ X);=\,?(M8K-FSV4"CVKV.5Z7-30(; OXN-\D>3J M?3ZNSG"/ZG39P$I-43N^BO2;^*YZ= , =]:@+_,DKVRROJ007:YRKP)T?8#M MEI_+B?=U+D)OKRQ"%]]G07+?&O35D)^?)G=WS7F[7Y2"RKD 43Z5U6BUJ#9? MQ!CS"(4)O*ZB_%U9UKTP;*\L*\?1KT9E.97H.3C&:Z9SLDF>G7:)M9I0N*ZT M&N&%W2?E\-V-RZN;C5:[J*\N"ICGZI;=U@\5+L_[;$ZV<)D&XY3!$V0"/U2] MO)H?K:U:_GV)[PGMBJN8>A?B+\OR>Q*.P*^:G0(#XO$J;B=1C@I['ZJ< M'RL;!5_C%J^AKET8%3(=0O)(5/^J^K26''KU<>5L/WA[>_'M!=LOQRRVFZ9J M4%X(GAPD6-.9>]?]#JQFO*Q;&I= $N/*W&\<9*RK:V-=-M95VUC7D@X%F^MO M&S=H^['X!EQ4O[&;4=MSNP5?['4N5?C3MOI[I? M1X&V7M4_EZ^RKVK^AY70KJQT5Z=Z2(4[9H O5K3?NW9\OJ;9UHZOHIREA>0; MTM!C%Y!KZI@GMZ6(=H\B\FV@NW%,RAXR?M)@#RT770GW RT3E46=NZL4K5\A MH<10?'^>/F;=8)XN25NP98*V3'#/98(+S-J6S9U&V=P<'FR];J[ZAE5H9LOE M]EDN9ZOE]E$MMYUBN4/+L>[9'&N;8UW;'.MY36P5'%95E**/#5C$JSPA+T^Z M?7_? =605D'QH#+2SXN0$^ @?Y*,]#7.)LUGA5JRA=T0N3) M\M''Y:9LU>GNJT[70]]0$8L'%3ZL*3[M''GQZ4E7BY8(8RM&;<7H%BI&]SA4 M]O[,;^/2K79OX'1:[J&5;I4'M>5;MGS+EF_5LTS(EF_5\UYL^98MW[+E6[9\ MRY9OU3*UT99OG5RBJKO5V6SU H MWSJFFH&AT^EW3J9FP%9OG1HG[K>=WF!; M"%ZO\]OBK2-BQ%NM]ZX]Z=KBK=/CQ)V6 VJQ+=XZEN(M';/9@W7 MDBCRD=1Q&2>SM5R'6LNUD.RRMW(NDU!6EG3-X]PQE'6MNP);V76@E5TEHNZ\ MNJM>M_FJ=L\]7WFJ1]V,:-;DV+&D@7;@D9;T/BH!8T+J&:+&FU1 MHRUJW/,$P'7S_DHA]9:68)\-".RX[*'LX"'#,8J97+%R-2F6,N! ]#RI M%K4H2M@7#-]%OI@)^(\:>T;9[KKZII@AOD>HJEJ@"5G_DH9T/<8'0%< G*I, MC]&P8^\#,9JB'^P#R$0XP"78;R!(Y&3$MP$(8YHNA;C]0?_TM0 UGD_8GR*( MTIO@"E0"(2>_ZYM"3EB"*4%3,B$C$-V.OA(YA@T5!M) 3L 2UNE5],SOYY>O MS_\'Y"Q*_P\DMMG[]Q?LJ?)^R._U5/L&>T.SF51AEIQ1KV_I//=!([K0)5 . MT6E1&F5\+O5**0UA3\4WJ'V4YY)B%4^>SI\&3Z&RP*2=>I4KQ,9_ ]3QM14( M%44<7KF-(/+"7+D02 ."H\-SP,:4#F*LJ,!$"ZNJ1P2$ D" ?DHI&9 A53@@ M(89T;LTQRXD\;G =^.C2*LHGJ(ZNA,)?N7]%*LA^Z/%2>&7^G=M[RE7-S2N0 MD\ H:"IGH:-^%B!.]:4"\+8<:*B$8+[$Q+N^1?%-*/PKN%!9T $:!+H^2'^5 MI7 (T;HZA;H(1!CYDFRHXA'D]3A/HB"=2/\C+J"EC>E\^5R0D=OC M9^VG0@&EI+W+4F%^HQ7F<_1-CID[;'=(84G$+!$IK*YPEU %N+7<:Q=TUJ2@ M;5\ZG%;=QC@(B;Q-1F"@KSJ*9NU.R?$E,H_*RY0&!^ZSM#3$.%#<^SP,OH&?3LHDZ$1X7[4!6HI@]PF^B^.G1G/+B? ML-UF1'@1^\07WF1@S.Q-^'V, /]FF2AS=%M#JO%V'7)2^_&,BLN RT2?84V:;2.JK[ MU]J'1*0 ]2X,ZTH6/4OB:9S).FPI<*1T'0N?[#B#4X7\!K#*D.&&XN"@2^!& M (M5Q?WTV/Q3;+76)(L;JQO7Y;HI^Q<@3V&'D:^&G/X8YE&_D*%AM'F4^:H^ M5WS7.$9<_6NL[-/"P:,<.![)+>+0DT#&/TJ/B7+'CZD- A)-$%'-LXQ\OBA6P NC M!$-C>8@QJI1,?HE31*ZX)FP<4!6.$<61A(-Y(-P.7D"#G:O!RQCGR M5X%4K!!(5&A+5U/8P^,O#=%$!WVBQU1T"4"##$. M=(^!^?U+5SSR\B#-TLK\Z-)-DC1*+TG%*Z(M".6$T$YZZ>24JX_0UVAZ92@J M SM1>H4I8?2^=3;'4K^)$O2XC\LW%UIWD.<(4M6>Q? S:-&NS'X$B%)\5++$ M(MA6-IA9ZF&:@Y?A'ZG8?O,=D>["I+NV-__[>$:M1K2WB1>]@,#433#DL>&Q M%[ ^E:B1+0?)2*M4I!E=P\TC:179*AZ%?;0V-2[.F!1N"?@UJ?BH>$A,G;]$ M#!=A>_N=>KZ,>I!^!4JB9J.86:R0DZ,E F MPT2JI1#V3XK'4I4C'3>YIG8417L8Y=!_X+$6T%KMYYZO(T*GK" "D4X#D:?" MXX*V=B;_&HM"V2ZW &KLOW/NW>K.4@F>U5A%Y9/LRU.]W+U9;YZ\PB>K>;(R M."I^;,6,Z7:TOWH/+)A8K]K2NK,63@C-D5:<^$(Q*F*KF.6F?+^JIY=\JC#9 M@#!G"")R#@7%1KZ8#Z- *)Y3N5(:$,230$L?DVN/C"]C5^3^RI,E9H(REU), M;@_2B69MF#&5Z28WQ8\J[YRA]41,P;26130A$SF,0;&D1 HC>X]=\S#??F+M M9M2T+""PPY8Z&Y+/TK#%AL2C1/8AT<[2X_X@Y1Q>GR3. O_O3[[Z_0X?MH0+ M__ '7SN]?OLK'PV'7X>NWQJU.F+4'PR?2)M$_N)=)J:N6W@L34;TU6T.6CWU M](YHK325<6,JA.!BGG/9AJ)TKYJ[W:U,*_>)[+7,T%;MJDJ$,UT\9=P/V2S5 M6&@-@_ZH\$;9><\QLD7*KFXI0P+SV6OA&8[NMFROV=9]-5N.UFQG\ I,\PH7 MN;?,]85GLIM8.>DH'V4"=Q3>EEL2RQQ$3IFX1*U'9?5%&,I6JYBF+94DS#Y; M_GN*>6K-$',V"# S[DG'H>HDI\);C]2^;*'RZRX/]F4^G6(V?T5JD_W_>%[L MI9M<<%,LDM8^>Z[MN*&:.VATN[8_U/H(XN98L-6&:AU[+S6\EUZC90FFCA=C M"::6]])IN"U[+_6[%TLO=;V79MO>2_WNI=\8V'NIX;U8/E;7>[%\K([W8OE8 M/>_%\K&ZWDO3WDL-[V78:-K&]C6\%\O'ZGHOEH_5\5Z&=G)*+>_%\C%[+_9> M[L/'VGU[+X]V+_?L]GQG7']O0!C< PB/RBCV,$%H]9"@'S_M77'I(SON25WN M73'4XSKMH=ZM%X?(N_[^I/7D@2C=WL0W>^UU.?G::U=C MO^VM_]"MN[AHS8Z^GMJQHD2"XIQZ&UL4^'$4Z-=-L*]%@?-0S4G_B%GO)W[_ M]K0_[A78^TB:AQNF#[/(CV?T[^]\*@Z% VP72Q: L1M_AK3PCP>!ON X$(M! MN\,@Z48X'@3Z7\$/1@>I%_YLRV8]'ER2&L]3]YE%*(M06T2HED6H/2&4\J\< M'4:U+4;M#Z/Z1Z5 28RJ=H2PJ+47U'(;S:-"K2]QQL,J-CW085*O I<5R;:CW"HL[JL9&'[:PL%D==Q^L9DZ_9@G;:^]=4%>S2[>X;W%_$??=0=_IMUV+^]O'_?J!81NX+ZL)CP+WR2QI;3V1 MNF:7;G%_B[B/%6A'@?NN,QA:C>=Q*BEJ!H;M8#YF)QT)YC?[ \=M+>H\1^%V MLTA_+.XX>\O6-[?HFVL=ZUU:_X3U3UC?G,5]B_L%[O?:3K?=L;AO_1,GYYMK M#9I.KVG]TA;W3] W!ZB/LWPMZA^_!6N=*&'YB9W[T M=CX_FD%KK_Y1J_3LS9_>S=_5,O\T;OZN!O6/+^1K 2+_A;]+?J?&OK7NV9J M)U"XJZV_17^+_D>-_NN[P5OT/UKTKWG%[([0?\?MPAX1_8\B[^XWCN]ZVV"_ M\L060]8XK>Z>5:YO/]J[/)KD.5O8:A.(3BB!J-WK.4V;/&=Q_P1QO^\,ACV+ M^39]Z.12YVQ9J\7]4TV=&_9LRJC-FSN]O+EVO^,,NOWC=*U9E#\6WYN]9>N5 M6_3*V9)6ZYDX(<^$]SN&]Q_T3\O,MGS/ M(OL)LSF+_J>+_K9^R5:O6O0_;?2WU:LGBOZV>M56K];.:7LIL@E[E2>PHZM) M>JRNZ2/(H+L?9;_YXQ,[@WM-@TBD]EJ/)V7.%K+:M*$32AMJ=[ ;N$V9L[A_ M>KAO"UEMTI!-F+.X;W'_I!+FNA;M;;;A;W3\C187U[%=SO#+M.:XG.8WU[QX/R)Y=AQR.??4D$3_/DUE[J M<;CB+"V?FN>B[OA12\]'#>!BZ<;2C:4;2S>'YC&I.]W4TMM8 [A8NK%T MRAK Q=*-!4/-?9K;@POY,Y]G?!2*7?"]^:W23V\$G@]N(O35HV?R5EZX+?C) MAL?Q@^L?WWZC1$"]!_H$_IS(7;H-=RBF+V=Q&F1!#'',;)B[\UZ7\O]1L1@Q9>E\6S%\U&3VA//XL07"6!H) JH M,IYG,6NR)J[['!;6_Z5;+79!O\0=A'R6BA?Z'R^W0*O%=1D?T?X1&W 39R&_ MC?/LQ3CX+GP30?[*TRP8WYK 4T=4R%)UM?_07N<(GW8!NUS# 0<+M/W4?3;/ M3^:(?P&['[I=^2>^"':53'GXTB06]=&37S['(S@7^[/!7E.\KO_R?9R(2/T[ M92D/>7++^!00,&/C.&&8O,>"R MS'S;$V74 MZS? OWYR^P.GU>LZ#&#F3=@-3]F,!SX#_/N0S.T EL"EVHV"2!?XC470[2-H MJVX(^BJ.\A1>K-!!8Y["2(5 \"7W/ LCSS!;H)LPK*)8.*[\')DAZG"+):( M="8\_(@!LH;Q+>8?,WZ5"('_2MG35 B*7+>:+]^43YR73]#;WU3>W')?XA;> M 0'(^(';?-9@U9T7-,.>!L\>:_<8H7D:&._G-QRPS6>C6WKE*(8_D13](($7 MQ0D\D;(LX5'*/10@\(3<- D20:2)/_S ;^4A@)H%OH"S*?\K3D"JPO9!2(LT MPW/@L^]2SCWV(?B_A$\"-H*7^VN(6,H:0]YYH> )ZE63.>IK(]94Q>0C:QRM MCE:6"DUI.)3*3RDG_V,C86V<2LGM%A'?E3@;)8)_.^-C6/@%#V_X;:H]>J \ MEOQ";PK!P$#5:'=_9L:_2^EM;&?*OY\9$%.D?!:*/%,C9U-Z?Y0N($ M'L&[!_YL!=/IS'N._:^ M2:X.@B5-<_B*M"@I"E _XVPFDC&NCM*$^#D#-(V$KR21NX8;+Z=Q5X%.$L!N MS+S12AOOR2\?\RS-0*S K;(W_\Y1")U+D L '*OA2>FH-=*8=QV'2;;R(PD M'1^TG7H/EB'WBMQ9,1YD4IYD;GH') K0 M0?2#E GU3$A>&H4,\LBN,LT1LS M;-,G/^)$ZC=Z:YNG&?AJ+!G#,N,POM& U']3>M8+*6]O '1WRCF#:Q:/\E$* M%D\V;['OV'EE_&YSW#&M^\=M[6?O94_WTFOT>_9B:G@QEF!J>2_#1G/M' I[ M+Y9>[+T8]])LK&WE;^]E7_0RM'RLAO?2O&/TA;V7_=Q+M]$9VGNIW[U8N5_/ M>QG<,"^C):R?!VGO9$[VX#=<2S.-=S'T; M MP5$-L;$ ;W ,)Q3Y7:!TSN"ON<)% ."U$6<@3N"20O#O'#OS\9/'D@P-J# MQF"H\WN*W(39=P;L-O"93F5[1(@.[@_0M7DB,Y07J4P#X9$O__$G3S#E1OXA M\T:*U)"3PKB'(ECGH0C6-4I;,K 9@$66G M,+DKX:%N+/;WO,SDC,<'):CKC 9WQ?%/! W6!\U/D3_<%;"N&4Q^U&IZG.AQ MS8!DA>V>8')7U/0486+QY/[1PE.$B<63^T?)3A$F=T:H#A@H]8P.';CR9HV_ MW3N+[MF"R*))'=#DT%Q%E\++DR +1*J[>!^&LVAP!QYLK]'\@3E]'NU"']GM ML[,+M#[<:A8N]R1W>Y R7TI.]RAQ HLD-:#\T.<0]*V?S MDV\B6Z:76*/=DHHUVBV:6*-]$S[ZS\@727@+.[1&^U$8[8]VH;O(U:@S9>_& MV*\S!*PE?SQLS5KR1W67CZN9/FHRX6'I'=:D?S2T^ ,[[RY/,;4V_2$RP/J+ M &O36S0Y1IM>?!>)%Z3"/RSA:HWZG=^HM>JM56^M^F/A:X]NU3]*AP"E\R>' M(J9JC]"'YA"XG/!$)YG9(E/K"EB+$-87<(@BL/8\T_H"+)H,0KM=X ZPVPWH!3EW&'YD6H=!0\%/%V"%AP4$X$>?U&2\!LPK.# MPH;:V)"GYFY0JM0R!+(5!M:TM!X(BR;U09-#\T!4NCZGSJ%(9.M^V/%]'H_O MX>R1^:"?[F^RQ(>!G,MXAPTE;XK_Q:97+_'EL; MW-K@&R!.!66V9W4?S["+W_GT8.3K9LKSXG^W9T4?S[U_";+07ORF=O'QW+L$ MC-*L^^V;&LW'<^T2,'^(-!/^25W_=HS@XT&$92CP0+N8>]^NDCB/_!=_\SPAQN-Z M@>%S/()#L#\;[#4Z2=S^R_=Q(J*M8?YNSU][-Z.VFFN.%1=O/CKL8L*#!%YM M<>$Q \Q[186%Q(3V6B"91YDE@J;: MK:'%@L<,TM<<"ZS&5!M\D7,$CT]TJEF QTP(A^!MJ3W^[X,I["Z?=Q^NE$,< M'&HE0SU\+UNM"K&H.# X+3[GHA6*!8WEM' M-U#M@6(QI2:N(JO@'07J[,-K5'N@[,7EM#>"JEWGB?NG5O&^Q7GFPQ MA^.(/$>UNJZ+MQ\/X8YJSZ=VW;6AWO&@4\:$7?=[V!(F=+LMI]?>:C[!GBM0 MMID&<^"!NT?O^G@X"2ZGS)IVW75B'ZDK)WZ_.]4OK1)25TR0OH0#EUK*]C\: M?*Z==5][-+:V_PFDB)PR@C^ZV^!08P.GC!2/[D&H/P1JW2URKSD<=06*'5YA MF>-1^#!J#P&+ X_NY[!:T^$AQ:.[/&H/@KFUYWFVF8G%E[I7T3P. MOK1[ Z?3<@^[EL:V,CFT I;#R?2PG&_O-2PUR >I%]5ONP5JO6_3ZCVUH7[; MDN1@">$0?!^UQ_^C%@8'XAGY3SZ=O61?$L'3/+D]T$NM/:;;%B,6=0[(.5)_ MH!Q:BQ';3V2OZ2D6*);1UM$74WN@6$RIB9_':G-'@3JVGTA=_$7[39MYGN%< MP5_^RP^N?_P@C?*"]< E^@3^G,A11@#@H9B^G,5I@//"7R0BY%EP+0H;H_DS M'M#837D99UXA?PVSK,7X^"[ M\$V\^"M/LV!\:T)*G4=A1=4+^$,;F\]BQUU@*OMJRAE4*8.0UFU50[55VESS M]"*"/_0@\D]\$>PWF?*P,II;??3DER\3D0H6SQ")4I9.>!BRD?#BJ6#&]$TV MXJGP63Z+(Y9-!+N(I[#/6S6B*F7P_#3&?-\:]22"NX8 LG0DO& ?PRPSN M6V1LA@,<4\93!A<=!A%\$\@WPF)>C@A7++6@.'87RLP2Z%()=QJ_GR3?F&<_V&E-T$V82]TUMMX8;=V][ .QFKV*>^&P".,=]P'- .>),4@$@^TQ$*4>2<>"G O W81Y/)RQ.F/AW#C+(8>,D MGN)*>9(@ L(W^!IXL,!T%H_'0 Y)00+7]. 8<)R=>QZ<*D,B^BS2C&>$O V& M!YK?O"_&0$GIZI\AO<&7O/PR,;Z$!>,<=A=$<,: AZSX*F5^+A 6^/T4/DSP M:Y A"($P0)!(:@)68/P^$;,X4,IGHUL\\"*DLPG/ MX&/0;/R4]L*G"!*$P=HUZ'/ ?:1?+Q<<.$R[#> M.,?O[^ .;$8:38K4SV_@!*FD8"0)'_&_)(IYHN;P\@ 7]0-U1"G[HCC#S\- MY' JAT@O%%= =B09D?F0P(;W!5,@^VL>A/0![-F0W,LY28!\ J=N^_)Q^/L\ MBG)X^6>B:<5(Q/<)J-K[1LV*JK2A]E]/T?T:>*27 8Y<&+CS^ )\-32KA@RJ MIYN:5[O9[)\"*8O$$DBC,ZDI"F0)$I I^ZGM@*6$E,P$Z*-L1/P#V$#Y"-(+ MZJU!EL%/IT(0Z^7P%Q"E[X"RBT3 @4E\#Z;Y%'_\D]NBUP+52\9X*SC)]27O M5WJL?K%<[U[O7-AX M2\E$QC&J3?@&93<*8'BP&.@%043,D1@8*0H@^\ D( 9*6UEZ>Z954;)2W#Z< MV( 1[9:]AF-.1WI;;9?L@+;R=>0KX)7R;VU(T5O@*1\T'80,P@GD M%0^-_<-?7AZ2*A!([2SQ2YWJ_/*"?8EG@UC<()[.!'DWGKP;N79 M ,2#9P& 46%:GX5BG)E>J#/R%M$G50]*ENA5#3_)DTW3A#K-AKNV7LYPT!CO M1[5B#&2@0:+_IBRF%Z-$\&]G-P"$)0Z;.:=/Z3PJ'N4C4'CR;-Y5M#>OI'L/ M=YOA5OHQ#V6KT5Y;W&KO93_WXC8LN=3Q6MQ&^-CEF!J>"^6C]7S M6BP?J^?%6#Y6SWNQ?*R>UV+Y6#TOQO*Q>MZ+Y6/UO!;+QQ[U8C:O:EQU0W=Z M,$^QI?)=WL.:P60A2'A/('EQB!_^_4GKR4/IO-6HVTRNM3'4MP)3N3"V\H8G MD?"+\.GC:@='AC>/(JIK!J-=Y5.O%Y.G"!1+3):8+#%98K+$5"L8'1AU_1"4 M[MDTYM!LJ?U@T*,;5W=UC%EK&>@4YM&IFTBQRI'[Q -_!5!J*HKL_6_C_BGI M\5"N_$FB=K94=*9F[JAV_MP:I$J!U'O7L.]8P M!3[3)=V'PRI^YU.Q/4:Q7[U1J@:+_WT4:7 \*!!$$DP7/)T*^Q?UE$WBZ MCFMQW^+^*>)^RW6ZG8[%?8O[IX?[O:;36X+[]RU&<<(G[$\11.E-<&6#%M: /T$#'J24#5I8W#])W+=!"XO[IXK[-FAA+Z'C(PR,YAQG7W,X?9O"[UT1&.9GYYUS3F MI:C]R .8/T;L/+\",+)66\XN<];,1KME-[R<+N8V:2A;.N$);"T>+\XGF^5) MFG,YLA*'D.&03#WZ+I*C)5,]W S6=MD;&E_+WNEIJ.Q3R*,&N\29<6O6N0G" MD%W#IS3%-KQE-#N7SV9)_#W T;'PT>J)RA+=#9+S0L$39.63.0QM(V0?H\WO M2G[=ZFB&77!KTH6KS7O_8R.&81Q+\8X68>B5.),MD/D85G[!PQM^FZIC]H>- M=DE4>E<(![A^5$*8\>^2@QC;P6EJ!L@J ]74SZHSU?2'=[1B-AA%RVWTJFRV MXS;ZW4>ZJSE)VBO%*&>31(S__N1O7SY>+!53=Y+C%^*Y@.(7,F.HV6S+26CA\VGP7=U(-RG@P\"HT(N!9L4^)XI[ +'+,/S MN/ X3V@<.FW E[-&:>7Y^9^;;P.'8H?T701O->:-?@2).(*U7'Q1 3 U(]KC MJ03%2,AAH&L'>ZJE4+C^!&:.BX-.Y8>-U6)KYZ3LGE6T,ST+ M%I =U#!O@@C9ZLYI;(^@INEU-]')'HM?(<&)[R+Q C@T?.45E*9W%RQ2VAH- M<;G:0:*M4'FVHUR86$"M#>:T#5Q3J1NK;V)7XWKG=_0Q3];@AQY[?X-<=HR# MYV/-+>E'\AFX&%^DL!Z@,,VL!NX+NZ&1\"*2L^3+0?+X:3S&EP59RC1! #K! MAW#K"?RK&(GM(#:G>0A"+$OE./L8A06@ZB1&/.%IYC UC)F^?PXD-8M1E 4\ MQ%^#:!CE!5F9^YAP..5("#@!X)*#(H$(8"18,$498Y 72"5/I 5%J5?@BH"> M^&P>(?00/!X $@0QG-[^[QR..0Z*)=77#78.%Y#!M9QI'X$'S(!T H0 M/?'<08H,%;8+5IA(JC@N]UH"3.V3^V"_!"E>K8^Z#_YFR=QX4EK*\>F(TH'4 ML!"=;N)"*9K27/("RY:-H =D"TA6K%QN;SCU4=%O2:8E=>,._^4)J< ![J!9$=B M00+##^4)U+CVI3CQ#O;@2UGKK$-, R#J=0I_]*I+WDZL! \" ,77 TF$N4^J M.[ S6"UC80 (15RVPC$#>-D,)]W#^?F5(,:YP$4Y:(=))&Z)D:[!6]*+->8N MTY1A.P!*4!=2X*=IR7 1EHJ?EI\1Z\\3S4WWAJD7)1R974 MQ25WW9/4OGR!FF(029%<4(%$,Q*1@!!3B20E\27*7@.*)(7 ,1EY(35Q\V3P M,3Z-@'0 -_J6,.+4M]5OYM!R8/R-5L&"Z53 %V18C,18;DCQ14=>]_)3J^M' MPA@5=@-IFN6INK(+VZW@P,O&23RE=VNG!JVQRNR 7Z]8EW!=+1NB1DA+D7,% M701PF]]$MM130(@=WM@:#<&R5_GE>2M6S M.Y(N+.#T@?:_D4\=KPD^%O@(9\@$)#2C''5$NI6EP'%,;DL71RS.,?D;LCNM MN,L/4E,'V$CL^T),4^D;@)L'F#?89_.5^)Q46H345+CBK5'UC!G<33H6)OLH MW7?B^RQ(N';VF6 @17$I*\0@\<3 ?L8@ZS.DQ)]Y.MF:LW8\_($F))$4U!5 M,PZB ET=6:ID2UHX4X*H6%=R4I0>B.0Q6<&;[JR$2L5"8D\QGMUJOOQ\^4_Z ME_ORV;PX3466A? KV"-)S#A9>>6HDD1:,H[@FGP-YZ6DA2RX0E#J8;DB'=2G M&T4"AQT:>RIQRP#W C[A^]2] M7R5"[HCD=J&OD?2^0;Y3:#3S-M$<&M-I8+,W^)\HEN>*\ZSPD',"[&N@.:*P MMG1-M1H;!'%J&'!T;<#1!AP?%G#X[)+((U.'/*"-R]-K! MMBZ%)W^-RJ7;:SV=/I/_UCPL$5=YJ*0=1;_H(,\D TM(8YK"P4N-5/@YO=*0 MD^2!3"5+6[5J@_V3(+3Q-AUB_!G_;BRI %KZ$I3$QKCJ-TXQ- )%!TR]>" LN_#IE3Y5EIA7K%*25I2CB5[KX@I6^2("6$#='6F?/[*71%802*?NF!V3&&SGFT;D#9 MPS!6/"+2-*T%4ONNI:<5XT().MNE*8VFMN'[O8IY*/W*I&"MI\B=*>C <X"98"M)\&^@<59>F^O&=C!,.$@Q7>S9@<73(%@/A!, 85D$<1$'.2*J\ M<9WQ&%]\71KI57?7#K&C(IMO-=U5^WN* MKU1J,I^88KH*:O##*7(TP])1S&OYGJO^<&1+ MP!128#A&:$3O;/46)'3=@O^%V23.KS '@D6 Y'>'0=Q#H/FE!,Y9X/_]R==! MJR>\EM_]VN2#[M=.9\"_\J$[_-KK>7W1;K5[S=;HB=39Y2_>96+JMH"UYJ"= MW'Z\B8 Y3H)9/%:Z\2L@/U!\ O6CG>:8E-)AD!(]$ME(GBES M?#K.9AQA5 #M< ;Y;0HA#OE"\<.V;O@YS4R\-94$F*H%L6**9TT45>4N+F1 ^OD>_B"(L9D#8B&'#_S$4 ME3-4.$F#(;5#FJ (ZWCA3!JIJL"\)58'UQ!AH"PT552YZ+3$,M":)<:[ M!]=S11"< K=%]5<9=/!TJM[@8"!%[H:R;,14,F5,/EAZ\9REFAJ#L32.U>\Q M/%NZ$,W CL[R4>Y:Z0.5(1]8"IZDJ)J\0)D@&A?9"^0UE LZ,O:&^5W25WKW MN_T@1563?)*5%>07@9GFJ9>17LD2*&!?Q!M!!HBF@$VA),Q#B)>>:9W)LQ07 M43\ YM9KRCOV^6UJ7-\&EZWOMZ14-%K53I1@W.!4!!G4Y=)B117BO/^[4F/3 M*A2,()H(B3>B"-Y0YI3,3O# ^D$5WGB?SG5JX+&!+/!E\"ND+P'1Q"P%*PJ+1C F!C'J?P&+F-?3_!!TP[4Z&']SR661^O0,L RTK> M%^B;#8=UNTVX*?3_3]@YV3<.J:M9_H!GFFS)--M=!^I]G:5.2WY!O 5Q'! NE1R,W+4>#ST M MQ* JP1FUUXK:%CE:ENA5C6+;)S]0_MUO-;KM=>7?!CH;2V+J_!@01$-)_TW% MV2\DQ[H!N-S)*8Q*CN)1/@*9F6?S)6Y=M[V<^] M@ 3L]>W%U.]B+,'4\UZ08 ;V8FIX,8U^R][+H]W+YETF'ZR;[;TU3_FFP3T@ M]:ALOF8P60A![*8SU5U*2MVF9?].H07M4=8#QD<687:(,&N%=,V@M*/^;NL% M9-V(:!G9W+/7\8Y$SD'1AF4@QRAQ+LEM:26-E316TEA)4P_:V T#.2B0')Q< MT=;+!07##E"^'!QZ[$":G+3LV!M66(EB68:5*+]0UK 5)(9W&Q*OX\W73!3L MP PP>NIXGA#C\5Y/_QEG!V7LSP9[C>=T^R_?QXF(&(T(W!)=U^S(6U?N=W^\ M=43=7HO@J\:J]IW^L.VTA\-M,_5COOS!D5Q^N]UP^]OFZ36[^)\/64G_C>.[ MWC;8KSS!5F*M[3'GHR'&/6O1#Z.\5K/C--W!,6G2V^:PM;K4_V=5WH-7>2]% M-F&O\B3![GTI>]JVFNXI:;KM?LOINFVKYYZ>GNLVNENT;VJIYNZ8M>_SJ+_& M-$WC?2!&4U2*.U8I/@ZEV!WV'+?7M4JQ58J/EW/63&Y\X,DW]CJXY!$VYN]: ME?B45&+7&71<9^ANG>4>\^4?BU+<;PQ9CL-QCOOH# M4(NWQYAK=I$GI.?:'%6;G6QOWF8GV^SD8U:_UQ:GX+1;8P);M+Q0I1C,!LJ[ M&J&4/F-/!\^V6K12,[A997Z9,M]T>L.>TW2M/G]<^OQ&M]_I- 8=Z^<^2OW_ MATHVK5IH#0)[\]8@L ;!H1L$W9\9]?=6TY*W6Y9>-T#LB_773!FL 6 L?M38 M6*@#8*RIL->CODLY]]B'X/\2/@G8TZ'-AZF;2O_ VDFGW>LY@T'KF!3[H\Z( MV=!-UVANL3KKT#7VYS1UNC)#\>$[;91[U3W)Z!-C"CE0@)@N&>-8GN:\Q:W\ T^=,/R3WP1["N9\K#2'4Y]].27BSA*@S2C(?=/@V<2&UI.T^T[@]:0 MI31TBDU$Z+/1+?N0-.03E8X[#OQ2_[37[#MMMZ]_&&/K/?SENR01U[%'2/4E M@8O#!3_'J6"OQ10PZ98]C1/ 0+'XY#-\%.#L35:L3P&T\BM5"0+KT_LR?(<0 M,LS& "S>(;D="1@V?,=8:#@=,>-HL# MCYE'@U3@$F/OFX1<$-%.(C[%\!ZK:'7XIFL%/-=I=GM.K]>_S]M^#4(O!DAQ M1".'O7]_X=">GUX_ SW#;;4==]A;]4(3'LKW@"]/!#QXE0 [V,W039A,'J,P%_P-MP]W(_#78!=,7A1'IQ0 *Y M+F(=!W!3[T>!IX9?>NII?I4(,86O4H?-\B3-X1?E0?AL%L/CC*N@*?-%"D3+ M,XF*<9ZP48SUEW!((PI+)P^2'S\52T7&QG$"W\->O9#G*7Q(""-ON[B@QBK( M^C'\(HHS"0,>W<)1O#P*>'*+D "( 5)1$B+9>&87A*,"%AKERUZXB)BPX/! M-&6CHIDR$6V23H*91H4&>ZWW$T1>F/N"M5N J'UWGD$@$*HG>4O\2]&\IG'S M0Y.\S4JN ,/?BGAIXQL1YI*MMIQN?^ ,.WT6SU"2DZ#+B#_@8[=P6>*[2+P@ MQ2MOL$*965!DK$Q\#)G8.@R9*-O=K&"D2]"NVVTYO79K,Z2S.+=;G&L?!,ZI M?A^;XUR[-W Z+=?B7!UQKG,8.$<-#%:@G*GI]ZF^ #6@+ D\U*WD;Y26$10/ M!M.I\ /0OD#B&_A7(FF,.IP'XEVPH7RIT@XMANX60[LUQU &2F>WNJILUH3O;<>RF*X$],FV'0+!N&X3FO8<]K=UH(9CKO[5Z/8X+OH&J@0[:$= M'Z38,]J:*_E!87%4J!MV W8;DG$^@RM4G(%,VAN>H TH3?:*+"-S" \K?&W- M:&@-6F"'+X J1A-&GCK=&5CD=@?+Z42+32LU#PSM^C5' M.]:NL-VE4G,-]RZT.?88*"GC(49,Q@L%3S T-IG#I39"H!K*V7H;\QT81)>-8*KC4(DRZ$F>C1/!O9WP,*[_@X0V_374"PK#1 M+M%?[ZHMXSB-=O=G9OR[##$9VYGR[V<&R*H!(_DS_5DB(U[JPX6@UY.Y]Q8D MW7(;O6H6UHMYU^OVNT^TWE?Y;D+]YE8NJV56CV,TDP ,4DF*4 ._I;^%^ MOM6/MG/:A:SXU:DKN#_%+=L-9N:QZ'!R9=-TXVK;&"B/4N K^*5D>Z]5")B] MBWPQ$Y@]XPF"W];U2TWT\T=KK2D.DV009/ &;Q%( (P/[$L\\V(*_9NWOX?= M?P'>?!%/9QBP1H& (=PHCCQX90),%[TI9O2ZLG7V%#&XU7RI/Z4_W9?/'"5A M,"#L>:!;XS6.X;Y RU8^&/'O'&B!344VB2FLKQZ$!1M[N\E@]35B)__D.O!@ M]7.=RO!?SX.]W=O'B'W@MZSM.F (MEH. 55?9"4#@[-4[[Q(PI BNKS,Q8P, M\W4@ZJ\#5(]T,H?,SB!23//9+$ZR3T'VI3KX3OCF4@DG>.E MXR>$7DC>UX(!3Q?(*8'SC_(TB##'#5=)%"N N\#=JT6?X7;U(1 [Q7?@^M&5 M(%R;\5O*-\%U?FI+.2!9#FR!W8(=@(D#^[F]=Q'[/;X6TQ'L!*ZO+:]OV3UA M2X$I4[L*_)S8*()DG&=Y4JS)QIB^ M4WA((S@,(YXE0.T#09Q-@/6.!!PGPIN%5_R6@_B5V-?>&\6^5=DI>)M,0NFU M\"1<%6FTJZ0!@B.^BF UWSPZAF/CJ2CQ#)76P+P(1"*W2W#(K+#.A!\N +'G&?,S]/D -0 MT$0D4\W%"U Y"XP8OU;,&)].XEL>9H%(YTY'9B@>L<&^D%@(,DQM*Q<)YADC M)NT!0 6&G*(%PN\5QT>NZ+.KG,LT19]-X>73?&ILQ10D2.J=_(!8O4:N"1TMP'YF!'P#\$K18BA.@RQ^?+/$1Q)0 ",M$[.*%0,GT MW-(3&LHUPJV$D[:>)9U.4E A'GH2\CN,6&:!,$@'*]"KR* MA1ML<_$,YD4PI1.5&R1])YT BQKS4&(*GZ';B9X$[>.G=JN+5.HLT5D-.0^_ MDP=$=\&,[E(Q.> ^:1P&/BV<(JLK-,923]VIN*\MT2_76!6T'?;GKY\DNRUP MIRI2(ZG%:CK02-/J*Z29TILI@[GPW1@$)U&MO&5$^$ KRJ2NW7"R'_ [_?M9 M@MH=]_$\M#!1+!D7:&B&]/14\!3$I_P>( /&*.P3)=P'#N_1:-IA3U,@[]_C M3+ V4;8O0(*'Z;,&>U?*.\4:RFU-^3?<@D^A!9!F&A$+X\1D&%F,>A,L_5-' M:IJE+NZZ2@MOL',TT<$>S\.LE(L:N"N575Z^%'3=1'"IC! 5\"2YQ66O>9@# M4^)@M>&; ]A>U4P/RJR58)[O C$EZ/.-)?2*15#(2P(I8R- :,4:0%5/XIYC. MPOA6""W]%(NNJ:_S#>V6&'U=O)UOQ2C)L9BJU2&)W%QGP4<*WE+_K5KQ'\". MTW>'@GP23%$2HL<[B'*2BN@9$J@W7DP",0:=E=R='V6;3WV#52QX!;JTCY8K MH,/2M4'' (M?FCB"+"AX"TV%K:C/#;;$4;%@^688$@$K(I%:1BF)YTR;,G*" MRRYJR:#]HNB>\K_B!.7\7*':LC.:7@IREI@FR%/0 Y_M#:?1;; 4]H6I9MZ] M\HZ.4$E)>8BH14Z^QH#!7D/RHOS4:C3+O_#T\(FK/T&%$3Z,\BDADD1*^*\K M'Y6WI^+@P&O#VT9U VC0A"FHRG"^ )D\P%/96:0QPYN!H7@\G;!1'.4I>XIW MHF(NK_ 3'7!A^8QI-9O,)]#;T'<2XWZ[Q7Y#]*>;!];;ED=KEX==^:A;'$VZ M:6@;9$@%F.*K,>_UYR_L,YC;0%".?$:2ZRO0R4&I #WD ]AU8!4:W[V)_#A) MY8W)UQ*ZH:D 2B60A'HV(#N:['A0PLEZEV2%(:3$K\8;1B*,;U[LJ3Z^]<@I M!NHQ[!KPY/G^<@]H ]7$@O_\V[#7'[ZL6?:!(AU$3I-\T B,4L)P9(H>!IE\ M+GU^RVC*;?Y%+&?3/TXN!I&DTI-8 MT$=!"Z5;<0G)..AJ4>%E) 9-<=20W9 ?>A&+[!;9[T+V!;WC@7C>D7A>X#?< M4^DQ!_3^2Q3HG?%O(M*L6BOCI+/$D<".&M.8>J%HS1I]G5C@%$H]S-0B90 , M#R!5_E(;+\)\"V*&8@@RV]1X5?$\]BEQ6!C 'D$+)&7V.:P:3/F5BBE&(I!5 M6L;VH[F-%5DC,H!":0.)"EW6B2P?.P_44N6#J-)46:H$^9,K_=A("8++[C$" M8UD84;NMX" 8,O^3)Z"+%;C]/W]<,/351R+$;^4J8%FE^>@OE:ZL@_,8+/(R M&00J+"RPE;]3[!AH![/#\\KZ%-/F55:Q!M>7NRY)3A1NTYV%=W24PB&X5#P0 MJ&)VX1]8R9M'LIC3R-4U$]\I7[?JXS)[496=,?'V5/.?4'G-SM#>]#'U%Z-T M,B*K(W83#J_ 6.D,^&L0YVE8"6\$^$6 65\4PX'[NA' 0-'>1'\.XM' &@5 M/&3G:.$O0-0$#Y8"P$KMMM/M]LU@T8ILZ#GH/J6P#:;ALY]DA.>92N$O&U9) M0*N+,X BN?F4^P(#1#I9FCP..FI=?=6^PC9+-*E:A4?OR-/B*'4OPGS$]IM% M>FA@7>;W?4BF:WD!#CF'HPR]G3= M.'M6='QKD(RBRE>QBT6#L5BP2J9@(($ M'Z;:;S:GKP&/PJ@ 0[]N\0)SO6R%(U,Z 8JT7![XYJ9*E^%8QAE^:C;ZK<*C MAQN1O$XMJ;S52V!F?=4G3WGWC]!]_/SAS9[W67>@?C2R%#O+LI.Y]^\\2"A= MHPW6I,J^*+O[F3C_,9D*]AXL3(>]B[Q&48R!]U 68G"9075&# =YEDS72&/J M&XAZA4A ;T8:$=DL!+-!YH !&<-?422)-N1YY%%O1,R%<:1-/)]I8Z9(,]R% M3IU+59Z=-XGB,+ZZ97D&-_)_DNEBEHFY.EG+_RW30E\%,9W-*3G"YQB E[$_ M&VRNH:D!QD+9OYCP *R*(J_O%?:0=%14[TTQOT\%]J0R] G@&_B42@-P3XFK MEEEG4B;VZ_+TG:P5>*R+^H21^:8-B( ^4(D\(/]58K!E"4:: L3W]YJ(W$0I:YLM* M1%5'5.$8V-\:XRHR^X,(-4VI7I1:RU'8H:P6*"A5^0G1IKPE25(-KCC424-Z M=*5*.Q+SU02NTV]W=U#@9XY\:/=FIY/3/1/]?*" ?.TXBN6F'G'CX&%RGP)LW,$ M5YWGY>;*;BRE7=-L#-Q6=[,5C%?(3BUDO&![0@RB1>1^<,PZNC'VMR?LCL39 MA(?C,PHQJG($LM$B#Q]V!TU&X8J"Q-2718UJ$4XW^AS.@UKY2_0=6V:8592< MSIU*3IJ/L&T_M1LQ!AM(Z4P1*9J4<1)RN=IM!67P 1%\0]*%APZG5ZGD "F M(&9/,:*K_Y(@5TS@4Q) =D'C-E-#!2SU*$FBPP$1\8I?2N*E&AL6 MY>2#@9^M6L90-]")V1IVG%ZGU0",,P2?%&9F?=\5_H-JZ950G&.4%)6:DSNM MGI0ZM+\"E@K,*_>'')N"95'9'VI!/;05JX6F8V3J%9>_BD%*.5".-)VNOVAT^RUS?:@68ES)N84Y91+JAI;5-.XZT8#B\8J_K8<2/40]Y+J M9M3KCKKCH<>_N@.??^V(0??KL#ON?!TU_:8_]A:O=0//_,ICG.=^('>W MTX3]825?OR1+XIJ 5"&J]8E2T=7?U,\EB<>"3 $,C>N@51&H5V."RHY0&?#> M*TQ*QV\_20N[Q"3V%H2P0S(_G[+W[S\Y1;TV)[A@#7">%$GX9J7P.(AX1/[S MLF88Y=IU &!2O[OS!WH"! 79\!?_SD$O% GE-5!?!L>P>*1(*6=#H-,LO"WC MD#KKMSP?^3F6](_ '>2@*=RJQCI7>&R_I)$H;2&**Z3Q$#R7\1HZFTY- M+PA(W^\8[&X>2C:V[*Y5%\OY"Z_+S7WAW^MY7X_$NN2]P:'1 @:S &Q A_[F M/KY=\@[\FZ)XQ!".XZ+/P7S_2#RQMM<=Q=&9%"+%73_\BG_TQ@XNQ->S(3X; MXMM[B.^'=.H+"B]A/Z#7PF@OM$WY?5+ II0\-2RGK*(L&@V5FFDQ7PT<3 M\CC.X#1XDZ1/8J88^GZU,S,P6K*6+1Y+MI>4;$^%O>:4UKH(FD^@OGNW& "9 M!]ZG1)R=HXI[C:,WQ^I[2AY!*(*@1^C\#E) ?E/D?&(9H $*^C9.=NP(F3]- MD.IZ0]JVU%?$&>GPU^3U (G+BR/.\(@9JI!+Q)PTVDJ$H9ZO#Y1^'."59Z'. M0\0\H04LGI#)U$"'C#092\NE*-._M\A%#VXI; O_/AV5>NX5*R0/6"'-1],@ M*_R#\T$@1]&R"8ZLK!W"6P@%A'- \8(!K,(9-F>^"XXVQ M+HM.I/G=O:W#3&ED7Y>V_WS.P=S9#C [3;D/1Y['>V[3^^J[ MX\[73F&IHLR6U"#]Z3F7S64FF5E MHK*2FO-%F#S/XCE[)TOT/M3[755]610RSM5(RN,6;VGT?S9!-%?U:!@AQNNQ M0?88&XHH&.F_S[#0\H6T,V\ *G?:=T;M:?$H'Z5QF&?BD>VZU<$>][Z)P^J_ MU?+1^EA8\EK4:1$56'P(Q1#U?![ ,2/MX^M,5IO_3AK MD/FP+_!!J+O3H[4;KL6W]1K.8QR)ZW>>I<([ ZZ)\XM>""DH*[UI_O/?>9R] MO',Y^=C+)RK$,LFRV8OGSV]N;AJP0.,JOGY^GG@3T*_2Y\*_XLESGV?\N=L< MM%NMYG.@*-?M=%K-CMMO=MO]5N]Y=MWI][O][E?QO7WF-B;9= N=7.X,\)RK M245R>AOENO@,![RA*TUEKKZ+O#B9Q4DQ<($ZIE.Y=NI((8HEGT9HB/U7FL\6 MU;A^ V-@Y*70JBNJDEJI7T(#:O(SO.V@B-P*H-HSA&.6,"V+4%;"F!*FUVXV M.RAA!FZSW2()T]J5A/E"#3P*V8*"1@N=5[ MPJ])U)S?@,1YFXS5;S.TB;9(?BAD:H+!4LCR0Z7-?*#DOJ]3E2_9&O MTVA;A+*R8UYV-#L],%*^BY"$1]-MM5WQO=,985%[J[\K^6'$V:G+".4*8]^9 M(N_W4GAY0D-6'TNB-*U$L0R@/D>J/_)U&AV+4,/LW;MW['PVXXE0/34?B_]W+?^WY%J?(]4?^3J-KD6HX^/_FUH4 ME9@'F!'=8:O3;/=:K>[S;-KJ#%N]ON]^%=_=W65J80!#V@_K>EEJ\;+0!/:Q M)$O'2A;+".ISI+N1K[RJ/6#>T$;2CU6L/"R2WF[V!H/N\/EUN]<>M#'Y=[CG MY-\_8JI:+P+D;"2R&QSCMSQ'BW[\[@/\GONW9Q^X+QP<#. PV4>/4\R]VO9( MC@5SVX\DDEI6(ED>4I\CU1_YAC;R;H62*90ZS9;;=7L@E/J=5K^/=D[S;+ K MJ?00 ?0;=DZ9L,_![!MGKT3RK2I_SF=)H+KQM4GV/)8Y9*TARRIJ=*3:6T,V M;&\%3T7P]+N#U@ $S[#?&3:EX!GN3?"L,6%:4HQ@)R^4/QN(J%^+^1OO/I&) M]$@BR(9Z+-.HT9'JCWQ#&^JW4LB40L-F<]#KMIYGUUVWW>_WI!C:>:!GK3AZ M*T9)CNTZ7>HA[@X?*[YCI8DE_OHQVAFY1;^FJ&ANWZ>^LUO)>0JTQ"%7PYO"&#?#@&T M0P"7X>K=0P!K-:*DQD+7:GRUE\]'FJD#2]H@Z9&J>P]-U7%[0Q=3=?JMUM#= ML5-[:>7"VV ,"AU]A7J?PTAIH6F#6:SBIE04IZ:1=50.#[Y$C,=RLOW:B@6G MF &9IB)CGW)X&4^%H6N.@U#&:-4,%K44!84>18]L6\^%93SU.5+]D0^6M*7= M5I09HJS;[+3:0^QFZW8[_5V+LLL<+)**$*G6+OR6A\H)/B AU'7ND73ZCU?_ M8/^\/'_TENH]*X4LSZC/D>J/?+!DSV+4<4JA!S88:35[_6''Q08C+;??;7>I MPTAK=Y+H UD\Z228L7=D.:7+3)S'\H=;0\82?(V.5'_DPR4M1AV?")GO4;C+ M^.FE\&(]H(G\65G,]BL6;#F;)>(:':G^R =+#BQ&G818V%E+#F/BTN%*A;T& M4*U(J#T!'V_H?FC1Z23DPI%^?PVU<\^D:/A1C63W0 Y*.783V:[F'[6 T#K8UA M.4"=CE1_@>(V+3X=GT39>G/TW4;1RRE+*R+I'V1#]*YLB+X01E>USW\VYLJ? M\1DSQ,X>,8YNVZE;UE&G(QV *++=-JPHVD04[:SP>0NB:*XRK?82R+K6ZGR< M_;.+(Q8_MNF&%3^;B)_V 8D?^/H;^Q?80<$EQ]*9=Q&<.R,OWYHTB:#_>T7'^GSK7 #W@2"!(?6 %9CC&W41G+^@^(4(^8 M];A%'.,1U MJQS35N%9_*[1D>J/?&WW:?#,,LU3T)?;.]27/^>A4(T_VOS,[3SESYZ[75_^ M2WYQ@?(X>O,5J.M*,L67YYZ[(X^\[$)&GU0"X F $BB7O%97"?1.P TX! W0 M.\G.#1BX>"YSI* KYE)[ 5P/7%\BR:QH?'^O!T2?1T#-);IA4YNITR/0.?6P M9U/LHFN9YD%&H<\VDC2@IAD>$*$"T\671GC,Q(AQ%:OX#\$"):<^8+-"1HR.YCL._X1 MK%O ;X&:5'SP25*\'GP"4.5*BC?X@7ELLD#7]IA,,% B4&+!T5MQ2AST+P!4 MQ:#$ 7;MP U7P2ZH]\V2QPL#00)!%AO+%2?(X=DY@*H8!#DD(^I1X$?@QS)! MN>+\>-'_!4!5#'Z\P!9Q@1J!&LN"XHI3X]77,P!5,:CQBA-Y! 4XU\"0I0+S MRQCRO8\MEXA_'7K_\8/XB$JR78*Y;-U8OZX6MO2T*5\;X5& ?F^M\LF#KSO5 M)C*)5M3.1FOJ(V/U5W&GSNJFJJT^?XC77@8/WG$6>$[-9B[CIV\,]>>G6+.T MY#;4*-V1FL4)_E;#(_'F4^S.\6*FFWG2JS=__,EBW!%WC*A6LA^0D,AF^T<4 M^R[[8ZLS)_BA%NLR#8J:2T:2.=3/HFMR]+5RU_IK0Z,=9!I*AH7M51"L,2.&FB)&Q=/9^0T^A+O M ]G5NA3Y1CNLZ?K QL1?CZI"N7Q5S<4+%OBG./#9QO@46AN81@L8/G.&'S!1 M(W0E."I,+HAMB60TQ#Y&YU0 ]W@D9V22(/;K0I9&4T0ERB'>*DYU1KU# M(E@TVG5CJ2(\YI'E""(IX\A QDHQA)_/X)R7H2CJ*K.QNA0-YAH;C>@#<>)J M^-]@YM/1(MYYD1;4O+E&5B^JZR:L9"T4D8RI3VI"5FVI->8<+R.@NUO"=VR^ MW93E#>E\ZK+H;NWS.R3ZRQZCN>"!D: & M!\VI/U:_O#X;J,>)Q0/,%_J\:[.W.JEZ2V@!HON':*-Z$%W[\;YP&L65AS^1 MQ[(+L#8!K)F"M0E@30762YE!0"/54$AM 5(S16H+D)H*J7U1N!L^WP.@Y@#4 M-@!U=_T/8,T6K!T :RJP_AZX"WU<20C4-@ U4Z"> %!3 37*(:_Y] 1@FBE, MNP#39RE_U 68Y@#37I%ABG9$:'0K"A&^)^B*LX?%ZB"%"*AH>':.S%:MG\*= M"NYD!D ]E]H!G&8[W6]4&:A]SPNPNT&BR#1JGY='>2SD41XD\2@/(^5< &HT MU?,F8#=;[!9ZK>JEV.7DGLX4*O=(MDOCU0#$YH'80B]=YN/(*: ,H\0%GH1:L\07D99F3OA1G9 9;9PK)P2U3G M"B1C 3T)E"+!P:@^&HJW!L20131Q"$["PIMPI$?Q'5PDA\PK65Y&9>Y]$T,T MU(^')R=02\J(Y5)5%B/J_'QTVVY8'=)LM6Y/C$[CMH4=?-MM$>,6.]TF,6UB MMNW>41CEOY_FQ=%C,==Y?(>)H?YEV][3@^T]L+UG MA^T]1Q'=7/_VZY?^S9]?SZYOF^U.IUT<9EG5+$,JOPKX+,!>;(+NOX!R?7ZT M&(R-G"N(<62VCQV=B5$\(']T]F"/L7='4-_VW^EB9(9W+@L>"VO>"=P%LG$@ MI_Y\Z4OPT/CWEB=J)&\*^I^*E%AEC=R0UN"Q(B#+AX0.J9$X"3_Q*%8@# M?\RX:*I3+Y_RV]?6,ET#Q2EJVYB^$!**NI)B]]FN>\U:W7JWE>=.KMB#Z?O^ M&=O4>A5KW-;HMUO M?^Z(/,U[$7U.']",N=1!D=F6:UO?S]Z+8BS1"O17'0UUGH(+QHE7:ARF'K%" M(2])[2X56@6H,:')CX#O'1J,,156L_@F#R>A,IO&.X D0/+UFSP84S(2]CZQ M [5X_\=H1&W"U7[RH? ;;)]Q0"(@\?6;?'S%J6?3*7:WX?CVD<,&"C+I5@S/ M/LEQ7WGFTFNW"/$BY]PB+IM'3OE(N*=L+L8;385SSKR9]-VUWZY+CDT 2&Z@ MGKIJXRFVJ4]%0^55%EYUA&$LUQ0=F<@5G/GI9WY-HQ> MF=O7*6?KGFGB-8UW5TN@N>OH30D^$/#D+KTQ$WM+A*7[_"I['1+JL:I&W[99X/ER<1),_;RK M#:9^H2N>.WT<6']703Y+;NI?8OX-#>DU]GP&AGZFX>];X8$5[_'E;GL3:D]$/SD+K&@GTNGGPM5_XKC!>03Y// [.^!("AWF3TPCLQ=8A,U]4&>:/:=(VOT M$ES5,V849+C+EC7"-/:9-2*^W*L3-NA+:TD<]#69I*$9,L=FLHE[1IWD7!-' MR\I:S%F(?\;^Q/WX/U!+ P04 " #LKI)8L[X"9DHD !M-@( & 'AE M;&(M,C R,S$R,S%X97@Q,&0W+FAT;>T]:7/BN+9_18]9;KHJ$,R:D)Y4==/I MU[G565XG\WKNIU?"%L'3QF:\9)E;][\_R1N&@"P);!\2AND-''1T='3VY?U_ MU>OG]@3;.C'0E[O+K\AP]&!*;!_I+L$^???1]"?HSIG-L(TNB>N:EH4^NJ9Q M3Q#2FHUN0VNU&LUZ_>P]_:YA_$../4"=(^WDJ-5L=5!3&W2Z@VX3?;A$![_? M#=^%3W^Z'M[]Z^8\6O;F]X]?+X:H5C\Z^MX>'AU]NOL4?=!I-#5TYV+;,WW3 ML;%U='1^54.UB>_/!D='CX^/C<=VPW'OC^Z^'4W\J=4YLAS'(PW#-VIG[]D[ M]'>"C;/W4^)CI$^PZQ'_M]KO=Y_KQ_0)W_0MG;D&,]G[PWS 7G^ MLT5^JTVQ>V_:==^9#=K-F7]*?_*(?KSTS%/]T33\R4!K-G\YG6'#,.W[ND7& M_D#3&EIO_IYKWD_\P7&CWZ'O.='>!BZQL&\^$/;EF:_5+8+=P43?G"FV_W$8O4/_](AKCO]Q&C[MF7\3 M"BK=GV7:I#XA(9@4])-3GSSY=6R9]W0U]NYIA)%!N]&9^:@9_](:K0@YHQ1Z MQW+SG=07'Z^=G3]-S)'I,U+KOS\:4:S/ MMK+%1C=GDSJ]!,3-V27[1LY&Y^B,R23 Q#8/8%,Q??SIN-=NG[X\84'L,@L'@-O 7K$9>8=BI MG=W2#VSC_5&P=G&+^!3PNC?#.N5U@V;CI%OD@=7.$ ^: M?]0"6EP:2E!#9: MC4XEV&@=LU>1Z_H.;^$71-%[I41Q2:8CXGH3,AQ%/YH90?O$Z M+\A-X%+UTR,2UT1KM"NDBR5@ZLV&5BPT'^Y=0E*&6JBB$HM5^O>L7&V^U$J6 M)':%ZD&K&Z'/I-BTJ1;4:'93Q6@0:@5:HQ]OI!N)&:Z&53N[FY@>2@1Z!/SZ MQY=95OCU*/_G%N1D<8OX#IJS7C3G.\6MF-QGE"';XE8[\-EA)4^6S\E__2MP M_-.,]L<#MD(X4V*+ 'Z7 ^M+'M?KBA^*Z4D?.5WA6'R!*3:(RA)]B4U@A=LO MMXO0DB$%K1)+3GH8-E-!\Y[;:".XZ/-VQD6?=L5L1#OQ)^NN9+?'7J(;,? S MR,.06.#*>0A%%N?9%">'^0]M!$NKV6KSUMCWQ3FSM_83%R_#4L>^%GKRX M_/[E1AZE$CK!UZ]#(=(1VU@!D*8G_XE8^!&[/%FV^OPEL&&94]-7D#)22^!( M^2]R$=V9SK"]\1+E\_:#2.7Z&#P3]]>?VB>G[P[S-<4_AN=?BZ2\C]\^7'VZ MY5W#C0GOXFK8*.*>IWO J,#[DZY"3W46'ZPB$<4<9S,B6NF16//-6UPWHET% M-]DV%O]#)]9;W/>[BC:]EB\)J:#IC;FX%.(/$0N29A =\:M+%0%!(;^7UL5( MZ^K%[L7EQ\Q=%MZJ)J5<0@< M64L" 4++Y#/EM?=6XN!"OLQY4&NS%WM0R ?K/Z,MF4R\90XH0ZO<_3Z,]AG? MW49AESA##9&;3:4Q,6TAB$W;,!],(\"6]8RPAS!B -#A)1[T\_,. MOG\Y_W;^@6<1;Q;V:$NH//R;M38HT19?(:9"8?DG\IVSZ#M5()YB'H.(EVH6["]UQ1QTJP0-=(K MR2WT0I#-,QU1*$68=>B,T24O=2#5Y'C>X#G)31"/*6ZF%FJ2/!$=)([L0U2) M ;8]QU%5%3()O8AYFVMGY52II398>V=,L"4+K+]H@/4:7:G$[Z(-,)D<6L6; M)<.3$PO,=AY5EI)0? WBF5PO_5:LIL)%3*@F*2U2^+GG&]XO[:+"Z%PFF51) MCQ+P9&3=D@4?F1>,_B2ZD@HE(WO5Z+M7..E).6R).U6R9F3X6N2(MHVP"X"' M(A]_R2+T>'?NQ8EO/H#74PXQI"/'-]WIF&/E>Q>Z#]#^.L6?G8"?S VGXAQFFE&%$$Y MB''JN_27D>P@>BP-#1[Y1O;31<+82. _$)=MW(I;J(3RGH)_2LG?)R&AD@$E M>Q?/$M#[4*K85N2?%;!?IJAGAF M^A1O?Q-N=Y?B][C&"JJJ"\).'^H=,T/R\L1*/U*)!*KB85NB_.H!6B'I(6%+ MT+*MA$] PE/@024G<>]L&7B*O!808-E$Q2X#4T(VSYOG3[8C8'M6@25ACTX9 M6')86//1%$E.J@)7XH9D&<@RR)BJ6D OGP"JXFP0$-R\-%B 7T!O@BT+3? # M";TO4X)M"J:'L*>[YH@8R'?8!U,@YRI4.U"*^CG)I*',4[87S?7(N&_UDY!- M]/D1\TH'84*]P?ZFIE1:^5^X[+J5[C?QAL[W]L#G)=*6]6NLV64I>O< MK8***D'KW"5$;EOMQ!,*3.GNOU"Z/^0IW5EJ,$QO1K$R,.T0I2/+T7_$7Y[D M1<(P>E.Y73TPP-TJK4;$'*N'!;B;7"3GJ#)=$ R6A#*%]VB2Z(!?!;+$NTJ5 M@2R1IO% 2:KD0()(&6T5F!)(FBX14P:A$(J4])>.*IE.'*7

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μ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end XML 107 xelb-20231231x10k_htm.xml IDEA: XBRL DOCUMENT 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2024-04-12 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2023-11-01 2023-11-30 0001083220 xelb:HalstonBrandMember srt:MinimumMember 2023-05-15 2023-05-15 0001083220 xelb:HalstonBrandMember srt:MaximumMember 2023-05-15 2023-05-15 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 2022-05-31 0001083220 2023-10-17 2023-10-17 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2024-04-12 2024-04-12 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 2022-05-31 0001083220 xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember us-gaap:SubsequentEventMember xelb:ImWhpLlcMember 2024-04-12 2024-04-12 0001083220 xelb:OfficeSpaceLeaseMember 2023-01-01 2023-12-31 0001083220 xelb:UnconsolidatedAffiliateMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2023-01-01 2023-12-31 0001083220 xelb:HalstonHeritageMember 2022-01-01 2022-12-31 0001083220 2022-05-27 2022-05-27 0001083220 xelb:XcelTermLoanMember 2021-12-30 2021-12-30 0001083220 xelb:HalstonBrandMember 2023-01-01 2023-12-31 0001083220 xelb:IsaacMizrahisMember 2020-02-24 2020-02-24 0001083220 xelb:LongabergerQurateAgreementMember 2023-01-01 2023-12-31 0001083220 xelb:LogoQurateAgreementMember 2023-01-01 2023-12-31 0001083220 xelb:CWonderQurateAgreementMember 2023-01-01 2023-12-31 0001083220 xelb:HalstonHeritageMember 2019-02-11 2019-02-11 0001083220 xelb:LoriGoldsteinBrandMember 2021-04-01 2021-04-01 0001083220 us-gaap:SubsequentEventMember 2024-02-16 2024-02-16 0001083220 xelb:LoriGoldsteinBrandMember 2023-01-01 2023-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2022-01-01 2022-12-31 0001083220 xelb:HalstonBrandMember 2023-05-15 2023-05-15 0001083220 xelb:HalstonBrandMember 2023-05-15 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:LongabergerLicensingLLCMember 2023-01-01 2023-12-31 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001083220 xelb:ConsultantsMember 2023-01-01 2023-12-31 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001083220 xelb:ConsultantsMember 2022-01-01 2022-12-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001083220 srt:DirectorMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001083220 srt:DirectorMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001083220 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001083220 us-gaap:RetainedEarningsMember 2023-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001083220 us-gaap:RetainedEarningsMember 2022-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001083220 us-gaap:RetainedEarningsMember 2021-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2021-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-12-31 0001083220 us-gaap:RestrictedStockMember 2022-05-01 2022-05-31 0001083220 us-gaap:RestrictedStockMember 2022-04-01 2022-04-30 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001083220 srt:ExecutiveOfficerMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001083220 us-gaap:CommonStockMember 2023-12-31 0001083220 us-gaap:CommonStockMember 2022-12-31 0001083220 us-gaap:CommonStockMember 2021-12-31 0001083220 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 xelb:NonManagementDirectorsMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001083220 us-gaap:PerformanceSharesMember 2023-01-01 2023-12-31 0001083220 us-gaap:PerformanceSharesMember xelb:TargetPrice5Member 2023-12-31 0001083220 us-gaap:PerformanceSharesMember xelb:TargetPrice4Member 2023-12-31 0001083220 us-gaap:PerformanceSharesMember xelb:TargetPrice3Member 2023-12-31 0001083220 us-gaap:PerformanceSharesMember xelb:TargetPrice2Member 2023-12-31 0001083220 us-gaap:PerformanceSharesMember xelb:TargetPrice1Member 2023-12-31 0001083220 us-gaap:PerformanceSharesMember 2023-12-31 0001083220 xelb:NonManagementDirectorsMember us-gaap:EmployeeStockOptionMember 2023-04-01 2023-04-30 0001083220 xelb:ConsultantMember us-gaap:EmployeeStockOptionMember 2022-04-26 2022-04-26 0001083220 xelb:EmployeeMember us-gaap:EmployeeStockOptionMember 2022-04-20 2022-04-20 0001083220 srt:ManagementMember us-gaap:EmployeeStockOptionMember 2022-04-20 2022-04-20 0001083220 us-gaap:EmployeeStockOptionMember 2023-12-31 0001083220 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001083220 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001083220 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001083220 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001083220 us-gaap:WarrantMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-12-31 0001083220 us-gaap:WarrantMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-01-01 2023-12-31 0001083220 us-gaap:WarrantMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-01-01 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-12-31 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001083220 xelb:IsaacMizrahisMember us-gaap:RestrictedStockMember 2022-05-31 2022-05-31 0001083220 xelb:NonManagementDirectorsMember 2023-08-23 2023-08-23 0001083220 xelb:EmployeeMember 2023-07-20 2023-07-20 0001083220 xelb:ConsultantMember 2023-05-15 2023-05-15 0001083220 xelb:ConsultantMember 2023-04-17 2023-04-17 0001083220 xelb:ConsultantMember 2023-01-01 2023-01-01 0001083220 xelb:IsaacMizrahisMember xelb:ConsultantMember us-gaap:RestrictedStockMember 2022-05-31 2022-05-31 0001083220 xelb:EmployeeMember 2022-05-31 2022-05-31 0001083220 xelb:SeniorManagementMember us-gaap:RestrictedStockMember 2022-04-20 2022-04-20 0001083220 xelb:NonManagementDirectorsMember us-gaap:RestrictedStockMember 2022-04-20 2022-04-20 0001083220 xelb:ConsultantMember us-gaap:RestrictedStockMember 2022-04-20 2022-04-20 0001083220 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001083220 xelb:NonManagementDirectorsMember us-gaap:CommonStockMember xelb:ShareBasedPaymentArrangementTrancheSixMember 2023-08-23 2023-08-23 0001083220 xelb:NonManagementDirectorsMember us-gaap:CommonStockMember xelb:ShareBasedPaymentArrangementTrancheFourMember 2023-08-23 2023-08-23 0001083220 xelb:NonManagementDirectorsMember us-gaap:EmployeeStockOptionMember 2023-08-23 2023-08-23 0001083220 xelb:NonManagementDirectorsMember us-gaap:CommonStockMember xelb:ShareBasedPaymentArrangementTrancheSixMember 2022-04-20 2022-04-20 0001083220 xelb:NonManagementDirectorsMember us-gaap:CommonStockMember xelb:ShareBasedPaymentArrangementTrancheFiveMember 2022-04-20 2022-04-20 0001083220 xelb:NonManagementDirectorsMember us-gaap:RestrictedStockMember 2021-04-20 2021-04-20 0001083220 us-gaap:ScenarioPlanMember 2023-01-01 2023-12-31 0001083220 xelb:IMTopcoLLCMember xelb:YearEndingDecember312025Member us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember xelb:TwelveMonthPeriodEndingMarch312025Member us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2022-12-16 0001083220 srt:MaximumMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2022-05-31 0001083220 xelb:IMTopcoLLCMember 2023-11-01 2023-11-30 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2023-01-01 2023-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001083220 xelb:HalstonBrandMember us-gaap:LicenseMember 2023-01-01 2023-12-31 0001083220 us-gaap:ProductMember 2023-01-01 2023-12-31 0001083220 us-gaap:LicenseMember 2023-01-01 2023-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001083220 us-gaap:ProductMember 2022-01-01 2022-12-31 0001083220 us-gaap:LicenseMember 2022-01-01 2022-12-31 0001083220 xelb:IsaacMizrahisMember 2022-05-31 2022-05-31 0001083220 xelb:NewLoanAndSecurityAgreementMember 2022-05-31 2022-05-31 0001083220 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001083220 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-05-27 2022-05-27 0001083220 xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-05-31 2022-05-31 0001083220 us-gaap:TrademarksMember 2022-01-01 2022-12-31 0001083220 us-gaap:SubsequentEventMember xelb:PublicOfferingAndPrivatePlacementMember 2024-03-15 2024-03-15 0001083220 2024-03-01 2024-03-31 0001083220 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2024-03-14 2024-03-14 0001083220 us-gaap:SubsequentEventMember xelb:PublicOfferingMember 2024-03-19 2024-03-19 0001083220 xelb:OrmeLiveMember us-gaap:RelatedPartyMember 2023-12-04 2023-12-04 0001083220 xelb:OrmeLiveMember 2023-12-01 2023-12-31 0001083220 xelb:IMTopcoLLCMember 2022-05-27 2022-05-27 0001083220 xelb:NewLoanAndSecurityAgreementMember 2021-12-30 2021-12-30 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2022-05-31 0001083220 xelb:IndefiniteLivedMember 2023-12-31 0001083220 2017-12-31 0001083220 srt:RetailSiteMember 2022-01-01 2022-12-31 0001083220 us-gaap:SubsequentEventMember 2024-01-26 2024-01-26 0001083220 2022-01-01 2023-12-31 0001083220 xelb:IsaacMizrahisMember 2023-01-01 2023-12-31 0001083220 xelb:IsaacMizrahisMember 2022-01-01 2022-12-31 0001083220 xelb:IsaacMizrahisMember 2021-01-01 2021-12-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-11-01 2023-11-30 0001083220 xelb:LongabergerLicensingLLCMember xelb:HilcoGlobalMember 2023-12-31 0001083220 xelb:OrmeLiveMember 2023-12-31 0001083220 xelb:OrmeLiveMember srt:DirectorMember us-gaap:RelatedPartyMember 2023-12-04 0001083220 xelb:OrmeLiveMember us-gaap:RelatedPartyMember 2023-12-04 0001083220 xelb:IMTopcoLLCMember 2022-05-31 0001083220 xelb:IMTopcoLLCMember 2022-05-27 0001083220 xelb:UnconsolidatedAffiliateMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2022-12-31 0001083220 us-gaap:SubsequentEventMember 2024-01-12 0001083220 srt:MinimumMember xelb:OfficeSpaceLeaseMember 2023-01-01 2023-12-31 0001083220 srt:MaximumMember xelb:OfficeSpaceLeaseMember 2023-01-01 2023-12-31 0001083220 xelb:MainHeadquartersLeaseMember 2023-01-01 2023-12-31 0001083220 us-gaap:SubsequentEventMember 2024-01-12 2024-01-12 0001083220 xelb:XcelTermLoanMember 2023-01-01 2023-12-31 0001083220 xelb:XcelTermLoanMember 2022-01-01 2022-12-31 0001083220 2022-05-31 2022-05-31 0001083220 xelb:ImTopcoMember 2023-01-01 2023-12-31 0001083220 xelb:ImTopcoMember 2022-01-01 2022-12-31 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-12-31 0001083220 xelb:IMTopcoLLCMember 2022-01-01 2022-12-31 0001083220 srt:RetailSiteMember 2023-01-01 2023-12-31 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-01-01 2022-12-31 0001083220 srt:MinimumMember 2023-12-31 0001083220 srt:MaximumMember 2023-12-31 0001083220 us-gaap:TrademarksMember 2023-12-31 0001083220 us-gaap:IntellectualPropertyMember 2023-12-31 0001083220 us-gaap:TrademarksMember 2022-12-31 0001083220 us-gaap:IntellectualPropertyMember 2022-12-31 0001083220 2022-05-31 0001083220 xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember us-gaap:SubsequentEventMember xelb:ImWhpLlcMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember xelb:ImWhpLlcMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember xelb:ImWhpLlcMember 2023-12-31 0001083220 xelb:IMTopcoLLCMember 2023-12-31 0001083220 xelb:IMTopcoLLCMember 2022-05-31 0001083220 xelb:IMTopcoLLCMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-05-27 0001083220 us-gaap:EmployeeStockOptionMember 2022-12-31 0001083220 xelb:SeniorManagementMember 2022-04-20 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-05-27 0001083220 us-gaap:SwapMember 2023-10-19 0001083220 us-gaap:SwapMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember xelb:IsraelDiscountBankOfNewYorkMember 2023-10-19 0001083220 xelb:HalstonBrandMember 2023-12-31 0001083220 xelb:NewLoanAndSecurityAgreementMember 2023-10-19 2023-10-19 0001083220 xelb:NewLoanAndSecurityAgreementMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-10-19 0001083220 xelb:NewLoanAndSecurityAgreementMember xelb:LiborLondonInterbankOfferedRateMember 2021-12-30 0001083220 xelb:XcelTermLoanMember 2023-12-31 0001083220 xelb:XcelTermLoanMember 2022-12-31 0001083220 xelb:NewLoanAndSecurityAgreementMember 2021-12-30 0001083220 xelb:NewLoanAndSecurityAgreementMember 2023-12-31 0001083220 2023-10-31 0001083220 xelb:NewLoanAndSecurityAgreementMember 2023-10-19 0001083220 xelb:IsaacMizrahisMember xelb:LaughClubAnnualFeeMember us-gaap:RelatedPartyMember 2022-02-24 2022-02-24 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001083220 xelb:HalstonBrandMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001083220 us-gaap:SubsequentEventMember xelb:PublicOfferingMember 2024-03-15 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-05-15 0001083220 us-gaap:RestrictedStockMember 2022-12-31 0001083220 srt:ExecutiveVicePresidentMember us-gaap:SubsequentEventMember xelb:PublicOfferingMember 2024-03-15 0001083220 srt:DirectorMember us-gaap:SubsequentEventMember xelb:PublicOfferingMember 2024-03-15 0001083220 srt:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember xelb:PublicOfferingMember 2024-03-15 0001083220 us-gaap:SubsequentEventMember xelb:PublicOfferingAndPrivatePlacementMember 2024-03-15 0001083220 xelb:AgreementsMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:ExecutiveVicePresidentMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:DirectorMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 us-gaap:RestrictedStockMember 2023-12-31 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2021Member 2023-12-31 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2011Member 2023-12-31 0001083220 xelb:EquityIncentivePlan2021Member 2023-12-31 0001083220 xelb:EquityIncentivePlan2021Member 2022-12-31 0001083220 us-gaap:WarrantMember 2023-12-31 0001083220 us-gaap:WarrantMember 2022-12-31 0001083220 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2024-03-19 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-05-15 0001083220 2021-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2023-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2022-12-31 0001083220 xelb:OfficeSpaceLeaseMember 2023-12-31 0001083220 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001083220 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001083220 xelb:EmployeeMember 2023-01-01 2023-12-31 0001083220 xelb:DirectorAndConsultantsMember 2023-01-01 2023-12-31 0001083220 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001083220 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001083220 xelb:NonManagementDirectorsMember 2022-01-01 2022-12-31 0001083220 xelb:EmployeeMember 2022-01-01 2022-12-31 0001083220 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001083220 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001083220 2022-01-01 2022-12-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001083220 srt:ExecutiveOfficerMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001083220 srt:ExecutiveOfficerMember 2022-01-01 2022-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001083220 2023-12-31 0001083220 2022-12-31 0001083220 2023-10-01 2023-12-31 0001083220 2023-06-30 0001083220 2024-04-03 0001083220 2023-01-01 2023-12-31 shares iso4217:USD utr:sqft iso4217:USD shares pure xelb:item xelb:Y -1.07 -0.20 19711637 19624669 P18Y P7Y P3Y 0001083220 2023 FY false P5Y P7Y P5Y P7Y P3Y P6Y P1Y7M27D P8Y6M16D P7M27D 0.5 0 0 0 0 19624860 19795053 0.5 P4Y6M 10-K true 2023-12-31 --12-31 false 001-37527 XCEL BRANDS, INC. DE 76-0307819 550 Seventh Avenue, 11th Floor New York NY 10018 347 727-2474 Common Stock, $0.001 par value per share XELB NASDAQ No No Yes Yes Non-accelerated Filer true false false false 17934000 23492117 688 Marcum LLP New York, NY 2998000 4608000 3454000 5110000 453000 2845000 398000 1457000 7303000 14020000 634000 1418000 4453000 5420000 41520000 47665000 17585000 19195000 1107000 165000 110000 64357000 74915000 71660000 88935000 2127000 3870000 889000 88000 372000 568000 109000 416000 1258000 1376000 750000 964000 243000 6469000 6561000 4021000 5839000 3556000 3971000 5432000 6396000 40000 17020000 12235000 23489000 18796000 0.001 0.001 1000000 1000000 0.001 0.001 50000000 50000000 19795053 19624860 20000 20000 103861000 103592000 -53849000 -32797000 50032000 70815000 -1861000 -676000 48171000 70139000 71660000 88935000 9156000 14737000 8599000 11044000 17755000 25781000 6918000 7980000 10837000 17801000 9910000 16802000 13361000 16280000 23271000 33082000 6954000 7263000 20586000 2060000 1202000 359000 445000 900000 -20644000 -2260000 113000 1187000 268000 16000 -2324000 -381000 -3527000 -21025000 -5787000 1212000 -431000 -22237000 -5356000 -1185000 -1338000 -21052000 -4018000 -1.07 -0.20 19711637 19624669 19571119 20000 103039000 -28779000 662000 74942000 534000 534000 178727 281000 281000 53882 85000 85000 50000 20064 33000 33000 65275 97000 97000 33557 50000 50000 240000 357000 357000 -4018000 -1338000 -5356000 19624860 20000 103592000 -32797000 -676000 70139000 161000 161000 26000 26000 40000 5000 66668 45000 45000 7300 10000 10000 61225 27000 27000 -21052000 -1185000 -22237000 19795053 20000 103861000 -53849000 -1861000 48171000 -22237000 -5356000 6954000 7263000 100000 274000 22000 156000 242000 620000 787000 413000 -2060000 -1202000 -2324000 1107000 -965000 20586000 359000 445000 900000 -869000 -2117000 -2391000 -530000 -1034000 -566000 4356000 54000 -2936000 -1426000 -525000 -244000 35000 -224000 -6545000 -14182000 45386000 150000 600000 459000 100000 265000 209000 44521000 27000 442000 5000000 301000 29000000 1511000 4726000 -30953000 -1610000 -614000 4608000 5222000 2998000 4608000 -283000 56000 1032000 99000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1.   Nature of Operations, Background, and Basis of Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Xcel Brands, Inc. (“Xcel” and, together with its subsidiaries, the “Company”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the “Halston Brand”), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the “C Wonder Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the “Isaac Mizrahi Brand”), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands. </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company manages the Longaberger Brand through its </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party (see Note 3 for additional details).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in IM Topco, LLC and continues to participate in the operations of the business; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting (see Note 3 for additional details).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch in 2024.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Prior to 2023, and for a portion of 2023, the Company also engaged in certain wholesale and direct-to-consumer sales of products under its brands. The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Consolidated Statements of Operations, separately from the Company’s licensing revenues. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Management’s Plans  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company incurred a net loss attributable to Company stockholders of approximately $21.1 million and $4.0 million during the years ended December 31, 2023 and 2022, respectively (which included non-cash expenses of approximately $9.0 million and $8.2 million, respectively), and had an accumulated deficit of approximately $53.8 million and $32.8 million as of December 31, 2023 and 2022, respectively. Net cash used in operating activities was $6.5 million in 2023 and $14.2 million in 2022. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations) of approximately $2.1 million and $8.8 million as of December 31, 2023 and 2022, respectively. The Company’s cash and cash equivalents were approximately $3.0 million and $4.6 million as of December </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">31, 2023 and 2022, respectively. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions were executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to develop and launch in 2024 and beyond. In the second quarter of 2023, the Company entered into a new master license agreement for the Halston Brand, covering men’s, women’s, and children’s apparel, fashion accessories, and other product categories, with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 5 for details).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">These restructuring initiatives were substantially completed as of June 30, 2023.   </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Further, in October 2023, the Company entered into a new term loan agreement in the amount of $5 million (see Note 6 for details). Subsequent to year end, in January 2024, the Company entered into a sublease of its offices at 1333 Broadway in New York, NY (see Note 12 for details), and in March 2024, the Company issued new shares of common stock for net proceeds of approximately $2 million (see Note 12 for details).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Based on these recent events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Annual Report on Form 10-K; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of December 31, 2023, have been alleviated. </p> 0.50 0.30 0.30 -21100000 -4000000.0 9000000.0 8200000 -53800000 -32800000 -6500000 -14200000 2100000 8800000 3000000.0 4600000 6000000 9000000 5000000 2000000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2.   Summary of Significant Accounting Policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Principles of Consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements include the accounts of Xcel, its wholly owned subsidiaries, and entities in which Xcel has a controlling financial interest as of and for the years ended December 31, 2023 (the "Current Year") and 2022 (the "Prior Year"). The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). All significant intercompany accounts and transactions have been eliminated in consolidation, and net earnings have been adjusted by the portion of operating results of consolidated entities attributable to noncontrolling interests.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Investments in Unconsolidated Affiliates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company holds a noncontrolling equity interest in IM Topco, LLC, which was entered into during the Prior Year, and a noncontrolling equity interest in ORME Live, Inc., which was entered into during the Current Year. These investments are accounted for in accordance with ASC Topic 323, “Investments – Equity Method and Joint Ventures,” as the Company has the ability to exercise significant influence over their operating and financial policies of these affiliates, but does not control the affiliates. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes its share of the ongoing operating results of these affiliates within other operating costs and expenses (income) in the accompanying consolidated statements of operations. The Company’s investments in unconsolidated affiliates are reviewed for impairment whenever there are indicators that their carrying value may not be recoverable; if a decrease in value of the investment has occurred and such decrease is determined to be other than temporary in nature, the Company shall record an impairment charge to reduce the carrying amount of the investment to its fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 3 for additional information related to the Company’s investments in unconsolidated affiliates.  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company deems the following items to require significant estimates from management:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Allowances for credit losses;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Useful lives of trademarks;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Assumptions used in the valuation of intangible assets, including cash flow estimates for initial determinations of fair value and/or impairment analysis; and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Stock-based compensation.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All highly liquid investments with original maturities of three months or less are considered to be cash equivalents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Accounts Receivable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are reported net of an allowance for credit losses. As of December 31, 2023 and 2022, the Company had $3.5 million and $5.1 million, respectively, of accounts receivable, net of allowances of $0.8 million and $0, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A rollforward of the allowance for credit losses for the Current Year is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit loss expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 787</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Write-offs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recoveries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 787</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company recognized credit loss expense of $0.4 million in the Prior Year, which was related to the bankruptcy of several retail customers due to the 2020 – 2023 coronavirus disease pandemic. The Company wrote-off approximately $1.5 million of such customers’ outstanding receivable balances in the Prior Year. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Additionally, on October 17, 2023, the Company and one of the licensees managed under the Halston Master License (see Note 5) entered into an amendment of their respective licensing agreement. Under this amendment, the payment terms of the $0.76 million outstanding balance due to the Company were changed such that this receivable (and collection thereof) became contractually contingent upon the licensee’s future performance. The licensee is also required to pay interest to the Company on a monthly basis until the outstanding balance is paid in full. The Company recorded a non-cash charge of $0.76 million within other selling, general and administrative expenses in the Current Year related to the restructuring of this licensing arrangement, in order to write-down the previously-recorded receivable to zero, which is not included in the credit loss expense and allowance for credit losses amounts set forth above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">There is no earned revenue that has been accrued but not billed as of December 31, 2023 and 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023 and 2022, approximately $0.04 million and $1.7 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the Prior Year, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During both the Current Year and Prior Year, the Company paid less than $0.1 million in fees to the agent under the aforementioned services agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Inventory</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All of the Company’s inventory consists of finished goods. As of December 31, 2022, inventory was composed of jewelry, wholesale apparel, and home goods. During the Current Year, as a result of the restructuring of its business operating model, the Company sold all of its wholesale apparel inventory and substantially all of its remaining fine jewelry inventory to its new business partners and licensees. Thus, as of December 31, 2023, inventory was primarily composed of home goods and related items for the Longaberger Brand. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Inventory is recorded at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of its inventories in order to identify obsolete, slow-moving, or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventories, the Company </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">will record a write-down to net realizable value in the period that the decline in value is first recognized. Write-downs for inventory shrinkage, representing the risk of physical loss of inventory, are estimated based on historical experience and are adjusted based upon physical inventory counts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Property and Equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Furniture, equipment, and software are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over their estimated useful lives, generally <span style="-sec-ix-hidden:Hidden_t14xJ_H6wEiaI1cHxotvVw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> (3) to <span style="-sec-ix-hidden:Hidden_sLN7fBswmk6r6Kyv3zuktg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">seven</span></span> (7) years. Depreciation expense for the years ended December 31, 2023 and 2022 was approximately $0.8 million and $1.1 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Leasehold improvements are amortized over the shorter of their estimated useful lives or the terms of the leases. Betterments and improvements are capitalized, while repairs and maintenance are expensed as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Costs to develop or acquire software for internal use incurred during the preliminary project stage and the post implementation stage are expensed, while internal and external costs to acquire or develop software for internal use incurred during the application development stage – including design, configuration, coding, testing, and installation – are generally capitalized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s long-lived property and equipment assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on a discounted cash flows analysis or appraisals. The inputs utilized in the impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurement.”</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognized impairment charges of $0.3 million in the Prior Year related to store fixtures purchased for an apparel program with one of the Company’s retail partners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Trademarks and Other Intangible Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s finite-lived intangible assets are amortized over their estimated useful lives of <span style="-sec-ix-hidden:Hidden_kpjV_Kqi7k2QPg04y94rsw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> (3) to <span style="-sec-ix-hidden:Hidden_p9GkUWxF4ky4bHCu0sIDMg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">eighteen</span></span> (18) years. The Company re-evaluates the remaining useful life of its finite-lived intangible assets on an annual basis, based on consideration of current events and circumstances, the expected use of the asset, and the effects of demand, competition, and other economic factors. No changes were made to the estimated useful lives of intangible assets in the Current Year or Prior Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value, based on a discounted cash flows analysis or appraisals. The inputs utilized in the finite-lived intangible assets impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in ASC Topic 820. No impairment charges were recorded related to intangible assets for the Current Year or Prior Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 4 for additional information related to the Company’s trademarks and other intangible assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Deferred Finance Costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company incurred costs (primarily professional fees and lender underwriting fees) in connection with borrowings under term loans. These costs have been deferred on the consolidated balance sheet as a reduction to the carrying value of the associated borrowings, and are being amortized as interest expense over the term of the related borrowings using the effective interest method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Contingent Obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired is greater than the consideration paid, any contingent obligations are recognized and recorded as the positive difference between the fair value of the assets acquired and the consideration paid for the acquired assets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired are equal to the consideration paid, any contingent obligations are recognized based upon the Company’s best estimate of the amount that will be paid to settle the liability. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the applicable accounting guidance, the Company is required to carry such contingent liability balances on its consolidated balance sheet until the measurement period of the earn-out expires and all related contingencies have been resolved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recorded contingent obligations in connection with the purchase of the Halston Heritage trademarks in 2019 and the purchase of the LOGO by Lori Goldstein trademarks in 2021, but no amount has been recorded for the contingent obligation related to the sale of a majority interest in the Isaac Mizrahi Brand in 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 9 for additional information related to the Company’s contingent obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue Recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company applies the guidance in ASC Topic 606, “Revenue from Contracts with Customers” to recognize revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Licensing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes revenue continuously over time as it satisfies its continuous obligation of granting access to its licensed intellectual properties, which are deemed symbolic intellectual properties under the applicable revenue accounting guidance. Payments are typically due after sales have occurred and have been reported by the licensees or, where applicable, in accordance with minimum guaranteed payment provisions. The timing of performance obligations is typically consistent with the timing of payments, though there may be differences if contracts provide for advances or significant escalations of contractually guaranteed minimum payments. With the exception of the Halston Master License agreement described in Note 5, there were no such differences that would have a material impact on the Company’s consolidated balance sheets at December 31, 2023 and 2022. In accordance with ASC 606-10-55-65, the Company recognizes net licensing revenue at the later of when (1) the subsequent sale or usage occurs or (2) the performance obligation to which some or all of the sales- or usage-based royalty has been allocated is satisfied (in whole or in part). More specifically, the Company separately identifies:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Contracts for which, based on experience, royalties are expected to exceed any applicable minimum guaranteed payments, and to which an output-based measure of progress based on the “right to invoice” practical expedient is applied because the royalties due for each period correlate directly with the value to the customer of the Company’s performance in each period (this approach is identified as “View A” by the FASB Revenue Recognition Transition Resource Group, “TRG”); and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Contracts for which revenue is recognized based on minimum guaranteed payments using an appropriate measure of progress, in which minimum guaranteed payments are straight-lined over the term of the contract and recognized ratably based on the passage of time, and to which the royalty recognition constraint to the sales-based royalties in excess of minimum guaranteed is applied and such sales-based royalties are recognized to the distinct period only when the minimum guaranteed is exceeded on a cumulative basis (this approach is identified as “View C” by the TRG).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s unconditional right to receive consideration based on the terms and conditions of licensing contracts is presented as accounts receivable on the accompanying consolidated balance sheets. The Company does not typically perform by transferring goods or services to customers before the customer pays consideration or before payment is due, thus the amounts of contract assets as defined by ASC 606-10-45-3 related to licensing contracts were not material as of December 31, 2023 and 2022. The Company typically does not receive consideration in advance of performance and, consequently, amounts of contract liabilities as defined by ASC 606-10-45-2 related to licensing contracts were not material as of December 31, 2022; however, as of December 31, 2023, the Company has recognized approximately $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet related to the Halston Master License agreement (see Note 5).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company does not disclose the amount attributable to unsatisfied or partially satisfied performance obligations for variable revenue contracts (identified under “View A” above) in accordance with the optional exemption allowed under ASC 606. The Company did not have any revenue recognized in the reporting period from performance obligations satisfied, or partially satisfied, in previous periods. Remaining minimum guaranteed payments for active contracts as of December 31, 2023 are expected to be recognized ratably in accordance with View C over the remaining term of each contract based on the passage of time and through December 2028, subject to renewal or extension upon termination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Wholesale Sales</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Prior to the restructuring of the Company’s business model and operations in the Current Year, the Company generated a portion of its revenue through the design, sourcing, and sale of branded jewelry and apparel to both domestic and international customers who, in turn, sold the products to the consumer. The Company recognized such revenue within net sales in the accompanying consolidated statements of operations when performance obligations identified under the terms of contracts with its customers were satisfied, which occurred upon the transfer of control of the merchandise in accordance with the contractual terms and conditions of the sale. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Direct-to-Consumer Sales</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s revenue associated with its e-commerce jewelry operations and the Longaberger Brand (prior to the restructuring of the Company’s business model and operations in the Current Year) was recognized within net sales in the accompanying consolidated statements of operations at the point in time when product is shipped to the customer. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Advertising Costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All costs associated with production for the Company’s advertising, marketing, and promotion are expensed during the periods when the activities take place. All other advertising costs, such as print and online media, are expensed when the advertisement occurs. The Company incurred approximately $1.0 million and $2.6 million in advertising and marketing costs for the Current Year and Prior Year, respectively, which are included within other selling, general and administrative expenses in the accompanying consolidated statements of operations.  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Leases </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The Company determines if an arrangement is a lease (as defined in ASC Topic 842, “Leases”) at the inception of the arrangement. The Company generally recognizes a right-of-use (“ROU”) asset, representing its right to use the underlying leased asset for the lease term, and a liability for its obligation to make future lease payments (the lease liability) at commencement date (the date on which the lessor makes the underlying asset available for use) based on the present value of lease payments over the lease term. The Company does not recognize ROU assets and lease liabilities for lease terms of 12 months or less, but recognizes such lease payments in operations on a straight-line basis over the lease terms. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As the Company’s leases typically do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For real estate leases of office space, the Company accounts for the lease and non-lease components as a single lease component. Variable lease payments that do not depend on an index or rate (such as real estate taxes and building insurance and lessee’s shares thereof), if any, are excluded from lease payments at lease commencement date for initial measurement. Subsequent to initial measurement, these variable payments are recognized when the event determining the amount of variable consideration to be paid occurs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Lease expense for operating lease payments is generally recognized on a straight-line basis over the lease term. The Company recognizes income from subleases (in which the Company is the sublessor) on a straight-line basis over the term of the sublease, as a reduction to lease expense. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 9 for additional information related to the Company’s leases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock-Based Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The fair value of stock options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected life of the awards and the expected stock price volatility over the terms of the awards. The expected life is based on the estimated average life of options and warrants using the simplified method; the Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The risk-free rate is based on the U.S. Treasury rate for the expected term at the time of grant, volatility is based on the historical volatility of the Company’s common stock, and the expected dividend assumption is based on the Company’s history and expectation of dividend payouts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant, based on the quoted market price of the Company’s common shares on the NASDAQ Capital Market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Non-employee awards are measured at the grant date fair value of the equity instruments to be issued, and the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for forfeitures as a reduction of compensation cost in the period when such forfeitures occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 7 for additional information related to stock-based compensation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Current income taxes are based on the respective period’s taxable income for federal and state income tax reporting purposes. Deferred tax assets and liabilities are determined based on the differences between the financial statement and income tax bases of assets and liabilities, using enacted tax rates and laws that will be in effect for the year in which the differences are expected to reverse. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A valuation allowance is recognized when necessary to reduce deferred tax assets to the amount expected to be realized. In determining the need for a valuation allowance, management reviews both positive and negative evidence, including current and historical results of operations, future income projections, and the overall prospects of the Company’s business. A valuation allowance is established if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company applies the FASB guidance on accounting for uncertainty in income taxes, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and also addresses derecognition, classification, interest, and penalties related to uncertain tax positions. The Company has no unrecognized tax benefits as of December 31, 2023 and 2022. Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2020 through December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The income tax effects of changes in tax laws are recognized in the period when enacted. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 10 for additional information related to income taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC Topic 820, “Fair Value Measurement,” defines fair value and establishes a framework for measuring fair value under U.S. GAAP. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of the Company’s assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of term loan debt approximates fair value due to the floating interest rate structure of the term loan agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company limits its credit risk with respect to cash and cash equivalents by maintaining such balances with high quality financial institutions. At times, the Company’s cash and cash equivalents may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are not considered </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">significant due to the collection history and due to the nature of the Company’s royalty revenues. Generally, the Company does not require collateral or other security to support accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Earnings (Loss) Per Share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted earnings (loss) per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants using the treasury stock method. The difference between basic and diluted weighted-average common shares results from the assumption that all dilutive stock options and warrants outstanding were exercised into common stock if the effect is not anti-dilutive. See Note 8 for additional information related to earnings (loss) per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Recently Adopted Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Issued Accounting Pronouncements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively, and is effective for fiscal years beginning after December 15, 2024. The Company does not anticipate that the adoption of this ASU will have a significant impact on its consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Investments in Unconsolidated Affiliates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company holds a noncontrolling equity interest in IM Topco, LLC, which was entered into during the Prior Year, and a noncontrolling equity interest in ORME Live, Inc., which was entered into during the Current Year. These investments are accounted for in accordance with ASC Topic 323, “Investments – Equity Method and Joint Ventures,” as the Company has the ability to exercise significant influence over their operating and financial policies of these affiliates, but does not control the affiliates. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes its share of the ongoing operating results of these affiliates within other operating costs and expenses (income) in the accompanying consolidated statements of operations. The Company’s investments in unconsolidated affiliates are reviewed for impairment whenever there are indicators that their carrying value may not be recoverable; if a decrease in value of the investment has occurred and such decrease is determined to be other than temporary in nature, the Company shall record an impairment charge to reduce the carrying amount of the investment to its fair value.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company deems the following items to require significant estimates from management:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Allowances for credit losses;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Useful lives of trademarks;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Assumptions used in the valuation of intangible assets, including cash flow estimates for initial determinations of fair value and/or impairment analysis; and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:19.8pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:16.2pt;text-indent:0pt;white-space:nowrap;">●</span>Stock-based compensation.</div><div style="margin-top:12pt;"></div> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All highly liquid investments with original maturities of three months or less are considered to be cash equivalents.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Accounts Receivable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are reported net of an allowance for credit losses. As of December 31, 2023 and 2022, the Company had $3.5 million and $5.1 million, respectively, of accounts receivable, net of allowances of $0.8 million and $0, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A rollforward of the allowance for credit losses for the Current Year is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit loss expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 787</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Write-offs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recoveries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 787</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company recognized credit loss expense of $0.4 million in the Prior Year, which was related to the bankruptcy of several retail customers due to the 2020 – 2023 coronavirus disease pandemic. The Company wrote-off approximately $1.5 million of such customers’ outstanding receivable balances in the Prior Year. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Additionally, on October 17, 2023, the Company and one of the licensees managed under the Halston Master License (see Note 5) entered into an amendment of their respective licensing agreement. Under this amendment, the payment terms of the $0.76 million outstanding balance due to the Company were changed such that this receivable (and collection thereof) became contractually contingent upon the licensee’s future performance. The licensee is also required to pay interest to the Company on a monthly basis until the outstanding balance is paid in full. The Company recorded a non-cash charge of $0.76 million within other selling, general and administrative expenses in the Current Year related to the restructuring of this licensing arrangement, in order to write-down the previously-recorded receivable to zero, which is not included in the credit loss expense and allowance for credit losses amounts set forth above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">There is no earned revenue that has been accrued but not billed as of December 31, 2023 and 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023 and 2022, approximately $0.04 million and $1.7 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the Prior Year, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During both the Current Year and Prior Year, the Company paid less than $0.1 million in fees to the agent under the aforementioned services agreement.</p> 3500000 5100000 800000 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit loss expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 787</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Write-offs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recoveries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 787</p></td></tr></table> 787000 787000 400000 1500000 760000 760000 0 0 40000.00 1700000 100000 100000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Inventory</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All of the Company’s inventory consists of finished goods. As of December 31, 2022, inventory was composed of jewelry, wholesale apparel, and home goods. During the Current Year, as a result of the restructuring of its business operating model, the Company sold all of its wholesale apparel inventory and substantially all of its remaining fine jewelry inventory to its new business partners and licensees. Thus, as of December 31, 2023, inventory was primarily composed of home goods and related items for the Longaberger Brand. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Inventory is recorded at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of its inventories in order to identify obsolete, slow-moving, or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventories, the Company </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">will record a write-down to net realizable value in the period that the decline in value is first recognized. Write-downs for inventory shrinkage, representing the risk of physical loss of inventory, are estimated based on historical experience and are adjusted based upon physical inventory counts.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Property and Equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Furniture, equipment, and software are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over their estimated useful lives, generally <span style="-sec-ix-hidden:Hidden_t14xJ_H6wEiaI1cHxotvVw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> (3) to <span style="-sec-ix-hidden:Hidden_sLN7fBswmk6r6Kyv3zuktg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">seven</span></span> (7) years. Depreciation expense for the years ended December 31, 2023 and 2022 was approximately $0.8 million and $1.1 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Leasehold improvements are amortized over the shorter of their estimated useful lives or the terms of the leases. Betterments and improvements are capitalized, while repairs and maintenance are expensed as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Costs to develop or acquire software for internal use incurred during the preliminary project stage and the post implementation stage are expensed, while internal and external costs to acquire or develop software for internal use incurred during the application development stage – including design, configuration, coding, testing, and installation – are generally capitalized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s long-lived property and equipment assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on a discounted cash flows analysis or appraisals. The inputs utilized in the impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurement.”</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognized impairment charges of $0.3 million in the Prior Year related to store fixtures purchased for an apparel program with one of the Company’s retail partners.</p> 800000 1100000 300000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Trademarks and Other Intangible Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s finite-lived intangible assets are amortized over their estimated useful lives of <span style="-sec-ix-hidden:Hidden_kpjV_Kqi7k2QPg04y94rsw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> (3) to <span style="-sec-ix-hidden:Hidden_p9GkUWxF4ky4bHCu0sIDMg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">eighteen</span></span> (18) years. The Company re-evaluates the remaining useful life of its finite-lived intangible assets on an annual basis, based on consideration of current events and circumstances, the expected use of the asset, and the effects of demand, competition, and other economic factors. No changes were made to the estimated useful lives of intangible assets in the Current Year or Prior Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. To perform such impairment testing, the Company groups assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluates the asset group against the sum of undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value, based on a discounted cash flows analysis or appraisals. The inputs utilized in the finite-lived intangible assets impairment analysis are classified as Level 3 inputs within the fair value hierarchy as defined in ASC Topic 820. No impairment charges were recorded related to intangible assets for the Current Year or Prior Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 4 for additional information related to the Company’s trademarks and other intangible assets.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Deferred Finance Costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company incurred costs (primarily professional fees and lender underwriting fees) in connection with borrowings under term loans. These costs have been deferred on the consolidated balance sheet as a reduction to the carrying value of the associated borrowings, and are being amortized as interest expense over the term of the related borrowings using the effective interest method.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Contingent Obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired is greater than the consideration paid, any contingent obligations are recognized and recorded as the positive difference between the fair value of the assets acquired and the consideration paid for the acquired assets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">When accounting for asset acquisitions, if any contingent obligations exist and the fair value of the assets acquired are equal to the consideration paid, any contingent obligations are recognized based upon the Company’s best estimate of the amount that will be paid to settle the liability. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the applicable accounting guidance, the Company is required to carry such contingent liability balances on its consolidated balance sheet until the measurement period of the earn-out expires and all related contingencies have been resolved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recorded contingent obligations in connection with the purchase of the Halston Heritage trademarks in 2019 and the purchase of the LOGO by Lori Goldstein trademarks in 2021, but no amount has been recorded for the contingent obligation related to the sale of a majority interest in the Isaac Mizrahi Brand in 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 9 for additional information related to the Company’s contingent obligations.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue Recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company applies the guidance in ASC Topic 606, “Revenue from Contracts with Customers” to recognize revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Licensing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes revenue continuously over time as it satisfies its continuous obligation of granting access to its licensed intellectual properties, which are deemed symbolic intellectual properties under the applicable revenue accounting guidance. Payments are typically due after sales have occurred and have been reported by the licensees or, where applicable, in accordance with minimum guaranteed payment provisions. The timing of performance obligations is typically consistent with the timing of payments, though there may be differences if contracts provide for advances or significant escalations of contractually guaranteed minimum payments. With the exception of the Halston Master License agreement described in Note 5, there were no such differences that would have a material impact on the Company’s consolidated balance sheets at December 31, 2023 and 2022. In accordance with ASC 606-10-55-65, the Company recognizes net licensing revenue at the later of when (1) the subsequent sale or usage occurs or (2) the performance obligation to which some or all of the sales- or usage-based royalty has been allocated is satisfied (in whole or in part). More specifically, the Company separately identifies:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Contracts for which, based on experience, royalties are expected to exceed any applicable minimum guaranteed payments, and to which an output-based measure of progress based on the “right to invoice” practical expedient is applied because the royalties due for each period correlate directly with the value to the customer of the Company’s performance in each period (this approach is identified as “View A” by the FASB Revenue Recognition Transition Resource Group, “TRG”); and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Contracts for which revenue is recognized based on minimum guaranteed payments using an appropriate measure of progress, in which minimum guaranteed payments are straight-lined over the term of the contract and recognized ratably based on the passage of time, and to which the royalty recognition constraint to the sales-based royalties in excess of minimum guaranteed is applied and such sales-based royalties are recognized to the distinct period only when the minimum guaranteed is exceeded on a cumulative basis (this approach is identified as “View C” by the TRG).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s unconditional right to receive consideration based on the terms and conditions of licensing contracts is presented as accounts receivable on the accompanying consolidated balance sheets. The Company does not typically perform by transferring goods or services to customers before the customer pays consideration or before payment is due, thus the amounts of contract assets as defined by ASC 606-10-45-3 related to licensing contracts were not material as of December 31, 2023 and 2022. The Company typically does not receive consideration in advance of performance and, consequently, amounts of contract liabilities as defined by ASC 606-10-45-2 related to licensing contracts were not material as of December 31, 2022; however, as of December 31, 2023, the Company has recognized approximately $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet related to the Halston Master License agreement (see Note 5).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company does not disclose the amount attributable to unsatisfied or partially satisfied performance obligations for variable revenue contracts (identified under “View A” above) in accordance with the optional exemption allowed under ASC 606. The Company did not have any revenue recognized in the reporting period from performance obligations satisfied, or partially satisfied, in previous periods. Remaining minimum guaranteed payments for active contracts as of December 31, 2023 are expected to be recognized ratably in accordance with View C over the remaining term of each contract based on the passage of time and through December 2028, subject to renewal or extension upon termination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Wholesale Sales</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Prior to the restructuring of the Company’s business model and operations in the Current Year, the Company generated a portion of its revenue through the design, sourcing, and sale of branded jewelry and apparel to both domestic and international customers who, in turn, sold the products to the consumer. The Company recognized such revenue within net sales in the accompanying consolidated statements of operations when performance obligations identified under the terms of contracts with its customers were satisfied, which occurred upon the transfer of control of the merchandise in accordance with the contractual terms and conditions of the sale. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Direct-to-Consumer Sales</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s revenue associated with its e-commerce jewelry operations and the Longaberger Brand (prior to the restructuring of the Company’s business model and operations in the Current Year) was recognized within net sales in the accompanying consolidated statements of operations at the point in time when product is shipped to the customer. Shipping to customers was accounted for as a fulfillment activity and was recorded within other selling, general and administrative expenses. </p> 4400000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Advertising Costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All costs associated with production for the Company’s advertising, marketing, and promotion are expensed during the periods when the activities take place. All other advertising costs, such as print and online media, are expensed when the advertisement occurs. The Company incurred approximately $1.0 million and $2.6 million in advertising and marketing costs for the Current Year and Prior Year, respectively, which are included within other selling, general and administrative expenses in the accompanying consolidated statements of operations.  </p> 1000000.0 2600000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Leases </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The Company determines if an arrangement is a lease (as defined in ASC Topic 842, “Leases”) at the inception of the arrangement. The Company generally recognizes a right-of-use (“ROU”) asset, representing its right to use the underlying leased asset for the lease term, and a liability for its obligation to make future lease payments (the lease liability) at commencement date (the date on which the lessor makes the underlying asset available for use) based on the present value of lease payments over the lease term. The Company does not recognize ROU assets and lease liabilities for lease terms of 12 months or less, but recognizes such lease payments in operations on a straight-line basis over the lease terms. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As the Company’s leases typically do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For real estate leases of office space, the Company accounts for the lease and non-lease components as a single lease component. Variable lease payments that do not depend on an index or rate (such as real estate taxes and building insurance and lessee’s shares thereof), if any, are excluded from lease payments at lease commencement date for initial measurement. Subsequent to initial measurement, these variable payments are recognized when the event determining the amount of variable consideration to be paid occurs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Lease expense for operating lease payments is generally recognized on a straight-line basis over the lease term. The Company recognizes income from subleases (in which the Company is the sublessor) on a straight-line basis over the term of the sublease, as a reduction to lease expense. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 9 for additional information related to the Company’s leases.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock-Based Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The fair value of stock options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected life of the awards and the expected stock price volatility over the terms of the awards. The expected life is based on the estimated average life of options and warrants using the simplified method; the Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The risk-free rate is based on the U.S. Treasury rate for the expected term at the time of grant, volatility is based on the historical volatility of the Company’s common stock, and the expected dividend assumption is based on the Company’s history and expectation of dividend payouts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant, based on the quoted market price of the Company’s common shares on the NASDAQ Capital Market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Non-employee awards are measured at the grant date fair value of the equity instruments to be issued, and the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for forfeitures as a reduction of compensation cost in the period when such forfeitures occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 7 for additional information related to stock-based compensation.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Current income taxes are based on the respective period’s taxable income for federal and state income tax reporting purposes. Deferred tax assets and liabilities are determined based on the differences between the financial statement and income tax bases of assets and liabilities, using enacted tax rates and laws that will be in effect for the year in which the differences are expected to reverse. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A valuation allowance is recognized when necessary to reduce deferred tax assets to the amount expected to be realized. In determining the need for a valuation allowance, management reviews both positive and negative evidence, including current and historical results of operations, future income projections, and the overall prospects of the Company’s business. A valuation allowance is established if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company applies the FASB guidance on accounting for uncertainty in income taxes, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and also addresses derecognition, classification, interest, and penalties related to uncertain tax positions. The Company has no unrecognized tax benefits as of December 31, 2023 and 2022. Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2020 through December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The income tax effects of changes in tax laws are recognized in the period when enacted. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 10 for additional information related to income taxes.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC Topic 820, “Fair Value Measurement,” defines fair value and establishes a framework for measuring fair value under U.S. GAAP. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of the Company’s assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of term loan debt approximates fair value due to the floating interest rate structure of the term loan agreement.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company limits its credit risk with respect to cash and cash equivalents by maintaining such balances with high quality financial institutions. At times, the Company’s cash and cash equivalents may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are not considered </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">significant due to the collection history and due to the nature of the Company’s royalty revenues. Generally, the Company does not require collateral or other security to support accounts receivable.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Earnings (Loss) Per Share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted earnings (loss) per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants using the treasury stock method. The difference between basic and diluted weighted-average common shares results from the assumption that all dilutive stock options and warrants outstanding were exercised into common stock if the effect is not anti-dilutive. See Note 8 for additional information related to earnings (loss) per share.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Recently Adopted Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Issued Accounting Pronouncements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively, and is effective for fiscal years beginning after December 15, 2024. The Company does not anticipate that the adoption of this ASU will have a significant impact on its consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">3. Acquisitions and Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Sale of Majority Interest in Isaac Mizrahi Brand</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The purchase price paid by WHP to the Company at the closing of the transaction in exchange for the 70% membership interest in IM Topco consisted of $46.2 million in cash. The Company incurred approximately $0.9 million of expenses directly related to this transaction, including legal fees and agent fees, of which $0.1 million of the agent fees were paid through the issuance of 65,275 shares of the Company’s common stock, which were recognized as a reduction to the gain from the transaction. The Company recognized a net pre-tax gain from the transaction of $20.6 million, which is classified </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">as a component of other operating costs and expenses (income) in the consolidated statement of operations for the Prior Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to the May 27, 2022 purchase agreement, the Company was also entitled to receive an “earn-out” payment in the amount of $2.0 million if, during the period from January 1, 2023 through December 31, 2023, (i) IM Topco received Net Royalty Revenue (as defined in the purchase agreement) in an amount equal to or greater than $17.5 million and (ii) IM Topco generated EBITDA (as defined in the purchase agreement) in an amount equal to or greater than $11.8 million. These conditions were not met during 2023, and ultimately the Company did not receive any additional “earn-out” payment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Additionally, the purchase agreement provided that, in the event IM Topco receives less than $13.347 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on the third anniversary of the closing, WHP would be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP for such period, as an adjustment to the purchase price, payable in either cash or equity interests in IM Topco held by the Company. This provision was subsequently amended in November 2023, as described further below, and was subsequently further amended in April 2024 (see Note 12 for additional information).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the May 27, 2022 membership purchase agreement, the Company and WHP also entered into an Amended and Restated Limited Liability Company Agreement of IM Topco (the “Business Venture Agreement”) governing the operation of IM Topco as a partnership between the Company and WHP following the closing. Pursuant to the Business Venture Agreement, IM Topco is managed by a single Manager appointed by the vote of a majority-in-interest of IM Topco’s members, and WHP serves as the sole Manager of IM Topco. The Business Venture Agreement contains customary provisions for the governance of a partnership, including with respect to decision making, access to information, restrictions on transfer of interests, and covenants. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to the Business Venture Agreement, IM Topco’s Net Cash Flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">first, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to WHP, until WHP has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$8,852,000 </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(subject to adjustment in certain circumstances as set forth in the agreement);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">second, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,316,200 </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(subject to adjustment in certain circumstances as set forth in the agreement); and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">thereafter, in proportion to the members’ respective ownership interests.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The distribution provisions in the Business Venture Agreement were subsequently amended in April 2024 (see Note 12 for additional information).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company also entered into a number of other related agreements on May 31, 2022 in connection with the transaction, including a services agreement with IM Topco and a license agreement with IM Topco (see Note 11 for details), while the Company’s employment agreement with Mr. Mizrahi and the Company’s services agreement with Laugh Club (see Note 11) were transferred to IM Topco. Further, the Company’s licensing agreement with Qurate Retail Group related to the Isaac Mizrahi Brand (see Note 5) was assigned to IM Topco as of May 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Management assessed and evaluated the ownership structure and other terms of the May 27, 2022 membership purchase agreement and Business Venture Agreement, as well as considered the Company’s continuing involvement with the Isaac Mizrahi Brand through the aforementioned services agreement and license agreement with IM Topco, and concluded that (i) IM Topco is not a Variable Interest Entity under ASC Topic 810, and (ii) the Company has significant influence over, but does not control, IM Topco. As such, on May 31, 2022, the Company de-recognized the carrying amount of the Isaac Mizrahi Brand trademarks of $44.5 million and recognized the fair value of its retained interest in IM Topco of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">approximately $19.8 million as an equity method investment. The fair value of the Company’s retained interest was determined by applying the Company’s ownership percentage to the implied enterprise value of IM Topco, which was calculated based on the price paid by WHP for the 70% controlling interest, as the May 31, 2022 sale transaction was considered an arms-length transaction between knowledgeable market participants and the most relevant and reasonable indication of value to utilize. The inputs and assumptions for this nonrecurring fair value measurement are classified as Level 3 within the fair value hierarchy defined in ASC Topic 820.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Investment in IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for its interest in the ongoing operations of IM Topco as a component of other operating costs and expenses (income) under the equity method of accounting. Based on the aforementioned distribution provisions set forth in the Business Venture Agreement, the Company recognized an equity method loss of approximately $2.1 and $1.2 million related to its investment for the years ended December 31, 2023 and 2002, respectively. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for all of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal to Xcel’s share of amortization expense.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Summarized financial information for IM Topco is as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,791</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,791</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Loss) income from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,961)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 316</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net (loss) income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,961)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 316</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents financial information for the period commencing May 31, 2022 (the date of the sale of a majority interest in IM Topco) through December 31, 2022.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the Prior Year (subsequent to the May 27, 2022 transaction), the Company made a capital contribution to IM Topco of $0.6 million in cash, which did not change the Company’s noncontrolling ownership interest of 30%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which the parties agreed to waive the purchase price adjustment provision until the measurement period ending March 31, 2024. In exchange, Xcel agreed to make additional royalty payments to IM Topco totaling $0.45 million over the next 11 months. As a result of this amendment, the Company recognized a $0.45 million increase to the carrying value basis of its equity method investment and a corresponding increase in current liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The provisions of the membership purchase agreement were subsequently further amended in April 2024 (see Note 12 for additional information).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Investment in Orme Live, Inc.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s consolidated balance sheet. The Company accounts for its interest in the operations of ORME as a component of other operating costs and expenses (income) under the equity method of accounting; the Company’s proportional share of the operating results of ORME were not material in the Current Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Sale of Investment in Unconsolidated Affiliate</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company previously held a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016. This investment did not have a readily determinable fair value and in accordance with ASC 820-10-35-59, the investment was valued at cost, less impairment, plus or minus observable price changes of an identical or similar investment of the same issuer. This investment was included within other assets on the Company’s consolidated balance sheet at December 31, 2022, at a carrying value of $0.1 million. During the Current Year, the Company sold its ownership interest in this entity, and recognized a gain of $0.36 million related to the sale within other operating costs and expenses (income) on the consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Longaberger Licensing, LLC Variable Interest Entity </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Since 2019, Xcel has been party to a limited liability company agreement (the “LLC Agreement”) with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC Agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.</p> 0.70 0.70 46200000 900000 100000 65275 20600000 2000000.0 17500000 11800000 13347000 4 P3Y 16000000 1 8852000 1 1316200 44500000 19800000 0.70 2100000 1200000 0.70 0.30 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Summarized financial information for IM Topco is as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,791</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,791</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Loss) income from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,961)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 316</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net (loss) income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,961)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 316</p></td></tr></table> 12119000 7791000 12119000 7791000 -1961000 316000 -1961000 316000 600000 0.30 450000 450000 150000 0.30 100000 360000 0.50 0.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">4.   <b style="font-weight:bold;white-space:pre-wrap;">Trademarks and Other Intangibles </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Trademarks and other intangibles, net consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,431</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,449</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 358</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,789</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 41,520</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,534</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,644</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 47,665</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the Prior Year, the Company sold its $44.5 million of indefinite-lived trademarks related to the Isaac Mizrahi Brand (see Note 3 for details). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Amortization expense for intangible assets was approximately $6.1 million for both the Current Year and Prior Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Estimated future amortization expense related to finite-lived intangible assets over the remaining useful lives is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Expense</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,115</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,177</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,506</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,504</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,504</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter (through 2036)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,714</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,520</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Trademarks and other intangibles, net consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,431</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,449</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 358</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,789</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 41,520</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,534</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,644</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 47,665</b></p></td></tr></table> P15Y 68880000 27431000 41449000 P8Y 429000 358000 71000 69309000 27789000 41520000 P15Y 68880000 21346000 47534000 P8Y 429000 298000 131000 69309000 21644000 47665000 44500000 6100000 6100000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Estimated future amortization expense related to finite-lived intangible assets over the remaining useful lives is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Expense</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,115</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,177</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,506</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,504</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,504</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter (through 2036)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,714</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,520</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 6115000 4177000 3506000 3504000 3504000 20714000 41520000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">5.   <b style="font-weight:bold;white-space:pre-wrap;">Significant Contracts </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Qurate Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Through its wholly owned subsidiaries, the Company has entered into direct-to-retail license agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements (individually, each a “Qurate Agreement”), pursuant to which the Company designs, and Qurate sources and sells, various products under the LOGO by Lori Goldstein brand, the Longaberger brand, and the C Wonder brand. The Company was also previously party to similar agreements with Qurate related to the IsaacMizrahiLIVE brand and the Judith Ripka brand. Qurate owns the rights to all designs produced under these agreements, and the agreements include the sale of products across various categories through Qurate’s television media (including QVC and HSN) and related internet sites.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to these agreements, the Company has granted to Qurate and its affiliates the exclusive, worldwide right to promote the Company’s branded products, and the right to use and publish the related trademarks, service marks, copyrights, designs, logos, and other intellectual property rights owned, used, licensed and/or developed by the Company, for varying terms as set forth below. In connection with the Qurate Agreements and during the same periods, Qurate and its subsidiaries have the exclusive, worldwide right to use the names, likenesses, images, voices, and performances of the Company’s spokespersons to promote the respective products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Xcel Commenced</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Qurate</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Agreement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current Term Expiry</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Automatic Renewal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Brand with Qurate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Product Launch</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">LOGO Qurate Agreement (QVC)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">November 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">one-year period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">April 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2009</p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Longaberger Qurate Agreement (QVC)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">October 31, 2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">two-year period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">November 2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">C Wonder Qurate Agreement (HSN)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">two-year period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">On May 31, 2022, in connection with the sale of a majority interest in the Isaac Mizrahi brand to a third party, the Qurate Agreement related to the IsaacMizrahiLIVE brand was assigned to IM Topco, LLC. See Note 3 for additional details.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">On August 30, 2022, Qurate and Xcel amended the licensing agreement for the Judith Ripka brand to terminate the license period effective December 31, 2021. Effective January 1, 2022, the agreement entered a sell-off period, under which Qurate was allowed to continue to license the Ripka brand on a non-exclusive basis for as long as necessary to sell off any of its remaining inventory. The sell-off period ended in 2023.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based upon the net retail sales of the specified branded products. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Qurate Agreements generally prohibit the Company from selling products under the specified respective brands to a direct competitor of Qurate without Qurate’s consent. Under certain of the Qurate Agreements, the Company may, with the permission of Qurate, sell the respective branded products via certain specified sales channels in exchange for making reverse royalty payments to Qurate based on the net retail sales of such products through such channels. However, the Company is generally restricted from selling products under the specified respective brands or trademarks to certain mass merchants. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Also, under certain of the Qurate Agreements, the Company may be required for a period of time to pay a royalty participation fee to Qurate on revenue earned from the sale, license, consignment, or any other form of distribution of any products, bearing, marketed in connection with, or otherwise associated with the specified trademarks and brands. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Net licensing revenue from Qurate totaled $6.0 million and $11.4 million for the Current Year and Prior Year, respectively, representing approximately 34% and 44% of the Company’s total net revenue, respectively. As of December 31, 2023 and 2022, the Company had receivables from Qurate of $1.5 million and $0.9 million, representing approximately 43% and 17% of the Company’s accounts receivable, respectively. The December 31, 2023 and 2022 Qurate receivables did not include any earned revenue accrued but not yet billed as of the respective balance sheet dates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Halston Master License</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.4 million of deferred revenue contract liabilities on its consolidated balance sheet as of December 31, 2023 related to this contract, of which $0.9 million was classified as a current liability and approximately $3.5 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 5.0 years. Net licensing revenue recognized from the Halston Master License was $1.6 million for the Current Year, representing approximately 9% of the Company’s total net revenue for the Current Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Additionally, in connection with the Halston Master License, the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the Current Year was approximately $0.03 million. As of December 31, 2023, no portion of this warrant had vested.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Xcel Commenced</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Qurate</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Agreement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current Term Expiry</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Automatic Renewal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Brand with Qurate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Product Launch</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">LOGO Qurate Agreement (QVC)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">November 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">one-year period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">April 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2009</p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Longaberger Qurate Agreement (QVC)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">October 31, 2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">two-year period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">November 2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:33.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">C Wonder Qurate Agreement (HSN)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">two-year period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr></table> 2024-11-01 P1Y April 2021 2009 2025-10-31 P2Y November 2019 2019 2024-12-31 P2Y March 2023 2023 6000000.0 11400000 0.34 0.44 1500000 900000 0.43 0.17 P25Y P5Y P20Y P5Y 5000000.0 P25Y 4400000 900000 3500000 P5Y 1600000 0.09 P10Y 1000000 1.50 30000.00 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">6.   <b style="font-weight:bold;white-space:pre-wrap;">Debt </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company’s net carrying amount of debt was comprised of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unamortized deferred finance costs related to term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (279)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the Current Year and Prior Year, the Company incurred interest expense of approximately $0.4 million and $1.2 million, respectively, related to term loan debt. The effective interest rate related to term loan debt was approximately 11.6% and 9.8% for the Current Year and Prior Year, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Previous Term Loan Debt (through May 31, 2022)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On December 30, 2021, Xcel, as Borrower, and its wholly-owned subsidiaries entered into a loan and security agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”), as lead arranger and as administrative agent and collateral agent, and the financial institutions party thereto as lenders. Pursuant to this loan agreement, the lenders made a term loan in the aggregate amount of $29.0 million. This term loan bore interest at “LIBOR” plus 7.5% per annum, with “LIBOR” defined as the greater of (a) the rate of interest per annum for deposits in dollars for an interest period equal to three months as published by Bloomberg or a comparable or successor quoting service at approximately 11:00 a.m. (London time) two business days prior to the last business day of each calendar month and (b) 1.0% per annum.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Upon entering into the December 2021 loan agreement, Xcel paid a 1.75% closing fee to FEAC for the benefit of the lenders; the Company also paid approximately $0.5 million of various legal and other fees in connection with the execution of the loan agreement. These fees and costs totaling approximately $0.97 million were deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, to be subsequently amortized to interest expense over the term of the debt using the effective interest method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The December 2021 term loan was to mature on April 14, 2025. Principal on this debt was payable in quarterly installments of $625,000 on each of March 31, June 30, September 30 and December 31 of each year, commencing on March 31, 2022 and ending on March 31, 2025, with a final payment of $20,875,000 on the maturity date of April 14, 2025. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The December 2021 term loan agreement also contained customary covenants, including reporting requirements, trademark preservation, and certain financial covenants; the Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Extinguishment of Previous Term Loan Debt</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On May 31, 2022, the Company used $30.1 million of the proceeds received from the transaction related to the Isaac Mizrahi Brand (see Note 3) to repay all amounts outstanding under the December 30, 2021 term loan agreement with FEAC, consisting of $28.4 million in principal amount, a $1.4 million prepayment fee, and approximately $0.3 million in interest and related expenses. As a result, the Company recognized a loss on early extinguishment of debt of approximately $2.3 million during the Prior Year, consisting of approximately $1.4 million of debt prepayment premium, the immediate write-off of approximately $0.8 million of unamortized deferred finance costs, and approximately $0.1 million of other costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">New Term Loan Debt</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.30 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with October 2023 loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;">As of December 31, 2023, the aggregate remaining principal payments under the October 2023 term loan were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount of</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Principal</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Payment</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">Interest on the October 2023 term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The October 2023 term loan agreement contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company’s net carrying amount of debt was comprised of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unamortized deferred finance costs related to term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (279)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 5000000 279000 4721000 750000 3971000 400000 1200000 0.116 0.098 29000000.0 0.075 0.010 0.0175 500000 970000 625000 20875000 30100000 28400000 1400000 300000 -2300000 1400000 800000 100000 5000000.0 300000 250000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount of</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Principal</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Payment</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td></tr></table> 750000 1000000 1000000 1000000 1250000 5000000 0.0425 0.0425 0.0946 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">7.   Stockholders’ Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has authority to issue up to 51,000,000 shares, consisting of 50,000,000 shares of common stock and 1,000,000 shares of preferred stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 4,000,000 shares of common stock are eligible for issuance under the 2021 Plan. The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock-Based Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Total expense recognized for all forms of stock-based compensation was approximately $0.22 million and $0.72 million in the Current Year and Prior Year, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Of the Current Year expense amount, approximately $0.02 related to employees and approximately $0.20 related to directors and consultants; all of this expense was recorded as a direct operating cost in the accompanying statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Of the Prior Year expense amount, approximately $0.41 million related to employees and approximately $0.31 million related to directors and consultants; approximately $0.62 million was recorded as a direct operating cost and approximately $0.10 million was recorded within other operating costs and expenses (income). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Options granted under the Company’s equity incentive plans expire at various times – either <span style="-sec-ix-hidden:Hidden_f_zjbGhASUiy9QagwWDU3g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>, <span style="-sec-ix-hidden:Hidden_SDmZogJTuEGAS7HnKGOoZw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">seven</span></span>, or ten years from the date of grant, depending on the particular grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the Company’s stock option activity for the Current Year is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 200,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (87,750)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (578,020)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.96</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December 31, 2023, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,148,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,398,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Current Year stock option grants were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">In April 2023, the Company granted options to purchase an aggregate of </span><span style="background:#ffffff;">100,000</span><span style="background:#ffffff;"> shares of common stock to a key individual. The exercise price of the options is </span><span style="background:#ffffff;">$1.50</span><span style="background:#ffffff;"> per share, and the vesting of such options is dependent upon the achievement of certain revenue targets. </span><span style="background:#ffffff;">None</span><span style="background:#ffffff;"> of these options were vested as of December 31, 2023. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">On August 23, 2023 the Company granted options to purchase an aggregate of </span><span style="background:#ffffff;">100,000</span><span style="background:#ffffff;"> shares of common stock to non-management directors. The exercise price of the options is </span><span style="background:#ffffff;">$1.51</span><span style="background:#ffffff;"> per share, and </span><span style="background:#ffffff;">50%</span><span style="background:#ffffff;"> of the options vest on each of April 1, 2024 and April 1, 2025.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Prior Year stock option grants were as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 20, 2022, the Company granted options to purchase an aggregate of 380,850 shares of common stock to various employees. The exercise price of the options is $1.62 per share, and all options vested immediately on the date of grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 20, 2022 the Company granted options to purchase an aggregate of 125,000 shares of common stock to non-management directors. The exercise price of the options is $1.62 per share. Half of the options vested on April 20, 2023, and the remaining half of the options will vest on April 20, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 26, 2022, the Company granted options to purchase an aggregate of 100,000 shares of common stock to a consultant. The exercise price of the options is $1.58 per share, and all options vested immediately on the date of grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The fair values of the options granted were estimated at the respective dates of grant using the Black-Scholes option pricing model with the following range of assumptions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">89 – 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">57 – 93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected Dividend Yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected Life (Term, in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.75 – 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.67 – 3.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-Free Interest Rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4.0 – 4.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1.6 – 2.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Compensation expense related to stock options for the Current Year and Prior Year was approximately $0.1 million and $0.5 million, respectively. Total unrecognized compensation expense related to unvested stock options (excluding stock options with performance-based vesting) at December 31, 2023 amounts to approximately $0.1 million and is expected to be recognized over a weighted average period of 1.05 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Of the total stock options outstanding at December 31, 2023, the vesting of 3,500,000 options is contingent upon the Company’s common stock achieving certain target prices as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Target Prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of Options Vesting</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$3.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 1,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$5.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 850,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$7.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 700,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$9.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 550,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$11.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 400,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023, none of these 3,500,000 performance-based stock options have vested, and no compensation expense has been recorded related to such options.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes the Company’s stock option activity for non-vested options for the Current Year:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 200,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.68</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (135,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.68</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.89</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Stock Awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the Company’s restricted stock activity for the Current Year is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.71</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.01</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (108,968)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.08</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.62</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.69</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Current Year stock award grants were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 17, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On May 15, 2023, the Company issued 50,000 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On July 20, 2023, the Company issued 7,300 shares of common stock to an employee, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On August 23, 2023, the Company issued an aggregate of 40,000 shares of common stock to non-management directors, of which 50% shall vest on April 1, 2024, and 50% shall vest on April 1, 2025.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Prior Year stock award grants were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 20, 2022, the Company issued an aggregate of 50,000 shares of common stock to non-management directors, which vest evenly over two years. <span style="-sec-ix-hidden:Hidden_oR1cSnaMd0OffbbNdZu4rQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Half</span></span> of these shares vested on April 20, 2023, and <span style="-sec-ix-hidden:Hidden_fpL3Gh0FP0CrqnHWIKHdCw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the remaining half</span></span> shall vest on April 20, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 20, 2022, the Company issued 20,064 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On May 31, 2022, the Company issued 65,275 shares of common stock to a consultant in connection with the transaction related to the Isaac Mizrahi Brand (see Note 3); these shares vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On May 31, 2022, the Company issued 33,557 shares of common stock to Isaac Mizrahi, which vested immediately (see Note 11 for additional details).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Additionally, on April 20, 2022, the Company issued 178,727 shares of common stock to a member of senior management as payment for a performance bonus earned in 2021. These shares vested immediately. The Company had previously recognized compensation expense of approximately $0.28 million in the 2021 to accrue for this performance bonus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Notwithstanding the foregoing, each grantee may extend the first anniversary of all or a portion of the restricted stock by six months and, thereafter one or more times may further extend such date with respect to all or a portion of the restricted stock until the next following date exactly six months thereafter, by providing written notice of such election to extend such date with respect to all or a portion of the restricted stock prior to such date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Total compensation expense related to stock awards for the Current Year and Prior Year (inclusive of the amounts detailed above) was approximately $0.1 million and $0.3 million, respectively. Total unrecognized compensation expense related to unvested restricted stock grants at December 31, 2023 amounts to $0.1 million and is expected to be recognized over a weighted average period of 1.06 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table provides information with respect to restricted stock purchased and retired by the Company during the Current Year and Prior Year:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased as</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Part of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Actual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Publicly</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price Paid</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Announced</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Re-Purchased</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">per Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">None</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">April 20, 2022 (i)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 53,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84,000</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">May 31, 2022 (i)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 358,000</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 293,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 442,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">​</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The shares were exchanged from employees and directors in connection with the income tax withholding obligations on behalf of such employees and directors from the vesting of restricted stock or the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Restricted Stock Units</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">There were no restricted stock units outstanding as of December 31, 2023 and 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Available Under the Company’s Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At December 31, 2023, there were 3,103,941 shares of common stock available for award grants under the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Reserved for Issuance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At December 31, 2023, there were 8,368,546 shares of common stock reserved for issuance, including 4,771,255 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,103,941 shares available for issuance under the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Warrants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Warrants granted by the Company expire at various times – either <span style="-sec-ix-hidden:Hidden_LUpdnGDnc0KwXbLYrU6GXQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>, <span style="-sec-ix-hidden:Hidden_X9x9FW1OBUCF8ORfWx-8VQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">seven</span></span>, or ten years from the date of grant, depending on the particular grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the Company’s warrant activity for the Current Year is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding and exercisable at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_KbKphb4zW0-65HFRTPOf0g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 1.57</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3pfU9DRjmEKeffhzG_zqHQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 8.46</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_FzXi2KA_dEybbpiIhueAAw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 0.57</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-style:normal;font-weight:normal;">See Note 5 for information regarding the warrant to purchase </span><span style="font-style:normal;font-weight:normal;">1,000,000</span><span style="font-style:normal;font-weight:normal;"> shares of common stock granted during the Current Year in connection with the Halston Master License; the Company recognized contra-revenue of approximately </span><span style="font-style:normal;font-weight:normal;">$0.03</span><span style="font-style:normal;font-weight:normal;"> million in the Current Year with respect to this warrant. There was </span><span style="font-style:normal;font-weight:normal;">no</span><span style="font-style:normal;font-weight:normal;"> compensation expense related to other warrants recognized in the Current Year or Prior Year. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Dividends</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company has not paid any dividends to date.</p> 51000000 50000000 1000000 4000000 220000 720000 20000.00 200000 410000 310000 620000 100000 P10Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the Company’s stock option activity for the Current Year is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 200,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (87,750)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (578,020)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.96</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December 31, 2023, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,148,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,398,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p> 5614310 2.12 P4Y9M3D 200000 1.51 87750 0.80 578020 2.96 5148540 2.03 P4Y3M3D 1398540 2.88 P1Y7M28D 100000 1.50 0 100000 1.51 0.50 380850 1.62 125000 1.62 100000 1.58 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The fair values of the options granted were estimated at the respective dates of grant using the Black-Scholes option pricing model with the following range of assumptions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">89 – 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">57 – 93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected Dividend Yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected Life (Term, in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.75 – 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.67 – 3.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-Free Interest Rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4.0 – 4.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1.6 – 2.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table> 0.89 0.90 0.57 0.93 P2Y9M P10Y P0Y8M1D P3Y3M 0.040 0.047 0.016 0.028 100000 500000 100000 P1Y18D 3500000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Target Prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of Options Vesting</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$3.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 1,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$5.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 850,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$7.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 700,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$9.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 550,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$11.00 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:39.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 400,000</p></td></tr></table> 3.00 1000000 5.00 850000 7.00 700000 9.00 550000 11.00 400000 0 3500000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes the Company’s stock option activity for non-vested options for the Current Year:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 200,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.68</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (135,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.68</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.89</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr></table> 3697500 0.05 200000 0.68 135000 0.68 12500 0.89 3750000 0.05 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the Company’s restricted stock activity for the Current Year is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.71</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.01</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (108,968)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.08</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.62</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.69</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 333333 3.71 113968 1.01 108968 1.08 5000 1.62 333333 3.69 8334 8334 50000 7300 40000 0.50 0.50 50000 P2Y 20064 65275 33557 178727 280000 100000 300000 100000 P1Y21D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table provides information with respect to restricted stock purchased and retired by the Company during the Current Year and Prior Year:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased as</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Part of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Actual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Publicly</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price Paid</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Announced</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Re-Purchased</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">per Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">None</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">April 20, 2022 (i)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 53,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84,000</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">May 31, 2022 (i)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 358,000</p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Total 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 293,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 442,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">​</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The shares were exchanged from employees and directors in connection with the income tax withholding obligations on behalf of such employees and directors from the vesting of restricted stock or the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.</span></td></tr></table><div style="margin-top:12pt;"></div> 53882 1.57 84000000 240000 1.49 358000000 293882 1.50 442000000 0 0 0 3103941 8368546 4771255 493350 3103941 3103941 P10Y 116065 3.15 1000000 1.50 1116065 1.67 116065 3.15 1000000 30000.00 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">8. Earnings (Loss) Per Share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the years ended December 31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:32.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:34.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,052)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,018)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,711,637</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,624,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,711,637</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,624,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1.07)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted net per share</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1.07)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As a result of the net loss presented for the Current Year and Prior Year, the Company calculated diluted loss per share using basic weighted-average shares outstanding for both years, as utilizing diluted shares would be anti-dilutive to loss per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The computation of basic and diluted loss per share excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,148,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,264,605</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,730,375</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:32.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:34.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,052)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,018)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,711,637</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,624,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,711,637</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,624,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1.07)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted net per share</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1.07)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> -21052000 -4018000 19711637 19624669 19711637 19624669 -1.07 -0.20 -1.07 -0.20 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,148,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td></tr><tr><td style="vertical-align:bottom;width:66.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,264,605</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,730,375</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 5148540 5614310 1116065 116065 6264605 5730375 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">9.   Commitments and Contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company's real estate leases have remaining lease terms between approximately 5 to 7 years. As of December 31, 2023, the weighted average remaining lease term was 3.83 years and the weighted average discount rate was 6.25%. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023, the Company leased approximately 29,600 square feet of office space at 1333 Broadway, 10th floor, New York, New York for its corporate offices and operations facility. This lease commenced on March 1, 2016 and expires on October 30, 2027. This lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company previously leased approximately 1,300 square feet of retail space for its former retail store location in Westchester, New York, which was closed in the Prior Year. In the Current Year, the Company successfully negotiated a settlement with the lessor resulting in the termination of this lease, and recognized a gain related to the settlement of $0.4 million within other operating costs and expenses (income) in the consolidated statement of operations. The Company had recorded an impairment charge of $0.7 million to fully impair the right-of-use asset for this lease in the Prior Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company also previously leased certain office space in New York, New York, which was subleased to a third-party subtenant through February 27, 2022, and the Company's lease of this office space expired by its terms on February 28, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the years ended December 31, 2023 and 2022, total lease expense included in selling, general and administrative expenses on the Company's consolidated statements of operations was approximately $1.6 million for both periods. The Company’s total lease costs for the years ended December 31, 2023 and 2022 were comprised of the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,337</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,474</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short-term lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 55</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Variable lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 233</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 217</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sublease income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (104)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,642</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Cash paid for amounts included in the measurement of operating lease liabilities was $1.6 million and $1.7 million in the Current Year and Prior Year, respectively. Cash received from subleasing in the Prior Year was $0.1 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023, the maturities of lease liabilities were as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;"> </span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,294</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,950</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">671</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,279</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,258</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,021</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Employment Agreements </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company has employment contracts with certain executives and key employees. The future minimum payments under these contracts are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Employment</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contract</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Payments</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,292</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,837</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total future minimum employment contract payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,729</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition to the employment contract payments stated above, the Company’s employment contracts with certain executives and key employees contain performance-based bonus provisions. These provisions include bonuses based on the Company achieving revenues in excess of established targets and/or on operating results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain of the employment agreements contain severance and/or change in control provisions. Aggregate potential severance compensation amounted to approximately $2.9 million as of December 31, 2023. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Halston Heritage Earn-Out</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">In connection with the February 11, 2019 purchase of the Halston Heritage trademarks, the Company agreed to pay the seller additional consideration (the “Halston Heritage Earn-Out”) of up to an aggregate of </span><span style="font-style:normal;font-weight:normal;">$6.0</span><span style="font-style:normal;font-weight:normal;"> million, based on royalties earned from 2019 through December 31, 2022. The final royalty target year for the Halston Heritage Earn-Out ended on December 31, 2022, and the seller ultimately did not earn any additional consideration based on the formula set forth in the related asset purchase agreement. As such, during the Prior Year, the Company recorded a </span><span style="font-style:normal;font-weight:normal;">$0.9</span><span style="font-style:normal;font-weight:normal;"> million gain on the reduction of contingent obligations in the accompanying consolidated statement of operations. As of December 31, 2022, there were no amounts remaining under the Halston Heritage Earn-Out.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Lori Goldstein Earn-Out</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the <span style="-sec-ix-hidden:Hidden_UfVZ_mYoUkiV2mEyMbw7mQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">six</span></span> calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and thus $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability. The $0.2 million of additional consideration was paid to the seller during the Current Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. Accordingly, as of December 31, 2023, $1.0 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Isaac Mizrahi Transaction</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 3), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">No amount has been recorded in the accompanying consolidated balance sheets related to this contingent obligation. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Legal Proceedings</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation pending against the Company as of December 31, 2023 is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">See Note 12 for information related to certain legal matters which arose subsequent to December 31, 2023.</p> P5Y P7Y P3Y9M29D 0.0625 29600 2027-10-30 1300 400000 700000 2022-02-27 2022-02-28 2022-02-28 1600000 <table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,337</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,474</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short-term lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 55</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Variable lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 233</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 217</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sublease income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (104)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,642</p></td></tr></table> 1337000 1474000 62000 55000 233000 217000 104000 1632000 1642000 1600000 1700000 100000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023, the maturities of lease liabilities were as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;"> </span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,294</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,950</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">671</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,279</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,258</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,021</p></td></tr></table> 1552000 1552000 1552000 1294000 5950000 671000 5279000 1258000 4021000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company has employment contracts with certain executives and key employees. The future minimum payments under these contracts are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Employment</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contract</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Payments</b></p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,292</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,150</p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,837</p></td></tr><tr><td style="vertical-align:top;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total future minimum employment contract payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,729</p></td></tr></table> 4292000 2150000 2150000 2150000 2150000 4837000 17729000 2900000 6000000.0 900000 12500000 6600000 200000 200000 6400000 200000 1000000.0 1000000.0 5400000 13300000 4 P3Y 16000000 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">10.   Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The income tax provision (benefit) for income taxes in the consolidated statements of operations consists of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years Ended December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 300</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 234</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 534</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 727</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (509)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (456)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (965)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total provision (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,212</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (431)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The reconciliation of the federal statutory income tax rate to the Company’s effective tax rate reflected in the income tax provision (benefit) shown in the consolidated statements of operations is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years Ended December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">U.S. statutory federal rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local rate, net of federal tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6.14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Excess compensation deduction</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.27)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5.32)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal true-ups</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5.09)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Life insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.12)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.52)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33.16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income tax (provision) benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6.15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The significant components of net deferred tax assets (liabilities) of the Company consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred tax assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 712</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal, state and local net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,127</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,175</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued compensation and other accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 451</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 748</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Allowance for doubtful accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Basis difference arising from discounted note payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Charitable contribution carryover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 169</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 497</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,733</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,143</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,537)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred tax assets, net of valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,196</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,143</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred tax liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Basis difference arising from intangible assets of acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,196)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,036)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,196)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,036)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023 and 2022, the Company had approximately $28.6 million and $10.9 million, respectively, of federal net operating loss carryforwards ("NOLs") available to offset future taxable income. The NOL as of December 31, 2017 of $0.3 million has an expiration period through 2037. The NOL generated during tax years beginning after December 31, 2017 of $28.3 million has an indefinite life and does not expire.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As of December 31, 2023 and 2022, management does not believe the Company has any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its consolidated financial statements. The Company will continue to evaluate its uncertain tax positions in future periods to determine if measurement and recognition in its consolidated financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the Current Year, the Company recognized a valuation allowance in order to reduce deferred tax assets to the amount expected to be realized. The change in the valuation allowance from December 31, 2022 to December 31, 2023 was approximately $6.5 million.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years Ended December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 300</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 234</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 534</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 727</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (509)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (456)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (965)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total provision (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,212</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (431)</p></td></tr></table> 22000 300000 83000 234000 105000 534000 727000 -509000 380000 -456000 1107000 -965000 1212000 -431000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years Ended December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">U.S. statutory federal rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local rate, net of federal tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6.14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Excess compensation deduction</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.27)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5.32)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal true-ups</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5.09)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Life insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.12)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.52)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33.16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income tax (provision) benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6.15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table> 0.2100 0.2100 0.0636 0.0610 -0.0014 -0.0614 -0.0027 -0.0532 0.0018 -0.0509 -0.0012 -0.0052 -0.3316 -0.0615 0.1003 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred tax assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 712</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal, state and local net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,127</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,175</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued compensation and other accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 451</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 748</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Allowance for doubtful accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Basis difference arising from discounted note payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Charitable contribution carryover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 169</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 497</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,733</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,143</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,537)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred tax assets, net of valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,196</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,143</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred tax liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Basis difference arising from intangible assets of acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,196)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,036)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,196)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,036)</p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td></tr></table> 712000 712000 8127000 3175000 451000 748000 231000 11000 11000 1000 169000 497000 31000 9733000 5143000 6537000 3196000 5143000 3196000 4036000 3196000 4036000 1107000 28600000 10900000 300000 28300000 6500000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">11.   Related Party Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As described in Note 3, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Services Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2023, the Company recognized service fee income related to this agreement of $150,000. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">License Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the year ended December 31, 2023, the estimated amount of such shortfall was approximately $325,000, which the Company recognized as royalty expense in the consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which the parties agreed to waive the purchase price adjustment provision until the measurement period ending March 31, 2024 (see Note 3 for details). In exchange, Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Isaac Mizrahi</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Isaac Mizrahi is a principal stockholder and former employee of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Employment Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On February 24, 2020, the Company entered into an employment agreement with Mr. Mizrahi for him to continue to serve as Chief Design Officer of the Isaac Mizrahi Brand. This employment agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (see Note 3 for details).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The employment agreement provided Mr. Mizrahi with a base salary of $1.8 million, $2.0 million, and $2.1 million per annum for 2020, 2021, and 2022, respectively. Mr. Mizrahi was also eligible to receive an annual cash bonus (the “Bonus”) up to an amount equal to $2.5 million less base salary for 2020 and $3.0 million less base salary for 2021 and 2022. The Bonus consisted of the DRT Revenue, Bonus, the Brick-and-Mortar Bonus, the Endorsement Bonus and the Monday Bonus, if any, as determined in accordance with the below:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">“DRT Bonus” means for any calendar year an amount equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the aggregate net revenue related to sales of Isaac Mizrahi Brand products through direct response television. The DRT Revenue Bonus shall be reduced by the amount of the Monday Bonus.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">“Brick-and-Mortar Bonus” means for any calendar year an amount equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the net revenues from sales of products under the Isaac Mizrahi Brand, excluding DRT revenue and endorsement revenues.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">“Endorsement Bonus” means for any calendar year an amount equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">40%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of revenues derived from projects undertaken by the Company with one or more third parties solely for Mr. Mizrahi to endorse the third party’s products through the use of Mr. Mizrahi’s name, likeness, and/or image, and neither the Company nor Mr. Mizrahi provides licensing or design.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">“Monday Bonus” means </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$10,000</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> for each appearance by Mr. Mizrahi on Qurate’s QVC channel on Mondays (subject to certain expectations) up to a maximum of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">40</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> such appearances in a calendar year.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In addition, on May 31, 2022, all 522,500 unvested shares of restricted stock of the Company held by Mr. Mizrahi (for which all stock-based compensation expense had been previously recognized in prior periods) were immediately vested, with 240,000 of such shares being surrendered for cancellation in satisfaction of withholding tax obligations. Also on May 31, 2022, the Company issued 33,557 additional shares of common stock of the Company (valued at $50,000) to Mr. Mizrahi, which vested immediately, and made a $100,000 cash payment to Mr. Mizrahi</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Laugh Club Services Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On February 24, 2020 the Company entered into a services agreement with Laugh Club, an entity wholly-owned by Mr. Mizrahi, pursuant to which Laugh Club provided services to Mr. Mizrahi necessary for Mr. Mizrahi to perform his services pursuant to the employment agreement. The Company paid Laugh Club an annual fee of $0.72 million for such services. This services agreement remained in effect through May 31, 2022. On May 31, 2022, this agreement was transferred to IM Topco as part of the transaction in which the Company sold a majority interest in the Isaac Mizrahi Brand trademarks to a third party (see Note 3 for details).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">ORME</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On December 4, 2023, the Company acquired a 30% equity ownership interest in ORME, a short-form video and social commerce marketplace that is planned to launch in 2024, for a purchase price of $150,000. ORME licenses the technology utilized by its marketplace from KonnectBio Inc., in which Robert W. D’Loren, the Company’s Chairman of the Board, Chief Executive Officer, and President, owns an approximate 20% noncontrolling interest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 300000 600000 150000 400000 325000 450000 450000 1800000 2000000.0 2100000 2500000 3000000.0 0.10 0.10 0.40 10000 40 522500 240000 33557 50000 100000 720000 0.30 150000 0.20 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">12.</b></span>Subsequent Events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Leasing Transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and shall expire seven years from the commencement date in 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On January 26, 2024, the Company, as lessor, entered into a lease agreement for the sublease of its former corporate offices and operations facility located at 1333 Broadway, 10th floor, New York, New York to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of this sublease is approximately $0.8 million per year. As a result of entering into this sublease, the Company recognized an impairment charge of approximately $2.1 million related to the right-of-use asset. The loss recognition will coincide with the departure date. February 29, 2024 has been determined to be the date of a fundamental change to the use of the 1333 Broadway premises.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Public Offering and Private Placement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="background:#ffffff;">On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC </span>(the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,421 shares of the Company’s common stock at a price to the public of $0.65 per share. In connection with the Offering, Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares of common stock, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1,735,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 178,953 shares of common stock (the “Representative’s Warrants”) as compensation. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the <span style="-sec-ix-hidden:Hidden_lhwY_1qeVE2_iagxQkVvkg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">four and one-half-year</span></span> period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $265,000. The purchase of the Private Placement Shares closed concurrently with the Offering. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,063 shares and the total net proceeds received was approximately $2,000,000. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">IM Topco </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 membership purchase agreement and the Business Venture Agreement. Under these amendments, the parties agreed to the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If IM Topco royalties are less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$13.5</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million for the twelve-month period ending March 31, 2025 or less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">12.5%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">17.5%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, and WHP’s ownership interest in IM Topco would increase from </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">70%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">82.5%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco under the second amendment (which totaled </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$375,000</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> as of December 31, 2023). </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">On and after January 1, 2026, WHP shall receive </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million.   </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Legal Matters</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the March 31, 2021 asset purchase agreement for failure to pay $963,642 earned in 2023 in accordance with the provisions of the Lori Goldstein Earn-Out (as described in Note 9) under the terms of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to Ms. Goldstein’s failure to make all of the QVC appearances as required by her employment agreement, the Company was not willing to pay the amount due in a lump sum, but instead would make the payment in four quarterly installments. Failure to amicably resolve this dispute could adversely affect the Company’s cash flows and the availability of Ms. Goldstein’s services.</p> P7Y 500000 800000 2100000 3284421 0.65 146250 146250 32500 1735000 178953 0.8125 132589 132589 29464 0.98 294642 265000 3579063 2000000 13500000 18000000.0 0.125 0.30 0.175 0.70 0.825 375000 0.50 1000000.0 963642 false false false false

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